[
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "864f138d-94ae-4c3d-8d88-05fde5e1bc4e",
        "_rev": "_WpvYGJC-CY",
        "nanopub": {
            "id": "864f138d-94ae-4c3d-8d88-05fde5e1bc4e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "Microarray",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17884812",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:\"T-helper 17 cell\")\t",
                    "relation": "positiveCorrelation",
                    "object": "r(HGNC:RORC)"
                },
                {
                    "subject": "a(CL:\"T-helper 17 cell\")\t",
                    "relation": "positiveCorrelation",
                    "object": "r(HGNC:TNFRSFR12A)"
                },
                {
                    "subject": "a(CL:\"T-helper 17 cell\")\t",
                    "relation": "positiveCorrelation",
                    "object": "r(HGNC:IL1R1)"
                },
                {
                    "subject": "a(CL:\"T-helper 17 cell\")\t",
                    "relation": "positiveCorrelation",
                    "object": "r(HGNC:CXCL1)"
                },
                {
                    "subject": "a(CL:\"T-helper 17 cell\")\t",
                    "relation": "positiveCorrelation",
                    "object": "r(HGNC:CCL20)"
                },
                {
                    "subject": "a(CL:\"T-helper 17 cell\")",
                    "relation": "positiveCorrelation",
                    "object": "r(HGNC:IL17A)"
                }
            ],
            "evidence": "See Table 1\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "dd0d0119-9e0d-40e7-9b58-361f205a10d3",
        "_rev": "_WpvYGJC-CF",
        "nanopub": {
            "id": "dd0d0119-9e0d-40e7-9b58-361f205a10d3",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Chang, Yih-Hsin",
                    "Lin, I-Ling",
                    "Tsay, Gregory J",
                    "Yang, Shun-Chun",
                    "Yang, Tzi-Peng",
                    "Ho, Kuo-Ting",
                    "Hsu, Tsai-Ching",
                    "Shiau, Ming-Yuh"
                ],
                "database": {
                    "id": "18471998",
                    "name": "PubMed"
                },
                "source_name": "Clinical biochemistry",
                "title": "Elevated circulatory MMP-2 and MMP-9 levels and activities in patients with rheumatoid arthritis and systemic lupus erythematosus.",
                "abstract": "Matrix metalloproteinases (MMPs) are suggested to play important roles in rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE). This study is to examine the MMPs expressions and activities in Taiwanese RA and SLE patients."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:MMP9)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:MMP9)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "p(HGNC:MMP2)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "p(HGNC:MMP2)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "MMP-2 levels in control subjects, RA and SLE patients were 146.1 \u00b1 34.2, 194.0 \u00b1 24.2 and 208.9 \u00b1 75.9 ng/mL respectively, and for MMP-9 were 51.4 \u00b1 57.1, 567.7 \u00b1 313.1 and 208.7 \u00b1 105.5 ng/mL respectively. Both MMP-2 and MMP-9 levels and activities from all patients were significantly higher than that from control subjects.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0a2f47aa-0681-4928-918c-fba408987800",
        "_rev": "_WpvYGJC--B",
        "nanopub": {
            "id": "0a2f47aa-0681-4928-918c-fba408987800",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "<0.05",
                    "type": "p-value"
                }
            ],
            "citation": {
                "authors": [
                    "Krishnan, Sandeep",
                    "Juang, Yuang-Taung",
                    "Chowdhury, Bhabadeb",
                    "Magilavy, Abigail",
                    "Fisher, Carolyn U",
                    "Nguyen, Hang",
                    "Nambiar, Madhusoodana P",
                    "Kyttaris, Vasileios",
                    "Weinstein, Arthur",
                    "Bahjat, Rena",
                    "Pine, Polly",
                    "Rus, Violeta",
                    "Tsokos, George C"
                ],
                "database": {
                    "id": "19018007",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology (Baltimore, Md. : 1950)",
                "title": "Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells.",
                "abstract": "Diminished expression of TCR zeta and reciprocal up-regulation and association of FcRgamma with the TCR/CD3 complex is a hallmark of systemic lupus erythematosus (SLE) T cells. In this study we explored whether differential molecular associations of the spleen tyrosine kinase Syk that preferentially binds to FcRgamma contribute to pathological amplification of signals downstream of this \"rewired TCR\" in SLE. We detected higher amounts of Syk expression and activity in SLE compared with normal T cells. Selective inhibition of the activity of Syk reduced the strength of TCR-induced calcium responses and slowed the rapid kinetics of actin polymerization exclusively in SLE T cells. Syk and ZAP-70 also associated differently with key molecules involved in cytoskeletal and calcium signaling in SLE T cells. Thus, while Vav-1 and LAT preferentially bound to Syk, phospholipase C-gamma1 bound to both Syk and ZAP-70. Our results show that differential associations of Syk family kinases contribute to the enhanced TCR-induced signaling responses in SLE T cells. Thus, we propose molecular targeting of Syk as a measure to control abnormal T cell responses in SLE."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:SYK)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "We detected higher amounts of Syk expression and activity in SLE compared with normal T cells.",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "Diminished expression of TCR zeta and reciprocal up-regulation and association of FcRgamma with the TCR/CD3 complex is a hallmark of systemic lupus erythematosus (SLE) T cells. In this study we explored whether differential molecular associations of the spleen tyrosine kinase Syk that preferentially binds to FcRgamma contribute to pathological amplification of signals downstream of this \"rewired TCR\" in SLE. We detected higher amounts of Syk expression and activity in SLE compared with normal T cells. Selective inhibition of the activity of Syk reduced the strength of TCR-induced calcium responses and slowed the rapid kinetics of actin polymerization exclusively in SLE T cells. Syk and ZAP-70 also associated differently with key molecules involved in cytoskeletal and calcium signaling in SLE T cells. Thus, while Vav-1 and LAT preferentially bound to Syk, phospholipase C-gamma1 bound to both Syk and ZAP-70. Our results show that differential associations of Syk family kinases contribute to the enhanced TCR-induced signaling responses in SLE T cells. Thus, we propose molecular targeting of Syk as a measure to control abnormal T cell responses in SLE.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5447dd61-1807-4ae3-822e-d1bf86804e6e",
        "_rev": "_WpvYGJG-A2",
        "nanopub": {
            "id": "5447dd61-1807-4ae3-822e-d1bf86804e6e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "Immunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "7528775",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:IL12), ma(GO:\"Receptor Binding\"))",
                    "relation": "increases",
                    "object": "p(HGNC:JAK2, pmod(Ph))"
                }
            ],
            "evidence": "As shown in Fig. 2 C, the 130-kD JAK2 kinase was tyrosine phosphorylated in immunoprecipitates from IL-12-treated cells (lane 2) but not from unstimulated cells (lane 1).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "85ac6533-2930-47ab-8cc6-469703375774",
        "_rev": "_WpvYGJG-Ab",
        "nanopub": {
            "id": "85ac6533-2930-47ab-8cc6-469703375774",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"Mv 1 Lu cell\"",
                    "label": "Mv 1 Lu cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "9311995",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TGFB)",
                    "relation": "increases",
                    "object": "p(HGNC:SMAD2, pmod(Ph))"
                }
            ],
            "evidence": "The phosphorylation of Smad2 and Smad3, but not of Smad1/Smad5 and Smad4, were strongly induced upon addition of TGF-\u03b21 in Mv1Lu cells\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3ba1bbaa-9642-49ee-acd6-f8290c009f72",
        "_rev": "_WpvYGJC-AX",
        "nanopub": {
            "id": "3ba1bbaa-9642-49ee-acd6-f8290c009f72",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "28713531",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fasting\")",
                    "relation": "increases",
                    "object": "p(HGNC:BDNF)"
                }
            ],
            "evidence": "The BDNF levels in the second group were increased significantly by 25% compared to the control group (P<0.05). In addition, the levels of BDNF in the third group were significantly increased compared to second group by 29% and control group by 47%.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "581de48b-3d51-4451-8b0f-72d1ac75d33d",
        "_rev": "_WpvYGJC--D",
        "nanopub": {
            "id": "581de48b-3d51-4451-8b0f-72d1ac75d33d",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "siRNA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16622035",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:JAK2), ma(GO:\"Kinase Activity\")",
                    "relation": "increases",
                    "object": "ma(p(HGNC:STAT3), ma(GO:\"positive regulation of transcription by transcription factor localization\"))"
                }
            ],
            "evidence": "To examine whether STAT3 is indeed a signal transduction molecule that directly regulates the expression of IL-17, T cells from IL-1Ra\u0001/\u0001 mice were treated with STAT3 siRNA and cultured. The expression of the STAT3 gene was suppressed by STAT3 siRNA (Fig. 7C), and the IL-23-induced expression of IL-17 mRNA was suppressed only in cells treated with STAT3 siRNA (Fig. 7C).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "19dcf9b6-fcb6-4fea-942e-53898e2d9605",
        "_rev": "_WpvYGJG-Br",
        "nanopub": {
            "id": "19dcf9b6-fcb6-4fea-942e-53898e2d9605",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "FACS",
                    "type": "Methodology"
                },
                {
                    "id": "CL:macrophage",
                    "label": "macrophage",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "7687627",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL10)",
                    "relation": "decreases",
                    "object": "bp(GO:\"Macrophage Proliferation\")"
                }
            ],
            "evidence": "The proliferative response to soluble anti-CD3 observed in the presence of irradiated CM, LPS, or 4\u00b0C cultured M4 (ICE) was inhibited by 40 to 80% in the presence of IL-10 (Table I);\n",
            "metadata": {
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "cf5de298-6c22-44dd-8680-1fd33f98d3b0",
        "_rev": "_WpvYGJC--5",
        "nanopub": {
            "id": "cf5de298-6c22-44dd-8680-1fd33f98d3b0",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "DLN Cells",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "15657292",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "complex(GO:\"Interleukin 23 complex\")\t",
                    "relation": "increases",
                    "object": "r(HGNC:TNF)"
                },
                {
                    "subject": "complex(GO:\"Interleukin 23 complex\")\t",
                    "relation": "increases",
                    "object": "r(HGNC:IL6)"
                },
                {
                    "subject": "complex(GO:\"Interleukin 23 complex\")\t",
                    "relation": "increases",
                    "object": "r(HGNC:IL17F)"
                },
                {
                    "subject": "complex(GO:\"Interleukin 23 complex\")",
                    "relation": "increases",
                    "object": "r(HGNC:IL17A)"
                }
            ],
            "evidence": "IL-17, IL-17F, IL-6, and TNF RNA levels were also significantly elevated\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c76acc3f-1835-4d9f-8530-c9f79b0289c6",
        "_rev": "_WpvYGI6--w",
        "nanopub": {
            "id": "c76acc3f-1835-4d9f-8530-c9f79b0289c6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=11",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "n=21",
                    "type": "Cohort"
                },
                {
                    "id": "MESH:Sepsis",
                    "label": "Sepsis",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "12615625",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:CXCL8))"
                },
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IL1B))"
                },
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:TNF))"
                }
            ],
            "evidence": "During n-3 lipid infusion, release of these cytokines decreased by approximately 30%.\u00a0\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ab610b08-8f1a-425d-9e83-c4f0497aaea7",
        "_rev": "_WpvYGJ--_-",
        "nanopub": {
            "id": "ab610b08-8f1a-425d-9e83-c4f0497aaea7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Crossover study with 15 healthy subjects",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "21385360",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Fasting\")",
                    "relation": "decreases",
                    "object": "r(complex(GO:\"interleukin-23 complex\"))"
                }
            ],
            "evidence": "We observed a 4- to 5-fold higher IL-23 mRNA expression in subjects when they were on the TMD diet compared to OMD die\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "cc3a8b73-4b12-41ec-8955-69be1b3ea9ed",
        "_rev": "_WpvYGJG-AE",
        "nanopub": {
            "id": "cc3a8b73-4b12-41ec-8955-69be1b3ea9ed",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Electrophoretic Shift Assay",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"epithelial cell of umbilical artery\"",
                    "label": "epithelial cell of umbilical artery",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "9057029",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"vitamin C\")\t",
                    "relation": "decreases",
                    "object": "p(HGNC:TNF)"
                },
                {
                    "subject": "a(CHEBI:\"vitamin C\")",
                    "relation": "decreases",
                    "object": "p(HGNC:IL1B)"
                }
            ],
            "evidence": "Vitamin C was found to inhibit IL1 and TNF pathways in both primary and transformed endothelial cells, at concentrations from 5-20mM\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "64454f19-ea16-4a49-915c-d9f7a56b8463",
        "_rev": "_WpvYGJG--_",
        "nanopub": {
            "id": "64454f19-ea16-4a49-915c-d9f7a56b8463",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "95 SLE patients, 40 non-SLE patients, and 34 healthy controls",
                    "type": "cohort"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Chi, Shuhong",
                    "Yu, Yunxia",
                    "Shi, Juan",
                    "Zhang, Yurong",
                    "Yang, Jijuan",
                    "Yang, Lijuan",
                    "Liu, Xiaoming"
                ],
                "database": {
                    "id": "26549923",
                    "name": "PubMed"
                },
                "source_name": "Disease markers",
                "title": "Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis.",
                "abstract": "An early diagnosis of lupus nephritis (LN) has an important clinical implication in guiding treatments of systemic lupus erythematosus (SLE) in clinical settings. In this study, the diagnostic values of circulating autoantibodies to C1q alone or in combination with other markers for accessing active SLE and LN were evaluated."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:C3)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                }
            ],
            "evidence": "Serum concentrations of complements C3 and C4 were lower in patients with active SLE and LN relative to those with respective inactive SLE and non-LN groups ( for LN versus non-LN) (Table 3).\u00a0",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "An early diagnosis of lupus nephritis (LN) has an important clinical implication in guiding treatments of systemic lupus erythematosus (SLE) in clinical settings. In this study, the diagnostic values of circulating autoantibodies to C1q alone or in combination with other markers for accessing active SLE and LN were evaluated.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c7863de3-02cd-48d9-90ed-f0fb9c1d0732",
        "_rev": "_WpvYGJ--An",
        "nanopub": {
            "id": "c7863de3-02cd-48d9-90ed-f0fb9c1d0732",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:tuberculosis",
                    "label": "tuberculosis",
                    "type": "Disease"
                },
                {
                    "id": "MESH:\"CD4-Positive T-Lymphocytes\"",
                    "label": "CD4-Positive T-Lymphocytes",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "28582466",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:Tuberculosis)",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNCSTAT5, pmod(P, Tyr, 694))"
                }
            ],
            "evidence": "Next, we measured IL-7-induced STAT5 phosphorylation and detected decreased phosphorylated STAT5 in CD4+\u00a0T cells from tuberculosis patients as compared to healthy contacts (p = 0.04) (Fig 5a).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3e4631cc-9a24-477e-b2f8-2d5681fab7d9",
        "_rev": "_WpvYGJC-An",
        "nanopub": {
            "id": "3e4631cc-9a24-477e-b2f8-2d5681fab7d9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Leffler, Jonatan",
                    "Bengtsson, Anders A",
                    "Blom, Anna M"
                ],
                "database": {
                    "id": "24845390",
                    "name": "PubMed"
                },
                "source_name": "Annals of the rheumatic diseases",
                "title": "The complement system in systemic lupus erythematosus: an update.",
                "abstract": "The complement system plays a major role in the autoimmune disease, systemic lupus erythematosus (SLE). However, the role of complement in SLE is complex since it may both prevent and exacerbate the disease. In this review, we explore the latest findings in complement-focused research in SLE. C1q deficiency is the strongest genetic risk factor for SLE, although such deficiency is very rare. Various recently discovered genetic associations include mutations in the complement receptors 2 and 3 as well as complement inhibitors, the latter related to earlier onset of nephritis. Further, autoantibodies are a distinct feature of SLE that are produced as the result of an adaptive immune response and how complement can affect that response is also being reviewed. SLE generates numerous disease manifestations involving contributions from complement such as glomerulonephritis and the increased risk of thrombosis. Furthermore, since most of the complement system is present in plasma, complement is very accessible and may be suitable as biomarker for diagnosis or monitoring of disease activity. This review highlights the many roles of complement for SLE pathogenesis and how research has progressed during recent years."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:anti-cardiolipin)",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:C2)"
                },
                {
                    "subject": "a(anti-C1Q)",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:C2)"
                }
            ],
            "evidence": "C2 deficiency has a frequency of 1 in 20 000 and increases the risk of infections and SLE with antibodies against C1q and car-diolipin.",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "The complement system plays a major role in the autoimmune disease, systemic lupus erythematosus (SLE). However, the role of complement in SLE is complex since it may both prevent and exacerbate the disease. In this review, we explore the latest findings in complement-focused research in SLE. C1q deficiency is the strongest genetic risk factor for SLE, although such deficiency is very rare. Various recently discovered genetic associations include mutations in the complement receptors 2 and 3 as well as complement inhibitors, the latter related to earlier onset of nephritis. Further, autoantibodies are a distinct feature of SLE that are produced as the result of an adaptive immune response and how complement can affect that response is also being reviewed. SLE generates numerous disease manifestations involving contributions from complement such as glomerulonephritis and the increased risk of thrombosis. Furthermore, since most of the complement system is present in plasma, complement is very accessible and may be suitable as biomarker for diagnosis or monitoring of disease activity. This review highlights the many roles of complement for SLE pathogenesis and how research has progressed during recent years.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5280fd32-9255-4918-af9d-450c319dc382",
        "_rev": "_WpvYGJG-Am",
        "nanopub": {
            "id": "5280fd32-9255-4918-af9d-450c319dc382",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Ohrvall, M",
                    "Tengblad, S",
                    "Ekstrand, B",
                    "Siegbahn, A",
                    "Vessby, B"
                ],
                "database": {
                    "id": "7980703",
                    "name": "PubMed"
                },
                "source_name": "Atherosclerosis",
                "title": "Malondialdehyde concentration in plasma is inversely correlated to the proportion of linoleic acid in serum lipoprotein lipids.",
                "abstract": "It has been suggested that the susceptibility of low density lipoprotein (LDL) to oxidative stress depends on the balance between its contents of polyunsaturated fatty acids and antioxidants. In a healthy reference population (n = 103), the plasma concentration of malondialdehyde (MDA) (mean 0.86, range 0.50-1.27 mumol/l) was positively correlated to the serum concentrations of LDL cholesterol (r = 0.31, P = 0.001), very low density lipoprotein triglycerides (r = 0.25, P = 0.009) and apolipoprotein B (r = 0.23, P = 0.03), and negatively correlated to lipid corrected alpha tocopherol in serum (r = -0.22, P = 0.02) and lipoprotein(a) (Lp(a)) (r = -0.26, P = 0.01). Plasma MDA was negatively correlated to the content of linoleic acid in the serum lipoprotein phospholipids (r = -0.35, P = 0.0008). In a stepwise regression analysis 12% of the variation in plasma MDA was explained by variations in the content of linoleic acid and 27% after addition of Lp(a) and abdominal sagittal diameter. The significant negative relation between plasma MDA and the amount of linoleic acid in the lipoprotein lipids indicates that other factors, e.g. the availability of anti-oxidants and the lipoprotein metabolism, may be of greater importance for intravascular lipid peroxidation than the proportion of polyunsaturated fatty acids in the lipoprotein lipids."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:malonaldehyde)",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:alpha-Tocopherol)"
                }
            ],
            "evidence": "In a healthy reference population (n = 103), the plasma concentration of malondialdehyde (MDA) (mean 0.86, range 0.50-1.27 mumol/l) was positively correlated to the serum concentrations of LDL cholesterol (r = 0.31, P = 0.001), very low density lipoprotein triglycerides (r = 0.25, P = 0.009) and apolipoprotein B (r = 0.23, P = 0.03), and negatively correlated to lipid corrected alpha tocopherol in serum (r = -0.22, P = 0.02) and lipoprotein(a) (Lp(a)) (r = -0.26, P = 0.01).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ab17673b-593d-4fa1-a9c1-60f5e5ef7fb9",
        "_rev": "_WpvYGJG--s",
        "nanopub": {
            "id": "ab17673b-593d-4fa1-a9c1-60f5e5ef7fb9",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "DLN Cells",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "15657292",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "complex(GO\"Interleukin 23 complex\")",
                    "relation": "increases",
                    "object": "r(HGNC:IL23R)"
                }
            ],
            "evidence": "Conversely, IL-23 drives high mRNA expression of IL-23R, but little IL-12R\u03b22, consistent with the ability of these cells to respond to IL-23 (Fig. 4\u00a0A).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c74ca33d-fbb1-4afe-8929-986f20796263",
        "_rev": "_WpvYGJG-Ac",
        "nanopub": {
            "id": "c74ca33d-fbb1-4afe-8929-986f20796263",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "FACS",
                    "type": "Methodology"
                },
                {
                    "id": "CL:monocyte",
                    "label": "monocyte",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "1655948",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL10)",
                    "relation": "decreases",
                    "object": "surf(complex(GO:\"MHC2 complex\"))"
                }
            ],
            "evidence": "). In Fig. 4, it is furthermore shown that II.-10 strongly downregulated this increased HLA-DR expression on human monocytes. IL-10 (100 U/ml) reduced the constitutive HLA-DR expression by 90% after 40 h of culture.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4c64a2f4-3d1e-48a0-b034-22ef9605f855",
        "_rev": "_WpvYGJ--_H",
        "nanopub": {
            "id": "4c64a2f4-3d1e-48a0-b034-22ef9605f855",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Immunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"BA/F3 cell\"",
                    "label": "BA/F3 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "12023369",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:JAK2)",
                    "relation": "association",
                    "object": "p(HGNC:IL23R)"
                },
                {
                    "subject": "p(HGNC:STAT3)",
                    "relation": "association",
                    "object": "p(HGNC:IL23R)"
                },
                {
                    "subject": "complex(HGNC:\"Interleukin 23 complex\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL23R, pmod(Ph))"
                }
            ],
            "evidence": "In addition, Jak2 and Stat3 physically associate with IL-23R, the latter in a ligand-dependent manner, and IL-23R itself is tyrosine-phosphorylated in response to IL-23 (Fig. 7\u21d1d).\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8245579a-29ce-40bd-ae20-d7839ba6ae75",
        "_rev": "_WpvYGJC-_B",
        "nanopub": {
            "id": "8245579a-29ce-40bd-ae20-d7839ba6ae75",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "70 SLE with(15) or without subsequent LN",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "19515233",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"anti-C1q\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Renal Disease\")"
                }
            ],
            "evidence": "Anti-C1q elevation had 50% positive predictive value (15/30) and 100% (18/18) negative predictive value for subsequent class IV or V lupus nephritis\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ec2d9d0e-2c41-489d-a936-d26148bf1398",
        "_rev": "_WpvYGJ--_1",
        "nanopub": {
            "id": "ec2d9d0e-2c41-489d-a936-d26148bf1398",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=23",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "PDAI",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:\"colonic mucosa\"",
                    "label": "colonic mucosa",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"ulcerative colitis\"",
                    "label": "ulcerative colitis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "17934776",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"VSL#3\"",
                    "relation": "decreases",
                    "object": "path(MESH:\"Ulcerative colitis\")"
                }
            ],
            "evidence": "The median bowel frequency significantly decreased from 10 (range, 8\u201315) to 6 (range, 3\u201312) after probiotic treatment (P<0.001)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8dabc58e-777b-431a-9a5d-b95937d45061",
        "_rev": "_WpvYGJ--_p",
        "nanopub": {
            "id": "8dabc58e-777b-431a-9a5d-b95937d45061",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "2745570",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:neutrophil)",
                    "relation": "increases",
                    "object": "sec(p(HGNC:TGFB))"
                }
            ],
            "evidence": "However, conditioned medium from LPS-stimulated monocytes (24 hours) contained higher levels of TGF-beta activity, indicated by the formation of numerous large colonies (Fig. Id).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a7cfb93b-5937-4fba-9c4f-a6fa85690d10",
        "_rev": "_WpvYGJC-Bf",
        "nanopub": {
            "id": "a7cfb93b-5937-4fba-9c4f-a6fa85690d10",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.773",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "Eighty-five patients were recruited into the study",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "HPLC",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                },
                {
                    "id": "MESH:\"Diabetes Mellitus, Type 2\"",
                    "label": "Diabetes Mellitus, Type 2",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10221661",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:Glycine betaine)\t",
                    "relation": "positiveCorrelation",
                    "object": "a(\"Trigonellene\")"
                },
                {
                    "subject": "a(CHEBI:Glycine betaine)",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:carnitine)"
                }
            ],
            "evidence": "The analysis identified plasma carnitine (P=0.03), urine carnitine (P=0.001) and urine trigonelline (P=0.005) concentrations as being statistically significant independent predictors of glycine betaine excretion in diabetic patients (r=0.773)\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "aac35805-1a6b-4ddd-83b8-77577cb8a839",
        "_rev": "_WpvYGJG-Av",
        "nanopub": {
            "id": "aac35805-1a6b-4ddd-83b8-77577cb8a839",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.26",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "1919 SLE cases from 9 independent Caucasian SLE case series and 4813 independent controls",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "21379322",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"anti-dsDNA\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                }
            ],
            "evidence": "Correlation between anti-dsDNA production and renal disease (r\u200a=\u200a0.26) and between malar rash and photosensitivity (r\u200a=\u200a0.18) is also observed. (Table S2)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ae1e041a-1d78-4125-9eaf-e25da3b6e7e9",
        "_rev": "_WpvYGJ--Aw",
        "nanopub": {
            "id": "ae1e041a-1d78-4125-9eaf-e25da3b6e7e9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "n=8",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Muscle, Skeletal\"",
                    "label": "Muscle, Skeletal",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "24476467",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Exercise\")",
                    "relation": "positiveCorrelation",
                    "object": "r(HGNC:IL6)"
                }
            ],
            "evidence": "All exercise modes upregulated IL-6 expression (Fig. 3G) at 1 h postexercise (CE = 4.0 \u00b1 0.7; RE = 3.0 \u00b1 0.6; AE = 3.4 \u00b1 0.5) (p < 0.05)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8a5ffe99-2b5e-4d1a-bdc0-eef35c6dbbfb",
        "_rev": "_WpvYGJC-_V",
        "nanopub": {
            "id": "8a5ffe99-2b5e-4d1a-bdc0-eef35c6dbbfb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Coimmunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"A549 cell\"",
                    "label": "A549 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "17035243",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17RA)",
                    "relation": "association",
                    "object": "p(HGNC:ACT1)"
                }
            ],
            "evidence": "\u00a0When Full-length HA-tagged Act1 and FLAG-tagged IL-17RA (16) proteins were simultaneously expressed in 293 cells, HA-tagged Act1 was co-immunoprecipitated by a FLAG antibody (Fig. 2A),\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "76893697-1505-4bba-9078-959692ba5708",
        "_rev": "_WpvYGJC-Ao",
        "nanopub": {
            "id": "76893697-1505-4bba-9078-959692ba5708",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Noris, Marina",
                    "Remuzzi, Giuseppe"
                ],
                "database": {
                    "id": "24161035",
                    "name": "PubMed"
                },
                "source_name": "Seminars in nephrology",
                "title": "Overview of complement activation and regulation.",
                "abstract": "Complement is an important component of the innate immune system that is crucial for defense from microbial infections and for clearance of immune complexes and injured cells. In normal conditions complement is tightly controlled by a number of fluid-phase and cell surface proteins to avoid injury to autologous tissues. When complement is hyperactivated, as occurs in autoimmune diseases or in subjects with dysfunctional regulatory proteins, it drives a severe inflammatory response in numerous organs. The kidney appears to be particularly vulnerable to complement-mediated inflammatory injury. Injury may derive from deposition of circulating active complement fragments in glomeruli, but complement locally produced and activated in the kidney also may have a role. Many kidney disorders have been linked to abnormal complement activation, including immune-complex-mediated glomerulonephritis and rare genetic kidney diseases, but also tubulointerstitial injury associated with progressive proteinuric diseases or ischemia-reperfusion."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:C3B)\t",
                    "relation": "increases",
                    "object": "p(HGNC:C5A)"
                },
                {
                    "subject": "p(HGNC:C3B)\t",
                    "relation": "increases",
                    "object": "p(HGNC:C5B)"
                },
                {
                    "subject": "p(HGNC:C5B)\t",
                    "relation": "directlyIncreases",
                    "object": "complex(p(HGNC:C5B), p(HGNC:C9)"
                },
                {
                    "subject": "complex(p(HGNC:C4B),p(HGNC:C2A),p(HGNC:C3b))\t",
                    "relation": "increases",
                    "object": "p(HGNC:C5B)"
                },
                {
                    "subject": "complex(p(HGNC:C4B),p(HGNC:C2A),p(HGNC:C3b))\t",
                    "relation": "increases",
                    "object": "p(HGNC:C5A)"
                },
                {
                    "subject": "complex(p(HGNC:C4B),p(HGNC:C2A),p(HGNC:C3b))\t",
                    "relation": "decreases",
                    "object": "p(HGNC:C5)"
                },
                {
                    "subject": "complex(p(HGNC:C4B),p(HGNC:C2A))\t",
                    "relation": "directlyIncreases",
                    "object": "complex(p(HGNC:C4B),p(HGNC:C2A),p(HGNC:C3b))"
                }
            ],
            "evidence": "The incorporation of C3b in the C3 convertases results in the formation of the C5 convertases: C3bBbC3b for the AP and C4bC2aC3b for the CP and LP (Fig. 1). These C5 convertases cleave C5 into C5a and C5b, ultimately resulting in the formation of the multimeric MAC (C5b-9) (Fig. 1).",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Complement is an important component of the innate immune system that is crucial for defense from microbial infections and for clearance of immune complexes and injured cells. In normal conditions complement is tightly controlled by a number of fluid-phase and cell surface proteins to avoid injury to autologous tissues. When complement is hyperactivated, as occurs in autoimmune diseases or in subjects with dysfunctional regulatory proteins, it drives a severe inflammatory response in numerous organs. The kidney appears to be particularly vulnerable to complement-mediated inflammatory injury. Injury may derive from deposition of circulating active complement fragments in glomeruli, but complement locally produced and activated in the kidney also may have a role. Many kidney disorders have been linked to abnormal complement activation, including immune-complex-mediated glomerulonephritis and rare genetic kidney diseases, but also tubulointerstitial injury associated with progressive proteinuric diseases or ischemia-reperfusion.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7e96f81b-dbf6-46d6-9eee-7df98cb196a6",
        "_rev": "_WpvYGJC-BQ",
        "nanopub": {
            "id": "7e96f81b-dbf6-46d6-9eee-7df98cb196a6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Erythrocytes",
                    "label": "Erythrocytes",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "8608252",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "catof(p(HGNC:CAT))",
                    "relation": "directlyDecreases",
                    "object": "a(CHEBI:\"hydrogen peroxide\")"
                }
            ],
            "evidence": "Purified enzymes were mixed to form a cell-free system that simulated the conditions for removal of hydrogen peroxide within human erythrocytes. Human glutathione peroxidase disposed of hydrogen peroxide (H2O2) at a rate that was only 17% of the rate at which human catalase simultaneously removed hydrogen peroxide. \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f37efd0a-92c2-4289-8828-b271dad8aee4",
        "_rev": "_WpvYGJC-B4",
        "nanopub": {
            "id": "f37efd0a-92c2-4289-8828-b271dad8aee4",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.68",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLAM-R",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL3)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\""
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "57d79e01-b57f-46ce-8310-4c5bbe847c81",
        "_rev": "_WpvYGI6--W",
        "nanopub": {
            "id": "57d79e01-b57f-46ce-8310-4c5bbe847c81",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CLO:\"U937(CD59+) cell\"",
                    "label": "U937(CD59+) cell",
                    "type": "CellLine"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Obajimi, Oluwakemi",
                    "Black, Kenneth D",
                    "Glen, Iain",
                    "Ross, Brian M"
                ],
                "comments": "full text not available\n",
                "database": {
                    "id": "17198751",
                    "name": "PubMed"
                },
                "source_name": "Prostaglandins, leukotrienes, and essential fatty acids",
                "title": "Antioxidant modulation of oxidant-stimulated uptake and release of arachidonic acid in eicosapentaenoic acid-supplemented human lymphoma U937 cells.",
                "abstract": "Omega-3 polyunsaturated fatty acids (PUFA) are increasingly finding use as treatments for a variety of medical conditions. PUFA supplementation can, however, result in increased oxidative stress causing elevated turnover rate of membrane phospholipids, impairment of membrane integrity and increased formation of inflammatory mediators. The aim of this study was to determine which antioxidant compounds were most effective in ameliorating the stimulation of phospholipid turnover by oxidative stress. U937 cells were supplemented with eicosapentaenoic acid and either ascorbic acid, alpha-tocopherol, beta-carotene or astaxanthin prior to being challenged with oxidant. Although all antioxidants were found to be effective in decreasing oxidant-stimulated peroxide formation, only alpha-tocopherol significantly decreased oxidant-stimulated release of 3H-labeled arachidonic acid (AA), while ascorbic acid markedly increased release. All antioxidants except alpha-tocopherol decreased oxidant-stimulated 3H-AA uptake. Our data suggest that antioxidants are not equally effective in combating the effects of oxidative stress upon membrane phospholipid turnover, and that optimal protection will require mixtures of antioxidants."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"alpha-Tocopherol acetate\")",
                    "relation": "decreases",
                    "object": "a(CHEBI:\"arachidonic acid\")"
                }
            ],
            "evidence": "Although all antioxidants were found to be effective in decreasing oxidant-stimulated peroxide formation, only alpha-tocopherol significantly decreased oxidant-stimulated release of 3H-labeled arachidonic acid (AA), while ascorbic acid markedly increased release.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4e6a90a4-6c60-4d94-be95-55d2aac4a378",
        "_rev": "_WpvYGJ---F",
        "nanopub": {
            "id": "4e6a90a4-6c60-4d94-be95-55d2aac4a378",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Lymphocytes",
                    "label": "Lymphocytes",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Bortoluzzi, Alessandra",
                    "Vincenzi, Fabrizio",
                    "Govoni, Marcello",
                    "Padovan, Melissa",
                    "Ravani, Annalisa",
                    "Borea, Pier Andrea",
                    "Varani, Katia"
                ],
                "database": {
                    "id": "27566294",
                    "name": "PubMed"
                },
                "source_name": "Arthritis research & therapy",
                "title": "A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus.",
                "abstract": "Adenosine is a purine nucleoside implicated in the regulation of the innate and adaptive immune systems, acting through its interaction with four cell surface receptors: A1, A2A, A2B, and A3. There is intense interest in understanding how adenosine functions in health and during disease, but surprisingly little is known about the actual role of adenosine-mediated mechanisms in systemic lupus erythematosus (SLE). With this background, the aim of the present study was to test the hypothesis that dysregulation of A1, A2A, A2B, and A3 adenosine receptors (ARs) in lymphocytes of patients with SLE may be involved in the pathogenesis of the disease and to examine the correlations between the status of the ARs and the clinical parameters of SLE."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:ADAR)\t",
                    "relation": "decreases",
                    "object": "p(HGNC:IL2)"
                },
                {
                    "subject": "p(HGNC:ADAR)\t",
                    "relation": "decreases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "p(HGNC:ADAR)\t",
                    "relation": "decreases",
                    "object": "p(HGNC:IL1B)"
                }
            ],
            "evidence": "The anti-inflammatory effect of A2AAR activation induced by CGS-21680 was also confirmed when we analyzed the production of other proinflammatory ILs, such as IL-6 (Fig. 3c), IL-1\u03b2 (Fig. 3d), and IL-2 (Fig. 4a). As reported in Table 3, a greater inhibitory effect was obtained in lymphocytes of patients with SLE.\u00a0",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Adenosine is a purine nucleoside implicated in the regulation of the innate and adaptive immune systems, acting through its interaction with four cell surface receptors: A1, A2A, A2B, and A3. There is intense interest in understanding how adenosine functions in health and during disease, but surprisingly little is known about the actual role of adenosine-mediated mechanisms in systemic lupus erythematosus (SLE). With this background, the aim of the present study was to test the hypothesis that dysregulation of A1, A2A, A2B, and A3 adenosine receptors (ARs) in lymphocytes of patients with SLE may be involved in the pathogenesis of the disease and to examine the correlations between the status of the ARs and the clinical parameters of SLE.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a4b8dc9a-5785-426b-b156-33824249951c",
        "_rev": "_WpvYGJG-_n",
        "nanopub": {
            "id": "a4b8dc9a-5785-426b-b156-33824249951c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "EMSA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "10545482",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:ethanol)",
                    "relation": "decreases",
                    "object": "act(complex(p(HGNC:NFKB1),p(HGNC:NFKB2)), ma(tscript)))"
                }
            ],
            "evidence": "In contrast, when LPS was combined with\u00a0in vitro\u00a0ethanol treatment (25 mM), we found that ethanol inhibited the binding of NF\u03baB to the consensus DNA sequence by 74.3 \u00b1 7.3% (five different experiments).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8b3ffdd5-3ea7-4bb5-b52e-5b16f2d794ad",
        "_rev": "_WpvYGJG-_y",
        "nanopub": {
            "id": "8b3ffdd5-3ea7-4bb5-b52e-5b16f2d794ad",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "8 young and 8 older healthy volunteers",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "FACS",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "22882710",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"Lactobacillus casei\u00a0Shirota\")",
                    "relation": "increases",
                    "object": "bp(GO:\"natural killer cell activation\")"
                },
                {
                    "subject": "a(\"Lactobacillus rhamnosus GG\")",
                    "relation": "increases",
                    "object": "GO:\"natural killer cell activation\""
                },
                {
                    "subject": "a(\"B.\u00a0infantis\u00a0CCUG 52486\")",
                    "relation": "increases",
                    "object": "bp(GO:\"natural killer cell activation\")"
                }
            ],
            "evidence": "NK cell activation was assessed by the expression of the leucocyte activation antigen CD69 and CD25 on CD3\u2212CD56+\u00a0NK cells and CD8+/CD8\u2212\u00a0subsets[\u2026]All of the probiotics tended to promote CD69 and CD25 expression in both young and older subjects with little strain specificity.\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "865f5e9c-2182-4bd7-8ddd-60facd7f2088",
        "_rev": "_WpvYGJ---5",
        "nanopub": {
            "id": "865f5e9c-2182-4bd7-8ddd-60facd7f2088",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"type 2 diabetes mellitus\"",
                    "label": "type 2 diabetes mellitus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "23936331",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Diabetes Mellitus\")",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:Betaine)"
                }
            ],
            "evidence": "Patients with diabetes mellitus (n = 264) had a median excretion more than three times higher than those without.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2890c1f1-d947-446a-abdd-b6939d7f4ada",
        "_rev": "_WpvYGJ--BQ",
        "nanopub": {
            "id": "2890c1f1-d947-446a-abdd-b6939d7f4ada",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "270 SLE patients",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "11296952",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"IgA anti-beta2-GPI\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Venous Thrombosis\")"
                },
                {
                    "subject": "p(\"IgG anticardiolipin\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arterial Thrombosis\")"
                },
                {
                    "subject": "p(\"IgA anti-beta2-GPI\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Thrombosis\")"
                }
            ],
            "evidence": "In stepwise multivariate logistic regression analysis, the variable that was associated with thrombosis was IgA anti-beta2-GPI. The occurrence of arterial thrombosis was associated with IgG aCL and that of venous thrombosis was related to IgA anti-beta2-GPI in stepwise multivariate analysis.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "df4d4c8a-f8dd-41c6-baf2-1c7a4bdafd2b",
        "_rev": "_WpvYGJ--CN",
        "nanopub": {
            "id": "df4d4c8a-f8dd-41c6-baf2-1c7a4bdafd2b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"Diabetes Mellitus, Experimental\"",
                    "label": "Diabetes Mellitus, Experimental",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:liver",
                    "label": "liver",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "24755741",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "MESH:\"Diabetes Mellitus, Experimental\"",
                    "relation": "decreases",
                    "object": "p(HGNC:PRKAA1, pmod(P, Thr, 172))"
                }
            ],
            "evidence": "As shown in\u00a0Fig. 1C,\u00a0D, the active form of AMPK, as determined by Western blot of phosphorylated AMPK (pAMPK) at the Thr172 position (15,\u00a016), was decreased in livers of diabetic mice compared to nondiabetic mice.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c664c0ca-0d89-4484-b0b0-7e2bc5ef979f",
        "_rev": "_WpvYGJC-B2",
        "nanopub": {
            "id": "c664c0ca-0d89-4484-b0b0-7e2bc5ef979f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Muzio, M",
                    "Ni, J",
                    "Feng, P",
                    "Dixit, V M"
                ],
                "database": {
                    "id": "9374458",
                    "name": "PubMed"
                },
                "source_name": "Science (New York, N.Y.)",
                "title": "IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling.",
                "abstract": "The interleukin-1 receptor (IL-1R) signaling pathway leads to nuclear factor kappa B (NF-kappaB) activation in mammals and is similar to the Toll pathway in Drosophila: the IL-1R-associated kinase (IRAK) is homologous to Pelle. Two additional proximal mediators were identified that are required for IL-1R-induced NF-kappaB activation: IRAK-2, a Pelle family member, and MyD88, a death domain-containing adapter molecule. Both associate with the IL-1R signaling complex. Dominant negative forms of either attenuate IL-1R-mediated NF-kappaB activation. Therefore, IRAK-2 and MyD88 may provide additional therapeutic targets for inhibiting IL-1-induced inflammation."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:MYD88)\t",
                    "relation": "increases",
                    "object": "p(HGNC:NFKB1)"
                },
                {
                    "subject": "p(HGNC:MYD88)",
                    "relation": "increases",
                    "object": "p(HGNC:TRAF6)"
                }
            ],
            "evidence": "Ectopic expression of MyD88 stronglyinduced NF-kB activity in a concentration-dependentmanner. Similarly, a truncatedversion of MyD88 encoding theNH2-terminal domain (DD)\u2014MyD88(1-151)\u2014activated NF-kB, albeit to a lesserextent (Fig. 3C). MyD88-induced NF-kBactivity was specifically inhibited by expressionconstructs of TRAF6 but not byTRAF2 dominant negatives. ThereforeTRAF6 and MyD88 probably participatein the same signaling pathway, andTRAF6 functions downstream of MyD88(Fig. 3D).",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "The interleukin-1 receptor (IL-1R) signaling pathway leads to nuclear factor kappa B (NF-kappaB) activation in mammals and is similar to the Toll pathway in Drosophila: the IL-1R-associated kinase (IRAK) is homologous to Pelle. Two additional proximal mediators were identified that are required for IL-1R-induced NF-kappaB activation: IRAK-2, a Pelle family member, and MyD88, a death domain-containing adapter molecule. Both associate with the IL-1R signaling complex. Dominant negative forms of either attenuate IL-1R-mediated NF-kappaB activation. Therefore, IRAK-2 and MyD88 may provide additional therapeutic targets for inhibiting IL-1-induced inflammation.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "88ae203f-47bf-4c5d-8b89-7fd8d8f27f8e",
        "_rev": "_WpvYGJ--Ai",
        "nanopub": {
            "id": "88ae203f-47bf-4c5d-8b89-7fd8d8f27f8e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "DAS28",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "102 RA patients",
                    "type": "cohort"
                },
                {
                    "id": "",
                    "label": "0.014",
                    "type": "p-value"
                }
            ],
            "citation": {
                "authors": [
                    "Azzeh, Firas Sultan",
                    "Kensara, Osama Adnan"
                ],
                "database": {
                    "id": "26063950",
                    "name": "PubMed"
                },
                "source_name": "Disease markers",
                "title": "Vitamin D Is a Good Marker for Disease Activity of Rheumatoid Arthritis Disease.",
                "abstract": "This study was conducted to find out the optimal vitamin D cutoff point in predicting activity of RA disease."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"vitamin D\")",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "A significant inverse correlation between serum 25(OH)D levels and DAS28 (r = \u22120.277, P = 0.014) was shown.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a0401fa8-e0c2-44c6-804d-f148cd32cdf5",
        "_rev": "_WpvYGJG--9",
        "nanopub": {
            "id": "a0401fa8-e0c2-44c6-804d-f148cd32cdf5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Seventy-one SLE patients with low disease activity (mean SLEDAI\u2009=\u20091.62 standard error (SE) 0.37, range 0-8) were compared to 51 controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "0.008",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "CES-D",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "GC-MS",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "22508802",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:F2-Isoprostanes)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:Depression)"
                }
            ],
            "evidence": "F(2)-isoprostane was higher in SLE patients with fatigue compared to not-fatigued SLE subjects (p\u2009=\u2009.0076) who were otherwise similar in ethnicity, disease activity and cardiovascular risk factors. Plasma F(2)-isoprostane was strongly correlated with FSS and Profile of Somatic Fatigue (Prof-S) (p\u2009<\u2009.0001), VAS fatigue (p\u2009=\u2009.005), CES-D (p\u2009=\u2009.008) and with BMI (p\u2009=\u2009.0001.) In a multivariate model, F(2)-isoprostane was a significant predictor of FSS after adjustment for age, BMI, pain and depression (p\u2009=\u2009.0002).\n",
            "metadata": {
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "cf899065-4867-4ede-b21d-3a1db42b32b6",
        "_rev": "_WpvYGJG--C",
        "nanopub": {
            "id": "cf899065-4867-4ede-b21d-3a1db42b32b6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "DAS28",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "110 RA patients, 55 age/sex matched controls",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Shrivastava, A K",
                    "Singh, H V",
                    "Raizada, A",
                    "Singh, S K",
                    "Pandey, A",
                    "Singh, N",
                    "Yadav, D S",
                    "Sharma, H"
                ],
                "database": {
                    "id": "24656623",
                    "name": "PubMed"
                },
                "source_name": "Allergologia et immunopathologia",
                "title": "Inflammatory markers in patients with rheumatoid arthritis.",
                "abstract": "Autoimmune diseases such as rheumatoid arthritis (RA) are the consequence of a persistent imbalance between pro- and anti-inflammatory immune mechanisms, leading to chronic inflammation. The objective of this study was to determine whether the high sensitive C-reactive protein (hs-CRP) and cytokines are elevated in RA patients and to investigate the relationship between these markers and disease activity in RA, measured by disease activity score 28 (DAS28)."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CRP)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "\tp(HGNC:IL10)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:TNF)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "We found that RA patients had significantly higher levels of serum hs-CRP (p<0.001), IL-6 (p<0.001), TNF-\u03b1 (p<0.001), and IL-10 (p<0.01) as compared to healthy controls. hs-CRP, IL-6 and TNF-\u03b1 correlated positively (p<0.001) and IL-10 correlated negatively (p<0.01) with DAS28.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "392cf570-271b-4cb1-92d7-ee78e73995c1",
        "_rev": "_WpvYGJG-Ao",
        "nanopub": {
            "id": "392cf570-271b-4cb1-92d7-ee78e73995c1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "37 patients with pAPS, 11 SLE patients, and 21 age- and gender-matched HC",
                    "type": "cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Alvarez-Rodriguez, Lorena",
                    "Riancho-Zarrabeitia, Leyre",
                    "Calvo-Al\u00e9n, Jime",
                    "L\u00f3pez-Hoyos, Marcos",
                    "Mart\u00ednez-Taboada, Victor"
                ],
                "database": {
                    "id": "29462939",
                    "name": "PubMed"
                },
                "source_name": "International journal of molecular sciences",
                "title": "Peripheral B-Cell Subset Distribution in Primary Antiphospholipid Syndrome.",
                "abstract": "B-cell differentiation and B-cell tolerance checkpoints may be different in antiphospholipid syndrome (APS) from systemic lupus erythematosus (SLE) and can help to understand differences between them. Our aim was to define alterations of B-cell subsets in patients with primary APS (pAPS) and to compare them with SLE patients and healthy controls (HC)."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNFSF13B)",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "A positive correlation was found between serum BAFF and IL-6 levels in patients with SLE but not in pAPS (p = 0.011).",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "B-cell differentiation and B-cell tolerance checkpoints may be different in antiphospholipid syndrome (APS) from systemic lupus erythematosus (SLE) and can help to understand differences between them. Our aim was to define alterations of B-cell subsets in patients with primary APS (pAPS) and to compare them with SLE patients and healthy controls (HC).",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "10a9c7ac-4280-4b90-84f4-5ef3567502a0",
        "_rev": "_WpvYGJG-_m",
        "nanopub": {
            "id": "10a9c7ac-4280-4b90-84f4-5ef3567502a0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "immunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Muzio, M",
                    "Ni, J",
                    "Feng, P",
                    "Dixit, V M"
                ],
                "database": {
                    "id": "9374458",
                    "name": "PubMed"
                },
                "source_name": "Science (New York, N.Y.)",
                "title": "IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling.",
                "abstract": "The interleukin-1 receptor (IL-1R) signaling pathway leads to nuclear factor kappa B (NF-kappaB) activation in mammals and is similar to the Toll pathway in Drosophila: the IL-1R-associated kinase (IRAK) is homologous to Pelle. Two additional proximal mediators were identified that are required for IL-1R-induced NF-kappaB activation: IRAK-2, a Pelle family member, and MyD88, a death domain-containing adapter molecule. Both associate with the IL-1R signaling complex. Dominant negative forms of either attenuate IL-1R-mediated NF-kappaB activation. Therefore, IRAK-2 and MyD88 may provide additional therapeutic targets for inhibiting IL-1-induced inflammation."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL1R1)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:MYD88)"
                }
            ],
            "evidence": "Given the significant sequence homologybetween MyD88 and IL-1RAcP, weasked whether the two could interact. Oncoexpression, MyD88 and IL-1RAcPformed an immunoprecipitable complex.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "The interleukin-1 receptor (IL-1R) signaling pathway leads to nuclear factor kappa B (NF-kappaB) activation in mammals and is similar to the Toll pathway in Drosophila: the IL-1R-associated kinase (IRAK) is homologous to Pelle. Two additional proximal mediators were identified that are required for IL-1R-induced NF-kappaB activation: IRAK-2, a Pelle family member, and MyD88, a death domain-containing adapter molecule. Both associate with the IL-1R signaling complex. Dominant negative forms of either attenuate IL-1R-mediated NF-kappaB activation. Therefore, IRAK-2 and MyD88 may provide additional therapeutic targets for inhibiting IL-1-induced inflammation.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "83cb88d2-36c9-427b-bb45-de7665e03715",
        "_rev": "_WpvYGI6--u",
        "nanopub": {
            "id": "83cb88d2-36c9-427b-bb45-de7665e03715",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "P = 0.0046",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "36 SLE patients and 42 HC",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "22549432",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:N-acetyl-L-cysteine)",
                    "relation": "decreases",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Considered together, 2.4 gm and 4.8 gm NAC reduced the SLEDAI score after 1 month (P = 0.0007), 2 months (P = 0.0009), 3 months (P = 0.0030), and 4 months (P = 0.0046); the BILAG score after 1 month (P = 0.029) and 3 months (P = 0.009); and the FAS score after 2 months (P = 0.0006) and 3 months (P = 0.005).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "900581fb-275a-4b44-bc9e-efddc76a347b",
        "_rev": "_WpvYGJG-A6",
        "nanopub": {
            "id": "900581fb-275a-4b44-bc9e-efddc76a347b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "10 old and 10 young males",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9469419",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(GO:aging)",
                    "relation": "decreases",
                    "object": "p(HGNC:BCL2)"
                }
            ],
            "evidence": "We found that Bcl-2 levels in aging (n\u00a0= 10) T cell subsets were significantly (p\u00a0< 0.001) lower (MFC, mean \u00b1 SD: CD4+, 513 \u00b1 18; CD8+, 476 \u00b1 21) as compared with young (n\u00a0= 10) controls (MFC, mean \u00b1 SD: CD4+, 570 \u00b1 12; CD8+, 536 \u00b1 20).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "41de1e85-f190-4574-a940-895203a89ad9",
        "_rev": "_WpvYGJG-Bw",
        "nanopub": {
            "id": "41de1e85-f190-4574-a940-895203a89ad9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Gauzzi, M C",
                    "Velazquez, L",
                    "McKendry, R",
                    "Mogensen, K E",
                    "Fellous, M",
                    "Pellegrini, S"
                ],
                "database": {
                    "id": "8702790",
                    "name": "PubMed"
                },
                "source_name": "The Journal of biological chemistry",
                "title": "Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase.",
                "abstract": "Tyk2 and JAK1, members of the Janus kinase (JAK) family of protein tyrosine kinases, are required for interferon-alpha/beta binding and signaling. Both enzymes are associated with the interferon-alpha/beta receptor, and upon ligand binding, they undergo tyrosine phosphorylation and catalytic activation in an interdependent manner. To identify residues involved in Tyk2 regulation and to understand the basis of the interdependence of Tyk2 and JAK1, six mutated versions of Tyk2 bearing single or multiple point mutations in the tyrosine kinase domain were studied in a cell line lacking endogenous Tyk2. The Y1054F/Y1055F substitutions in the putative activation loop prevented ligand-dependent activation of Tyk2, without abolishing its catalytic potential. The K930R mutation in the ATP binding site generated a kinase-negative protein, which however, still became phosphorylated upon interferon-alpha treatment. The Y1054F/Y1055F substitutions in this kinase-negative Tyk2 abolished the induced phosphorylation. These results indicate that Tyk2 is activated by phosphorylation on Tyr-1054 and/or Tyr-1055 and that this phosphorylation requires another kinase, most likely JAK1. While the Tyk2 forms mutated on Tyr-1054 and Tyr-1055 or on Lys-930 allowed some inducible gene expression, the combination of the three point mutations totally abolished signaling."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:JAK1)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:TYK2, pmod(Ph, TYR, 1055))"
                },
                {
                    "subject": "p(HGNC:JAK1)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:TYK2, pmod(Ph, TYR, 1054))"
                }
            ],
            "evidence": "These results indicate that Tyk2 is activated by phosphorylation on Tyr-1054 and/or Tyr-1055 and that this phosphorylation requires another kinase, most likely JAK1.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "80f2a5a5-1f34-4533-bde5-6ffea3fa8646",
        "_rev": "_WpvYGJG-B_",
        "nanopub": {
            "id": "80f2a5a5-1f34-4533-bde5-6ffea3fa8646",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.37",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "SLAM-R",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0fa4c93c-050c-417e-9ae6-ce1056daf61e",
        "_rev": "_WpvYGJ---G",
        "nanopub": {
            "id": "0fa4c93c-050c-417e-9ae6-ce1056daf61e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "8457224",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Arthritis, Rheumatoid\")",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "path(MESH:\"Arthritis, Rheumatoid\")",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:TNF)"
                }
            ],
            "evidence": "Serum levels of TNFa, IL-6, and HA were significantly higher in the RA population than in the control group.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3232e7f6-59df-4db5-8666-235e7f8348d6",
        "_rev": "_WpvYGJC--d",
        "nanopub": {
            "id": "3232e7f6-59df-4db5-8666-235e7f8348d6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Affinity Chromatography",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive B cell\"",
                    "label": "naive B cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "comments": "BSF-1 and BCDF-gamma were both demonstrated to be the same protein, and later renamed to IL-4 (2966762)\n",
                "database": {
                    "id": "3932582",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL4)\t",
                    "relation": "decreases",
                    "object": "sec(p(\"IgG3\"))"
                },
                {
                    "subject": "p(HGNC:IL4)\t",
                    "relation": "increases",
                    "object": "sec(p(\"IgG1\"))"
                }
            ],
            "evidence": "2-10 U/ml of BSF-1 in conjunction with S-GAMIg or S-GAM-6 caused striking increases in [~H]thymidine uptake and induction of lgG1 secretion and parallel inhibition of IgG3 secretion in LPS-stimulated cells (Fig. 1).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ffe73313-1ab4-43a9-8784-893471db5426",
        "_rev": "_WpvYGJ--Ca",
        "nanopub": {
            "id": "ffe73313-1ab4-43a9-8784-893471db5426",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15987711",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Lupus Erythematosus, Systemic\")",
                    "relation": "negativeCorrelation",
                    "object": "act(p(HGNC:ICOS), ma(GO:\"T cell proliferation\"))"
                }
            ],
            "evidence": "As shown in\u00a0Fig. 3A, anti-ICOS in the presence of anti-CD3 only enhanced proliferative responses of PBMCs from healthy subjects, but failed to enhance responses of PBMCs from very active SLE patients, compared with stimulation by anti-CD3 and HIgG.\u00a0\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ecd702c2-f070-420e-b4f0-04788db2f7f9",
        "_rev": "_WpvYGJC-BH",
        "nanopub": {
            "id": "ecd702c2-f070-420e-b4f0-04788db2f7f9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "2212667",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:neutrophil)",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL1B))"
                }
            ],
            "evidence": "When PMN were cultured in the presence of TNF, or the combination of IL-la plus TNF, IL-la Ag was detectable in the cell lysates as early as 1 h.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d43ec8c6-c61a-41a7-b345-07a91a6185c9",
        "_rev": "_WpvYGJC-_6",
        "nanopub": {
            "id": "d43ec8c6-c61a-41a7-b345-07a91a6185c9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "BILAG",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "70 SLE patients and 20 healthy controls",
                    "type": "Cohort"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "28502135",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNF)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Estimated serum sTRAIL, TNF-\u03b1 and IL-6 levels showed positive significant correlation with calculated BILAG activity score, while estimated serum IL-10 levels showed negative significant correlation with activity score.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e185d702-aaa5-4e24-9f4a-b60ac31e796e",
        "_rev": "_WpvYGJG-Bc",
        "nanopub": {
            "id": "e185d702-aaa5-4e24-9f4a-b60ac31e796e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "IFN-G Production",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8700208",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT4)",
                    "relation": "increases",
                    "object": "bp(GO:\"T-helper 1 cell differentiation\")"
                }
            ],
            "evidence": "However, anti-CD3 restimulation of T cells from littermate stat4-/- mice resulted in a dramatically reduced IFN-G production, a function that is normally not affected by the absence of Stat4. [...] These results therefore support a unique role for Stat4 in IL-12 promoted differentiation of Th1 cells.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ef9dbfb0-ec80-4d85-bbd6-9c7502d6d000",
        "_rev": "_WpvYGJ--_I",
        "nanopub": {
            "id": "ef9dbfb0-ec80-4d85-bbd6-9c7502d6d000",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "comments": "Couldn't find good object ontology for \"flow mediated dilution\"",
                "database": {
                    "id": "18504327",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"L-cysteine glutathione disulfide\")",
                    "relation": "positiveCorrelation",
                    "object": "a(bp(MESH:\"Regional Blood Flow\"))"
                },
                {
                    "subject": "a(CHEBI:\"L-cysteine glutathione disulfide\")",
                    "relation": "biomarkerFor",
                    "object": "a(bp(MESH:\"Oxidative Stress\"))"
                }
            ],
            "evidence": "Linear regression analyses demonstrated significant inverse correlations between FMD and CySS and CySSG, indicating that a higher level of oxidative stress measured by these markers was associated with lower FMD.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5f5f51a4-69d8-413c-bc06-9e30fec00215",
        "_rev": "_WpvYGJ---4",
        "nanopub": {
            "id": "5f5f51a4-69d8-413c-bc06-9e30fec00215",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9200453",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL2)\t",
                    "relation": "increases",
                    "object": "p(HGNC:STAT5, pmod(Ph))"
                },
                {
                    "subject": "p(HGNC:IL2)",
                    "relation": "increases",
                    "object": "p(HGNC:STAT3, pmod(Ph))"
                }
            ],
            "evidence": "As shown in Figure 5, stimulation of activated T cells with IL-2 induced tyrosine phosphorylation of both Stat 3 (Fig. SA) and Stat 5 (Fig. 5B) proteins\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "cf506df8-01a0-4d04-8640-1be1eab2a515",
        "_rev": "_WpvYGJ--Bb",
        "nanopub": {
            "id": "cf506df8-01a0-4d04-8640-1be1eab2a515",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:Neutrophils",
                    "label": "Neutrophils",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "27413244",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:squalene)\t",
                    "relation": "decreases",
                    "object": "r(HGNC:IFNG)"
                },
                {
                    "subject": "a(CHEBI:squalene)",
                    "relation": "decreases",
                    "object": "r(HGNC:IL1B)"
                }
            ],
            "evidence": ". Moreover, the expression of cytokine genes TNF-\u03b1, IL-1\u03b2, IL-6 and IFN-\u03b3 was significantly reduced by squalene (50 \u0006M, 18 h) in LPS-treated human neutrophils\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ec78292d-e907-4e80-aa9c-3dfceb2208f9",
        "_rev": "_WpvYGJ--B4",
        "nanopub": {
            "id": "ec78292d-e907-4e80-aa9c-3dfceb2208f9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=15",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "10051376",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Curcumin)",
                    "relation": "decreases",
                    "object": "p(HGNC:TNF)"
                },
                {
                    "subject": "a(MESH:Curcumin)",
                    "relation": "decreases",
                    "object": "p(HGNC:IL1B)"
                },
                {
                    "subject": "a(MESH:Curcumin)",
                    "relation": "decreases",
                    "object": "p(SP:P13500)"
                },
                {
                    "subject": "a(MESH:Curcumin)",
                    "relation": "decreases",
                    "object": "p(EG:6348)"
                },
                {
                    "subject": "a(MESH:Curcumin)",
                    "relation": "decreases",
                    "object": "p(SP:P10145)"
                }
            ],
            "evidence": "Our results showed that curcumin inhibited the production of IL-8, MIP-1a, MCP-1, IL-1b and TNF-a by PMA- or LPS-stimulated peripheral blood monocytes and alveolar macrophages. C\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2cbc2c18-5cd7-4486-9d73-8b116f1cccf1",
        "_rev": "_WpvYGJC-Aj",
        "nanopub": {
            "id": "2cbc2c18-5cd7-4486-9d73-8b116f1cccf1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=23",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "IBDQ",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17934776",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"VSL#3\")",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Inflammatory Bowel Diseases\")"
                }
            ],
            "evidence": "The median IBDQ score, at the end of the study, was significantly improved compared with baseline\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c3d1ff56-cbfa-4ba0-834f-64f1fce30c50",
        "_rev": "_WpvYGJC-BU",
        "nanopub": {
            "id": "c3d1ff56-cbfa-4ba0-834f-64f1fce30c50",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:tuberculosis",
                    "label": "tuberculosis",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "28582466",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:Tuberculosis)",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "we measured plasma IL-6 levels and detected increased IL-6 concentrations in tuberculosis patients as compared to healthy contacts (p < 0.001) (Fig 5d)\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bee4486b-449e-4697-a737-c20f63d9b029",
        "_rev": "_WpvYGJG-BZ",
        "nanopub": {
            "id": "bee4486b-449e-4697-a737-c20f63d9b029",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.506",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n 6 patients with chronic active hepatitis (CAH) [3 females and 3 males: mean age = 51 f 3 yr (S.E.)], 11 patients with liver cirrhosis (LC) (6 females and 5 males: mean age = 61 f 3 years) and 5 patients with hepatocellular carcinoma (HCC) (5 males: mean age = 57 * 6 years), all of whom had an underlying cirrhosis, and 3 other patients with cholelithiasis (male, 39 years), obstructive jaundice due to bile duct cancer (male, 69 years) and chronic pancreatitis (male, 47 years). As normal controls, 12 healthy volunteers (6 females and 6 males: mean age = 38 f 3 years) were used",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "HPLC",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "3356409",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:pipecolic acid)",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:\"bile acid\")"
                }
            ],
            "evidence": "Similar positive correlations were found when plasma levels of pipecolic acid were correlated with bile acid (r = 0.506; p < 0.05) and with bilirubin (r = 0.488; p < 0.05).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "359a85aa-5cad-46e2-b543-aec02e14f43f",
        "_rev": "_WpvYGI6--T",
        "nanopub": {
            "id": "359a85aa-5cad-46e2-b543-aec02e14f43f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:\"skeletal muscle tissue\"",
                    "label": "skeletal muscle tissue",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "authors": [
                    "van der Lans, Anouk A J J",
                    "Boon, Mari\u00ebtte R",
                    "Haks, Mari\u00eblle C",
                    "Quinten, Edwin",
                    "Schaart, Gert",
                    "Ottenhoff, Tom H",
                    "van Marken Lichtenbelt, Wouter D"
                ],
                "database": {
                    "id": "26149277",
                    "name": "PubMed"
                },
                "source_name": "Physiological reports",
                "title": "Cold acclimation affects immune composition in skeletal muscle of healthy lean subjects.",
                "abstract": "Low environmental temperatures have a profound effect on biological processes in the body, including the immune system. Cold exposure coincides with hormonal changes, which may directly or indirectly alter the immune system, even in the skeletal muscle. The aim of the present study was to investigate the effect of cold acclimation on immune composition in skeletal muscle. Skeletal muscle biopsies were obtained from 17 healthy lean subjects before and after 10\u00a0days of mild cold exposure (15 \u00b0: C, 6\u00a0h/day). Nonshivering thermogenesis was calculated by indirect calorimetry. We found that cold acclimation increased nonshivering thermogenesis from 10.8\u00a0\u00b1\u00a07.5 before to 17.8\u00a0\u00b1\u00a011.1% after cold acclimation (P\u00a0<\u00a00.01), but did not affect plasma catecholamine nor cytokine levels. In contrast, cold acclimation affected mRNA expression of several immune cell markers in skeletal muscle. It downregulated expression of the Th17 markers RORC (-28%, P\u00a0<\u00a00.01) and NEDD4L (-15%, P\u00a0<\u00a00.05), as well as the regulatory T-cell marker FOXP3 (-13%, P\u00a0<\u00a00.05). Furthermore, cold acclimation downregulated expression of the M2 macrophage markers CCL22 (-50%, P\u00a0<\u00a00.05), CXCL13 (-17%, P\u00a0<\u00a00.05) and CD209 (-15%, P\u00a0<\u00a00.05), while the M1 macrophage marker IL12B was upregulated (+141%, P\u00a0<\u00a00.05). Cold acclimation also enhanced several markers related to interferon (IFN) signaling, including TAP1 (+12%, P\u00a0<\u00a00.01), IFITM1/3 (+11%, P\u00a0<\u00a00.05), CD274 (+36%, P\u00a0<\u00a00.05) and STAT 2 (+10%, P\u00a0<\u00a00.05). In conclusion, 10\u00a0days of intermittent cold exposure induces marked changes in the expression of immune cell markers in skeletal muscle of healthy lean subjects. The physiological consequences and therapeutic relevance of these changes remain to be determined."
            },
            "assertions": [
                {
                    "subject": "bp(GO:\"cold acclimation\")",
                    "relation": "increases",
                    "object": "r(HGNC:STAT2)"
                },
                {
                    "subject": "bp(GO:\"cold acclimation\")",
                    "relation": "increases",
                    "object": "r(HGNC:CD274)"
                },
                {
                    "subject": "bp(GO:\"cold acclimation\")",
                    "relation": "increases",
                    "object": "r(HGNC:IFITM3)"
                },
                {
                    "subject": "bp(GO:\"cold acclimation\")",
                    "relation": "increases",
                    "object": "r(HGNC:IFITM1)"
                },
                {
                    "subject": "bp(GO:\"cold acclimation\")",
                    "relation": "increases",
                    "object": "r(HGNC:TAP1)"
                },
                {
                    "subject": "bp(GO:\"cold acclimation\")",
                    "relation": "increases",
                    "object": "r(HGNC:IL12B)"
                },
                {
                    "subject": "bp(GO:\"cold acclimation\")",
                    "relation": "decreases",
                    "object": "r(HGNC:CD209)"
                },
                {
                    "subject": "bp(GO:\"cold acclimation\")",
                    "relation": "decreases",
                    "object": "r(HGNC:CXCL13)"
                },
                {
                    "subject": "bp(GO:\"cold acclimation\")",
                    "relation": "decreases",
                    "object": "r(HGNC:CCL22)"
                },
                {
                    "subject": "bp(GO:\"cold acclimation\")",
                    "relation": "decreases",
                    "object": "r(HGNC:FOXP3)"
                },
                {
                    "subject": "bp(GO:\"cold acclimation\")",
                    "relation": "decreases",
                    "object": "r(HGNC:NEDD4L)"
                },
                {
                    "subject": "bp(GO:\"cold acclimation\")",
                    "relation": "decreases",
                    "object": "r(HGNC:RORC)"
                }
            ],
            "evidence": "In contrast, cold acclimation affected mRNA expression of several immune cell markers in skeletal muscle. It downregulated expression of the Th17 markers RORC (-28%, P < 0.01) and NEDD4L (-15%, P < 0.05), as well as the regulatory T-cell marker FOXP3 (-13%, P < 0.05). Furthermore, cold acclimation downregulated expression of the M2 macrophage markers CCL22 (-50%, P < 0.05), CXCL13 (-17%, P < 0.05) and CD209 (-15%, P < 0.05), while the M1 macrophage marker IL12B was upregulated (+141%, P < 0.05). Cold acclimation also enhanced several markers related to interferon (IFN) signaling, including TAP1 (+12%, P < 0.01), IFITM1/3 (+11%, P < 0.05), CD274 (+36%, P < 0.05) and STAT 2 (+10%, P < 0.05). ",
            "metadata": {
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "fecce065-3834-4e6b-87ea-d4f7e1b1c7d8",
        "_rev": "_WpvYGJ--A-",
        "nanopub": {
            "id": "fecce065-3834-4e6b-87ea-d4f7e1b1c7d8",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Ray, A"
                ],
                "comments": "MAZ=SAF-1",
                "database": {
                    "id": "10975860",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology (Baltimore, Md. : 1950)",
                "title": "A SAF binding site in the promoter region of human gamma-fibrinogen gene functions as an IL-6 response element.",
                "abstract": "Expression of fibrinogen is highly induced during inflammation, and such abnormal expression of this protein is considered as a major cardiovascular risk factor. IL-6 is one of the main mediators of abnormal expression of fibrinogen leading to the pathogenic conditions. Transient transfection and EMSA were performed to investigate the molecular mechanism of IL-6-induced gamma-fibrinogen gene expression in hepatic cells. Using progressively deleted 5' fragments of the gamma-fibrinogen promoter coupled to chloramphenicol acetyltransferase gene, an IL-6 responsive element located between positions -273 and -259 was identified. Mutation of this element abrogates IL-6 responsiveness of the gamma-fibrinogen promoter. Interaction of this promoter with a zinc finger transcription factor, serum amyloid A activating factor (SAF)-1, was demonstrated by EMSA. Furthermore, overexpression of wild-type SAF-1 in transfected liver cells can increase transcription of the gamma-fibrinogen promoter. These data show that transcription factor SAF-1 is involved in the regulation of IL-6-mediated induction of the human gamma-fibrinogen gene in liver cells."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:MAZ)",
                    "relation": "increases",
                    "object": "p(HGNC:FGG)"
                },
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "increases",
                    "object": "p(HGNC:MAZ)"
                }
            ],
            "evidence": "To determine the identity of this protein, Absagainst a variety of IL-6-inducible and liver-specific transcriptionfactors were used (Fig. 5B). The IL-6-inducible DNA-protein complex was not inhibited by C/EBP-, NF-kB-, STAT3-, Egr-1-, Sp1-,HNF-1-, or HNF-3-specific Abs (Fig. 5B, lanes 2\u20136 and 8 and 9).In lane 2, some super shifting is seen with C/EBP Ab, which isnonreproducible and therefore should be regarded as an electrophores is artifact. Only an anti-SAF-1 (18) polyclonal Ab (lane 7)could inhibit the formation of this complex. For further verification,preadsorbed anti-SAF-1 Ab was used in the DNA binding assay, and such a preparation of Ab failed to neutralize this complex(lane 12). Also, an oligonucleotide containing the consensus binding element for SAF-1 (18) inhibited this DNA-protein complex (Fig. 5A, lane 8). These results characterized and verified interaction of SAF-1 transcription factor with the IL-6-responsive element (2273/2259) of the human g-fibrinogen gene.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Expression of fibrinogen is highly induced during inflammation, and such abnormal expression of this protein is considered as a major cardiovascular risk factor. IL-6 is one of the main mediators of abnormal expression of fibrinogen leading to the pathogenic conditions. Transient transfection and EMSA were performed to investigate the molecular mechanism of IL-6-induced gamma-fibrinogen gene expression in hepatic cells. Using progressively deleted 5' fragments of the gamma-fibrinogen promoter coupled to chloramphenicol acetyltransferase gene, an IL-6 responsive element located between positions -273 and -259 was identified. Mutation of this element abrogates IL-6 responsiveness of the gamma-fibrinogen promoter. Interaction of this promoter with a zinc finger transcription factor, serum amyloid A activating factor (SAF)-1, was demonstrated by EMSA. Furthermore, overexpression of wild-type SAF-1 in transfected liver cells can increase transcription of the gamma-fibrinogen promoter. These data show that transcription factor SAF-1 is involved in the regulation of IL-6-mediated induction of the human gamma-fibrinogen gene in liver cells.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bc8db8ea-f0d2-4d56-b395-432ed4863905",
        "_rev": "_WpvYGJG-AT",
        "nanopub": {
            "id": "bc8db8ea-f0d2-4d56-b395-432ed4863905",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Crohn Disease\"",
                    "label": "Crohn Disease",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "comments": "done in rats, confirmed in humans",
                "database": {
                    "id": "10940278",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:butyrate)",
                    "relation": "increases",
                    "object": "p(HGNC:NFKBIA)"
                }
            ],
            "evidence": ". In the presence of butyrate, this eVect was abolished and IkB levels were stable throughout the period of stimulation with LPS. Similar results were obtained with PBMC and LPMC of CD patients (data not shown).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "40acd203-57ae-441e-8f29-1feec9add1bd",
        "_rev": "_WpvYGJG--t",
        "nanopub": {
            "id": "40acd203-57ae-441e-8f29-1feec9add1bd",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18549798",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:Jak3)",
                    "relation": "association",
                    "object": "r(HGNC:IFNG)"
                }
            ],
            "evidence": "",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6212cbbd-d0bc-46d5-a5ec-ad0e5a4a9d6b",
        "_rev": "_WpvYGJ--BB",
        "nanopub": {
            "id": "6212cbbd-d0bc-46d5-a5ec-ad0e5a4a9d6b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "9322188",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Zinc)",
                    "relation": "decreases",
                    "object": "p(SP:P10145)"
                }
            ],
            "evidence": "These data show that zinc supplementation caused a marked decrease in IL-8 expression by endothelial cells in response to TNF-mediated cell activation over a 6- hour period.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "abf632a9-cf23-4ebb-9564-5e3d3eac6042",
        "_rev": "_WpvYGJG-Bo",
        "nanopub": {
            "id": "abf632a9-cf23-4ebb-9564-5e3d3eac6042",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "EMSA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Macrophages",
                    "label": "Macrophages",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "17997324",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Olive Oil\")",
                    "relation": "decreases",
                    "object": "tloc(complex(p(HGNC:NFKB1),p(HGNC:NFKB2)), fromloc(GOCC:\"\"cytoplasm\"\"), toloc(GOCC:\"\"nucleus\"\"))"
                }
            ],
            "evidence": "MPC-OOE (evaluated at 10uM) effectively inhibits NF-B nuclear translocation in unstimulated (lane 6) and PMA-stimulated (lane 7) cells\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a81bbf51-762f-4b45-94c3-cee68fbb4f61",
        "_rev": "_WpvYGJ--CA",
        "nanopub": {
            "id": "a81bbf51-762f-4b45-94c3-cee68fbb4f61",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL2)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": " In addition, levels of plasma IP-10, MCP-1 and MCP-3 (Figure 2D), along with IL-8 and ICAM-1 (Supplementary Figure 2H), were significantly elevated in pre-flare periods compared to periods of stable disease.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4abed325-966c-46c1-8763-0c6a6eebeea6",
        "_rev": "_WpvYGI6--O",
        "nanopub": {
            "id": "4abed325-966c-46c1-8763-0c6a6eebeea6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Microscopy",
                    "type": "Methodology"
                },
                {
                    "id": "HMVEC",
                    "label": "",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "11350788",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL8)",
                    "relation": "increases",
                    "object": "a(MESH:\"Stress Fibers\")"
                }
            ],
            "evidence": "The addition of IL-8 to HMVECs or HMECs caused increased F-actin formation in both cell types (Fig. 1).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ebe9c27d-552a-4c72-a881-64cc3c0a47d1",
        "_rev": "_WpvYGJ--_i",
        "nanopub": {
            "id": "ebe9c27d-552a-4c72-a881-64cc3c0a47d1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "",
                    "label": "8 healthy males",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:\"Muscle, Skeletal\"",
                    "label": "Muscle, Skeletal",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "authors": [
                    "Vendelbo, Mikkel Holm",
                    "M\u00f8ller, Andreas Buch",
                    "Christensen, Britt",
                    "Nellemann, Birgitte",
                    "Clasen, Berthil Frederik Forrest",
                    "Nair, K Sreekumaran",
                    "J\u00f8rgensen, Jens Otto Lunde",
                    "Jessen, Niels",
                    "M\u00f8ller, Niels"
                ],
                "database": {
                    "id": "25020061",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Fasting increases human skeletal muscle net phenylalanine release and this is associated with decreased mTOR signaling.",
                "abstract": "Fasting is characterised by profound changes in energy metabolism including progressive loss of body proteins. The underlying mechanisms are however unknown and we therefore determined the effects of a 72-hour-fast on human skeletal muscle protein metabolism and activation of mammalian target of rapamycin (mTOR), a key regulator of cell growth."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:Fasting)",
                    "relation": "increases",
                    "object": "act(complex(GO:\"TORC1 complex\", ma(kin))"
                },
                {
                    "subject": "bp(MESH:Fasting)",
                    "relation": "causesNoChange",
                    "object": "p(HGNC:RPS6, pmod(Ph))"
                },
                {
                    "subject": "bp(MESH:Fasting)",
                    "relation": "decreases",
                    "object": "p(HGNC:ULK1, pmod (Ph, Ser, 757))"
                },
                {
                    "subject": "bp(MESH:Fasting)",
                    "relation": "decreases",
                    "object": "p(EG:1978, pmod (Ph, Thr, 46))"
                }
            ],
            "evidence": "To test whether the reduced mTOR phosphorylation was associated with reduced mTOR complex 1 (mTORC1) signaling we examined downstream signaling to eukaryotic translation initiation factor 4E binding protein 1 (4EBP1), UNK-51-like kinase 1 (ULK1) and ribosomal protein S6 (rpS6). After 72 hours of fasting phosphorylation was significantly decreased on both 4EBP1 Thr46 (observed by increased non-phosphorylated 4EBP1) and ULK1Ser757 (Figure 3C and \u200band4A).4A). The ratio of phosphorylated vs. total rpS6 expression was unaltered after fasting (Figure 3D). ",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true,
                "gd:abstract": "Fasting is characterised by profound changes in energy metabolism including progressive loss of body proteins. The underlying mechanisms are however unknown and we therefore determined the effects of a 72-hour-fast on human skeletal muscle protein metabolism and activation of mammalian target of rapamycin (mTOR), a key regulator of cell growth."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ac872460-e35f-40ab-a909-41932e3c6320",
        "_rev": "_WpvYGJC--i",
        "nanopub": {
            "id": "ac872460-e35f-40ab-a909-41932e3c6320",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "OR=15.69",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "237 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "17895304",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"anti-lupus anticoagulant\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arterial Thrombosis\")"
                }
            ],
            "evidence": "Adjusted risk for arterial thrombosis was increased in groups A [odds ratio (OR) 15.69, 95% confidential interval (CI) 4.79\u201451.42, P < 0.001] and B (OR 7.63, 95% CI 2.00\u201429.08, P = 0.003), but not in group C when compared with group D. \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2a56e22f-3bb3-4c40-90c1-15bcb98ebac7",
        "_rev": "_WpvYGJC-CU",
        "nanopub": {
            "id": "2a56e22f-3bb3-4c40-90c1-15bcb98ebac7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "80 SLE patients, 80 HCs",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Bortoluzzi, Alessandra",
                    "Vincenzi, Fabrizio",
                    "Govoni, Marcello",
                    "Padovan, Melissa",
                    "Ravani, Annalisa",
                    "Borea, Pier Andrea",
                    "Varani, Katia"
                ],
                "database": {
                    "id": "27566294",
                    "name": "PubMed"
                },
                "source_name": "Arthritis research & therapy",
                "title": "A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus.",
                "abstract": "Adenosine is a purine nucleoside implicated in the regulation of the innate and adaptive immune systems, acting through its interaction with four cell surface receptors: A1, A2A, A2B, and A3. There is intense interest in understanding how adenosine functions in health and during disease, but surprisingly little is known about the actual role of adenosine-mediated mechanisms in systemic lupus erythematosus (SLE). With this background, the aim of the present study was to test the hypothesis that dysregulation of A1, A2A, A2B, and A3 adenosine receptors (ARs) in lymphocytes of patients with SLE may be involved in the pathogenesis of the disease and to examine the correlations between the status of the ARs and the clinical parameters of SLE."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:ADAR)\t",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:Serositis)"
                },
                {
                    "subject": "p(HGNC:ADAR)",
                    "relation": "increases",
                    "object": "p(HGNC:IL10)"
                },
                {
                    "subject": "p(HGNC:ADAR)",
                    "relation": "negativeCorrelation",
                    "object": "a(anti-dsDNA)"
                }
            ],
            "evidence": "In addition, A2AAR density inversely correlated with serositis (p\u2009=\u20090.0043), hypocomplementemia (p\u2009=\u20090.0005), and anti-dsDNA positivity (Table 2).\n\nThe incubation of lymphocytes with the A2AAR agonist CGS-21680 (1 \u03bcM) augmented basal IL-10 release in lymphocytes from healthy subjects and from patients with SLE (Fig. 4b).\u00a0",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "690a5586-2ada-41d6-88fa-2916eacdfb3b",
        "_rev": "_WpvYGJG-_q",
        "nanopub": {
            "id": "690a5586-2ada-41d6-88fa-2916eacdfb3b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Scott, M L",
                    "Fujita, T",
                    "Liou, H C",
                    "Nolan, G P",
                    "Baltimore, D"
                ],
                "database": {
                    "id": "8319912",
                    "name": "PubMed"
                },
                "source_name": "Genes & development",
                "title": "The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms.",
                "abstract": "Transcription factor NF-kappa B (p50/p65) is generally localized to the cytoplasm by its inhibitor I kappa B. Overproduced I kappa B, free from NF-kappa B, is rapidly degraded. Overexpression of p65 increases endogenous I kappa B protein in both carcinoma and lymphoid cells by two mechanisms: protein stabilization and increased transcription of I kappa B mRNA. In contrast, p65 delta, a naturally occurring splice variant, fails to markedly augment I kappa B protein levels. Both overexpressed p65 and coexpressed p50 are cytoplasmic, whereas p65 delta is partly nuclear, indicating that the I kappa B induced by p65 can maintain NF-kappa B in the cytoplasm. Thus, p65 and I kappa B are linked in an autoregulatory loop, ensuring that NF-kappa B is held in the cytoplasm until cells are specifically induced to translocate it to the nucleus."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:NFKBIA)",
                    "relation": "directlyIncreases",
                    "object": "complex(p(HGNC:NFKB1), p(HGNC:RELA), p(HGNC:NFKBIA, loc(MESH:Cytoplasm))"
                }
            ],
            "evidence": "Transcription factor NF-kappa B (p50/p65) is generally localized to the cytoplasm by its inhibitor I kappa B. Overproduced I kappa B, free from NF-kappa B, is rapidly degraded.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Transcription factor NF-kappa B (p50/p65) is generally localized to the cytoplasm by its inhibitor I kappa B. Overproduced I kappa B, free from NF-kappa B, is rapidly degraded. Overexpression of p65 increases endogenous I kappa B protein in both carcinoma and lymphoid cells by two mechanisms: protein stabilization and increased transcription of I kappa B mRNA. In contrast, p65 delta, a naturally occurring splice variant, fails to markedly augment I kappa B protein levels. Both overexpressed p65 and coexpressed p50 are cytoplasmic, whereas p65 delta is partly nuclear, indicating that the I kappa B induced by p65 can maintain NF-kappa B in the cytoplasm. Thus, p65 and I kappa B are linked in an autoregulatory loop, ensuring that NF-kappa B is held in the cytoplasm until cells are specifically induced to translocate it to the nucleus.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b92eb41c-1187-4f2d-8a4e-cd4ee298220c",
        "_rev": "_WpvYGJC--M",
        "nanopub": {
            "id": "b92eb41c-1187-4f2d-8a4e-cd4ee298220c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "authors": [
                    "Kim, W",
                    "Min, S",
                    "Cho, M",
                    "Youn, J",
                    "Min, J",
                    "Lee, S",
                    "Park, S",
                    "Cho, C",
                    "Kim, H",
                    "Kim, W U",
                    "Min, S Y",
                    "Cho, M L",
                    "Min, D J",
                    "Lee, S H",
                    "Park, S H",
                    "Cho, C S",
                    "Kim, H Y"
                ],
                "database": {
                    "id": "10606980",
                    "name": "PubMed"
                },
                "source_name": "Clinical and experimental immunology",
                "title": "The role of IL-12 in inflammatory activity of patients with rheumatoid arthritis (RA).",
                "abstract": "The aim of this study was to investigate the role of IL-12 in patients with RA. IL-12 (p70) and its associated cytokines were measured in sera and synovial fluid (SF) using an enzyme-linked immunosorbent method. Seven American College of Rheumatology (ACR) core set measures as well as IL-12 levels were sequentially monitored at the commencement and 4 months after treatment with a low-dose steroid and disease-modifying anti-rheumatic drugs (DMARDs). In sera, 64 (42.2%) of 152 RA patients had detectable concentrations of IL-12 (p70), whereas one (1.4%) of 69 osteoarthritis (OA) patients and five (10%) of 50 healthy controls had detectable IL-12 (P < 0.001). The median level of circulating IL-12 was also higher in RA patients (P < 0.001). In SF, the number of patients with detectable IL-12 and the median IL-12 levels were significantly higher in RA patients (n = 53) than in OA patients (n = 22). In paired samples (n = 53) of sera and SF from RA patients, IL-12 levels were higher in the SF than in sera (P < 0.001). Patients with detectable IL-12 (n = 51) in sera had higher tender joint scores (P = 0.003), swollen joint scores (P < 0.001) and C-reactive protein (CRP; P = 0.036), than those without (n = 55). Four months after treatment with DMARDs, the improved group showed a larger IL-12 decrease than the non-improved group (P = 0.017). The levels of IL-12 correlated positively with those of IL-2, interferon-gamma, IL-6, and tumour necrosis factor-alpha, but were correlated inversely with those of IL-10. Our results demonstrate that IL-12 levels reflect RA disease activity and that IL-12 is involved in the production of proinflammatory cytokines. An IL-12 blockade could be useful for the treatment of RA."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL12A)",
                    "relation": "increases",
                    "object": "p(HGNC:IFNG)"
                }
            ],
            "evidence": "It has been documented that IL-12 synergizes with a variety of cytokines and induces the production of IFN-\u03b3 and proinflammatory cytokines",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "The aim of this study was to investigate the role of IL-12 in patients with RA. IL-12 (p70) and its associated cytokines were measured in sera and synovial fluid (SF) using an enzyme-linked immunosorbent method. Seven American College of Rheumatology (ACR) core set measures as well as IL-12 levels were sequentially monitored at the commencement and 4 months after treatment with a low-dose steroid and disease-modifying anti-rheumatic drugs (DMARDs). In sera, 64 (42.2%) of 152 RA patients had detectable concentrations of IL-12 (p70), whereas one (1.4%) of 69 osteoarthritis (OA) patients and five (10%) of 50 healthy controls had detectable IL-12 (P < 0.001). The median level of circulating IL-12 was also higher in RA patients (P < 0.001). In SF, the number of patients with detectable IL-12 and the median IL-12 levels were significantly higher in RA patients (n = 53) than in OA patients (n = 22). In paired samples (n = 53) of sera and SF from RA patients, IL-12 levels were higher in the SF than in sera (P < 0.001). Patients with detectable IL-12 (n = 51) in sera had higher tender joint scores (P = 0.003), swollen joint scores (P < 0.001) and C-reactive protein (CRP; P = 0.036), than those without (n = 55). Four months after treatment with DMARDs, the improved group showed a larger IL-12 decrease than the non-improved group (P = 0.017). The levels of IL-12 correlated positively with those of IL-2, interferon-gamma, IL-6, and tumour necrosis factor-alpha, but were correlated inversely with those of IL-10. Our results demonstrate that IL-12 levels reflect RA disease activity and that IL-12 is involved in the production of proinflammatory cytokines. An IL-12 blockade could be useful for the treatment of RA.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "36dddc9c-27a5-449e-bc72-abf85b4603be",
        "_rev": "_WpvYGJC-_K",
        "nanopub": {
            "id": "36dddc9c-27a5-449e-bc72-abf85b4603be",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15100259",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(GO:\"regulatory T cell differentiation\")",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL10))"
                }
            ],
            "evidence": "Time course studies revealed down-regulation of IL-2 production by day 3, poor IFN-\u03b3 production at all times, and an increase in IL-10-producing cells beginning at day 3 (Fig. 7\u21d3A).\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a0c1b998-da98-471b-a078-9ef2e6697e71",
        "_rev": "_WpvYGJG--p",
        "nanopub": {
            "id": "a0c1b998-da98-471b-a078-9ef2e6697e71",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "21215659",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT3)",
                    "relation": "regulates",
                    "object": "bp(GO:\"T helper 2 cell differentiation\")"
                }
            ],
            "evidence": "STAT3 phosphorylation occurred early in differentiation, peaked at 48 hours and decreased by 72 hours (Figure 1A and B).\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "78107019-a4cd-4c4a-a96b-f7a331ff21ad",
        "_rev": "_WpvYGJC-_2",
        "nanopub": {
            "id": "78107019-a4cd-4c4a-a96b-f7a331ff21ad",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "151 SLE; 77 LN",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "15286009",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"anti-C1q\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Renal disease\")"
                }
            ],
            "evidence": "Patients with active lupus nephritis (BILAG A or B) had a higher prevalence of anti-C1q than those with no renal disease (74% v 32%; relative risk (RR) = 2.3 (95% confidence interval, 1.6 to 3.3)) (p<0.0001).  Anti-C1q in SLE are associated with renal involvement. \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d8e34d55-0dd5-4efd-8760-a9aadfec1f54",
        "_rev": "_WpvYGJ--Aq",
        "nanopub": {
            "id": "d8e34d55-0dd5-4efd-8760-a9aadfec1f54",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10358188",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNF)\t",
                    "relation": "increases",
                    "object": "r(HGNC:MIP1B)"
                },
                {
                    "subject": "p(HGNC:TNF)",
                    "relation": "increases",
                    "object": "r(HGNC:MIP1A)"
                }
            ],
            "evidence": ". Fig. 4, A and B show that exogenous TNF-a alone provided a potent stimulus for increased expression of MIP-1a and MIP-1b gene transcripts.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6df6f57e-d424-4ba8-a2df-5129b363ca9e",
        "_rev": "_WpvYGJC--Z",
        "nanopub": {
            "id": "6df6f57e-d424-4ba8-a2df-5129b363ca9e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"naive B cell\"",
                    "label": "naive B cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Thymidine Incorporation",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "comments": "BSF-1 and BCDF-gamma were both demonstrated to be the same protein, and later renamed to IL-4 (2966762)\n",
                "database": {
                    "id": "3932582",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL4)",
                    "relation": "increases",
                    "object": "bp(GO:\"B cell proliferation\")"
                }
            ],
            "evidence": "2-10 U/ml of BSF-1 in conjunction with S-GAMIg or S-GAM-6 caused striking increases in [~H]thymidine uptake and induction of lgG1 secretion and parallel inhibition of IgG3 secretion in LPS-stimulated cells (Fig. 1).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4203b081-c0f6-4414-aec3-576aef13d979",
        "_rev": "_WpvYGJG-Ai",
        "nanopub": {
            "id": "4203b081-c0f6-4414-aec3-576aef13d979",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:obesity",
                    "label": "obesity",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8968852",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Weight Loss\")\t",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:IGFBP3)"
                },
                {
                    "subject": "bp(MESH:\"Weight Loss\")\t",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:IGFBP1)"
                },
                {
                    "subject": "bp(MESH:\"Weight Loss\")\t",
                    "relation": "negativeCorrelation",
                    "object": "p(SP:P05019)"
                },
                {
                    "subject": "bp(MESH:\"Weight Loss\")",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IGFBP2)"
                },
                {
                    "subject": "bp(MESH:\"Weight Loss\")",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IGF2)"
                }
            ],
            "evidence": "After weight loss (8.1 +/- 2.0 kg) IGF-II and IGFBP-2 increased and IGF-I, IGFBP-1, IGFBP-3 and the ratio IGF-I/IGFBP-3 decreased significantly\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "46c4ee09-3371-4747-9df2-6aecae653082",
        "_rev": "_WpvYGJ--_s",
        "nanopub": {
            "id": "46c4ee09-3371-4747-9df2-6aecae653082",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "RT-PCR, FACS, Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"CD4-positive helper T cell\"",
                    "label": "CD4-positive helper T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "14676299",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TGFB)",
                    "relation": "increases",
                    "object": "bp(GO:\"regulatory T cell differentiation\")"
                }
            ],
            "evidence": "Thus, costimulation of\u00a0Foxp3-negative CD4+CD25\u2212\u00a0naive responder T cells with TCR engagement in the presence of TGF-\u03b2 induces de novo expression of\u00a0Foxp3, concomitant with conversion to a population of CD4+CD25+\u00a0Foxp3\u00a0+\u00a0T cells phenotypically and functionally indistinguishable from professional Treg.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ef919a4d-5b96-4e9e-bcc3-05ffcdf3feba",
        "_rev": "_WpvYGJ--AC",
        "nanopub": {
            "id": "ef919a4d-5b96-4e9e-bcc3-05ffcdf3feba",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Reporter Assay",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"EL4 cell\"",
                    "label": "EL4 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "10761931",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TBX21)",
                    "relation": "increases",
                    "object": "r(HGNC:IFNG)"
                }
            ],
            "evidence": "Remarkably, ectopic expression of T-bet in EL4 cells led to substantial IFN\u03b3 production (Figure 4D). These results are a novel demonstration of a Th1 restricted transcription factor capable of transactivating the IFN\u03b3 gene and inducing endogenous IFN\u03b3 production.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9724f64b-40ed-496c-97a2-82dba3089543",
        "_rev": "_WpvYGJC--1",
        "nanopub": {
            "id": "9724f64b-40ed-496c-97a2-82dba3089543",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Muzio, M",
                    "Ni, J",
                    "Feng, P",
                    "Dixit, V M"
                ],
                "database": {
                    "id": "9374458",
                    "name": "PubMed"
                },
                "source_name": "Science (New York, N.Y.)",
                "title": "IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling.",
                "abstract": "The interleukin-1 receptor (IL-1R) signaling pathway leads to nuclear factor kappa B (NF-kappaB) activation in mammals and is similar to the Toll pathway in Drosophila: the IL-1R-associated kinase (IRAK) is homologous to Pelle. Two additional proximal mediators were identified that are required for IL-1R-induced NF-kappaB activation: IRAK-2, a Pelle family member, and MyD88, a death domain-containing adapter molecule. Both associate with the IL-1R signaling complex. Dominant negative forms of either attenuate IL-1R-mediated NF-kappaB activation. Therefore, IRAK-2 and MyD88 may provide additional therapeutic targets for inhibiting IL-1-induced inflammation.",
                "date_published": "1997-11-28"
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IRAK2)",
                    "relation": "increases",
                    "object": "p(HGNC:TRAF6)"
                }
            ],
            "evidence": "Both IRAK and IRAK-2coprecipitated with TRAF6 but not withthe related TRAF2 adapter molecule (Fig.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "The interleukin-1 receptor (IL-1R) signaling pathway leads to nuclear factor kappa B (NF-kappaB) activation in mammals and is similar to the Toll pathway in Drosophila: the IL-1R-associated kinase (IRAK) is homologous to Pelle. Two additional proximal mediators were identified that are required for IL-1R-induced NF-kappaB activation: IRAK-2, a Pelle family member, and MyD88, a death domain-containing adapter molecule. Both associate with the IL-1R signaling complex. Dominant negative forms of either attenuate IL-1R-mediated NF-kappaB activation. Therefore, IRAK-2 and MyD88 may provide additional therapeutic targets for inhibiting IL-1-induced inflammation.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7584cc9d-273b-47ca-ba4a-add091d1ae3d",
        "_rev": "_WpvYGJG-BH",
        "nanopub": {
            "id": "7584cc9d-273b-47ca-ba4a-add091d1ae3d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.46",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:MMP7)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "129274a3-6357-4f72-9774-edd1473e3986",
        "_rev": "_WpvYGJC--R",
        "nanopub": {
            "id": "129274a3-6357-4f72-9774-edd1473e3986",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "15 renal failure patients, 30 haemodialysis patients, and 10 HC",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "HPLC",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"kidney failure\"",
                    "label": "kidney failure",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10516995",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Kidney Failure, Chronic\")\t",
                    "relation": "negativeCorrelation",
                    "object": "a(CHEBI:\"guanidinoacetic acid\")"
                },
                {
                    "subject": "path(MESH:\"Kidney Failure, Chronic\")\t",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:methylguanidine)"
                },
                {
                    "subject": "path(MESH:\"Kidney Failure, Chronic\")",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:\"N-amidinoaspartic acid\")"
                }
            ],
            "evidence": "An increase in urinary excretion of guanidnosuccinic acid and methylguanidine, and a reduction in urinary excretion of guanidinoacetic acid were observed in non-hemodalysis patients with end-stage renal disease\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f49e81b7-77ac-4d3e-a305-3dfa20a71f82",
        "_rev": "_WpvYGJC-_3",
        "nanopub": {
            "id": "f49e81b7-77ac-4d3e-a305-3dfa20a71f82",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "<0.05",
                    "type": "p-value"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "CL:\"aortic endothelial cell\"",
                    "label": "aortic endothelial cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Du, Yunfeng",
                    "Navab, Mohamad",
                    "Shen, Melody",
                    "Hill, James",
                    "Pakbin, Payam",
                    "Sioutas, Constantinos",
                    "Hsiai, Tzung K",
                    "Li, Rongsong"
                ],
                "database": {
                    "id": "23751346",
                    "name": "PubMed"
                },
                "source_name": "Biochemical and biophysical research communications",
                "title": "Ambient ultrafine particles reduce endothelial nitric oxide production via S-glutathionylation of eNOS.",
                "abstract": "Exposure to airborne particulate pollutants is intimately linked to vascular oxidative stress and inflammatory responses with clinical relevance to atherosclerosis. Particulate matter (PM) has been reported to induce endothelial dysfunction and atherosclerosis. Here, we tested whether ambient ultrafine particles (UFP, diameter <200 nm) modulate eNOS activity in terms of nitric oxide (NO) production via protein S-glutathionylation. Treatment of human aortic endothelial cells (HAEC) with UFP significantly reduced NO production. UFP-mediated reduction in NO production was restored in the presence of JNK inhibitor (SP600125), NADPH oxidase inhibitor (Apocynin), anti-oxidant (N-acetyl cysteine), and superoxide dismutase mimetics (Tempol and MnTMPyP). UFP exposure increased the GSSG/GSH ratio and eNOS S-glutathionylation, whereas over-expression of Glutaredoxin-1 (to inhibit S-glutathionylation) restored UFP-mediated reduction in NO production by nearly 80%. Thus, our findings suggest that eNOS S-glutathionylation is a potential mechanism underlying ambient UFP-induced reduction of NO production.",
                "date_published": "2013-07-05"
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Particulate Matter\")",
                    "relation": "increases",
                    "object": "a(CHEBI:\"glutathione disulfide\")"
                }
            ],
            "evidence": "In HAEC exposed to UFP, GSH levels were decreased (control=17.1\u00b11.8 \u03bcM, UFP=12.0 \u00b12.4 \u03bcM, n=4, p < 0.05), whereas GSSG levels were increased (control=0.62\u00b10.26 \u03bcM, UFP=1.60 \u00b10.20 \u03bcM, n=4, p < 0.05) (Fig. 2A).\u00a0",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "p-value": "<0.05",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "300bc4a5-00d1-4feb-a1b8-dcdc243457c0",
        "_rev": "_WpvYGJG--8",
        "nanopub": {
            "id": "300bc4a5-00d1-4feb-a1b8-dcdc243457c0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "C-Reactive Protein",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "34 RA patients,\u00a032 HC age/sex matched",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "van Roon, J A G",
                    "Glaudemans, K A F M",
                    "Bijlsma, J W J",
                    "Lafeber, F P J G"
                ],
                "database": {
                    "id": "12525379",
                    "name": "PubMed"
                },
                "source_name": "Annals of the rheumatic diseases",
                "title": "Interleukin 7 stimulates tumour necrosis factor alpha and Th1 cytokine production in joints of patients with rheumatoid arthritis.",
                "abstract": "A large number of activated T cells are found in the joints of patients with rheumatoid arthritis (RA). Interleukin 7 (IL7), a T cell growth factor and a regulator of Th1 and Th2 cytokine production, is produced by synoviocytes from patients with RA."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL7)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "CRP levels, available in 23 patients with RA, correlated positively with serum IL7 levels (rs=0.406, p<0.05, fig 1B).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7bbd9fe5-dc43-4607-8d9d-24c3b82b33e2",
        "_rev": "_WpvYGI6--g",
        "nanopub": {
            "id": "7bbd9fe5-dc43-4607-8d9d-24c3b82b33e2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Yan, H",
                    "Krishnan, K",
                    "Greenlund, A C",
                    "Gupta, S",
                    "Lim, J T",
                    "Schreiber, R D",
                    "Schindler, C W",
                    "Krolewski, J J"
                ],
                "database": {
                    "id": "8605876",
                    "name": "PubMed"
                },
                "source_name": "The EMBO journal",
                "title": "Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein.",
                "abstract": "Interferon-alpha (IFN alpha) induces rapid tyrosine phosphorylation of its receptors, two JAK kinases and three STAT transcription factors. One kinase, p135tyk2, is complexed with the IFNaR1 receptor, and may catalyze some of these phosphorylation events. We demonstrate that, in vitro, p135tyk2 phosphorylates two tyrosines on IFNaR1. A phosphopeptide corresponding to the major phosphorylation site (Tyr466) binds STAT2, but not STAT1, in an SH-2-dependent manner. Furthermore, only latent, non-phosphorylated STAT2 interacts with this phosphopeptide. When this phosphopeptide is introduced into permeabilized cells, the IFN alpha-dependent tyrosine phosphorylation of both STATs is blocked. Finally, mutant versions of IFNaR1, in which Tyr466 is changed to phenylalanine, can act in a dominant negative manner to inhibit phosphorylation of STAT2. These observations are consistent with a model in which IFNaR1 mediates the interaction between JAK kinases and the STAT transcription factors."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TYK2, pmod(Ph, 135))\t",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:IFNAR1, pmod(Ph, TYR, 481)"
                },
                {
                    "subject": "p(HGNC:TYK2, pmod(Ph, 135))",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:IFNAR1, pmod(Ph, TYR, 466)"
                }
            ],
            "evidence": "IFNaR1 is phosphorylated in vitro at two sites by p135tyk2",
            "metadata": {
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5ed44e34-f2c0-486d-bd24-e91a336f3e8e",
        "_rev": "_WpvYGJ--_j",
        "nanopub": {
            "id": "5ed44e34-f2c0-486d-bd24-e91a336f3e8e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "r=0.63",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL15)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0c7fda8f-ecc5-48f0-9925-ee94e1956841",
        "_rev": "_WpvYGJC-_o",
        "nanopub": {
            "id": "0c7fda8f-ecc5-48f0-9925-ee94e1956841",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "518 SLE (southern Chinese cohort)",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "NPSLE",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "11327248",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"IgG anticardiolipin\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Univariate analysis revealed that NP-SLE was associated with a positive lupus anticoagulant (LAC) (p = 0.001), a strongly positive IgG anticardiolipin (aCL) (p = 0.01). leukopenia (p = 0.01), lymphopenia (p = 0.03), thrombocytopenia (p = 0.03), and pulmonary involvement (p = 0.03).\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ece5a052-6535-423c-aeb4-602e5011941d",
        "_rev": "_WpvYGJG--k",
        "nanopub": {
            "id": "ece5a052-6535-423c-aeb4-602e5011941d",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12417590",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "complex(GO\"Interleukin 23 complex\")",
                    "relation": "increases",
                    "object": "r(HGNC:IL17)"
                }
            ],
            "evidence": "IL-23 promoted elevated levels of IL-17 mRNA (Fig.\u00a02\u00a0B). IL-17 mRNA levels were increased several hundred-fold within 6 h of IL-23 exposure and remained elevated in the continued presence of IL-23.\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "36451022-1b03-40d6-bdc7-8cb5fe38cbc1",
        "_rev": "_WpvYGI6--p",
        "nanopub": {
            "id": "36451022-1b03-40d6-bdc7-8cb5fe38cbc1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"B cell\"",
                    "label": "B cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12446913",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL4)",
                    "relation": "increases",
                    "object": "p(\"IgE\")"
                }
            ],
            "evidence": "Strikingly, the strong up-regulation of IgE seen in the IL-21R\u2013/\u2013 mice completely disappeared in IL-4\u2013/\u2013 IL-21R\u2013/\u2013 mice (Fig. 3B, lower right panel), which indicated that the increased IgE in IL-21R\u2013/\u2013 mice was strictly dependent on IL-4\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "00a063d0-ad03-4f8b-85e5-e795438ae3d0",
        "_rev": "_WpvYGJC-AM",
        "nanopub": {
            "id": "00a063d0-ad03-4f8b-85e5-e795438ae3d0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "8457224",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNF)",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "Serum concentrations of TNFa correlated significantly with serum levels of IL-6 both in RA patients (r = 0.487, P = 0.007; n = 32) (Figure 3)\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3322e091-b2f8-47b8-9ab4-9a6ebaedf549",
        "_rev": "_WpvYGJG-A5",
        "nanopub": {
            "id": "3322e091-b2f8-47b8-9ab4-9a6ebaedf549",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "Crossover study with 15 healthy subjects",
                    "type": "Cohort"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Dixit, Vishwa Deep",
                    "Yang, Hyunwon",
                    "Sayeed, Khaleel S",
                    "Stote, Kim S",
                    "Rumpler, William V",
                    "Baer, David J",
                    "Longo, Dan L",
                    "Mattson, Mark P",
                    "Taub, Dennis D"
                ],
                "database": {
                    "id": "21385360",
                    "name": "PubMed"
                },
                "source_name": "Journal of inflammation (London, England)",
                "title": "Controlled meal frequency without caloric restriction alters peripheral blood mononuclear cell cytokine production.",
                "abstract": "Intermittent fasting (IF) improves healthy lifespan in animals by a mechanism involving reduced oxidative damage and increased resistance to stress. However, no studies have evaluated the impact of controlled meal frequency on immune responses in human subjects."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Fasting\")",
                    "relation": "increases",
                    "object": "p(HGNC:CRP)"
                }
            ],
            "evidence": "CRP levels were elevated in subjects when they were on the OMD diet compared to the TMD diet (Figure\u00a0\u200b(Figure1A).1A)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation",
                "gd:abstract": "Intermittent fasting (IF) improves healthy lifespan in animals by a mechanism involving reduced oxidative damage and increased resistance to stress. However, no studies have evaluated the impact of controlled meal frequency on immune responses in human subjects."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6861f678-8015-4efd-9760-00c3a271c255",
        "_rev": "_WpvYGJ--_w",
        "nanopub": {
            "id": "6861f678-8015-4efd-9760-00c3a271c255",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "r=0.52",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL8)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "21e4d1d2-17a1-4080-9c9e-a780f0c74102",
        "_rev": "_WpvYGJ--Co",
        "nanopub": {
            "id": "21e4d1d2-17a1-4080-9c9e-a780f0c74102",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Electrophoretic Mobility Shift Assay (EMSA)",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Wang, P",
                    "Wu, P",
                    "Siegel, M I",
                    "Egan, R W",
                    "Billah, M M"
                ],
                "database": {
                    "id": "7721885",
                    "name": "PubMed"
                },
                "source_name": "The Journal of biological chemistry",
                "title": "Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms.",
                "abstract": "Our previous studies in human monocytes have demonstrated that interleukin (IL)-10 inhibits lipopolysaccharide (LPS)-stimulated production of inflammatory cytokines, IL-1 beta, IL-6, IL-8, and tumor necrosis factor (TNF)-alpha by blocking gene transcription. Using electrophoretic mobility shift assays (EMSA), we now show that, in monocytes stimulated with LPS or TNF alpha, IL-10 inhibits nuclear stimulation of nuclear factor kappa B (NF kappa B), a transcription factor involved in the expression of inflammatory cytokine genes. Several other transcription factors including NF-IL-6, AP-1, AP-2, GR, CREB, Oct-1, and Sp-1 are not affected by IL-10. This selective inhibition by IL-10 of NF kappa B activation occurs rapidly and in a dose-dependent manner and correlates well with IL-10's cytokine synthesis inhibitory activity in terms of both kinetics and dose responsiveness. Furthermore, compounds such as tosylphenylalanyl chloromethyl ketone and pyrrolidinedithiocarbamate that are known to selectively inhibit NF kappa B activation block cytokine gene transcription in LPS-stimulated monocytes. Taken together, these results suggest that inhibition of NF kappa B activation may be an important mechanism for IL-10 suppression of cytokine gene transcription in human monocytes. IL-4, another cytokine that inhibits cytokine mRNA accumulation in monocytes, shows little inhibitory effect on LPS-induced NF kappa B activation. Further examination reveals that, unlike IL-10, IL-4 enhances mRNA degradation and does not suppress cytokine gene transcription. These data indicate that IL-10 and IL-4 inhibit cytokine production by different mechanisms."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL10)",
                    "relation": "decreases",
                    "object": "p(HGNC:NFKB1)"
                }
            ],
            "evidence": "Incubation of PBMC with IL-10 alone for up to 1.5 h had no effect on nuclear NF\u03baB. However, when IL-10 was added 5 min before LPS, NF\u03baB translocation induced by LPS was completely inhibited (Fig. 1 B). Under the same conditions, production of IL-6 and IL-8 was also inhibited (data not shown). Stimulation of PBMC with a different stimulus, TNF\u03b1, caused nuclear localization of NF\u03baB, but to a smaller degree than LPS. TNF\u03b1-induced NF\u03baB translocation (and cytokine synthesis under the same experimental conditions) was inhibited by IL-10 treatment. Thus, IL-10 inhibits NF\u03baB activation in PBMC in response to two distinct stimulating agents.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Our previous studies in human monocytes have demonstrated that interleukin (IL)-10 inhibits lipopolysaccharide (LPS)-stimulated production of inflammatory cytokines, IL-1 beta, IL-6, IL-8, and tumor necrosis factor (TNF)-alpha by blocking gene transcription. Using electrophoretic mobility shift assays (EMSA), we now show that, in monocytes stimulated with LPS or TNF alpha, IL-10 inhibits nuclear stimulation of nuclear factor kappa B (NF kappa B), a transcription factor involved in the expression of inflammatory cytokine genes. Several other transcription factors including NF-IL-6, AP-1, AP-2, GR, CREB, Oct-1, and Sp-1 are not affected by IL-10. This selective inhibition by IL-10 of NF kappa B activation occurs rapidly and in a dose-dependent manner and correlates well with IL-10's cytokine synthesis inhibitory activity in terms of both kinetics and dose responsiveness. Furthermore, compounds such as tosylphenylalanyl chloromethyl ketone and pyrrolidinedithiocarbamate that are known to selectively inhibit NF kappa B activation block cytokine gene transcription in LPS-stimulated monocytes. Taken together, these results suggest that inhibition of NF kappa B activation may be an important mechanism for IL-10 suppression of cytokine gene transcription in human monocytes. IL-4, another cytokine that inhibits cytokine mRNA accumulation in monocytes, shows little inhibitory effect on LPS-induced NF kappa B activation. Further examination reveals that, unlike IL-10, IL-4 enhances mRNA degradation and does not suppress cytokine gene transcription. These data indicate that IL-10 and IL-4 inhibit cytokine production by different mechanisms.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3a4be931-51b0-487b-937b-38bd2d0534a3",
        "_rev": "_WpvYGI6--a",
        "nanopub": {
            "id": "3a4be931-51b0-487b-937b-38bd2d0534a3",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18641361",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Lupus Erythematosus, Systemic\")",
                    "relation": "positiveCorrelation",
                    "object": "r(HGNC:IFNG)"
                }
            ],
            "evidence": "\u00a0Peripheral blood T cells from patients with SLE expressed significantly larger amounts of IFN-\u03b3 mRNA than those from normal controls after CD28 costimulation (p\u00a0= 0.009; Mann-Whitney\u00a0U\u00a0test) (Fig. 1\u21d3C).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "aa816fd3-2d47-482f-86f3-11ef32b3e09d",
        "_rev": "_WpvYGI6--I",
        "nanopub": {
            "id": "aa816fd3-2d47-482f-86f3-11ef32b3e09d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "RNA Hybridization",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8790368",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "increases",
                    "object": "r(HGNC:NOS2)"
                }
            ],
            "evidence": "Autoradiography of these specimens showed little :fE hybridization to control untreated cells. Following cytokine treatment, however, there was strong hybridization of the iNOS riboprobe to neutrophils within the cell population (Fig. 5).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "49a8fabe-9653-413d-b073-8043e8ce5c55",
        "_rev": "_WpvYGJ--BV",
        "nanopub": {
            "id": "49a8fabe-9653-413d-b073-8043e8ce5c55",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:\"lymph node\"",
                    "label": "lymph node",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12594853",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:JAK2, pmod(Ph))",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IFNG))"
                }
            ],
            "evidence": "Addition of A1 to IL-12-stimulated 2D6 cell cultures induced a dose-dependent inhibition of IFN- + production. In contrast, B42 failed to produce any inhibitory effect (Fig. 3A\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d1ecb60f-9b9f-45fb-9e44-853c113fbf1f",
        "_rev": "_WpvYGJG-_k",
        "nanopub": {
            "id": "d1ecb60f-9b9f-45fb-9e44-853c113fbf1f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "12 VKH patients, 20 controlled",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:\"Dendritic Cells\"",
                    "label": "Dendritic Cells",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Yang, Yan",
                    "Qi, Jian",
                    "Wang, Qian",
                    "Du, Liping",
                    "Zhou, Yan",
                    "Yu, Hongsong",
                    "Kijlstra, Aize",
                    "Yang, Peizeng"
                ],
                "comments": "Very small sample size\n",
                "database": {
                    "id": "23482469",
                    "name": "PubMed"
                },
                "source_name": "Investigative ophthalmology & visual science",
                "title": "Berberine suppresses Th17 and dendritic cell responses.",
                "abstract": "Berberine (BBR) has been shown to exert immunosuppressive and anti-inflammatory effects in several autoimmune diseases. This study was designed to investigate the possible effect of BBR on Th17 and dendritic cell (DC) responses."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:berberine)",
                    "relation": "decreases",
                    "object": "sec(complex(GO:\"interleukin-23 complex\"))"
                },
                {
                    "subject": "a(CHEBI:berberine)",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IL1B))"
                },
                {
                    "subject": "a(CHEBI:berberine)",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IL6))"
                }
            ],
            "evidence": "On the one hand, BBR downregulated the expression of costimulatory molecules (CD40, CD80, and CD86) and, on the other hand, it inhibited IL-6, IL-1\u03b2, and IL-23 secretion by DCs.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f9080884-a366-44b4-b7fd-66fae0275f57",
        "_rev": "_WpvYGJG-AH",
        "nanopub": {
            "id": "f9080884-a366-44b4-b7fd-66fae0275f57",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:monocyte",
                    "label": "monocyte",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "30 RA patients, 30 HC",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Sahar SaadGanebaAbd El-Wahab ShamsEl-BrashyaEman AbdelalimBarakaaAbeer A.AboelazmbShaza A.Abdul Basseta"
                ],
                "comments": "https://www.sciencedirect.com/science/article/pii/S1110116415001064?via%3Dihub#!",
                "database": {
                    "id": "",
                    "name": "PubMed"
                },
                "title": "Peroxisome proliferator-activated receptor gamma expression in peripheral monocytes from rheumatoid arthritis patients",
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:PPARG)",
                    "relation": "negativeCorrelation",
                    "object": "path(DAS28)"
                }
            ],
            "evidence": "In RA patients, monocyte PPAR\u03b3 expression levels showed significant negative correlations with morning stiffness durations, total joint count, visual analog scale for pain, DAS-28 and HAQ (p > 0.001) and with swelling joint count, erythrocyte sedimentation rate and platelet count (p < 0.05).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "82d9e862-ca5e-4d7a-82bb-562b1038cdef",
        "_rev": "_WpvYGI6--M",
        "nanopub": {
            "id": "82d9e862-ca5e-4d7a-82bb-562b1038cdef",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "An obese male patient aged 48 years with a history of gout of 8 years' duration was re-admitted to the ward in relapse.",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "The patient fasted for 34 days. Serial values of the serum uric acid are recorded in Fig. 1. From this, it can be seen that between the 5th and 9th days of fasting the serum uric acid rose from 4 to 15 mg/ 100 ml and remained above this latter value for a further 28 days. The patient was given a 400 calorie diet and the level of serum uric acid fell from 23-8 to 13 mg/100 ml within 3 days. On discharge it was still elevated at 15 mg/100 ml.",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:gout",
                    "label": "gout",
                    "type": "Disease"
                }
            ],
            "citation": {
                "comments": "no p-value given",
                "database": {
                    "id": "5821185",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Fasting\")",
                    "relation": "increases",
                    "object": "a(CHEBI:\"uric acid\")"
                }
            ],
            "evidence": "The patient fasted for 34 days. Serial values of the serum uric acid are recorded in Fig. 1. From this, it can be seen that between the 5th and 9th days of fasting the serum uric acid rose from 4 to 15 mg/ 100 ml and remained above this latter value for a further 28 days. The patient was given a 400 calorie diet and the level of serum uric acid fell from 23-8 to 13 mg/100 ml within 3 days. On discharge it was still elevated at 15 mg/100 ml.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "117ac03b-3835-4b0e-80ed-d351206699dc",
        "_rev": "_WpvYGJG-BO",
        "nanopub": {
            "id": "117ac03b-3835-4b0e-80ed-d351206699dc",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Thanei, Sophia",
                    "Vanhecke, Dominique",
                    "Trendelenburg, Marten"
                ],
                "database": {
                    "id": "26148903",
                    "name": "PubMed"
                },
                "source_name": "Clinical immunology (Orlando, Fla.)",
                "title": "Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways.",
                "abstract": "Autoantibodies against complement C1q (anti-C1q) strongly correlate with the occurrence of lupus nephritis and hypocomplementemia in systemic lupus erythematosus (SLE). Although a direct pathogenic role of anti-C1q has been suggested, the assumed complement-activating capacity remains to be elucidated. Using an ELISA-based assay, we found that anti-C1q activate the classical (CP) and lectin pathways (LP) depending on the anti-C1q immunoglobulin-class repertoire present in the patient's serum. IgG anti-C1q resulted in the activation of the CP as reflected by C4b deposition in the presence of purified C1 and C4 in a dose-dependent manner. The extent of C4b deposition correlated with anti-C1q levels in SLE patients but not in healthy controls. Our data indicate that SLE patient-derived anti-C1q can activate the CP and the LP but not the alternative pathway of complement. These findings are of importance for the understanding of the role of anti-C1q in SLE suggesting a direct link to hypocomplementemia."
            },
            "assertions": [
                {
                    "subject": "a(anti-c1q)\t",
                    "relation": "increases",
                    "object": "bp(GO:\"complement activation, classical pathway\")"
                },
                {
                    "subject": "a(anti-c1q)\t",
                    "relation": "increases",
                    "object": "bp(GO:\"complement activation, lectin pathway\")"
                },
                {
                    "subject": "a(anti-c1q)",
                    "relation": "increases",
                    "object": "bp(GO:\"complement activation\")"
                }
            ],
            "evidence": "Anti-C1q autoantibodies from systemic lupus erythematosus patients activate the complement system via both the classical and lectin pathways",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "Autoantibodies against complement C1q (anti-C1q) strongly correlate with the occurrence of lupus nephritis and hypocomplementemia in systemic lupus erythematosus (SLE). Although a direct pathogenic role of anti-C1q has been suggested, the assumed complement-activating capacity remains to be elucidated. Using an ELISA-based assay, we found that anti-C1q activate the classical (CP) and lectin pathways (LP) depending on the anti-C1q immunoglobulin-class repertoire present in the patient's serum. IgG anti-C1q resulted in the activation of the CP as reflected by C4b deposition in the presence of purified C1 and C4 in a dose-dependent manner. The extent of C4b deposition correlated with anti-C1q levels in SLE patients but not in healthy controls. Our data indicate that SLE patient-derived anti-C1q can activate the CP and the LP but not the alternative pathway of complement. These findings are of importance for the understanding of the role of anti-C1q in SLE suggesting a direct link to hypocomplementemia.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e3ab3b78-0937-4dc3-89fc-01b9ded3523d",
        "_rev": "_WpvYGJG-At",
        "nanopub": {
            "id": "e3ab3b78-0937-4dc3-89fc-01b9ded3523d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:\"lipid metabolism disorder\"",
                    "label": "lipid metabolism disorder",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "p=0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=76",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Immunophlerometry",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12818406",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"linoleic acid\")",
                    "relation": "decreases",
                    "object": "p(HGNC:SAA1)"
                }
            ],
            "evidence": "CRP, SAA and IL-6 levels showed a statistically significant reduction after administration of ALA (Table 3).\u00a0\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "41675b73-4b5f-4fbb-acdf-07c543f9dad4",
        "_rev": "_WpvYGJC-Bk",
        "nanopub": {
            "id": "41675b73-4b5f-4fbb-acdf-07c543f9dad4",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Lin, A L",
                    "Elford, H L"
                ],
                "database": {
                    "id": "6997299",
                    "name": "PubMed"
                },
                "source_name": "The Journal of biological chemistry",
                "title": "Adenosine deaminase impairment and ribonucleotide reductase activity and levels in HeLa cells.",
                "abstract": "Adenosine deaminase (adenosine aminohydrolase, EC 3.5.4.4)-deficient patients recently were found to have abnormally high levels of dATP, a negative allosteric effector of ribonucleotide reductase (ribonucleoside-diphosphate reductase, 2'-deoxyribonucleoside-diphosphate:oxidized thioredoxin 2'-oxidoreductase, EC 1.17.4.1). Therefore it was proposed that the immunodeficiency associated with adenosine deaminase deficiency is mediated through inhibition of ribonucleotide reductase and hence DNA replication. HeLa cells, treated with an adenosine deaminase inhibitor, erythro-9(2-hydroxy-3-nonyl)adenine, and deoxyadenosine to mimic the adenosine deaminase-deficient state, were monitored to determine directly the effects on ribonucleotide reductase activity and levels. A low concentration of erythro-9-(2-hydroxy-3-nonyl)adenine, which did not inhibit cell growth, nevertheless retarded the cells in G2 + M phase of the cell cycle and increased reductase activity. Reductase activity was also elevated in cells treated with a low level of deoxyadenosine which did not affect the cell cycle or cell growth. However, ribonucleotide reductase activity was reduced to one-half of the control value in cells treated with either enough deoxyadenosine to inhibit cell growth or with a combination of erythro-9(2-hydroxy-3-nonyl)adenine and deoxyadenosine, each at concentrations which individually do not inhibit cell growth. Removal of deoxynucleotides, particularly dATP, from these extracts increased ribonucleotide reductase activity to several-fold higher than control values. The reduced activity of ribonucleotide reductase in the simulated adenosine deaminase-deficient HeLa cells provides direct evidence for the thesis that adenosine deaminase deficiency disease is mediated through elevated levels of dATP which inhibit ribonucleotide reductase. In addition, the cell cycle patterns and ribonucleotide reductase levels suggest that the regulatory substance(s) that controls the level of ribonucleotide reductase is not operative until the late S or G2 phase of the cell cycle."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:ADA)",
                    "relation": "increases",
                    "object": "a(CHEBI:inosine)"
                },
                {
                    "subject": "p(HGNC:ADA)",
                    "relation": "decreases",
                    "object": "a(CHEBI:adenosine)"
                }
            ],
            "evidence": "\u00a0Adenosinedeaminase catalyzes the conversion of both adenosine and 2\u2019-deoxyadenosine to inosine and 2\u2019-deoxyinosine, respectively.\u00a0",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f872846a-1148-40e9-b02f-6e2273e6e85d",
        "_rev": "_WpvYGJ--At",
        "nanopub": {
            "id": "f872846a-1148-40e9-b02f-6e2273e6e85d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.003",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "60 SLE",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "16754628",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:TBX21)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "Patients who developed lupus flare during the 4\u2009yrs of follow-up had higher baseline urinary T-bet (7.64 \u00b1 8.34 vs 2.37 \u00b1 2.15, P = 0.003), but not GATA-3 expression (1.45 \u00b1 1.87 vs 1.34 \u00b1 2.76, P = 0.8), than those who did not flare.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8ba946a9-00c7-443c-bb9b-2d64c41ea431",
        "_rev": "_WpvYGJC-BJ",
        "nanopub": {
            "id": "8ba946a9-00c7-443c-bb9b-2d64c41ea431",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8022486",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL4)",
                    "relation": "increases",
                    "object": "p(HGNC:JAK3, pmod(Ph))"
                },
                {
                    "subject": "p(HGNC:IL2)",
                    "relation": "increases",
                    "object": "p(HGNC:JAK3, pmod(Ph))"
                }
            ],
            "evidence": "IL-2 and IL-4 induced tyrosine phosphorylation of jak-3\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "68d9abf8-a46e-4ded-a88b-d950ed9aeaa6",
        "_rev": "_WpvYGJG--J",
        "nanopub": {
            "id": "68d9abf8-a46e-4ded-a88b-d950ed9aeaa6",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "DLN Cells",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "15657292",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "complex(GO:\"Interleukin 23 complex\")\t",
                    "relation": "increases",
                    "object": "r(HGNC:GMCSF)"
                },
                {
                    "subject": "complex(GO:\"Interleukin 23 complex\")\t",
                    "relation": "increases",
                    "object": "r(HGNC:CCR1)"
                },
                {
                    "subject": "complex(GO:\"Interleukin 23 complex\")\t",
                    "relation": "increases",
                    "object": "r(HGNC:CCL22)"
                },
                {
                    "subject": "complex(GO:\"Interleukin 23 complex\")\t",
                    "relation": "increases",
                    "object": "r(HGNC:CCL20)"
                },
                {
                    "subject": "complex(GO:\"Interleukin 23 complex\")\t",
                    "relation": "increases",
                    "object": "r(HGNC:CCL17)"
                },
                {
                    "subject": "complex(GO:\"Interleukin 23 complex\")\t",
                    "relation": "increases",
                    "object": "r(HGNC:CCL7)"
                }
            ],
            "evidence": "However, IL-23 induced, in addition to IL-17 and IL-17F, elevated expression of genes such as CCL7, CCL17, CCL20, CCL22, CCR1, and GM-CSF.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7c1d280a-24ed-45c8-b0f6-ccfe805165a2",
        "_rev": "_WpvYGJG-_-",
        "nanopub": {
            "id": "7c1d280a-24ed-45c8-b0f6-ccfe805165a2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ARC20",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "611 patients",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Fleischmann, Roy",
                    "Kremer, Joel",
                    "Cush, John",
                    "Schulze-Koops, Hendrik",
                    "Connell, Carol A",
                    "Bradley, John D",
                    "Gruben, David",
                    "Wallenstein, Gene V",
                    "Zwillich, Samuel H",
                    "Kanik, Keith S",
                    ", "
                ],
                "database": {
                    "id": "22873530",
                    "name": "PubMed"
                },
                "source_name": "The New England journal of medicine",
                "title": "Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis.",
                "abstract": "Tofacitinib (CP-690,550) is a novel oral Janus kinase inhibitor that is being investigated as a targeted immunomodulator and disease-modifying therapy for rheumatoid arthritis."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:tofacitinib)",
                    "relation": "decreases",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "At month 3, a higher percentage of patients in the tofacitinib groups than in the placebo groups met the criteria for an ACR 20 response (59.8% in the 5-mg tofacitinib group and 65.7% in the 10-mg tofacitinib group vs. 26.7% in the combined placebo groups, P<0.001 for both comparisons).\u00a0\n\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bcd60c01-c42c-4622-aad4-69e1a0fcd87c",
        "_rev": "_WpvYGJC-Bl",
        "nanopub": {
            "id": "bcd60c01-c42c-4622-aad4-69e1a0fcd87c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.0011",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "20 individuals with GAD (8 male, 12 female) and 20 controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Thymidine Incorporation",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "20865305",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"Substance P\")",
                    "relation": "increases",
                    "object": "bp(GO:\"T cell proliferation\")"
                }
            ],
            "evidence": "On the other hand, the PHA-induced T cell proliferation in the control cell cultures was enhanced by SP (Fig. 1a)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "206f1963-38d3-4fb8-b03e-0ee9ac1165bd",
        "_rev": "_WpvYGJ--B_",
        "nanopub": {
            "id": "206f1963-38d3-4fb8-b03e-0ee9ac1165bd",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17587156",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL10)\t",
                    "relation": "negativeCorrelation",
                    "object": "p(EG:720)"
                },
                {
                    "subject": "p(HGNC:IL10)\t",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:C3)"
                },
                {
                    "subject": "p(HGNC:IL10)\t",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "p(HGNC:IL10)",
                    "relation": "positiveCorrelation",
                    "object": "p(\"anti-dsDNA\")"
                }
            ],
            "evidence": "Serum IL-10 level was also significantly elevated in active SLE patients and revealed positive correlation with SLEDAI and anti-double-stranded DNA (dsDNA) titer and negative correlation with C3, C4, and lymphocyte counts.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f027ddec-71b6-441c-af8d-2aacfdc827fa",
        "_rev": "_WpvYGJG-AK",
        "nanopub": {
            "id": "f027ddec-71b6-441c-af8d-2aacfdc827fa",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "MESH:D009504",
                    "label": "Neutrophils",
                    "type": "Anatomy;Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Carr, A C",
                    "Winterbourn, C C"
                ],
                "database": {
                    "id": "9355763",
                    "name": "PubMed"
                },
                "source_name": "The Biochemical journal",
                "title": "Oxidation of neutrophil glutathione and protein thiols by myeloperoxidase-derived hypochlorous acid.",
                "abstract": "Neutrophils, when stimulated, generate reactive oxygen species including myeloperoxidase-derived HOCl. There is an associated decrease in reduced glutathione (GSH) concentration. We have shown that neutrophil GSH levels decrease on exposure to reagent HOCl, whereas the equivalent concentration of H2O2 had no effect. GSH loss occurred without cell lysis, was not reversible, and was accompanied by the loss of an equivalent proportion of the total protein thiols. No glutathione disulphide was formed. Studies with 35S-labelled cells indicated that much of the GSH lost was accounted for by mixed disulphides with protein and a product that co-migrated on HPLC with a novel compound formed in the reaction of HOCl and pure GSH. The properties of this compound are consistent with an intramolecular sulphonamide. Neutrophils stimulated with PMA lost 30-40% of their GSH and a similar proportion of protein thiols. Little glutathione disulphide was formed and the products were the same as seen with HOCl-treated cells. From the results and studies with inhibitors and scavengers, we conclude that HOCl was responsible for the GSH loss. Propargylglycine and buthionine sulphoximine, inhibitors of glutathione synthesis, enhanced GSH loss, but their effects were due to the production of long-lived chloramines that oxidized GSH with greater efficiency than HOCl, rather than to the inhibition of GSH synthesis. The lack of thiol selectivity by HOCl and irreversibility of oxidation means that GSH will provide limited antioxidant protection for thiol enzymes in stimulated neutrophils."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"hypochlorous acid\")",
                    "relation": "decreases",
                    "object": "a(CHEBI:glutathione)"
                }
            ],
            "evidence": "\"The addition of HOCl to resting neutrophils caused\nconcentration-dependent losses of intracellular GSH and a\nproportionate number of protein thiols (Figure 1).\"",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5a0687ad-43a0-4e76-b903-221b2c99a29d",
        "_rev": "_WpvYGJ---7",
        "nanopub": {
            "id": "5a0687ad-43a0-4e76-b903-221b2c99a29d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "22783398",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Nucleosomes)\t",
                    "relation": "positiveCorrelation",
                    "object": "p(GO:His4, pmod(Me3, Lys, 20))"
                },
                {
                    "subject": "a(MESH:Nucleosomes)",
                    "relation": "positiveCorrelation",
                    "object": "p(GO:His3, pmod(Me3, Lys, 9))"
                }
            ],
            "evidence": "Analysis with the Pearson\u2019s test revealed a significant positive correlation between cNUCs and H3K9me3 or H4K20me3 (p<0.001 for both histone marks)\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "40398391-8b4e-4023-8d21-1c54a108c279",
        "_rev": "_WpvYGJ--_B",
        "nanopub": {
            "id": "40398391-8b4e-4023-8d21-1c54a108c279",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.16",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "0.03",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "1518 men and 1524 women",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15992645",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Seafood)",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "All inflammatory markers showed an inverse dose-response relationship with fish consumption (Table 2).\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c4d87694-4fc5-42ef-b74a-f1473e2d5883",
        "_rev": "_WpvYGI6--e",
        "nanopub": {
            "id": "c4d87694-4fc5-42ef-b74a-f1473e2d5883",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "MRI",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "authors": [
                    "Verstovsek, Srdan",
                    "Mesa, Ruben A",
                    "Gotlib, Jason",
                    "Levy, Richard S",
                    "Gupta, Vikas",
                    "DiPersio, John F",
                    "Catalano, John V",
                    "Deininger, Michael",
                    "Miller, Carole",
                    "Silver, Richard T",
                    "Talpaz, Moshe",
                    "Winton, Elliott F",
                    "Harvey, Jimmie H",
                    "Arcasoy, Murat O",
                    "Hexner, Elizabeth",
                    "Lyons, Roger M",
                    "Paquette, Ronald",
                    "Raza, Azra",
                    "Vaddi, Kris",
                    "Erickson-Viitanen, Susan",
                    "Koumenis, Iphigenia L",
                    "Sun, William",
                    "Sandor, Victor",
                    "Kantarjian, Hagop M"
                ],
                "comments": "\u00a0INCB018424 is ruxolitinib",
                "database": {
                    "id": "22375971",
                    "name": "PubMed"
                },
                "source_name": "The New England journal of medicine",
                "title": "A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis.",
                "abstract": "Ruxolitinib, a selective inhibitor of Janus kinase (JAK) 1 and 2, has clinically significant activity in myelofibrosis."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:ruxolitinib)",
                    "relation": "decreases",
                    "object": "path(MESH:Splenomegaly)"
                }
            ],
            "evidence": "The primary end point was reached in 41.9% of patients in the ruxolitinib group as compared with 0.7% in the placebo group (P<0.001). A reduction in spleen volume was maintained in patients who received ruxolitinib; 67.0% of the patients with a response had the response for 48 weeks or more. There was an improvement of 50% or more in the total symptom score at 24 weeks in 45.9% of patients who received ruxolitinib as compared with 5.3% of patients who received placebo (P<0.001)",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ff4206ff-4939-4b6f-974b-18ee97896895",
        "_rev": "_WpvYGJ---h",
        "nanopub": {
            "id": "ff4206ff-4939-4b6f-974b-18ee97896895",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:tuberculosis",
                    "label": "tuberculosis",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "28582466",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:Tuberculosis)",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:IL7R)"
                }
            ],
            "evidence": "Tuberculosis patients had significantly lower sIL-7R concentrations as compared to healthy contacts (p < 0.001) (Fig 1a).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "32cc03fd-768e-463e-b2c2-19a17506178b",
        "_rev": "_WpvYGJC--6",
        "nanopub": {
            "id": "32cc03fd-768e-463e-b2c2-19a17506178b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12540401",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"Cold Exposure\")",
                    "relation": "positiveCorrelation",
                    "object": "bp(GO:\"nicotinamide metabolic process\")"
                }
            ],
            "evidence": "Of the stresses studied, cold exposure significantly increased the urinary excretory outputs of the nicotinamide metabolites.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2494c3b5-2386-41ea-8cc5-f884eae01e90",
        "_rev": "_WpvYGI6--Z",
        "nanopub": {
            "id": "2494c3b5-2386-41ea-8cc5-f884eae01e90",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18549798",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:Jak3)",
                    "relation": "association",
                    "object": "r(HGNC:TBX21)"
                }
            ],
            "evidence": "Jak3\u2212/\u2212\u00a0cells fail to induce T-bet under non-skewing conditions, perhaps as a result of their failure to produce any IFN-\u03b3 following activation.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e63c8b40-dabc-4a85-9603-5ad16d57903e",
        "_rev": "_WpvYGJC-BY",
        "nanopub": {
            "id": "e63c8b40-dabc-4a85-9603-5ad16d57903e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL5)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "In contrast, consistent with the results above, levels of several inflammatory mediators varied between pre-flare and non-flare periods (Figure 2 and Supplementary Table 4). Impending flares were associated with increased Th1, Th2, and Th17 (Figure 2A\u2013C) type cytokines, compared to both self non-flare and matched healthy control samples (Supplementary Figure 2A\u2013C).\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7deedeb9-0374-47be-93d4-e30b26d2d04e",
        "_rev": "_WpvYGJG-AJ",
        "nanopub": {
            "id": "7deedeb9-0374-47be-93d4-e30b26d2d04e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "FACS",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16648838",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:FOXP3)",
                    "relation": "biomarkerFor",
                    "object": "bp(GO:\"regulatory T cell differentiation\")"
                }
            ],
            "evidence": "T cells generated in the presence of TGF-b and expressing Foxp3 (GFP\u00fe) were anergic and inhibited the proliferative response of CD4\u00feCD252 T cells similar to naturally occurring CD4\u00feCD25\u00fe Treg cells (Fig. 3c), demonstrating that TGF-b does induce bona fide Treg cells\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6828cff9-4bb8-4868-ad22-249f4a100ac2",
        "_rev": "_WpvYGJ---f",
        "nanopub": {
            "id": "6828cff9-4bb8-4868-ad22-249f4a100ac2",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17277312",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite(p(HGNC:IL6), complex(GO:\"Interleukin 23 complex\"))",
                    "relation": "increases",
                    "object": "act(p(HGNC:STAT3))"
                }
            ],
            "evidence": "Since the activation of STAT3C still requires cytokine-mediated phosphorylation, in the presence of IL-6 and IL-23 or under THi differentiation conditions, STAT3C greatly increased the numbers of IL-17- producing cells (Fig. 2A)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0d37731a-c733-4987-99af-b83912e2df09",
        "_rev": "_WpvYGJG--K",
        "nanopub": {
            "id": "0d37731a-c733-4987-99af-b83912e2df09",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:obesity",
                    "label": "obesity",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8968852",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(DO:obesity)\t",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IGFBP3)"
                },
                {
                    "subject": "path(DO:obesity)\t",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IGFBP2)"
                },
                {
                    "subject": "path(DO:obesity)\t",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IGFBP1)"
                },
                {
                    "subject": "path(DO:obesity)",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IGF1)"
                }
            ],
            "evidence": "\u00a0Compared to 100 normal-weight girls of same age the obese subjects had increased levels of IGF-I, IGFBP-1, IGFBP-2, and IGFBP-3\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0f5103d5-36e6-4b43-8c04-bd7b1aafcf28",
        "_rev": "_WpvYGJ--Cd",
        "nanopub": {
            "id": "0f5103d5-36e6-4b43-8c04-bd7b1aafcf28",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:Neutrophils",
                    "label": "Neutrophils",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "27413244",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:squalene)",
                    "relation": "decreases",
                    "object": "r(HGNC:IL1B)"
                }
            ],
            "evidence": "). The expression of the pro-inflammatory cytokine genes TNF-\u03b1 and IL-1\u03b2 but not IL-6 or IL-10 was significantly reduced by squalene (50 \u0006M, 18 h) in LPS-treated human monocytes\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "044c032b-3c23-4360-8cc1-b8c5e076b371",
        "_rev": "_WpvYGI6--2",
        "nanopub": {
            "id": "044c032b-3c23-4360-8cc1-b8c5e076b371",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:\"type 2 diabetes mellitus\"",
                    "label": "type 2 diabetes mellitus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17151862",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:BDNF)",
                    "relation": "negativeCorrelation",
                    "object": "a(CHEBI:glucose)"
                }
            ],
            "evidence": "A univariate model showed that this association was due to an inverse correlation between plasma BDNF and fasting plasma glucose (p\u2009<\u20090.0001, Pearson correlation coefficient\u2009=\u2009\u22120.3).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "83c861dc-266c-4d2c-8cdf-8f1d590c95f5",
        "_rev": "_WpvYGJC-BT",
        "nanopub": {
            "id": "83c861dc-266c-4d2c-8cdf-8f1d590c95f5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "DO11.10 Cells",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "12006974",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT4)",
                    "relation": "increases",
                    "object": "act(p(HGNC:IL12), ma(GO:\"cytokine secretion\"))"
                }
            ],
            "evidence": "In addition, IL-12-IL-18-induced IFN-G remained depenent on STAT4 in Th1 cells, despite ectopic T-bet expression\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f1b6e6fb-9b5f-4fd6-8cd1-a9d4c3424e6b",
        "_rev": "_WpvYGJG-_A",
        "nanopub": {
            "id": "f1b6e6fb-9b5f-4fd6-8cd1-a9d4c3424e6b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "1370356",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:\"regulatory T cell\")",
                    "relation": "increases",
                    "object": "p(HGNC:TGFB)"
                }
            ],
            "evidence": "Rabbit anti-TGF-f3 antibody abrogated the suppression mediated by the supernatants in a dose-dependent fashion (Fig. 2).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5675141b-944a-40e6-9f4a-532f5df40f5b",
        "_rev": "_WpvYGJ--Ba",
        "nanopub": {
            "id": "5675141b-944a-40e6-9f4a-532f5df40f5b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15153495",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT4)",
                    "relation": "increases",
                    "object": "r(HGNC:IFNG)"
                }
            ],
            "evidence": "\u00a0Of the 16 genes that were immediately induced in response to IL-12 treatment, only\u00a0Ifn\u03b3 was clearly regulated through STAT4 signaling.\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "88638d7f-0fc2-4e60-9c4b-c723ba3dc8c3",
        "_rev": "_WpvYGJG-_B",
        "nanopub": {
            "id": "88638d7f-0fc2-4e60-9c4b-c723ba3dc8c3",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "DAS28",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "70 RA patients, 30 SLE patients, 25 other autoimmune diseases, 20 osteoarthritis (OA), and 35 HC",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Ni, Min",
                    "Wei, Wei",
                    "Wang, Yichao",
                    "Zhang, Na",
                    "Ding, Hongmei",
                    "Shen, Chen",
                    "Zheng, Fang"
                ],
                "database": {
                    "id": "23532497",
                    "name": "PubMed"
                },
                "source_name": "Journal of clinical immunology",
                "title": "Serum levels of calreticulin in correlation with disease activity in patients with rheumatoid arthritis.",
                "abstract": "The aim of our study was to investigate the contribution of serum calreticulin (CRT) in the assessment of disease activity in rheumatoid arthritis (RA)."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CRT)\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "Significant positive correlation of CRT with DAS28, ESR and CRP was found in RA patients.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c83ebfc3-74fd-406f-a90d-dc0a687379ba",
        "_rev": "_WpvYGJC-CW",
        "nanopub": {
            "id": "c83ebfc3-74fd-406f-a90d-dc0a687379ba",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "RT-PCR, Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"CD4-positive helper T cell\"",
                    "label": "CD4-positive helper T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12612578",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:FOXP3)",
                    "relation": "biomarkerFor",
                    "object": "bp(GO:\"regulatory T cell differentiation\")"
                }
            ],
            "evidence": "These results identify Foxp3 as a molecular marker unique to CD4+ CD25+ regulatory T cells, and suggest a functional role for this molecule in these cells.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5e4c8e97-50c0-4a3a-a2d0-efdcd1f0877d",
        "_rev": "_WpvYGJ--Bq",
        "nanopub": {
            "id": "5e4c8e97-50c0-4a3a-a2d0-efdcd1f0877d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                },
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "database": {
                    "id": "1997655",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:neutrophil)",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL8))"
                }
            ],
            "evidence": ". By contrast, NAP-1/ID8 release by PMN exposed to LPS for the same period was 0.6 \u00b1 0.4 ng/ml (n = 3), and thus exceeded only slightly the values observed in control cultures (0 .08-0.2 ng/ml). T\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "147faa9c-60a7-4ebb-8663-0321d89b0928",
        "_rev": "_WpvYGJC-BS",
        "nanopub": {
            "id": "147faa9c-60a7-4ebb-8663-0321d89b0928",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "qPCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "28 HC",
                    "type": "Cohort"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "comments": "Peripheral blood mononuclear cells from healthy donors were cultured with 1,000 units/ml interferon-\u03b1 (IFN\u03b1) or IFN\u03b3 for 24 hours, and RNA was analyzed by quantitative real-time polymerase chain reaction\n",
                "database": {
                    "id": "15593221",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNG)\t",
                    "relation": "increases",
                    "object": "r(HGNC:PSMB8)"
                },
                {
                    "subject": "p(HGNC:IFNG)\t",
                    "relation": "increases",
                    "object": "r(HGNC:CXCL10)"
                },
                {
                    "subject": "p(HGNC:IFNG)\t",
                    "relation": "increases",
                    "object": "r(HGNC:CXCL9)"
                },
                {
                    "subject": "p(HGNC:IFNG)\t",
                    "relation": "increases",
                    "object": "r(HGNC:IRF1)"
                },
                {
                    "subject": "p(HGNC:IFNG)\t",
                    "relation": "increases",
                    "object": "r(HGNC:SERPING1)"
                },
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "increases",
                    "object": "r(HGNC:GBP1)"
                }
            ],
            "evidence": "Of 9 IFIG candidates for preferential regulation by IFN\u03b3, 6 were confirmed: guanylate binding protein 1 (GBP1); serine proteinase inhibitor, clade G, member 1 (SERPING1); interferon regulatory factor 1 (IRF1); chemokine (C-X-C motif) ligand 9 (CXCL9); chemokine (C-X-C motif) ligand 10 (CXCL10); and proteasome (prosome, macropain) subunit, beta type, 8 (PSMB8).\n",
            "metadata": {
                "project": "Lupus Interferon Signatures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a7da3281-8c94-4dbd-b3d3-f386b6606c1b",
        "_rev": "_WpvYGJG-Bd",
        "nanopub": {
            "id": "a7da3281-8c94-4dbd-b3d3-f386b6606c1b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"Human Umbilical Vein Endothelial Cells\"",
                    "label": "Human Umbilical Vein Endothelial Cells",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Wen, Ya-Dan",
                    "Wang, Hong",
                    "Kho, Sok-Hong",
                    "Rinkiko, Suguro",
                    "Sheng, Xiong",
                    "Shen, Han-Ming",
                    "Zhu, Yi-Zhun"
                ],
                "database": {
                    "id": "23393548",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress.",
                "abstract": "Hydrogen sulfide (H\u2082S) has been shown to have cytoprotective effects in models of hypertension, ischemia/reperfusion and Alzheimer's disease. However, little is known about its effects or mechanisms of action in atherosclerosis. Therefore, in the current study we evaluated the pharmacological effects of H\u2082S on antioxidant defenses and mitochondria protection against hydrogen peroxide (H\u2082O\u2082) induced endothelial cells damage."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Malondialdehyde)",
                    "relation": "biomarkerFor",
                    "object": "a(bp(MESH:\"Oxidative Stress\"))"
                },
                {
                    "subject": "a(MESH:\"Hydrogen Peroxide\")",
                    "relation": "increases",
                    "object": "a(MESH:Malondialdehyde)"
                }
            ],
            "evidence": "Treatment with H2O2 significantly increased cellular MDA levels indicating the elevation of oxidative stress (P<0.01, vs. control).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "300ec458-8fb6-4af0-b9c1-69c732d60cd2",
        "_rev": "_WpvYGJC-AH",
        "nanopub": {
            "id": "300ec458-8fb6-4af0-b9c1-69c732d60cd2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "\"p<0.01 (LPS) p<0.02 (SEB)\"",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "n=19",
                    "type": "Cohort"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16433741",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:ethanol)",
                    "relation": "decreases",
                    "object": "p(HGNC:IL1B)"
                }
            ],
            "evidence": "Fig. 1. Moderate alcohol intake inhibits monocyte production of tumor necrosis factor a (TNF-a) and IL-1b and increases IL-10\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "11fd9670-6232-4b9d-9d33-71b7ae32eece",
        "_rev": "_WpvYGJ---v",
        "nanopub": {
            "id": "11fd9670-6232-4b9d-9d33-71b7ae32eece",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ACR20",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "45 RA (includes 11 no treatment RA controls)",
                    "type": "cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Choy, E H S",
                    "Isenberg, D A",
                    "Garrood, T",
                    "Farrow, S",
                    "Ioannou, Y",
                    "Bird, H",
                    "Cheung, N",
                    "Williams, B",
                    "Hazleman, B",
                    "Price, R",
                    "Yoshizaki, K",
                    "Nishimoto, N",
                    "Kishimoto, T",
                    "Panayi, G S"
                ],
                "comments": "MRA is anti-IL6",
                "database": {
                    "id": "12483717",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Therapeutic benefit of blocking interleukin-6 activity with an anti-interleukin-6 receptor monoclonal antibody in rheumatoid arthritis: a randomized, double-blind, placebo-controlled, dose-escalation trial.",
                "abstract": "To investigate the safety and efficacy of MRA, a recombinant human anti-interleukin-6 (anti-IL-6) receptor monoclonal antibody of the IgG1 subclass that inhibits the function of IL-6, in patients with established rheumatoid arthritis (RA)."
            },
            "assertions": [
                {
                    "subject": "a(anti-IL6R)",
                    "relation": "increases",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "In the secondary analysis of the ACR 20% response, the treatment difference between 5 mg/kg of MRA and placebo was maintained until week 8. The 5-mg/kg MRA group demonstrated a consistent treatment difference from placebo across all secondary efficacy variables. A significant increase in the number of patients with a ACR 20% response was also noted in the 10-mg/kg MRA group versus the placebo group at weeks 6 and 8.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6a863a05-e45c-4cdf-9d1b-1748e4c0bf59",
        "_rev": "_WpvYGJG---",
        "nanopub": {
            "id": "6a863a05-e45c-4cdf-9d1b-1748e4c0bf59",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Reporter Assay",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "AE7",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "16275766",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TBX21, pmod(Ph, S, 508))",
                    "relation": "directlyIncreases",
                    "object": "r(HGNC:IL2)"
                }
            ],
            "evidence": "DNA binding activity of RelA to the IL-2 promoter was reduced markedly in the presence of T-bet (Fig. 7 A).",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "49ac425a-3b14-464f-af2b-8cb9ee6c7161",
        "_rev": "_WpvYGI6--4",
        "nanopub": {
            "id": "49ac425a-3b14-464f-af2b-8cb9ee6c7161",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:obesity",
                    "label": "obesity",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "1263845",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fasting\")",
                    "relation": "increases",
                    "object": "a(CHEBI:\"uric acid\")"
                }
            ],
            "evidence": "With increasing ketonemia the serum uric acid rose from a control value of\u00a05.9 +/- 0.4 to 12.5 +/0 1.0\u00a0at 7 days and then decreased progressively to\u00a07.7 +/- 1.3\u00a0by 28 days despite sustained ketonemia.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f5f82ef0-0f0d-4ce2-9371-f8bc3c553e73",
        "_rev": "_WpvYGJC-CJ",
        "nanopub": {
            "id": "f5f82ef0-0f0d-4ce2-9371-f8bc3c553e73",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Cell",
                    "id": "MESH:D020298",
                    "label": "U937 Cells"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Obajimi, Oluwakemi",
                    "Black, Kenneth D",
                    "Glen, Iain",
                    "Ross, Brian M"
                ],
                "database": {
                    "id": "17198751",
                    "name": "PubMed"
                },
                "source_name": "Prostaglandins, leukotrienes, and essential fatty acids",
                "title": "Antioxidant modulation of oxidant-stimulated uptake and release of arachidonic acid in eicosapentaenoic acid-supplemented human lymphoma U937 cells.",
                "abstract": "Omega-3 polyunsaturated fatty acids (PUFA) are increasingly finding use as treatments for a variety of medical conditions. PUFA supplementation can, however, result in increased oxidative stress causing elevated turnover rate of membrane phospholipids, impairment of membrane integrity and increased formation of inflammatory mediators. The aim of this study was to determine which antioxidant compounds were most effective in ameliorating the stimulation of phospholipid turnover by oxidative stress. U937 cells were supplemented with eicosapentaenoic acid and either ascorbic acid, alpha-tocopherol, beta-carotene or astaxanthin prior to being challenged with oxidant. Although all antioxidants were found to be effective in decreasing oxidant-stimulated peroxide formation, only alpha-tocopherol significantly decreased oxidant-stimulated release of 3H-labeled arachidonic acid (AA), while ascorbic acid markedly increased release. All antioxidants except alpha-tocopherol decreased oxidant-stimulated 3H-AA uptake. Our data suggest that antioxidants are not equally effective in combating the effects of oxidative stress upon membrane phospholipid turnover, and that optimal protection will require mixtures of antioxidants.",
                "date_published": "2007-02-01"
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:alpha-tocopherol)",
                    "relation": "decreases",
                    "object": "a(CHEBI:\"arachidonic acid\")"
                }
            ],
            "evidence": "",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4dbb1f6c-d30c-4523-b96c-e897aacae63a",
        "_rev": "_WpvYGJ--AO",
        "nanopub": {
            "id": "4dbb1f6c-d30c-4523-b96c-e897aacae63a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:\"synovial membrane of synovial joint\"",
                    "label": "synovial membrane of synovial joint",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:fibroblast",
                    "label": "fibroblast",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9647250",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL1B)",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL6))"
                },
                {
                    "subject": "p(HGNC:IL17)",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL6))"
                }
            ],
            "evidence": "Both human rIL-1\u03b2 and rIL-17 induced IL-6 and leukemia inhibitory factor (LIF) production by synovial fibroblasts in a dose-dependent manner.\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9ec94e69-a676-473a-a8f3-df4ae6f26e17",
        "_rev": "_WrNIRte---",
        "nanopub": {
            "id": "9ec94e69-a676-473a-a8f3-df4ae6f26e17",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "36 SLE, 18 HC",
                    "type": "cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Ren, Yi",
                    "Tang, Jinling",
                    "Mok, M Y",
                    "Chan, Albert W K",
                    "Wu, Adrian",
                    "Lau, C S"
                ],
                "database": {
                    "id": "14558095",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus.",
                "abstract": "To evaluate whether patients with systemic lupus erythematosus (SLE) have a higher rate of apoptosis in and secondary necrosis of polymorphonuclear neutrophils (PMNs) and macrophages compared with controls; to compare the rate of macrophage phagocytic clearance of apoptotic PMNs in patients with SLE and healthy controls; to evaluate whether in vitro PMN and macrophage apoptosis and secondary necrosis, and the ability of macrophages to phagocytose apoptotic bodies, are correlated with lupus disease activity; and to determine whether macrophage clearance of apoptotic bodies in patients with SLE and normal controls is related to certain serum factors."
            },
            "assertions": [
                {
                    "subject": "a(secondary necrotic PMNs)\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "the percentage of secondary necroticPMNs from patients with SLE was also significantly higher than the percentage of necrotic PMNs from controls.",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "To evaluate whether patients with systemic lupus erythematosus (SLE) have a higher rate of apoptosis in and secondary necrosis of polymorphonuclear neutrophils (PMNs) and macrophages compared with controls; to compare the rate of macrophage phagocytic clearance of apoptotic PMNs in patients with SLE and healthy controls; to evaluate whether in vitro PMN and macrophage apoptosis and secondary necrosis, and the ability of macrophages to phagocytose apoptotic bodies, are correlated with lupus disease activity; and to determine whether macrophage clearance of apoptotic bodies in patients with SLE and normal controls is related to certain serum factors.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.9010000",
                "gd:updateTS": "2018-04-17T13:27:53.833Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7a6c7f79-eac7-43d7-8fc1-132be1182bc3",
        "_rev": "_WpvYGI6--s",
        "nanopub": {
            "id": "7a6c7f79-eac7-43d7-8fc1-132be1182bc3",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "n=16 intervention and n=12 controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "p=0.014",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "PDAI",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"ulcerative colitis\"",
                    "label": "ulcerative colitis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "18240282",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"VSL#3\")",
                    "relation": "decreases",
                    "object": "path(MESH:\"Ulcerative colitis\")"
                }
            ],
            "evidence": "Patients treated with VSL#3 showed a slight but significant reduction in PDAI score after 3 months of treatment compared with baseline.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d0fec31b-0825-4270-a63c-8142ea0d37ad",
        "_rev": "_WpvYGJC-Bh",
        "nanopub": {
            "id": "d0fec31b-0825-4270-a63c-8142ea0d37ad",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "8 young and 8 older healthy volunteers",
                    "type": "Cohort"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "22882710",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"B. longum SP 07/3\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL10)"
                }
            ],
            "evidence": "There was a significant effect of age on the production of IL-6 (P\u00a0< 0.05), IFN-\u03b3 (P\u00a0< 0.01) and RANTES (P\u00a0< 0.001), and of probiotics (P\u00a0< 0.001) on production of IL-1\u03b2, IFN-\u03b3, IL-6, IL-10, GM-CSF and RANTES (Figs\u00a05\u00a0and\u00a06)\n",
            "metadata": {
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e8ff6bf7-999d-48c0-9eba-0a31fde9b99b",
        "_rev": "_WpvYGJ--_T",
        "nanopub": {
            "id": "e8ff6bf7-999d-48c0-9eba-0a31fde9b99b",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Reporter Assay",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "Northern Blot",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10761931",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "sec(p(HGNC:IFNG))",
                    "relation": "biomarkerFor",
                    "object": "bp(GO:\"T-helper 1 cell differentiation\")"
                },
                {
                    "subject": "p(HGNC:TBX21)",
                    "relation": "decreases",
                    "object": "bp(GO:\"T-helper 2 cell differentiation\")"
                }
            ],
            "evidence": "Introduction of T-bet/GFP RV not only induced IFN\u03b3 production but also induced a substantial shift in the Th2 developmental program of these Thp cells toward the Th1 phenotype as evidenced by the large number of IFN\u03b3-producing cells (53%) and the reduced number of IL-4-producing cells (4%).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "56df1afd-2142-4da6-abc6-fa3fee9f16fc",
        "_rev": "_WpvYGJ--Ci",
        "nanopub": {
            "id": "56df1afd-2142-4da6-abc6-fa3fee9f16fc",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.33",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "mSLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "267 SLE patients followed up longitudinally over 1 year (1,166 total clinic visits).",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "19790071",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL2)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "p(HGNC:CCL19)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "p(HGNC:CXCL10)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "The chemokine-high group had significantly higher mSLEDAI scores compared to the chemokine-low group (p=1\u00d710\u22123, Supplementary Table S3). Furthermore, the chemokine score was significantly correlated with mSLEDAI (p<0.0001), as were anti-dsDNA, complement components, and lymphocyte count (p<0.0001), ESR (p=0.0004), and WBC count (p=0.003; Supplementary Table S5). \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "97cd29bd-708a-46e1-92f4-a941138abca1",
        "_rev": "_WpvYGJ--Cp",
        "nanopub": {
            "id": "97cd29bd-708a-46e1-92f4-a941138abca1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17A)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                },
                {
                    "subject": "p(HGNC:IL13)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "In contrast, consistent with the results above, levels of several inflammatory mediators varied between pre-flare and non-flare periods (Figure 2 and Supplementary Table 4). Impending flares were associated with increased Th1, Th2, and Th17 (Figure 2A\u2013C) type cytokines, compared to both self non-flare and matched healthy control samples (Supplementary Figure 2A\u2013C).\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1c17a3fc-06b1-4216-898f-35930511d730",
        "_rev": "_WpvYGJC-_Z",
        "nanopub": {
            "id": "1c17a3fc-06b1-4216-898f-35930511d730",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"HeLa Cells\"",
                    "label": "HeLa Cells",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Huang, Ying",
                    "Li, Wenge",
                    "Kong, Ah-Ng Tony"
                ],
                "database": {
                    "id": "23190551",
                    "name": "PubMed"
                },
                "source_name": "Cell & bioscience",
                "title": "Anti-oxidative stress regulator NF-E2-related factor 2 mediates the adaptive induction of antioxidant and detoxifying enzymes by lipid peroxidation metabolite 4-hydroxynonenal.",
                "abstract": "NF-E2-related factor 2 (NRF2) regulates a battery of antioxidative and phase II drug metabolizing/detoxifying genes through binding to the antioxidant response elements (ARE). NRF2-ARE signaling plays a central role in protecting cells from a wide spectrum of reactive toxic species including reactive oxygen/nitrogen species (RONS). 4-hydroxylnonenal (4-HNE) is a major end product from lipid peroxidation of omega-6 polyunsaturated fatty acids (PUFA) induced by oxidative stress, and it is highly reactive to nucleophilic sites in DNA and proteins, causing cytotoxicity and genotoxicity. In this study, we examined the role of NRF2 in regulating the 4-HNE induced gene expression of antioxidant and detoxifying enzymes."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:4-hydroxynon-2-enal)",
                    "relation": "increases",
                    "object": "r(HGNC:HMOX1)"
                }
            ],
            "evidence": "When HeLa cells were treated with 4-HNE, in agreement with the enhanced ARE-luciferase activity, RT-PCR results showed that 4-HNE induced the transcription of AKR1C1, GSTA4 and HO-1 in a dose-dependent manner (Figure \u200b3A).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4690be5d-7680-434e-8160-a8874e111d68",
        "_rev": "_WpvYGJ--Aj",
        "nanopub": {
            "id": "4690be5d-7680-434e-8160-a8874e111d68",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.61",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "112 gastric carcinoma patients, 115 healthy controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "11182046",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(GO:aging)",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:FASL)"
                }
            ],
            "evidence": "Linear regression analysis revealed a significant negative correlation between age and plasma sFasL concentration (r=0.61, p<0.0001)\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2da7dfe1-a35a-4d9e-b8b7-fa0f4269d482",
        "_rev": "_WpvYGJC-BR",
        "nanopub": {
            "id": "2da7dfe1-a35a-4d9e-b8b7-fa0f4269d482",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "Colorimetric Quantification of GAG",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Chondrocytes",
                    "label": "Chondrocytes",
                    "type": "Cell"
                },
                {
                    "id": "MESH:Osteoarthritis",
                    "label": "Osteoarthritis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "14600251",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"(-)-epigallocatechin 3-gallate\")",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IL1B))"
                }
            ],
            "evidence": "EGCG inhibited the IL-1\u03b2-induced release of GAG from human cartilage explants in vitro.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5c185eef-baf3-49be-b9e0-a00459fbacf5",
        "_rev": "_WpvYGJG-Aa",
        "nanopub": {
            "id": "5c185eef-baf3-49be-b9e0-a00459fbacf5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "comments": "behind paywall",
                "database": {
                    "id": "17587156",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)\t",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:CRP)"
                },
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Serum IL-6 level was significantly elevated in active SLE patients and correlated with the SLE activity index (SLEDAI), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1856e810-4246-4b8f-8ad5-376d3cf9873e",
        "_rev": "_WpvYGI6--5",
        "nanopub": {
            "id": "1856e810-4246-4b8f-8ad5-376d3cf9873e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r= 0.734",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "76 SLE patients, 36 age- and sex-matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "20201076",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"anti-malondialdehyde\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "In addition, a significant correlation was observed between the levels of anti-MDA or anti-HNE antibodies and the SLEDAI score (r = 0.734 and r = 0.647, respectively)\n",
            "metadata": {
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6f56d302-be76-4fd0-8a2a-83914182b3fb",
        "_rev": "_WpvYGJ--B9",
        "nanopub": {
            "id": "6f56d302-be76-4fd0-8a2a-83914182b3fb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"B cell\"",
                    "label": "B cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Thymidine Incorporation",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "database": {
                    "id": "7507958",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL13)",
                    "relation": "increases",
                    "object": "bp(GO:\"B cell differentiation\")"
                }
            ],
            "evidence": "As shown in Figure 3, IL-13 induced proliferation of sorted s~+, CDlO', CD19+ cells cultured in the presence of anti-CD40 mAb\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "40e427e0-187a-4666-ae46-c53b482753f1",
        "_rev": "_WpvYGJ--Bm",
        "nanopub": {
            "id": "40e427e0-187a-4666-ae46-c53b482753f1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:Neutrophils",
                    "label": "Neutrophils",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "27413244",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:squalene)",
                    "relation": "decreases",
                    "object": "r(HGNC:MMP9)"
                }
            ],
            "evidence": "As shown in Fig. 6A, the incubation with 50 \u0006M of squalene for 18 h caused a significant down-regulation of MMP-1 and MMP-9 gene expression in LPStreated human monocytes\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5cd75f5f-6eb6-464e-bcdf-5548839fa1b1",
        "_rev": "_WpvYGJ--CX",
        "nanopub": {
            "id": "5cd75f5f-6eb6-464e-bcdf-5548839fa1b1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.59",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "SLAM-R",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL5)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c50a762b-903f-495e-abaa-3689cb7e457f",
        "_rev": "_WpvYGJ--_Y",
        "nanopub": {
            "id": "c50a762b-903f-495e-abaa-3689cb7e457f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "120 SLE patients,120 HCs",
                    "type": "cohort"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Gao, Zhao-Wei",
                    "Zhao, Guan-Hua",
                    "Zhang, Zhe",
                    "Huang, Jing",
                    "Li, Zi-Yue",
                    "Zhang, Hui-Zhong",
                    "Dong, Ke"
                ],
                "database": {
                    "id": "29376206",
                    "name": "PubMed"
                },
                "source_name": "Immunologic research",
                "title": "Serum adenosine deaminase activity is increased in systemic lupus erythematosus patients and correlated with disease activity.",
                "abstract": "Adenosine deaminase (ADA) has been found to be involved in autoimmune disease progression. To assess the potential application of serum ADA activity in diagnosing systemic lupus erythematosus (SLE) and evaluating SLE disease activity, we investigated the serum ADA activity of 120 SLE patients and 120 healthy controls in the present study. The results showed that serum ADA activity in SLE patients was significantly increased (median (IQR)\u2009=\u200914 (11-19)\u00a0U/L) compared with that in healthy controls (median (IQR)\u2009=\u20098 (7-10)\u00a0U/L). Based on a receiver operating characteristic curve analysis, the optimal cut-off value for using serum ADA activity to diagnose SLE patients was 10.5\u00a0U/L (specificity, 84.2%; sensitivity, 78.3%). The diagnostic performance of serum ADA activity for SLE patients was better than that of other conventional haematology markers. Moreover, serum ADA activity displayed an increasing trend with increasing SLE disease activity. Spearman's correlation analysis showed that serum ADA activity was positively correlated with SLE disease activity. These findings suggest that serum ADA activity could be a diagnostic marker for SLE; moreover, measuring serum ADA activity may be helpful for evaluating and monitoring the disease activity of SLE patients."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:ADA)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "The results showed that serum ADA activity in SLE patients was significantly increased (median (IQR)\u2009=\u200914 (11-19) U/L) compared with that in healthy controls (median (IQR)\u2009=\u20098 (7-10) U/L).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "385a845a-63ad-4226-a2f9-daceee7d24e2",
        "_rev": "_WpvYGJ--Bz",
        "nanopub": {
            "id": "385a845a-63ad-4226-a2f9-daceee7d24e2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=-0.26",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p=0.002",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "171 patients with SLE and 50 normal controls",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "15897306",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "negativeCorrelation",
                    "object": "complex(MESH:\"Hemoglobin\")"
                }
            ],
            "evidence": "Levels of IL6 were significantly higher (p = 0.005) in patients with active compared with inactive haematological disease, as scored by the BILAG index. Further analysis showed that this association was dependent on an inverse correlation (p = 0.002, r = -0.26) between IL6 levels and haemoglobin levels in patients with SLE.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2e40d04e-0aed-434f-ba34-60248b733adc",
        "_rev": "_WpvYGJC-B9",
        "nanopub": {
            "id": "2e40d04e-0aed-434f-ba34-60248b733adc",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"B cell\"",
                    "label": "B cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "7507958",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite(p(HGNC:IL7), p(HGNC:IL13))\t",
                    "relation": "increases",
                    "object": "p(\"IgE\")"
                },
                {
                    "subject": "composite(p(HGNC:IL7), p(HGNC:IL13))\t",
                    "relation": "increases",
                    "object": "p(\"IgG4\")"
                },
                {
                    "subject": "composite(p(HGNC:IL7), p(HGNC:IL13))\t",
                    "relation": "increases",
                    "object": "p(\"IgG\")"
                },
                {
                    "subject": "composite(p(HGNC:IL7), p(HGNC:IL13))",
                    "relation": "increases",
                    "object": "p(\"IgM\")"
                }
            ],
            "evidence": "When IL-7 was added to cultures of fetal BM cells and CD4+ T cells, IL-13 induced significant levels of IgM, IgG, IgG4, and IgE production (Fig. 1A)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c80b2515-6da1-4cad-b6ac-8a96ffc9f99b",
        "_rev": "_WpvYGJ---j",
        "nanopub": {
            "id": "c80b2515-6da1-4cad-b6ac-8a96ffc9f99b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "MESH:\"HeLa Cells\"",
                    "label": "HeLa Cells",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Huang, Ying",
                    "Li, Wenge",
                    "Kong, Ah-Ng Tony"
                ],
                "database": {
                    "id": "23190551",
                    "name": "PubMed"
                },
                "source_name": "Cell & bioscience",
                "title": "Anti-oxidative stress regulator NF-E2-related factor 2 mediates the adaptive induction of antioxidant and detoxifying enzymes by lipid peroxidation metabolite 4-hydroxynonenal.",
                "abstract": "NF-E2-related factor 2 (NRF2) regulates a battery of antioxidative and phase II drug metabolizing/detoxifying genes through binding to the antioxidant response elements (ARE). NRF2-ARE signaling plays a central role in protecting cells from a wide spectrum of reactive toxic species including reactive oxygen/nitrogen species (RONS). 4-hydroxylnonenal (4-HNE) is a major end product from lipid peroxidation of omega-6 polyunsaturated fatty acids (PUFA) induced by oxidative stress, and it is highly reactive to nucleophilic sites in DNA and proteins, causing cytotoxicity and genotoxicity. In this study, we examined the role of NRF2 in regulating the 4-HNE induced gene expression of antioxidant and detoxifying enzymes."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:4-hydroxynon-2-enal)",
                    "relation": "increases",
                    "object": "p(HGNC:NFE2L2)"
                }
            ],
            "evidence": "HeLa cells were treated with 10 \u03bcM 4-HNE for 0, 0.5,1 and 4 h. 4-HNE markedly elevated the nuclear NRF2 protein level, with the highest accumulation at 0.5 h after treatment (Figure 1C). \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a8a83dc0-4d82-48e2-bdd4-c941de4a99cd",
        "_rev": "_WpvYGJ--A1",
        "nanopub": {
            "id": "a8a83dc0-4d82-48e2-bdd4-c941de4a99cd",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "232 SLE patients; 26 myositis; 81 SSc; 88 Sjogren's; 165 RA; 400 Healthy",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"lupus nephritis\"",
                    "label": "lupus nephritis",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "28281463",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"anti-SM\")",
                    "relation": "positiveCorrelation",
                    "object": "bp(MESH:\"Proteinuria\")"
                }
            ],
            "evidence": "a remarkable association was found between anti-Sm and proteinuria\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0439525c-9ee4-49ec-bacf-85b014a1b219",
        "_rev": "_WpvYGJC-A8",
        "nanopub": {
            "id": "0439525c-9ee4-49ec-bacf-85b014a1b219",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Immunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "7528775",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:IL12), ma(GO:\"Receptor Binding\"))",
                    "relation": "increases",
                    "object": "p(HGNC:TYK2, pmod(Ph))"
                }
            ],
            "evidence": "\"Since the 135-kD substrate was of the approximate molecular mass of TYK2, the antiphosphotyrosine immunoprecipitates shown in Fig. 1 were reprobed with antiserum to TYK2 (Fig. 2 A). A single band corresponding to the 135-kD phosphoprotein was detected d only in antiphosphotyrosine immunoprecipitates from\ncells stimulated with IL-12 (Fig. 2 A, lanes 2-5) and not\nfrom unstimulated cells (lane 1) or cells stimulated with\nIL-2 (lane 6), \"\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "057aaaea-4aa9-4c9d-8412-720041aef452",
        "_rev": "_WpvYGJ--BG",
        "nanopub": {
            "id": "057aaaea-4aa9-4c9d-8412-720041aef452",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "p<0.002",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "12 VKH patients, 20 controlled",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "FCM",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"dendritic cell\"",
                    "label": "dendritic cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "23482469",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:berberine)",
                    "relation": "decreases",
                    "object": "surf(p(HGNC:CD80))"
                }
            ],
            "evidence": "BBR also suppressed the expression of costimulatory molecules in DCs, which is in agreement with earlier findings in animals, which showed that BBR was able to downregulate the expression of CD80 and CD86 in mouse DCs stimulated by LPS.\u00a0\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "39bb399d-c927-450c-bdec-fd7248cb0d0a",
        "_rev": "_WpvYGJ--_2",
        "nanopub": {
            "id": "39bb399d-c927-450c-bdec-fd7248cb0d0a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "272 Chinese SLE",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "15801016",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"IgG anti-beta2-GPI\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Vascular Thrombosis\")"
                },
                {
                    "subject": "p(\"IgG anticardiolipin\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Vascular Thrombosis\")"
                },
                {
                    "subject": "p(\"anti-lupus anticoagulant\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Vascular Thrombosis\")"
                }
            ],
            "evidence": "The prevalence of LAC, IgG aCL, and IgG anti-beta2-GPI antibodies was 22.4%, 29.0%, and 7.7%, respectively. There were 38 episodes of thrombosis after a mean duration of followup of 11.0 +/- 6.8 SD years, giving a thrombotic rate of 1.26/100 patient-years. All aPL were shown to be associated with vascular thrombosis. IgG anti-beta2-GPI antibodies were found to be associated with recurrent thrombosis [8.0/100 patient-years or 25.0% (7/28)]. \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "cda903ec-cbd8-40b4-ab32-5a12b19552f6",
        "_rev": "_WpvYGJC-_J",
        "nanopub": {
            "id": "cda903ec-cbd8-40b4-ab32-5a12b19552f6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "11009421",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:A20)",
                    "relation": "decreases",
                    "object": "act(complex(HGNC:\"NFKB complex\"), ma(tscript))"
                }
            ],
            "evidence": "A20-deficient cells fail to terminate TNF-induced NF-kappaB responses\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d0cd1066-890f-48c2-a326-c31e71ebec0e",
        "_rev": "_WpvYGJ--Bv",
        "nanopub": {
            "id": "d0cd1066-890f-48c2-a326-c31e71ebec0e",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"embryonic fibroblast\"",
                    "label": "embryonic fibroblast",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10748240",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17)",
                    "relation": "increases",
                    "object": "p(HGNC:IKBA, pmod(Ph))"
                }
            ],
            "evidence": "On the other hand, IKK activity in the TRAF6\u2212/\u2212\u00a0cells was enhanced only by TNF and not by IL-1 or IL-17. These results indicate that, like TNF and IL-1, IL-17 activates NF-\u03baB by inducing the catalytic activity of the IKKs, and that IL-17\u2013induced IKK activation involves TRAF6.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "dce46f93-558b-4337-a0f8-2600a54d00da",
        "_rev": "_WpvYGJC-By",
        "nanopub": {
            "id": "dce46f93-558b-4337-a0f8-2600a54d00da",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.06",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "Crossover study with 27 healthy subjects",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "19359242",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "r(HGNC:IL5)"
                }
            ],
            "evidence": "A significant decrease in expression was observed for IL-1\u00df, IL-10, and IL-23. Additionally, IL-5 and IL-17 showed strong trends toward decreased expression after supplementation.\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ed458b3d-efaa-4c52-b3e8-4ee606325ac9",
        "_rev": "_WpvYGJG-_e",
        "nanopub": {
            "id": "ed458b3d-efaa-4c52-b3e8-4ee606325ac9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"B cell\"",
                    "label": "B cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Histology",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12446913",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite(p(HGNC:IL4), p(HGNC:IL21))",
                    "relation": "increases",
                    "object": "bp(GO:\"regulation of germinal center formation\""
                }
            ],
            "evidence": "Although germinal centers were relatively normal in mice lacking either IL-4 or IL-21R (14), in IL-4\u2013/\u2013 IL21R\u2013/\u2013 mice germinal centers were disorganized, with decreased numbers of apoptotic bodies in macrophages (Fig. 3D), consistent with diminished somatic mutation and defective affinity maturation.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "301e6186-b675-44a8-a4bf-f62b49050bb2",
        "_rev": "_WpvYGJG-_w",
        "nanopub": {
            "id": "301e6186-b675-44a8-a4bf-f62b49050bb2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Colamonici, O",
                    "Yan, H",
                    "Domanski, P",
                    "Handa, R",
                    "Smalley, D",
                    "Mullersman, J",
                    "Witte, M",
                    "Krishnan, K",
                    "Krolewski, J"
                ],
                "database": {
                    "id": "7526154",
                    "name": "PubMed"
                },
                "source_name": "Molecular and cellular biology",
                "title": "Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase.",
                "abstract": "Binding of type I interferons (IFNs) to their receptors induces rapid tyrosine phosphorylation of multiple proteins, including the alpha and beta subunits of the receptor, the polypeptides that form the transcriptional activator ISGF3 alpha (Stat113, Stat84, and Stat91), and the p135tyk2 and Jak-1 tyrosine kinases. In this report, we demonstrate that the alpha subunit of the type I IFN receptor (IFN-R) corresponds to the product of a previously cloned receptor subunit cDNA and, further, that the p135tyk2 tyrosine kinase directly binds and tyrosine phosphorylates this receptor subunit. Glutathione S-transferase (GST) fusion proteins encoding the different regions of the cytoplasmic domain of the alpha subunit can bind the p135tyk2 contained in human cell lysates. The association between the alpha subunit and Tyk2 was demonstrated by immunoblotting with anti-Tyk2 and antiphosphotyrosine antibodies and by using an in vitro kinase assay. Analogous experiments were then performed with recombinant baculoviruses encoding constitutively active Jak family tyrosine kinases. In this case, p135tyk2, but not Jak-1 or Jak-2 protein, binds to the GST-IFN-R proteins, suggesting that the interaction between these two proteins is both direct and specific. We also demonstrate that Tyk2, from extracts of either IFN alpha-treated human cells or insect cells infected with the recombinant baculoviruses, can catalyze in vitro phosphorylation of GST-IFN-R protein in a specific manner. Deletion mutants of the GST-IFN-R protein were used to localize both the binding and tyrosine phosphorylation site(s) to a 46-amino-acid juxtamembrane region of the alpha subunit, which shows sequence homology to functionally similar regions of other cytokine receptor proteins. These data support the hypothesis that the Tyk2 protein functions as part of a receptor complex to initiate intracellular signaling in response to type I IFNs."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNAR1)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:TYK2)"
                }
            ],
            "evidence": "The association between the alpha subunit and Tyk2 was demonstrated by immunoblotting with anti-Tyk2 and antiphosphotyrosine antibodies and by using an in vitro kinase assay. Analogous experiments were then performed with recombinant baculoviruses encoding constitutively active Jak family tyrosine kinases. In this case, p135tyk2, but not Jak-1 or Jak-2 protein, binds to the GST-IFN-R proteins, suggesting that the interaction between these two proteins is both direct and specific. We also demonstrate that Tyk2, from extracts of either IFN alpha-treated human cells or insect cells infected with the recombinant baculoviruses, can catalyze in vitro phosphorylation of GST-IFN-R protein in a specific manner.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "145f4b03-b8df-4ac8-9f18-3bad8a5b6a97",
        "_rev": "_WpvYGJG-Bz",
        "nanopub": {
            "id": "145f4b03-b8df-4ac8-9f18-3bad8a5b6a97",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "",
                    "label": "immunoprecipitation",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "authors": [
                    "Ngo, Vu N",
                    "Young, Ryan M",
                    "Schmitz, Roland",
                    "Jhavar, Sameer",
                    "Xiao, Wenming",
                    "Lim, Kian-Huat",
                    "Kohlhammer, Holger",
                    "Xu, Weihong",
                    "Yang, Yandan",
                    "Zhao, Hong",
                    "Shaffer, Arthur L",
                    "Romesser, Paul",
                    "Wright, George",
                    "Powell, John",
                    "Rosenwald, Andreas",
                    "Muller-Hermelink, Hans Konrad",
                    "Ott, German",
                    "Gascoyne, Randy D",
                    "Connors, Joseph M",
                    "Rimsza, Lisa M",
                    "Campo, Elias",
                    "Jaffe, Elaine S",
                    "Delabie, Jan",
                    "Smeland, Erlend B",
                    "Fisher, Richard I",
                    "Braziel, Rita M",
                    "Tubbs, Raymond R",
                    "Cook, J R",
                    "Weisenburger, Denny D",
                    "Chan, Wing C",
                    "Staudt, Louis M"
                ],
                "database": {
                    "id": "21179087",
                    "name": "PubMed"
                },
                "source_name": "Nature",
                "title": "Oncogenically active MYD88 mutations in human lymphoma.",
                "abstract": "The activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL) remains the least curable form of this malignancy despite recent advances in therapy. Constitutive nuclear factor (NF)-\u03baB and JAK kinase signalling promotes malignant cell survival in these lymphomas, but the genetic basis for this signalling is incompletely understood. Here we describe the dependence of ABC DLBCLs on MYD88, an adaptor protein that mediates toll and interleukin (IL)-1 receptor signalling, and the discovery of highly recurrent oncogenic mutations affecting MYD88 in ABC DLBCL tumours. RNA interference screening revealed that MYD88 and the associated kinases IRAK1 and IRAK4 are essential for ABC DLBCL survival. High-throughput RNA resequencing uncovered MYD88 mutations in ABC DLBCL lines. Notably, 29% of ABC DLBCL tumours harboured the same amino acid substitution, L265P, in the MYD88 Toll/IL-1 receptor (TIR) domain at an evolutionarily invariant residue in its hydrophobic core. This mutation was rare or absent in other DLBCL subtypes and Burkitt's lymphoma, but was observed in 9% of mucosa-associated lymphoid tissue lymphomas. At a lower frequency, additional mutations were observed in the MYD88 TIR domain, occurring in both the ABC and germinal centre B-cell-like (GCB) DLBCL subtypes. Survival of ABC DLBCL cells bearing the L265P mutation was sustained by the mutant but not the wild-type MYD88 isoform, demonstrating that L265P is a gain-of-function driver mutation. The L265P mutant promoted cell survival by spontaneously assembling a protein complex containing IRAK1 and IRAK4, leading to IRAK4 kinase activity, IRAK1 phosphorylation, NF-\u03baB signalling, JAK kinase activation of STAT3, and secretion of IL-6, IL-10 and interferon-\u03b2. Hence, the MYD88 signalling pathway is integral to the pathogenesis of ABC DLBCL, supporting the development of inhibitors of IRAK4 kinase and other components of this pathway for the treatment of tumours bearing oncogenic MYD88 mutations."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:MYD88)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:IRAK4)"
                },
                {
                    "subject": "p(HGNC:MYD88)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:IRAK1)"
                }
            ],
            "evidence": "Immunoprecipitation of MYD88\u2013GFP with anti-GFP antibodies brought down IRAK1 and IRAK4, two kinases known to associate with MYD88 upon TLR or IL-1 stimulation (Fig. 3a)3.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "21877c8f-d557-4988-a821-f5e38558c02f",
        "_rev": "_WpvYGI6--t",
        "nanopub": {
            "id": "21877c8f-d557-4988-a821-f5e38558c02f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Ritchie Index",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "93 RA patients, 70 age/sex matched controls, 20 OA disease controls",
                    "type": "cohort"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "authors": [
                    "Madhok, R",
                    "Crilly, A",
                    "Watson, J",
                    "Capell, H A"
                ],
                "database": {
                    "id": "8484679",
                    "name": "PubMed"
                },
                "source_name": "Annals of the rheumatic diseases",
                "title": "Serum interleukin 6 levels in rheumatoid arthritis: correlations with clinical and laboratory indices of disease activity.",
                "abstract": "In rheumatoid synovium interleukin 6 (IL-6) is the most abundantly expressed cytokine. Increased serum levels have been previously reported in patients with rheumatoid arthritis (RA). In this study serum IL-6 levels were measured in a well defined cohort using a bioassay (B9 cells) and levels were correlated with conventional clinical and laboratory indices of disease activity. Levels were significantly higher in serum from patients with RA (median 55 IU/ml; interquartile range 28-139) compared with serum from disease (median 7 IU/ml; 1-23) and normal controls (median 10 IU/ml; 7-12). No difference was observed between men and women. Levels did not correlate with disease duration. Significant associations were observed between IL-6 and C reactive protein and between the Ritchie articular index and duration of morning stiffness. No other correlations were observed. The value of these findings in the monitoring of RA and as an indicator of response to second line treatment needs to be established."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "Serum IL-6 values were significantly higher in patients with RA (median 55 IU/ml; 28-139) than in disease (20 subjects, median 7 IU/ml; 1-23) (p<0.0001) and normal controls (70 subjects, median 10 IU/ml; 7-12) (p<0.0001)",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5ce87e06-48af-4370-bfe3-7f88a4495694",
        "_rev": "_WpvYGJ--A4",
        "nanopub": {
            "id": "5ce87e06-48af-4370-bfe3-7f88a4495694",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "database": {
                    "id": "",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:SOCS3)",
                    "relation": "increases",
                    "object": "complex(p(HGNC:SOCS3), p(HGNC:NR2C2), p(HGNC:TRAF6))"
                }
            ],
            "evidence": "When cotransfecting cells with SOCS-3 and TAK1 and/or TRAF6 in different combinations, binding of SOCS-3 to TAK-1 as well as TRAF6 was observed. This interaction was specific because no immunoprecipitation was observed using normal rabbit serum instead of SOCS-3 antibody (data not shown). These results indicate that SOCS-3 associates with both TAK1 and TRAF6; however, these interactions might be indirect and mediated by other signaling components.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "cc0acd0e-2642-455d-9b3b-7c4e1ebd5fd0",
        "_rev": "_WpvYGJC-AZ",
        "nanopub": {
            "id": "cc0acd0e-2642-455d-9b3b-7c4e1ebd5fd0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.02",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=32 healthy donors",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:monocyte",
                    "label": "monocyte",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9531313",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL10)",
                    "relation": "decreases",
                    "object": "act(p(HGNC:IL17), ma(GO:\"cytokine secretion\"))"
                }
            ],
            "evidence": "In contrast, only IL-10 exerted a significant suppressive effect on IL-17-induced TNF-\u03b1 release (99%,\u00a0p\u00a0< 0.02,\u00a0n\u00a0= 3)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5f20f6e5-c5b6-4e5b-bfe4-c5b81bb0c380",
        "_rev": "_WpvYGJ--_J",
        "nanopub": {
            "id": "5f20f6e5-c5b6-4e5b-bfe4-c5b81bb0c380",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "21215659",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT6)",
                    "relation": "increases",
                    "object": "r(HGNC:GATA3)"
                }
            ],
            "evidence": "The loss of\u00a0Gata3\u00a0and\u00a0Maf\u00a0expression in STAT6-deficient Th2 cells was greater than in STAT3-deficient Th2 cells.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9f072794-cb38-46a7-815a-2d799a40bd58",
        "_rev": "_WpvYGJC-_8",
        "nanopub": {
            "id": "9f072794-cb38-46a7-815a-2d799a40bd58",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.032",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "Sandwich Immunoassay",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "267 SLE patients followed longitudinally for one year",
                    "type": "Cohort"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "19790071",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL19)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "We first performed univariate Cox proportional hazards regression to identify variables with significant ability to predict flare (increase in SLEDAI \u22653; Table 1). As expected, the chemokine score was significantly associated with flare, both as a binary variable (chemokine-high vs. chemokine-intermediate/low; p=0.0001), and as a continuous variable (p=0.0002). The individual chemokine levels for CXCL10 (IP-10) and CCL19 (Mip-3B) were also significant (p=0.0001 and p=0.03, respectively).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "eab0d241-6c79-40c3-be53-9818e2d518fb",
        "_rev": "_WpvYGJ--BT",
        "nanopub": {
            "id": "eab0d241-6c79-40c3-be53-9818e2d518fb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "EMSA",
                    "type": "Methodology"
                },
                {
                    "id": "EFO:HeLa",
                    "label": "HeLa",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "3140380",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "complex(HGNC:IKB complex)",
                    "relation": "directlyDecreases",
                    "object": "act(complex(HGNC:NFKB Complex\"), ma(GO:\"positive regulation of transcription by transcription factor localization\"))"
                }
            ],
            "evidence": "Here we demonstrate a protein inhibitor (called IKB) in cytosolic fractions of unstimulated pre-B cells that can convert NF-KB into an inactive DOC-dependent form by a reversible, saturable, and specific reaction.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3119b16b-aaf1-48a6-a839-5d26c071a756",
        "_rev": "_WpvYGI6--q",
        "nanopub": {
            "id": "3119b16b-aaf1-48a6-a839-5d26c071a756",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Veldkamp, Christopher T",
                    "Kiermaier, Eva",
                    "Gabel-Eissens, Skylar J",
                    "Gillitzer, Miranda L",
                    "Lippner, David R",
                    "DiSilvio, Frank A",
                    "Mueller, Casey J",
                    "Wantuch, Paeton L",
                    "Chaffee, Gary R",
                    "Famiglietti, Michael W",
                    "Zgoba, Danielle M",
                    "Bailey, Asha A",
                    "Bah, Yaya",
                    "Engebretson, Samantha J",
                    "Graupner, David R",
                    "Lackner, Emily R",
                    "LaRosa, Vincent D",
                    "Medeiros, Tysha",
                    "Olson, Michael L",
                    "Phillips, Andrew J",
                    "Pyles, Harley",
                    "Richard, Amanda M",
                    "Schoeller, Scott J",
                    "Touzeau, Boris",
                    "Williams, Larry G",
                    "Sixt, Michael",
                    "Peterson, Francis C"
                ],
                "database": {
                    "id": "26115234",
                    "name": "PubMed"
                },
                "source_name": "Biochemistry",
                "title": "Solution Structure of CCL19 and Identification of Overlapping CCR7 and PSGL-1 Binding Sites.",
                "abstract": "CCL19 and CCL21 are chemokines involved in the trafficking of immune cells, particularly within the lymphatic system, through activation of CCR7. Concurrent expression of PSGL-1 and CCR7 in naive T-cells enhances recruitment of these cells to secondary lymphoid organs by CCL19 and CCL21. Here the solution structure of CCL19 is reported. It contains a canonical chemokine domain. Chemical shift mapping shows the N-termini of PSGL-1 and CCR7 have overlapping binding sites for CCL19 and binding is competitive. Implications for the mechanism of PSGL-1's enhancement of resting T-cell recruitment are discussed. "
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL2)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:CCR7)"
                }
            ],
            "evidence": "CCL19 and CCL21 are chemokines involved in the trafficking of immune cells, particularly within the lymphatic system, through activation of CCR7.",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "CCL19 and CCL21 are chemokines involved in the trafficking of immune cells, particularly within the lymphatic system, through activation of CCR7. Concurrent expression of PSGL-1 and CCR7 in naive T-cells enhances recruitment of these cells to secondary lymphoid organs by CCL19 and CCL21. Here the solution structure of CCL19 is reported. It contains a canonical chemokine domain. Chemical shift mapping shows the N-termini of PSGL-1 and CCR7 have overlapping binding sites for CCL19 and binding is competitive. Implications for the mechanism of PSGL-1's enhancement of resting T-cell recruitment are discussed. ",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "65f435ea-e20d-4ae2-8b46-10068b4944c3",
        "_rev": "_WpvYGJ--_y",
        "nanopub": {
            "id": "65f435ea-e20d-4ae2-8b46-10068b4944c3",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Intracellular Cytokine Staining",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16648838",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TGFB)\t",
                    "relation": "increases",
                    "object": "p(HGNC:FOXP3)"
                },
                {
                    "subject": "p(HGNC:TGFB)",
                    "relation": "increases",
                    "object": "bp(GO:\"regulatory T cell differentiation\")"
                }
            ],
            "evidence": ". Addition of TGF-b in the culture resulted in the generation of Foxp3\u00fe T cells but not IL-17 or IFN-g production;\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b35fcdf3-bb43-4719-af8f-5cd963bc032c",
        "_rev": "_WpvYGJG--V",
        "nanopub": {
            "id": "b35fcdf3-bb43-4719-af8f-5cd963bc032c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8700209",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT4)",
                    "relation": "association",
                    "object": "sec(p(HGNC:IFNG))"
                }
            ],
            "evidence": "In contrast to activated cells from control mice, which show a 15-fold increase in ifn-g secretion following IL-12 stimulation, lymphocytes from Stat4-/- mice do not show enhanced IFN-G secretion.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8eb94dff-f711-45c4-9b50-062d783971c1",
        "_rev": "_WpvYGJ--_v",
        "nanopub": {
            "id": "8eb94dff-f711-45c4-9b50-062d783971c1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "11397944",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TBX21)",
                    "relation": "regulates",
                    "object": "bp(GO:\"T-helper 1 cell differentiation\")"
                }
            ],
            "evidence": "Ectopic T-bet, but not sham virus, fully corrected the IFN-g defect (Fig. 2A), and transduced cells maintained heritable IFN-g expression (22), suggesting that T-bet is responsible for STAT4- independent TH1 differentiation. T\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f42a145c-813a-4195-a6b0-b8c8ad4f4695",
        "_rev": "_WpvYGJ--A0",
        "nanopub": {
            "id": "f42a145c-813a-4195-a6b0-b8c8ad4f4695",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "32 healthy donors",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Radioimmunoassay",
                    "type": "Methodology"
                },
                {
                    "id": "CL:monocyte",
                    "label": "monocyte",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9531313",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:3',5'-cyclic AMP)",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:TNF)"
                }
            ],
            "evidence": "Furthermore, cAMP mimetics such as IBMX, forskolin, PGE2, and cholera toxin reversed the IL-17-induced increase in TNF-\u03b1 release (Fig. 3\u21d3B); basal levels of TNF-\u03b1 release were abrogated completely by the latter cAMP-elevating substances.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "58b4a5e7-7dd4-41dd-bfe5-f3603f348400",
        "_rev": "_WpvYGJC-AF",
        "nanopub": {
            "id": "58b4a5e7-7dd4-41dd-bfe5-f3603f348400",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Neutrophils",
                    "label": "Neutrophils",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "McDonald, P P",
                    "Bald, A",
                    "Cassatella, M A"
                ],
                "database": {
                    "id": "9129050",
                    "name": "PubMed"
                },
                "source_name": "Blood",
                "title": "Activation of the NF-kappaB pathway by inflammatory stimuli in human neutrophils.",
                "abstract": "Activated neutrophils have the ability to upregulate the expression of many genes, in particular those encoding cytokines and chemokines, and to subsequently release the corresponding proteins. Although little is known to date concerning the regulation of gene transcription in neutrophils, it is noteworthy that many of these genes depend on the activation of transcription factors, such as NF-kappaB, for inducible expression. We therefore investigated whether NF-kappaB/Rel proteins are expressed in human neutrophils, as well as their fate on cell activation. We now report that dimers consisting of p50 NFkappaB1, p65 RelA, and/or c-Rel are present in neutrophils and that the greater part of these protein complexes is physically associated with cytoplasmic IkappaB-alpha in resting cells. Following neutrophil stimulation with proinflammatory agonists (such as lipopolysaccharide [LPS], tumor necrosis factor-alpha [TNF-alpha], and fMet-Leu-Phe) that induce the production of cytokines and chemokines in these cells, NF-kappaB/Rel proteins translocated to nuclear fractions, resulting in a transient induction of NF-kappaB DNA binding activity, as determined in gel mobility shift assays. The onset of both processes was found to be closely paralleled by, and dependent on, IkappaB-alpha degradation. Proinflammatory neutrophil stimuli also promoted the accumulation of IkappaB-alpha mRNA transcripts, resulting in the reexpression of the IkappaB-alpha protein. To our knowledge, this constitutes the first indication that NF-kappaB activation may underlie the action of proinflammatory stimuli towards human neutrophil gene expression and, as such, adds a new facet to our understanding of neutrophil biology."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:LPS)",
                    "relation": "increases",
                    "object": "p(HGNC:NFKB1)"
                },
                {
                    "subject": "p(HGNC:TNF)",
                    "relation": "increases",
                    "object": "p(HGNC:NFKB1)"
                },
                {
                    "subject": "p(HGNC:IL1B)",
                    "relation": "increases",
                    "object": "p(HGNC:NFKB1)"
                }
            ],
            "evidence": "A similar time course of NF-kB activation was observed when neutrophils were exposed to 100 U/mL TNF-a or 10 ng/mL IL-1b (Fig 7B), although the latter cytokine proved to be significantly less potent than LPS or TNF-a in inducing this response, in agreement with our immunoblot data",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Activated neutrophils have the ability to upregulate the expression of many genes, in particular those encoding cytokines and chemokines, and to subsequently release the corresponding proteins. Although little is known to date concerning the regulation of gene transcription in neutrophils, it is noteworthy that many of these genes depend on the activation of transcription factors, such as NF-kappaB, for inducible expression. We therefore investigated whether NF-kappaB/Rel proteins are expressed in human neutrophils, as well as their fate on cell activation. We now report that dimers consisting of p50 NFkappaB1, p65 RelA, and/or c-Rel are present in neutrophils and that the greater part of these protein complexes is physically associated with cytoplasmic IkappaB-alpha in resting cells. Following neutrophil stimulation with proinflammatory agonists (such as lipopolysaccharide [LPS], tumor necrosis factor-alpha [TNF-alpha], and fMet-Leu-Phe) that induce the production of cytokines and chemokines in these cells, NF-kappaB/Rel proteins translocated to nuclear fractions, resulting in a transient induction of NF-kappaB DNA binding activity, as determined in gel mobility shift assays. The onset of both processes was found to be closely paralleled by, and dependent on, IkappaB-alpha degradation. Proinflammatory neutrophil stimuli also promoted the accumulation of IkappaB-alpha mRNA transcripts, resulting in the reexpression of the IkappaB-alpha protein. To our knowledge, this constitutes the first indication that NF-kappaB activation may underlie the action of proinflammatory stimuli towards human neutrophil gene expression and, as such, adds a new facet to our understanding of neutrophil biology.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1c9896f1-1f94-44c8-bfa9-0f47a170ce2e",
        "_rev": "_WpvYGJG-Bp",
        "nanopub": {
            "id": "1c9896f1-1f94-44c8-bfa9-0f47a170ce2e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"type 2 diabetes mellitus\"",
                    "label": "type 2 diabetes mellitus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "11126411",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:UCP3)\t",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:BMI)"
                },
                {
                    "subject": "p(HGNC:UCP3)",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:\"Body Weight\")"
                },
                {
                    "subject": "r(HGNC:UCP3)\t",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:\"Body Weight\")"
                },
                {
                    "subject": "r(HGNC:UCP3)",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:BMI)"
                }
            ],
            "evidence": "\u00a0Notably, the change in UCP3L mRNA expression and UCP3 protein content after the very low calorie diet were negatively associated with changes in body weight (r\u00a0= \u2013 0.97,\u00a0p\u00a0= 0.006 and\u00a0r\u00a0= \u2013 0.83,\u00a0p\u00a0= 0.043, respectively) and BMI (r\u00a0= \u2013 0.99,\u00a0p\u00a0= 0.0007 and\u00a0r\u00a0= \u2013 0.9,\u00a0p= 0.016, respectively)\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "416cff80-22fc-4716-9efc-51fababb9fb6",
        "_rev": "_WpvYGJG--Z",
        "nanopub": {
            "id": "416cff80-22fc-4716-9efc-51fababb9fb6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "37 HC, 35 eRA",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Ahmed, Usman",
                    "Anwar, Attia",
                    "Savage, Richard S",
                    "Costa, Matthew L",
                    "Mackay, Nicola",
                    "Filer, Andrew",
                    "Raza, Karim",
                    "Watts, Richard A",
                    "Winyard, Paul G",
                    "Tarr, Joanna",
                    "Haigh, Richard C",
                    "Thornalley, Paul J",
                    "Rabbani, Naila"
                ],
                "comments": "The formation of citrulline residues in proteins occurs by a post-translational modification of arginine residues catalysed by members of the peptidylarginine deiminase (PAD) family of enzymes5 (Figure 1a). This process is considered to be a marker of inflammation.",
                "database": {
                    "id": "25788417",
                    "name": "PubMed"
                },
                "source_name": "Scientific reports",
                "title": "Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health.",
                "abstract": "There is currently no biochemical test for detection of early-stage osteoarthritis (eOA). Tests for early-stage rheumatoid arthritis (eRA) such as rheumatoid factor (RF) and anti-cyclic citrullinated peptide (CCP) antibodies require refinement to improve clinical utility. We developed robust mass spectrometric methods to quantify citrullinated protein (CP) and free hydroxyproline in body fluids. We detected CP in the plasma of healthy subjects and surprisingly found that CP was increased in both patients with eOA and eRA whereas anti-CCP antibodies were predominantly present in eRA. A 4-class diagnostic algorithm combining plasma/serum CP, anti-CCP antibody and hydroxyproline applied to a cohort gave specific and sensitive detection and discrimination of eOA, eRA, other non-RA inflammatory joint diseases and good skeletal health. This provides a first-in-class plasma/serum-based biochemical assay for diagnosis and type discrimination of early-stage arthritis to facilitate improved treatment and patient outcomes, exploiting citrullinated protein and related differential autoimmunity."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CP)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:Osteoarthritis)"
                },
                {
                    "subject": "p(HGNC:CP)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "CP was increased 4-fold in serum protein of patients with eRA and surprisingly was even higher, increased 5-fold, in patients with eOA, with respect to healthy controls.\u00a0\n\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c819dafa-ab08-47b5-bf43-d6006fbaef8a",
        "_rev": "_WpvYGJG-AL",
        "nanopub": {
            "id": "c819dafa-ab08-47b5-bf43-d6006fbaef8a",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "comments": "no full text",
                "database": {
                    "id": "16648837",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL4)",
                    "relation": "decreases",
                    "object": "act(p(HGNC:TGFB))"
                },
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "decreases",
                    "object": "act(p(HGNC:TGFB))"
                }
            ],
            "evidence": "The action of TGF-\u03b2 on naive T cells is antagonized by interferon-\u03b3 and IL-4, thus providing a mechanism for divergence of the TH1, TH2 and TH17 lineages.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ddb6548f-fdfb-45a6-9f90-f4a47d7fadf0",
        "_rev": "_WpvYGJ--BA",
        "nanopub": {
            "id": "ddb6548f-fdfb-45a6-9f90-f4a47d7fadf0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Mak, Anselm",
                    "Kow, Nien Yee"
                ],
                "database": {
                    "id": "24864268",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology research",
                "title": "The pathology of T cells in systemic lupus erythematosus.",
                "abstract": "Systemic lupus erythematosus (SLE) is characterized by the production of a wide array of autoantibodies. Thus, the condition was traditionally classified as a \"B-cell disease\". Compelling evidence has however shown that without the assistance of the helper T lymphocytes, it is indeed difficult for the \"helpless\" B cells to become functional enough to trigger SLE-related inflammation. T cells have been recognized to be crucial in the pathogenicity of SLE through their capabilities to communicate with and offer enormous help to B cells for driving autoantibody production. Recently, a number of phenotypic and functional alterations which increase the propensity to trigger lupus-related inflammation have been identified in lupus T cells. Here, potential mechanisms involving alterations in T-cell receptor expressions, postreceptor downstream signalling, epigenetics, and oxidative stress which favour activation of lupus T cells will be discussed. Additionally, how regulatory CD4+, CD8+, and \u03b3\u03b4 T cells tune down lupus-related inflammation will be highlighted. Lastly, while currently available outcomes of clinical trials evaluating therapeutic agents which manipulate the T cells such as calcineurin inhibitors indicate that they are at least as efficacious and safe as conventional immunosuppressants in treating lupus glomerulonephritis, larger clinical trials are undoubtedly required to validate these as-yet favourable findings.",
                "date_published": "2014-01-01"
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL2)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": " In addition, the FoxP3+ Helios+ T cells isolated from 20 lupus patients were shown to have lower IL-2 and IFN\u03b3 productions when compared with those from FoxP3+ Helios\u2212 T cells",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "Systemic lupus erythematosus (SLE) is characterized by the production of a wide array of autoantibodies. Thus, the condition was traditionally classified as a \"B-cell disease\". Compelling evidence has however shown that without the assistance of the helper T lymphocytes, it is indeed difficult for the \"helpless\" B cells to become functional enough to trigger SLE-related inflammation. T cells have been recognized to be crucial in the pathogenicity of SLE through their capabilities to communicate with and offer enormous help to B cells for driving autoantibody production. Recently, a number of phenotypic and functional alterations which increase the propensity to trigger lupus-related inflammation have been identified in lupus T cells. Here, potential mechanisms involving alterations in T-cell receptor expressions, postreceptor downstream signalling, epigenetics, and oxidative stress which favour activation of lupus T cells will be discussed. Additionally, how regulatory CD4+, CD8+, and \u03b3\u03b4 T cells tune down lupus-related inflammation will be highlighted. Lastly, while currently available outcomes of clinical trials evaluating therapeutic agents which manipulate the T cells such as calcineurin inhibitors indicate that they are at least as efficacious and safe as conventional immunosuppressants in treating lupus glomerulonephritis, larger clinical trials are undoubtedly required to validate these as-yet favourable findings.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "cc25ecac-a483-422e-adc7-5e8d9b60fc0c",
        "_rev": "_WpvYGJC-_S",
        "nanopub": {
            "id": "cc25ecac-a483-422e-adc7-5e8d9b60fc0c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SDI",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "comments": "behind paywall",
                "database": {
                    "id": "16924394",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL4)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Elevation of MIP-1beta correlated with higher SDI score.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "99ce36ac-259c-42bd-b815-d74d0a0b1f17",
        "_rev": "_WpvYGJ--_E",
        "nanopub": {
            "id": "99ce36ac-259c-42bd-b815-d74d0a0b1f17",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Northern Blot",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "PL17",
                    "type": "CellLine"
                },
                {
                    "id": "",
                    "label": "AE7",
                    "type": "CellLine"
                },
                {
                    "id": "",
                    "label": "OF6",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "10761931",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:TBX21)",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IFNG)"
                }
            ],
            "evidence": "\u00a0In conclusion, while neither cell type expresses T-bet at baseline, both B cells and NK cells can be induced to express T-bet under conditions that result in IFN\u03b3 production. Thus, the pattern of T-bet expression correlates well with the production of IFN\u03b3.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "00f22a12-2ee1-41da-bd8d-2b2492e6529a",
        "_rev": "_WpvYGJC-B8",
        "nanopub": {
            "id": "00f22a12-2ee1-41da-bd8d-2b2492e6529a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "52 samples from 26 LN patients, 10 samples from healthy females",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "16518330",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:VEGFA)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                }
            ],
            "evidence": "Urinary interferon-producing protein 10 and its CXC chemokine receptor (CXCR)3, transforming growth factor-\u03b2 (TGF-\u03b2), and vascular endothelial growth factor (VEGF) mRNA levels were analyzed by quantitative real-time polymerase chain reactions. Levels of chemokine or growth factor mRNAs in urine could distinguish class IV LN from others, with a sensitivity of 85% and a specificity of 94%. \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bbc60f07-bf42-4d01-866f-268ea4941797",
        "_rev": "_WpvYGJ--As",
        "nanopub": {
            "id": "bbc60f07-bf42-4d01-866f-268ea4941797",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.5",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "84 patients; 74/10 F/M",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "7521807",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:VCAM1)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Levels of sVCAM-1 correlated with SLEDAI scores (P < 0.05) and, inversely, with levels of C3 (P = 0.01).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b21af58d-b513-413d-b95c-7464365774e8",
        "_rev": "_WpvYGJ--_x",
        "nanopub": {
            "id": "b21af58d-b513-413d-b95c-7464365774e8",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"Muscle Fibers, Skeletal\"",
                    "label": "Muscle Fibers, Skeletal",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "26149277",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Cryotherapy\")",
                    "relation": "decreases",
                    "object": "r(HGNC:FOXP3)"
                },
                {
                    "subject": "a(MESH:\"Cryotherapy\")",
                    "relation": "decreases",
                    "object": "r(HGNC:NEDD4L)"
                },
                {
                    "subject": "a(MESH:\"Cryotherapy\")",
                    "relation": "decreases",
                    "object": "r(HGNC:RORC)"
                }
            ],
            "evidence": " In contrast, cold acclimation affected mr() expression of several immune cell markers in skeletal muscle. It downregulated expression of the Th17 markers RORC (-28%, P < 0.01) and NEDD4L (-15%, P < 0.05), as well as the regulatory T-cell marker FOXP3 (-13%, P < 0.05). \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Th17 Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6882b1b9-df78-4dd1-8d92-b10361c068c5",
        "_rev": "_WpvYGJC--t",
        "nanopub": {
            "id": "6882b1b9-df78-4dd1-8d92-b10361c068c5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "EFO:HEK293",
                    "label": "HEK293",
                    "type": "CellLine"
                },
                {
                    "id": "",
                    "label": "coimmunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Wesche, H",
                    "Henzel, W J",
                    "Shillinglaw, W",
                    "Li, S",
                    "Cao, Z"
                ],
                "comments": "unphosphorylatable IRAK mutant is IRAK(K239S)",
                "database": {
                    "id": "9430229",
                    "name": "PubMed"
                },
                "source_name": "Immunity",
                "title": "MyD88: an adapter that recruits IRAK to the IL-1 receptor complex.",
                "abstract": "IL-1 is a proinflammatory cytokine that signals through a receptor complex of two different transmembrane chains to generate multiple cellular responses, including activation of the transcription factor NF-kappaB. Here we show that MyD88, a previously described protein of unknown function, is recruited to the IL-1 receptor complex following IL-1 stimulation. MyD88 binds to both IRAK (IL-1 receptor-associated kinase) and the heterocomplex (the signaling complex) of the two receptor chains and thereby mediates the association of IRAK with the receptor. Ectopic expression of MyD88 or its death domain-containing N-terminus activates NF-kappaB. The C-terminus of MyD88 interacts with the IL-1 receptor and blocks NF-kappaB activation induced by IL-1, but not by TNF. Thus, MyD88 plays the same role in IL-1 signaling as TRADD and Tube do in TNF and Toll pathways, respectively: it couples a serine/threonine protein kinase to the receptor complex."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IRAK1, pmod(Ph))",
                    "relation": "directlyDecreases",
                    "object": "complex(p(HGNC:IRAK1), p(HGNC:MYD88))"
                }
            ],
            "evidence": "Immunoblotting analysis of the anti-Flag immunoprecipitates showed that the full-length protein and the N- and C-terminal portions of MyD88 each can bind to the kinase defective form of IRAK.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bcbd3b97-10b3-4a79-a788-9cd8a445e61c",
        "_rev": "_WpvYGJG-AO",
        "nanopub": {
            "id": "bcbd3b97-10b3-4a79-a788-9cd8a445e61c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:D006367",
                    "label": "HeLa Cells",
                    "type": "Cell"
                },
                {
                    "id": "MESH:D018938",
                    "label": "Caco-2 Cells",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Lorenzo, Yolanda",
                    "Azqueta, Amaia",
                    "Luna, Luisa",
                    "Bonilla, F\u00e9lix",
                    "Dom\u00ednguez, Gemma",
                    "Collins, Andrew R"
                ],
                "database": {
                    "id": "19056931",
                    "name": "PubMed"
                },
                "source_name": "Carcinogenesis",
                "title": "The carotenoid beta-cryptoxanthin stimulates the repair of DNA oxidation damage in addition to acting as an antioxidant in human cells."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:beta-cryptoxanthin",
                    "relation": "decreases",
                    "object": "bp(MESH:\"DNA Damage\")"
                }
            ],
            "evidence": "Incubation of H(2)O(2)-treated cells with beta-cryptoxanthin led to a doubling of the rate of rejoining of strand breaks and had a similar effect on the rate of removal of oxidized purines by base excision repair.",
            "metadata": {
                "Methodology": "damage induced by H2O2 or visible light in the presence of a photosensitizer",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "261f7f8a-cdef-4616-8a79-5ca5f835db4b",
        "_rev": "_WpvYGJ--B3",
        "nanopub": {
            "id": "261f7f8a-cdef-4616-8a79-5ca5f835db4b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "18641361",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Lupus Erythematosus, Systemic\")",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IFNG)"
                }
            ],
            "evidence": "Peripheral blood T cells from patients with SLE (n\u00a0= 46) produced significantly larger amounts of IFN-\u03b3 than those from normal controls (n\u00a0= 33) with CD28 costimulation\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "610afc86-2241-4488-bd47-113d15cf524b",
        "_rev": "_WpvYGJG--w",
        "nanopub": {
            "id": "610afc86-2241-4488-bd47-113d15cf524b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Gel Electrophoresis, DPA reaction",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"lymphocyte of B lineage\"",
                    "label": "lymphocyte of B lineage",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8376764",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL4)",
                    "relation": "decreases",
                    "object": "bp(GO:\"apoptotic process\")"
                }
            ],
            "evidence": "IL-4 at 25 U/ml was shown to decrease the percentage of spontaneous DNA fragmentation by gel electrophoresis (Fig. 2A) and by DPAreaction from 33.6 2 3.0% (SE) with no stimulus to 22.6 2 3.3% (Fig. 2B).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3de12619-c7e3-4a63-89aa-6a0baa874b1b",
        "_rev": "_WpvYGJC-_U",
        "nanopub": {
            "id": "3de12619-c7e3-4a63-89aa-6a0baa874b1b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15657292",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "complex(GO\"Interleukin 23 complex\")",
                    "relation": "decreases",
                    "object": "bp(GO:\"T-helper 1 cell differentiation\")"
                }
            ],
            "evidence": "Administration of rIL-23 promoted the expansion of ThIL-17\u00a0cells, and reduced the growth of Th1 cells after 5 d of culture (Fig. 2, A and B).\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f6fd5876-d93b-416b-aeeb-72cc35179393",
        "_rev": "_WpvYGJC--H",
        "nanopub": {
            "id": "f6fd5876-d93b-416b-aeeb-72cc35179393",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.48",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLAM-R",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CXCL9)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "81283325-95d5-43c8-959d-b51aac676af5",
        "_rev": "_WpvYGJG--A",
        "nanopub": {
            "id": "81283325-95d5-43c8-959d-b51aac676af5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Immunoprecipitation/SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"CTLL cell\"",
                    "label": "CTLL cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "8022485",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL4)",
                    "relation": "increases",
                    "object": "act(p(HGNC:JAK3, pmod(Ph, Tyr)), ma(GO:\"Kinase activity\"))"
                }
            ],
            "evidence": "With these, IL-2 and IL-4 induced in vitro kindase activity was readily detected (fig. 4b) and the single phosphorylated protein comigrated with Jak-3.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "583cd034-a359-4237-ba2b-6af0a545c4ad",
        "_rev": "_WpvYGJC-BC",
        "nanopub": {
            "id": "583cd034-a359-4237-ba2b-6af0a545c4ad",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Katsiari, Christina G",
                    "Kyttaris, Vasileios C",
                    "Juang, Yuang-Taung",
                    "Tsokos, George C"
                ],
                "database": {
                    "id": "16224536",
                    "name": "PubMed"
                },
                "source_name": "The Journal of clinical investigation",
                "title": "Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus.",
                "abstract": "Decreased IL-2 production in systemic lupus erythematosus (SLE) represents a central component of the disease immunopathology. We report that the message, protein, and enzymatic activity of the catalytic subunit of protein phosphatase 2A (PP2Ac), but not PP1, are increased in patients with SLE regardless of disease activity and treatment and in a disease-specific manner. Treatment of SLE T cells with PP2Ac-siRNA decreased the protein levels and activity of PP2Ac in a specific manner and increased the levels of phosphorylated cAMP response element-binding protein and its binding to the IL2 and c-fos promoters, as well as increased activator protein 1 activity, causing normalization of IL-2 production. Our data document increased activity of PP2A as a novel SLE disease-specific abnormality and define a distinct mechanism whereby it represses IL-2 production. We propose the use of PP2Ac-siRNA as a novel tool to correct T cell IL-2 production in SLE patients."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:PPP2CA)",
                    "relation": "decreases",
                    "object": "p(HGNC:CREBBP, pmod(Ph))"
                }
            ],
            "evidence": "PP2Ac-siRNA decreased the protein levels and activity of PP2Ac in a specific manner and increased the levels of phosphorylated cAMP response element-binding protein and its binding to the IL2 and c-fos promoters, as well as increased activator protein 1 activity, causing normalization of IL-2 production.",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "Decreased IL-2 production in systemic lupus erythematosus (SLE) represents a central component of the disease immunopathology. We report that the message, protein, and enzymatic activity of the catalytic subunit of protein phosphatase 2A (PP2Ac), but not PP1, are increased in patients with SLE regardless of disease activity and treatment and in a disease-specific manner. Treatment of SLE T cells with PP2Ac-siRNA decreased the protein levels and activity of PP2Ac in a specific manner and increased the levels of phosphorylated cAMP response element-binding protein and its binding to the IL2 and c-fos promoters, as well as increased activator protein 1 activity, causing normalization of IL-2 production. Our data document increased activity of PP2A as a novel SLE disease-specific abnormality and define a distinct mechanism whereby it represses IL-2 production. We propose the use of PP2Ac-siRNA as a novel tool to correct T cell IL-2 production in SLE patients.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d354991c-c117-4a25-9b76-67d179cc2934",
        "_rev": "_WpvYGJG-AR",
        "nanopub": {
            "id": "d354991c-c117-4a25-9b76-67d179cc2934",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "70 RA patients, 30 SLE patients, 25 other autoimmune diseases, 20 osteoarthritis (OA), and 35 HC",
                    "type": "cohort"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "erythrocyte sedimentation rate",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Ni, Min",
                    "Wei, Wei",
                    "Wang, Yichao",
                    "Zhang, Na",
                    "Ding, Hongmei",
                    "Shen, Chen",
                    "Zheng, Fang"
                ],
                "database": {
                    "id": "23532497",
                    "name": "PubMed"
                },
                "source_name": "Journal of clinical immunology",
                "title": "Serum levels of calreticulin in correlation with disease activity in patients with rheumatoid arthritis.",
                "abstract": "The aim of our study was to investigate the contribution of serum calreticulin (CRT) in the assessment of disease activity in rheumatoid arthritis (RA)."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CRT)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "Significant positive correlation of CRT with DAS28, ESR and CRP was found in RA patients.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "The aim of our study was to investigate the contribution of serum calreticulin (CRT) in the assessment of disease activity in rheumatoid arthritis (RA).",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "533bc933-9316-4243-8953-240b8e234e66",
        "_rev": "_WpvYGJC-CV",
        "nanopub": {
            "id": "533bc933-9316-4243-8953-240b8e234e66",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "80 SLE with (40) and without (40) renal disease, 40 HC (Chinese cohort)",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "15975968",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CXCL10)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "p(HGNC:CXCL9)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Upon subgroup analysis, IP10, RANTES, MIG, MCP\u20101, IL8, and IL18 correlated significantly with SLEDAI score of the SLE group, while IP10, IL8, IL10, and IL18 concentrations correlated significantly with SLEDAI of RSLE patients (all p<0.05). \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "05fdc877-427b-4fdf-a6f2-047b13fd6a2b",
        "_rev": "_WpvYGI6--K",
        "nanopub": {
            "id": "05fdc877-427b-4fdf-a6f2-047b13fd6a2b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "n=13",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "CFU counting",
                    "type": "Methodology"
                },
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "6338840",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:Fasting)",
                    "relation": "increases",
                    "object": "bp(GO:phagocytosis)"
                }
            ],
            "evidence": "The bactericidal capacity improved during fasting, both in comparison with the initial value (p<OO1).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "85721e7d-e9fb-40d5-a6f3-4a2b76da9419",
        "_rev": "_WpvYGJ--_3",
        "nanopub": {
            "id": "85721e7d-e9fb-40d5-a6f3-4a2b76da9419",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CXCL8)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": " In addition, levels of plasma IP-10, MCP-1 and MCP-3 (Figure 2D), along with IL-8 and ICAM-1 (Supplementary Figure 2H), were significantly elevated in pre-flare periods compared to periods of stable disease.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6d0dd365-994e-424f-906c-985ae47215f1",
        "_rev": "_WpvYGJC-AL",
        "nanopub": {
            "id": "6d0dd365-994e-424f-906c-985ae47215f1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.647 (r)",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "76 SLE patients, 36 age- and sex-matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "20201076",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"anti-hydroxynonenal\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "In addition, a significant correlation was observed between the levels of anti-MDA or anti-HNE antibodies and the SLEDAI score (r = 0.734 and r = 0.647, respectively)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "470037ea-6193-45b8-844d-c7df48a8b79e",
        "_rev": "_WpvYGJ--Am",
        "nanopub": {
            "id": "470037ea-6193-45b8-844d-c7df48a8b79e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "DAS28",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "33 RA patients, 14 HC",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Tung, Chien-Hsueh",
                    "Lu, Ming-Chi",
                    "Lai, Ning-Sheng",
                    "Wu, Shu-Fen"
                ],
                "database": {
                    "id": "28837666",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Tumor necrosis factor-\u03b1 blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis.",
                "abstract": "CD154 (commonly referred to as CD40-ligand) is a critical T cell factor that participates in the pathogenesis of autoimmune and is over-expressed in rheumatoid arthritis (RA). TNF-\u03b1 blockade treatment had dramatic efficacy in RA."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:TNFA blockade treatment)",
                    "relation": "decreases",
                    "object": "path(SDIS:\"erythrocyte sedimentation rate\")"
                },
                {
                    "subject": "a(CHEBI:TNFA blockade treatment)",
                    "relation": "decreases",
                    "object": "path(MESH:\"C-Reactive Protein\")"
                },
                {
                    "subject": "a(CHEBI:TNFA blockade treatment)",
                    "relation": "decreases",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:CD154)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"C-Reactive Protein\")"
                },
                {
                    "subject": "p(HGNC:CD154)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "The levels of expressed CD154 were significantly associated with RA disease activity score DAS28 (p = 0.0043; r2 = 0.126) (Fig 2A) and inflammatory marker CRP (p = 0.009; r2 = 0.11) (Fig 2B).\u00a0\n\nThe CD154 expression levels were significantly attenuated after treatment (as mean percentage of gated CD4+ T cells: mean \u00b1SD: 2.94 \u00b1 3.12% versus 7.21 \u00b1 5.64% at baseline, p < 0.0001) (Fig 1A and 1B, S1 Table). Besides, clinical disease activity, determined by ESR, CRP levels and DAS28, was also significantly reduced after TNF-\u03b1 blockade (mean \u00b1SD: 17.8 \u00b1 16.6 versus 29.2 \u00b1 22.5 at baseline, p = 0.0001; 0.44 \u00b1 0.54 versus 1.45 \u00b1 1.47 at baseline, p = 0.0002; 4.86 \u00b1 1.16 versus 5.88 \u00b1 0.85 at baseline, p = 0.0001; respectively) (Fig 1C and 1D, Table 2).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2e83d763-f33e-4e3e-b6b6-57cca06bf855",
        "_rev": "_WpvYGJG-Bg",
        "nanopub": {
            "id": "2e83d763-f33e-4e3e-b6b6-57cca06bf855",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:tuberculosis",
                    "label": "tuberculosis",
                    "type": "Disease"
                },
                {
                    "id": "MESH:\"CD8-Positive T-Lymphocytes\"",
                    "label": "CD8-Positive T-Lymphocytes",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "28582466",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:Tuberculosis)",
                    "relation": "negativeCorrelation",
                    "object": "surf(p(HGNC:IL7R))"
                }
            ],
            "evidence": "We detected lower mean mIL-7R expression for CD8+\u00a0T cells (p = 0.02)\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2c7a9390-926b-4c71-bd0f-939d01bb5d31",
        "_rev": "_WpvYGJC--p",
        "nanopub": {
            "id": "2c7a9390-926b-4c71-bd0f-939d01bb5d31",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "immunofluorescence",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"HBE135-E6E7 cell\"",
                    "label": "HBE135-E6E7 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "27723765",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17A)",
                    "relation": "increases",
                    "object": "tloc(p(HGNC:ACT1), fromloc(GOCC:\"Membrane\"), toloc(GOCC:\"Nucleus\"))"
                }
            ],
            "evidence": ". Immunofluorescence analysis confirmed the increased nuclear presence of endogenous Act1 following IL-17A stimulation (Fig 1B)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d08123f6-75a0-4cfa-bf2c-61630925b86c",
        "_rev": "_WpvYGJC-A9",
        "nanopub": {
            "id": "d08123f6-75a0-4cfa-bf2c-61630925b86c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"type 2 diabetes mellitus\"",
                    "label": "type 2 diabetes mellitus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "11126411",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Fasting\")",
                    "relation": "decreases",
                    "object": "r(HGNC:UCP3)"
                },
                {
                    "subject": "bp(MESH:\"Fasting\")",
                    "relation": "decreases",
                    "object": "r(HGNC:UCP2)"
                }
            ],
            "evidence": "Expression of UCP2 and UCP3 mRNA were significantly reduced after 10 weeks of diet (p\u00a0< 0.05)\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ab8bfc62-d5f4-4995-b7bf-7f8a47b9c0dc",
        "_rev": "_WpvYGJ--_r",
        "nanopub": {
            "id": "ab8bfc62-d5f4-4995-b7bf-7f8a47b9c0dc",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "11999883",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL16)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Finally, we followed the disease activity of SLE patients over time, which showed significant correlation between the SLE disease activity index and IL-16, ESR and the complement components C3, C4 and CH50.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "15d2fb6a-96e3-4f5c-b648-f09ddabcedd1",
        "_rev": "_WpvYGJG-_4",
        "nanopub": {
            "id": "15d2fb6a-96e3-4f5c-b648-f09ddabcedd1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Incubation of CD8+ T-cells with B-cells and measurement of Ab production",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9498764",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite(p(HGNC:IL2),p(HGNC:TGFB))",
                    "relation": "increases",
                    "object": "act(a(CL:\"regulatory T cell\"))"
                },
                {
                    "subject": "composite(p(HGNC:IL2),p(HGNC:TGFB))",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IGG))"
                }
            ],
            "evidence": "Figure 6\u21d3shows that neither IL-2 nor TGF-\u03b2 alone were sufficient for the generation of suppressor activity. However, when CD8+\u00a0T cells were exposed to both cytokines, there was an 80% suppression of Ig production in the four experiments summarized.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6bcd75cd-bb6f-4269-acad-41d1aec5d5b0",
        "_rev": "_WpvYGJ---o",
        "nanopub": {
            "id": "6bcd75cd-bb6f-4269-acad-41d1aec5d5b0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:\"type 2 diabetes mellitus\"",
                    "label": "type 2 diabetes mellitus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17151862",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:Hyperglycemia)",
                    "relation": "decreases",
                    "object": "p(HGNC:BDNF)"
                }
            ],
            "evidence": "When blood glucose levels were maintained at 15\u00a0mmol/l for 3\u00a0h, this inhibited BDNF output from the brain (effect of time:\u00a0p\u2009=\u20090.009)\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a602bf91-213e-4152-8e0a-5561321e2b90",
        "_rev": "_WpvYGJC-Ba",
        "nanopub": {
            "id": "a602bf91-213e-4152-8e0a-5561321e2b90",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"CD4-positive helper T cell\"",
                    "label": "CD4-positive helper T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12612578",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(GO:\"regulatory T cell differentiation\")",
                    "relation": "increases",
                    "object": "p(HGNC:FOXP3)"
                }
            ],
            "evidence": "Foxp3 protein was highly expressed in CD4+ CD25+ regulatory T cells and was virtually undetectable in both resting and activated CD4+ CD25\u2013 T cells (Fig. 1b). Furthermore, Foxp3 protein expression was increased upon in vitro activation of CD4+ CD25+ regulatory T cells.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "14560c61-d657-4f12-8434-93e36eca5f2e",
        "_rev": "_WpvYGJC-A5",
        "nanopub": {
            "id": "14560c61-d657-4f12-8434-93e36eca5f2e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "17 patients and 6 healthy controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:intestine",
                    "label": "intestine",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "10940278",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:butyrate)",
                    "relation": "decreases",
                    "object": "r(HGNC:TNF)"
                }
            ],
            "evidence": "In the presence of butyrate, TNF levels decreased dose dependently in both inflamed (p=0.0001) and non-inflamed (p=0.0153) biopsies. With 10 mM butyrate, TNF levels (as well as IL-6 and, less consistently, IL-1\u00e2) returned to control values. Similarly, 2 mM butyrate strongly inhibited LPS induced TNF production by PBMC in both CD patients and control subjects (fig 1B).\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "671ba1cb-8f3c-430c-b553-19c4dc0b0018",
        "_rev": "_WpvYGJC-Bn",
        "nanopub": {
            "id": "671ba1cb-8f3c-430c-b553-19c4dc0b0018",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "31 LN,\u00a021 Active Lupus no LN, 30 Inactive Lupus, 11 HC. Almost all patients on prednisone; other drugs allowed as well. Brazilian cohort; sex not reported",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "25799079",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:thiol)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                }
            ],
            "evidence": "However, ROC analysis with LN non-class IV v/s class IV, an AUC of 0.72 and cutoff \u226490.90 \u03bcmol/L, was observed (Fig. 3B). Furthermore, a sensitivity of 80% and an improved specificity of 72%, demonstrated that thiols is a reliable marker to discriminate patients with nephritis disease activity.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "12a859ce-d158-44cc-8c5f-cc5d5fa0f9d6",
        "_rev": "_WpvYGJC-AO",
        "nanopub": {
            "id": "12a859ce-d158-44cc-8c5f-cc5d5fa0f9d6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "OR=7.63",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p=0.003",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "237 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17895304",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"anticardiolipin\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arterial Thrombosis\")"
                }
            ],
            "evidence": "Adjusted risk for arterial thrombosis was increased in groups A [odds ratio (OR) 15.69, 95% confidential interval (CI) 4.79\u201451.42, P < 0.001] and B (OR 7.63, 95% CI 2.00\u201429.08, P = 0.003), but not in group C when compared with group D. \n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9eef466d-3dc4-492d-b89d-065219920fb7",
        "_rev": "_WpvYGJG-AQ",
        "nanopub": {
            "id": "9eef466d-3dc4-492d-b89d-065219920fb7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ACR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "472 patients, 4 treatment groups (121 of which are placebo)",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Bresnihan, B",
                    "Alvaro-Gracia, J M",
                    "Cobby, M",
                    "Doherty, M",
                    "Domljan, Z",
                    "Emery, P",
                    "Nuki, G",
                    "Pavelka, K",
                    "Rau, R",
                    "Rozman, B",
                    "Watt, I",
                    "Williams, B",
                    "Aitchison, R",
                    "McCabe, D",
                    "Musikic, P"
                ],
                "database": {
                    "id": "9870876",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.",
                "abstract": "To evaluate the efficacy and safety of interleukin-1 receptor antagonist (IL-1Ra) in patients with rheumatoid arthritis (RA)."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:IL1R treatment)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "Statistically significant improvements compared with placebo were observed at 24 weeks in the 150 mg/day IL-1Ra group for all individual ACR clinical parameters (Table 2). ",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "da43aba2-b463-4616-ba70-a10186529cd7",
        "_rev": "_WpvYGJG--I",
        "nanopub": {
            "id": "da43aba2-b463-4616-ba70-a10186529cd7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:\"Peyer's patch\"",
                    "label": "Peyer's patch",
                    "type": "Anatomy"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "3498768",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL5)",
                    "relation": "increases",
                    "object": "sec(p(\"IgA\"))"
                }
            ],
            "evidence": "However, as illustrated in Figure 1, addition of IL-5 to LPS-activated B cells stimulated a significant enhancement of IgA secretion\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9cd018d7-7a63-465a-86fa-47303bf88f3b",
        "_rev": "_WpvYGJ--AU",
        "nanopub": {
            "id": "9cd018d7-7a63-465a-86fa-47303bf88f3b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Yamada, Daisaku",
                    "Kobayashi, Shogo",
                    "Wada, Hiroshi",
                    "Kawamoto, Koichi",
                    "Marubashi, Shigeru",
                    "Eguchi, Hidetoshi",
                    "Ishii, Hideshi",
                    "Nagano, Hiroaki",
                    "Doki, Yuichiro",
                    "Mori, Masaki"
                ],
                "database": {
                    "id": "23298711",
                    "name": "PubMed"
                },
                "source_name": "European journal of cancer (Oxford, England : 1990)",
                "title": "Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer.",
                "abstract": "The mechanisms of progression in biliary tract cancer (BTC) with inflammation, including epithelial-mesenchymal transition (EMT), are not well understood. We focused on two inflammation-associated cytokines, interleukin-6 (IL-6) and transforming growth factor-beta 1 (TGF-\u03b21), and investigated their expression and activity, as well as their relationship to key features of malignancy, in tumour samples from patients with BTC and in cultured BTC cells.",
                "date_published": "2013-05-01"
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TGFB1)",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "Addition of rh IL-6 and TGF-\u03b21 increased endogenous IL-6 and TGF-\u03b21 expression through crosstalk and induced cell invasion, EMT and chemoresistance.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "The mechanisms of progression in biliary tract cancer (BTC) with inflammation, including epithelial-mesenchymal transition (EMT), are not well understood. We focused on two inflammation-associated cytokines, interleukin-6 (IL-6) and transforming growth factor-beta 1 (TGF-\u03b21), and investigated their expression and activity, as well as their relationship to key features of malignancy, in tumour samples from patients with BTC and in cultured BTC cells.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ad3e1021-9285-4008-ae2d-bccd435ad87a",
        "_rev": "_WpvYGJC-_0",
        "nanopub": {
            "id": "ad3e1021-9285-4008-ae2d-bccd435ad87a",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17884812",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:\"T-helper 17 cell\")",
                    "relation": "positiveCorrelation",
                    "object": "r(HGNC:RORGT)"
                }
            ],
            "evidence": "The transcription factor ROR\u0001t is essential for Th17 differentiation (14). Culture of na\u0131\u00a8ve CD4\u0001 T cells under standard Th17 conditions markedly up-regulates expression of this transcription factor (Fig. 2A).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f26e84cb-0f47-4461-95da-505d4d9873bd",
        "_rev": "_WpvYGJ--_9",
        "nanopub": {
            "id": "f26e84cb-0f47-4461-95da-505d4d9873bd",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "AE7",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "16275766",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:GSK3)",
                    "relation": "increases",
                    "object": "p(HGNC:TBX21, pmod(Ph, S, 508))"
                }
            ],
            "evidence": "Furthermore, T-bet was phosphorylated by GSK-3 without prephosphorylation by CKI in vitro, which suggested that T-bet was phosphorylated by endogenous CKI in 293T cells.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9fe8e23f-8e72-418a-9901-7357aae86aaf",
        "_rev": "_WpvYGJG-_7",
        "nanopub": {
            "id": "9fe8e23f-8e72-418a-9901-7357aae86aaf",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Lai Kwan Lam, Queenie",
                    "King Hung Ko, Otis",
                    "Zheng, Bo-Jian",
                    "Lu, Liwei"
                ],
                "database": {
                    "id": "18820032",
                    "name": "PubMed"
                },
                "source_name": "Proceedings of the National Academy of Sciences of the United States of America",
                "title": "Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis.",
                "abstract": "Rheumatoid arthritis (RA) is a chronic disease characterized by synovial inflammation and joint damage. Although both T cells and B cells mediate the disease pathogenesis, proinflammatory cytokines are critically involved. The TNF superfamily member B cell-activating factor (BAFF) plays an important role in humoral immunity and in autoimmune diseases, including RA. Here, we show that intra-articular injection of lentivirus expressing shRNA for BAFF gene silencing provides long-term suppression of arthritic development in a collagen-induced arthritis model. Local BAFF gene targeting inhibited proinflammatory cytokine expression, suppressed generation of plasma cells and Th17 cells, and markedly ameliorated joint pathology. Lentivirus targets dendritic cells in the joint tissue and BAFF gene silencing inhibits dendritic cell maturation and their function in driving Th17-cell differentiation in vitro. Moreover, we revealed a previously unrecognized role for BAFF in promoting the expansion of Th17 cells and demonstrated IL-17 as a crucial effector cytokine for BAFF-mediated proinflammatory effects during collagen-induced arthritis development. Taken together, these findings identify BAFF as a valuable gene-silencing target potentially for the effective treatment of RA."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNFSF13B)",
                    "relation": "increases",
                    "object": "r(HGNC:IL6)"
                }
            ],
            "evidence": "Analysis of LV-shBAFF\u2013treated joint tissue revealed significantlydown-regulated mRNA levels of IL-17A and IL-17F. IL-6 andIL-23 were also markedly reduced in their expression (Fig. S4Aonline). Moreover, chemokine levels of CXCL12, CXCL13, andCCL19 were significantly down-regulated. As expected, the contraryresults were observed in the LV-BAFF\u2013treated group (Fig. 2G\u2013J; Fig. S4B online).down-regulated mRNA levels of IL-17A and IL-17F. IL-6 andIL-23 were also markedly reduced in their expression (Fig. S4Aonline). Moreover, chemokine levels of CXCL12, CXCL13, andCCL19 were significantly down-regulated. As expected, the contraryresults were observed in the LV-BAFF\u2013treated group (Fig. 2G\u2013J; Fig. S4B online).",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Rheumatoid arthritis (RA) is a chronic disease characterized by synovial inflammation and joint damage. Although both T cells and B cells mediate the disease pathogenesis, proinflammatory cytokines are critically involved. The TNF superfamily member B cell-activating factor (BAFF) plays an important role in humoral immunity and in autoimmune diseases, including RA. Here, we show that intra-articular injection of lentivirus expressing shRNA for BAFF gene silencing provides long-term suppression of arthritic development in a collagen-induced arthritis model. Local BAFF gene targeting inhibited proinflammatory cytokine expression, suppressed generation of plasma cells and Th17 cells, and markedly ameliorated joint pathology. Lentivirus targets dendritic cells in the joint tissue and BAFF gene silencing inhibits dendritic cell maturation and their function in driving Th17-cell differentiation in vitro. Moreover, we revealed a previously unrecognized role for BAFF in promoting the expansion of Th17 cells and demonstrated IL-17 as a crucial effector cytokine for BAFF-mediated proinflammatory effects during collagen-induced arthritis development. Taken together, these findings identify BAFF as a valuable gene-silencing target potentially for the effective treatment of RA.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "df183b1d-04f8-4b2e-a5bf-a4174f877d4c",
        "_rev": "_WpvYGJG-_U",
        "nanopub": {
            "id": "df183b1d-04f8-4b2e-a5bf-a4174f877d4c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Helicobacter Infections\"",
                    "label": "Helicobacter Infections",
                    "type": "Disease"
                },
                {
                    "id": "CLO:\"MKN-45 cell\"",
                    "label": "MKN-45 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "18347582",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"L. acidophilus ATCC 832\")",
                    "relation": "decreases",
                    "object": "p(HGNC:CXCL8)"
                }
            ],
            "evidence": "In this system, pretreatment with CM containing L. acidophilusproducing CLA significantly decreased the IL-8 releases induced by H. pylori in a dose-dependent manner (Figure 1).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ebf3951e-67ef-49f4-8303-324d4776a48b",
        "_rev": "_WpvYGJG-BY",
        "nanopub": {
            "id": "ebf3951e-67ef-49f4-8303-324d4776a48b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Boulanger, Martin J",
                    "Chow, Dar-chone",
                    "Brevnova, Elena E",
                    "Garcia, K Christopher"
                ],
                "comments": "IL6ST is gp130",
                "database": {
                    "id": "12829785",
                    "name": "PubMed"
                },
                "source_name": "Science (New York, N.Y.)",
                "title": "Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.",
                "abstract": "Interleukin-6 (IL-6) is an immunoregulatory cytokine that activates a cell-surface signaling assembly composed of IL-6, the IL-6 alpha-receptor (IL-6Ralpha), and the shared signaling receptor gp130. The 3.65 angstrom-resolution structure of the extracellular signaling complex reveals a hexameric, interlocking assembly mediated by a total of 10 symmetry-related, thermodynamically coupled interfaces. Assembly of the hexameric complex occurs sequentially: IL-6 is first engaged by IL-6Ralpha and then presented to gp130in the proper geometry to facilitate a cooperative transition into the high-affinity, signaling-competent hexamer. The quaternary structures of other IL-6/IL-12 family signaling complexes are likely constructed by means of a similar topological blueprint."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "directlyDecreases",
                    "object": "complex(p(HGNC:IL6), p(HGNC:IL6R))"
                },
                {
                    "subject": "complex(p(HGNC:IL6), p(HGNC:IL6R))",
                    "relation": "directlyIncreases",
                    "object": "complex(p(HGNC:IL6R), p(HGNC:IL6), p(HGNC:IL6ST), loc(GO:\"cell surface\"))"
                }
            ],
            "evidence": "Interleukin-6 (IL-6) is an immunoregulatory cytokine that activates a cell-surface signaling assembly composed of IL-6, the IL-6 \u03b1-receptor (IL-6R\u03b1), and the shared signaling receptor gp130.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Interleukin-6 (IL-6) is an immunoregulatory cytokine that activates a cell-surface signaling assembly composed of IL-6, the IL-6 alpha-receptor (IL-6Ralpha), and the shared signaling receptor gp130. The 3.65 angstrom-resolution structure of the extracellular signaling complex reveals a hexameric, interlocking assembly mediated by a total of 10 symmetry-related, thermodynamically coupled interfaces. Assembly of the hexameric complex occurs sequentially: IL-6 is first engaged by IL-6Ralpha and then presented to gp130in the proper geometry to facilitate a cooperative transition into the high-affinity, signaling-competent hexamer. The quaternary structures of other IL-6/IL-12 family signaling complexes are likely constructed by means of a similar topological blueprint.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4b51e790-e603-4baa-84a7-d18ebbe40242",
        "_rev": "_WpvYGJ---8",
        "nanopub": {
            "id": "4b51e790-e603-4baa-84a7-d18ebbe40242",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "abstract": "Urinary 8-hydroxydeoxyguanosine (8-OH-dG) and 7-methylguanine (m7Gua) were measured by a column-switching high performance liquid chromatography method as markers of oxidative and methylating DNA damage, respectively. We investigated the associations between urinary 8-OH-dG or m7Gua and various lifestyle and demographic factors, such as age and sex. The urinary 8-OH-dG excretion level was positively correlated with cigarette smoking, but inversely correlated with fruit consumption, physical activity and total energy consumed per day. A multiple regression analysis revealed that daily physical activity and healthy meal combinations decreased the urinary 8-OH-dG level, whereas alcohol consumption increased it. In terms of the urinary m7Gua measurement, cigarette smoking, age and consumption of meat, fish, egg, soybean, etc. were positively correlated with the urinary m7Gua level, whereas body weight, BMI, physical activity, and dietary index score, which indicates good nutritional balance, were negatively correlated with the amount of m7Gua. Based on a multiple regression analysis, cigarette smoking and age correlated with the m7Gua level, while high BMI and healthy meal combinations have significant reducing effects on m7Gua level. Therefore, the urinary m7Gua level is considered to be a useful marker of DNA methylation, not only from smoking, but also from aging and unhealthy dietary habits.",
                "authors": [
                    "Tamae, Kazuyoshi",
                    "Kawai, Kazuaki",
                    "Yamasaki, Sayumi",
                    "Kawanami, Kiyoshi",
                    "Ikeda, Masato",
                    "Takahashi, Ken",
                    "Miyamoto, Toshiaki",
                    "Kato, Noritada",
                    "Kasai, Hiroshi"
                ],
                "database": {
                    "id": "19469016",
                    "name": "PubMed"
                },
                "date_published": "2009-04-01",
                "source_name": "Cancer science",
                "title": "Effect of age, smoking and other lifestyle factors on urinary 7-methylguanine and 8-hydroxydeoxyguanosine."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:8-hydroxy-2'-deoxyguanosine)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Cigarette Smoking\")"
                }
            ],
            "evidence": "The urinary 8-OH-dG excretion level was positively correlated with cigarette smoking, but inversely correlated with fruit consumption, physical activity and total energy consumed per day.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "72ff1ba5-bbe7-4df1-8be7-b4969c3bfc4b",
        "_rev": "_WpvYGJC--l",
        "nanopub": {
            "id": "72ff1ba5-bbe7-4df1-8be7-b4969c3bfc4b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "267 SLE patients",
                    "type": "cohort"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Bauer, Jason W",
                    "Petri, Michelle",
                    "Batliwalla, Franak M",
                    "Koeuth, Thearith",
                    "Wilson, Joseph",
                    "Slattery, Catherine",
                    "Panoskaltsis-Mortari, Angela",
                    "Gregersen, Peter K",
                    "Behrens, Timothy W",
                    "Baechler, Emily C"
                ],
                "database": {
                    "id": "19790071",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study.",
                "abstract": "Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by unpredictable flares of disease activity and irreversible damage to multiple organ systems. An earlier study showed that SLE patients carrying an interferon (IFN) gene expression signature in blood have elevated serum levels of IFN-regulated chemokines. These chemokines were associated with more-severe and active disease and showed promise as SLE disease activity biomarkers. This study was designed to validate IFN-regulated chemokines as biomarkers of SLE disease activity in 267 SLE patients followed up longitudinally."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL19)",
                    "relation": "positiveCorrelation",
                    "object": "path(DO:\"systemic lupus erythematosus\")"
                }
            ],
            "evidence": "The levels of CXCL10 (IP-10) and CCL19 (MIP-3B), but not CCL2 (MCP-1), were significantly higher in patients with active SLE (defined as SLEDAI \u22656, n=76) compared to inactive SLE (SLEDAI \u22642 and PGA=0, n=105; Figure 2A and B).",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by unpredictable flares of disease activity and irreversible damage to multiple organ systems. An earlier study showed that SLE patients carrying an interferon (IFN) gene expression signature in blood have elevated serum levels of IFN-regulated chemokines. These chemokines were associated with more-severe and active disease and showed promise as SLE disease activity biomarkers. This study was designed to validate IFN-regulated chemokines as biomarkers of SLE disease activity in 267 SLE patients followed up longitudinally.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7aa52998-413e-4a6a-b365-00f7fe8443d2",
        "_rev": "_WpvYGJC-Aa",
        "nanopub": {
            "id": "7aa52998-413e-4a6a-b365-00f7fe8443d2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Frob\u00f8se, Helle",
                    "R\u00f8nn, Sif Groth",
                    "Heding, Peter E",
                    "Mendoza, Heidi",
                    "Cohen, Philip",
                    "Mandrup-Poulsen, Thomas",
                    "Billestrup, Nils"
                ],
                "database": {
                    "id": "16543409",
                    "name": "PubMed"
                },
                "source_name": "Molecular endocrinology (Baltimore, Md.)",
                "title": "Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex.",
                "abstract": "IL-1 plays a major role in inflammation and autoimmunity through activation of nuclear factor kappa B (NFkappaB) and MAPKs. Although a great deal is known about the mechanism of activation of NFkappaB and MAPKs by IL-1, much less is known about the down-regulation of this pathway. Suppressor of cytokine signaling (SOCS)-3 was shown to inhibit IL-1-induced transcription and activation of NFkappaB and the MAPKs JNK and p38, but the mechanism is unknown. We show here that SOCS-3 inhibits NFkappaB-dependent transcription induced by overexpression of the upstream IL-1 signaling molecules MyD88, IL-1R-activated kinase 1, TNF receptor-associated factor (TRAF)6, and TGFbeta-activated kinase (TAK)1, but not when the MAP3K MAPK/ERK kinase kinase-1 is used instead of TAK1, indicating that the target for SOCS-3 is the TRAF6/TAK1 signaling complex. By coimmunoprecipitation, it was shown that SOCS-3 inhibited the association between TRAF6 and TAK1 and that SOCS-3 coimmunoprecipitated with TAK1 and TRAF6. Furthermore, SOCS-3 inhibited the IL-1-induced catalytic activity of TAK1. Because ubiquitination of TRAF6 is required for activation of TAK1, we analyzed the role of SOCS-3 on TRAF6 ubiquitination and found that SOCS-3 inhibited ubiquitin modification of TRAF6. These results indicate that SOCS-3 inhibits IL-1 signal transduction by inhibiting ubiquitination of TRAF6, thus preventing association and activation of TAK1."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:SOCS3)",
                    "relation": "decreases",
                    "object": "GO:\"NIK/NF-kappaB signaling\""
                }
            ],
            "evidence": "However, in the presence of SOCS-3, significantly less I\u03baB\u03b1 degradation in response to IL-1 was observed, 33% degraded (P < 0.05 compared with IL-1 alone). Also, we investigated the effect of SOCS-3 on NF\u03baB DNA binding in response to different durations of IL-1 stimulation. We found that 15 and 30 min of IL-1 stimulation resulted in induction of NF\u03baB DNA binding, which was significantly reduced after doxycycline-induced SOCS-3 expression. We observed a 34% and 24% degradation by SOCS-3 after 15 and 30 min, respectively (P < 0.05 for both observations) (Fig. 3B).",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "IL-1 plays a major role in inflammation and autoimmunity through activation of nuclear factor kappa B (NFkappaB) and MAPKs. Although a great deal is known about the mechanism of activation of NFkappaB and MAPKs by IL-1, much less is known about the down-regulation of this pathway. Suppressor of cytokine signaling (SOCS)-3 was shown to inhibit IL-1-induced transcription and activation of NFkappaB and the MAPKs JNK and p38, but the mechanism is unknown. We show here that SOCS-3 inhibits NFkappaB-dependent transcription induced by overexpression of the upstream IL-1 signaling molecules MyD88, IL-1R-activated kinase 1, TNF receptor-associated factor (TRAF)6, and TGFbeta-activated kinase (TAK)1, but not when the MAP3K MAPK/ERK kinase kinase-1 is used instead of TAK1, indicating that the target for SOCS-3 is the TRAF6/TAK1 signaling complex. By coimmunoprecipitation, it was shown that SOCS-3 inhibited the association between TRAF6 and TAK1 and that SOCS-3 coimmunoprecipitated with TAK1 and TRAF6. Furthermore, SOCS-3 inhibited the IL-1-induced catalytic activity of TAK1. Because ubiquitination of TRAF6 is required for activation of TAK1, we analyzed the role of SOCS-3 on TRAF6 ubiquitination and found that SOCS-3 inhibited ubiquitin modification of TRAF6. These results indicate that SOCS-3 inhibits IL-1 signal transduction by inhibiting ubiquitination of TRAF6, thus preventing association and activation of TAK1.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d0cacd8b-4973-4d45-ab75-ebf210bb4c52",
        "_rev": "_WpvYGJC-BK",
        "nanopub": {
            "id": "d0cacd8b-4973-4d45-ab75-ebf210bb4c52",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.17",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "0.004",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "1518 men and 1524 women",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15992645",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Seafood)",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:SAA1)"
                }
            ],
            "evidence": "All inflammatory markers showed an inverse dose-response relationship with fish consumption (Table 2).\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "84c9341a-fad1-4dbf-bcb6-93d195d90029",
        "_rev": "_WpvYGJ--B5",
        "nanopub": {
            "id": "84c9341a-fad1-4dbf-bcb6-93d195d90029",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"dendritic cell\"",
                    "label": "dendritic cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10898488",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:\"regulatory T cell\")",
                    "relation": "decreases",
                    "object": "r(HGNC:CD80)"
                }
            ],
            "evidence": "Reverse transcription (RT)-PCR analysis demonstrated that the steady-state level of CD80 mRNA was significantly lower in DC co-cultured with CD4+ CD25+ cells\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0ecb530e-ad73-43ef-8cce-f89b6e70d02c",
        "_rev": "_WpvYGJC-_l",
        "nanopub": {
            "id": "0ecb530e-ad73-43ef-8cce-f89b6e70d02c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "31 LN,\u00a021 Active Lupus no LN, 30 Inactive Lupus, 11 HC. Almost all patients on prednisone; other drugs allowed as well. Brazilian cohort; sex not reported",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "25799079",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:C3)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                }
            ],
            "evidence": "C3 levels in serum decreased in LN (74.13\u00b158.08) patients in comparison to C (168.10\u00b139.66), IL (143.90\u00b150.11) and AL (101.20\u00b177.64) patient groups.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "74cecbaa-9728-4d43-b6f4-20c123ad877a",
        "_rev": "_WpvYGJ--CB",
        "nanopub": {
            "id": "74cecbaa-9728-4d43-b6f4-20c123ad877a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Immunoblotting",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "10545482",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:ethanol)",
                    "relation": "increases",
                    "object": "p(HGNC:NFKBIA, pmod(P, Ser, 32))"
                }
            ],
            "evidence": "However, in monocytes treated with ethanol alone, the levels of phosphorylated I\u03baB\u03b1 did not change as compared to unstimulated monocytes (Fig. 5B). These results indicate that in human monocytes ethanol prevents LPS-induced increase in phosphorylated I\u03baB\u03b1 levels without preventing degradation of cytoplasmic I\u03baB\u03b1 levels.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f992a6bf-a7c9-40d7-bb30-be3df2188c7e",
        "_rev": "_WpvYGJ--Ag",
        "nanopub": {
            "id": "f992a6bf-a7c9-40d7-bb30-be3df2188c7e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"Vogt-Koyanagi-Harada disease\"",
                    "label": "Vogt-Koyanagi-Harada disease",
                    "type": "Disease"
                },
                {
                    "id": "",
                    "label": "12 VKH patients, 20 controlled",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "FACS",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "12",
                    "type": "Cohort"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Yang, Yan",
                    "Qi, Jian",
                    "Wang, Qian",
                    "Du, Liping",
                    "Zhou, Yan",
                    "Yu, Hongsong",
                    "Kijlstra, Aize",
                    "Yang, Peizeng"
                ],
                "database": {
                    "id": "23482469",
                    "name": "PubMed"
                },
                "source_name": "Investigative ophthalmology & visual science",
                "title": "Berberine suppresses Th17 and dendritic cell responses.",
                "abstract": "Berberine (BBR) has been shown to exert immunosuppressive and anti-inflammatory effects in several autoimmune diseases. This study was designed to investigate the possible effect of BBR on Th17 and dendritic cell (DC) responses."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:berberine)",
                    "relation": "decreases",
                    "object": "bp(GO:\"T-helper 17 type immune response\")"
                }
            ],
            "evidence": "The aforementioned experiment revealed a direct inhibitory effect of BBR on the Th17 response.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a2fc4d75-639b-4a1e-a206-7ae72017c65e",
        "_rev": "_WpvYGJC-_e",
        "nanopub": {
            "id": "a2fc4d75-639b-4a1e-a206-7ae72017c65e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "n=16 intervention and n=12 controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "p=0.008",
                    "type": "p-value"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:\"colonic mucosa\"",
                    "label": "colonic mucosa",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"ulcerative colitis\"",
                    "label": "ulcerative colitis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "18240282",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"VSL#3\")",
                    "relation": "increases",
                    "object": "r(HGNC:FOXP3)"
                }
            ],
            "evidence": "A significant increase in mRNA content was seen at the second observation in patients treated with VSL#3 compared with controls, in whom Foxp3 mRNA remained essentially constant in the 2 observations\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "083309fc-177e-4c71-bb5b-edfe79997b8d",
        "_rev": "_WpvYGJ--AG",
        "nanopub": {
            "id": "083309fc-177e-4c71-bb5b-edfe79997b8d",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "Flow cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "15657292",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL12)",
                    "relation": "decreases",
                    "object": "bp(GO:\"T-helper 17 cell differentiation\")"
                }
            ],
            "evidence": "In contrast, addition of rIL-12 promoted Th1 but reduced ThIL-17growth (Fig. 2\u00a0A and B).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "569fdb6e-8482-405b-8a48-1539dbf2cb9f",
        "_rev": "_WpvYGJC--k",
        "nanopub": {
            "id": "569fdb6e-8482-405b-8a48-1539dbf2cb9f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Antibody-Mediated Inhibition",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"regulatory T cell\"",
                    "label": "regulatory T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "11238621",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:\"regulatory T cell\")",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL10))"
                }
            ],
            "evidence": "\u00a0Neutralization of IL-4 and IL-10 completely abrogated the transfer of tolerance toward B10 alloantigens; B10 skin grafts were rejected by six of seven mice in this group (p\u00a0< 0.05; vs GL113),\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "16e4cc50-c9c2-46b6-a3ec-c4259a229be9",
        "_rev": "_WpvYGJG-_W",
        "nanopub": {
            "id": "16e4cc50-c9c2-46b6-a3ec-c4259a229be9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "",
                    "label": "counting",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "1655948",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL10)",
                    "relation": "decreases",
                    "object": "bp(GO:\"T cell proliferation\")"
                }
            ],
            "evidence": "Addition of IL-10 or v-IL-10 to the cultures of T cels, TT, and monocytes preincubated with IL-10 or v-IL-10 abolished the TT-specific proliferative response of purified T cells almost completely.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e9f52656-f7c5-423c-955e-8d49022ab0e6",
        "_rev": "_WpvYGJG-Bb",
        "nanopub": {
            "id": "e9f52656-f7c5-423c-955e-8d49022ab0e6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"regulatory T cell\"",
                    "label": "regulatory T cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "15940144",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:\"regulatory T cell\")",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL10))"
                }
            ],
            "evidence": "Instead, effector T cells generated in response to\u00a0L reuteri\u2013 or\u00a0L casei\u2013treated mature DCs produced increased levels of IL-10 (Fig 2,\u00a0B; MF-control 3.56 \u00b1 0.25 ng/mL).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "73530923-9c19-434d-8505-1b907a434af8",
        "_rev": "_WpvYGJC-A1",
        "nanopub": {
            "id": "73530923-9c19-434d-8505-1b907a434af8",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Nitrotyrosine Staining",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8790368",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:NOS2)",
                    "relation": "increases",
                    "object": "a(CHEBI:peroxynitrite)"
                }
            ],
            "evidence": "Nitrotyrosine staining of these suspensions showed the presence of nitrotyrosine on the surface of ingested bacteria that increased with time following addition of bacteria, reaching a maximum after 60 min incubation (Fig. 6 c and d).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0c74f250-77fd-4add-a4c2-7d538b357632",
        "_rev": "_WpvYGJC-_a",
        "nanopub": {
            "id": "0c74f250-77fd-4add-a4c2-7d538b357632",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15220936",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL12)",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IFNG))"
                }
            ],
            "evidence": "By contrast, as shown in\u00a0Figure 1, IL-12 alone stimulated IFN\u03b3\u00a0production, in a concentration-dependent manner, reaching a plateau after 50\u2009ng/ml.\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "272c6550-31fb-46b3-ad8a-56d154438cba",
        "_rev": "_WpvYGJG-BB",
        "nanopub": {
            "id": "272c6550-31fb-46b3-ad8a-56d154438cba",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.049",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "DAS28",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "47 RA patients, 42 OA patients, 41 HC",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Cerezo, Lucie Andr\u00e9s",
                    "Kuklov\u00e1, Mark\u00e9ta",
                    "Hulejov\u00e1, Hana",
                    "Vernerov\u00e1, Zde\u0148ka",
                    "Kasp\u0159\u00edkov\u00e1, Nikola",
                    "Veigl, David",
                    "Pavelka, Karel",
                    "Vencovsk\u00fd, Ji\u0159\u00ed",
                    "\u0160enolt, Ladislav"
                ],
                "database": {
                    "id": "26339140",
                    "name": "PubMed"
                },
                "source_name": "Mediators of inflammation",
                "title": "Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis.",
                "abstract": "Progranulin (PGRN) is implicated in the pathogenesis of rheumatoid arthritis (RA). The aim of this study was to assess the relationship between PGRN and disease activity in RA."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:PGRN)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "Serum PGRN levels correlated with DAS28 (r = 0.327, P = 0.049) and HAQ score (r = 0.323, P = 0.032",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9740a94d-d476-49c4-9e52-fb57f0d4a547",
        "_rev": "_WpvYGJC--3",
        "nanopub": {
            "id": "9740a94d-d476-49c4-9e52-fb57f0d4a547",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"D10.G4.1 cell\"",
                    "label": "D10.G4.1 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "9160750",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:GATA3)\t",
                    "relation": "increases",
                    "object": "r(HGNC:IL10)"
                },
                {
                    "subject": "p(HGNC:GATA3)\t",
                    "relation": "increases",
                    "object": "r(HGNC:IL13)"
                },
                {
                    "subject": "p(HGNC:GATA3)\t",
                    "relation": "increases",
                    "object": "r(HGNC:IL6)"
                },
                {
                    "subject": "p(HGNC:GATA3)",
                    "relation": "increases",
                    "object": "r(HGNC:IL4)"
                }
            ],
            "evidence": "GATA-3 expression was significantly reduced in both lines with the expression in D10.3.4.2 cells slightly higher than in D10.3.4.1 cells (Figure 3). As shown in\u00a0Figure 4A, compared with the control transfectant D10.3, the expression of\u00a0IL-4,\u00a0IL-6, and\u00a0IL-13mRNA in D10.3.4.1 cells was abolished and the expression of\u00a0IL-10\u00a0mRNA was also greatly inhibited.\u00a0IL-5\u00a0gene expression was apparently also inhibited, albeit to a lesser extent. I\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "59162d84-e22c-49ed-8390-e214c60bcf3d",
        "_rev": "_WpvYGJC-At",
        "nanopub": {
            "id": "59162d84-e22c-49ed-8390-e214c60bcf3d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.837",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "15 renal failure patients, 30 haemodialysis patients, and 10 HC",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "HPLC",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"kidney failure\"",
                    "label": "kidney failure",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10516995",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"N-amidinoaspartic acid\")",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:creatinine)"
                }
            ],
            "evidence": "There was a sigmkant correlation between urinary IMG or GiSA excretion and plasma creatinine levels (r = 0.92'3, p < 0.001 and v = 0.837, p < 0.001, respectively).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "54d47515-c4c1-436c-bc5a-ea46599aaffb",
        "_rev": "_WpvYGJG-_x",
        "nanopub": {
            "id": "54d47515-c4c1-436c-bc5a-ea46599aaffb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "77 SLE, 22 disease controls, 28 HC",
                    "type": "Cohort"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "15880830",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "r(EG:5610)\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "r(HGNC:IFIT1)\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "r(HGNC:IFI44)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "r(HGNC:IFI44)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Kidney Diseases\")"
                },
                {
                    "subject": "r(HGNC:IFIT1)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Kidney Diseases\")"
                },
                {
                    "subject": "r(EG:5610)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Kidney Diseases\")"
                }
            ],
            "evidence": "Renal disease, low complement, and the SDI score were also independently associated with a high IFN\u03b1 score.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "62921e0e-15cc-4a04-8cca-c6945e897ce7",
        "_rev": "_WpvYGJC-CX",
        "nanopub": {
            "id": "62921e0e-15cc-4a04-8cca-c6945e897ce7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "418 SLE or APS patients",
                    "type": "Cohort"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16960938",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"lupus anticoagulant\")",
                    "relation": "positiveCorrelation",
                    "object": "p(\"IgM anti-beta2-GPI\")"
                }
            ],
            "evidence": "A positive association was found between the presence of the LAC by dilute RVVT and anti-beta2-GPI IgG (p < 0.0001), IgM (p < 0.0001), and IgA (p = 0.0002) antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ccd777e0-0e3c-4c77-9646-6b073c5bdd0d",
        "_rev": "_WpvYGJ--A7",
        "nanopub": {
            "id": "ccd777e0-0e3c-4c77-9646-6b073c5bdd0d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "27413244",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Squalene)",
                    "relation": "decreases",
                    "object": "r(HGNC:TNF)"
                }
            ],
            "evidence": "). The expression of the pro-inflammatory cytokine genes TNF-\u03b1 and IL-1\u03b2 but not IL-6 or IL-10 was significantly reduced by squalene (50 \u0006M, 18 h) in LPS-treated human monocytes\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ac84eacf-64d4-4a71-af0f-40070477fd9f",
        "_rev": "_WpvYGJ--CR",
        "nanopub": {
            "id": "ac84eacf-64d4-4a71-af0f-40070477fd9f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Monocytes",
                    "label": "Monocytes",
                    "type": "Cell"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "comments": "the table actually shows that RA patients have higher expressions\n",
                "database": {
                    "id": "27822475",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Arthritis, Rheumatoid\")",
                    "relation": "positiveCorrelation",
                    "object": "surf(p(HGNC:CCR6))"
                },
                {
                    "subject": "path(MESH:\"Arthritis, Rheumatoid\")",
                    "relation": "positiveCorrelation",
                    "object": "surf(p(HGNC:RANK))"
                }
            ],
            "evidence": "As presented in\u00a0Table 1, the rates of RANKhighon monocytes, CCR6+\u00a0on monocyte, and CCR6+\u00a0on RANK (\u2013) monocytes in RA patients were significantly higher in HV, respectively.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3509439a-883f-42dc-aa12-59c9f82116c7",
        "_rev": "_WpvYGJ--_6",
        "nanopub": {
            "id": "3509439a-883f-42dc-aa12-59c9f82116c7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "36 SLE, 18 HC",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Ren, Yi",
                    "Tang, Jinling",
                    "Mok, M Y",
                    "Chan, Albert W K",
                    "Wu, Adrian",
                    "Lau, C S"
                ],
                "database": {
                    "id": "14558095",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus.",
                "abstract": "To evaluate whether patients with systemic lupus erythematosus (SLE) have a higher rate of apoptosis in and secondary necrosis of polymorphonuclear neutrophils (PMNs) and macrophages compared with controls; to compare the rate of macrophage phagocytic clearance of apoptotic PMNs in patients with SLE and healthy controls; to evaluate whether in vitro PMN and macrophage apoptosis and secondary necrosis, and the ability of macrophages to phagocytose apoptotic bodies, are correlated with lupus disease activity; and to determine whether macrophage clearance of apoptotic bodies in patients with SLE and normal controls is related to certain serum factors."
            },
            "assertions": [
                {
                    "subject": "a(apoptotic PMNs)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "\u00a0the percentage of apoptotic PMNs from patients with SLE was significantly higher than that of PMNs from healthy subjects.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1ac826f0-67f9-486e-99a0-bcd416e574ce",
        "_rev": "_WpvYGJ--CY",
        "nanopub": {
            "id": "1ac826f0-67f9-486e-99a0-bcd416e574ce",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "21215659",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT3)",
                    "relation": "increases",
                    "object": "r(HGNC:GATA3)"
                }
            ],
            "evidence": "See Fig. 3A\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1cff6929-dbca-4096-ae8f-b30451d109da",
        "_rev": "_WpvYGJC-_Y",
        "nanopub": {
            "id": "1cff6929-dbca-4096-ae8f-b30451d109da",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.38",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:ICAM3)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3332798f-c437-43f6-b49d-c1c1b10968df",
        "_rev": "_WpvYGJC-_i",
        "nanopub": {
            "id": "3332798f-c437-43f6-b49d-c1c1b10968df",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "AE7",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "16275766",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TBX21, pmod(Ph, S, 508))",
                    "relation": "decreases",
                    "object": "p(HGNC:IL2)"
                }
            ],
            "evidence": "However, the mutation of S508 to alanine abolished the ability of T-bet to repress the expression of both mRNA transcripts encoding IL-2 and IL-2 protein (Fig. 3, E and F).\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6c6b2b54-56b6-4eb7-8ff6-e1035c06546c",
        "_rev": "_WpvYGJ---N",
        "nanopub": {
            "id": "6c6b2b54-56b6-4eb7-8ff6-e1035c06546c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "25 renal flare, 22 nonrenal flare, 28 healthy controls, 33 disease controls (non flare SLE)",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "15601744",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:1-methylcyclopropene)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "Urine MCP-1 was increased beginning 2 to 4 mo before flare.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6fcbd9ce-a973-4868-83eb-3edcc0b7391e",
        "_rev": "_WpvYGJ--_q",
        "nanopub": {
            "id": "6fcbd9ce-a973-4868-83eb-3edcc0b7391e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "\t<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "33 RA patients, 14 HC",
                    "type": "cohort"
                },
                {
                    "id": "",
                    "label": "DAS28",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "authors": [
                    "Rooney, Terence",
                    "Scherzer, Rebecca",
                    "Shigenaga, Judy K",
                    "Graf, Jonathan",
                    "Imboden, John B",
                    "Grunfeld, Carl"
                ],
                "database": {
                    "id": "21441551",
                    "name": "PubMed"
                },
                "source_name": "Rheumatology (Oxford, England)",
                "title": "Levels of plasma fibrinogen are elevated in well-controlled rheumatoid arthritis.",
                "abstract": "Patients with RA have systemic inflammation and increased risk of cardiovascular (CV) events, including thrombosis. Levels of fibrinogen, a pro-thrombotic protein with predictive value for CV disease (CVD), are elevated during systemic inflammation. We compared circulating fibrinogen levels in patients with RA with healthy controls and evaluated the relationship with measures of disease activity."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Fibrinogen)\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "We next examined the associations of measures of disease activity with fibrinogen in RA patients. Joint counts, CDAI, SDAI and DAS-28 also showed positive, statistically significant associations with fibrinogen. Disease activity markers that included an inflammatory marker (SDAI, DAS-28-ESR and DAS-28-CRP) showed strong associations (all r\u2009>\u20090.4, P\u2009<\u20090.0001)",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Patients with RA have systemic inflammation and increased risk of cardiovascular (CV) events, including thrombosis. Levels of fibrinogen, a pro-thrombotic protein with predictive value for CV disease (CVD), are elevated during systemic inflammation. We compared circulating fibrinogen levels in patients with RA with healthy controls and evaluated the relationship with measures of disease activity.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6b4c1baf-c5a3-44d9-bf6e-2fce569eee5b",
        "_rev": "_WpvYGJC--Y",
        "nanopub": {
            "id": "6b4c1baf-c5a3-44d9-bf6e-2fce569eee5b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=17",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:\"Hypertriglyceridemic Waist\"",
                    "label": "Hypertriglyceridemic Waist",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "19158225",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "p(HGNC:MMP2)"
                }
            ],
            "evidence": "there was a significant 15% reduction in the concentration of serum CRP and a significant 7% increase in the concentration of plasma MMP-2 when compared with their concentrations at baseline (Fig. 1).\u00a0\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "461e9ccc-8e76-46b3-a449-bb0bc231f53b",
        "_rev": "_WpvYGJC-_r",
        "nanopub": {
            "id": "461e9ccc-8e76-46b3-a449-bb0bc231f53b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "n 6 patients with chronic active hepatitis (CAH) [3 females and 3 males: mean age = 51 f 3 yr (S.E.)], 11 patients with liver cirrhosis (LC) (6 females and 5 males: mean age = 61 f 3 years) and 5 patients with hepatocellular carcinoma (HCC) (5 males: mean age = 57 * 6 years), all of whom had an underlying cirrhosis, and 3 other patients with cholelithiasis (male, 39 years), obstructive jaundice due to bile duct cancer (male, 69 years) and chronic pancreatitis (male, 47 years). As normal controls, 12 healthy volunteers (6 females and 6 males: mean age = 38 f 3 years) were used",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "HPLC",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "3356409",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Carcinoma, Hepatocellular\")",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:\"pipecolic acid\")"
                },
                {
                    "subject": "path(GO:\"Cirrhosis\")",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:\"pipecolic acid\")"
                }
            ],
            "evidence": "The mean levels of LC and HCC patients were 1.93 f 0.24 and 2.22 & 0.49 nmoles per ml, respectively, both of which were significantly higher than those in normal controls (p < 0.01)\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0d1b21e2-21a0-40e9-8134-90eeca0a8333",
        "_rev": "_WpvYGJG-_R",
        "nanopub": {
            "id": "0d1b21e2-21a0-40e9-8134-90eeca0a8333",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"Human Umbilical Vein Endothelial Cells\"",
                    "label": "Human Umbilical Vein Endothelial Cells",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Wen, Ya-Dan",
                    "Wang, Hong",
                    "Kho, Sok-Hong",
                    "Rinkiko, Suguro",
                    "Sheng, Xiong",
                    "Shen, Han-Ming",
                    "Zhu, Yi-Zhun"
                ],
                "database": {
                    "id": "23393548",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress.",
                "abstract": "Hydrogen sulfide (H\u2082S) has been shown to have cytoprotective effects in models of hypertension, ischemia/reperfusion and Alzheimer's disease. However, little is known about its effects or mechanisms of action in atherosclerosis. Therefore, in the current study we evaluated the pharmacological effects of H\u2082S on antioxidant defenses and mitochondria protection against hydrogen peroxide (H\u2082O\u2082) induced endothelial cells damage."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"hydrogen peroxide\")",
                    "relation": "decreases",
                    "object": "p(SP:P36969)"
                },
                {
                    "subject": "a(MESH:\"Hydrogen Peroxide\")",
                    "relation": "decreases",
                    "object": "p(HGNC:SOD2)"
                },
                {
                    "subject": "a(MESH:\"Hydrogen Peroxide\")",
                    "relation": "decreases",
                    "object": "p(HGNC:SOD1)"
                },
                {
                    "subject": "a(MESH:\"Hydrogen Peroxide\")",
                    "relation": "decreases",
                    "object": "p(HGNC:CAT)"
                }
            ],
            "evidence": "When cells were stimulated with H2O2 a significant decreases in the activities of superoxide dismutase (SOD), catalase, glutathione Peroxidase (GPx) and glutathione S-transferase (GST) were observed (P<0.05, vs. control, n\u200a=\u200a6).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6064e1ec-cef9-4fae-a30d-290e283c5ed2",
        "_rev": "_WpvYGJG-A4",
        "nanopub": {
            "id": "6064e1ec-cef9-4fae-a30d-290e283c5ed2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "70 SLE patients and 20 healthy controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "BILAG",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "28502135",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Estimated serum sTRAIL, TNF-\u03b1 and IL-6 levels showed positive significant correlation with calculated BILAG activity score, while estimated serum IL-10 levels showed negative significant correlation with activity score.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2ee43236-aa5f-4922-bec4-f67904ce15d0",
        "_rev": "_WpvYGJC-AW",
        "nanopub": {
            "id": "2ee43236-aa5f-4922-bec4-f67904ce15d0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "40 SLE,\u00a030 HCs",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Henriques, Ana",
                    "Teixeira, Lu\u00eds",
                    "In\u00eas, Lu\u00eds",
                    "Carvalheiro, Tiago",
                    "Gon\u00e7alves, Ana",
                    "Martinho, Ant\u00f3nio",
                    "Pais, Maria Lu\u00edsa",
                    "da Silva, Jos\u00e9 Ant\u00f3nio Pereira",
                    "Paiva, Artur"
                ],
                "database": {
                    "id": "23377197",
                    "name": "PubMed"
                },
                "source_name": "Clinical rheumatology",
                "title": "NK cells dysfunction in systemic lupus erythematosus: relation to disease activity.",
                "abstract": "Through their cytotoxic capacities and cytokine production, natural killer (NK) cells modulate autoimmune diseases. However, their role in the pathogenesis of systemic lupus erythematosus (SLE) has not been extensively studied. The aim of this study was to analyse the immunophenotypic and functional characteristics of the two major NK cell subsets in SLE and relate them with disease activity. Peripheral blood samples from 44 patients with active (n\u2009=\u200918) and inactive SLE (n\u2009=\u200926) and 30 controls were analysed by flow cytometry to evaluate NK cell subsets, according to: the differential expression of CXCR3 and CD57; expression of granzyme B and perforin; and production of interferon gamma (IFN-\u03b3) and tumor necrosis alpha (TNF-\u03b1), after PMA/ionomycin activation. A clear decrease in absolute and relative numbers of circulating NK cells was found in SLE, particularly in active disease, while the proportions of the major NK cell subsets were unaffected. Active SLE was associated with a reduced CXCR3 expression on both NK cell subsets and a lower frequency of CD56(dim) NK cells expressing CXCR3. Furthermore, granzyme B expression was decreased in both SLE groups, but the percentage of NK cells expressing granzyme B and perforin was higher, particularly in active disease. We found a significant decrease in the percentage of CD56(bright) and CD56(dim) NK cells producing TNF-\u03b1 and of its expression on CD56(dim) NK cells in active disease, while IFN-\u03b3 expression on CD56(bright) NK cells was increased in both SLE groups. Our findings suggest that NK cell subsets exhibit unique phenotypic and functional changes that are particularly evident in active SLE, and they may have the potential to affect the disease outcome."
            },
            "assertions": [
                {
                    "subject": "a(CL:\"natural killer cell\")",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "A clear decrease in absolute and relative numbers of circulating NK cells was found in SLE, particularly in active disease, while the proportions of the major NK cell subsets were unaffected\n\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1bb72984-5c0f-4110-81d2-735b90d7f813",
        "_rev": "_WpvYGJG-_E",
        "nanopub": {
            "id": "1bb72984-5c0f-4110-81d2-735b90d7f813",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18504327",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Glutathione Disulfide\"",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Glutathione Disulfide\")"
                }
            ],
            "evidence": "Thus, CySS and GSH were inversely correlated, (r  0.24; P 0.008), and CySSG was correlated with both GSH (r 0.66; P 0.0001) and GSSG (r 0.58; P 0.0001).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bcee617d-b5e7-4a25-b47b-5ad1d33dacbc",
        "_rev": "_WpvYGJG-_3",
        "nanopub": {
            "id": "bcee617d-b5e7-4a25-b47b-5ad1d33dacbc",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "DAS28",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "35 RA patients, 30 HC",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Conigliaro, Paola",
                    "Triggianese, Paola",
                    "Chimenti, Maria Sole",
                    "Lucchetti, Ramona",
                    "Kroegler, Barbara",
                    "Perricone, Roberto"
                ],
                "database": {
                    "id": "27683140",
                    "name": "PubMed"
                },
                "source_name": "The Journal of international medical research",
                "title": "Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab.",
                "abstract": "To evaluate prospectively serological markers at baseline and during treatment in patients with rheumatoid arthritis (RA) initiating rituximab treatment, following failure of antitumour necrosis factor (TNF)-\u03b1 therapy."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IgM)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:C3)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "here was a direct correlation between C3 and DAS28 at 12 months after treatment initiation in the study population as a whole (P\u2009=\u20090.03, r\u2009=\u20090.5; Figure 1B).\n\nIn the study population as a whole, serum IgM concentrations were significantly lower than baseline after 6, 12 and 18 months\u2019 treatment (P\u2009=\u20090.04, P\u2009=\u20090.03, and P\u2009=\u20090.02, respectively; Figure 1C). Furthermore, a direct correlation was observed between IgM levels and DAS28 in responding patients, after 6, 12 and 18 months\u2019 treatment (6 months P\u2009=\u20090.01, r\u2009=\u20090.5; 12 months P\u2009=\u20090.03, r\u2009=\u20090.7; 18 months P\u2009=\u20090.01, r\u2009=\u20090.5; Figure 1D\u2013F).\u00a0",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c5b3ac92-196b-4efa-a529-5546edfb3a61",
        "_rev": "_WpvYGJ--BD",
        "nanopub": {
            "id": "c5b3ac92-196b-4efa-a529-5546edfb3a61",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Leffler, Jonatan",
                    "Bengtsson, Anders A",
                    "Blom, Anna M"
                ],
                "database": {
                    "id": "24845390",
                    "name": "PubMed"
                },
                "source_name": "Annals of the rheumatic diseases",
                "title": "The complement system in systemic lupus erythematosus: an update.",
                "abstract": "The complement system plays a major role in the autoimmune disease, systemic lupus erythematosus (SLE). However, the role of complement in SLE is complex since it may both prevent and exacerbate the disease. In this review, we explore the latest findings in complement-focused research in SLE. C1q deficiency is the strongest genetic risk factor for SLE, although such deficiency is very rare. Various recently discovered genetic associations include mutations in the complement receptors 2 and 3 as well as complement inhibitors, the latter related to earlier onset of nephritis. Further, autoantibodies are a distinct feature of SLE that are produced as the result of an adaptive immune response and how complement can affect that response is also being reviewed. SLE generates numerous disease manifestations involving contributions from complement such as glomerulonephritis and the increased risk of thrombosis. Furthermore, since most of the complement system is present in plasma, complement is very accessible and may be suitable as biomarker for diagnosis or monitoring of disease activity. This review highlights the many roles of complement for SLE pathogenesis and how research has progressed during recent years."
            },
            "assertions": [
                {
                    "subject": "a(anti-c1q)",
                    "relation": "decreases",
                    "object": "p(HGNC:C1Q)"
                }
            ],
            "evidence": "C1q antibodies could result in decreased C1q levels, mimicking a C1q-deficient state with impaired clearance of dying cells.",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "The complement system plays a major role in the autoimmune disease, systemic lupus erythematosus (SLE). However, the role of complement in SLE is complex since it may both prevent and exacerbate the disease. In this review, we explore the latest findings in complement-focused research in SLE. C1q deficiency is the strongest genetic risk factor for SLE, although such deficiency is very rare. Various recently discovered genetic associations include mutations in the complement receptors 2 and 3 as well as complement inhibitors, the latter related to earlier onset of nephritis. Further, autoantibodies are a distinct feature of SLE that are produced as the result of an adaptive immune response and how complement can affect that response is also being reviewed. SLE generates numerous disease manifestations involving contributions from complement such as glomerulonephritis and the increased risk of thrombosis. Furthermore, since most of the complement system is present in plasma, complement is very accessible and may be suitable as biomarker for diagnosis or monitoring of disease activity. This review highlights the many roles of complement for SLE pathogenesis and how research has progressed during recent years.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "274e73d7-c766-4820-9a94-2fca021b5611",
        "_rev": "_WpvYGJC--x",
        "nanopub": {
            "id": "274e73d7-c766-4820-9a94-2fca021b5611",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "CDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "33 RA patients, 14 HC",
                    "type": "cohort"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                },
                {
                    "id": "",
                    "label": "<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "MESH:Blood",
                    "label": "Blood",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "105 RA patients, 62 controls",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Rooney, Terence",
                    "Scherzer, Rebecca",
                    "Shigenaga, Judy K",
                    "Graf, Jonathan",
                    "Imboden, John B",
                    "Grunfeld, Carl"
                ],
                "database": {
                    "id": "21441551",
                    "name": "PubMed"
                },
                "source_name": "Rheumatology (Oxford, England)",
                "title": "Levels of plasma fibrinogen are elevated in well-controlled rheumatoid arthritis.",
                "abstract": "Patients with RA have systemic inflammation and increased risk of cardiovascular (CV) events, including thrombosis. Levels of fibrinogen, a pro-thrombotic protein with predictive value for CV disease (CVD), are elevated during systemic inflammation. We compared circulating fibrinogen levels in patients with RA with healthy controls and evaluated the relationship with measures of disease activity."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Fibrinogen)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "We next examined the associations of measures of disease activity with fibrinogen in RA patients. Joint counts, CDAI, SDAI and DAS-28 also showed positive, statistically significant associations with fibrinogen. Disease activity markers that included an inflammatory marker (SDAI, DAS-28-ESR and DAS-28-CRP) showed strong associations (all r\u2009>\u20090.4, P\u2009<\u20090.0001)",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "21fe2d26-8fc3-45f2-8c96-6cc17bf5d827",
        "_rev": "_WpvYGJG--H",
        "nanopub": {
            "id": "21fe2d26-8fc3-45f2-8c96-6cc17bf5d827",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Immunoblot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Cartilage",
                    "label": "Cartilage",
                    "type": "Anatomy"
                },
                {
                    "id": "MESH:Osteoarthritis",
                    "label": "Osteoarthritis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "14600251",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"(\u2212)-epigallocatechin 3-gallate\")\t",
                    "relation": "decreases",
                    "object": "p(HGNC:MMP13)"
                },
                {
                    "subject": "a(CHEBI:\"(\u2212)-epigallocatechin 3-gallate\")",
                    "relation": "decreases",
                    "object": "p(HGNC:MMP1)"
                }
            ],
            "evidence": "As shown in\u00a0Fig. 2, stimulation of human chondrocytes with IL-1\u03b2 induced the expression and release of MMP-1 and MMP-13 in the culture supernatant as determined by Western immunoblotting.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d09d8229-480c-40c4-8ca6-d161e8e321f0",
        "_rev": "_WpvYGJ--Bt",
        "nanopub": {
            "id": "d09d8229-480c-40c4-8ca6-d161e8e321f0",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15657292",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL12)",
                    "relation": "increases",
                    "object": "bp(GO:\"T-helper 1 cell differentiation\")"
                }
            ],
            "evidence": "In contrast, addition of rIL-12 promoted Th1 but reduced ThIL-17growth (Fig. 2\u00a0A and B).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f8a0226a-cfce-45dc-8cc1-4adc3899ee39",
        "_rev": "_WpvYGJ--BN",
        "nanopub": {
            "id": "f8a0226a-cfce-45dc-8cc1-4adc3899ee39",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.4",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "800 SLE patients",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLAM-R",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL5)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "769d67f3-013a-46a7-89c7-f876f069339e",
        "_rev": "_WpvYGJ--Af",
        "nanopub": {
            "id": "769d67f3-013a-46a7-89c7-f876f069339e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "DO11.10 Cells",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "12006974",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TBX21)",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IFNG))"
                }
            ],
            "evidence": "With PMA-ionomycin stimulation, T-bet strongly increased IFN-G expression, inducing the production of 1180 ng/ml of IFN-G in wild-type Th2 cells and 1800 ng/ml of IFN-G in STAT4-/- Th1 cells compared to 1380 ng/ml in wild-type Th1 controls.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e205585d-01c5-4817-b3bc-e3241c36da48",
        "_rev": "_WpvYGJC-_A",
        "nanopub": {
            "id": "e205585d-01c5-4817-b3bc-e3241c36da48",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Monocytes",
                    "label": "Monocytes",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "27822475",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "surf(p(HGNC:RANK))",
                    "relation": "positiveCorrelation",
                    "object": "surf(p(HGNC:CCR6))"
                }
            ],
            "evidence": "The high-level expression of RANK on CD14+\u00a0cells was correlated with that of CCR6 in HV.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0ad9667e-18a3-457c-81fd-b13f1ebcd5fe",
        "_rev": "_WpvYGJC---",
        "nanopub": {
            "id": "0ad9667e-18a3-457c-81fd-b13f1ebcd5fe",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Moore, K P",
                    "Darley-Usmar, V",
                    "Morrow, J",
                    "Roberts, L J"
                ],
                "database": {
                    "id": "7614720",
                    "name": "PubMed"
                },
                "source_name": "Circulation research",
                "title": "Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite.",
                "abstract": "F2-Isoprostanes are novel bioactive prostaglandin F2-like compounds produced by nonenzymatic free radical-catalyzed peroxidation of arachidonic acid. F2-Isoprostanes are initially formed in situ on phospholipids and subsequently released. Quantification of the F2-isoprostanes has been found to represent a valuable and reliable marker of lipid peroxidation. Oxidative modification of low-density lipoprotein (LDL) is a key process for the recognition of LDL by the scavenger receptors on macrophages. The oxidative mechanism responsible for the modification of LDL in vivo remains unclear, but an attractive candidate is the powerful oxidant peroxynitrite, which can be formed by reaction of nitric oxide and superoxide in the vessel wall. To further explore the potential role of peroxynitrite in the oxidative modification of plasma lipids, we investigated whether incubation of LDL and plasma with peroxynitrite or SIN-1, which decomposes to form nitric oxide and superoxide, catalyzes the formation of F2-isoprostanes. Incubation of LDL with peroxynitrite (0.125 to 1 mmol/L) or SIN-1 (0.5 and 1 mmol/L) induced a concentration-dependent increase in the formation of F2-isoprostanes, reaching a maximum of 5.5 +/- 2.05-fold (SEM) and 18.2 +/- 4.0-fold above control values, respectively. The increase of F2-isoprostanes induced by SIN-1 was essentially completely inhibited by superoxide dismutase. Incubation of plasma with peroxynitrite or SIN-1 yielded similar results. These results indicate that peroxynitrite can induce the formation of F2-isoprostanes in lipoproteins. Since F2-isoprostanes can exert potent biological activity such as vasoconstriction, they may contribute to the vascular pathobiology associated with atherosclerosis."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:peroxynitrite",
                    "relation": "increases",
                    "object": "a(MESH:F2-Isoprostanes)"
                }
            ],
            "evidence": "Incubation of plasma with peroxynitrite or SIN-1 yielded results similar to those observed with LDL. Esterified F2-isoprostanes increased in all plasma samples incubated with either peroxynitrite or SIN-1 (n=3) (Fig 5). \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8dab0a80-5a55-4153-9c27-cf6497822bae",
        "_rev": "_WpvYGJG-A1",
        "nanopub": {
            "id": "8dab0a80-5a55-4153-9c27-cf6497822bae",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "DLN cells",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "15657292",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "complex(GO\"Interleukin 23 complex\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "complex(GO\"Interleukin 23 complex\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL17)"
                }
            ],
            "evidence": "In contrast, CD4+\u00a0T cells isolated from IL-23p19\u2212/\u2212\u00a0mice displayed reduced IL-6 and undetectable IL-17 production (Fig. 1\u00a0B).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "26bb00f8-2b2b-4cf8-b833-4c8bda74de71",
        "_rev": "_WpvYGJG--e",
        "nanopub": {
            "id": "26bb00f8-2b2b-4cf8-b833-4c8bda74de71",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "EFO:\"HUVEC cell line\"",
                    "label": "HUVEC cell line",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "authors": [
                    "Herbst, U",
                    "Toborek, M",
                    "Kaiser, S",
                    "Mattson, M P",
                    "Hennig, B"
                ],
                "database": {
                    "id": "10497308",
                    "name": "PubMed"
                },
                "source_name": "Journal of cellular physiology",
                "title": "4-Hydroxynonenal induces dysfunction and apoptosis of cultured endothelial cells.",
                "abstract": "Lipolytic products of triglyceride-rich lipoproteins, i.e., free fatty acids, may cause activation and dysfunction of the vascular endothelium. Mechanisms of these effects may include lipid peroxidation. One of the major and biologically active products of peroxidation of n-6 fatty acids, such as linoleic acid or arachidonic acid, is the aldehyde 4-hydroxynonenal (HNE). To study the hypothesis that HNE may be a critical factor in endothelial cell dysfunction caused by free fatty acids, human umbilical endothelial cells (HUVEC) were treated with up to160 microM of linoleic or arachidonic acid. HNE formation was detected by immunocytochemistry in cells treated for 24 h with either fatty acid, but more markedly with arachidonic acid. To study the cellulareffects of HNE, HUVEC were treated with different concentrations of this aldehyde, and several markers of endothelial cell dysfunction were determined. Exposure to HNE for 6 and 9 h resulted in increased cellular oxidative stress. However, short time treatment with HNE did not cause activation of nuclear factor-kappaB (NF-kappaB). In addition, HUVEC exposure to HNE caused a dose-dependent decrease in production of both interleukin-8 (IL-8) and intercellular adhesion molecule-1 (ICAM-1). On the other hand, HNE exerted prominent cytotoxic effects in cultured HUVEC, manifested by morphological changes, diminished cellular viability, and impaired endothelial barrier function. Furthermore, HNE treatment induced apoptosis of HUVEC. These data provide evidence that HNE does not contribute to NF-kappaB-related mechanisms of the inflammatory response in HUVEC, but rather to endothelial dysfunction, cytotoxicity, and apoptotic cell death."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"linoleic acid\")",
                    "relation": "increases",
                    "object": "a(CHEBI:4-hydroxynon-2-enal)"
                },
                {
                    "subject": "a(CHEBI:\"arachidonic acid\")",
                    "relation": "increases",
                    "object": "a(CHEBI:4-hydroxynon-2-enal)"
                }
            ],
            "evidence": "To study the hypothesis that HNE may be a critical factor in endothelial cell dysfunction caused by free fatty acids, human umbilical endothelial cells (HUVEC) were treated with up to160 \u03bcM of linoleic or arachidonic acid. HNE formation was detected by immunocytochemistry in cells treated for 24 h with either fatty acid, but more markedly with arachidonic acid. ",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "faaf4f58-2df9-469c-b4c0-cc7896cae024",
        "_rev": "_WpvYGJG-_I",
        "nanopub": {
            "id": "faaf4f58-2df9-469c-b4c0-cc7896cae024",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.005",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "36 SLE patients, 42 healthy controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "FAS",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "22549432",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:N-acetyl-L-cysteine)",
                    "relation": "decreases",
                    "object": "path(MESH:Fatigue)"
                }
            ],
            "evidence": "Considered together, 2.4 gm and 4.8 gm NAC reduced the SLEDAI score after 1 month (P = 0.0007), 2 months (P = 0.0009), 3 months (P = 0.0030), and 4 months (P = 0.0046); the BILAG score after 1 month (P = 0.029) and 3 months (P = 0.009); and the FAS score after 2 months (P = 0.0006) and 3 months (P = 0.005).\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "62976b26-853b-483a-ae09-50f52b3b0cb4",
        "_rev": "_WpvYGJC-Bv",
        "nanopub": {
            "id": "62976b26-853b-483a-ae09-50f52b3b0cb4",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "31 LN,\u00a021 Active Lupus no LN, 30 Inactive Lupus, 11 HC. Almost all patients on prednisone; other drugs allowed as well. Brazilian cohort; sex not reported",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "25799079",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:creatinine)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                }
            ],
            "evidence": "Serum creatinine is the most widely used screening test to identify abnormalities in renal function; we observed increased levels in LN (1.27\u00b10.41) compared to control (C) (0.60\u00b10.13), IL (0.61\u00b10.16) and AL (0.59\u00b10.18) groups.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": true,
        "isPublished": true,
        "_key": "ed096a47-2022-41c6-96e2-4e86f76f936e",
        "_rev": "_WrQd9f2---",
        "nanopub": {
            "id": "ed096a47-2022-41c6-96e2-4e86f76f936e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "abstract": "The efficacy and safety of sifalimumab were assessed in a phase IIb, randomised, double-blind, placebo-controlled study (NCT01283139) of adults with moderate to severe active systemic lupus erythematosus (SLE).",
                "authors": [
                    "Khamashta, Munther",
                    "Merrill, Joan T",
                    "Werth, Victoria P",
                    "Furie, Richard",
                    "Kalunian, Kenneth",
                    "Illei, Gabor G",
                    "Drappa, Jorn",
                    "Wang, Liangwei",
                    "Greth, Warren",
                    ", "
                ],
                "database": {
                    "id": "27009916",
                    "name": "PubMed"
                },
                "source_name": "Annals of the rheumatic diseases",
                "title": "Sifalimumab, an anti-interferon-\u03b1 monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "increases",
                    "object": "path(DO:\"systemic lupus erythematosus\")"
                }
            ],
            "evidence": "test",
            "metadata": {
                "gd:abstract": "The efficacy and safety of sifalimumab were assessed in a phase IIb, randomised, double-blind, placebo-controlled study (NCT01283139) of adults with moderate to severe active systemic lupus erythematosus (SLE).",
                "gd:createTS": "2018-04-17T17:06:39.6550000",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-17T17:21:17.841Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9126275f-d1ef-4396-831f-4e0f9c53d073",
        "_rev": "_WpvYGJC-AS",
        "nanopub": {
            "id": "9126275f-d1ef-4396-831f-4e0f9c53d073",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"Arthritis, Rheumatoid\"",
                    "label": "Arthritis, Rheumatoid",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Fibroblasts",
                    "label": "Fibroblasts",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Nguyen, Hung N",
                    "Noss, Erika H",
                    "Mizoguchi, Fumitaka",
                    "Huppertz, Christine",
                    "Wei, Kevin S",
                    "Watts, Gerald F M",
                    "Brenner, Michael B"
                ],
                "database": {
                    "id": "28228280",
                    "name": "PubMed"
                },
                "source_name": "Immunity",
                "title": "Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast Production of Inflammatory Mediators.",
                "abstract": "Fibroblasts are major contributors to and regulators of inflammation and dominant producers of interleukin-6 (IL-6) in inflammatory diseases like rheumatoid arthritis. Yet, compared to leukocytes, the regulation of inflammatory pathways in fibroblasts is largely unknown. Here, we report that analyses of genes coordinately upregulated with IL-6 pointed to STAT4 and leukemia inhibitory factor (LIF) as potentially linked. Gene silencing revealed that STAT4 was required for IL-6 transcription. STAT4 was recruited to the IL-6 promoter after fibroblast activation, and LIF receptor (LIFR) and STAT4 formed a molecular complex that, together with JAK1 and TYK2 kinases, controlled STAT4 activation. Importantly, a positive feedback loop involving autocrine LIF, LIFR, and STAT4 drove sustained IL-6 transcription. Besides IL-6, this autorine loop also drove the production of other key inflammatory factors including IL-8, granulocyte-colony stimulating factor (G-CSF), IL-33, IL-11, IL-1\u03b1, and IL-1\u03b2. These findings define the transcriptional regulation of fibroblast-mediated inflammation as distinct from leukocytes."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT4)",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "On the other hand, while silencing of ELF3, EHF, and STAT1 did not appear to alter IL-6 production, STAT4 silencing resulted in marked reduction of IL-6. STAT4 has not previously been implicated in IL-6 regulation, so we chose to focus on STAT4 for further study.",
            "metadata": {
                "": "Inflammation Index",
                "gd:abstract": "Fibroblasts are major contributors to and regulators of inflammation and dominant producers of interleukin-6 (IL-6) in inflammatory diseases like rheumatoid arthritis. Yet, compared to leukocytes, the regulation of inflammatory pathways in fibroblasts is largely unknown. Here, we report that analyses of genes coordinately upregulated with IL-6 pointed to STAT4 and leukemia inhibitory factor (LIF) as potentially linked. Gene silencing revealed that STAT4 was required for IL-6 transcription. STAT4 was recruited to the IL-6 promoter after fibroblast activation, and LIF receptor (LIFR) and STAT4 formed a molecular complex that, together with JAK1 and TYK2 kinases, controlled STAT4 activation. Importantly, a positive feedback loop involving autocrine LIF, LIFR, and STAT4 drove sustained IL-6 transcription. Besides IL-6, this autorine loop also drove the production of other key inflammatory factors including IL-8, granulocyte-colony stimulating factor (G-CSF), IL-33, IL-11, IL-1\u03b1, and IL-1\u03b2. These findings define the transcriptional regulation of fibroblast-mediated inflammation as distinct from leukocytes.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "75b2c6ce-c8ab-4893-851a-833c480c4a99",
        "_rev": "_WpvYGJ---Y",
        "nanopub": {
            "id": "75b2c6ce-c8ab-4893-851a-833c480c4a99",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CLO:\"COS-7 cell\"",
                    "label": "COS-7 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "22427510",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:NOX5)",
                    "relation": null,
                    "object": "a(MESH:\"Hydrogen Peroxide\")"
                },
                {
                    "subject": "p(HGNC:NOX5)",
                    "relation": "increases",
                    "object": "a(MESH:Superoxides)"
                }
            ],
            "evidence": "In unstimulated COS-7 cells, Nox5-alpha and Nox5-beta produced both superoxide and hydrogen peroxide, whereas Nox5-delta, -gamma, and -epsilon (short) failed to produce detectable ROS (Fig. 3, B and C).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8c7fe94e-5ec5-4c42-ad0a-41ea8b392aa4",
        "_rev": "_WpvYGJG-BN",
        "nanopub": {
            "id": "8c7fe94e-5ec5-4c42-ad0a-41ea8b392aa4",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "50 SLE patients",
                    "type": "cohort"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Yang, Ji",
                    "Chu, Yiwei",
                    "Yang, Xue",
                    "Gao, Di",
                    "Zhu, Lubing",
                    "Yang, Xinrong",
                    "Wan, Linlin",
                    "Li, Ming"
                ],
                "database": {
                    "id": "19404966",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.",
                "abstract": "To investigate the relative abundance and activities of Th17 cells and natural Treg cells in systemic lupus erythematosus (SLE)."
            },
            "assertions": [
                {
                    "subject": "a(CL:\"T-helper 17 cell\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL17A)"
                }
            ],
            "evidence": "Both the percentage of circulating Th17 cells and the ability to produce interleukin-17A (IL-17A) were increased in samples derived from patients with active SLE.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "To investigate the relative abundance and activities of Th17 cells and natural Treg cells in systemic lupus erythematosus (SLE).",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "87707381-ff0d-4a59-946b-f5660a24e9ee",
        "_rev": "_WpvYGJC-BA",
        "nanopub": {
            "id": "87707381-ff0d-4a59-946b-f5660a24e9ee",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL12A)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "In contrast, consistent with the results above, levels of several inflammatory mediators varied between pre-flare and non-flare periods (Figure 2 and Supplementary Table 4). Impending flares were associated with increased Th1, Th2, and Th17 (Figure 2A\u2013C) type cytokines, compared to both self non-flare and matched healthy control samples (Supplementary Figure 2A\u2013C).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c98c4943-2479-469a-9766-dc7899efc945",
        "_rev": "_WpvYGJC-BE",
        "nanopub": {
            "id": "c98c4943-2479-469a-9766-dc7899efc945",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"type 2 diabetes mellitus\"",
                    "label": "type 2 diabetes mellitus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "7850995",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Diabetes Mellitus\")",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:\"glycine betaine\")"
                }
            ],
            "evidence": "Diabetic and renal patient groups (Fig. 2) had higher excretions, significantly different from the normal group (Table 2)\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "88d76a60-9c04-48d6-ba23-b54e7b8112dc",
        "_rev": "_WpvYGI6--Y",
        "nanopub": {
            "id": "88d76a60-9c04-48d6-ba23-b54e7b8112dc",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15153495",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT4)",
                    "relation": "increases",
                    "object": "bp(GO:\"T-helper 1 cell differentiation\")"
                }
            ],
            "evidence": "\u00a0As expected, in the cells polarized with IL-12 to the Th1 direction (anti-CD3 + anti-CD28 + IL-12 + anti-IL-4), IFN-\u03b3 production in response to PMA and ionomycin was highly increased in wild-type cells, whereas in STAT4-deficient cells the production remained at the basal level (Fig. 3\u21d3b).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7e1c229c-2961-4cf6-b9a9-7bd16a60aa1e",
        "_rev": "_WpvYGJG-Ah",
        "nanopub": {
            "id": "7e1c229c-2961-4cf6-b9a9-7bd16a60aa1e",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17277312",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite(p(HGNC:IL6), complex(GO:\"Interleukin 23 complex\"))",
                    "relation": "association",
                    "object": "bp(GO:\"T-helper 17 cell differentiation\")"
                }
            ],
            "evidence": "Although IL-23 was a poor inducer of THi differentiation by itself, the combination of IL-6 and IL-23 led to greatly enhanced development of THi cells (Fig. 1B)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f7cb37a6-58f3-4b52-af5e-73739fe5214a",
        "_rev": "_WpvYGJC-_k",
        "nanopub": {
            "id": "f7cb37a6-58f3-4b52-af5e-73739fe5214a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"COS-1 cell\"",
                    "label": "COS-1 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "9311995",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TGFB)",
                    "relation": "increases",
                    "object": "tloc(complex(p(HGNC:SMAD2), p(HGNC:SMAD3)), fromloc(GOCC:\"cytoplasm\"), toloc(GOCC:\"nucleus\")"
                }
            ],
            "evidence": "in the absence of ligand, staining for Smad2 and Smad3 as well as Smad4 was seen predominantly in the cytoplasm of the cells, whereas after stimulation with TGF-B1 for 1h, the staining in each case significantly accumulated in the nucleus\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "aa46aa48-de25-438d-af3d-7e740f479807",
        "_rev": "_WpvYGJG-_Q",
        "nanopub": {
            "id": "aa46aa48-de25-438d-af3d-7e740f479807",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Northern Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9120387",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT4, pmod(Ph))",
                    "relation": "positiveCorrelation",
                    "object": "r(HGNC:IL12RB2))"
                }
            ],
            "evidence": "Thus, IFN-\u03b3 regulates IL-12 responsiveness with the same pattern as it regulates IL-12R \u03b22 expression in developing Th cells (Fig.\u00a0\u200b(Fig.5).5).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "97a6d1ba-363f-44fe-ae87-18ccf28250f7",
        "_rev": "_WpvYGJC-_O",
        "nanopub": {
            "id": "97a6d1ba-363f-44fe-ae87-18ccf28250f7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "31 LN,\u00a021 Active Lupus no LN, 30 Inactive Lupus, 11 HC. Almost all patients on prednisone; other drugs allowed as well. Brazilian cohort; sex not reported",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "authors": [
                    "Lalwani, Pritesh",
                    "de Souza, Giselle Katiane Bonfim Bacelar",
                    "de Lima, Domingos Savio Nunes",
                    "Passos, Luiz Fernando Souza",
                    "Boechat, Antonio Luiz",
                    "Lima, Emerson Silva"
                ],
                "database": {
                    "id": "25799079",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Serum thiols as a biomarker of disease activity in lupus nephritis.",
                "abstract": "Lupus Nephritis (LN) develops in more than half of the Systemic Lupus Erythematous (SLE) patients. However, lack of reliable, specific biomarkers for LN hampers clinical management of patients and impedes development of new therapeutics. The goal of this study was to investigate whether oxidative stress biomarkers in patients with SLE is predictive of renal pathology. Serum biochemical and oxidative stress markers were measured in patients with inactive lupus, active lupus with and without nephritis and compared to healthy control group. To assess the predictive performance of biomarkers, Receiver Operating Characteristic (ROC) curves were constructed and cut-offs were used to identify SLE patients with nephritis. We observed an increased oxidative stress response in all SLE patients compared to healthy controls. Among the several biomarkers tested, serum thiols had a significant inverse association with SLE Disease Activity Index (SLEDAI). Interestingly, thiols were able too aptly differentiate between SLE patients with and without renal pathology, and serum thiol levels were not affected by immunosuppressive drug therapy. The decreased thiols in SLE correlated significantly with serum creatinine and serum C3 levels. Further retrospective evaluation using serum creatinine or C3 levels in combination with thiol's cutoff values from ROC analysis, we could positively predict chronicity of renal pathology in SLE patients. In summary, serum thiols emerge as an inexpensive and reliable indicator of LN, which may not only help in early identification of renal pathology but also aid in the therapeutic management of the disease, in developing countries with resource poor settings."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:thiol)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Serum thiol levels were used for ROC curve (Fig. 3A) analysis, AL group v/s LN group, which had an area under curve (AUC) of 0.77, and a sensitivity of 80% and specificity of 60% with a cutoff \u2264124 \u03bcmol/L (Fig. 3A).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation",
                "gd:abstract": "Lupus Nephritis (LN) develops in more than half of the Systemic Lupus Erythematous (SLE) patients. However, lack of reliable, specific biomarkers for LN hampers clinical management of patients and impedes development of new therapeutics. The goal of this study was to investigate whether oxidative stress biomarkers in patients with SLE is predictive of renal pathology. Serum biochemical and oxidative stress markers were measured in patients with inactive lupus, active lupus with and without nephritis and compared to healthy control group. To assess the predictive performance of biomarkers, Receiver Operating Characteristic (ROC) curves were constructed and cut-offs were used to identify SLE patients with nephritis. We observed an increased oxidative stress response in all SLE patients compared to healthy controls. Among the several biomarkers tested, serum thiols had a significant inverse association with SLE Disease Activity Index (SLEDAI). Interestingly, thiols were able too aptly differentiate between SLE patients with and without renal pathology, and serum thiol levels were not affected by immunosuppressive drug therapy. The decreased thiols in SLE correlated significantly with serum creatinine and serum C3 levels. Further retrospective evaluation using serum creatinine or C3 levels in combination with thiol's cutoff values from ROC analysis, we could positively predict chronicity of renal pathology in SLE patients. In summary, serum thiols emerge as an inexpensive and reliable indicator of LN, which may not only help in early identification of renal pathology but also aid in the therapeutic management of the disease, in developing countries with resource poor settings."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "727c5ded-2686-49d8-a7b5-0d9e773dde54",
        "_rev": "_WpvYGJ--_V",
        "nanopub": {
            "id": "727c5ded-2686-49d8-a7b5-0d9e773dde54",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "52 samples from 26 LN patients, 10 samples from healthy females",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "16518330",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:CXCR3)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                },
                {
                    "subject": "r(HGNC:CXCL10)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                }
            ],
            "evidence": "Urinary interferon-producing protein 10 and its CXC chemokine receptor (CXCR)3, transforming growth factor-\u03b2 (TGF-\u03b2), and vascular endothelial growth factor (VEGF) mRNA levels were analyzed by quantitative real-time polymerase chain reactions. Levels of chemokine or growth factor mRNAs in urine could distinguish class IV LN from others, with a sensitivity of 85% and a specificity of 94%. \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1f5a2f27-17d8-4b15-9a08-ed6e8919e260",
        "_rev": "_WpvYGJC-C_",
        "nanopub": {
            "id": "1f5a2f27-17d8-4b15-9a08-ed6e8919e260",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "80 SLE with (40) and without (40) renal disease, 40 HC (Chinese cohort)",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "15975968",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL18)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Upon subgroup analysis, IP10, RANTES, MIG, MCP\u20101, IL8, and IL18 correlated significantly with SLEDAI score of the SLE group, while IP10, IL8, IL10, and IL18 concentrations correlated significantly with SLEDAI of RSLE patients (all p<0.05). \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5e903e08-8d91-4f0d-b863-c1bb3be245e1",
        "_rev": "_WpvYGJG--u",
        "nanopub": {
            "id": "5e903e08-8d91-4f0d-b863-c1bb3be245e1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.002",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "73 patients with\u00a0diffuse proliferative glomerulonephritis (51 without renal flare, 22 with renal flare)",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "17659436",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL5)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "The patients experiencing renal flare showed higher urinary RANTES, MCP-1 and M-CSF. However, independent predictors of renal flares were increased urinary RANTES and M-CSF.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "91a2e47d-44da-4bf8-be97-fff350afc32b",
        "_rev": "_WpvYGJ--AF",
        "nanopub": {
            "id": "91a2e47d-44da-4bf8-be97-fff350afc32b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "EMSA",
                    "type": "Methodology"
                },
                {
                    "id": "PBL",
                    "label": "",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "7719938",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:IL2), ma(GO:\"Receptor Binding\"))",
                    "relation": "increases",
                    "object": "p(HGNC:STAT5, pmod(Ph))"
                }
            ],
            "evidence": "However, an antiserum to Stat5 supershifted the complexes induced by IL-2 in both fresh and preactivated PBL (Figure 3A, lanes 5 and lo), indicating that these complexes contained Stat5 \n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9302c34e-289e-4e2e-898e-9676e998cbdb",
        "_rev": "_WpvYGJG-AS",
        "nanopub": {
            "id": "9302c34e-289e-4e2e-898e-9676e998cbdb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15790681",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:FOXP3)",
                    "relation": "directlyDecreases",
                    "object": "complex(GO:\"NfkB complex\")"
                }
            ],
            "evidence": "Coimmunoprecipitation using a monoclonal anti-HA antibody and Western blotting with anti-P65 specific antibody revealed that Foxp3 also physically associates with endogenous P65 (Fig. 4B)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d223d1a8-be34-49c4-af9f-ddaae84da1eb",
        "_rev": "_WpvYGJ--AM",
        "nanopub": {
            "id": "d223d1a8-be34-49c4-af9f-ddaae84da1eb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.59",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "SLAM-R",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:GDNF)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "253dd4a1-9dc6-4881-b296-05e18538d55a",
        "_rev": "_WpvYGJC-B1",
        "nanopub": {
            "id": "253dd4a1-9dc6-4881-b296-05e18538d55a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "EFO:\"DU 145\"",
                    "label": "DU 145",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "16177117",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Zinc)",
                    "relation": "decreases",
                    "object": "r(HGNC:IL1B)"
                }
            ],
            "evidence": "LPS-induced TNF- and IL-1\u0001 mRNA expressions were blocked by addition of zinc (25 M) plus pyrithione (50 M)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "eb0bb6db-1c7f-419e-a491-0b434d1109de",
        "_rev": "_WpvYGJ--_O",
        "nanopub": {
            "id": "eb0bb6db-1c7f-419e-a491-0b434d1109de",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Hashizume, M",
                    "Hayakawa, N",
                    "Mihara, M"
                ],
                "database": {
                    "id": "18786965",
                    "name": "PubMed"
                },
                "source_name": "Rheumatology (Oxford, England)",
                "title": "IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.",
                "abstract": "We investigated the influence of cytokines on the expression of RANK ligand (RANKL) in fibroblast-like synoviocytes from RA patients (RA-FLS)."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNFSF11)",
                    "relation": "increases",
                    "object": "bp(GO:\"osteoclast differentiation\")"
                }
            ],
            "evidence": "RANK ligand (RANKL) is an essential factor for osteoclastogenesis [3, 4]; it stimulates precursor cells of the myeloid lineage to differentiate into osteoclasts by binding to its signalling receptor, RANK [5, 6]. RANKL also stimulates osteoclast migration, fusion, activation and survival, so it acts at all stages of osteoclast generation and activity.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "We investigated the influence of cytokines on the expression of RANK ligand (RANKL) in fibroblast-like synoviocytes from RA patients (RA-FLS).",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "43846674-5ac3-4bea-a31c-0fba3b054ae6",
        "_rev": "_WpvYGJG-_V",
        "nanopub": {
            "id": "43846674-5ac3-4bea-a31c-0fba3b054ae6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Immunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"BA/F3 cell\"",
                    "label": "BA/F3 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "12023369",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL23R)",
                    "relation": "increases",
                    "object": "p(HGNC:IL12RB1)"
                }
            ],
            "evidence": "In the presence of IL-23, IL-23R can be immunoprecipitated in association with IL-12R\u03b21 (Fig. 7\u21d1c).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2b0c7abe-dcad-4e9e-a203-17869155a610",
        "_rev": "_WpvYGJG-Bq",
        "nanopub": {
            "id": "2b0c7abe-dcad-4e9e-a203-17869155a610",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:kidney",
                    "label": "kidney",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Leffler, Jonatan",
                    "Bengtsson, Anders A",
                    "Blom, Anna M"
                ],
                "database": {
                    "id": "24845390",
                    "name": "PubMed"
                },
                "source_name": "Annals of the rheumatic diseases",
                "title": "The complement system in systemic lupus erythematosus: an update.",
                "abstract": "The complement system plays a major role in the autoimmune disease, systemic lupus erythematosus (SLE). However, the role of complement in SLE is complex since it may both prevent and exacerbate the disease. In this review, we explore the latest findings in complement-focused research in SLE. C1q deficiency is the strongest genetic risk factor for SLE, although such deficiency is very rare. Various recently discovered genetic associations include mutations in the complement receptors 2 and 3 as well as complement inhibitors, the latter related to earlier onset of nephritis. Further, autoantibodies are a distinct feature of SLE that are produced as the result of an adaptive immune response and how complement can affect that response is also being reviewed. SLE generates numerous disease manifestations involving contributions from complement such as glomerulonephritis and the increased risk of thrombosis. Furthermore, since most of the complement system is present in plasma, complement is very accessible and may be suitable as biomarker for diagnosis or monitoring of disease activity. This review highlights the many roles of complement for SLE pathogenesis and how research has progressed during recent years."
            },
            "assertions": [
                {
                    "subject": "a(anti-C1Q)",
                    "relation": "increases",
                    "object": "a(GO:\"immune complex formation\")"
                }
            ],
            "evidence": "More importantly, the autoantibodies form immune complexes (ICs) that deposit in the kidney glomeruli. These ICs effectively activate the classical complement pathway and cause tissue damage, which leads to lupus nephritis (LN).",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "The complement system plays a major role in the autoimmune disease, systemic lupus erythematosus (SLE). However, the role of complement in SLE is complex since it may both prevent and exacerbate the disease. In this review, we explore the latest findings in complement-focused research in SLE. C1q deficiency is the strongest genetic risk factor for SLE, although such deficiency is very rare. Various recently discovered genetic associations include mutations in the complement receptors 2 and 3 as well as complement inhibitors, the latter related to earlier onset of nephritis. Further, autoantibodies are a distinct feature of SLE that are produced as the result of an adaptive immune response and how complement can affect that response is also being reviewed. SLE generates numerous disease manifestations involving contributions from complement such as glomerulonephritis and the increased risk of thrombosis. Furthermore, since most of the complement system is present in plasma, complement is very accessible and may be suitable as biomarker for diagnosis or monitoring of disease activity. This review highlights the many roles of complement for SLE pathogenesis and how research has progressed during recent years.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "81ad19aa-d2d1-433d-ab04-d55a6c3af110",
        "_rev": "_WpvYGJG-_a",
        "nanopub": {
            "id": "81ad19aa-d2d1-433d-ab04-d55a6c3af110",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16990136",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite(p(HGNC:IL6),p(HGNC:TGFB))",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL17))"
                }
            ],
            "evidence": "We confirmed that a combination of IL-6 and TGF-\u03b2 in the presence of neutralizing antibodies against IFN\u03b3 and IL-4 resulted in robust induction of IL-17 in wild-type cells\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": true,
        "isPublished": true,
        "_key": "4c3ac5ba-f9f0-4cc0-9237-1bb897364c30",
        "_rev": "_WrQe_12---",
        "nanopub": {
            "id": "4c3ac5ba-f9f0-4cc0-9237-1bb897364c30",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "abstract": "The efficacy and safety of sifalimumab were assessed in a phase IIb, randomised, double-blind, placebo-controlled study (NCT01283139) of adults with moderate to severe active systemic lupus erythematosus (SLE).",
                "authors": [
                    "Khamashta, Munther",
                    "Merrill, Joan T",
                    "Werth, Victoria P",
                    "Furie, Richard",
                    "Kalunian, Kenneth",
                    "Illei, Gabor G",
                    "Drappa, Jorn",
                    "Wang, Liangwei",
                    "Greth, Warren",
                    ", "
                ],
                "database": {
                    "id": "27009916",
                    "name": "PubMed"
                },
                "source_name": "Annals of the rheumatic diseases",
                "title": "Sifalimumab, an anti-interferon-\u03b1 monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "increases",
                    "object": "path(DO:\"systemic lupus erythematosus\")"
                }
            ],
            "evidence": "tests",
            "metadata": {
                "gd:abstract": "The efficacy and safety of sifalimumab were assessed in a phase IIb, randomised, double-blind, placebo-controlled study (NCT01283139) of adults with moderate to severe active systemic lupus erythematosus (SLE).",
                "gd:createTS": "2018-04-17T17:15:56.9500000",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-17T17:21:20.250Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bb420e07-ad00-4c5c-8ab1-8c4039e7e29d",
        "_rev": "_WpvYGJC--A",
        "nanopub": {
            "id": "bb420e07-ad00-4c5c-8ab1-8c4039e7e29d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Muzio, M",
                    "Ni, J",
                    "Feng, P",
                    "Dixit, V M"
                ],
                "database": {
                    "id": "9374458",
                    "name": "PubMed"
                },
                "source_name": "Science (New York, N.Y.)",
                "title": "IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling.",
                "abstract": "The interleukin-1 receptor (IL-1R) signaling pathway leads to nuclear factor kappa B (NF-kappaB) activation in mammals and is similar to the Toll pathway in Drosophila: the IL-1R-associated kinase (IRAK) is homologous to Pelle. Two additional proximal mediators were identified that are required for IL-1R-induced NF-kappaB activation: IRAK-2, a Pelle family member, and MyD88, a death domain-containing adapter molecule. Both associate with the IL-1R signaling complex. Dominant negative forms of either attenuate IL-1R-mediated NF-kappaB activation. Therefore, IRAK-2 and MyD88 may provide additional therapeutic targets for inhibiting IL-1-induced inflammation.",
                "date_published": "1997-11-28"
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL1B)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:IL1R1)"
                }
            ],
            "evidence": "After binding to IL-1, the IL-1R type I(IL-1RI) associates with the IL-1R accessoryprotein (IL-1RAcP) and initiates asignaling cascade that results in the activationof NF-kB (1\u20136).",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "The interleukin-1 receptor (IL-1R) signaling pathway leads to nuclear factor kappa B (NF-kappaB) activation in mammals and is similar to the Toll pathway in Drosophila: the IL-1R-associated kinase (IRAK) is homologous to Pelle. Two additional proximal mediators were identified that are required for IL-1R-induced NF-kappaB activation: IRAK-2, a Pelle family member, and MyD88, a death domain-containing adapter molecule. Both associate with the IL-1R signaling complex. Dominant negative forms of either attenuate IL-1R-mediated NF-kappaB activation. Therefore, IRAK-2 and MyD88 may provide additional therapeutic targets for inhibiting IL-1-induced inflammation.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9873f08d-b8f2-4452-a284-002f5694ecbc",
        "_rev": "_WpvYGJG-BF",
        "nanopub": {
            "id": "9873f08d-b8f2-4452-a284-002f5694ecbc",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Immunohistochemistry",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"interstitial nephritis\"",
                    "label": "interstitial nephritis",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:nephron",
                    "label": "nephron",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12707385",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Nephritis, Interstitial\")",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:PDGFC)"
                }
            ],
            "evidence": "At sites of fibrosing lesions, tubulointerstitial PDGF-C expression was markedly upregulated in all cases analyzed (Figure 5, A and B).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "93c5dfaa-db75-492d-9653-422835288ffb",
        "_rev": "_WpvYGJ---r",
        "nanopub": {
            "id": "93c5dfaa-db75-492d-9653-422835288ffb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"CD8-Positive T-Lymphocytes\"",
                    "label": "CD8-Positive T-Lymphocytes",
                    "type": "Cell"
                },
                {
                    "id": "MESH:\"CD4-Positive T-Lymphocytes\"",
                    "label": "CD4-Positive T-Lymphocytes",
                    "type": "Cell"
                },
                {
                    "id": "DO:\"human immunodeficiency virus infectious disease\"",
                    "label": "human immunodeficiency virus infectious disease",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "16425129",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(DO:\"human immunodeficiency virus infectious disease\")",
                    "relation": "negativeCorrelation",
                    "object": "surf(p(HGNC:IL7R))"
                }
            ],
            "evidence": "Preliminary investigations using whole blood revealed decreased cell-surface CD127 expression on CD45RO+CD4+\u00a0and CD8+\u00a0T cells from patients with PHI and patients with CHI (data not shown).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "44f665ed-ce8c-4bbc-8d9e-205f5fbb9601",
        "_rev": "_WpvYGI6--X",
        "nanopub": {
            "id": "44f665ed-ce8c-4bbc-8d9e-205f5fbb9601",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "r=0.519",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p=0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "40 patients with SLE and 30 healthy controls.",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "20952466",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "m(HGNC:MIR146A)",
                    "relation": "positiveCorrelation",
                    "object": "bp(MESH:\"Glomerular Filtration Rate\")"
                }
            ],
            "evidence": "Estimated glomerular filtration rate (eGFR) correlated with both serum miR-146a (r = 0.519, p = 0.001) and miR-155 (r = 0.384, p = 0.014).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "fe93b1de-da61-45c8-befc-2fb33f18cba0",
        "_rev": "_WpvYGJC-CZ",
        "nanopub": {
            "id": "fe93b1de-da61-45c8-befc-2fb33f18cba0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "",
                    "label": "Relapse Rate",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "Two Years",
                    "type": "Time"
                },
                {
                    "id": "",
                    "label": "p=0.0003",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=16",
                    "type": "Cohort"
                },
                {
                    "id": "MESH:\"Crohn Disease\"",
                    "label": "Crohn Disease",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "20503448",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Diet, Vegetarian\")",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Crohn Disease\")"
                }
            ],
            "evidence": "\u00a0Life table analysis showed that the cumulative relapse rate at 2 years was significantly lower in the SVD group than in the omnivorous group (P\u00a0= 0.0003) (Figure\u00a0\u200b(Figu\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c1fb8e09-5c40-4046-8070-a6524a762023",
        "_rev": "_WpvYGJG-BR",
        "nanopub": {
            "id": "c1fb8e09-5c40-4046-8070-a6524a762023",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=11",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:Sepsis",
                    "label": "Sepsis",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12615625",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "During n-3 lipid infusion, release of these cytokines decreased by approximately 30%.\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4db44f81-f7ce-4102-b941-9d14b6407919",
        "_rev": "_WpvYGI6--i",
        "nanopub": {
            "id": "4db44f81-f7ce-4102-b941-9d14b6407919",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "BILAG activity score",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "28502135",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "p(HGNC:TNF)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "p(HGNC:IL10)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Estimated serum sTRAIL, TNF-\u03b1 and IL-6 levels showed positive significant correlation with calculated BILAG activity score, while estimated serum IL-10 levels showed negative significant correlation with activity score.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f562711a-f709-48d1-9e67-b0ed33e96819",
        "_rev": "_WpvYGJ--BE",
        "nanopub": {
            "id": "f562711a-f709-48d1-9e67-b0ed33e96819",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Coimmunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"COS-1 cell\"",
                    "label": "COS-1 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "8700888",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:IL2), ma(GO:\"Receptor Binding\"))",
                    "relation": "increases",
                    "object": "bp(GO:Ras mediated signal transduction)"
                }
            ],
            "evidence": "8, Y392, and Y510 differentially coupled to these two pathways. Shc, an adaptor protein that can initiate activation of the Ras pathway (35), associates with IL-2R3 (22) and is tyrosine-phosphorylated in response to IL-2. Using 32D transfectants, we found that only those constructs retaining y338 showed significant Shc association\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e644b935-b7e1-49a3-b2b5-ec34d45348d1",
        "_rev": "_WpvYGJC-CA",
        "nanopub": {
            "id": "e644b935-b7e1-49a3-b2b5-ec34d45348d1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"COS-1 cell\"",
                    "label": "COS-1 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "9311995",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:SMAD2)",
                    "relation": "association",
                    "object": "p(HGNC:TBR1)"
                }
            ],
            "evidence": "Thus, both Smad2 and Smad3 form stable complexes with kinase inactive T\u03b2R-I; complexes with wild-type T\u03b2R-I may be T\u03b2R-1 activation induces interaction between too transient to be able to be detected\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "788f3043-95cf-42b5-a03b-a384902b1994",
        "_rev": "_WpvYGJG-An",
        "nanopub": {
            "id": "788f3043-95cf-42b5-a03b-a384902b1994",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"CD4-positive helper T cell\"",
                    "label": "CD4-positive helper T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12612578",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(GO:\"regulatory T cell differentiation\")",
                    "relation": "increases",
                    "object": "r(HGNC:FOXP3)"
                }
            ],
            "evidence": "Real-time quantitative polymerase chain reaction (PCR) analysis revealed that Foxp3 mRNA levels were increased \u223c40-fold in freshly isolated CD4+ CD25+ T cells when compared with CD4+ CD25\u2013 T cells (Fig. 1a).\n",
            "metadata": {
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2cd6fe3e-fd84-4af3-9345-b83a5e66b915",
        "_rev": "_WpvYGJC-_h",
        "nanopub": {
            "id": "2cd6fe3e-fd84-4af3-9345-b83a5e66b915",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.5",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "SLAM-R",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CXCL10)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "39055f1b-e7ce-44a8-ac38-a8bf41b5f0a1",
        "_rev": "_WpvYGJG-B4",
        "nanopub": {
            "id": "39055f1b-e7ce-44a8-ac38-a8bf41b5f0a1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.024",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "87 SLE (41 with history of thrombosis)",
                    "type": "Cohort"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12559629",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"IgM antiphosphatidylinositol\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:Thrombosis)"
                }
            ],
            "evidence": "Thrombosis was significantly associated with IgG-aPA (p = 0.044), IgG-aPI (p = 0.038), IgG-aPS (p = 0.026), IgG-abeta(2)-GPI, IgM-aPA (p = 0.044), IgM-aPI (p = 0.024), and IgM-aPS (p = 0.01), irrespective of antibody titer, whereas IgG-aCL were associated with thrombosis and thrombocytopenia when taken at medium-high titer (p = 0.009 and p = 0.046, respectively).\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b2f37143-cc5a-4759-a0fa-eea9d6bcb77c",
        "_rev": "_WpvYGJG-_8",
        "nanopub": {
            "id": "b2f37143-cc5a-4759-a0fa-eea9d6bcb77c",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "32 healthy donors",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Northern Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CL:monocyte",
                    "label": "monocyte",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9531313",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17)\t",
                    "relation": "increases",
                    "object": "r(HGNC:TNF)"
                },
                {
                    "subject": "p(HGNC:IL17)\t",
                    "relation": "increases",
                    "object": "r(HGNC:IL1B)"
                }
            ],
            "evidence": "Incubation of IL-17 with adherent monocytes resulted initially (i.e., 5\u201330 min) in a diminution of the steady state IL-1\u03b2 and TNF-\u03b1 mRNAs, with levels exceeding controls after 1 h and remaining relatively constant for up to 8 h.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8184b720-70bf-42ea-a735-c08a995a530e",
        "_rev": "_WpvYGJC-B6",
        "nanopub": {
            "id": "8184b720-70bf-42ea-a735-c08a995a530e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Neutrophils",
                    "label": "Neutrophils",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "Northern Blot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "McDonald, P P",
                    "Bald, A",
                    "Cassatella, M A"
                ],
                "database": {
                    "id": "9129050",
                    "name": "PubMed"
                },
                "source_name": "Blood",
                "title": "Activation of the NF-kappaB pathway by inflammatory stimuli in human neutrophils.",
                "abstract": "Activated neutrophils have the ability to upregulate the expression of many genes, in particular those encoding cytokines and chemokines, and to subsequently release the corresponding proteins. Although little is known to date concerning the regulation of gene transcription in neutrophils, it is noteworthy that many of these genes depend on the activation of transcription factors, such as NF-kappaB, for inducible expression. We therefore investigated whether NF-kappaB/Rel proteins are expressed in human neutrophils, as well as their fate on cell activation. We now report that dimers consisting of p50 NFkappaB1, p65 RelA, and/or c-Rel are present in neutrophils and that the greater part of these protein complexes is physically associated with cytoplasmic IkappaB-alpha in resting cells. Following neutrophil stimulation with proinflammatory agonists (such as lipopolysaccharide [LPS], tumor necrosis factor-alpha [TNF-alpha], and fMet-Leu-Phe) that induce the production of cytokines and chemokines in these cells, NF-kappaB/Rel proteins translocated to nuclear fractions, resulting in a transient induction of NF-kappaB DNA binding activity, as determined in gel mobility shift assays. The onset of both processes was found to be closely paralleled by, and dependent on, IkappaB-alpha degradation. Proinflammatory neutrophil stimuli also promoted the accumulation of IkappaB-alpha mRNA transcripts, resulting in the reexpression of the IkappaB-alpha protein. To our knowledge, this constitutes the first indication that NF-kappaB activation may underlie the action of proinflammatory stimuli towards human neutrophil gene expression and, as such, adds a new facet to our understanding of neutrophil biology."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNF)",
                    "relation": "increases",
                    "object": "r(HGNC:NFKBIA)"
                }
            ],
            "evidence": "That IkB-a protein is synthesized de novo following neutrophil stimulation with LPS, TNF-a, or fMLP prompted us to investigate whether this response might be paralleled by changes in IkB-a mRNA steady-state levels.\u00a0Neutrophils were, therefore, stimulated for varying lengths of time with either LPS, TNF-a, or fMLP; total RNA was\u00a0then extracted and processed for Northern blot analysis. Figure 5 shows that a low quantity of IkB-a transcripts was consistently detected in resting neutrophils; following cell\u00a0exposure to either LPS or TNF-a, a dramatic and sustained\u00a0accumulation of IkB-a mRNA was observed.\u00a0",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Activated neutrophils have the ability to upregulate the expression of many genes, in particular those encoding cytokines and chemokines, and to subsequently release the corresponding proteins. Although little is known to date concerning the regulation of gene transcription in neutrophils, it is noteworthy that many of these genes depend on the activation of transcription factors, such as NF-kappaB, for inducible expression. We therefore investigated whether NF-kappaB/Rel proteins are expressed in human neutrophils, as well as their fate on cell activation. We now report that dimers consisting of p50 NFkappaB1, p65 RelA, and/or c-Rel are present in neutrophils and that the greater part of these protein complexes is physically associated with cytoplasmic IkappaB-alpha in resting cells. Following neutrophil stimulation with proinflammatory agonists (such as lipopolysaccharide [LPS], tumor necrosis factor-alpha [TNF-alpha], and fMet-Leu-Phe) that induce the production of cytokines and chemokines in these cells, NF-kappaB/Rel proteins translocated to nuclear fractions, resulting in a transient induction of NF-kappaB DNA binding activity, as determined in gel mobility shift assays. The onset of both processes was found to be closely paralleled by, and dependent on, IkappaB-alpha degradation. Proinflammatory neutrophil stimuli also promoted the accumulation of IkappaB-alpha mRNA transcripts, resulting in the reexpression of the IkappaB-alpha protein. To our knowledge, this constitutes the first indication that NF-kappaB activation may underlie the action of proinflammatory stimuli towards human neutrophil gene expression and, as such, adds a new facet to our understanding of neutrophil biology.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0e4facaa-5a35-4344-b936-dfcd9a1f3a99",
        "_rev": "_WpvYGJ--_S",
        "nanopub": {
            "id": "0e4facaa-5a35-4344-b936-dfcd9a1f3a99",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "Flow cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "15657292",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "complex(GO\"Interleukin 23 complex\")",
                    "relation": "increases",
                    "object": "bp(GO:\"T-helper 17 cell differentiation\")"
                }
            ],
            "evidence": "Administration of rIL-23 promoted the expansion of ThIL-17\u00a0cells, and reduced the growth of Th1 cells after 5 d of culture (Fig. 2, A and B).\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "52cf963f-2b17-4c5f-9998-2919ca9bf42b",
        "_rev": "_WpvYGJ---O",
        "nanopub": {
            "id": "52cf963f-2b17-4c5f-9998-2919ca9bf42b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "r=0.48",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLAM-R",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL15)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7a22a285-210d-426f-8aa6-b55034ad5406",
        "_rev": "_WpvYGJ--AH",
        "nanopub": {
            "id": "7a22a285-210d-426f-8aa6-b55034ad5406",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Fibroblasts",
                    "label": "Fibroblasts",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Nguyen, Hung N",
                    "Noss, Erika H",
                    "Mizoguchi, Fumitaka",
                    "Huppertz, Christine",
                    "Wei, Kevin S",
                    "Watts, Gerald F M",
                    "Brenner, Michael B"
                ],
                "database": {
                    "id": "28228280",
                    "name": "PubMed"
                },
                "source_name": "Immunity",
                "title": "Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast Production of Inflammatory Mediators.",
                "abstract": "Fibroblasts are major contributors to and regulators of inflammation and dominant producers of interleukin-6 (IL-6) in inflammatory diseases like rheumatoid arthritis. Yet, compared to leukocytes, the regulation of inflammatory pathways in fibroblasts is largely unknown. Here, we report that analyses of genes coordinately upregulated with IL-6 pointed to STAT4 and leukemia inhibitory factor (LIF) as potentially linked. Gene silencing revealed that STAT4 was required for IL-6 transcription. STAT4 was recruited to the IL-6 promoter after fibroblast activation, and LIF receptor (LIFR) and STAT4 formed a molecular complex that, together with JAK1 and TYK2 kinases, controlled STAT4 activation. Importantly, a positive feedback loop involving autocrine LIF, LIFR, and STAT4 drove sustained IL-6 transcription. Besides IL-6, this autorine loop also drove the production of other key inflammatory factors including IL-8, granulocyte-colony stimulating factor (G-CSF), IL-33, IL-11, IL-1\u03b1, and IL-1\u03b2. These findings define the transcriptional regulation of fibroblast-mediated inflammation as distinct from leukocytes."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:EBP)",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "p(HGNC:STAT3)",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "p(HGNC:RELA)",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "p(HGNC:NFKB1)",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "We observed that silencing of transcription factors known to regulate IL-6 such as NF-kB/p52, NF-kB/p65, C/EBPb, C/EBPd, and STAT3 all reduced IL-6 production, with p52, p65, and C/EBPb having the strongest effects.\u00a0",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Fibroblasts are major contributors to and regulators of inflammation and dominant producers of interleukin-6 (IL-6) in inflammatory diseases like rheumatoid arthritis. Yet, compared to leukocytes, the regulation of inflammatory pathways in fibroblasts is largely unknown. Here, we report that analyses of genes coordinately upregulated with IL-6 pointed to STAT4 and leukemia inhibitory factor (LIF) as potentially linked. Gene silencing revealed that STAT4 was required for IL-6 transcription. STAT4 was recruited to the IL-6 promoter after fibroblast activation, and LIF receptor (LIFR) and STAT4 formed a molecular complex that, together with JAK1 and TYK2 kinases, controlled STAT4 activation. Importantly, a positive feedback loop involving autocrine LIF, LIFR, and STAT4 drove sustained IL-6 transcription. Besides IL-6, this autorine loop also drove the production of other key inflammatory factors including IL-8, granulocyte-colony stimulating factor (G-CSF), IL-33, IL-11, IL-1\u03b1, and IL-1\u03b2. These findings define the transcriptional regulation of fibroblast-mediated inflammation as distinct from leukocytes.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "70f5a548-ea46-4691-8c2e-abba0bb28ad7",
        "_rev": "_WpvYGJ---T",
        "nanopub": {
            "id": "70f5a548-ea46-4691-8c2e-abba0bb28ad7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "n=15",
                    "type": "Cohort"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "L-M Bioassay",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10545482",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:ethanol)",
                    "relation": "decreases",
                    "object": "p(HGNC:TNF)"
                }
            ],
            "evidence": "Figure 1\u00a0illustrates that a single dose of biologically relevant\u00a0in vitro\u00a0ethanol treatment (25 mM) given at the time of LPS stimulation resulted in a significant down-regulation of monocyte TNF-\u03b1 production (P\u00a0< 0.001,\u00a0n =\u00a015)\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b7328312-729c-4dbb-91c3-536954a90d81",
        "_rev": "_WpvYGI6--8",
        "nanopub": {
            "id": "b7328312-729c-4dbb-91c3-536954a90d81",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Intracellular Cytokine Staining",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18845758",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "surf(p(HGNC:CTLA4))",
                    "relation": "increases",
                    "object": "act(a(MESH:\"T lymphocytes, regulatory\"))"
                }
            ],
            "evidence": "\"Costaining of intracellular cytokines and Foxp3 revealed an increased frequency of interleukin-2 (IL-2)\u2013, IL-4\u2013, and IFN-g\u2013producing Foxp3\u2013 CD4+ cells in both the spleen and lymph node (LN) of diseased CKO and KO mice (Fig. 2R and fig. S3). IL-17\u2013secreting (Th17) cells increased in KO but not CKO mice, suggesting that Th17 cells might contribute to the rapid disease progression in the former. Thus, CTLA-4\u2013deficient Tregs fail to control the spontaneous activation of other T cells and their differentiation into Th1 and Th2 lineage\ncells that mediate autoimmune disease and allergy\"\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9e6c03c0-d9ce-4d03-b94a-8cbd3380d3b9",
        "_rev": "_WpvYGJ--BO",
        "nanopub": {
            "id": "9e6c03c0-d9ce-4d03-b94a-8cbd3380d3b9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "14 astrocytoma, 35 Glioblastoma, and 15 non-malignant brain controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"brain glioblastoma multiforme\"",
                    "label": "brain glioblastoma multiforme",
                    "type": "Disease"
                },
                {
                    "id": "DO:astrocytoma",
                    "label": "astrocytoma",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18362893",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Brain Neoplasms\")",
                    "relation": "positiveCorrelation",
                    "object": "r(HGNC:FGF5)"
                }
            ],
            "evidence": "FGF5 mRNA levels were found to be significantly higher in astrocytomas (N=14) and GBM (N=35) tissue specimens as compared to non-malignant brain (epilepsy,\u00a0N=10; schizophrenia,\u00a0N=5;\u00a0Figure 1a, upper panel).\u00a0\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3f9a86e7-0bc1-41c2-8159-5599f2efad31",
        "_rev": "_WpvYGJ--Bf",
        "nanopub": {
            "id": "3f9a86e7-0bc1-41c2-8159-5599f2efad31",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Pickering, M C",
                    "Walport, M J"
                ],
                "database": {
                    "id": "10725062",
                    "name": "PubMed"
                },
                "source_name": "Rheumatology (Oxford, England)",
                "title": "Links between complement abnormalities and systemic lupus erythematosus.",
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:C2)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "p(HGNC:C4)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "p(HGNC:C1Q)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "The measurement of complement antigenic levels and functional activity in serum is commonly used as a marker of disease activity in SLE. During periods of active disease, serum complement activity is usually reduced. Typically, levels of the classical pathway components (C1q, C2, C4) are low and, especially in patients with severe disease, may be accompanied by a reduction in C3 levels.\u00a0",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c2b975b3-740e-458f-bfa4-a50b8ee02f09",
        "_rev": "_WpvYGJC--K",
        "nanopub": {
            "id": "c2b975b3-740e-458f-bfa4-a50b8ee02f09",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"225 cell\"",
                    "label": "225 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "10602027",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL2RB, pmod(Ph, Tyr, 510))\t",
                    "relation": "association",
                    "object": "p(HGNC:STAT5)"
                },
                {
                    "subject": "p(HGNC:IL2RB, pmod(Ph, Tyr, 510))",
                    "relation": "association",
                    "object": "p(HGNC:STAT3)"
                },
                {
                    "subject": "p(HGNC:IL2RB, pmod(Ph, Tyr, 510))",
                    "relation": "association",
                    "object": "p(HGNC:STAT1A)"
                },
                {
                    "subject": "p(HGNC:IL2RB, pmod(Ph, Tyr, 510))",
                    "relation": "association",
                    "object": "p(HGNC:STAT1B)"
                }
            ],
            "evidence": "Western blotting with specific antibodies showed that this region of the gel indeed contains the STAT1 \u00bc and \u0082 isoforms, STAT3 and STAT5 A and B\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e1776c66-5252-4f68-8c86-ff1a28464f2d",
        "_rev": "_WpvYGJ--_A",
        "nanopub": {
            "id": "e1776c66-5252-4f68-8c86-ff1a28464f2d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Neutrophils",
                    "label": "Neutrophils",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "27413244",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Squalene)",
                    "relation": "decreases",
                    "object": "r(HGNC:IL6)"
                },
                {
                    "subject": "a(MESH:Squalene)",
                    "relation": "decreases",
                    "object": "r(HGNC:TNF)"
                }
            ],
            "evidence": ". Moreover, the expression of cytokine genes TNF-\u03b1, IL-1\u03b2, IL-6 and IFN-\u03b3 was significantly reduced by squalene (50 \u0006M, 18 h) in LPS-treated human neutrophils\n",
            "metadata": {
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "93a097f8-786f-4712-b48e-18ffb4c5c123",
        "_rev": "_WpvYGJC-_C",
        "nanopub": {
            "id": "93a097f8-786f-4712-b48e-18ffb4c5c123",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:obesity",
                    "label": "obesity",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "5773094",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fasting\")",
                    "relation": "increases",
                    "object": "a(CHEBI:serine)"
                },
                {
                    "subject": "a(MESH:\"Fasting\")",
                    "relation": "increases",
                    "object": "a(CHEBI:threonine)"
                },
                {
                    "subject": "a(MESH:\"Fasting\")",
                    "relation": "increases",
                    "object": "a(CHEBI:glycine)"
                }
            ],
            "evidence": "Glycine, threonine, and serine demontrated a delayed though progressive increase during the course of starvation.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "caf75b4b-f288-40f8-acc7-7e28ff328b9a",
        "_rev": "_WpvYGI6--B",
        "nanopub": {
            "id": "caf75b4b-f288-40f8-acc7-7e28ff328b9a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Immunoblot",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "DO11.10 Cells",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "12006974",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TBX21)",
                    "relation": "increases",
                    "object": "p(HGNC:IL12RB2))"
                }
            ],
            "evidence": "T-bet expressing STAT1 -/- Th2 cells expressed IL-12RB2 more highly than Th1 controls\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d3cb5ecb-8eed-4a18-9500-1c47df6de7b9",
        "_rev": "_WpvYGJC--Q",
        "nanopub": {
            "id": "d3cb5ecb-8eed-4a18-9500-1c47df6de7b9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"Latent Tuberculosis\"",
                    "label": "Latent Tuberculosis",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "27853753",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Latent Tuberculosis\")",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IFNG)"
                }
            ],
            "evidence": "LTBI was associated with higher circulating concentrations of interferon-gamma (median, 3 pg/mL; IQR, 2 \u2013 5) compared to non-LTBI (median, 2.5 pg/mL; IQR, 1.5 \u2013 3.5);\u00a0P\u00a0< 0.001\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d0807b26-05e1-4f8c-bfdc-3d47c226c840",
        "_rev": "_WpvYGJC-AQ",
        "nanopub": {
            "id": "d0807b26-05e1-4f8c-bfdc-3d47c226c840",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Fluorimetric Assay",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "\u00a02832315",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "increases",
                    "object": "a(CHEBI:superoxide)"
                },
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "increases",
                    "object": "bp(MESH:\"Oxygen Consumption\")"
                }
            ],
            "evidence": "For example, 02 consumption (in nM/min/107 PMN) in response to FMLP (20 nM) or Con A (50 pg/ml) was, for control PMN, 21-6 + 6-6 (n = 6) and 11 -0 + 4-2 (n = 8) and for rIFN-y-treated PMN (50 U/ ml; 2 hr of incubation) 31 5 + 5-6 and 20-2 + 7-2, respectively.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "564111a9-0764-438b-96c9-c889a08edf2a",
        "_rev": "_WpvYGJ--BL",
        "nanopub": {
            "id": "564111a9-0764-438b-96c9-c889a08edf2a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                },
                {
                    "id": "CL:\"dendritic cell\"",
                    "label": "dendritic cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Hatesuer, Bastian",
                    "Hoang, Hang Thi Thu",
                    "Riese, Peggy",
                    "Trittel, Stephanie",
                    "Gerhauser, Ingo",
                    "Elbahesh, Husni",
                    "Geffers, Robert",
                    "Wilk, Esther",
                    "Schughart, Klaus"
                ],
                "database": {
                    "id": "27811478",
                    "name": "PubMed"
                },
                "source_name": "Journal of innate immunity",
                "title": "Deletion of Irf3 and Irf7 Genes in Mice Results in Altered Interferon Pathway Activation and Granulocyte-Dominated Inflammatory Responses to Influenza A Infection.",
                "abstract": "The interferon (IFN) pathway plays an essential role in the innate immune response following viral infections and subsequent shaping of adaptive immunity. Infections with influenza A viruses (IAV) activate the IFN pathway after the recognition of pathogen-specific molecular patterns by respective pattern recognition receptors. The IFN regulatory factors IRF3 and IRF7 are key players in the regulation of type I and III IFN genes. In this study, we analyzed the role of IRF3 and IRF7 for the host response to IAV infections in Irf3-/-, Irf7-/-, and Irf3-/-Irf7-/- knockout mice. While the absence of IRF3 had only a moderate impact on IFN expression, deletion of IRF7 completely abolished IFN\u03b1 production after infection. In contrast, lack of both IRF3 and IRF7 resulted in the absence of both IFN\u03b1 and IFN\u03b2 after IAV infection. In addition, IAV infection of double knockout mice resulted in a strong increase of mortality associated with a massive influx of granulocytes in the lung and reduced activation of the adaptive immune response."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IRF7)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:IFNB1)"
                },
                {
                    "subject": "p(HGNC:IRF7)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:IFNA1)"
                }
            ],
            "evidence": "deletion of IRF7 completely abolished IFN\u03b1 production after infection",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c4807641-58fa-4d62-b193-64c91e77b4c7",
        "_rev": "_WpvYGJG-_F",
        "nanopub": {
            "id": "c4807641-58fa-4d62-b193-64c91e77b4c7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-vaue"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "88 SLE, 29 non-SLE, 10 HC",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "16756635",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:CCL5)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Expression level of RANTES correlated with the SLEDAI score (r = 0.57; P < 0.001) and renal score in SLEDAI (r = 0.60; P < 0.001). \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "cbc18b12-5234-47d4-8f77-e4b2ccbbdd98",
        "_rev": "_WpvYGJC-_u",
        "nanopub": {
            "id": "cbc18b12-5234-47d4-8f77-e4b2ccbbdd98",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "complex(GO:\"transforming growth factor beta complex\")",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "TGF-\u03b2 significantly decreased during pre-flare periods, but the apparent decrease in IL-10 levels was not significant (Figure 2F).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c382f5e2-c1c0-4b52-8a3a-4cb1976b9483",
        "_rev": "_WpvYGJC-Ar",
        "nanopub": {
            "id": "c382f5e2-c1c0-4b52-8a3a-4cb1976b9483",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.009",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "SELENA-SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "48 SLE, 48 matched HC, 22 rheumatic disease controls",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "16947629",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:ISG15)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "r(HGNC:MX1)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "r(HGNC:OASL)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "r(HGNC:OAS1)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "r(HGNC:LY6E)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "When patients were divided into 3 groups according to their SELENA SLEDAI instrument scores (0\u20134, 5\u201312, and 12) (22), there was a significant difference between the groups (P 0.001 by Kruskal-Wallis test); patients with active disease (SLEDAI scores of 5\u201312) or with severe disease activity (SLEDAI scores 12) had higher IFN scores compared with patients with inactive or mild disease activity (SLEDAI scores of 0\u20134) (P 0.009 and P 0.002, respectively) (Figure 2A).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8f71b1ef-001a-485b-9c62-13e3200773d7",
        "_rev": "_WpvYGJG--6",
        "nanopub": {
            "id": "8f71b1ef-001a-485b-9c62-13e3200773d7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "80 SLE patients",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "VAS Fatigue",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "20235208",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Vitamin D\")",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Fatigue\")"
                }
            ],
            "evidence": "We found an inverse significant association between 25(OH)D levels and the VAS score at T2 (P = 0.001).\u00a0\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e2a5b2f6-a78c-4b32-a903-7ebc59b41be5",
        "_rev": "_WpvYGJC-_Q",
        "nanopub": {
            "id": "e2a5b2f6-a78c-4b32-a903-7ebc59b41be5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Helicobacter Infections\"",
                    "label": "Helicobacter Infections",
                    "type": "Disease"
                },
                {
                    "id": "CLO:\"MKN-45 cell\"",
                    "label": "MKN-45 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "18347582",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"L. acidophilus ATCC 832\")",
                    "relation": "decreases",
                    "object": "r(HGNC:CXCL8)"
                }
            ],
            "evidence": "The result of this experiment showed that the upregulated expression of IL-8 mRNA was significantly reduced by the addition of CLAcontaining CM (Figure 2a).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a3b91118-5fbd-4e34-a156-fdcf944fcc19",
        "_rev": "_WpvYGJC-A0",
        "nanopub": {
            "id": "a3b91118-5fbd-4e34-a156-fdcf944fcc19",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Villanueva, Eneida",
                    "Yalavarthi, Srilakshmi",
                    "Berthier, Celine C",
                    "Hodgin, Jeffrey B",
                    "Khandpur, Ritika",
                    "Lin, Andrew M",
                    "Rubin, Cory J",
                    "Zhao, Wenpu",
                    "Olsen, Stephen H",
                    "Klinker, Matthew",
                    "Shealy, David",
                    "Denny, Michael F",
                    "Plumas, Joel",
                    "Chaperot, Laurence",
                    "Kretzler, Matthias",
                    "Bruce, Allen T",
                    "Kaplan, Mariana J"
                ],
                "database": {
                    "id": "21613614",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology (Baltimore, Md. : 1950)",
                "title": "Netting neutrophils induce endothelial damage, infiltrate tissues, and expose immunostimulatory molecules in systemic lupus erythematosus.",
                "abstract": "An abnormal neutrophil subset has been identified in the PBMC fractions from lupus patients. We have proposed that these low-density granulocytes (LDGs) play an important role in lupus pathogenesis by damaging endothelial cells and synthesizing increased levels of proinflammatory cytokines and type I IFNs. To directly establish LDGs as a distinct neutrophil subset, their gene array profiles were compared with those of autologous normal-density neutrophils and control neutrophils. LDGs significantly overexpress mRNA of various immunostimulatory bactericidal proteins and alarmins, relative to lupus and control neutrophils. In contrast, gene profiles of lupus normal-density neutrophils do not differ from those of controls. LDGs have heightened capacity to synthesize neutrophils extracellular traps (NETs), which display increased externalization of bactericidal, immunostimulatory proteins, and autoantigens, including LL-37, IL-17, and dsDNA. Through NETosis, LDGs have increased capacity to kill endothelial cells and to stimulate IFN-\u03b1 synthesis by plasmacytoid dendritic cells. Affected skin and kidneys from lupus patients are infiltrated by netting neutrophils, which expose LL-37 and dsDNA. Tissue NETosis is associated with increased anti-dsDNA in sera. These results expand the potential pathogenic roles of aberrant lupus neutrophils and suggest that dysregulation of NET formation and its subsequent responses may play a prominent deleterious role."
            },
            "assertions": [
                {
                    "subject": "a(LDGs)",
                    "relation": "increases",
                    "object": "a(NETs)"
                }
            ],
            "evidence": "We tested if NET formation differed in lupus LDGs relative to control neutrophils or autologous neutrophils. At baseline, peripheral blood LDGs demonstrated significantly enhanced NET formation right after isolation when compared to healthy control neutrophils or autologous lupus neutrophils (Figures 2A\u2013B).\u00a0",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "aca5a308-88e3-430e-968e-bad4fadadd37",
        "_rev": "_WpvYGJ--_g",
        "nanopub": {
            "id": "aca5a308-88e3-430e-968e-bad4fadadd37",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Coimmunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "CL:fibroblast",
                    "label": "fibroblast",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16785495",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17RA)",
                    "relation": "increases",
                    "object": "p(HGNC:IL17RC)"
                }
            ],
            "evidence": "Human IL-17RA is present in immunoprecipitates brought down with the anti-Flag monoclonal M2 Ab used to immunoprecipitate IL-17RC (Fig. 3\u21d3a), and IL-17RC is present in immunoprecipitates brought down with an Ab against IL-17RA (Fig. 3\u21d3b).\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "565c996a-9221-4fab-a5ba-14f47e5bcf04",
        "_rev": "_WpvYGJG--S",
        "nanopub": {
            "id": "565c996a-9221-4fab-a5ba-14f47e5bcf04",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Leffler, Jonatan",
                    "Bengtsson, Anders A",
                    "Blom, Anna M"
                ],
                "database": {
                    "id": "24845390",
                    "name": "PubMed"
                },
                "source_name": "Annals of the rheumatic diseases",
                "title": "The complement system in systemic lupus erythematosus: an update.",
                "abstract": "The complement system plays a major role in the autoimmune disease, systemic lupus erythematosus (SLE). However, the role of complement in SLE is complex since it may both prevent and exacerbate the disease. In this review, we explore the latest findings in complement-focused research in SLE. C1q deficiency is the strongest genetic risk factor for SLE, although such deficiency is very rare. Various recently discovered genetic associations include mutations in the complement receptors 2 and 3 as well as complement inhibitors, the latter related to earlier onset of nephritis. Further, autoantibodies are a distinct feature of SLE that are produced as the result of an adaptive immune response and how complement can affect that response is also being reviewed. SLE generates numerous disease manifestations involving contributions from complement such as glomerulonephritis and the increased risk of thrombosis. Furthermore, since most of the complement system is present in plasma, complement is very accessible and may be suitable as biomarker for diagnosis or monitoring of disease activity. This review highlights the many roles of complement for SLE pathogenesis and how research has progressed during recent years."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:C1Q)",
                    "relation": "decreases",
                    "object": "a(GO:\"inflammasome complex\")"
                }
            ],
            "evidence": "C1q is not only an important opsonin but further acts to ensure silent removal of the apoptotic cells by preventing inflammasome assembly. ",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true,
                "gd:abstract": "The complement system plays a major role in the autoimmune disease, systemic lupus erythematosus (SLE). However, the role of complement in SLE is complex since it may both prevent and exacerbate the disease. In this review, we explore the latest findings in complement-focused research in SLE. C1q deficiency is the strongest genetic risk factor for SLE, although such deficiency is very rare. Various recently discovered genetic associations include mutations in the complement receptors 2 and 3 as well as complement inhibitors, the latter related to earlier onset of nephritis. Further, autoantibodies are a distinct feature of SLE that are produced as the result of an adaptive immune response and how complement can affect that response is also being reviewed. SLE generates numerous disease manifestations involving contributions from complement such as glomerulonephritis and the increased risk of thrombosis. Furthermore, since most of the complement system is present in plasma, complement is very accessible and may be suitable as biomarker for diagnosis or monitoring of disease activity. This review highlights the many roles of complement for SLE pathogenesis and how research has progressed during recent years."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b1bcff5a-6764-454a-b325-856b8d3a797e",
        "_rev": "_WpvYGJG-_N",
        "nanopub": {
            "id": "b1bcff5a-6764-454a-b325-856b8d3a797e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "comments": "no full text",
                "database": {
                    "id": "16648837",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TGFB)",
                    "relation": "increases",
                    "object": "p(HGNC:IL23R)"
                }
            ],
            "evidence": "TGF-\u03b2 acts to upregulate IL-23R expression, thereby conferring responsiveness to IL-23.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d269a449-9e00-43af-a96c-41b67a5e7c0c",
        "_rev": "_WpvYGJC-_-",
        "nanopub": {
            "id": "d269a449-9e00-43af-a96c-41b67a5e7c0c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Prostatic Neoplasms\"",
                    "label": "Prostatic Neoplasms",
                    "type": "Disease"
                },
                {
                    "id": "EFO:\"DU 145\"",
                    "label": "DU 145",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "12429649",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Zinc)",
                    "relation": "decreases",
                    "object": "tloc(p(HGNC:RELA), fromloc(GOCC:\"cytoplasm\"), toloc(GOCC:\"nucleus\"))"
                }
            ],
            "evidence": "The findings presented in Fig. 1A\u21d3\u00a0demonstrate that in the presence of pyrithione, 0.5 \u03bcg/ml of zinc almost completely abolished TNF-\u03b1-induced nuclear accumulation of RelA in both PC-3 and DU-145 cell lines.\u00a0\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0dbc9e02-4e4d-46e0-91bc-4b5a84559ef4",
        "_rev": "_WpvYGJ---K",
        "nanopub": {
            "id": "0dbc9e02-4e4d-46e0-91bc-4b5a84559ef4",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Northern Blot",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "n=15",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "10545482",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:ethanol)\t",
                    "relation": "decreases",
                    "object": "r(HGNC:IL1B)"
                },
                {
                    "subject": "a(CHEBI:ethanol)\t",
                    "relation": "decreases",
                    "object": "r(HGNC:TNF)"
                }
            ],
            "evidence": "Similar to the protein levels, the LPS-induced TNF-\u03b1 mRNA at 2 h was substantially decreased (58 \u00b1 15.1%;\u00a0n =\u00a03) by\u00a0in vitro\u00a0ethanol (25 mM) treatment given simultaneously with LPS.\u00a0\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7161554b-0e1a-414d-8244-94d602676a60",
        "_rev": "_WpvYGJ---E",
        "nanopub": {
            "id": "7161554b-0e1a-414d-8244-94d602676a60",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16990136",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:RORGT)",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL17))"
                }
            ],
            "evidence": "In contrast, CD4+\u00a0T cells from\u00a0Ror\u03b3\u2212/\u2212\u00a0mice (which lack both ROR\u03b3 and ROR\u03b3t) displayed a marked reduction in IL-17+\u00a0cells after in vitro polarization.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e6f5c40f-768c-429c-9cf3-d0f31351da91",
        "_rev": "_WpvYGJG-__",
        "nanopub": {
            "id": "e6f5c40f-768c-429c-9cf3-d0f31351da91",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "MTT Assay",
                    "type": "Methodology"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "CL:\"epithelial cell of umbilical artery\"",
                    "label": "epithelial cell of umbilical artery",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "8925935",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"lipoic acid\")",
                    "relation": "decreases",
                    "object": "act(complex(p(HGNC:NFKB1),p(HGNC:NFKB2)), ma(tscript)))"
                }
            ],
            "evidence": "As shown in Fig. 21, the 50% effective dose of LA was found to be 267ug/mL (1.29mM) while the 50% nonselective cytotoxic dose was 750 ug/ml (3.6mM).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1f59f416-924f-4e72-bd3c-c4664b36184c",
        "_rev": "_WpvYGJ--BZ",
        "nanopub": {
            "id": "1f59f416-924f-4e72-bd3c-c4664b36184c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Frob\u00f8se, Helle",
                    "R\u00f8nn, Sif Groth",
                    "Heding, Peter E",
                    "Mendoza, Heidi",
                    "Cohen, Philip",
                    "Mandrup-Poulsen, Thomas",
                    "Billestrup, Nils"
                ],
                "database": {
                    "id": "16543409",
                    "name": "PubMed"
                },
                "source_name": "Molecular endocrinology (Baltimore, Md.)",
                "title": "Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex.",
                "abstract": "IL-1 plays a major role in inflammation and autoimmunity through activation of nuclear factor kappa B (NFkappaB) and MAPKs. Although a great deal is known about the mechanism of activation of NFkappaB and MAPKs by IL-1, much less is known about the down-regulation of this pathway. Suppressor of cytokine signaling (SOCS)-3 was shown to inhibit IL-1-induced transcription and activation of NFkappaB and the MAPKs JNK and p38, but the mechanism is unknown. We show here that SOCS-3 inhibits NFkappaB-dependent transcription induced by overexpression of the upstream IL-1 signaling molecules MyD88, IL-1R-activated kinase 1, TNF receptor-associated factor (TRAF)6, and TGFbeta-activated kinase (TAK)1, but not when the MAP3K MAPK/ERK kinase kinase-1 is used instead of TAK1, indicating that the target for SOCS-3 is the TRAF6/TAK1 signaling complex. By coimmunoprecipitation, it was shown that SOCS-3 inhibited the association between TRAF6 and TAK1 and that SOCS-3 coimmunoprecipitated with TAK1 and TRAF6. Furthermore, SOCS-3 inhibited the IL-1-induced catalytic activity of TAK1. Because ubiquitination of TRAF6 is required for activation of TAK1, we analyzed the role of SOCS-3 on TRAF6 ubiquitination and found that SOCS-3 inhibited ubiquitin modification of TRAF6. These results indicate that SOCS-3 inhibits IL-1 signal transduction by inhibiting ubiquitination of TRAF6, thus preventing association and activation of TAK1."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:NFKB1)",
                    "relation": "increases",
                    "object": "p(HGNC:SOCS3)"
                }
            ],
            "evidence": "The expression of CIS, SOCS-1, SOCS-2, and SOCS-3 is induced in response to stimulation by a wide variety of cytokines, and as transcription of the Socs genes is induced by cytokine-induced signal transducer and activator of transcription (STAT) and NF\u03baB transcription factors, the corresponding SOCS proteins inhibit the same pathway initiating their production, indicating that SOCS proteins form part of a classical negative feedback loop",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "IL-1 plays a major role in inflammation and autoimmunity through activation of nuclear factor kappa B (NFkappaB) and MAPKs. Although a great deal is known about the mechanism of activation of NFkappaB and MAPKs by IL-1, much less is known about the down-regulation of this pathway. Suppressor of cytokine signaling (SOCS)-3 was shown to inhibit IL-1-induced transcription and activation of NFkappaB and the MAPKs JNK and p38, but the mechanism is unknown. We show here that SOCS-3 inhibits NFkappaB-dependent transcription induced by overexpression of the upstream IL-1 signaling molecules MyD88, IL-1R-activated kinase 1, TNF receptor-associated factor (TRAF)6, and TGFbeta-activated kinase (TAK)1, but not when the MAP3K MAPK/ERK kinase kinase-1 is used instead of TAK1, indicating that the target for SOCS-3 is the TRAF6/TAK1 signaling complex. By coimmunoprecipitation, it was shown that SOCS-3 inhibited the association between TRAF6 and TAK1 and that SOCS-3 coimmunoprecipitated with TAK1 and TRAF6. Furthermore, SOCS-3 inhibited the IL-1-induced catalytic activity of TAK1. Because ubiquitination of TRAF6 is required for activation of TAK1, we analyzed the role of SOCS-3 on TRAF6 ubiquitination and found that SOCS-3 inhibited ubiquitin modification of TRAF6. These results indicate that SOCS-3 inhibits IL-1 signal transduction by inhibiting ubiquitination of TRAF6, thus preventing association and activation of TAK1.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "87cf160b-1d07-474a-ab21-5a65fead3637",
        "_rev": "_WpvYGI6--z",
        "nanopub": {
            "id": "87cf160b-1d07-474a-ab21-5a65fead3637",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "2419430",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(GO:\"T helper 1 cells\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL3)"
                },
                {
                    "subject": "a(GO:\"T helper 1 cells\")",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL2))"
                }
            ],
            "evidence": "The bioactivities detected in activated TH1 supernatants were consistent with the synthesis of IL 2, IL 3, and interferon-y.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "902b1ad9-5525-4b8e-83c4-7416b011c943",
        "_rev": "_WpvYGJ--CS",
        "nanopub": {
            "id": "902b1ad9-5525-4b8e-83c4-7416b011c943",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12417590",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL12)",
                    "relation": "decreases",
                    "object": "p(HGNC:IL17)"
                }
            ],
            "evidence": "As seen in (Fig.5\u00a0A), IL-12 decreased IL-17 levels in a dose-dependent manner.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1484e781-9fe8-48d2-a4ea-263f8176d7e3",
        "_rev": "_WpvYGJC-_x",
        "nanopub": {
            "id": "1484e781-9fe8-48d2-a4ea-263f8176d7e3",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "37 HC, 35 eRA",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Ahmed, Usman",
                    "Anwar, Attia",
                    "Savage, Richard S",
                    "Costa, Matthew L",
                    "Mackay, Nicola",
                    "Filer, Andrew",
                    "Raza, Karim",
                    "Watts, Richard A",
                    "Winyard, Paul G",
                    "Tarr, Joanna",
                    "Haigh, Richard C",
                    "Thornalley, Paul J",
                    "Rabbani, Naila"
                ],
                "database": {
                    "id": "25788417",
                    "name": "PubMed"
                },
                "source_name": "Scientific reports",
                "title": "Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health.",
                "abstract": "There is currently no biochemical test for detection of early-stage osteoarthritis (eOA). Tests for early-stage rheumatoid arthritis (eRA) such as rheumatoid factor (RF) and anti-cyclic citrullinated peptide (CCP) antibodies require refinement to improve clinical utility. We developed robust mass spectrometric methods to quantify citrullinated protein (CP) and free hydroxyproline in body fluids. We detected CP in the plasma of healthy subjects and surprisingly found that CP was increased in both patients with eOA and eRA whereas anti-CCP antibodies were predominantly present in eRA. A 4-class diagnostic algorithm combining plasma/serum CP, anti-CCP antibody and hydroxyproline applied to a cohort gave specific and sensitive detection and discrimination of eOA, eRA, other non-RA inflammatory joint diseases and good skeletal health. This provides a first-in-class plasma/serum-based biochemical assay for diagnosis and type discrimination of early-stage arthritis to facilitate improved treatment and patient outcomes, exploiting citrullinated protein and related differential autoimmunity."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:anti-CCP)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "Most patients with eRA were positive for anti-CCP antibodies whereas healthy controls, eOA and non-RA were all negative. For eRA, plasma CP in patients positive for anti\u2013CCP antibodies was significantly higher than plasma CP of healthy controls - 0.259 (0.186\u20130.607) mmol/mol arg, P < 0.01 but not in patients negative for anti\u2013CCP antibodies.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "38d34690-79af-4490-bc70-dcff44f72824",
        "_rev": "_WpvYGJC-Ak",
        "nanopub": {
            "id": "38d34690-79af-4490-bc70-dcff44f72824",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "CL:\"umbilical artery endothelial cell\"",
                    "label": "umbilical artery endothelial cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Watkins, M T",
                    "Patton, G M",
                    "Soler, H M",
                    "Albadawi, H",
                    "Humphries, D E",
                    "Evans, J E",
                    "Kadowaki, H"
                ],
                "database": {
                    "id": "10585861",
                    "name": "PubMed"
                },
                "source_name": "The Biochemical journal",
                "title": "Synthesis of 8-epi-prostaglandin F2alpha by human endothelial cells: role of prostaglandin H2 synthase.",
                "abstract": "The experiments described in this paper were designed to determine the mechanism underlying the increase in 8-isoprostaglandin F(2alpha) (8-epi-PGF(2alpha)) production by cultured human endothelial cells during reoxygenation following hypoxia. Human umbilical artery endothelial cells were grown on microcarrier beads and exposed to sequential periods of normoxia, hypoxia, and reoxygenation. The amount of 8-epi-PGF(2alpha) in the medium was determined by ELISA. The production of 8-epi-PGF(2alpha) decreased by greater than 90% during hypoxia. Upon reoxygenation 8-epi-PGF(2alpha) production increased linearly for 90 min reaching nearly 3 times normoxic levels. When added to the medium during reoxygenation, neither superoxide dismutase nor Tiron, a cell-permeable superoxide scavenger, inhibited 8-epi-PGF(2alpha) production. However, 8-epi-PGF(2alpha) production was inhibited by catalase. The production of 8-epi-PGF(2alpha) was also inhibited by indomethacin and aspirin. Exogenous hydrogen peroxide stimulated 8-epi-PGF(2alpha) production by normoxic cells, and aspirin inhibited the hydrogen peroxide-mediated increase in 8-epi-PGF(2alpha) production. These results indicate that the reactive oxygen species responsible for 8-epi-PGF(2alpha) synthesis during reoxygenation is hydrogen peroxide and that in endothelial cells 8-epi-PGF(2alpha) synthesis is mediated by prostaglandin H(2) synthase (PGHS). To verify the role of PGHS in 8-epi-PGF(2alpha) synthesis, human PGHS-1 was expressed in COS-7 cells, a PGHS negative cell line that does not synthesize 8-epi-PGF(2alpha). In the presence of exogenous arachidonic acid the COS-7 cells expressing human PGHS-1 produced substantial amounts of PGE(2) and 8-epi-PGF(2alpha). These data indicate that human PGHS-1 can support the synthesis of 8-epi-PGF(2alpha) and that 8-epi-PGF(2alpha) synthesis by cultured human endothelial cells during reoxygenation is dependent on the activity of PGHS-1."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CAT)",
                    "relation": "decreases",
                    "object": "a(CHEBI:\"8-epi-prostaglandin F2alpha\")"
                }
            ],
            "evidence": "In contrast, catalase(1200 units/ml) significantly inhibited 8-epi-PGF2alpha production during all reoxygenation intervals.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "42a69f81-b3d3-4351-a986-c206315d9c2a",
        "_rev": "_WpvYGJC-Bp",
        "nanopub": {
            "id": "42a69f81-b3d3-4351-a986-c206315d9c2a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Krishnan, Sandeep",
                    "Juang, Yuang-Taung",
                    "Chowdhury, Bhabadeb",
                    "Magilavy, Abigail",
                    "Fisher, Carolyn U",
                    "Nguyen, Hang",
                    "Nambiar, Madhusoodana P",
                    "Kyttaris, Vasileios",
                    "Weinstein, Arthur",
                    "Bahjat, Rena",
                    "Pine, Polly",
                    "Rus, Violeta",
                    "Tsokos, George C"
                ],
                "database": {
                    "id": "19018007",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology (Baltimore, Md. : 1950)",
                "title": "Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells.",
                "abstract": "Diminished expression of TCR zeta and reciprocal up-regulation and association of FcRgamma with the TCR/CD3 complex is a hallmark of systemic lupus erythematosus (SLE) T cells. In this study we explored whether differential molecular associations of the spleen tyrosine kinase Syk that preferentially binds to FcRgamma contribute to pathological amplification of signals downstream of this \"rewired TCR\" in SLE. We detected higher amounts of Syk expression and activity in SLE compared with normal T cells. Selective inhibition of the activity of Syk reduced the strength of TCR-induced calcium responses and slowed the rapid kinetics of actin polymerization exclusively in SLE T cells. Syk and ZAP-70 also associated differently with key molecules involved in cytoskeletal and calcium signaling in SLE T cells. Thus, while Vav-1 and LAT preferentially bound to Syk, phospholipase C-gamma1 bound to both Syk and ZAP-70. Our results show that differential associations of Syk family kinases contribute to the enhanced TCR-induced signaling responses in SLE T cells. Thus, we propose molecular targeting of Syk as a measure to control abnormal T cell responses in SLE."
            },
            "assertions": [
                {
                    "subject": "complex(p(HGNC:SYK), p(PLCG1))",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Detection of association between Syk and PLC-\u03b31 exclusively in SLE T cells is significant in this regard (Fig. 5\u21d1C).",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "Diminished expression of TCR zeta and reciprocal up-regulation and association of FcRgamma with the TCR/CD3 complex is a hallmark of systemic lupus erythematosus (SLE) T cells. In this study we explored whether differential molecular associations of the spleen tyrosine kinase Syk that preferentially binds to FcRgamma contribute to pathological amplification of signals downstream of this \"rewired TCR\" in SLE. We detected higher amounts of Syk expression and activity in SLE compared with normal T cells. Selective inhibition of the activity of Syk reduced the strength of TCR-induced calcium responses and slowed the rapid kinetics of actin polymerization exclusively in SLE T cells. Syk and ZAP-70 also associated differently with key molecules involved in cytoskeletal and calcium signaling in SLE T cells. Thus, while Vav-1 and LAT preferentially bound to Syk, phospholipase C-gamma1 bound to both Syk and ZAP-70. Our results show that differential associations of Syk family kinases contribute to the enhanced TCR-induced signaling responses in SLE T cells. Thus, we propose molecular targeting of Syk as a measure to control abnormal T cell responses in SLE.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4b40d9b8-ce8f-48de-b9a3-20d88c634cce",
        "_rev": "_WpvYGJC-Bu",
        "nanopub": {
            "id": "4b40d9b8-ce8f-48de-b9a3-20d88c634cce",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "DAS28",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "62 RA patients",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Connolly, Mary",
                    "Mullan, Ronan H",
                    "McCormick, Jennifer",
                    "Matthews, Clare",
                    "Sullivan, Owen",
                    "Kennedy, Aisling",
                    "FitzGerald, Oliver",
                    "Poole, A Robin",
                    "Bresnihan, Barry",
                    "Veale, Douglas J",
                    "Fearon, Ursula"
                ],
                "database": {
                    "id": "22076945",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Acute-phase serum amyloid A regulates tumor necrosis factor \u03b1 and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy.",
                "abstract": "To investigate the relationship between acute-phase serum amyloid A (A-SAA) and joint destruction in inflammatory arthritis."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Serum Amyloid A Protein\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "The baseline A-SAA level but not the ESR or the CRP level correlated with the 28-joint swollen joint count and was independently associated with 1-year radiographic progression (P = 0.038).\u00a0",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7e09861f-333c-40d2-be7b-c87c20b495cf",
        "_rev": "_WpvYGJG-B3",
        "nanopub": {
            "id": "7e09861f-333c-40d2-be7b-c87c20b495cf",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"Dendritic Cells\"",
                    "label": "Dendritic Cells",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "23482469",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Berberine)",
                    "relation": "decreases",
                    "object": "surf(p(HGNC:CD86))"
                },
                {
                    "subject": "a(CHEBI:berberine)",
                    "relation": "decreases",
                    "object": "surf(p(HGNC:CD80))"
                },
                {
                    "subject": "a(CHEBI:berberine)",
                    "relation": "decreases",
                    "object": "surf(p(HGNC:CD40))"
                }
            ],
            "evidence": "BBR also suppressed the expression of costimulatory molecules in DCs, which is in agreement with earlier findings in animals, which showed that BBR was able to downregulate the expression of CD80 and CD86 in mouse DCs stimulated by LPS.\u00a0\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c7942b25-8d9b-4ffb-a0cb-0f15c4e447c7",
        "_rev": "_WpvYGJC--S",
        "nanopub": {
            "id": "c7942b25-8d9b-4ffb-a0cb-0f15c4e447c7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Reporter Assay",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "EFO:THP-1",
                    "label": "THP-1",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "9523025",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:tocopherol)",
                    "relation": "decreases",
                    "object": "r(HGNC:TNF)"
                }
            ],
            "evidence": ". TS inhibited the induction of LPS-stimulated PLAP activity controlled by the TNF-\u03b1 promoter in a concentration-dependent manner. I\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1134bddc-b281-4065-b0c5-cda3ee8aec5e",
        "_rev": "_WpvYGJC--u",
        "nanopub": {
            "id": "1134bddc-b281-4065-b0c5-cda3ee8aec5e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "Reporter Assay",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "12419306",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "act(p(HGNC:PPARG), ma(GOMF:\"DNA binding\")"
                }
            ],
            "evidence": "Docosahexaenoic acid suppresses ciglitazone- or carbaprostacyclin (cPGI2)-induced transactivation ofperoxisome proliferatorresponsive element for PPARa=c or PPARd, respectively, in HCT 116 cells.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c781a756-b6a3-4341-b361-501b08960b37",
        "_rev": "_WpvYGJC-_W",
        "nanopub": {
            "id": "c781a756-b6a3-4341-b361-501b08960b37",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15100259",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite(p(HGNC:IL2),p(HGNC:TGFB))",
                    "relation": "increases",
                    "object": "r(HGNC:FOXP3)"
                }
            ],
            "evidence": "e assessed levels of this transcription factor in Treg1 after allostimulation of naive CD4+\u00a0cells with IL-2 and TGF-\u03b2, and in Treg2 educated by Treg1 from CD4+CD25\u2212\u00a0precursors. Fig. 5\u21d3\u00a0shows dramatic up-regulation of\u00a0FoxP3\u00a0mRNA in both of these CD4+\u00a0regulatory subsets.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2838a5f1-db6c-4050-9d97-d3c721b422ee",
        "_rev": "_WpvYGJC-BZ",
        "nanopub": {
            "id": "2838a5f1-db6c-4050-9d97-d3c721b422ee",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL2)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9c9ba674-9ead-4909-a962-441f8c08bb98",
        "_rev": "_WpvYGJ--Ch",
        "nanopub": {
            "id": "9c9ba674-9ead-4909-a962-441f8c08bb98",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Ahmadzadeh, Mojgan",
                    "Rosenberg, Steven A"
                ],
                "database": {
                    "id": "16304057",
                    "name": "PubMed"
                },
                "source_name": "Blood",
                "title": "IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients.",
                "abstract": "Interleukin-2 (IL-2) is historically known as a T-cell growth factor. Accumulating evidence from knockout mice suggests that IL-2 is crucial for the homeostasis and function of CD4+ CD25+ regulatory T cells in vivo. However, the impact of administered IL-2 in an immune intact host has not been studied in rodents or humans. Here, we studied the impact of IL-2 administration on the frequency and function of human CD4+ CD25(hi) T cells in immune intact patients with melanoma or renal cancer. We found that the frequency of CD4+ CD25(hi) T cells was significantly increased after IL-2 treatment, and these cells expressed phenotypic markers associated with regulatory T cells. In addition, both transcript and protein levels of Foxp3, a transcription factor exclusively expressed on regulatory T cells, were consistently increased in CD4 T cells following IL-2 treatment. Functional analysis of the increased number of CD4+ CD25(hi) T cells revealed that this population exhibited potent suppressive activity in vitro. Collectively, our results demonstrate that administration of high-dose IL-2 increased the frequency of circulating CD4+ CD25(hi) Foxp3+ regulatory T cells. Our findings suggest that selective inhibition of IL-2-mediated enhancement of regulatory T cells may improve the therapeutic effectiveness of IL-2 administration."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL2)",
                    "relation": "increases",
                    "object": "a(CL:\"regulatory T cell\")"
                }
            ],
            "evidence": "CD4 T cells isolated after IL-2 administration exhibited significantly higher expression of Foxp3, a surrogate molecular marker for regulatory T cells, since its expression is limited to regulatory T cells14,15 and not to activated or naive T cells.",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "Interleukin-2 (IL-2) is historically known as a T-cell growth factor. Accumulating evidence from knockout mice suggests that IL-2 is crucial for the homeostasis and function of CD4+ CD25+ regulatory T cells in vivo. However, the impact of administered IL-2 in an immune intact host has not been studied in rodents or humans. Here, we studied the impact of IL-2 administration on the frequency and function of human CD4+ CD25(hi) T cells in immune intact patients with melanoma or renal cancer. We found that the frequency of CD4+ CD25(hi) T cells was significantly increased after IL-2 treatment, and these cells expressed phenotypic markers associated with regulatory T cells. In addition, both transcript and protein levels of Foxp3, a transcription factor exclusively expressed on regulatory T cells, were consistently increased in CD4 T cells following IL-2 treatment. Functional analysis of the increased number of CD4+ CD25(hi) T cells revealed that this population exhibited potent suppressive activity in vitro. Collectively, our results demonstrate that administration of high-dose IL-2 increased the frequency of circulating CD4+ CD25(hi) Foxp3+ regulatory T cells. Our findings suggest that selective inhibition of IL-2-mediated enhancement of regulatory T cells may improve the therapeutic effectiveness of IL-2 administration.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e7c2346d-8d69-4cc2-b262-91292138a00a",
        "_rev": "_WpvYGJ---9",
        "nanopub": {
            "id": "e7c2346d-8d69-4cc2-b262-91292138a00a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Spectrofluorometry",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8120414",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL8)",
                    "relation": "increases",
                    "object": "a(CHEBI:\"calcium(1+)\")"
                }
            ],
            "evidence": "See Figure 5\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "049cd11f-a419-4637-80e6-74f5fc69a581",
        "_rev": "_WpvYGJG-Az",
        "nanopub": {
            "id": "049cd11f-a419-4637-80e6-74f5fc69a581",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "EFO:THP-1",
                    "label": "THP-1",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "9547608",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IL6))"
                }
            ],
            "evidence": "As can be seen, the addition of DHA or EPA reduces IL-6 EC production\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1edf26d3-fd77-4fa9-8767-884a99bcb5f7",
        "_rev": "_WpvYGJG-Bs",
        "nanopub": {
            "id": "1edf26d3-fd77-4fa9-8767-884a99bcb5f7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=6",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "25494871",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Fasting\")",
                    "relation": "increases",
                    "object": "r(HGNC:BDNF)"
                }
            ],
            "evidence": "No change in BDNF mRNA was observed following exercise, while fasting upregulated BDNF by \u223c 3.5-fold\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "006ce22d-2c60-4b9d-b3c1-dd765dd5d432",
        "_rev": "_WpvYGJ---Q",
        "nanopub": {
            "id": "006ce22d-2c60-4b9d-b3c1-dd765dd5d432",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "95 SLE patients, 40 non-SLE patients, and 34 healthy controls",
                    "type": "cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "authors": [
                    "Chi, Shuhong",
                    "Yu, Yunxia",
                    "Shi, Juan",
                    "Zhang, Yurong",
                    "Yang, Jijuan",
                    "Yang, Lijuan",
                    "Liu, Xiaoming"
                ],
                "database": {
                    "id": "26549923",
                    "name": "PubMed"
                },
                "source_name": "Disease markers",
                "title": "Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis.",
                "abstract": "An early diagnosis of lupus nephritis (LN) has an important clinical implication in guiding treatments of systemic lupus erythematosus (SLE) in clinical settings. In this study, the diagnostic values of circulating autoantibodies to C1q alone or in combination with other markers for accessing active SLE and LN were evaluated."
            },
            "assertions": [
                {
                    "subject": "a(anti-C1q)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Panniculitis, Lupus Erythematosus\""
                },
                {
                    "subject": "a(anti-C1q)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                }
            ],
            "evidence": "The prevalence of anti-C1q antibodies was significantly higher in patients with SLE (50/95, 52.6%), active SLE (40/51, 78.4%), and LN (30/35, 85.7%) in comparison with non-SLE patient controls, patients with inactive SLE, and non-LN, respectively.\n\n\n\n",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a542a87d-9a7c-42ff-82d3-7c32d5ff8aed",
        "_rev": "_WpvYGJ--Bn",
        "nanopub": {
            "id": "a542a87d-9a7c-42ff-82d3-7c32d5ff8aed",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.497",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "SLEDAI-2k",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "26073684",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "There was a significant positive correlation between IL-6 and IL-17 serum concentrations during periods of disease activity (r=0.497, P=0.005) as well as during remission (r=0.662, P<0.001). ROC curve analysis for IL-6 and IL-17, as predictor of disease activity reviled, optimal cutoff level of 12.3 pg/ml and 19.7 pg/ml, with AUC=0.93, and 0.95, for both cytokines respectively, while as predictors of remission of active lupus nephritis, provide a cutoff value of IL-6 at 20.8 pg/ml, with AUC 0.80, and a cutoff value of IL-17 at 27.0 pg/ml, with AUC 0.82.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "60869922-52b4-421e-a447-cf0efcfb478b",
        "_rev": "_WpvYGJC-Ab",
        "nanopub": {
            "id": "60869922-52b4-421e-a447-cf0efcfb478b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18469800",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite (p(HGNC:IL21), p(HGNC:TGFB))",
                    "relation": "increases",
                    "object": "bp(GO:\"T-helper 17 cell differentiation\")"
                }
            ],
            "evidence": "Whereas IL-21, IL-1\u03b2 or IL-6 induced significant amounts of interferon-\u03b3 (IFN-\u03b3) secretion from naive T cells, the addition of TGF-\u03b2 with IL-21 suppressed IFN-\u03b3 secretion and induced differentiation of TH17 cells.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bacebf88-cce8-4c01-894b-5fe8baf87662",
        "_rev": "_WpvYGJC--b",
        "nanopub": {
            "id": "bacebf88-cce8-4c01-894b-5fe8baf87662",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [],
            "citation": {
                "database": {
                    "id": "176150",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "catof(p(HGNC:MPO))",
                    "relation": "directlyIncreases",
                    "object": "rxn(reactants(a(CHEBI:\"hydrogen peroxide\"),a(CHEBI:chloride)),products(a(CHEBI:\"hypochlorous acid\")))"
                }
            ],
            "evidence": "In this flow system, 90 mug of canine myeloperoxidase generated 80 muM HOCl in the presence of 200 muM H2O2 at a rate corresponding to a turnover of 100 min-1.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "aafe749d-e979-4b75-af14-b84a5dfe4ac4",
        "_rev": "_WpvYGJC--N",
        "nanopub": {
            "id": "aafe749d-e979-4b75-af14-b84a5dfe4ac4",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:D006367",
                    "label": "HeLa Cells",
                    "type": "Cell"
                },
                {
                    "id": "MESH:D018938",
                    "label": "Caco-2 Cells",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Lorenzo, Yolanda",
                    "Azqueta, Amaia",
                    "Luna, Luisa",
                    "Bonilla, F\u00e9lix",
                    "Dom\u00ednguez, Gemma",
                    "Collins, Andrew R"
                ],
                "database": {
                    "id": "19056931",
                    "name": "PubMed"
                },
                "source_name": "Carcinogenesis",
                "title": "The carotenoid beta-cryptoxanthin stimulates the repair of DNA oxidation damage in addition to acting as an antioxidant in human cells."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:beta-cryptoxanthin)",
                    "relation": "decreases",
                    "object": "bp(MESH:\"Oxidative Stress\")"
                }
            ],
            "evidence": "At low concentrations, close to those found in plasma, beta-cryptoxanthin does not itself cause damage, but protects transformed human cells (HeLa and Caco-2) from damage induced by H(2)O(2) or by visible light in the presence of a photosensitizer.",
            "metadata": {
                "Methodology": "damage induced by H2O2 or visible light in the presence of a photosensitizer",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "958bdde2-64dc-4e01-8dfa-8d298c6b5af1",
        "_rev": "_WpvYGJ--_k",
        "nanopub": {
            "id": "958bdde2-64dc-4e01-8dfa-8d298c6b5af1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Katsiari, Christina G",
                    "Kyttaris, Vasileios C",
                    "Juang, Yuang-Taung",
                    "Tsokos, George C"
                ],
                "database": {
                    "id": "16224536",
                    "name": "PubMed"
                },
                "source_name": "The Journal of clinical investigation",
                "title": "Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus.",
                "abstract": "Decreased IL-2 production in systemic lupus erythematosus (SLE) represents a central component of the disease immunopathology. We report that the message, protein, and enzymatic activity of the catalytic subunit of protein phosphatase 2A (PP2Ac), but not PP1, are increased in patients with SLE regardless of disease activity and treatment and in a disease-specific manner. Treatment of SLE T cells with PP2Ac-siRNA decreased the protein levels and activity of PP2Ac in a specific manner and increased the levels of phosphorylated cAMP response element-binding protein and its binding to the IL2 and c-fos promoters, as well as increased activator protein 1 activity, causing normalization of IL-2 production. Our data document increased activity of PP2A as a novel SLE disease-specific abnormality and define a distinct mechanism whereby it represses IL-2 production. We propose the use of PP2Ac-siRNA as a novel tool to correct T cell IL-2 production in SLE patients."
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:PPP2CA))",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "p(HGNC:PPP2CA)\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "r(HGNC:PPP2CA)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "We report that the message, protein, and enzymatic activity of the catalytic subunit of protein phosphatase 2A (PP2Ac), but not PP1, are increased in patients with SLE regardless of disease activity and treatment and in a disease-specific manner.",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "Decreased IL-2 production in systemic lupus erythematosus (SLE) represents a central component of the disease immunopathology. We report that the message, protein, and enzymatic activity of the catalytic subunit of protein phosphatase 2A (PP2Ac), but not PP1, are increased in patients with SLE regardless of disease activity and treatment and in a disease-specific manner. Treatment of SLE T cells with PP2Ac-siRNA decreased the protein levels and activity of PP2Ac in a specific manner and increased the levels of phosphorylated cAMP response element-binding protein and its binding to the IL2 and c-fos promoters, as well as increased activator protein 1 activity, causing normalization of IL-2 production. Our data document increased activity of PP2A as a novel SLE disease-specific abnormality and define a distinct mechanism whereby it represses IL-2 production. We propose the use of PP2Ac-siRNA as a novel tool to correct T cell IL-2 production in SLE patients.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "fa323ffe-aa59-484d-a3b6-62dcc0d5ec0d",
        "_rev": "_WpvYGJC-_H",
        "nanopub": {
            "id": "fa323ffe-aa59-484d-a3b6-62dcc0d5ec0d",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17277312",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:STAT3))\t",
                    "relation": "increases",
                    "object": "r(HGNC:IL17F)"
                },
                {
                    "subject": "act(p(HGNC:STAT3))\t",
                    "relation": "increases",
                    "object": "r(HGNC:IL17)"
                },
                {
                    "subject": "act(p(HGNC:STAT3))",
                    "relation": "increases",
                    "object": "r(HGNC:IL23R)"
                }
            ],
            "evidence": "STAT3C transduction resulted in up-regulation of IL-23R and THi cytokines IL-17 and IL-17F an\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a70a660c-b4a2-4e62-a910-a4bf69a199a0",
        "_rev": "_WpvYGJ--A9",
        "nanopub": {
            "id": "a70a660c-b4a2-4e62-a910-a4bf69a199a0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:hypogastrium",
                    "label": "hypogastrium",
                    "type": "Anatomy"
                },
                {
                    "id": "UBERON:epigastrium",
                    "label": "epigastrium",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:obesity",
                    "label": "obesity",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "19937152",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(DO:Obesity)",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:Collagen)"
                }
            ],
            "evidence": "Depletion of collagen, but not of elastic fibers, in cases with massive weight loss was confirmed. Changes were somewhat more severe in epigastrium (P=0.001) than hypogastrium (P=0.007). Correlation with age did not occur.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "62c2d72d-8eea-44bc-88e2-f54eeca95f62",
        "_rev": "_WpvYGJG-BM",
        "nanopub": {
            "id": "62c2d72d-8eea-44bc-88e2-f54eeca95f62",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.0002",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "418 SLE or APS patients",
                    "type": "Cohort"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16960938",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"lupus anticoagulant\")",
                    "relation": "positiveCorrelation",
                    "object": "p(\"IgA anti-beta2-GPI\")"
                }
            ],
            "evidence": "A positive association was found between the presence of the LAC by dilute RVVT and anti-beta2-GPI IgG (p < 0.0001), IgM (p < 0.0001), and IgA (p = 0.0002) antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "752f833e-49c5-4473-9b94-576dbb8c273d",
        "_rev": "_WpvYGJC-CH",
        "nanopub": {
            "id": "752f833e-49c5-4473-9b94-576dbb8c273d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"dendritic cell\"",
                    "label": "dendritic cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "abstract": "Berberine (BBR) has been shown to exert immunosuppressive and anti-inflammatory effects in several autoimmune diseases. This study was designed to investigate the possible effect of BBR on Th17 and dendritic cell (DC) responses.",
                "authors": [
                    "Yang, Yan",
                    "Qi, Jian",
                    "Wang, Qian",
                    "Du, Liping",
                    "Zhou, Yan",
                    "Yu, Hongsong",
                    "Kijlstra, Aize",
                    "Yang, Peizeng"
                ],
                "database": {
                    "id": "23482469",
                    "name": "PubMed"
                },
                "source_name": "Investigative ophthalmology & visual science",
                "title": "Berberine suppresses Th17 and dendritic cell responses."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:berberine)",
                    "relation": "decreases",
                    "object": "sec(complex(GO:\"interleukin-23 complex\"))"
                },
                {
                    "subject": "a(CHEBI:berberine)",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IL1B))"
                },
                {
                    "subject": "a(CHEBI:berberine)",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IL6))"
                },
                {
                    "subject": "a(CHEBI:berberine)",
                    "relation": "decreases",
                    "object": "surf(p(CD86)"
                },
                {
                    "subject": "a(CHEBI:berberine)",
                    "relation": "decreases",
                    "object": "surf(p(HGNC:CD80)"
                },
                {
                    "subject": "a(CHEBI:berberine)",
                    "relation": "decreases",
                    "object": "surf(p(HGNC:CD40)"
                },
                {
                    "subject": "a(CHEBI:berberine)",
                    "relation": "decreases",
                    "object": "bp(GO:\"T-helper 17 type immune response\")"
                },
                {
                    "subject": "path(DO:\"Vogt-Koyanagi-Harada disease\")",
                    "relation": "increases",
                    "object": "bp(GO:\"CD4-positive, alpha-beta T cell activation\") increases bp(GO:\"T-helper 17 type immune response\")"
                }
            ],
            "evidence": "RESULTS:\nActivation of CD4(+) T cells using anti-CD3 and anti-CD28 showed a higher Th17 response in active VKH patients. BBR showed a direct suppression of the Th17 response both in active VKH patients and healthy donors. It also suppressed the Th17 response indirectly by influencing DC maturation. On the one hand, BBR downregulated the expression of costimulatory molecules (CD40, CD80, and CD86) and, on the other hand, it inhibited IL-6, IL-1\u03b2, and IL-23 secretion by DCs.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2ca21f5b-80b4-45f3-b72a-61b5cfdeae9f",
        "_rev": "_WpvYGI6--v",
        "nanopub": {
            "id": "2ca21f5b-80b4-45f3-b72a-61b5cfdeae9f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "",
                    "label": "8 healthy males",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:\"skeletal muscle tissue\"",
                    "label": "skeletal muscle tissue",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "25020061",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:Fasting)",
                    "relation": "decreases",
                    "object": "p(HGNC:MTOR, pmod(Ph, Ser, 2448))"
                }
            ],
            "evidence": "Fasting significantly reduced phosphorylation of the activating site Ser2448\u00a0on mTOR by \u223c40% (p<0.05).\u00a0\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "df217cbc-eb08-4dac-ac1e-a81319850047",
        "_rev": "_WpvYGJG-AX",
        "nanopub": {
            "id": "df217cbc-eb08-4dac-ac1e-a81319850047",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"B cell\"",
                    "label": "B cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12446913",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite(p(HGNC:IL4), p(HGNC:IL21))\t",
                    "relation": "increases",
                    "object": "p(\"IgM\")"
                },
                {
                    "subject": "composite(p(HGNC:IL4), p(HGNC:IL21))\t",
                    "relation": "increases",
                    "object": "p(\"IgG2c\")"
                },
                {
                    "subject": "composite(p(HGNC:IL4), p(HGNC:IL21))\t",
                    "relation": "increases",
                    "object": "p(\"IgG2b\")"
                },
                {
                    "subject": "composite(p(HGNC:IL4), p(HGNC:IL21))",
                    "relation": "increases",
                    "object": "p(\"IgG2a\")"
                }
            ],
            "evidence": "the IL-4\u2013/\u2013 IL-21R\u2013/\u2013 mice showed severely impaired production of TNP-specific IgG1, IgG2a, IgG2b, and IgG3, and only about 10 to 20% of normal levels of IgM production (Fig. 3B)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f2e25d1b-0d88-46de-ad46-6f841cb1acda",
        "_rev": "_WpvYGJC--_",
        "nanopub": {
            "id": "f2e25d1b-0d88-46de-ad46-6f841cb1acda",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "EFO:HEK293T",
                    "label": "HEK293T",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "15258597",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:A20)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:RIP, pmod(Ub))"
                }
            ],
            "evidence": "A20 directly ubiquitinated RIP, thereby establishing RIP as an A20 substrate (Fig. 2c).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1171dde1-8aaf-4438-9616-2f1cec5f41b9",
        "_rev": "_WpvYGJC-B5",
        "nanopub": {
            "id": "1171dde1-8aaf-4438-9616-2f1cec5f41b9",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "not stated",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18469800",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL21)",
                    "relation": "decreases",
                    "object": "p(HGNC:FOXP3)"
                },
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "decreases",
                    "object": "p(HGNC:FOXP3)"
                }
            ],
            "evidence": "Induction of\u00a0FOXP3\u00a0was inhibited by IL-6 and to a greater extent by IL-21\u2014transcription factors that induce RORC2.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "79a2cc26-e5f9-4619-8d66-f3dff3cf5655",
        "_rev": "_WpvYGJG-BU",
        "nanopub": {
            "id": "79a2cc26-e5f9-4619-8d66-f3dff3cf5655",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Fibroblasts",
                    "label": "Fibroblasts",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Nguyen, Hung N",
                    "Noss, Erika H",
                    "Mizoguchi, Fumitaka",
                    "Huppertz, Christine",
                    "Wei, Kevin S",
                    "Watts, Gerald F M",
                    "Brenner, Michael B"
                ],
                "database": {
                    "id": "28228280",
                    "name": "PubMed"
                },
                "source_name": "Immunity",
                "title": "Autocrine Loop Involving IL-6 Family Member LIF, LIF Receptor, and STAT4 Drives Sustained Fibroblast Production of Inflammatory Mediators.",
                "abstract": "Fibroblasts are major contributors to and regulators of inflammation and dominant producers of interleukin-6 (IL-6) in inflammatory diseases like rheumatoid arthritis. Yet, compared to leukocytes, the regulation of inflammatory pathways in fibroblasts is largely unknown. Here, we report that analyses of genes coordinately upregulated with IL-6 pointed to STAT4 and leukemia inhibitory factor (LIF) as potentially linked. Gene silencing revealed that STAT4 was required for IL-6 transcription. STAT4 was recruited to the IL-6 promoter after fibroblast activation, and LIF receptor (LIFR) and STAT4 formed a molecular complex that, together with JAK1 and TYK2 kinases, controlled STAT4 activation. Importantly, a positive feedback loop involving autocrine LIF, LIFR, and STAT4 drove sustained IL-6 transcription. Besides IL-6, this autorine loop also drove the production of other key inflammatory factors including IL-8, granulocyte-colony stimulating factor (G-CSF), IL-33, IL-11, IL-1\u03b1, and IL-1\u03b2. These findings define the transcriptional regulation of fibroblast-mediated inflammation as distinct from leukocytes."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:LIFR)\t",
                    "relation": "increases",
                    "object": "p(HGNC:IL1A)"
                },
                {
                    "subject": "p(HGNC:LIFR)\t",
                    "relation": "increases",
                    "object": "p(HGNC:IL1B)"
                },
                {
                    "subject": "p(HGNC:LIFR)\t",
                    "relation": "increases",
                    "object": "p(HGNC:IL8)"
                },
                {
                    "subject": "p(HGNC:LIFR)",
                    "relation": "increases",
                    "object": "p(HGNC:IL11)"
                },
                {
                    "subject": "p(HGNC:LIFR)",
                    "relation": "increases",
                    "object": "p(HGNC:IL33)"
                },
                {
                    "subject": "p(HGNC:STAT4)\t",
                    "relation": "increases",
                    "object": "p(HGNC:IL33)"
                },
                {
                    "subject": "p(HGNC:STAT4)\t",
                    "relation": "increases",
                    "object": "p(HGNC:IL11)"
                },
                {
                    "subject": "composite(p(HGNC:TNF), p(HGNC:IL17A))",
                    "relation": "increases",
                    "object": "p(HGNC:IL33)"
                },
                {
                    "subject": "composite(p(HGNC:TNF), p(HGNC:IL17A))",
                    "relation": "increases",
                    "object": "p(HGNC:IL11)"
                },
                {
                    "subject": "p(HGNC:STAT4)",
                    "relation": "increases",
                    "object": "p(HGNC:IL1A)"
                },
                {
                    "subject": "composite(p(HGNC:TNF), p(HGNC:IL17A))",
                    "relation": "increases",
                    "object": "p(HGNC:IL1A)"
                },
                {
                    "subject": "composite(p(HGNC:TNF), p(HGNC:IL17A))",
                    "relation": "increases",
                    "object": "p(HGNC:IL1B)"
                },
                {
                    "subject": "composite(p(HGNC:TNF), p(HGNC:IL17A))",
                    "relation": "increases",
                    "object": "p(HGNC:IL8)"
                },
                {
                    "subject": "p(HGNC:STAT4)",
                    "relation": "increases",
                    "object": "p(HGNC:IL1B)"
                },
                {
                    "subject": "p(HGNC:STAT4)",
                    "relation": "increases",
                    "object": "p(HGNC:IL8)"
                }
            ],
            "evidence": "Moreover, besides IL-6, fibroblasts produced IL-8, G-CSF, IL-33, IL-11,IL-1a, and IL-1b after TNF and IL-17 stimulation, and the production of these cytokines and chemokines is markedly reduced when STAT4 or LIFR expression was silenced by siRNA.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Fibroblasts are major contributors to and regulators of inflammation and dominant producers of interleukin-6 (IL-6) in inflammatory diseases like rheumatoid arthritis. Yet, compared to leukocytes, the regulation of inflammatory pathways in fibroblasts is largely unknown. Here, we report that analyses of genes coordinately upregulated with IL-6 pointed to STAT4 and leukemia inhibitory factor (LIF) as potentially linked. Gene silencing revealed that STAT4 was required for IL-6 transcription. STAT4 was recruited to the IL-6 promoter after fibroblast activation, and LIF receptor (LIFR) and STAT4 formed a molecular complex that, together with JAK1 and TYK2 kinases, controlled STAT4 activation. Importantly, a positive feedback loop involving autocrine LIF, LIFR, and STAT4 drove sustained IL-6 transcription. Besides IL-6, this autorine loop also drove the production of other key inflammatory factors including IL-8, granulocyte-colony stimulating factor (G-CSF), IL-33, IL-11, IL-1\u03b1, and IL-1\u03b2. These findings define the transcriptional regulation of fibroblast-mediated inflammation as distinct from leukocytes.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d70b6314-dca1-4578-b5ec-e2edfa7b9258",
        "_rev": "_WpvYGJ---2",
        "nanopub": {
            "id": "d70b6314-dca1-4578-b5ec-e2edfa7b9258",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Site-directed mutagenesis",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16645171",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT5)",
                    "relation": "increases",
                    "object": "p(HGNC:FOXP3)"
                }
            ],
            "evidence": "In contrast, when the wild-type construct was cotransfected with a constitutively activated form of STAT5, STAT5a1*6,25\u00a0a prominent induction of luciferase activity was observed.\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "27c91070-ac8b-4f7a-a454-13a5aa6873aa",
        "_rev": "_WpvYGJC-Ai",
        "nanopub": {
            "id": "27c91070-ac8b-4f7a-a454-13a5aa6873aa",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "33 RA patients, 14 HC",
                    "type": "cohort"
                },
                {
                    "id": "",
                    "label": "SDAI",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "authors": [
                    "Rooney, Terence",
                    "Scherzer, Rebecca",
                    "Shigenaga, Judy K",
                    "Graf, Jonathan",
                    "Imboden, John B",
                    "Grunfeld, Carl"
                ],
                "database": {
                    "id": "21441551",
                    "name": "PubMed"
                },
                "source_name": "Rheumatology (Oxford, England)",
                "title": "Levels of plasma fibrinogen are elevated in well-controlled rheumatoid arthritis.",
                "abstract": "Patients with RA have systemic inflammation and increased risk of cardiovascular (CV) events, including thrombosis. Levels of fibrinogen, a pro-thrombotic protein with predictive value for CV disease (CVD), are elevated during systemic inflammation. We compared circulating fibrinogen levels in patients with RA with healthy controls and evaluated the relationship with measures of disease activity."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Fibrinogen)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "We next examined the associations of measures of disease activity with fibrinogen in RA patients. Joint counts, CDAI, SDAI and DAS-28 also showed positive, statistically significant associations with fibrinogen. Disease activity markers that included an inflammatory marker (SDAI, DAS-28-ESR and DAS-28-CRP) showed strong associations (all r\u2009>\u20090.4, P\u2009<\u20090.0001)",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Patients with RA have systemic inflammation and increased risk of cardiovascular (CV) events, including thrombosis. Levels of fibrinogen, a pro-thrombotic protein with predictive value for CV disease (CVD), are elevated during systemic inflammation. We compared circulating fibrinogen levels in patients with RA with healthy controls and evaluated the relationship with measures of disease activity.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "19fac1e4-2f8b-4954-868e-37d47fc69512",
        "_rev": "_WpvYGJC-Ap",
        "nanopub": {
            "id": "19fac1e4-2f8b-4954-868e-37d47fc69512",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"vein endothelial cell\"",
                    "label": "vein endothelial cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "7524649",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "sec(p(SP:P10145))"
                },
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IL6))"
                }
            ],
            "evidence": "\"As in the case of adhesion molecule expression on the cell surface, DHA inhibited HSVEC secretion of the soluble inflammatory mediators IL-6 and IL-8\nby IL-la, as assessed by EIA of the HSVEC supernates\n(Table 1).\n\"\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "38021975-7cf4-4ab2-b02e-142bf47777eb",
        "_rev": "_WpvYGJ---p",
        "nanopub": {
            "id": "38021975-7cf4-4ab2-b02e-142bf47777eb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.04",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=31",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "CDAI",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Crohn Disease\"",
                    "label": "Crohn Disease",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "10961730",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Saccharomyces boulardii\")",
                    "relation": "decreases",
                    "object": "path(MESH:\"Relapse\")"
                }
            ],
            "evidence": "Clinical relapses at six months were observed in 6 of the 16 patients on standard mesalamine maintenance and in 1 of the 16 patients receiving also Saccharomyces boulardii. The difference is statistically different (P 5 0.04\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "36f850df-8bce-48cf-a830-d129efa89500",
        "_rev": "_WpvYGJ---C",
        "nanopub": {
            "id": "36f850df-8bce-48cf-a830-d129efa89500",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"embryonic fibroblast\"",
                    "label": "embryonic fibroblast",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Coimmunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17035243",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:Act1)",
                    "relation": "decreases",
                    "object": "p(HGNC:IKBA)"
                }
            ],
            "evidence": "In addition, the level of I\u03baB\u03b1 protein was maintained in Act1-shRNA MEF, while I\u03baB\u03b1 was degraded in WT MEF upon IL-17 treatment, indicating a critical role of Act1 in activating NF-\u03baB pathway (Fig. 3C).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a0b357ff-0d87-4579-9795-e8dd0b187b32",
        "_rev": "_WpvYGJ--B8",
        "nanopub": {
            "id": "a0b357ff-0d87-4579-9795-e8dd0b187b32",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16200070",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL4)",
                    "relation": "decreases",
                    "object": "r(HGNC:IL23R)"
                }
            ],
            "evidence": "Compared with cells treated with IL-23 alone, there was a decrease of 41% in IL-23R expression in association with suppression of TH-17 cell development by exogenous IFN-g\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "75a130c4-ff4a-4c29-8f22-c27b8afe74ad",
        "_rev": "_WpvYGJC-AK",
        "nanopub": {
            "id": "75a130c4-ff4a-4c29-8f22-c27b8afe74ad",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"COS-1 cell\"",
                    "label": "COS-1 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "9311995",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TGFB)",
                    "relation": "increases",
                    "object": "complex(p(HGNC:SMAD2), p(HGNC:SMAD3))"
                }
            ],
            "evidence": "Only upon co-transfection of were transfected with indicated Smad constructs alone or constitutively active T\u03b2R-I did we observe co-immunoprecipitation of the Smad3 protein\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b846b301-ef8c-40d7-a2a4-1e22f507da75",
        "_rev": "_WpvYGJG-B1",
        "nanopub": {
            "id": "b846b301-ef8c-40d7-a2a4-1e22f507da75",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.11",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "1518 men and 1524 women",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "1599264515992645",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Seafood)",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:TNF)"
                }
            ],
            "evidence": "All inflammatory markers showed an inverse dose-response relationship with fish consumption (Table 2).\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8fb4dfd7-5fab-49a6-9ddf-e10f4524dd85",
        "_rev": "_WpvYGJ--Bi",
        "nanopub": {
            "id": "8fb4dfd7-5fab-49a6-9ddf-e10f4524dd85",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "FSS",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "GC-MS",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "p=.0002",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "Seventy-one SLE patients with low disease activity (mean SLEDAI\u2009=\u20091.62 standard error (SE) 0.37, range 0-8) were compared to 51 controls",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "22508802",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:F2-Isoprostanes)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Fatigue\")"
                }
            ],
            "evidence": "F(2)-isoprostane was higher in SLE patients with fatigue compared to not-fatigued SLE subjects (p\u2009=\u2009.0076) who were otherwise similar in ethnicity, disease activity and cardiovascular risk factors. Plasma F(2)-isoprostane was strongly correlated with FSS and Profile of Somatic Fatigue (Prof-S) (p\u2009<\u2009.0001), VAS fatigue (p\u2009=\u2009.005), CES-D (p\u2009=\u2009.008) and with BMI (p\u2009=\u2009.0001.) In a multivariate model, F(2)-isoprostane was a significant predictor of FSS after adjustment for age, BMI, pain and depression (p\u2009=\u2009.0002).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "718d1dfb-c9ef-4d59-a4bb-4382f41ac604",
        "_rev": "_WpvYGJC-AV",
        "nanopub": {
            "id": "718d1dfb-c9ef-4d59-a4bb-4382f41ac604",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.009",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "87 SLE (41 with history of thrombosis)",
                    "type": "Cohort"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12559629",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"IgG anticardiolipin\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:Thrombosis)"
                }
            ],
            "evidence": "Thrombosis was significantly associated with IgG-aPA (p = 0.044), IgG-aPI (p = 0.038), IgG-aPS (p = 0.026), IgG-abeta(2)-GPI, IgM-aPA (p = 0.044), IgM-aPI (p = 0.024), and IgM-aPS (p = 0.01), irrespective of antibody titer, whereas IgG-aCL were associated with thrombosis and thrombocytopenia when taken at medium-high titer (p = 0.009 and p = 0.046, respectively).\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "dc074fda-5612-46f1-ae2a-3f56f9728e4f",
        "_rev": "_WpvYGJC--a",
        "nanopub": {
            "id": "dc074fda-5612-46f1-ae2a-3f56f9728e4f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"B cell\"",
                    "label": "B cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "7507958",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL13)",
                    "relation": "increases",
                    "object": "BP(GO:\"Isotype switching\")"
                }
            ],
            "evidence": "As shown in Figure 2A, IL-13 induced IgM, total IgG, IgG4, and IgE synthesis in a dose-dependent fashion when fetal BM cells were cultured in the presence of anti-CD40 mAb\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "91846910-07cc-40b1-bf80-09e7b9efd2aa",
        "_rev": "_WrRPAYa---",
        "nanopub": {
            "id": "91846910-07cc-40b1-bf80-09e7b9efd2aa",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"synovial cell\"",
                    "label": "synovial cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Fossiez, F",
                    "Djossou, O",
                    "Chomarat, P",
                    "Flores-Romo, L",
                    "Ait-Yahia, S",
                    "Maat, C",
                    "Pin, J J",
                    "Garrone, P",
                    "Garcia, E",
                    "Saeland, S",
                    "Blanchard, D",
                    "Gaillard, C",
                    "Das Mahapatra, B",
                    "Rouvier, E",
                    "Golstein, P",
                    "Banchereau, J",
                    "Lebecque, S"
                ],
                "comments": "no p-value stated",
                "database": {
                    "id": "8676080",
                    "name": "PubMed"
                },
                "source_name": "The Journal of experimental medicine",
                "title": "T cell interleukin-17 induces stromal cells to produce proinflammatory and hematopoietic cytokines.",
                "abstract": "Analysis of the cDNA encoding murine interleukin (IL) 17 (cytotoxic T lymphocyte associated antigen 8) predicted a secreted protein sharing 57% amino acid identity with the protein predicted from ORF13, an open reading frame of Herpesvirus saimiri. Here we report on the cloning of human IL-17 (hIL-17), the human counterpart of murine IL-17. hIL-17 is a glycoprotein of 155 amino acids secreted as an homodimer by activated memory CD4+ T cells. Although devoid of direct effects on cells of hematopoietic origin, hIL-17 and the product of its viral counterpart, ORF13, stimulate epithelial, endothelial, and fibroblastic cells to secrete cytokines such as IL-6, IL-8, and granulocyte-colony-stimulating factor, as well as prostaglandin E2. Furthermore, when cultured in the presence of hIL-17, fibroblasts could sustain the proliferation of CD34+ hematopoietic progenitors and their preferential maturation into neutrophils. These observations suggest that hIL-17 may constitute (a) an early initiator of the T cell-dependent inflammmatory reaction; and (b) an element of the cytokine network that bridges the immune system to hematopoiesis.",
                "date_published": "1996-06-01"
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17)\t",
                    "relation": "increases",
                    "object": "sec(p(HGNC:CXCL8))"
                },
                {
                    "subject": "p(HGNC:IL17)\t",
                    "relation": "increases",
                    "object": "sec(a(CHEBI:\"prostaglandins E\"))"
                },
                {
                    "subject": "p(HGNC:IL17)\t",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL8))"
                },
                {
                    "subject": "p(HGNC:IL17)",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL6))"
                }
            ],
            "evidence": "In contrast, hlL-17 induced the secretion of IL-6, IL-8 , PGE 2, and G-CSF from primary cultures of synovial fibroblasts (Fig. 3, A, C, E, and G).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.9020000",
                "gd:updateTS": "2018-04-17T18:14:52.067Z",
                "gd:published": true,
                "gd:abstract": "Analysis of the cDNA encoding murine interleukin (IL) 17 (cytotoxic T lymphocyte associated antigen 8) predicted a secreted protein sharing 57% amino acid identity with the protein predicted from ORF13, an open reading frame of Herpesvirus saimiri. Here we report on the cloning of human IL-17 (hIL-17), the human counterpart of murine IL-17. hIL-17 is a glycoprotein of 155 amino acids secreted as an homodimer by activated memory CD4+ T cells. Although devoid of direct effects on cells of hematopoietic origin, hIL-17 and the product of its viral counterpart, ORF13, stimulate epithelial, endothelial, and fibroblastic cells to secrete cytokines such as IL-6, IL-8, and granulocyte-colony-stimulating factor, as well as prostaglandin E2. Furthermore, when cultured in the presence of hIL-17, fibroblasts could sustain the proliferation of CD34+ hematopoietic progenitors and their preferential maturation into neutrophils. These observations suggest that hIL-17 may constitute (a) an early initiator of the T cell-dependent inflammmatory reaction; and (b) an element of the cytokine network that bridges the immune system to hematopoiesis."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2ae314d2-7e00-41ae-8a83-c90c97560c06",
        "_rev": "_WpvYGJC-_N",
        "nanopub": {
            "id": "2ae314d2-7e00-41ae-8a83-c90c97560c06",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.497",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "SLEDAI-2K",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "77 SLE female, 70 sex- and age-matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "26073684",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17A)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "There was a significant positive correlation between IL-6 and IL-17 serum concentrations during periods of disease activity (r=0.497, P=0.005) as well as during remission (r=0.662, P<0.001). ROC curve analysis for IL-6 and IL-17, as predictor of disease activity reviled, optimal cutoff level of 12.3 pg/ml and 19.7 pg/ml, with AUC=0.93, and 0.95, for both cytokines respectively, while as predictors of remission of active lupus nephritis, provide a cutoff value of IL-6 at 20.8 pg/ml, with AUC 0.80, and a cutoff value of IL-17 at 27.0 pg/ml, with AUC 0.82.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "25637bd2-3a54-47cf-9fa3-916a5cd83a51",
        "_rev": "_WpvYGJG-_l",
        "nanopub": {
            "id": "25637bd2-3a54-47cf-9fa3-916a5cd83a51",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16200070",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL4)",
                    "relation": "decreases",
                    "object": "bp(GO:\"T-helper 17 cell differentiation\")"
                }
            ],
            "evidence": ". In the absence of IL-4 neutralization, TH-17 cell development was notably blunted compared with that in control conditions in which both IFN-g and IL-4 were neutralized (1.6% versus 8.4% IL-17+, respectively)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f7c1b887-2efb-4e01-b508-ff871302a5bd",
        "_rev": "_WpvYGJC-BB",
        "nanopub": {
            "id": "f7c1b887-2efb-4e01-b508-ff871302a5bd",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Hopkins Lupus Cohort (longitudinal study on 800 SLE patients)",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "r=0.63",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL19)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f675564b-debf-41d6-8758-1acaaa445c6d",
        "_rev": "_WpvYGJ----",
        "nanopub": {
            "id": "f675564b-debf-41d6-8758-1acaaa445c6d",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "In Vitro Kinase Assay",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"CTLL-2 cell\"",
                    "label": "CTLL-2 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "1996324",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:IL2), ma(GO:\"Receptor Binding\"))",
                    "relation": "increases",
                    "object": "act(p(HGNC:RAF1, pmod(Ph)), ma(GO:\"Kinase Activity\"))"
                }
            ],
            "evidence": "As shown in Table 1, IL-2 produced a 5- to 10-fold increase in the activity of Raf-1 kinase as measured by this assay\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "dcfbc5d7-c34e-43c7-9fe9-8a61a1db40c2",
        "_rev": "_WpvYGJG--d",
        "nanopub": {
            "id": "dcfbc5d7-c34e-43c7-9fe9-8a61a1db40c2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8624821",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT6)",
                    "relation": "regulates",
                    "object": "bp(GO:\"T helper 2 cell differentiation\")"
                }
            ],
            "evidence": "\u00a0In contrast, lymphocytes from\u00a0Stat6\u2212/\u2212\u00a0mice demonstrated an inability to produce IL-4 and IL-5 when cultured under identical conditions (Figure 5b). Thus, T lymphocytes from\u00a0Stat6\u2212/\u2212\u00a0mice are almost completely impaired in their ability to differentiate into Th2 cells, a result consistent with the notion that Stat6 is essential for mediating the differentiation signals induced by IL-4.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7de3aed9-8e65-4bbe-97e7-83792830b8ea",
        "_rev": "_WpvYGJG-Bf",
        "nanopub": {
            "id": "7de3aed9-8e65-4bbe-97e7-83792830b8ea",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Novick, D",
                    "Cohen, B",
                    "Rubinstein, M"
                ],
                "database": {
                    "id": "8181059",
                    "name": "PubMed"
                },
                "source_name": "Cell",
                "title": "The human interferon alpha/beta receptor: characterization and molecular cloning.",
                "abstract": "We describe a universal ligand-binding receptor for human interferons alpha and interferon beta (type I IFNs). A soluble 40 kDa IFN-alpha/beta receptor (p40) that blocks the activity of type I IFNs was purified from urine and sequenced. Antibodies raised against p40 completely block the activity of several type I IFNs and immuno-precipitate both a cellular 102 kDa IFN-alpha/beta receptor and its cross-linked complexes with IFN-alpha 2. The receptor is a disulfide-linked dimer, consisting of 51 kDa subunits. We isolated and expressed a 1.5 kb cDNA, coding for the IFN-alpha/beta receptor. Its 331 amino acid sequence includes a leader and a transmembrane region, while its ectodomain corresponds to p40. IFN-alpha/beta receptor is physically associated with the cytoplasmic Tyr kinase JAK1, hence, in addition to ligand binding, it is directly involved in signal transduction."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNA1",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:IFNAR1)"
                }
            ],
            "evidence": "A soluble 40 kDa IFN-alpha/beta receptor (p40) that blocks the activity of type I IFNs was purified from urine and sequenced. Antibodies raised against p40 completely block the activity of several type I IFNs and immuno-precipitate both a cellular 102 kDa IFN-alpha/beta receptor and its cross-linked complexes with IFN-alpha 2. The receptor is a disulfide-linked dimer, consisting of 51 kDa subunits. We isolated and expressed a 1.5 kb cDNA, coding for the IFN-alpha/beta receptor. Its 331 amino acid sequence includes a leader and a transmembrane region, while its ectodomain corresponds to p40.\u00a0",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "fa1d75a7-18c1-400c-bd06-399b25cc45e2",
        "_rev": "_WpvYGJ--_U",
        "nanopub": {
            "id": "fa1d75a7-18c1-400c-bd06-399b25cc45e2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "21602271",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:PDCD4)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Investigation of putative gene- targets showed that PDCD4 (a selective protein translation inhibitor) was suppressed by miR-21 and its expression was decreased in active SLE.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2103be72-d7c0-47bd-bd80-a2afa13032d6",
        "_rev": "_WpvYGJC-Ae",
        "nanopub": {
            "id": "2103be72-d7c0-47bd-bd80-a2afa13032d6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Intracellular Cytokine Staining",
                    "type": "Methodology"
                },
                {
                    "id": "EFO:\"MEL cell line\"",
                    "label": "MEL cell line",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "12006974",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT4)",
                    "relation": "increases",
                    "object": "p(HGNC:IFNG)"
                },
                {
                    "subject": "p(HGNC:STAT1)",
                    "relation": "increases",
                    "object": "p(HGNC:IFNG)"
                }
            ],
            "evidence": "Under Th1 conditions, STAT1-/- T cells produced ~50% as much IFN-G as wild-type controls, but STAT4-/- T cells showed much more reduced IFN-G production.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6dda94cd-20c1-401b-aee8-fc8f123ca57c",
        "_rev": "_WpvYGJ--BH",
        "nanopub": {
            "id": "6dda94cd-20c1-401b-aee8-fc8f123ca57c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "EFO:MCF-7",
                    "label": "MCF-7",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "10657898",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"DNA Damage\")",
                    "relation": "increases",
                    "object": "r(HGNC:BTG2)"
                }
            ],
            "evidence": "As expected from our previous study [3], levels of BTG2/TIS21 mRNA increased rapidly after exposure of wild-type p53(wtp53)\u00b1expressing cells to g radiation, to reach a maximum 3 h after exposure (Figure 1).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "943d212d-a257-4956-8c9d-89de932ba9c6",
        "_rev": "_WpvYGI6--6",
        "nanopub": {
            "id": "943d212d-a257-4956-8c9d-89de932ba9c6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "n=6",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Macrophages",
                    "label": "Macrophages",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "15797683",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:oleuropein)",
                    "relation": "decreases",
                    "object": "p(HGNC:IL1B)"
                }
            ],
            "evidence": "The addition of oleuropein glycoside at 10\u00014 M decreased the IL-1 concentration by an average of 80% to 1632 pg/mL (1203, 3040).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b911e20e-f357-40f6-ac3a-d9ceffeb7648",
        "_rev": "_WpvYGJC-A3",
        "nanopub": {
            "id": "b911e20e-f357-40f6-ac3a-d9ceffeb7648",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:tuberculosis",
                    "label": "tuberculosis",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "21189447",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Tuberculosis, Pulmonary\")",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IFNG)"
                }
            ],
            "evidence": "In TB patients, Mean + SD of IFN-\u03b3 was 48.69 + 28.78 pg/ml while it was 12.99 + 5.70 pg/ml in the control group\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a2773a8c-a583-4559-8828-0aded3d2e11d",
        "_rev": "_WpvYGJG-AF",
        "nanopub": {
            "id": "a2773a8c-a583-4559-8828-0aded3d2e11d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.04",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=48",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "MESH:\"Dermatitis, Atopic\"",
                    "label": "Dermatitis, Atopic",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "22955355",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Probiotic\")",
                    "relation": "decreases",
                    "object": "a(GO:\"T-helper 17 cell differentiation\")"
                }
            ],
            "evidence": "In individuals receiving probiotics IL-17-secreting, RORgT-expressing CD4 + T cells (Th17) reduced after 3 months of treatment (unstimulated: baseline vs. 3-mo treatment: P = 0.037; LPS-stimulated: baseline vs. 3-mo treatment: P = 0.046) (Figs. 4E, F)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "955c178a-9274-419a-8493-5eaaae9aabac",
        "_rev": "_WpvYGJC-CE",
        "nanopub": {
            "id": "955c178a-9274-419a-8493-5eaaae9aabac",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10229872",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL12)",
                    "relation": "increases",
                    "object": "p(HGNC:JAK2, pmod(Ph))"
                },
                {
                    "subject": "p(HGNC:IL12)",
                    "relation": "increases",
                    "object": "p(HGNC:TYK2, pmod(Ph))"
                }
            ],
            "evidence": "Western blot analysis of immunoprecipitates from Con A-activated T cells showed an increase in the tyrosine phosphorylation of Jak-2 (Fig. 1\u21d3A) and Tyk-2 (Fig. 1\u21d3B) following stimulation with 1 ng/ml of IL-12 for 15 min\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8642bf17-fa12-4602-a603-b4f8268d11dd",
        "_rev": "_WpvYGJ---J",
        "nanopub": {
            "id": "8642bf17-fa12-4602-a603-b4f8268d11dd",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15976028",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(MGI:Il6)",
                    "relation": "increases",
                    "object": "p(MGI:Cxcr3)"
                }
            ],
            "evidence": "Peritoneal inflammation was induced in WT and IL-6-/- mice, and the profile of the chemokine receptors CCR3, CCR4, CCR5, and CXCR3 was defined on the T cell infiltrate (Fig. 2). Although activation with SES resulted in a temporal increase in CD3+ T cells expressing CCR3, CCR4, CCR5, and CXCR3, the proportion of cells bearing these receptors was noticeably lower in the absence of IL-6.",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Monocyte chemoattractant protein-1 (MCP-1) is a potent chemokine synthesized by several cell types, e.g., inflammatory cells, such as monocytes, and resident renal cells, such as human tubular epithelial cells (TECs). Besides induction of monocyte recruitment, MCP-1 has been suggested to induce non-leukocytes to produce cytokines and adhesion molecules. Inflammation of the tubulointerstitium is a hallmark of many renal diseases and contributes to progression of renal failure; the purpose therefore of this study was to investigate the influence of MCP-1 on markers of inflammatory activation in human TECs. MCP-1 stimulated interleukin-6 (IL-6) secretion and intercellular adhesion molecule-1 (ICAM-1) synthesis in a time- and dose-dependent manner. In parallel, MCP-1 increased IL-6 and ICAM-1 mRNA expression in human TECs. Pretreatment with pertussis toxin, GF109203X, BAPTA-AM, and pyrrolidine dithiocarbamate inhibited MCP-1-dependent IL-6 and ICAM-1 synthesis, suggesting the involvement of Gi-proteins, protein kinase C, intracellular Ca(2+), and nuclear factor-kappaB (NF-kappaB) in MCP-1 signaling. Using electrophoretic gel mobility shift assay, we observed that MCP-1 stimulated binding activity of NF-kappaB. Binding activity of the activator protein-1 (AP-1), which has been implicated to regulate induction of the IL-6 gene together with NF-kappaB, was also stimulated by MCP-1. In the present experiments, NF-kappaB and AP-1 were involved in the MCP-1-mediated induction of IL-6, as demonstrated by cis element double-stranded (decoy) oligonucleotides (ODN). In contrast to IL-6 release, MCP-1-induced ICAM-1 expression was predominantly dependent on NF-kappaB activation. These results document for the first time that MCP-1 induces an inflammatory response in human TECs. This may be an important new mechanism in the pathogenesis of tubulointerstitial inflammation.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9043cfbd-8c01-49a5-8201-f410df795aa5",
        "_rev": "_WpvYGJC-_g",
        "nanopub": {
            "id": "9043cfbd-8c01-49a5-8201-f410df795aa5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r>0.80",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "discovery (14 active/inactive LN, 8 HC) and validation (28 active/inactive LN, 9 HC)",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "27211902",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(MESH:\"Ferritins\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                }
            ],
            "evidence": "Most importantly, four serum proteins (AXL, Ferritin, Angiostatin, and sTNFRII) had the capacity to distinguish active LN from inactive disease with ROC AUC exceeding 80%, all with p < 0.01 significance (Table 3).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "647a25a9-171e-4f79-9969-fd57e30b856e",
        "_rev": "_WpvYGJ--CC",
        "nanopub": {
            "id": "647a25a9-171e-4f79-9969-fd57e30b856e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "a cohort of egyptian patients: 70 juvenile patients with systemic lupus erythematosus (mean age, 13.0 \u00b1 4.2 years). Ninety age- and sex-matched children served as a controls",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "22057071",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNF)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "The mean serum TNF-alpha was significantly higher in the SLE patients compared to controls (P < .001).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "68f2b305-4378-4747-923b-58e0bc644e2c",
        "_rev": "_WpvYGJ--_G",
        "nanopub": {
            "id": "68f2b305-4378-4747-923b-58e0bc644e2c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "8 young and 8 older healthy volunteers",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "22882710",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"L. reuteri NCIMB 11951\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL10)"
                }
            ],
            "evidence": "There was a significant effect of age on the production of IL-6 (P\u00a0< 0.05), IFN-\u03b3 (P\u00a0< 0.01) and RANTES (P\u00a0< 0.001), and of probiotics (P\u00a0< 0.001) on production of IL-1\u03b2, IFN-\u03b3, IL-6, IL-10, GM-CSF and RANTES (Figs\u00a05\u00a0and\u00a06)\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ff90f679-5b25-4f0b-aab0-cf80b67e8c0a",
        "_rev": "_WpvYGJG-BD",
        "nanopub": {
            "id": "ff90f679-5b25-4f0b-aab0-cf80b67e8c0a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.42",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CXCL11)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e9010c31-8b8e-4126-b8fc-a954f19b0386",
        "_rev": "_WpvYGJC--E",
        "nanopub": {
            "id": "e9010c31-8b8e-4126-b8fc-a954f19b0386",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:liver",
                    "label": "liver",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Diabetes Mellitus, Experimental\"",
                    "label": "Diabetes Mellitus, Experimental",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "24755741",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "\ta(MESH:\"Diabetes Mellitus, Experimental\")",
                    "relation": "increases",
                    "object": "ma(p(HGNC:AMPD2))"
                }
            ],
            "evidence": "However, AMPD activity, determined by measuring the formation of ammonia from AMP, was significantly higher in the livers of diabetic mice (Fig. 1E), documenting that the loss of pAMPK in these mice is associated with increased activity of AMPD.",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5f012619-b728-420f-9c8b-7851e8a0b7ff",
        "_rev": "_WpvYGJC-BP",
        "nanopub": {
            "id": "5f012619-b728-420f-9c8b-7851e8a0b7ff",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "15 young and 15 old males",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "FACS",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:\"CD8-Positive T-Lymphocytes\"",
                    "label": "CD8-Positive T-Lymphocytes",
                    "type": "Cell"
                },
                {
                    "id": "MESH:\"CD4-Positive T-Lymphocytes\"",
                    "label": "CD4-Positive T-Lymphocytes",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9469419",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(GO:aging)",
                    "relation": "increases",
                    "object": "surf(p(HGNC:FAS))"
                }
            ],
            "evidence": "Figure 1\u21d3\u00a0shows a significantly higher (p\u00a0< 0.001) proportion of CD4+\u00a0and CD8+\u00a0T cells from aging subjects expressed Fas (percentage of mean \u00b1 SD: CD4+, 45 \u00b1 7; CD8+, 56 \u00b1 7) as compared with young subjects (percentage of mean \u00b1 SD: CD4+, 29 \u00b1 5; CD8+, 35 \u00b1 5).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0175dd93-0196-401b-a2a5-c6e67bfc8dc3",
        "_rev": "_WpvYGJ--AK",
        "nanopub": {
            "id": "0175dd93-0196-401b-a2a5-c6e67bfc8dc3",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Frob\u00f8se, Helle",
                    "R\u00f8nn, Sif Groth",
                    "Heding, Peter E",
                    "Mendoza, Heidi",
                    "Cohen, Philip",
                    "Mandrup-Poulsen, Thomas",
                    "Billestrup, Nils"
                ],
                "comments": "NR2C2=TAK1\nIKBKB=IKK",
                "database": {
                    "id": "16543409",
                    "name": "PubMed"
                },
                "source_name": "Molecular endocrinology (Baltimore, Md.)",
                "title": "Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex.",
                "abstract": "IL-1 plays a major role in inflammation and autoimmunity through activation of nuclear factor kappa B (NFkappaB) and MAPKs. Although a great deal is known about the mechanism of activation of NFkappaB and MAPKs by IL-1, much less is known about the down-regulation of this pathway. Suppressor of cytokine signaling (SOCS)-3 was shown to inhibit IL-1-induced transcription and activation of NFkappaB and the MAPKs JNK and p38, but the mechanism is unknown. We show here that SOCS-3 inhibits NFkappaB-dependent transcription induced by overexpression of the upstream IL-1 signaling molecules MyD88, IL-1R-activated kinase 1, TNF receptor-associated factor (TRAF)6, and TGFbeta-activated kinase (TAK)1, but not when the MAP3K MAPK/ERK kinase kinase-1 is used instead of TAK1, indicating that the target for SOCS-3 is the TRAF6/TAK1 signaling complex. By coimmunoprecipitation, it was shown that SOCS-3 inhibited the association between TRAF6 and TAK1 and that SOCS-3 coimmunoprecipitated with TAK1 and TRAF6. Furthermore, SOCS-3 inhibited the IL-1-induced catalytic activity of TAK1. Because ubiquitination of TRAF6 is required for activation of TAK1, we analyzed the role of SOCS-3 on TRAF6 ubiquitination and found that SOCS-3 inhibited ubiquitin modification of TRAF6. These results indicate that SOCS-3 inhibits IL-1 signal transduction by inhibiting ubiquitination of TRAF6, thus preventing association and activation of TAK1."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:NFKBIA, pmod(ph))",
                    "relation": "decreases",
                    "object": "complex(p(HGNC:NFKBIA), p(HGNC:NFKB1),p(HGNC:RELA))"
                },
                {
                    "subject": "complex(p(HGNC:IKBKB), p(HGNC:IKBKG), pmod(ph))",
                    "relation": "increases",
                    "object": "p(HGNC:NFKBIA, pmod(ph))"
                },
                {
                    "subject": "p(HGNC:NR2C2)",
                    "relation": "increases",
                    "object": "complex(p(HGNC:IKBKB), p(HGNC:IKBKG), pmod(ph))"
                }
            ],
            "evidence": "The TRAF6/TAK1/TAB1/TAB2 complex translocates to the cytosol, where it binds to the ubiquitin ligases Ubc13 and Uev1A (Fig. 1, step 4). This leads to the ubiquitination of TRAF6, triggering activation of TAK1 (7), which then phosphorylates the I\u03baB kinase (IKK) complex (Fig. 1, step 5). IKK phosphorylates I\u03baB, a cytosolic inhibitory protein that retains the transcription factor NF\u03baB in the cytoplasm (Fig. 1, step 6). Once phosphorylated, I\u03baB dissociates from its complex with NF\u03baB (Fig. 1, step 7) and is rapidly degraded by the proteasome (3, 8). The dissociation allows NF\u03baB to translocate to the nucleus and bind to various promoters whereby transcription is initiated (Fig. 1, step 8)\u00a0",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "IL-1 plays a major role in inflammation and autoimmunity through activation of nuclear factor kappa B (NFkappaB) and MAPKs. Although a great deal is known about the mechanism of activation of NFkappaB and MAPKs by IL-1, much less is known about the down-regulation of this pathway. Suppressor of cytokine signaling (SOCS)-3 was shown to inhibit IL-1-induced transcription and activation of NFkappaB and the MAPKs JNK and p38, but the mechanism is unknown. We show here that SOCS-3 inhibits NFkappaB-dependent transcription induced by overexpression of the upstream IL-1 signaling molecules MyD88, IL-1R-activated kinase 1, TNF receptor-associated factor (TRAF)6, and TGFbeta-activated kinase (TAK)1, but not when the MAP3K MAPK/ERK kinase kinase-1 is used instead of TAK1, indicating that the target for SOCS-3 is the TRAF6/TAK1 signaling complex. By coimmunoprecipitation, it was shown that SOCS-3 inhibited the association between TRAF6 and TAK1 and that SOCS-3 coimmunoprecipitated with TAK1 and TRAF6. Furthermore, SOCS-3 inhibited the IL-1-induced catalytic activity of TAK1. Because ubiquitination of TRAF6 is required for activation of TAK1, we analyzed the role of SOCS-3 on TRAF6 ubiquitination and found that SOCS-3 inhibited ubiquitin modification of TRAF6. These results indicate that SOCS-3 inhibits IL-1 signal transduction by inhibiting ubiquitination of TRAF6, thus preventing association and activation of TAK1.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3333a1a7-1974-4f67-bbe5-c54bdc70b9e1",
        "_rev": "_WpvYGJ--Ab",
        "nanopub": {
            "id": "3333a1a7-1974-4f67-bbe5-c54bdc70b9e1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"B cell\"",
                    "label": "B cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Thymidine Incorporation",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9233608",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "increases",
                    "object": "bp(GO:\"B cell differentiation\")"
                }
            ],
            "evidence": "The proliferative responses of both normal and xid B cells were substantially to completely blocked by anti-IFN-y, only slightly suppressed by anti-IL-2, and unaffected by anti-IL-4.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "50204136-2c61-4e4c-b894-fda7c02443a5",
        "_rev": "_WpvYGJ--CG",
        "nanopub": {
            "id": "50204136-2c61-4e4c-b894-fda7c02443a5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "mouse",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "database": {
                    "id": "10358188",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:neutrophil)",
                    "relation": "increases",
                    "object": "sec(p(HGNC:TNF))"
                }
            ],
            "evidence": "We also found that STAg stimulated production of TNF-a from the PMN.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e58e575c-ab49-4662-af43-0d82aedaeef3",
        "_rev": "_WpvYGJG-_5",
        "nanopub": {
            "id": "e58e575c-ab49-4662-af43-0d82aedaeef3",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:fibroblast",
                    "label": "fibroblast",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:\"synovial membrane of synovial joint\"",
                    "label": "synovial membrane of synovial joint",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "7499828",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17)",
                    "relation": "increases",
                    "object": "p(HGNC:IL8)"
                },
                {
                    "subject": "p(HGNC:IL17)",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "Purified hlL-17.Fc proteins induced IL-6 and IL-8 production in a dose-dependent manner (Fig. 3, A and C), while the control Fc did not.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e285de93-a718-4b8f-a198-218e688f7031",
        "_rev": "_WpvYGJG-BC",
        "nanopub": {
            "id": "e285de93-a718-4b8f-a198-218e688f7031",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Chromatin Precipitation",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"CD4-positive helper T cell\"",
                    "label": "CD4-positive helper T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16698929",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT3)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:IL17F)"
                },
                {
                    "subject": "p(HGNC:STAT3)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:IL17)"
                }
            ],
            "evidence": "Using CD4+\u00a0T cells from\u00a0CreMMTV\u00a0Socs3fl/fl\u00a0mice and wild-type littermate controls, we found that Stat3 bound to both\u00a0IL-17A\u00a0and\u00a0IL17F\u00a0promoters (Fig. 3e).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4b84865a-84d5-4950-8654-07401e00be8f",
        "_rev": "_WpvYGJ--AE",
        "nanopub": {
            "id": "4b84865a-84d5-4950-8654-07401e00be8f",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "32 healthy donors",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CL:monocyte",
                    "label": "monocyte",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9531313",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17)",
                    "relation": "increases",
                    "object": "act(p(HGNC:AP1), ma(GO:\"DNA binding\"))"
                },
                {
                    "subject": "p(HGNC:IL17)",
                    "relation": "increases",
                    "object": "act(complex(HGNC:\"NFkb complex\"), ma(GO:\"DNA binding\"))"
                }
            ],
            "evidence": "Indeed, IL-17 affected the level of nuclear DNA-binding proteins, recognizing the\u00a032P-labeled NF-\u03baB (identical to Ig enhancer NF-\u03baB site) oligonucleotide in a complex fashion.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e153d597-351b-4abd-8c70-2e7b167e2356",
        "_rev": "_WpvYGJG-Af",
        "nanopub": {
            "id": "e153d597-351b-4abd-8c70-2e7b167e2356",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.0038",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "77 SLE, 22 disease controls, 28 HC",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "15880830",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:IFI44)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "r(HGNC:IFIT1)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "r(EG:5610)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "We recorded all of these putative measures of lupus disease activity in our patients and found that all were significantly associated with a high IFN\u03b1 score (Figures 3A\u2013D), except for the CRP level, which, in contrast to the ESR, showed a trend toward increased production in the IFN\u03b1 low-score group (Table 2). \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "90f0f34f-8cb8-4730-b23d-4ea46a446a06",
        "_rev": "_WpvYGJG-Ap",
        "nanopub": {
            "id": "90f0f34f-8cb8-4730-b23d-4ea46a446a06",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.45",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:GDNF)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b157ecfe-f2c2-45f1-a179-54d0a3e28b23",
        "_rev": "_WpvYGJC-B-",
        "nanopub": {
            "id": "b157ecfe-f2c2-45f1-a179-54d0a3e28b23",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18993086",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT4)",
                    "relation": "increases",
                    "object": "r(HGNC:TBX21)"
                }
            ],
            "evidence": "We did observe a modest decrease in T-bet expression in the absence of Stat4, and expression levels were not recovered by the addition of IFN\u03b3.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "fae119ea-dcbd-4821-b777-f9046e0f9b11",
        "_rev": "_WpvYGJC-Bs",
        "nanopub": {
            "id": "fae119ea-dcbd-4821-b777-f9046e0f9b11",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"B cell\"",
                    "label": "B cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12446913",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL21)",
                    "relation": "increases",
                    "object": "p(\"IgG1\")"
                }
            ],
            "evidence": "Despite similar survival, at day 100 in the IL-21R\u2013/\u2013 mice, serum IgG1 was about one third that seen in wild-type mice (Fig. 1E, left), whereas IgE was increased about 20- to 25-fold (Fig. 1E, right)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "47b18231-36b6-4067-ae29-25fb0934115a",
        "_rev": "_WpvYGJ--Cq",
        "nanopub": {
            "id": "47b18231-36b6-4067-ae29-25fb0934115a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "EMSA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "n=19",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "16433741",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:ethanol)",
                    "relation": "decreases",
                    "object": "act(complex(p(HGNC:NFKB1),p(HGNC:NFKB2)), ma(tscript)))"
                }
            ],
            "evidence": "However, 18 hours after alcohol intake, NF-kB binding was reduced in LPS-stimulated monocytes (po0.01) compared with NF-kB activation prior to alcohol intake.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "feb7f79d-e26f-4c1c-92ba-cc094c983468",
        "_rev": "_WpvYGJ--CQ",
        "nanopub": {
            "id": "feb7f79d-e26f-4c1c-92ba-cc094c983468",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16172258",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL2)",
                    "relation": "increases",
                    "object": "r(HGNC:IL4)"
                }
            ],
            "evidence": "Adding anti\u2013IL-2 and anti-CD25 to cells that were cultured under neutral conditions completely inhibited the early (24 h) appearance of IL-4 mRNA but had no inhibitory effect on early GATA-3 mRNA (Fig. 2\u00a0C) or protein expression (not depicted).\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2189f3b1-596c-4eaf-a03a-bc18e4670df5",
        "_rev": "_WpvYGJG-_u",
        "nanopub": {
            "id": "2189f3b1-596c-4eaf-a03a-bc18e4670df5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "31 persons from families harboring PSEN1 or APP mutations",
                    "type": "Cohort"
                },
                {
                    "id": "DO:\"Alzheimer's disease\"",
                    "label": "Alzheimer's disease",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Ringman, John M",
                    "Fithian, Andrew T",
                    "Gylys, Karen",
                    "Cummings, Jeffrey L",
                    "Coppola, Giovanni",
                    "Elashoff, David",
                    "Pratico, Domenico",
                    "Moskovitz, Jackob",
                    "Bitan, Gal"
                ],
                "database": {
                    "id": "22584618",
                    "name": "PubMed"
                },
                "source_name": "Dementia and geriatric cognitive disorders",
                "title": "Plasma methionine sulfoxide in persons with familial Alzheimer's disease mutations.",
                "abstract": "Convergent evidence suggests that oxidative stress plays a central role in the pathology of Alzheimer's disease (AD). We asked if consequently, oxidation of methionine residues to methionine sulfoxide (MetO) was increased in plasma proteins of persons carrying familial AD (FAD) mutations.",
                "date_published": "2012-01-01"
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"methionine S-oxide\")",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:SOD1)"
                }
            ],
            "evidence": "In a subset of subjects for whom both measurements were available, MetO levels correlated well with plasma F2-isoprostane (r = 0.81, p < 0.001) and superoxide dismutase 1 (r = 0.52, p = 0.004) levels.",
            "metadata": {
                "gd:abstract": "Convergent evidence suggests that oxidative stress plays a central role in the pathology of Alzheimer's disease (AD). We asked if consequently, oxidation of methionine residues to methionine sulfoxide (MetO) was increased in plasma proteins of persons carrying familial AD (FAD) mutations.",
                "gd:creator": "vhoang@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d9a9ea3c-8ae0-43e6-a769-656e6c79c60e",
        "_rev": "_WpvYGJ---q",
        "nanopub": {
            "id": "d9a9ea3c-8ae0-43e6-a769-656e6c79c60e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "",
                    "label": "FACS",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"B cell\"",
                    "label": "B cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18656702",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite(p(HGNC:IL4), p(HGNC:IL21))",
                    "relation": "increases",
                    "object": "bp(GO:\"B cell differentiation\")"
                }
            ],
            "evidence": "As shown in Fig. 1A, percentages of IgG1+ B cells in the culture with IL-4 and IL-21 were more than those with IL-4 on day 3 and day 4 of culture. However, IgG1+ B cells were hardly detected in the culture without IL-4.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "df56c492-114f-4d92-9ef1-d10985c7a1b2",
        "_rev": "_WpvYGJ--AV",
        "nanopub": {
            "id": "df56c492-114f-4d92-9ef1-d10985c7a1b2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"B cell\"",
                    "label": "B cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Gel Electrophoresis, DPA reaction, Flow cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8376764",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:PKC)",
                    "relation": "decreases",
                    "object": "bp(GO:\"apoptotic process\")"
                }
            ],
            "evidence": "Treatment with PMA produced a decrease in DNA fragmentation by the DPAmethod (p < 0.01; Fig. 5A), by flow cytometry (Fig. 4), and by gel electrophoresis (Fig. 5B), whereas no change from unstimulated cultures (NS) was observed with the inactive analogue 4aPDD (Fig. 5A)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bf8ea460-aaa3-4229-b867-7057c4099449",
        "_rev": "_WpvYGJ--Cf",
        "nanopub": {
            "id": "bf8ea460-aaa3-4229-b867-7057c4099449",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "31 persons from families harboring PSEN1 or APP mutations",
                    "type": "Cohort"
                },
                {
                    "id": "DO:\"Alzheimer's disease\"",
                    "label": "Alzheimer's disease",
                    "type": "Disease"
                }
            ],
            "citation": {
                "authors": [
                    "Ringman, John M",
                    "Fithian, Andrew T",
                    "Gylys, Karen",
                    "Cummings, Jeffrey L",
                    "Coppola, Giovanni",
                    "Elashoff, David",
                    "Pratico, Domenico",
                    "Moskovitz, Jackob",
                    "Bitan, Gal"
                ],
                "database": {
                    "id": "22584618",
                    "name": "PubMed"
                },
                "source_name": "Dementia and geriatric cognitive disorders",
                "title": "Plasma methionine sulfoxide in persons with familial Alzheimer's disease mutations.",
                "abstract": "Convergent evidence suggests that oxidative stress plays a central role in the pathology of Alzheimer's disease (AD). We asked if consequently, oxidation of methionine residues to methionine sulfoxide (MetO) was increased in plasma proteins of persons carrying familial AD (FAD) mutations."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"methionine S-oxide\")",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:F2-Isoprostanes)"
                }
            ],
            "evidence": "In a subset of subjects for whom both measurements were available, MetO levels correlated well with plasma F2-isoprostane (r = 0.81, p < 0.001) and superoxide dismutase 1 (r = 0.52, p = 0.004) levels.",
            "metadata": {
                "gd:abstract": "Convergent evidence suggests that oxidative stress plays a central role in the pathology of Alzheimer's disease (AD). We asked if consequently, oxidation of methionine residues to methionine sulfoxide (MetO) was increased in plasma proteins of persons carrying familial AD (FAD) mutations.",
                "gd:creator": "vhoang@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "47cb6cf0-5fdc-47fa-b297-ac546c52fa9c",
        "_rev": "_WpvYGJC-_F",
        "nanopub": {
            "id": "47cb6cf0-5fdc-47fa-b297-ac546c52fa9c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "MESH:Sepsis",
                    "label": "Sepsis",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "abstract": "No Abstract Loaded.",
                "database": {
                    "id": "12615625",
                    "name": "PubMed"
                }
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "sec(p(SP:P10145))"
                },
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IL6))"
                },
                {
                    "subject": "a(MESH:\"Fish Oils\")\t",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IL1B))"
                },
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:TNF))"
                }
            ],
            "evidence": "During n-3 lipid infusion, release of these cytokines decreased by approximately 30%.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4de08111-e4de-45f6-adfa-7f052ff0f3ea",
        "_rev": "_WpvYGJ--Bk",
        "nanopub": {
            "id": "4de08111-e4de-45f6-adfa-7f052ff0f3ea",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "87 SLE (41 with history of thrombosis)",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12559629",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"IgG anti-beta2-GPI\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:Thrombosis)"
                }
            ],
            "evidence": "Thrombosis was significantly associated with IgG-aPA (p = 0.044), IgG-aPI (p = 0.038), IgG-aPS (p = 0.026), IgG-abeta(2)-GPI, IgM-aPA (p = 0.044), IgM-aPI (p = 0.024), and IgM-aPS (p = 0.01), irrespective of antibody titer, whereas IgG-aCL were associated with thrombosis and thrombocytopenia when taken at medium-high titer (p = 0.009 and p = 0.046, respectively).\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "243bce4c-9eb6-4185-abf5-4f8db763785d",
        "_rev": "_WpvYGJ--Bl",
        "nanopub": {
            "id": "243bce4c-9eb6-4185-abf5-4f8db763785d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:ICAM1)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": " In addition, levels of plasma IP-10, MCP-1 and MCP-3 (Figure 2D), along with IL-8 and ICAM-1 (Supplementary Figure 2H), were significantly elevated in pre-flare periods compared to periods of stable disease.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "18ed6136-ebcc-4f74-b2f0-6b6b897fcfda",
        "_rev": "_WpvYGJC-_9",
        "nanopub": {
            "id": "18ed6136-ebcc-4f74-b2f0-6b6b897fcfda",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "AE7",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "16275766",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TBX21, pmod(Ph, S, 508))",
                    "relation": "decreases",
                    "object": "r(HGNC:IL2)"
                }
            ],
            "evidence": "However, the mutation of S508 to alanine abolished the ability of T-bet to repress the expression of both mRNA transcripts encoding IL-2 and IL-2 protein (Fig. 3, E and F).\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3464465c-e367-4783-854c-8926cb4ee223",
        "_rev": "_WpvYGJ---W",
        "nanopub": {
            "id": "3464465c-e367-4783-854c-8926cb4ee223",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "EMSA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Helicobacter Infections\"",
                    "label": "Helicobacter Infections",
                    "type": "Disease"
                },
                {
                    "id": "CLO:\"MKN-45 cell\"",
                    "label": "MKN-45 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "18347582",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"L. acidophilus ATCC 832\")",
                    "relation": "decreases",
                    "object": "act(complex(p(HGNC:NFKB1),p(HGNC:NFKB2)), ma(tscript))"
                }
            ],
            "evidence": "As shown in Figure 4b, H. pylori activated NF-kB signals and the addition of CM containing CLA suppressed the NF-kB activation in MKN-45 cells.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d7a34295-ff33-4181-b7e9-d47597c64352",
        "_rev": "_WpvYGJG-Be",
        "nanopub": {
            "id": "d7a34295-ff33-4181-b7e9-d47597c64352",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Thymidine Incorporation",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "2117636",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite(p(HGNC:IL2), p(HGNC:IL4))",
                    "relation": "increases",
                    "object": "bp(GO:\"T helper 2 cell differentiation\")"
                }
            ],
            "evidence": "Both IL-2 and IL4 were essential for the appearance of cells that could produce IL4 in response to restimulation with anti-CD3 plus IL-2 .\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "20f7f328-cc04-427d-84e4-5a63ab641900",
        "_rev": "_WpvYGJC-CT",
        "nanopub": {
            "id": "20f7f328-cc04-427d-84e4-5a63ab641900",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"70Z/3 cell\"",
                    "label": "70Z/3 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "11057907",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite (p(HGNC:TRAF6), p(HGNC:Nemo))",
                    "relation": "increases",
                    "object": "p(HGNC:IKBKA), pmod(Ph))"
                }
            ],
            "evidence": "As shown in\u00a0Figure 1A, addition of recombinant TRAF6 to cell extracts prepared from 70Z pre-B cells led to the phosphorylation of endogenous I\u03baB\u03b1 that could be detected with a phospho-I\u03baB\u03b1-specific antibody (lane 2). This reaction is strictly dependent on NEMO, since cell extracts prepared from 1.3E2, a NEMO-deficient line derived from 70Z cells (Courtois et al. 1997), failed to phosphorylate I\u03baB\u03b1 in the presence of TRAF6 (lane 5)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "dedf882a-b5a9-4dbd-8502-235a957e1db1",
        "_rev": "_WpvYGJ---R",
        "nanopub": {
            "id": "dedf882a-b5a9-4dbd-8502-235a957e1db1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "132 Hispanic MS patients and 60 controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "19321461",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"D3 vitamins\")",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IL17A))"
                },
                {
                    "subject": "a(CHEBI:\"D3 vitamins\")",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL10))"
                }
            ],
            "evidence": "1,25 (OH)2\u00a0Vitamin D increases the development of IL-10 secreting cells and down-regulates the number of IL-6 and L-17 secreting cells.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2807f2bc-3370-430f-8ff6-eba7626a3bbe",
        "_rev": "_WpvYGJG-Bm",
        "nanopub": {
            "id": "2807f2bc-3370-430f-8ff6-eba7626a3bbe",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "EMSA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"embryonic fibroblast\"",
                    "label": "embryonic fibroblast",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10748240",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17)",
                    "relation": "increases",
                    "object": "complex(HGNC:\"NFKB complex\")"
                }
            ],
            "evidence": "\u00a0In wild-type cells, NF-\u03baB activation was detected 10 min after IL-17 treatment\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4257fd71-4e9b-42fd-a6ef-6e41a6036338",
        "_rev": "_WpvYGJ--_D",
        "nanopub": {
            "id": "4257fd71-4e9b-42fd-a6ef-6e41a6036338",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "FACS",
                    "type": "Methodology"
                },
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10914499",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:neutrophil)",
                    "relation": "increases",
                    "object": "p(HGNC:IL4)"
                }
            ],
            "evidence": "To further support IL\u20104 expression by neutrophils, cells were cultured for 18 h in the presence of Brefeldin A, a compound known to inhibit the intracellular protein transport and thus secretion. When submitted to intracellular IL\u20104 staining, two subpopulations of IL\u20104\u2010producing neutrophils could be distinguished: one containing small amounts of IL\u20104 and the other, more heterogeneous, presenting intracellular IL\u20104 accumulation\u00a0(Fig. 1B).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b98a1daf-d163-43da-af5a-0fae6c6c2f5d",
        "_rev": "_WpvYGJG--i",
        "nanopub": {
            "id": "b98a1daf-d163-43da-af5a-0fae6c6c2f5d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "EFO:HEK293",
                    "label": "HEK293",
                    "type": "CellLine"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Rutz, Mark",
                    "Metzger, Jochen",
                    "Gellert, Tanja",
                    "Luppa, Peter",
                    "Lipford, Grayson B",
                    "Wagner, Hermann",
                    "Bauer, Stefan"
                ],
                "database": {
                    "id": "15307186",
                    "name": "PubMed"
                },
                "source_name": "European journal of immunology",
                "title": "Toll-like receptor 9 binds single-stranded CpG-DNA in a sequence- and pH-dependent manner.",
                "abstract": "Toll-like receptors (TLR) recognize bacterial and viral components, but direct interaction of receptor and ligand is unclear. Here, we demonstrate that TLR9 binds directly and sequence-specifically to single-stranded unmethylated CpG-DNA containing a phosphodiester backbone. TLR9-CpG-DNA interaction occurs at the acidic pH (6.5-5.0) found in endosomes and lysosomes. By sequence comparison we identified a potential CpG-DNA binding domain homologous to that described for methyl-CpG-DNA binding proteins. Amino acid substitutions in this region abrogated CpG-DNA binding and led to loss of NF-kappaB activation. Furthermore, chloroquine and quinacrine, therapeutic agents for autoimmune diseases like rheumatoid arthritis and systemic lupus erythematosus, directly blocked TLR9-CpG-DNA interaction but not TLR2-Pam3Cys binding. Our results demonstrate direct binding of TLR9 to CpG-DNA and suggest that the therapeutic activity of chloroquine and quinacrine in autoimmune diseases may be due to its activity as a TLR9 antagonist and inhibitor of endosomal acidification."
            },
            "assertions": [
                {
                    "subject": "a(CpG DNA)",
                    "relation": "directlyIncreases",
                    "object": "act(p(HGNC:TLR9))"
                }
            ],
            "evidence": "Here, we demonstrate that TLR9 binds directly and sequence-specifically to single-stranded unmethylated CpG-DNA containing a phosphodiester backbone. TLR9-CpG-DNA interaction occurs at the acidic pH (6.5-5.0) found in endosomes and lysosomes. By sequence comparison we identified a potential CpG-DNA binding domain homologous to that described for methyl-CpG-DNA binding proteins. Amino acid substitutions in this region abrogated CpG-DNA binding and led to loss of NF-kappaB activation.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0961586d-b1c6-445a-877e-fadc96be54f6",
        "_rev": "_WpvYGJ--AI",
        "nanopub": {
            "id": "0961586d-b1c6-445a-877e-fadc96be54f6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "11581400",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL7)",
                    "relation": "increases",
                    "object": "bp(GO:\"T cell proliferation\")"
                }
            ],
            "evidence": "As can be observed in Fig.\u00a0\u200bFig.1,1, IL-7 induced the proliferation of T cells at 10 ng/ml (stimulation index = 11) and boosted PHA- and IL-2-induced cell proliferation activity in vitro, confirming a known property of this cytokine.\u00a0\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "832f97cb-ca29-41dd-926a-c2c0ce6f763a",
        "_rev": "_WpvYGJG-B5",
        "nanopub": {
            "id": "832f97cb-ca29-41dd-926a-c2c0ce6f763a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "comments": "no full text\n",
                "database": {
                    "id": "8167346",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL10)",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:TNF))"
                },
                {
                    "subject": "p(HGNC:IL10)",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IL1B))"
                },
                {
                    "subject": "p(HGNC:IL10)",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IL8))"
                }
            ],
            "evidence": "IL-10 inhibited the production of IL-1 alpha, IL-1 beta, IL-8, and TNF-alpha in LPS-stimulated PMNs, as it did in human blood mononuclear cell (MNC) preparations enriched in monocytes\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5334a956-db8c-4af0-bdc7-0b3fa46fff5b",
        "_rev": "_WpvYGJG--m",
        "nanopub": {
            "id": "5334a956-db8c-4af0-bdc7-0b3fa46fff5b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "p=0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=16",
                    "type": "Cohort"
                },
                {
                    "id": "MESH:\"Crohn Disease\"",
                    "label": "Crohn Disease",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "authors": [
                    "Chiba, Mitsuro",
                    "Abe, Toru",
                    "Tsuda, Hidehiko",
                    "Sugawara, Takeshi",
                    "Tsuda, Satoko",
                    "Tozawa, Haruhiko",
                    "Fujiwara, Katsuhiko",
                    "Imai, Hideo"
                ],
                "database": {
                    "id": "20503448",
                    "name": "PubMed"
                },
                "source_name": "World journal of gastroenterology",
                "title": "Lifestyle-related disease in Crohn's disease: relapse prevention by a semi-vegetarian diet.",
                "abstract": "To investigate whether semi-vegetarian diet (SVD) has a preventive effect against relapse of Crohn's disease (CD) in patients who have achieved remission, who are a high-risk group for relapse."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Diet, Vegetarian\")",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:CRP)"
                }
            ],
            "evidence": "The concentration of CRP also significantly decreased from 4.0 \u00b1 3.9 to 0.2 \u00b1 0.3 mg/dL (P\u00a0= 0.001)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation",
                "gd:abstract": "To investigate whether semi-vegetarian diet (SVD) has a preventive effect against relapse of Crohn's disease (CD) in patients who have achieved remission, who are a high-risk group for relapse."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a1f6ec33-142d-4c27-99f0-7a9f76c24518",
        "_rev": "_WpvYGJC--s",
        "nanopub": {
            "id": "a1f6ec33-142d-4c27-99f0-7a9f76c24518",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "0.660",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "IEMA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "42 enrolled patients had a mean age of 37.7 \u00b1 13.1 years, 88% were female and 67% Caucasians",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "22811690",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:B2M)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "S\u03b22M showed a stronger correlation with SLEDAI-2K (r = 0.660, p = 0.000) than S\u03b22M/SCysC (r = 0.180, p = 0.140).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2a527210-10ef-49e0-ad57-b1753061e457",
        "_rev": "_WpvYGJG-_0",
        "nanopub": {
            "id": "2a527210-10ef-49e0-ad57-b1753061e457",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Rinc\u00f3n, M",
                    "Anguita, J",
                    "Nakamura, T",
                    "Fikrig, E",
                    "Flavell, R A"
                ],
                "database": {
                    "id": "9053446",
                    "name": "PubMed"
                },
                "source_name": "The Journal of experimental medicine",
                "title": "Interleukin (IL)-6 directs the differentiation of IL-4-producing CD4+ T cells.",
                "abstract": "Interleukin (IL)-4 is the most potent factor that causes naive CD4+ T cells to differentiate to the T helper cell (Th) 2 phenotype, while IL-12 and interferon gamma trigger the differentiation of Th1 cells. However, the source of the initial polarizing IL-4 remains unclear. Here, we show that IL-6, probably secreted by antigen-presenting cells, is able to polarize naive CD4+ T cells to effector Th2 cells by inducing the initial production of IL-4 in CD4+ T cells. These results show that the nature of the cytokine (IL-12 or IL-6), which is produced by antigen-presenting cells in response to a particular pathogen, is a key factor in determining the nature of the immune response."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "increases",
                    "object": "a(MESH:\"Th2 Cells\")"
                }
            ],
            "evidence": "we show that IL-6 is able to initiate the polarization of naive CD4+ T cells to effector Th2 cells by inducing the production of endogenous IL-4. In addition, IL-6 also antagonizes the IL-12\u2013 mediated differentiation of Th1 cells. We postulate that IL-6 is a key factor in the choice between a Th1 or Th2 immune response.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "384be3ac-b3df-4094-9b3e-b401d4ff643f",
        "_rev": "_WpvYGJ--B2",
        "nanopub": {
            "id": "384be3ac-b3df-4094-9b3e-b401d4ff643f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.488",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n 6 patients with chronic active hepatitis (CAH) [3 females and 3 males: mean age = 51 f 3 yr (S.E.)], 11 patients with liver cirrhosis (LC) (6 females and 5 males: mean age = 61 f 3 years) and 5 patients with hepatocellular carcinoma (HCC) (5 males: mean age = 57 * 6 years), all of whom had an underlying cirrhosis, and 3 other patients with cholelithiasis (male, 39 years), obstructive jaundice due to bile duct cancer (male, 69 years) and chronic pancreatitis (male, 47 years). As normal controls, 12 healthy volunteers (6 females and 6 males: mean age = 38 f 3 years) were used",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "HPLC",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "3356409",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:pipecolic acid)",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:bilirubin)"
                }
            ],
            "evidence": "Similar positive correlations were found when plasma levels of pipecolic acid were correlated with bile acid (r = 0.506; p < 0.05) and with bilirubin (r = 0.488; p < 0.05).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3d00d02b-3312-48ed-a82d-bdc008b6201f",
        "_rev": "_WpvYGJC-_n",
        "nanopub": {
            "id": "3d00d02b-3312-48ed-a82d-bdc008b6201f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Ghosh, Chandra C",
                    "Ramaswami, Sitharam",
                    "Juvekar, Ashish",
                    "Vu, Hai-Yen",
                    "Galdieri, Luciano",
                    "Davidson, Dennis",
                    "Vancurova, Ivana"
                ],
                "database": {
                    "id": "20696864",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology (Baltimore, Md. : 1950)",
                "title": "Gene-specific repression of proinflammatory cytokines in stimulated human macrophages by nuclear I\u03baB\u03b1.",
                "abstract": "We have previously shown that increased nuclear accumulation of IkappaBalpha inhibits NF-kappaB activity and induces apoptosis in human leukocytes. In this study, we wanted to explore the possibility that the nucleocytoplasmic distribution of IkappaBalpha can be used as a therapeutic target for the regulation of NF-kappaB-dependent cytokine synthesis. Treatment of LPS-stimulated human U937 macrophages with an inhibitor of chromosome region maintenance 1-dependent nuclear export, leptomycin B, resulted in the increased nuclear accumulation of IkappaBalpha and inhibition of NF-kappaB DNA binding activity, caused by the nuclear IkappaBalpha-p65 NF-kappaB interaction. Surprisingly, however, whereas mRNA expression and cellular release of TNF-alpha, the beta form of pro-IL-1 (IL-1beta), and IL-6 were inhibited by the leptomycin B-induced nuclear IkappaBalpha, IL-8 mRNA expression and cellular release were not significantly affected. Analysis of in vivo recruitment of p65 NF-kappaB to NF-kappaB-regulated promoters by chromatin immunoprecipitation in U937 cells and human PBMCs indicated that although the p65 recruitment to TNF-alpha, IL-1beta, and IL-6 promoters was inhibited by the nuclear IkappaBalpha, p65 recruitment to IL-8 promoter was not repressed. Chromatin immunoprecipitation analyses using IkappaBalpha and S536 phosphospecific p65 NF-kappaB Abs demonstrated that although the newly synthesized IkappaBalpha induced by postinduction repression is recruited to TNF-alpha, IL-1beta, and IL-6 promoters but not to the IL-8 promoter, S536-phosphorylated p65 is recruited to IL-8 promoter, but not to TNF-alpha, IL-1beta, or IL-6 promoters. Together, these data indicate that the inhibition of NF-kappaB-dependent transcription by nuclear IkappaBalpha in LPS-stimulated macrophages is gene specific and depends on the S536 phosphorylation status of the recruited p65 NF-kappaB."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:NFKBIA)",
                    "relation": "decreases",
                    "object": "p(HGNC:IL1B)"
                },
                {
                    "subject": "p(HGNC:NFKBIA)",
                    "relation": "decreases",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "As shown in Fig. 7, in cells that were not stimulated with LPS,neither p65 nor p50 NF-kB were recruited to TNF-a, IL-1b, IL-6,or IL-8 promoters; this is consistent with the Western data demonstratingthat p65 NF-kB is not present in the nucleus of unstimulatedU937 cells (Fig. 5). However, whereas the p65 NF-kBrecruitment to these promoters in 6-h stimulated cells displayed6\u201315-fold enrichment, depending on the type of the promoter, p50NF-kB enrichment was only 1\u20134-fold. This is in agreement withstudies demonstrating that p50 associates with promoter regionsmainly through p65 NF-kB (5, 6). Interestingly, the lowest p50recruitment in the case of TNF-a and IL-8 promoters (Fig. 7A,7D) was associated with the lower mRNA levels (Fig. 3), suggestingthat mainly p65/65 NF-kB homodimers are recruited in vivo toTNF-a and IL-8 promoters in LPS-stimulated U937 macrophages,and this is associated with a lower level of transcriptional induction.The p50 NF-kB recruitment to IL-1b and IL-6 promoterswas reduced by LMB, similar to the recruitment of p65 NF-kB(Fig. 7B, 7C). Together, these data indicate that in vivo, p50/65NF-kB heterodimers are recruited to IL-1b and IL-6 promoters,and this binding is inhibited in the presence of IkBa.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "We have previously shown that increased nuclear accumulation of IkappaBalpha inhibits NF-kappaB activity and induces apoptosis in human leukocytes. In this study, we wanted to explore the possibility that the nucleocytoplasmic distribution of IkappaBalpha can be used as a therapeutic target for the regulation of NF-kappaB-dependent cytokine synthesis. Treatment of LPS-stimulated human U937 macrophages with an inhibitor of chromosome region maintenance 1-dependent nuclear export, leptomycin B, resulted in the increased nuclear accumulation of IkappaBalpha and inhibition of NF-kappaB DNA binding activity, caused by the nuclear IkappaBalpha-p65 NF-kappaB interaction. Surprisingly, however, whereas mRNA expression and cellular release of TNF-alpha, the beta form of pro-IL-1 (IL-1beta), and IL-6 were inhibited by the leptomycin B-induced nuclear IkappaBalpha, IL-8 mRNA expression and cellular release were not significantly affected. Analysis of in vivo recruitment of p65 NF-kappaB to NF-kappaB-regulated promoters by chromatin immunoprecipitation in U937 cells and human PBMCs indicated that although the p65 recruitment to TNF-alpha, IL-1beta, and IL-6 promoters was inhibited by the nuclear IkappaBalpha, p65 recruitment to IL-8 promoter was not repressed. Chromatin immunoprecipitation analyses using IkappaBalpha and S536 phosphospecific p65 NF-kappaB Abs demonstrated that although the newly synthesized IkappaBalpha induced by postinduction repression is recruited to TNF-alpha, IL-1beta, and IL-6 promoters but not to the IL-8 promoter, S536-phosphorylated p65 is recruited to IL-8 promoter, but not to TNF-alpha, IL-1beta, or IL-6 promoters. Together, these data indicate that the inhibition of NF-kappaB-dependent transcription by nuclear IkappaBalpha in LPS-stimulated macrophages is gene specific and depends on the S536 phosphorylation status of the recruited p65 NF-kappaB.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2f1fc8e5-18ea-4440-b9ac-9143b986d7f6",
        "_rev": "_WpvYGJC-Bd",
        "nanopub": {
            "id": "2f1fc8e5-18ea-4440-b9ac-9143b986d7f6",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "EMSA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"embryonic fibroblast\"",
                    "label": "embryonic fibroblast",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10748240",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17)\t",
                    "relation": "increases",
                    "object": "act(HGNC:JNK, ma(GO:\"Kinase activity\"))"
                }
            ],
            "evidence": "IL-17\u2013 and IL-1\u2013induced JNK activation was abolished in TRAF6 knockout cells but remained intact in TRAF2 knockout cells.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "59e6d11e-a838-4045-8b6c-d3960a6c8a61",
        "_rev": "_WpvYGJG--o",
        "nanopub": {
            "id": "59e6d11e-a838-4045-8b6c-d3960a6c8a61",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"lung endothelial cell\"",
                    "label": "lung endothelial cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16930739",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:SOD1)",
                    "relation": "decreases",
                    "object": "a(bp(MESH:\"Oxidative Stress\"))"
                }
            ],
            "evidence": "In this report, we demonstrated that transient supplementation of SOD1 protects endothelial cells against P. falciparum induced oxidative stress and apoptosis. \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f27e5edd-c3f8-4e6f-95e6-31a1b76478f3",
        "_rev": "_WpvYGJC--m",
        "nanopub": {
            "id": "f27e5edd-c3f8-4e6f-95e6-31a1b76478f3",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=8",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Muscle, Skeletal\"",
                    "label": "Muscle, Skeletal",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "24476467",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Exercise\")",
                    "relation": "positiveCorrelation",
                    "object": "r(HGNC:TNF)"
                }
            ],
            "evidence": "All exercise modes upregulated TNF mRNA expression (Fig. 3B) at 1 h postexercise (RE = 2.7 \u00b1 0.5; AE = 1.8 \u00b1 0.3; CE = 2.5 \u00b1 0.3 (p < 0.05);\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "07841231-493f-4a30-81df-ceaeaed660f7",
        "_rev": "_WpvYGJC-_G",
        "nanopub": {
            "id": "07841231-493f-4a30-81df-ceaeaed660f7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "611 patients",
                    "type": "cohort"
                },
                {
                    "id": "",
                    "label": "<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "HAQ-DI",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Fleischmann, Roy",
                    "Kremer, Joel",
                    "Cush, John",
                    "Schulze-Koops, Hendrik",
                    "Connell, Carol A",
                    "Bradley, John D",
                    "Gruben, David",
                    "Wallenstein, Gene V",
                    "Zwillich, Samuel H",
                    "Kanik, Keith S",
                    ", "
                ],
                "database": {
                    "id": "22873530",
                    "name": "PubMed"
                },
                "source_name": "The New England journal of medicine",
                "title": "Placebo-controlled trial of tofacitinib monotherapy in rheumatoid arthritis.",
                "abstract": "Tofacitinib (CP-690,550) is a novel oral Janus kinase inhibitor that is being investigated as a targeted immunomodulator and disease-modifying therapy for rheumatoid arthritis."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:tofacitinib)\t",
                    "relation": "decreases",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "The reductions from baseline in HAQ-DI scores were greater in the 5-mg and 10-mg tofacitinib groups than in the placebo groups (-0.50 and -0.57 points, respectively, vs. -0.19 points; P<0.001).",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Tofacitinib (CP-690,550) is a novel oral Janus kinase inhibitor that is being investigated as a targeted immunomodulator and disease-modifying therapy for rheumatoid arthritis.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3c1841bd-e160-48ef-9890-e41ce1e63b58",
        "_rev": "_WpvYGJG-A9",
        "nanopub": {
            "id": "3c1841bd-e160-48ef-9890-e41ce1e63b58",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.63",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "800 SLE patients",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "SLAM-R",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL19)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2eefbd5b-f7ce-46fe-bb5a-cc65c84ece78",
        "_rev": "_WpvYGJG-_P",
        "nanopub": {
            "id": "2eefbd5b-f7ce-46fe-bb5a-cc65c84ece78",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "6 healthy obese, nonobese, and 6 noninsulin-dependent diabetes patients",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "RIA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "7512573",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Fasting\")",
                    "relation": "decreases",
                    "object": "p(HGNC:IGF1)"
                }
            ],
            "evidence": "In NOB subjects, the mean prefasting IGF-I concentration of 256 +/- 21 ug/L decreased 16 % (P<0.05) after 2 days of fasting and 37% (P<0.001) at the end of the fast (Fig. 2).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ca3a0ac5-9792-4c0f-a82e-dd02a591f7ab",
        "_rev": "_WpvYGJC-AT",
        "nanopub": {
            "id": "ca3a0ac5-9792-4c0f-a82e-dd02a591f7ab",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "AE7",
                    "type": "CellLine"
                },
                {
                    "id": "",
                    "label": "OF6",
                    "type": "CellLine"
                },
                {
                    "id": "",
                    "label": "PL17",
                    "type": "CellLine"
                },
                {
                    "id": "",
                    "label": "Northern Blot",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "database": {
                    "id": "10761931",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TCR)",
                    "relation": "increases",
                    "object": "r(HGNC:TBX21)"
                }
            ],
            "evidence": "Further, T-bet expression was augmented by signals transmitted via the TCR as evidenced by the induction of T-bet transcripts by anti-CD3 at 6 and 24 hr. T-bet transcripts were not detected in untreated or PMA plus ionomycin\u2013treated EL4, a thymoma, M12, a B cell lymphoma, or Jurkat, a T cell lymphoma.\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1b9ccfa5-691f-4397-a8f5-61b19519797d",
        "_rev": "_WpvYGJG-_g",
        "nanopub": {
            "id": "1b9ccfa5-691f-4397-a8f5-61b19519797d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "Binding Assay",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "n=34 (17 healthy test subjects, 17 controls)",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "18580406",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Exercise\")",
                    "relation": "positiveCorrelation",
                    "object": "act(p(HGNC:PPARG), ma(tscript))"
                }
            ],
            "evidence": "\u00a0Figure 2b\u00a0demonstrates that after 4 wk of the current exercise program, there was a significant increase in PPAR\u03b3's ability to bind to an immobilized PPRE sequence (preexercise, 0.22 \u00b1 0.09 OD units; postexercise, 1.13 \u00b1 0.29 OD units).\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c3eeb33e-b367-483c-b47a-60d04d418132",
        "_rev": "_WpvYGJC-BD",
        "nanopub": {
            "id": "c3eeb33e-b367-483c-b47a-60d04d418132",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Hinson, R M",
                    "Williams, J A",
                    "Shacter, E"
                ],
                "comments": "PTGS2=COX2",
                "database": {
                    "id": "8643498",
                    "name": "PubMed"
                },
                "source_name": "Proceedings of the National Academy of Sciences of the United States of America",
                "title": "Elevated interleukin 6 is induced by prostaglandin E2 in a murine model of inflammation: possible role of cyclooxygenase-2.",
                "abstract": "Injection of mineral oils such as pristane into the peritoneal cavities of BALB/c mice results in a chronic peritonitis associated with high tissue levels of interleukin 6 (IL-6). Here we show that increased prostaglandin E2 (PGE2) synthesis causes induction of IL-6 and that expression of an inducible cyclooxygenase, Cox-2, may mediate this process. Levels of both PGE2 and IL-6 are elevated in inflammatory exudates from pristane-treated mice compared with lavage samples from untreated mice. The Cox-2 gene is induced in the peritoneal macrophage fraction isolated from the mice. A cause and effect relationship between increased macrophage PGE2 and IL-6 production is shown in vitro. When peritoneal macrophages are activated with an inflammatory stimulus (polymerized albumin), the Cox-2 gene is induced and secretion of PGE2 and IL-6 increases, with elevated PGE2 appearing before IL-6. Cotreatment with 1 microM indomethacin inhibits PGE2 production by the cells and reduces the induction of IL-6 mRNA but has no effect on Cox-2 mRNA, consistent with the fact that the drug inhibits catalytic activity of the cyclooxygenase but does not affect expression of the gene. Addition of exogenous PGE2 to macrophages induces IL-6 protein and mRNA synthesis, indicating that the eicosanoid stimulates IL-6 production at the level of gene expression. PGE2-stimulated IL-6 production is unaffected by addition of indomethacin. Taken together with the earlier finding that indomethacin diminishes the elevation of IL-6 in pristane-treated mice, the results show that PGE2 can induce IL-6 production in vivo and implicate expression of the Cox-2 gene in the regulation of this cytokine."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:PTGER2)",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "p(HGNC:PTGS2)",
                    "relation": "increases",
                    "object": "p(HGNC:PTGER2)"
                }
            ],
            "evidence": "This report provides evidence\nthat prostaglandins serve as the predominant stimulus for IL-6\nproduction in the pristane model. Elevated PGE2 probably\nderives from induction of Cox-2 expression.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Injection of mineral oils such as pristane into the peritoneal cavities of BALB/c mice results in a chronic peritonitis associated with high tissue levels of interleukin 6 (IL-6). Here we show that increased prostaglandin E2 (PGE2) synthesis causes induction of IL-6 and that expression of an inducible cyclooxygenase, Cox-2, may mediate this process. Levels of both PGE2 and IL-6 are elevated in inflammatory exudates from pristane-treated mice compared with lavage samples from untreated mice. The Cox-2 gene is induced in the peritoneal macrophage fraction isolated from the mice. A cause and effect relationship between increased macrophage PGE2 and IL-6 production is shown in vitro. When peritoneal macrophages are activated with an inflammatory stimulus (polymerized albumin), the Cox-2 gene is induced and secretion of PGE2 and IL-6 increases, with elevated PGE2 appearing before IL-6. Cotreatment with 1 microM indomethacin inhibits PGE2 production by the cells and reduces the induction of IL-6 mRNA but has no effect on Cox-2 mRNA, consistent with the fact that the drug inhibits catalytic activity of the cyclooxygenase but does not affect expression of the gene. Addition of exogenous PGE2 to macrophages induces IL-6 protein and mRNA synthesis, indicating that the eicosanoid stimulates IL-6 production at the level of gene expression. PGE2-stimulated IL-6 production is unaffected by addition of indomethacin. Taken together with the earlier finding that indomethacin diminishes the elevation of IL-6 in pristane-treated mice, the results show that PGE2 can induce IL-6 production in vivo and implicate expression of the Cox-2 gene in the regulation of this cytokine.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ef5f31ed-4674-4e97-acb2-d5f330c1aa6e",
        "_rev": "_WpvYGJG--a",
        "nanopub": {
            "id": "ef5f31ed-4674-4e97-acb2-d5f330c1aa6e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"epithelial cell of umbilical artery\"",
                    "label": "epithelial cell of umbilical artery",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "9322188",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Zinc)",
                    "relation": "decreases",
                    "object": "act(complex(p(HGNC:NFKB1),p(HGNC:NFKB2)), ma(tscript)))"
                }
            ],
            "evidence": "Zinc supplementation markedly attenuated TNF-mediate activation of NF-KB (Lane 4 compared to Lane 3)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2387575f-0ab4-451f-bd04-1783a749a782",
        "_rev": "_WpvYGJG-B0",
        "nanopub": {
            "id": "2387575f-0ab4-451f-bd04-1783a749a782",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "p=0.009",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=22 women",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "24673738",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"MESH:Lactobacillus casei\")",
                    "relation": "decreases",
                    "object": "p(HGNC:CRP)"
                }
            ],
            "evidence": "Table 2 presents the results for hs-CRP, tender and swollen joint counts, GH score and DAS28 for the two groups throughout the study. Significant decreases were observed in the parameters in the probiotic group. G\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1b8cf9f7-82b5-44b2-98b4-ed9fd7086a6c",
        "_rev": "_WpvYGJG-B-",
        "nanopub": {
            "id": "1b8cf9f7-82b5-44b2-98b4-ed9fd7086a6c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "1692808",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:Neutrophil)",
                    "relation": "increases",
                    "object": "sec(p(HGNC:CSF))"
                }
            ],
            "evidence": "Supematants of cells cultured with LPS contained G-CSF at 164.3 + 63 pg/ml (mean + standard deviation), ranging from 77 to 238 pg/ml, while control culture supernatant did not have detectable levels of G-CSF.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "044c10c7-b3ec-4337-ac01-74c64e2bdc55",
        "_rev": "_WpvYGJ---i",
        "nanopub": {
            "id": "044c10c7-b3ec-4337-ac01-74c64e2bdc55",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:D061307",
                    "label": "Human Umbilical Vein Endothelial Cells",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Wen, Ya-Dan",
                    "Wang, Hong",
                    "Kho, Sok-Hong",
                    "Rinkiko, Suguro",
                    "Sheng, Xiong",
                    "Shen, Han-Ming",
                    "Zhu, Yi-Zhun"
                ],
                "database": {
                    "id": "23393548",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress.",
                "abstract": "Hydrogen sulfide (H\u2082S) has been shown to have cytoprotective effects in models of hypertension, ischemia/reperfusion and Alzheimer's disease. However, little is known about its effects or mechanisms of action in atherosclerosis. Therefore, in the current study we evaluated the pharmacological effects of H\u2082S on antioxidant defenses and mitochondria protection against hydrogen peroxide (H\u2082O\u2082) induced endothelial cells damage."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"hydrogen peroxide\")",
                    "relation": "decreases",
                    "object": "p(HGNC:CAT)"
                }
            ],
            "evidence": "When cells were stimulated with H2O2 a significant decreases in the activities of superoxide dismutase (SOD), catalase, glutathione Peroxidase (GPx) and glutathione S-transferase (GST) were observed (P<0.05, vs. control, n\u200a=\u200a6).",
            "metadata": {
                "Methodology": "western blot",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "66aa0fa9-87bd-432e-8c32-1d75e4d175b4",
        "_rev": "_WpvYGJG-_X",
        "nanopub": {
            "id": "66aa0fa9-87bd-432e-8c32-1d75e4d175b4",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CLO:\"MT1.K cell\"",
                    "label": "MT1.K cell",
                    "type": "CellLine"
                },
                {
                    "id": "CLO:\"MT2 cell\"",
                    "label": "MT2 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "26109726",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:NOX5)",
                    "relation": "decreases",
                    "object": "a(MESH:\"Reactive Oxygen Species\")"
                }
            ],
            "evidence": "Catalase-inhibitable ROS generation was significantly attenuated in MT1siNox5a cells and MT2siNox5a cells compared with control cells (Fig. 4D), suggesting the involvement of Nox5a in ROS synthesis in HTLV1-infected cells.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "463d0a52-267e-4b9a-b7aa-4045474b3e07",
        "_rev": "_WpvYGJ--_4",
        "nanopub": {
            "id": "463d0a52-267e-4b9a-b7aa-4045474b3e07",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Reporter Assay",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"B cell\"",
                    "label": "B cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12023955",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT6)",
                    "relation": "directlyIncreases",
                    "object": "r(HGNC:BCL2L1)"
                }
            ],
            "evidence": "A single Stat6 site was able to reproducibly provide IL-4-induced reporter gene activity to thebcl-xL\u00a0promoter (Fig.\u00a04\u00a0C).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9a7dd3dc-b62b-411b-9c58-7217daebdec1",
        "_rev": "_WpvYGJ---L",
        "nanopub": {
            "id": "9a7dd3dc-b62b-411b-9c58-7217daebdec1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=-0.465",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p=0.003",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "40 patients with SLE and 30 healthy controls.",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "20952466",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "m(HGNC:MIR146A)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Serum miR-146a inversely correlated with proteinuria (r = -0.341, p = 0.031) and the SLE Disease Activity Index (r = -0.465, p = 0.003).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "32f62cdf-0b50-4f80-8485-14fe79228753",
        "_rev": "_WpvYGJC-_D",
        "nanopub": {
            "id": "32f62cdf-0b50-4f80-8485-14fe79228753",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:\"hepatocellular carcinoma\"",
                    "label": "hepatocellular carcinoma",
                    "type": "Disease"
                },
                {
                    "id": "EFO:HepG2",
                    "label": "HepG2",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "authors": [
                    "Labuschagne, Christiaan F",
                    "van den Broek, Niels J F",
                    "Postma, Pjotr",
                    "Berger, Ruud",
                    "Brenkman, Arjan B"
                ],
                "database": {
                    "id": "24244726",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "A protocol for quantifying lipid peroxidation in cellular systems by F2-isoprostane analysis.",
                "abstract": "Cellular systems are essential model systems to study reactive oxygen species and oxidative damage but there are widely accepted technical difficulties with available methods for quantifying endogenous oxidative damage in these systems. Here we present a stable isotope dilution UPLC-MS/MS protocol for measuring F2-isoprostanes as accurate markers for endogenous oxidative damage in cellular systems. F2-isoprostanes are chemically stable prostaglandin-like lipid peroxidation products of arachidonic acid, the predominant polyunsaturated fatty acid in mammalian cells. This approach is rapid and highly sensitive, allowing for the absolute quantification of endogenous lipid peroxidation in as little as ten thousand cells as well as damage originating from multiple ROS sources. Furthermore, differences in the endogenous cellular redox state induced by transcriptional regulation of ROS scavenging enzymes were detected by following this protocol. Finally we showed that the F2-isoprostane 5-iPF2\u03b1-VI is a metabolically stable end product, which is excreted from cells. Overall, this protocol enables accurate, specific and sensitive quantification of endogenous lipid peroxidation in cellular systems."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"arachidonic acid\")",
                    "relation": "increases",
                    "object": "a(CHEBI:\"8-epi-prostaglandin F2alpha\")"
                }
            ],
            "evidence": "By using these MRM transitions in combination with their chromatographic retention and co-elution with their corresponding deuterated internal standards, we demonstrated the formation of three F2-isoprostane isomers including 8-isoPGF2\u03b1-III; 5-iPF2\u03b1-VI and 8,12-iso-iPF2\u03b1-VI upon in vitro peroxidation of AA (Figure 2A-C).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "086d67d9-c902-4faa-b605-8c0e427d9ad8",
        "_rev": "_WpvYGJG-AI",
        "nanopub": {
            "id": "086d67d9-c902-4faa-b605-8c0e427d9ad8",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ACR20",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "499 patients with inadequate response to TNF antagonists (split up into 2 doses or placebo)",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Emery, P",
                    "Keystone, E",
                    "Tony, H P",
                    "Cantagrel, A",
                    "van Vollenhoven, R",
                    "Sanchez, A",
                    "Alecock, E",
                    "Lee, J",
                    "Kremer, J"
                ],
                "comments": "tocilizumab is an anti-IL-6 treatment",
                "database": {
                    "id": "18625622",
                    "name": "PubMed"
                },
                "source_name": "Annals of the rheumatic diseases",
                "title": "IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial.",
                "abstract": "The phase III RADIATE study examined the efficacy and safety of tocilizumab, an anti-IL-6 receptor monoclonal antibody in patients with rheumatoid arthritis (RA) refractory to tumour necrosis factor (TNF) antagonist therapy."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:tocilizumab)",
                    "relation": "increases",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "Both the 8 mg/kg (50.0%) and 4 mg/kg (30.4%) groups exhibited superior ACR20 responses compared with control (10.1%; less than p<0.001).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "76566f84-e2d9-4167-a675-eb32f7588bd1",
        "_rev": "_WpvYGJ--Ck",
        "nanopub": {
            "id": "76566f84-e2d9-4167-a675-eb32f7588bd1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Reporter Assay",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"EL4 cell\"",
                    "label": "EL4 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "7878466",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IKBA, pmod(Ph))",
                    "relation": "increases",
                    "object": "act(complex(HGNC:NFKB Complex\"), ma(GO:\"positive regulation of transcription by transcription factor localization\"))"
                }
            ],
            "evidence": "The mutations blocking signal-induced phosphorylation and proteolysis also prevented activation of NF-KB.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9a9e52d5-c7e9-4ba3-a51f-0361c8866647",
        "_rev": "_WpvYGJ---k",
        "nanopub": {
            "id": "9a9e52d5-c7e9-4ba3-a51f-0361c8866647",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "comments": "ex vivo",
                "database": {
                    "id": "16220542",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "increases",
                    "object": "bp(GO:\"osteoclast development\")"
                }
            ],
            "evidence": "IFN-c+ T cells (5 105 /well) induced a significantly larger number of osteoclasts than the medium with M-CSF alone (Fig. 2A, B).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "13b87bda-0ab8-4124-aa11-06a90bf0529a",
        "_rev": "_WpvYGJC-B7",
        "nanopub": {
            "id": "13b87bda-0ab8-4124-aa11-06a90bf0529a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:fibroblast",
                    "label": "fibroblast",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16785495",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:IL17), ma (GO:\"positive regulation of Cytokine secretion\")",
                    "relation": "increases",
                    "object": "composite(p(HGNC:IL17RA), p(HGNC:IL17RC))"
                }
            ],
            "evidence": "\u00a0Strikingly, however, IL-17RA\u2212/\u2212\u00a0fibroblasts expressing both human IL-17RA and human IL-17RC respond to human IL-17 and IL-17F (Fig. 2\u21d3a). Thus, the failure of human IL-17RA to signal in a mouse cell can be complemented by the cointroduction of human IL-17RC.\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bcfc4903-b178-4db4-8a74-c8dc29714622",
        "_rev": "_WpvYGJG-Bx",
        "nanopub": {
            "id": "bcfc4903-b178-4db4-8a74-c8dc29714622",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Synovial Fluid\"",
                    "label": "Synovial Fluid",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "authors": [
                    "Alan\u00e4r\u00e4, T",
                    "Karstila, K",
                    "Moilanen, T",
                    "Silvennoinen, O",
                    "Isom\u00e4ki, Pia"
                ],
                "database": {
                    "id": "20001767",
                    "name": "PubMed"
                },
                "source_name": "Scandinavian journal of rheumatology",
                "title": "Expression of IL-10 family cytokines in rheumatoid arthritis: elevated levels of IL-19 in the joints.",
                "abstract": "Interleukin (IL)-10 functions as an anti-inflammatory cytokine in rheumatoid arthritis (RA). New IL-10 family cytokines IL-19, IL-20, IL-22, IL-24, and IL-26 have recently been discovered. Information concerning the expression and function of these cytokines in autoimmune diseases is currently limited. The aim of this study was to investigate their expression in RA."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:IL10)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "IL-10 and IL-19 mRNA levels were significantly elevated in SFMCs from patients with RA compared with PBMCs from RA patients or healthy volunteers.\u00a0",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d3faf26a-f49c-4d07-b077-c4bdef143c72",
        "_rev": "_WpvYGJ--Cn",
        "nanopub": {
            "id": "d3faf26a-f49c-4d07-b077-c4bdef143c72",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "80 SLE with (40) and without (40) renal disease, 40 HC (Chinese cohort)",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "15975968",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL5)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "p(HGNC:CCL2)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Upon subgroup analysis, IP10, RANTES, MIG, MCP\u20101, IL8, and IL18 correlated significantly with SLEDAI score of the SLE group, while IP10, IL8, IL10, and IL18 concentrations correlated significantly with SLEDAI of RSLE patients (all p<0.05). \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "179e1255-014e-4404-8b80-1a5b005b1eaf",
        "_rev": "_WpvYGJG-Aj",
        "nanopub": {
            "id": "179e1255-014e-4404-8b80-1a5b005b1eaf",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "not stated",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18469800",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite (p(HGNC:IL21), p(HGNC:TGFB))\t",
                    "relation": "increases",
                    "object": "p(HGNC:IL17)"
                }
            ],
            "evidence": "When given a very strong\u00a0in vitro\u00a0stimulus, naive CD4+\u00a0T cells sorted from cord blood secreted IL-17A protein\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "40324dfa-bd23-4b75-8b54-ea1ccef07c39",
        "_rev": "_WpvYGJC-BF",
        "nanopub": {
            "id": "40324dfa-bd23-4b75-8b54-ea1ccef07c39",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "authors": [
                    "Hakkim, Abdul",
                    "F\u00fcrnrohr, Barbara G",
                    "Amann, Kerstin",
                    "Laube, Britta",
                    "Abed, Ulrike Abu",
                    "Brinkmann, Volker",
                    "Herrmann, Martin",
                    "Voll, Reinhard E",
                    "Zychlinsky, Arturo"
                ],
                "database": {
                    "id": "20439745",
                    "name": "PubMed"
                },
                "source_name": "Proceedings of the National Academy of Sciences of the United States of America",
                "title": "Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis.",
                "abstract": "Systemic lupus erythematosus (SLE) is an autoimmune disease in which patients develop autoantibodies to DNA, histones, and often to neutrophil proteins. These form immune complexes that are pathogenic and may cause lupus nephritis. In SLE patients, infections can initiate flares and are a major cause of mortality. Neutrophils respond to infections and release extracellular traps (NETs), which are antimicrobial and are made of DNA, histones, and neutrophil proteins. The timely removal of NETs may be crucial for tissue homeostasis to avoid presentation of self-antigens. We tested the hypothesis that SLE patients cannot clear NETs, contributing to the pathogenesis of lupus nephritis. Here we show that serum endonuclease DNase1 is essential for disassembly of NETs. Interestingly, a subset of SLE patients' sera degraded NETs poorly. Two mechanisms caused this impaired NET degradation: (i) the presence of DNase1 inhibitors or (ii) anti-NET antibodies prevented DNase1 access to NETs. Impairment of DNase1 function and failure to dismantle NETs correlated with kidney involvement. Hence, identification of SLE patients who cannot dismantle NETs might be a useful indicator of renal involvement. Moreover, NETs might represent a therapeutic target in SLE."
            },
            "assertions": [
                {
                    "subject": "a(anti-NET)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "To test this we retrospectively quantified anti-NET Abs using a modified ELISA (as described in Materials and Methods) in the sera. SLE sera, in particular those from nondegraders, contained high levels of anti-NET Abs (Fig. 4A).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "693eb503-8727-4989-9a5c-790ab0ac227a",
        "_rev": "_WpvYGJG--Q",
        "nanopub": {
            "id": "693eb503-8727-4989-9a5c-790ab0ac227a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "28 HC",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "qPCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "15593221",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNA2)",
                    "relation": "increases",
                    "object": "r(EG:5610)"
                },
                {
                    "subject": "p(HGNC:IFNA2)",
                    "relation": "increases",
                    "object": "r(HGNC:OAS3)"
                },
                {
                    "subject": "p(HGNC:IFNA2)",
                    "relation": "increases",
                    "object": "r(HGNC:IFI44)"
                },
                {
                    "subject": "p(HGNC:IFNA2)",
                    "relation": "increases",
                    "object": "r(HGNC:IFIT1)"
                }
            ],
            "evidence": "Among those genes tested were 4 IFIGs (of many good candidate genes) that were predicted to be preferentially induced by IFN\u03b1. Three of those showed significantly greater induction by IFN\u03b1 than by IFN\u03b3 (IFIT1, IFI44, and PRKR, all shown in microarray studies to be overexpressed in SLE and were selected for the IFN\u03b1 score calculation, while the fourth (OAS3) also showed a preference for induction by IFN\u03b1.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Interferon Signatures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3e7d9f5a-2468-4d11-bd37-d0781693c1c7",
        "_rev": "_WpvYGJ--BY",
        "nanopub": {
            "id": "3e7d9f5a-2468-4d11-bd37-d0781693c1c7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "flow cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "49 SLE patients, 34 RA patients, 18 BD patients, 20 AS patients, and 81 healthy controls",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Park, Yong-Wook",
                    "Kee, Seung-Jung",
                    "Cho, Young-Nan",
                    "Lee, Eun-Hee",
                    "Lee, Hwa-Youn",
                    "Kim, Eun-Mi",
                    "Shin, Min-Ho",
                    "Park, Jeong-Jin",
                    "Kim, Tae-Jong",
                    "Lee, Shin-Seok",
                    "Yoo, Dae-Hyun",
                    "Kang, Hyung-Sik"
                ],
                "database": {
                    "id": "19479851",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Impaired differentiation and cytotoxicity of natural killer cells in systemic lupus erythematosus.",
                "abstract": "To determine the cytotoxicity of natural killer (NK) cells and the level of differentiation of hematopoietic stem cells (HSCs) into NK cells in systemic lupus erythematosus (SLE)."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Lupus Erythematosus, Systemic\")",
                    "relation": "decreases",
                    "object": "bp(MESH:\"Killer Cells, Natural\", GO:\"hematopoietic stem cell differentiation\")"
                },
                {
                    "subject": "a(GO:\"natural killer cell mediated cytotoxicity\")",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "In SLE patients, circulating levels of NK cells were diminished and their cytotoxicities were impaired. Furthermore, the differentiation of HSCs into NK cells was found to be defective.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "81cf3a33-a997-483c-bc3a-e07aa715a948",
        "_rev": "_WpvYGJ---P",
        "nanopub": {
            "id": "81cf3a33-a997-483c-bc3a-e07aa715a948",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "abstract": "Complement is an important component of the innate immune system that is crucial for defense from microbial infections and for clearance of immune complexes and injured cells. In normal conditions complement is tightly controlled by a number of fluid-phase and cell surface proteins to avoid injury to autologous tissues. When complement is hyperactivated, as occurs in autoimmune diseases or in subjects with dysfunctional regulatory proteins, it drives a severe inflammatory response in numerous organs. The kidney appears to be particularly vulnerable to complement-mediated inflammatory injury. Injury may derive from deposition of circulating active complement fragments in glomeruli, but complement locally produced and activated in the kidney also may have a role. Many kidney disorders have been linked to abnormal complement activation, including immune-complex-mediated glomerulonephritis and rare genetic kidney diseases, but also tubulointerstitial injury associated with progressive proteinuric diseases or ischemia-reperfusion.",
                "authors": [
                    "Noris, Marina",
                    "Remuzzi, Giuseppe"
                ],
                "database": {
                    "id": "24161035",
                    "name": "PubMed"
                },
                "source_name": "Seminars in nephrology",
                "title": "Overview of complement activation and regulation."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:C5B)\t",
                    "relation": "directlyIncreases",
                    "object": "complex(p(HGNC:C5B), p(HGNC:C9)"
                }
            ],
            "evidence": "the terminal membrane attack complex (MAC, C5b-9) that directly lyses targeted (opsonized) pathogens or damaged self cells (Table 1).",
            "metadata": {
                "gd:abstract": "Complement is an important component of the innate immune system that is crucial for defense from microbial infections and for clearance of immune complexes and injured cells. In normal conditions complement is tightly controlled by a number of fluid-phase and cell surface proteins to avoid injury to autologous tissues. When complement is hyperactivated, as occurs in autoimmune diseases or in subjects with dysfunctional regulatory proteins, it drives a severe inflammatory response in numerous organs. The kidney appears to be particularly vulnerable to complement-mediated inflammatory injury. Injury may derive from deposition of circulating active complement fragments in glomeruli, but complement locally produced and activated in the kidney also may have a role. Many kidney disorders have been linked to abnormal complement activation, including immune-complex-mediated glomerulonephritis and rare genetic kidney diseases, but also tubulointerstitial injury associated with progressive proteinuric diseases or ischemia-reperfusion.",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "56e386bf-f9b2-42d2-a683-799b983a36f5",
        "_rev": "_WpvYGJ--A_",
        "nanopub": {
            "id": "56e386bf-f9b2-42d2-a683-799b983a36f5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=-0.71",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "31 LN,\u00a021 Active Lupus no LN, 30 Inactive Lupus, 11 HC",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "25799079",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:thiol)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "A significant and strong negative correlation of thiols was observed between SLEDAI (r2 = 0.51, p<0.0001), which is in line with previous observations that there is a decrease in serum thiol levels with disease progression.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "28297d1e-2fdf-4dfc-ba19-8e8c37085c2f",
        "_rev": "_WpvYGJC--V",
        "nanopub": {
            "id": "28297d1e-2fdf-4dfc-ba19-8e8c37085c2f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"umbilical artery endothelial cell\"",
                    "label": "umbilical artery endothelial cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Watkins, M T",
                    "Patton, G M",
                    "Soler, H M",
                    "Albadawi, H",
                    "Humphries, D E",
                    "Evans, J E",
                    "Kadowaki, H"
                ],
                "database": {
                    "id": "10585861",
                    "name": "PubMed"
                },
                "source_name": "The Biochemical journal",
                "title": "Synthesis of 8-epi-prostaglandin F2alpha by human endothelial cells: role of prostaglandin H2 synthase.",
                "abstract": "The experiments described in this paper were designed to determine the mechanism underlying the increase in 8-isoprostaglandin F(2alpha) (8-epi-PGF(2alpha)) production by cultured human endothelial cells during reoxygenation following hypoxia. Human umbilical artery endothelial cells were grown on microcarrier beads and exposed to sequential periods of normoxia, hypoxia, and reoxygenation. The amount of 8-epi-PGF(2alpha) in the medium was determined by ELISA. The production of 8-epi-PGF(2alpha) decreased by greater than 90% during hypoxia. Upon reoxygenation 8-epi-PGF(2alpha) production increased linearly for 90 min reaching nearly 3 times normoxic levels. When added to the medium during reoxygenation, neither superoxide dismutase nor Tiron, a cell-permeable superoxide scavenger, inhibited 8-epi-PGF(2alpha) production. However, 8-epi-PGF(2alpha) production was inhibited by catalase. The production of 8-epi-PGF(2alpha) was also inhibited by indomethacin and aspirin. Exogenous hydrogen peroxide stimulated 8-epi-PGF(2alpha) production by normoxic cells, and aspirin inhibited the hydrogen peroxide-mediated increase in 8-epi-PGF(2alpha) production. These results indicate that the reactive oxygen species responsible for 8-epi-PGF(2alpha) synthesis during reoxygenation is hydrogen peroxide and that in endothelial cells 8-epi-PGF(2alpha) synthesis is mediated by prostaglandin H(2) synthase (PGHS). To verify the role of PGHS in 8-epi-PGF(2alpha) synthesis, human PGHS-1 was expressed in COS-7 cells, a PGHS negative cell line that does not synthesize 8-epi-PGF(2alpha). In the presence of exogenous arachidonic acid the COS-7 cells expressing human PGHS-1 produced substantial amounts of PGE(2) and 8-epi-PGF(2alpha). These data indicate that human PGHS-1 can support the synthesis of 8-epi-PGF(2alpha) and that 8-epi-PGF(2alpha) synthesis by cultured human endothelial cells during reoxygenation is dependent on the activity of PGHS-1."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Hydrogen Peroxide\")",
                    "relation": "increases",
                    "object": "a(CHEBI:\"8-epi-prostaglandin F2alpha\")"
                }
            ],
            "evidence": "Hydrogen peroxide (50 uM) progressivelyincreased 8-epi-PGF2alpha production (Figure 4, solidbars).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b7505d50-3998-4972-ae8c-25f69e5ed022",
        "_rev": "_WpvYGJG-A_",
        "nanopub": {
            "id": "b7505d50-3998-4972-ae8c-25f69e5ed022",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=-0.677",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"lupus nephritis\"",
                    "label": "lupus nephritis",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "27365721",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:C4A)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Significant positive correlation was noticed between SLEDAI score and anti-dsDNA levels (0.01 level two-tailed prediction) and a significant negative correlation was observed with SLEDAI and C3, C4 levels (0.01 and 0.05 levels, two-tailed prediction) in our patients. On subgroup analysis it was noticed that this correlation is stronger for renal lupus. Negative correlation of SLEDAI and complement levels was not observed in non-renal flares.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d04a34aa-1bb0-46cf-8aa8-f5fa481d2784",
        "_rev": "_WpvYGJ--CK",
        "nanopub": {
            "id": "d04a34aa-1bb0-46cf-8aa8-f5fa481d2784",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:lymph",
                    "label": "lymph",
                    "type": "Anatomy"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Thymidine Incorporation",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12594853",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:JAK2, pmod(Ph))",
                    "relation": "increases",
                    "object": "bp(GO:\"T-helper 1 cell differentiation\")"
                }
            ],
            "evidence": "Cells from the 2D6 clone were stimulated with IL-12 in the presence of A1 and/or B42. Fig. 2A shows that A1 did not affect IL-12-driven 2D6 proliferation, whereas B42 induced a dose-dependent inhibition of the proliferation.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b4ba6f98-a53b-42a4-8649-a840e774561b",
        "_rev": "_WpvYGJG-_G",
        "nanopub": {
            "id": "b4ba6f98-a53b-42a4-8649-a840e774561b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "8554902",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Iron Chelating Agents\")",
                    "relation": "decreases",
                    "object": "complex(p(HGNC:NFKB1),p(HGNC:NFKB2))"
                }
            ],
            "evidence": "As shown in Figure 3A, the intensity of the specific NF-kB band was decreased when Ul cells were supplemented with 5 pM of DFO and stressed with either 1 or 3 mM H202 (lanes 6 and 7, respectively)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1f76458a-5b82-4b63-a1f2-9b8b04646dd2",
        "_rev": "_WpvYGJ--C_",
        "nanopub": {
            "id": "1f76458a-5b82-4b63-a1f2-9b8b04646dd2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"gamma-delta T cell\"",
                    "label": "gamma-delta T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18641345",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TYK2)",
                    "relation": "increases",
                    "object": "p(HGNC:IL17)"
                }
            ],
            "evidence": "As shown in Fig. 3A, the level of IL-17 production was significantly lower in T cells in Tyk2\u0001/\u0001 mice in response to exogenous IL-23, although the difference in the percentage of IL-17-producing T cells between Tyk2\u0001/\u0001 mice and Tyk2\u0006/\u0006 mice was lesser in response to higher amounts of exogenous IL-23.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5fc407d4-1f10-468f-9606-4087a83a7d4d",
        "_rev": "_WpvYGJC-_t",
        "nanopub": {
            "id": "5fc407d4-1f10-468f-9606-4087a83a7d4d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CLO:\"HL-60 cell\"",
                    "label": "HL-60 cell",
                    "type": "CellLine"
                },
                {
                    "id": "CLO:\"Raji cell\"",
                    "label": "Raji cell",
                    "type": "CellLine"
                },
                {
                    "id": "CLO:\"JURKAT cell\"",
                    "label": "JURKAT cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "authors": [
                    "Pompeia, Celine",
                    "Freitas, Jofre J S",
                    "Kim, Jung S",
                    "Zyngier, Szulim B",
                    "Curi, Rui"
                ],
                "database": {
                    "id": "12489694",
                    "name": "PubMed"
                },
                "source_name": "Biology of the cell",
                "title": "Arachidonic acid cytotoxicity in leukocytes: implications of oxidative stress and eicosanoid synthesis.",
                "abstract": "Arachidonic acid (AA)-induced cytotoxicity was evaluated in leukocytes: the human leukemia cell lines HL-60, Jurkat and Raji and in rat lymphocytes. Such cytotoxicity was dose- and time-dependent. At concentrations below 5 microM, AA was not toxic; at 10-400 microM, AA induced apoptosis and at concentrations beyond 400 microM, necrosis. The minimum exposure time to trigger cell death was of around 1 h, but the effect was increased by longer exposure times until 6-24 h. Apoptosis was morphologically characterized by a decrease in cell and nuclear volume, chromatin condensation and DNA fragmentation and the presence of lipid bodies, without changes in organelle integrity. Biochemically, AA-induced apoptosis was associated with internucleosomal fragmentation and caspase activation, evaluated by PARP cleavage and the use of a caspase inhibitor. Necrosis was characterized by increased cell volume, presence of loose chromatin, appearance of vacuoles, loss of membrane integrity and of the definition of organelles. The apoptotic effect of AA was studied as to oxidative-reductive imbalance and the participation of eicosanoids. Apoptotic AA treatment was accompanied by an increase in the quantity of thiobarbituric acid reactive substances (TBARS), low-level chemiluminescence and in the glutathione disulfide/reduced glutathione ratio, indicating oxidative stress. The addition of tocopherol, ascorbate, prostaglandin E2 and lipoxygenase inhibitors delayed cell death, whereas the inhibition of cyclooxygenase promoted AA-induced cell death. Cell treatment with AA was accompanied by increased cellular production of LTB4. AA, therefore, is cytotoxic at physiological and supraphysiological concentrations, causing apoptosis and necrosis. Cell treatment with apoptotic concentrations of AA involves oxidative stress and changes in eicosanoid biosynthesis."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Arachidonic Acid\"",
                    "relation": "increases",
                    "object": "a(CHEBI:malonaldehyde)"
                }
            ],
            "evidence": "Apoptotic AA treatment was accompanied by an increase in the quantity of thiobarbituric acid reactive substances (TBARS), low-level chemiluminescence and in the glutathione disulfide/reduced glutathione ratio, indicating oxidative stress. \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c4163eb8-0134-4e6e-8306-06bf1e16792a",
        "_rev": "_WpvYGJC-_P",
        "nanopub": {
            "id": "c4163eb8-0134-4e6e-8306-06bf1e16792a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17277312",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "association",
                    "object": "bp(GO:\"T-helper 17 cell differentiation\")"
                }
            ],
            "evidence": "\u0001. In Il-6 knock-out mice, THi cells were greatly reduced relative to WT mice, whereas IFN-\u0001-producing TH1 cells were only moderately affected (Fig. 1A).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f81bd09f-7fd6-4207-b139-0956fb64181f",
        "_rev": "_WpvYGJ--AS",
        "nanopub": {
            "id": "f81bd09f-7fd6-4207-b139-0956fb64181f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "The subjects included 22 healthy volunteers, 2 patients with\u00a0L-aromatic amino acid decarboxylase deficiency, 6 patients with peripheral autonomic failure, 9 patients with Shy-Drager syndrome, and 8 patients with nonmetastatic gastrointestinal carcinoma.",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "HPLC",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "10404831",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Fasting\")",
                    "relation": "decreases",
                    "object": "a(CHEBI:\"dopamine 3-O-sulfate\")"
                }
            ],
            "evidence": "Compared with overnight fasting, fasting for 4 days was associated with nonsignificant decreases in plasma concentrations of L-DOPA and dihydroxyphenylacetic acid and a significant decrease in plasma concentrations of dopamine sulfate (P\u00a0= 0.01;\u00a0Fig. 2)\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1283d27d-627b-46cf-a905-fc28e5a1c0ff",
        "_rev": "_WpvYGJ---c",
        "nanopub": {
            "id": "1283d27d-627b-46cf-a905-fc28e5a1c0ff",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "267 SLE patients followed longitudinally for one year",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "19790071",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CXCL10)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "We first performed univariate Cox proportional hazards regression to identify variables with significant ability to predict flare (increase in SLEDAI \u22653; Table 1). As expected, the chemokine score was significantly associated with flare, both as a binary variable (chemokine-high vs. chemokine-intermediate/low; p=0.0001), and as a continuous variable (p=0.0002). The individual chemokine levels for CXCL10 (IP-10) and CCL19 (Mip-3B) were also significant (p=0.0001 and p=0.03, respectively).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ca96f270-bc04-40b3-b2c5-8dfa8065ad2e",
        "_rev": "_WpvYGJC-BO",
        "nanopub": {
            "id": "ca96f270-bc04-40b3-b2c5-8dfa8065ad2e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "In contrast, consistent with the results above, levels of several inflammatory mediators varied between pre-flare and non-flare periods (Figure 2 and Supplementary Table 4). Impending flares were associated with increased Th1, Th2, and Th17 (Figure 2A\u2013C) type cytokines, compared to both self non-flare and matched healthy control samples (Supplementary Figure 2A\u2013C).\n",
            "metadata": {
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "afe064b7-5a5a-40f1-9164-d27e269ad6b3",
        "_rev": "_WpvYGJG-BK",
        "nanopub": {
            "id": "afe064b7-5a5a-40f1-9164-d27e269ad6b3",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "EFO:\"HUVEC cell line\"",
                    "label": "HUVEC cell line",
                    "type": "CellLine"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Wen, Ya-Dan",
                    "Wang, Hong",
                    "Kho, Sok-Hong",
                    "Rinkiko, Suguro",
                    "Sheng, Xiong",
                    "Shen, Han-Ming",
                    "Zhu, Yi-Zhun"
                ],
                "database": {
                    "id": "23393548",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress.",
                "abstract": "Hydrogen sulfide (H\u2082S) has been shown to have cytoprotective effects in models of hypertension, ischemia/reperfusion and Alzheimer's disease. However, little is known about its effects or mechanisms of action in atherosclerosis. Therefore, in the current study we evaluated the pharmacological effects of H\u2082S on antioxidant defenses and mitochondria protection against hydrogen peroxide (H\u2082O\u2082) induced endothelial cells damage."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"hydrogen peroxide\")",
                    "relation": "increases",
                    "object": "a(CHEBI:\"reactive oxygen species\")"
                }
            ],
            "evidence": "Administration of H2O2 induced an increase in the fluorescence intensity of H2DCFDA, as compared to the control group (P<0.05). Pre-incubation with NaHS inhibited the levels of ROS induced by H2O2 (P<0.05).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4aac9273-c2ed-492d-bbf7-1dbdc8cf959c",
        "_rev": "_WpvYGI6--o",
        "nanopub": {
            "id": "4aac9273-c2ed-492d-bbf7-1dbdc8cf959c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "15 renal failure patients, 30 haemodialysis patients, and 10 HC",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "HPLC",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"kidney failure\"",
                    "label": "kidney failure",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10516995",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Kidney Failure, Chronic\")\t",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:\"N(alpha)-acetyl-L-arginine\")"
                },
                {
                    "subject": "path(MESH:\"Kidney Failure, Chronic\")\t",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:creatinine)"
                },
                {
                    "subject": "path(MESH:\"Kidney Failure, Chronic\")\t",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:\"N-amidinoaspartic acid\")"
                },
                {
                    "subject": "path(MESH:\"Kidney Failure, Chronic\")",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:taurocyamine)"
                }
            ],
            "evidence": "In the plasma from patients with chronic renal failure, the peaks corresponding to GHBA, GBA, G and MG were detected. In addition, an increase in the peaks corresponding to TC, GSA, AA, and Cr compared to normal healthy subjects was observed (Figure 2b).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "96d2ed69-0407-4e67-bea7-ab4d76a03043",
        "_rev": "_WpvYGJG-BL",
        "nanopub": {
            "id": "96d2ed69-0407-4e67-bea7-ab4d76a03043",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Lymphocytes",
                    "label": "Lymphocytes",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Bortoluzzi, Alessandra",
                    "Vincenzi, Fabrizio",
                    "Govoni, Marcello",
                    "Padovan, Melissa",
                    "Ravani, Annalisa",
                    "Borea, Pier Andrea",
                    "Varani, Katia"
                ],
                "database": {
                    "id": "27566294",
                    "name": "PubMed"
                },
                "source_name": "Arthritis research & therapy",
                "title": "A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus.",
                "abstract": "Adenosine is a purine nucleoside implicated in the regulation of the innate and adaptive immune systems, acting through its interaction with four cell surface receptors: A1, A2A, A2B, and A3. There is intense interest in understanding how adenosine functions in health and during disease, but surprisingly little is known about the actual role of adenosine-mediated mechanisms in systemic lupus erythematosus (SLE). With this background, the aim of the present study was to test the hypothesis that dysregulation of A1, A2A, A2B, and A3 adenosine receptors (ARs) in lymphocytes of patients with SLE may be involved in the pathogenesis of the disease and to examine the correlations between the status of the ARs and the clinical parameters of SLE."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:ADAR)\t",
                    "relation": "decreases",
                    "object": "p(HGNC:IFNA1)"
                }
            ],
            "evidence": "In cultured lymphocytes of patients with SLE, a marked release of IFN-\u03b1 was observed following the incubation of the cells with 0.1 mg/ml lipopolysaccharide (LPS) for 24 h (Fig. 3a). Interestingly, CGS-21680 at concentrations of 100 nM and 1 \u03bcM was able to inhibit the LPS-induced IFN-\u03b1 release in lymphocytes of both patients with SLE and healthy subjects.\u00a0",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Adenosine is a purine nucleoside implicated in the regulation of the innate and adaptive immune systems, acting through its interaction with four cell surface receptors: A1, A2A, A2B, and A3. There is intense interest in understanding how adenosine functions in health and during disease, but surprisingly little is known about the actual role of adenosine-mediated mechanisms in systemic lupus erythematosus (SLE). With this background, the aim of the present study was to test the hypothesis that dysregulation of A1, A2A, A2B, and A3 adenosine receptors (ARs) in lymphocytes of patients with SLE may be involved in the pathogenesis of the disease and to examine the correlations between the status of the ARs and the clinical parameters of SLE.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "da7b3887-26a0-4eed-9c75-0894670d12dd",
        "_rev": "_WpvYGJG--r",
        "nanopub": {
            "id": "da7b3887-26a0-4eed-9c75-0894670d12dd",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Chaleckis, Romanas",
                    "Murakami, Itsuo",
                    "Takada, Junko",
                    "Kondoh, Hiroshi",
                    "Yanagida, Mitsuhiro"
                ],
                "database": {
                    "id": "27036001",
                    "name": "PubMed"
                },
                "source_name": "Proceedings of the National Academy of Sciences of the United States of America",
                "title": "Individual variability in human blood metabolites identifies age-related differences.",
                "abstract": "Metabolites present in human blood document individual physiological states influenced by genetic, epigenetic, and lifestyle factors. Using high-resolution liquid chromatography-mass spectrometry (LC-MS), we performed nontargeted, quantitative metabolomics analysis in blood of 15 young (29 \u00b1 4 y of age) and 15 elderly (81 \u00b1 7 y of age) individuals. Coefficients of variation (CV = SD/mean) were obtained for 126 blood metabolites of all 30 donors. Fifty-five RBC-enriched metabolites, for which metabolomics studies have been scarce, are highlighted here. We found 14 blood compounds that show remarkable age-related increases or decreases; they include 1,5-anhydroglucitol, dimethyl-guanosine, acetyl-carnosine, carnosine, ophthalmic acid, UDP-acetyl-glucosamine,N-acetyl-arginine,N6-acetyl-lysine, pantothenate, citrulline, leucine, isoleucine, NAD(+), and NADP(+) Six of them are RBC-enriched, suggesting that RBC metabolomics is highly valuable for human aging research. Age differences are partly explained by a decrease in antioxidant production or increasing inefficiency of urea metabolism among the elderly. Pearson's coefficients demonstrated that some age-related compounds are correlated, suggesting that aging affects them concomitantly. Although our CV values are mostly consistent with those CVs previously published, we here report previously unidentified CVs of 51 blood compounds. Compounds having moderate to high CV values (0.4-2.5) are often modified. Compounds having low CV values, such as ATP and glutathione, may be related to various diseases because their concentrations are strictly controlled, and changes in them would compromise health. Thus, human blood is a rich source of information about individual metabolic differences."
            },
            "assertions": [
                {
                    "subject": "bp(GO:aging)",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:\"ophthalmic acid\")"
                },
                {
                    "subject": "bp(GO:aging)",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:leucine)"
                }
            ],
            "evidence": "We found 14 blood compounds that show remarkable age-related increases or decreases; they include 1,5-anhydroglucitol, dimethyl-guanosine, acetyl-carnosine, carnosine, ophthalmic acid, UDP-acetyl-glucosamine,N-acetyl-arginine,N6-acetyl-lysine, pantothenate, citrulline, leucine, isoleucine, NAD(+), and NADP(+) ",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "035b8a9c-16ec-4419-b58e-43b2ba54756d",
        "_rev": "_WpvYGJ--A8",
        "nanopub": {
            "id": "035b8a9c-16ec-4419-b58e-43b2ba54756d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "DO:\"human immunodeficiency virus infectious disease\"",
                    "label": "human immunodeficiency virus infectious disease",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "16425129",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(DO:\"human immunodeficiency virus infectious disease\")",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IL7)"
                }
            ],
            "evidence": "We confirmed that patients with CHI have significantly increased plasma IL-7 levels before therapy (median, 3.07 pg/mL), compared with healthy volunteers (median, 1.2S pg/mL) (P<.001).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4fe05767-8298-48d6-9014-8cb50e13847b",
        "_rev": "_WpvYGJC--c",
        "nanopub": {
            "id": "4fe05767-8298-48d6-9014-8cb50e13847b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "p=0.000",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=22 women",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "24673738",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Lactobacillus casei\")",
                    "relation": "decreases",
                    "object": "p(SP:P29459)"
                }
            ],
            "evidence": "e. At the end of the study period, ANCOVA test revealed a significant difference between the groups for IL-6, IL-12, TNF-a and IL-10\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f99e160f-74e4-440f-9177-d3d66a632701",
        "_rev": "_WpvYGJ--Al",
        "nanopub": {
            "id": "f99e160f-74e4-440f-9177-d3d66a632701",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "21483218",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:Anxiety)",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:proline)"
                }
            ],
            "evidence": "Pro concentrations were related to nurse (\u03b2= 237.619, p = 0.002) and anxiety (\u03b2=17.992, p=0.001), with 0.199 of adjusted r2 .\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ed462429-86bd-41f0-87da-d094111db59b",
        "_rev": "_WpvYGJC-AP",
        "nanopub": {
            "id": "ed462429-86bd-41f0-87da-d094111db59b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Hakkim, Abdul",
                    "F\u00fcrnrohr, Barbara G",
                    "Amann, Kerstin",
                    "Laube, Britta",
                    "Abed, Ulrike Abu",
                    "Brinkmann, Volker",
                    "Herrmann, Martin",
                    "Voll, Reinhard E",
                    "Zychlinsky, Arturo"
                ],
                "database": {
                    "id": "20439745",
                    "name": "PubMed"
                },
                "source_name": "Proceedings of the National Academy of Sciences of the United States of America",
                "title": "Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis.",
                "abstract": "Systemic lupus erythematosus (SLE) is an autoimmune disease in which patients develop autoantibodies to DNA, histones, and often to neutrophil proteins. These form immune complexes that are pathogenic and may cause lupus nephritis. In SLE patients, infections can initiate flares and are a major cause of mortality. Neutrophils respond to infections and release extracellular traps (NETs), which are antimicrobial and are made of DNA, histones, and neutrophil proteins. The timely removal of NETs may be crucial for tissue homeostasis to avoid presentation of self-antigens. We tested the hypothesis that SLE patients cannot clear NETs, contributing to the pathogenesis of lupus nephritis. Here we show that serum endonuclease DNase1 is essential for disassembly of NETs. Interestingly, a subset of SLE patients' sera degraded NETs poorly. Two mechanisms caused this impaired NET degradation: (i) the presence of DNase1 inhibitors or (ii) anti-NET antibodies prevented DNase1 access to NETs. Impairment of DNase1 function and failure to dismantle NETs correlated with kidney involvement. Hence, identification of SLE patients who cannot dismantle NETs might be a useful indicator of renal involvement. Moreover, NETs might represent a therapeutic target in SLE.",
                "date_published": "2010-05-25"
            },
            "assertions": [
                {
                    "subject": "a(DNAse1 inhibitor)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Addition of DNase1 to nondegrader SLE sera did not restore NET degradation to the level of controls (Fig. 3A, green circles). These data suggested that mutations in DNase1 did not account for impaired NET degradation in our cohort (21, 22). Spiking these sera with MNase identified two groups of patient sera. In group 1, addition of MNase restored NET degradation (from median 29.7\u201395.2%), indicating the presence of DNase1-specific inhibitor(s) (Fig. 3A, green circles with black border). Further investigation will determine the nature of these inhibitors. In group 2, addition of MNase resulted only in a marginal increase in NET degradation (from median 10.5\u201320.9%; Fig. 3A, orange circles vs. orange circles with black border), indicating the presence of factor(s) that protect NETs from enzymatic degradation.",
            "metadata": {
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "73bed399-3a8a-4a66-b563-db128cd1d19f",
        "_rev": "_WpvYGJ--_u",
        "nanopub": {
            "id": "73bed399-3a8a-4a66-b563-db128cd1d19f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "EFO:HeLa",
                    "label": "HeLa",
                    "type": "CellLine"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Huang, Ying",
                    "Li, Wenge",
                    "Kong, Ah-Ng Tony"
                ],
                "database": {
                    "id": "23190551",
                    "name": "PubMed"
                },
                "source_name": "Cell & bioscience",
                "title": "Anti-oxidative stress regulator NF-E2-related factor 2 mediates the adaptive induction of antioxidant and detoxifying enzymes by lipid peroxidation metabolite 4-hydroxynonenal.",
                "abstract": "NF-E2-related factor 2 (NRF2) regulates a battery of antioxidative and phase II drug metabolizing/detoxifying genes through binding to the antioxidant response elements (ARE). NRF2-ARE signaling plays a central role in protecting cells from a wide spectrum of reactive toxic species including reactive oxygen/nitrogen species (RONS). 4-hydroxylnonenal (4-HNE) is a major end product from lipid peroxidation of omega-6 polyunsaturated fatty acids (PUFA) induced by oxidative stress, and it is highly reactive to nucleophilic sites in DNA and proteins, causing cytotoxicity and genotoxicity. In this study, we examined the role of NRF2 in regulating the 4-HNE induced gene expression of antioxidant and detoxifying enzymes.",
                "date_published": "2012-11-28"
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:4-hydroxynon-2-enal)",
                    "relation": "increases",
                    "object": "p(HGNC:NFE2L2)"
                }
            ],
            "evidence": "HeLa cells were treated with 10 \u03bcM 4-HNE for 0, 0.5,1 and 4 h. 4-HNE markedly elevated the nuclear NRF2 protein level, with the highest accumulation at 0.5 h after treatment (Figure 1C). ",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6a698635-8aca-4951-9c11-7ad2ec694540",
        "_rev": "_WpvYGJG-Ag",
        "nanopub": {
            "id": "6a698635-8aca-4951-9c11-7ad2ec694540",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "50 SLE patients",
                    "type": "cohort"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Yang, Ji",
                    "Chu, Yiwei",
                    "Yang, Xue",
                    "Gao, Di",
                    "Zhu, Lubing",
                    "Yang, Xinrong",
                    "Wan, Linlin",
                    "Li, Ming"
                ],
                "database": {
                    "id": "19404966",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Th17 and natural Treg cell population dynamics in systemic lupus erythematosus.",
                "abstract": "To investigate the relative abundance and activities of Th17 cells and natural Treg cells in systemic lupus erythematosus (SLE)."
            },
            "assertions": [
                {
                    "subject": "a(CL:\"T-helper 17 cell\")",
                    "relation": "increases",
                    "object": "path(MESH:Inflammation)"
                }
            ],
            "evidence": "Th17 cells and microenvironmental IL\u201017A are involved in vascular inflammation in SLE. Antagonism of Th17 cells by IL\u201017A\u2013blocking antibodies should be explored as a treatment of SLE.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "To investigate the relative abundance and activities of Th17 cells and natural Treg cells in systemic lupus erythematosus (SLE).",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "533b65ab-7030-4a5c-8145-77e7bc521fae",
        "_rev": "_WpvYGJC-Bj",
        "nanopub": {
            "id": "533b65ab-7030-4a5c-8145-77e7bc521fae",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "database": {
                    "id": "20150840",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(8-epi-PGF2alpha)",
                    "relation": "biomarkerFor",
                    "object": "a(bp(MESH:\"Oxidative Stress\"))"
                }
            ],
            "evidence": "8-iso-prostaglandin F2alpha (8-iso-PGF2alpha) is a stable isoprostane and reliable marker of oxidative stress in vivo.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "06440e79-6ecd-4cc9-8195-fe1b1101dcd3",
        "_rev": "_WpvYGJ--CH",
        "nanopub": {
            "id": "06440e79-6ecd-4cc9-8195-fe1b1101dcd3",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Immunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "BaF3",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "27193299",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL12RB1)",
                    "relation": "increases",
                    "object": "p(HGNC:TYK2)"
                }
            ],
            "evidence": "In contrast, Tyk2 was phosphorylated only in cells expressing E12R1 or E12R11E12R2 and not in cells expressing E12R2 alone\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "38e830f3-b250-4c60-99ba-8de3c382139a",
        "_rev": "_WpvYGJG--c",
        "nanopub": {
            "id": "38e830f3-b250-4c60-99ba-8de3c382139a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "Radioimmuno Assay",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "6 healthy obese, nonobese, and 6 noninsulin-dependent diabetes patients",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:obesity",
                    "label": "obesity",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "7512573",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Fasting\")",
                    "relation": "decreases",
                    "object": "p(HGNC:IGF1)"
                }
            ],
            "evidence": "In the OB subjects, the mean prefasting IGF-I concentration was 187 +/- 19 ug/L. A 23% (P<0.05) DECREASE IN igf-1 WAS FIRST OBSERVED IN THESE SUBJECTS AFTER 84H OF FASTING\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ef86200b-0e19-4c9c-8aa3-98ce33a9a58e",
        "_rev": "_WpvYGJC-_7",
        "nanopub": {
            "id": "ef86200b-0e19-4c9c-8aa3-98ce33a9a58e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CLO:\"Hep 3B cell\"",
                    "label": "Hep 3B cell",
                    "type": "CellLine"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Conti, P",
                    "Bartle, L",
                    "Barbacane, R C",
                    "Reale, M",
                    "Placido, F C",
                    "Sipe, J"
                ],
                "database": {
                    "id": "7790046",
                    "name": "PubMed"
                },
                "source_name": "Immunological investigations",
                "title": "Synergistic activation of serum amyloid A (SAA) by IL-6 and IL-1 in combination on human Hep 3B hepatoma cell line. Role of PGE2 and IL-1 receptor antagonist.",
                "abstract": "Serum amyloid A (SAA) protein is a major acute phase reactant in human and many other species. Infections and traumatic inflammation are characterized by a rapid increase of SAA; its concentration in the plasma may augment many-fold. Cytokines such as IL-1 and IL-6 are considered mediators of acute phase protein synthesis. The most accredited mechanism of action of IL-1 in inflammatory diseases is the stimulation of PGE2 release, which is highly dependent on the concentration of IL-1. In this study we found that human Hep 3B hepatoma cells treated with the combination of hrIL-6 (10ng/ml) plus hrIL-1 (1ng/ml) produced an augmentation in steady-state levels of SAA mRNA (87%) compared to hrIL-6 (10ng/ml) plus PGE2 (5 microM), which induced an increase of only 33%, compared to IL-6 alone, while cells treated with hrIL-6 plus PGE2 (0.5 microM) had a similar effect as hrIL-6 did alone. Moreover, the addition of exogenous PGE2 (5 microM) to the cell cultures produced no significant increase in concentration of SAA mRNA compared to the control. In addition, according to the data obtained by the blot analysis we also found, by ELISA method, that hrIL-6 acts in synergism with hrIL-1 on SAA protein secretion in human Hep 3B hepatoma cell cultures after 48 h incubation. In fact, the cell cultures treated with hrIL-6 plus hrIL-1 caused a higher release approximately 1.5-4-fold of SAA protein than the cells treated with IL-6 plus PGE2 5 microM or IL-1 + PGE2 5 microM, respectively. The synergistic effect of hrIL-6 plus hrIL-1 beta was inhibited by hrIL-1 receptor antagonist (hrIL-1ra) 50 micrograms/ml, a protein which specifically binds to the IL-1 receptor and is structurally similar to IL-1 beta but with no IL-1-like activity; while indomethacin (5 microM) was ineffective. These results strongly suggest that the synergism between hrIL-6 plus hrIL-1 on the transcription and the protein release of SAA release is not due to a PGE2-dependent process in human Hep 3B hepatoma cells. This finding highlights a specific biological effect of IL-1 not in relation to PGE2, suggesting a specific mechanism of action for IL-1 in regulating acute phase protein synthesis."
            },
            "assertions": [
                {
                    "subject": "a(p(IL6), p(HGNC:IL10))",
                    "relation": "increases",
                    "object": "p(HGNC:SAA1)"
                }
            ],
            "evidence": "In this study we found that human Hep 3B hepatoma cells treated with the combination of hrIL-6 (10ng/ml) plus hrIL-1 (1ng/ml) produced an augmentation in steady-state levels of SAA mRNA (87%) compared to hrIL-6 (10ng/ml) plus PGE2 (5 microM), which induced an increase of only 33%, compared to IL-6 alone, while cells treated with hrIL-6 plus PGE2 (0.5 microM) had a similar effect as hrIL-6 did alone. Moreover, the addition of exogenous PGE2 (5 microM) to the cell cultures produced no significant increase in concentration of SAA mRNA compared to the control. In addition, according to the data obtained by the blot analysis we also found, by ELISA method, that hrIL-6 acts in synergism with hrIL-1 on SAA protein secretion in human Hep 3B hepatoma cell cultures after 48 h incubation.",
            "metadata": {
                "gd:abstract": "Serum amyloid A (SAA) protein is a major acute phase reactant in human and many other species. Infections and traumatic inflammation are characterized by a rapid increase of SAA; its concentration in the plasma may augment many-fold. Cytokines such as IL-1 and IL-6 are considered mediators of acute phase protein synthesis. The most accredited mechanism of action of IL-1 in inflammatory diseases is the stimulation of PGE2 release, which is highly dependent on the concentration of IL-1. In this study we found that human Hep 3B hepatoma cells treated with the combination of hrIL-6 (10ng/ml) plus hrIL-1 (1ng/ml) produced an augmentation in steady-state levels of SAA mRNA (87%) compared to hrIL-6 (10ng/ml) plus PGE2 (5 microM), which induced an increase of only 33%, compared to IL-6 alone, while cells treated with hrIL-6 plus PGE2 (0.5 microM) had a similar effect as hrIL-6 did alone. Moreover, the addition of exogenous PGE2 (5 microM) to the cell cultures produced no significant increase in concentration of SAA mRNA compared to the control. In addition, according to the data obtained by the blot analysis we also found, by ELISA method, that hrIL-6 acts in synergism with hrIL-1 on SAA protein secretion in human Hep 3B hepatoma cell cultures after 48 h incubation. In fact, the cell cultures treated with hrIL-6 plus hrIL-1 caused a higher release approximately 1.5-4-fold of SAA protein than the cells treated with IL-6 plus PGE2 5 microM or IL-1 + PGE2 5 microM, respectively. The synergistic effect of hrIL-6 plus hrIL-1 beta was inhibited by hrIL-1 receptor antagonist (hrIL-1ra) 50 micrograms/ml, a protein which specifically binds to the IL-1 receptor and is structurally similar to IL-1 beta but with no IL-1-like activity; while indomethacin (5 microM) was ineffective. These results strongly suggest that the synergism between hrIL-6 plus hrIL-1 on the transcription and the protein release of SAA release is not due to a PGE2-dependent process in human Hep 3B hepatoma cells. This finding highlights a specific biological effect of IL-1 not in relation to PGE2, suggesting a specific mechanism of action for IL-1 in regulating acute phase protein synthesis.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "fc5a3007-dca6-4c11-96c2-04dbe47cf34e",
        "_rev": "_WpvYGJ---s",
        "nanopub": {
            "id": "fc5a3007-dca6-4c11-96c2-04dbe47cf34e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "190 SLE, 110 HC",
                    "type": "cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Denny, Michael F",
                    "Yalavarthi, Srilakshmi",
                    "Zhao, Wenpu",
                    "Thacker, Seth G",
                    "Anderson, Marc",
                    "Sandy, Ashley R",
                    "McCune, W Joseph",
                    "Kaplan, Mariana J"
                ],
                "database": {
                    "id": "20164424",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology (Baltimore, Md. : 1950)",
                "title": "A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs.",
                "abstract": "Neutrophil-specific genes are abundant in PBMC microarrays from lupus patients because of the presence of low-density granulocytes (LDGs) in mononuclear cell fractions. The functionality and pathogenicity of these LDGs have not been characterized. We developed a technique to purify LDGs from lupus PBMCs and assessed their phenotype, function, and potential role in disease pathogenesis. LDGs, their autologous lupus neutrophils, and healthy control neutrophils were compared with regard to their microbicidal and phagocytic capacities, generation of reactive oxygen species, activation status, inflammatory cytokine profile, and type I IFN expression and signatures. The capacity of LDGs to kill endothelial cells and their antiangiogenic potential were also assessed. LDGs display an activated phenotype, secrete increased levels of type I IFNs, TNF-alpha, and IFN-gamma, but show impaired phagocytic potential. LDGs induce significant endothelial cell cytotoxicity and synthesize sufficient levels of type I IFNs to disrupt the capacity of endothelial progenitor cells to differentiate into mature endothelial cells. LDG depletion restores the functional capacity of endothelial progenitor cells. We conclude that lupus LDGs are proinflammatory and display pathogenic features, including the capacity to synthesize type I IFNs. They may play an important dual role in premature cardiovascular disease development in systemic lupus erythematosus by simultaneously mediating enhanced vascular damage and inhibiting vascular repair."
            },
            "assertions": [
                {
                    "subject": "a(LDGs)\t",
                    "relation": "increases",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "PBMCs from 22 healthy individuals showed an average of 5% LDGs. This likely represents contaminating mature degranulated neutrophils in the PBMC preparations since most control samples were completely devoid of contaminating granulocytes. By comparison, all SLE preparations contained LDGs, which represented an average of 17% of total PBMCs, with a range of 1.2% to 54% (n=65, p<0.05). When total numbers of neutrophils present in the PBMC subset were compared, there was a highly significant difference between lupus patients and healthy controls (mean 0.26\u00d7106+0.08\u00d7106 cells/ml of blood versus 0.0046\u00d7106\u00b10.008\u00d7106cells/ml of blood, respectively; P=0.007) indicating an absolute significant increase which was not related to the lymphopenia commonly observed in SLE",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Neutrophil-specific genes are abundant in PBMC microarrays from lupus patients because of the presence of low-density granulocytes (LDGs) in mononuclear cell fractions. The functionality and pathogenicity of these LDGs have not been characterized. We developed a technique to purify LDGs from lupus PBMCs and assessed their phenotype, function, and potential role in disease pathogenesis. LDGs, their autologous lupus neutrophils, and healthy control neutrophils were compared with regard to their microbicidal and phagocytic capacities, generation of reactive oxygen species, activation status, inflammatory cytokine profile, and type I IFN expression and signatures. The capacity of LDGs to kill endothelial cells and their antiangiogenic potential were also assessed. LDGs display an activated phenotype, secrete increased levels of type I IFNs, TNF-alpha, and IFN-gamma, but show impaired phagocytic potential. LDGs induce significant endothelial cell cytotoxicity and synthesize sufficient levels of type I IFNs to disrupt the capacity of endothelial progenitor cells to differentiate into mature endothelial cells. LDG depletion restores the functional capacity of endothelial progenitor cells. We conclude that lupus LDGs are proinflammatory and display pathogenic features, including the capacity to synthesize type I IFNs. They may play an important dual role in premature cardiovascular disease development in systemic lupus erythematosus by simultaneously mediating enhanced vascular damage and inhibiting vascular repair.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d719dbab-6e6c-4cca-a53a-b6556e9fa85e",
        "_rev": "_WpvYGJ--_X",
        "nanopub": {
            "id": "d719dbab-6e6c-4cca-a53a-b6556e9fa85e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "143 patients allocated to either placebo or pioglitazone treatment",
                    "type": "cohort"
                },
                {
                    "id": "",
                    "label": "C-Reactive Protein",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Marder, Wendy",
                    "Khalatbari, Shokoufeh",
                    "Myles, James D",
                    "Hench, Rita",
                    "Lustig, Susan",
                    "Yalavarthi, Srilakshmi",
                    "Parameswaran, Aishwarya",
                    "Brook, Robert D",
                    "Kaplan, Mariana J"
                ],
                "database": {
                    "id": "24252844",
                    "name": "PubMed"
                },
                "source_name": "Journal of the American Heart Association",
                "title": "The peroxisome proliferator activated receptor-\u03b3 pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis.",
                "abstract": "Rheumatoid arthritis (RA) is associated with heightened mortality due to atherosclerotic cardiovascular disease (CVD). Inflammatory pathways in RA negatively affect vascular physiology and promote metabolic disturbances that contribute to CVD. We hypothesized that the peroxisome proliferator activated receptor-\u03b3 (PPAR-\u03b3) pioglitazone could promote potent vasculoprotective and anti-inflammatory effects in RA."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:pioglitazone)\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "When added to standard of care treatment of RA, disease activity measured by the DAS\u201028\u2010CRP28 significantly decreased from baseline measurements on the pioglitazone arm when compared to placebo arm (mean=0.31\u00b11.2 pioglitazone versus 0.15\u00b11.2, P=0.02) after 3 months of treatment.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Rheumatoid arthritis (RA) is associated with heightened mortality due to atherosclerotic cardiovascular disease (CVD). Inflammatory pathways in RA negatively affect vascular physiology and promote metabolic disturbances that contribute to CVD. We hypothesized that the peroxisome proliferator activated receptor-\u03b3 (PPAR-\u03b3) pioglitazone could promote potent vasculoprotective and anti-inflammatory effects in RA.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ff5e28e1-c677-47ae-be4e-2b05fb0f9fcc",
        "_rev": "_WpvYGJG-_Y",
        "nanopub": {
            "id": "ff5e28e1-c677-47ae-be4e-2b05fb0f9fcc",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Zhang, Zhikuan",
                    "Ohto, Umeharu",
                    "Shibata, Takuma",
                    "Krayukhina, Elena",
                    "Taoka, Masato",
                    "Yamauchi, Yoshio",
                    "Tanji, Hiromi",
                    "Isobe, Toshiaki",
                    "Uchiyama, Susumu",
                    "Miyake, Kensuke",
                    "Shimizu, Toshiyuki"
                ],
                "database": {
                    "id": "27742543",
                    "name": "PubMed"
                },
                "source_name": "Immunity",
                "title": "Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA.",
                "abstract": "Toll-like receptor 7 (TLR7) is a single-stranded RNA (ssRNA) sensor in innate immunity and also responds to guanosine and chemical ligands, such as imidazoquinoline compounds. However, TLR7 activation mechanism by these ligands remain largely unknown. Here, we generated crystal structures of three TLR7 complexes, and found that all formed an activated m-shaped dimer with two ligand-binding sites. The first site conserved in TLR7 and TLR8 was used for small ligand-binding essential for its activation. The second site spatially distinct from that of TLR8 was used for a ssRNA-binding that enhanced the affinity of the first-site ligands. The first site preferentially recognized guanosine and the second site specifically bound to uridine moieties in ssRNA. Our structural, biochemical, and mutagenesis studies indicated that TLR7 is a dual receptor for guanosine and uridine-containing ssRNA. Our findings have important implications for understanding of TLR7 function, as well as for therapeutic manipulation of TLR7 activation."
            },
            "assertions": [
                {
                    "subject": "a(ssRNA)",
                    "relation": "increases",
                    "object": "act(p(HGNC:TLR9))"
                }
            ],
            "evidence": "Our structural, biochemical, and mutagenesis studies indicated that TLR7 is a dual receptor for guanosine and uridine-containing ssRNA. ...\nMutations in the residues F408, D555, L557, and T586, all of which directly recognized first-site ligands, completely abolished the responsiveness of TLR7 to all types of stimulation, which indicated that the first site was essential for both chemical ligand- and ssRNA-induced TLR7 activation.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "16dbb12f-b830-43e7-beb4-a5373036d2eb",
        "_rev": "_WpvYGJ--Cc",
        "nanopub": {
            "id": "16dbb12f-b830-43e7-beb4-a5373036d2eb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:\"Vogt-Koyanagi-Harada disease\"",
                    "label": "Vogt-Koyanagi-Harada disease",
                    "type": "Disease"
                },
                {
                    "id": "",
                    "label": "12 VKH patients, 20 controlled",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "FACS",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "23482469",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:berberine)",
                    "relation": "decreases",
                    "object": "bp(GO:\"T-helper 17 cell differentiation\")"
                }
            ],
            "evidence": "In this study, we demonstrated that BBR could directly inhibit IL-17 production by CD4+\u00a0T cells and the DC-mediated differentiation of CD4+\u00a0IL-17+\u00a0T cells from both VKH patients and healthy donors.\u00a0\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "82110771-6703-4ca5-8eb1-d30117537eb7",
        "_rev": "_WpvYGJ---Z",
        "nanopub": {
            "id": "82110771-6703-4ca5-8eb1-d30117537eb7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.049",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "7,319 Chinese adults from the China Health and Nutrition Survey (CHNS).",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "linear mixed-effects model",
                    "type": "Methodology"
                },
                {
                    "id": "DO:obesity",
                    "label": "obesity",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "25618516",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(rs1458038)",
                    "relation": "positiveCorrelation",
                    "object": "bp(MESH:\"Blood Pressure\")"
                }
            ],
            "evidence": "The signal at rs1458038 exhibited a genotype-by-BMI interaction affecting blood pressure (P interaction = 0.0018 for SBP; P interaction = 0.049 for DBP), with the strongest variant effects in those with the highest BMI.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "00fa6fcb-39e7-4fa3-9985-184c9da2fbf5",
        "_rev": "_WpvYGI6--D",
        "nanopub": {
            "id": "00fa6fcb-39e7-4fa3-9985-184c9da2fbf5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "40 RA patients, 40 HC age/sex matched",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Chung, Soo-Jin",
                    "Kwon, Yong-Jin",
                    "Park, Min-Chan",
                    "Park, Yong-Beom",
                    "Lee, Soo-Kon"
                ],
                "database": {
                    "id": "21155043",
                    "name": "PubMed"
                },
                "source_name": "Yonsei medical journal",
                "title": "The correlation between increased serum concentrations of interleukin-6 family cytokines and disease activity in rheumatoid arthritis patients.",
                "abstract": "This study was performed to determine whether the serum concentrations of interleukin (IL)-6 family cytokines are elevated in patients with rheumatoid arthritis (RA) and to investigate the relationship between IL-6 family cytokine levels and disease activity in RA patients."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"C-Reactive Protein\")"
                }
            ],
            "evidence": "",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "This study was performed to determine whether the serum concentrations of interleukin (IL)-6 family cytokines are elevated in patients with rheumatoid arthritis (RA) and to investigate the relationship between IL-6 family cytokine levels and disease activity in RA patients.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3cde69ed-9da9-4ac5-88bd-281057d41707",
        "_rev": "_WpvYGJC-_5",
        "nanopub": {
            "id": "3cde69ed-9da9-4ac5-88bd-281057d41707",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9200453",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL2)",
                    "relation": "increases",
                    "object": "act(p(HGNC:JAK1))"
                }
            ],
            "evidence": "Stimulation of T cells with 100 U/ml of IL-2 induced an increase in the in vitro kinase activity of Jak-I.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "936c33b4-ddd1-4f89-8d84-6cc7b28ac261",
        "_rev": "_WpvYGJC--q",
        "nanopub": {
            "id": "936c33b4-ddd1-4f89-8d84-6cc7b28ac261",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:obesity",
                    "label": "obesity",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "26791187",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:alanine)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Insulin Resistance\")"
                },
                {
                    "subject": "a(CHEBI:tyrosine)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Insulin Resistance\")"
                }
            ],
            "evidence": "In addition, we showed that reductions in alanine and the AAA tyrosine were significantly related to improved insulin resistance (measured with the use of the homeostasis model assessment of insulin resistance), independent of weight loss, in both trials (both\u00a0P\u00a0< 0.05).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d128a49a-d96c-46a3-86f9-9d73e81b4332",
        "_rev": "_WpvYGJC-CQ",
        "nanopub": {
            "id": "d128a49a-d96c-46a3-86f9-9d73e81b4332",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"CD4-positive helper T cell\"",
                    "label": "CD4-positive helper T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "14676299",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TGFB)",
                    "relation": "increases",
                    "object": "r(HGNC:FOXP3)"
                }
            ],
            "evidence": "Significantly, stimulation of naive responder T cells with anti-CD3 and anti-CD28 (Fig. 4B) or with anti-CD3 and APCs (Fig. 4\u00a0C) in the presence of active TGF-\u03b2 dramatically induced\u00a0Foxp3expression, which was dependent on the levels of TGF-\u03b2 (Fig. 4\u00a0D),\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "96d5385d-176a-4fad-8e10-c7f65e35a7a5",
        "_rev": "_WpvYGJ--BX",
        "nanopub": {
            "id": "96d5385d-176a-4fad-8e10-c7f65e35a7a5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ROC>0.80",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "discovery (14 active/inactive LN, 8 HC) and validation (28 active/inactive LN, 9 HC)",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "27211902",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNFRSF1B)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                }
            ],
            "evidence": "Most importantly, four serum proteins (AXL, Ferritin, Angiostatin, and sTNFRII) had the capacity to distinguish active LN from inactive disease with ROC AUC exceeding 80%, all with p < 0.01 significance (Table 3).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d410c46c-ccb7-4839-a277-f2b90bce7a1d",
        "_rev": "_WpvYGJG-AW",
        "nanopub": {
            "id": "d410c46c-ccb7-4839-a277-f2b90bce7a1d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Anatomy;Cell",
                    "id": "MESH:D019169",
                    "label": "Jurkat Cells"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "abstract": "4-Hydroxynonenal (HNE), a diffusible product of lipid peroxidation, has been suggested to be a key mediator of oxidative stress-induced cell death. In this study, we partially characterized the mechanism of HNE-mediated cytotoxicity. Incubation of human T lymphoma Jurkat cells with 20-50 microM HNE led to cell death accompanied by DNA fragmentation. Western blot analysis showed that HNE-treatment induced time- and dose-dependent activation of caspase-8, caspase-9 and caspase-3. HNE-induced caspase-3 processing was confirmed by a flow cytometric demonstration of increased catalytic activity on the substrate peptide. HNE treatment also led to remarkable cleavage of poly(ADP-ribose) polymerase (PARP), which was prevented by pretreatment of cells with DEVD-FMK as a caspase-3 inhibitor. The HNE-mediated activation of caspases, cleavage of PARP and DNA fragmentation were blocked by antioxidants cysteine, N-acety-L-cysteine and dithiothreitol, but not by two other HNE-reactive amino acids lysine and histidine, or by cystine, the oxidized form of cysteine. HNE rapidly decreased levels of intracellular reduced glutathione (GSH) and its oxidized form GSSG, and these were also attenuated by the reductants. Coincubation of Jurkat cells with a blocking anti-Fas antibody prevented Fas-induced but not HNE-induced activation of caspase-3. HNE also activated caspase-3 in K562 cells that do not express functional Fas. Our results thereby demonstrate that HNE triggers oxidative stress-linked apoptotic cell death through activation of the caspase cascade. The results also suggest a possible mechanism involving a direct scavenge of intracellular GSH by HNE.",
                "authors": [
                    "Liu, W",
                    "Kato, M",
                    "Akhand, A A",
                    "Hayakawa, A",
                    "Suzuki, H",
                    "Miyata, T",
                    "Kurokawa, K",
                    "Hotta, Y",
                    "Ishikawa, N",
                    "Nakashima, I"
                ],
                "database": {
                    "id": "10652256",
                    "name": "PubMed"
                },
                "date_published": "2000-02-01",
                "source_name": "Journal of cell science",
                "title": "4-hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:4-hydroxynon-2-enal)",
                    "relation": "decreases",
                    "object": "a(CHEBI:glutathione)"
                }
            ],
            "evidence": "As shown in Fig. 4A, intracellular GSH concentration in HNE-treated\ncells fell rapidly, and the peak of reduction was observed at 2 hours after incubation.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bdc130b4-533a-4548-8347-b0acad8cb269",
        "_rev": "_WpvYGJC-Al",
        "nanopub": {
            "id": "bdc130b4-533a-4548-8347-b0acad8cb269",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Grammatikos, Alexandros P",
                    "Ghosh, Debjani",
                    "Devlin, Amy",
                    "Kyttaris, Vasileios C",
                    "Tsokos, George C"
                ],
                "database": {
                    "id": "24013589",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Spleen tyrosine kinase (Syk) regulates systemic lupus erythematosus (SLE) T cell signaling.",
                "abstract": "Engagement of the CD3/T cell receptor complex in systemic lupus erythematosus (SLE) T cells involves Syk rather than the zeta-associated protein. Because Syk is being considered as a therapeutic target we asked whether Syk is central to the multiple aberrantly modulated molecules in SLE T cells. Using a gene expression array, we demonstrate that forced expression of Syk in normal T cells reproduces most of the aberrantly expressed molecules whereas silencing of Syk in SLE T cells normalizes the expression of most abnormally expressed molecules. Protein along with gene expression modulation for select molecules was confirmed. Specifically, levels of cytokine IL-21, cell surface receptor CD44, and intracellular molecules PP2A and OAS2 increased following Syk overexpression in normal T cells and decreased after Syk silencing in SLE T cells. Our results demonstrate that levels of Syk affect the expression of a number of enzymes, cytokines and receptors that play a key role in the development of disease pathogenesis in SLE and provide support for therapeutic targeting in SLE patients."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:SYK)\t",
                    "relation": "increases",
                    "object": "p(HGNC:OAS2)"
                },
                {
                    "subject": "p(HGNC:SYK)\t",
                    "relation": "increases",
                    "object": "p(HGNC:PP2A)"
                },
                {
                    "subject": "p(HGNC:SYK)\t",
                    "relation": "increases",
                    "object": "p(HGNC:CD44)"
                },
                {
                    "subject": "p(HGNC:SYK)",
                    "relation": "increases",
                    "object": "p(HGNC:IL21)"
                }
            ],
            "evidence": "Using a gene expression array, we demonstrate that forced expression of Syk in normal T cells reproduces most of the aberrantly expressed molecules whereas silencing of Syk in SLE T cells normalizes the expression of most abnormally expressed molecules. Protein along with gene expression modulation for select molecules was confirmed. Specifically, levels of cytokine IL-21, cell surface receptor CD44, and intracellular molecules PP2A and OAS2 increased following Syk overexpression in normal T cells and decreased after Syk silencing in SLE T cells.",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "Engagement of the CD3/T cell receptor complex in systemic lupus erythematosus (SLE) T cells involves Syk rather than the zeta-associated protein. Because Syk is being considered as a therapeutic target we asked whether Syk is central to the multiple aberrantly modulated molecules in SLE T cells. Using a gene expression array, we demonstrate that forced expression of Syk in normal T cells reproduces most of the aberrantly expressed molecules whereas silencing of Syk in SLE T cells normalizes the expression of most abnormally expressed molecules. Protein along with gene expression modulation for select molecules was confirmed. Specifically, levels of cytokine IL-21, cell surface receptor CD44, and intracellular molecules PP2A and OAS2 increased following Syk overexpression in normal T cells and decreased after Syk silencing in SLE T cells. Our results demonstrate that levels of Syk affect the expression of a number of enzymes, cytokines and receptors that play a key role in the development of disease pathogenesis in SLE and provide support for therapeutic targeting in SLE patients.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "51d8b6c9-292c-48f8-a147-0c7045923cce",
        "_rev": "_WpvYGJC--j",
        "nanopub": {
            "id": "51d8b6c9-292c-48f8-a147-0c7045923cce",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "44 RA patients, 16 HC age/sex matched",
                    "type": "cohort"
                },
                {
                    "id": "",
                    "label": "DAS28",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "authors": [
                    "Rioja, Inmaculada",
                    "Hughes, Fiona J",
                    "Sharp, Catriona H",
                    "Warnock, Linda C",
                    "Montgomery, Doug S",
                    "Akil, Mohammed",
                    "Wilson, Anthony G",
                    "Binks, Michael H",
                    "Dickson, Marion C"
                ],
                "database": {
                    "id": "18668547",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.",
                "abstract": "To determine whether the plasma levels of a range of inflammatory proteins have utility as biomarkers of disease activity in rheumatoid arthritis (RA) patients."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CSF1)\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:CXCL13)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:CCL23)\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "In anti-TNF\u2013treated RA patients, plasma levels of CXCL13 were reduced after 1 and 7days of therapy, and levels of CCL23, M-CSF, andCXCL13 showed a statistically significant positive correlation with the DAS28 score.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "To determine whether the plasma levels of a range of inflammatory proteins have utility as biomarkers of disease activity in rheumatoid arthritis (RA) patients.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f80fd310-c8c9-4dbf-9acf-dfddc9a9fd58",
        "_rev": "_WpvYGJ---n",
        "nanopub": {
            "id": "f80fd310-c8c9-4dbf-9acf-dfddc9a9fd58",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [],
            "citation": {
                "authors": [
                    "Mitanchez, Delphine",
                    "Chavatte-Palmer, Pascale"
                ],
                "database": {
                    "id": "29421859",
                    "name": "PubMed"
                },
                "source_name": "Acta paediatrica (Oslo, Norway : 1992)",
                "title": "Review shows that maternal obesity induces serious adverse neonatal effects and is associated with childhood obesity in their offspring."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:AKT1)",
                    "relation": "increases",
                    "object": "p(HGNC:EGF)"
                }
            ],
            "evidence": "",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "18056547-09bc-40ea-91d6-18331c1cb0fc",
        "_rev": "_WpvYGJC-AC",
        "nanopub": {
            "id": "18056547-09bc-40ea-91d6-18331c1cb0fc",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "17 patients and 6 healthy controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "MESH:\"Crohn Disease\"",
                    "label": "Crohn Disease",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"gastrointestinal tract (lamina propria) macrophage\"",
                    "label": "gastrointestinal tract (lamina propria) macrophage",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "10940278",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:butyrate)",
                    "relation": "decreases",
                    "object": "r(HGNC:IL1B)"
                },
                {
                    "subject": "a(CHEBI:butyrate)",
                    "relation": "decreases",
                    "object": "r(HGNC:IL6)"
                },
                {
                    "subject": "a(CHEBI:butyrate)",
                    "relation": "decreases",
                    "object": "r(HGNC:LTA)"
                }
            ],
            "evidence": "Butyrate reduced mRNA cytokine expression dose dependently in both biopsies and isolated LPMC (fig 2A).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ae83c221-cc32-444e-b64a-c4bb180f5be7",
        "_rev": "_WpvYGI6--n",
        "nanopub": {
            "id": "ae83c221-cc32-444e-b64a-c4bb180f5be7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Lymphocytes",
                    "label": "Lymphocytes",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Bortoluzzi, Alessandra",
                    "Vincenzi, Fabrizio",
                    "Govoni, Marcello",
                    "Padovan, Melissa",
                    "Ravani, Annalisa",
                    "Borea, Pier Andrea",
                    "Varani, Katia"
                ],
                "database": {
                    "id": "27566294",
                    "name": "PubMed"
                },
                "source_name": "Arthritis research & therapy",
                "title": "A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus.",
                "abstract": "Adenosine is a purine nucleoside implicated in the regulation of the innate and adaptive immune systems, acting through its interaction with four cell surface receptors: A1, A2A, A2B, and A3. There is intense interest in understanding how adenosine functions in health and during disease, but surprisingly little is known about the actual role of adenosine-mediated mechanisms in systemic lupus erythematosus (SLE). With this background, the aim of the present study was to test the hypothesis that dysregulation of A1, A2A, A2B, and A3 adenosine receptors (ARs) in lymphocytes of patients with SLE may be involved in the pathogenesis of the disease and to examine the correlations between the status of the ARs and the clinical parameters of SLE."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:ADAR)\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Among these receptors, only A2AAR mRNA expression was significantly increased in patients with SLE respect to control subjects. Western blot and densitometric analysis indicated a significant increase in A2AAR protein expression in lymphocytes of patients with SLE compared with those of healthy subjects, while no differences were found in A1, A2B, or A3 ARs (Fig. 1b, c).",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Adenosine is a purine nucleoside implicated in the regulation of the innate and adaptive immune systems, acting through its interaction with four cell surface receptors: A1, A2A, A2B, and A3. There is intense interest in understanding how adenosine functions in health and during disease, but surprisingly little is known about the actual role of adenosine-mediated mechanisms in systemic lupus erythematosus (SLE). With this background, the aim of the present study was to test the hypothesis that dysregulation of A1, A2A, A2B, and A3 adenosine receptors (ARs) in lymphocytes of patients with SLE may be involved in the pathogenesis of the disease and to examine the correlations between the status of the ARs and the clinical parameters of SLE.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a42ca377-e563-4ae7-9d60-db2a711a4859",
        "_rev": "_WpvYGJ--Az",
        "nanopub": {
            "id": "a42ca377-e563-4ae7-9d60-db2a711a4859",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.38",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TGFBR3)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f98063b2-70d3-4d94-a2da-cd90bfee8104",
        "_rev": "_WpvYGJ--Bw",
        "nanopub": {
            "id": "f98063b2-70d3-4d94-a2da-cd90bfee8104",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.03",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=6",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Smith, L L",
                    "Anwar, A",
                    "Fragen, M",
                    "Rananto, C",
                    "Johnson, R",
                    "Holbert, D"
                ],
                "database": {
                    "id": "10879444",
                    "name": "PubMed"
                },
                "source_name": "European journal of applied physiology",
                "title": "Cytokines and cell adhesion molecules associated with high-intensity eccentric exercise.",
                "abstract": "Unaccustomed, eccentrically biased exercise induces trauma to muscle and/or connective tissue. Tissue damage activates an acute inflammatory response. Inflammation requires the effective interaction of different physiological and biological systems. Much of this is coordinated by the de novo synthesis of families of protein molecules, cytokines. The purpose of the present paper was to determine changes in blood levels of various cytokines in response to exercise-induced muscle damage that was effected using high-intensity eccentric exercise. Six healthy, untrained, college-age male subjects were required to perform the eccentric phase of a bench press and a leg curl (4 sets, 12 repetitions/set) at an intensity equivalent to 100% of their previously determined one-repetition maximum. Samples of blood were drawn at the following times: before exercise and 1.5, 6, 12, 24, 48, 72, 96, 120, and 144 h after exercise. These samples were analyzed for interleukins (IL): IL-1beta, IL-6, and IL-10; tumor necrosis factor-alpha; colony stimulating factors (CSF): granulocyte-CSF, macrophage-CSF, and GM-CSF; for cell adhesion molecules (CAM): P- and E-selectin, and intercellular cell adhesion molecule (ICAM-1), and vascular cell adhesion molecule (VCAM-1). Results were analyzed using a repeated-measures analysis of variance (P = 0.05). Compared to baseline values, IL-1beta was reduced (P = 0.03) at 6, 24, and 96-144 h after exercise; IL-6 was elevated (P = 0.01) at 12, 24, and 72 h after exercise; IL-10 was elevated (P = 0.009) between 72 and 144 h after exercise; M-CSF was elevated (P = 0.005) at 12 and 48-144 h after exercise; and P-selectin was reduced (P = 0.01) between 24 and 144 h after exercise. It is concluded that when high-intensity eccentric exercise is compared to strenuous endurance exercise, post-exercise changes in cytokines do occur, but they are generally of a smaller magnitude, and occur at a later time period after the termination of exercise."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Exercise\")",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:IL1B)"
                }
            ],
            "evidence": "IL-1b was significantly reduced (P \u0088 0.03) at 6, 24, and 120 h after exercise, compared to baseline values (Fig. 1).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation",
                "gd:abstract": "Unaccustomed, eccentrically biased exercise induces trauma to muscle and/or connective tissue. Tissue damage activates an acute inflammatory response. Inflammation requires the effective interaction of different physiological and biological systems. Much of this is coordinated by the de novo synthesis of families of protein molecules, cytokines. The purpose of the present paper was to determine changes in blood levels of various cytokines in response to exercise-induced muscle damage that was effected using high-intensity eccentric exercise. Six healthy, untrained, college-age male subjects were required to perform the eccentric phase of a bench press and a leg curl (4 sets, 12 repetitions/set) at an intensity equivalent to 100% of their previously determined one-repetition maximum. Samples of blood were drawn at the following times: before exercise and 1.5, 6, 12, 24, 48, 72, 96, 120, and 144 h after exercise. These samples were analyzed for interleukins (IL): IL-1beta, IL-6, and IL-10; tumor necrosis factor-alpha; colony stimulating factors (CSF): granulocyte-CSF, macrophage-CSF, and GM-CSF; for cell adhesion molecules (CAM): P- and E-selectin, and intercellular cell adhesion molecule (ICAM-1), and vascular cell adhesion molecule (VCAM-1). Results were analyzed using a repeated-measures analysis of variance (P = 0.05). Compared to baseline values, IL-1beta was reduced (P = 0.03) at 6, 24, and 96-144 h after exercise; IL-6 was elevated (P = 0.01) at 12, 24, and 72 h after exercise; IL-10 was elevated (P = 0.009) between 72 and 144 h after exercise; M-CSF was elevated (P = 0.005) at 12 and 48-144 h after exercise; and P-selectin was reduced (P = 0.01) between 24 and 144 h after exercise. It is concluded that when high-intensity eccentric exercise is compared to strenuous endurance exercise, post-exercise changes in cytokines do occur, but they are generally of a smaller magnitude, and occur at a later time period after the termination of exercise."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "07231725-68d7-46e7-bbd7-7ee1e2a1373c",
        "_rev": "_WpvYGJ--Ac",
        "nanopub": {
            "id": "07231725-68d7-46e7-bbd7-7ee1e2a1373c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"vein endothelial cell\"",
                    "label": "vein endothelial cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "20008294",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"D3 vitamins\")",
                    "relation": "decreases",
                    "object": "tloc(p(HGNC:STAT1), fromloc(GOCC:\"cytoplasm\"), toloc(GOCC:\"nucleus\"))"
                }
            ],
            "evidence": "Treatment with 1,25D resulted in significant reduction of IFN\u03b2 mRNA and of IFN\u03b2 induced STAT1 protein and STAT1 translocation to the nucleus (Fig. 2B).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b61bbe33-c981-4e6a-ac8d-797e8c7d50d9",
        "_rev": "_WpvYGJC-CP",
        "nanopub": {
            "id": "b61bbe33-c981-4e6a-ac8d-797e8c7d50d9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.72",
                    "type": "Coefficient"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "p<0.005",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "34 LN, 30 HC (Japanese cohort)",
                    "type": "Cohort"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Nishitani, Y",
                    "Kubo, A",
                    "Iwano, M",
                    "Minamino, N",
                    "Hamano, K",
                    "Fujimoto, T",
                    "Nishino, T",
                    "Shiiki, H",
                    "Yonemasu, K",
                    "Dohi, K"
                ],
                "database": {
                    "id": "11422212",
                    "name": "PubMed"
                },
                "source_name": "Clinical and experimental immunology",
                "title": "Imbalance between interleukin-6 and adrenomedullin mRNA levels in peripheral blood mononuclear cells of patients with lupus nephritis.",
                "abstract": "In this study, we measured the mRNA levels of adrenomedullin (AM), C-type natriuretic peptide, vascular endothelial growth factor, interleukin-1beta (IL-1beta) and interleukin-6 (IL-6) in peripheral blood mononuclear cells (PBMC) of 34 patients with lupus nephritis (LN) (15 active and 19 inactive) and 30 healthy volunteers. mRNA levels were measured using a real-time quantitative PCR METHOD: Compared with healthy volunteers, IL-6 mRNA levels were elevated in LN patients (P < 0.005), while AM mRNA levels were decreased (P < 0.05). Also, IL-6 mRNA levels were higher and AM mRNA levels lower in active LN patients compared with inactive LN patients. In addition, IL-6 mRNA levels positively correlated and AM mRNA levels negatively correlated with SLE disease activity index and laboratory findings, such as blood urea nitrogen, serum creatinine, 50% haemolytic unit of complement and urinary excretion of protein over 24 h. Furthermore, IL-6 mRNA levels were negatively correlated with AM mRNA levels within the same LN patients. With regard to pathological findings, our results showed that IL-6 mRNA levels were higher, and AM mRNA levels significantly lower in patients with a high activity index compared to those with a low activity index. Following treatment with prednisolone, IL-6 mRNA levels in active LN patients decreased and AM mRNA levels increased to levels comparable to those in inactive LN and healthy volunteers. In vitro studies further demonstrated that elevated IL-6 mRNA levels in active LN patient PBMC were suppressed by the addition of adrenomedullin. Our results suggest that an imbalance between IL-6 and AM levels may play an important role in the progression of SLE, and that the mRNA levels of these genes in PBMC may be used as a disease activity index for SLE."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:IL6)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Furthermore, IL-6 mRNA levels correlated positively, and AM mRNA levels correlated negatively, with SLEDAI (Fig. 2).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation",
                "gd:abstract": "In this study, we measured the mRNA levels of adrenomedullin (AM), C-type natriuretic peptide, vascular endothelial growth factor, interleukin-1beta (IL-1beta) and interleukin-6 (IL-6) in peripheral blood mononuclear cells (PBMC) of 34 patients with lupus nephritis (LN) (15 active and 19 inactive) and 30 healthy volunteers. mRNA levels were measured using a real-time quantitative PCR METHOD: Compared with healthy volunteers, IL-6 mRNA levels were elevated in LN patients (P < 0.005), while AM mRNA levels were decreased (P < 0.05). Also, IL-6 mRNA levels were higher and AM mRNA levels lower in active LN patients compared with inactive LN patients. In addition, IL-6 mRNA levels positively correlated and AM mRNA levels negatively correlated with SLE disease activity index and laboratory findings, such as blood urea nitrogen, serum creatinine, 50% haemolytic unit of complement and urinary excretion of protein over 24 h. Furthermore, IL-6 mRNA levels were negatively correlated with AM mRNA levels within the same LN patients. With regard to pathological findings, our results showed that IL-6 mRNA levels were higher, and AM mRNA levels significantly lower in patients with a high activity index compared to those with a low activity index. Following treatment with prednisolone, IL-6 mRNA levels in active LN patients decreased and AM mRNA levels increased to levels comparable to those in inactive LN and healthy volunteers. In vitro studies further demonstrated that elevated IL-6 mRNA levels in active LN patient PBMC were suppressed by the addition of adrenomedullin. Our results suggest that an imbalance between IL-6 and AM levels may play an important role in the progression of SLE, and that the mRNA levels of these genes in PBMC may be used as a disease activity index for SLE."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f26d79c2-9574-40b5-a12a-24dd62f76316",
        "_rev": "_WpvYGJC-_j",
        "nanopub": {
            "id": "f26d79c2-9574-40b5-a12a-24dd62f76316",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Chaleckis, Romanas",
                    "Murakami, Itsuo",
                    "Takada, Junko",
                    "Kondoh, Hiroshi",
                    "Yanagida, Mitsuhiro"
                ],
                "database": {
                    "id": "27036001",
                    "name": "PubMed"
                },
                "source_name": "Proceedings of the National Academy of Sciences of the United States of America",
                "title": "Individual variability in human blood metabolites identifies age-related differences.",
                "abstract": "Metabolites present in human blood document individual physiological states influenced by genetic, epigenetic, and lifestyle factors. Using high-resolution liquid chromatography-mass spectrometry (LC-MS), we performed nontargeted, quantitative metabolomics analysis in blood of 15 young (29 \u00b1 4 y of age) and 15 elderly (81 \u00b1 7 y of age) individuals. Coefficients of variation (CV = SD/mean) were obtained for 126 blood metabolites of all 30 donors. Fifty-five RBC-enriched metabolites, for which metabolomics studies have been scarce, are highlighted here. We found 14 blood compounds that show remarkable age-related increases or decreases; they include 1,5-anhydroglucitol, dimethyl-guanosine, acetyl-carnosine, carnosine, ophthalmic acid, UDP-acetyl-glucosamine,N-acetyl-arginine,N6-acetyl-lysine, pantothenate, citrulline, leucine, isoleucine, NAD(+), and NADP(+) Six of them are RBC-enriched, suggesting that RBC metabolomics is highly valuable for human aging research. Age differences are partly explained by a decrease in antioxidant production or increasing inefficiency of urea metabolism among the elderly. Pearson's coefficients demonstrated that some age-related compounds are correlated, suggesting that aging affects them concomitantly. Although our CV values are mostly consistent with those CVs previously published, we here report previously unidentified CVs of 51 blood compounds. Compounds having moderate to high CV values (0.4-2.5) are often modified. Compounds having low CV values, such as ATP and glutathione, may be related to various diseases because their concentrations are strictly controlled, and changes in them would compromise health. Thus, human blood is a rich source of information about individual metabolic differences.",
                "date_published": "2016-04-19"
            },
            "assertions": [
                {
                    "subject": "bp(GO:aging)",
                    "relation": "negativeCorrelation",
                    "object": "a(CHEBI:\"1,5-anhydro-D-glucitol\")"
                }
            ],
            "evidence": "We found 14 blood compounds that show remarkable age-related increases or decreases; they include 1,5-anhydroglucitol, dimethyl-guanosine, acetyl-carnosine, carnosine, ophthalmic acid, UDP-acetyl-glucosamine,N-acetyl-arginine,N6-acetyl-lysine, pantothenate, citrulline, leucine, isoleucine, NAD(+), and NADP(+) \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6c487990-604b-4cfb-a98c-cc7c6b214a27",
        "_rev": "_WpvYGJ--A6",
        "nanopub": {
            "id": "6c487990-604b-4cfb-a98c-cc7c6b214a27",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.003",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=657 women",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Turbidimetric Assay",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"epithelial cell of umbilical artery\"",
                    "label": "epithelial cell of umbilical artery",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "17413107",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Magnesium)",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:CRP)"
                }
            ],
            "evidence": "Age-adjusted geometric mean plasma concentrations of CRP, E-selectin, and sICAM-1 trended toward significant decreases with increasing quintiles of magnesium intake (P\u00a0for linear trend = 0.003 for CRP, 0.001 for E-selectin, and 0.03 for sICAM-1) (Table 3)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "106c56d4-029f-49ed-a51d-3eccb02a87ab",
        "_rev": "_WpvYGJG--f",
        "nanopub": {
            "id": "106c56d4-029f-49ed-a51d-3eccb02a87ab",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "11581400",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL7)",
                    "relation": "negativeCorrelation",
                    "object": "a(GO:\"CD4 positive T lymphocytes\")"
                }
            ],
            "evidence": "\u00a0Similarly, we have found a clear negative correlation between IL-7 levels in plasma and absolute CD4+\u00a0T-cell counts in HIV-positive individuals (r\u00a0= \u22120.621;\u00a0P< 0.001) (Fig.\u00a0\u200b(Fig.4A).4A).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b1f17632-28db-4f6a-8dce-77eec1db94ff",
        "_rev": "_WpvYGJC-_v",
        "nanopub": {
            "id": "b1f17632-28db-4f6a-8dce-77eec1db94ff",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"Bursa, Synovial\"",
                    "label": "Bursa, Synovial",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "Histology",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10116",
                    "label": "rat",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "2022923",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TGFB)",
                    "relation": "increases",
                    "object": "bp(MESH:Neutrophil Infiltration\")"
                }
            ],
            "evidence": "Within 4-6 h after the intra-articular injection of 1 microgram of hrTGF-beta 1 into rat knee joints, extensive recruitment of polymorphonuclear leukocytes (PMNs) was observed\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "401bd2e8-9421-499c-b5d4-a489338092af",
        "_rev": "_WpvYGJ--Ay",
        "nanopub": {
            "id": "401bd2e8-9421-499c-b5d4-a489338092af",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"Human Umbilical Vein Endothelial Cells\"",
                    "label": "Human Umbilical Vein Endothelial Cells",
                    "type": "Cell"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Herbst, U",
                    "Toborek, M",
                    "Kaiser, S",
                    "Mattson, M P",
                    "Hennig, B"
                ],
                "database": {
                    "id": "10497308",
                    "name": "PubMed"
                },
                "source_name": "Journal of cellular physiology",
                "title": "4-Hydroxynonenal induces dysfunction and apoptosis of cultured endothelial cells."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:4-hydroxynon-2-enal)",
                    "relation": "increases",
                    "object": "bp(MESH:\"Oxidative Stress\")"
                }
            ],
            "evidence": "Exposure to HNE for 6 and 9 h resulted in increased cellular oxidative stress.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "344d6dae-c313-44a0-a69d-5e52e613123c",
        "_rev": "_WpvYGJ--AT",
        "nanopub": {
            "id": "344d6dae-c313-44a0-a69d-5e52e613123c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Noris, Marina",
                    "Remuzzi, Giuseppe"
                ],
                "database": {
                    "id": "24161035",
                    "name": "PubMed"
                },
                "source_name": "Seminars in nephrology",
                "title": "Overview of complement activation and regulation.",
                "abstract": "Complement is an important component of the innate immune system that is crucial for defense from microbial infections and for clearance of immune complexes and injured cells. In normal conditions complement is tightly controlled by a number of fluid-phase and cell surface proteins to avoid injury to autologous tissues. When complement is hyperactivated, as occurs in autoimmune diseases or in subjects with dysfunctional regulatory proteins, it drives a severe inflammatory response in numerous organs. The kidney appears to be particularly vulnerable to complement-mediated inflammatory injury. Injury may derive from deposition of circulating active complement fragments in glomeruli, but complement locally produced and activated in the kidney also may have a role. Many kidney disorders have been linked to abnormal complement activation, including immune-complex-mediated glomerulonephritis and rare genetic kidney diseases, but also tubulointerstitial injury associated with progressive proteinuric diseases or ischemia-reperfusion."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:C5A)\t",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:C5AR1)"
                },
                {
                    "subject": "p(HGNC:C3A)\t",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:C3AR1)"
                }
            ],
            "evidence": "The resultant activation products C3a and C5a bind to C3aR and C5aR expressed on T cells and augment the strength of the induced T-cell response.62 C3aR and C5aR signaling in T cells enhance T-cell proliferation and diminish T-cell apoptosis. The immune cell\u2013derived and locally produced C3a and C5a also bind to C3aR/C5aR on antigen-presenting cells, inducing the release of cytokines (eg, interleukin-12 and interleukin-13) and up-regulating costimulatory molecules such as B7, further amplifying the immune response and directing T-cell phenotype toward interferon-\u03b3\u2013producing T-helper 1 immunity.",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Complement is an important component of the innate immune system that is crucial for defense from microbial infections and for clearance of immune complexes and injured cells. In normal conditions complement is tightly controlled by a number of fluid-phase and cell surface proteins to avoid injury to autologous tissues. When complement is hyperactivated, as occurs in autoimmune diseases or in subjects with dysfunctional regulatory proteins, it drives a severe inflammatory response in numerous organs. The kidney appears to be particularly vulnerable to complement-mediated inflammatory injury. Injury may derive from deposition of circulating active complement fragments in glomeruli, but complement locally produced and activated in the kidney also may have a role. Many kidney disorders have been linked to abnormal complement activation, including immune-complex-mediated glomerulonephritis and rare genetic kidney diseases, but also tubulointerstitial injury associated with progressive proteinuric diseases or ischemia-reperfusion.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "019674bd-61ba-433b-ac38-9ea7f8ee2eef",
        "_rev": "_WpvYGI6--G",
        "nanopub": {
            "id": "019674bd-61ba-433b-ac38-9ea7f8ee2eef",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Immunoblot",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"CD4-positive helper T cell\"",
                    "label": "CD4-positive helper T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16698929",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:SOCS3)",
                    "relation": "regulates",
                    "object": "p(HGNC:STAT3, pmod(Ph, Tyr))"
                }
            ],
            "evidence": "As shown in\u00a0Fig. 3d, IL-23-induced tyrosine phosphorylation of Stat3 was enhanced in the absence of Socs3.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ad44f74e-b88c-46ef-9749-6837eb0d33b6",
        "_rev": "_WpvYGJ--_m",
        "nanopub": {
            "id": "ad44f74e-b88c-46ef-9749-6837eb0d33b6",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [],
            "citation": {
                "authors": [
                    "Lacki, J K",
                    "Samborski, W",
                    "Mackiewicz, S H"
                ],
                "database": {
                    "id": "9184265",
                    "name": "PubMed"
                },
                "source_name": "Clinical rheumatology",
                "title": "Interleukin-10 and interleukin-6 in lupus erythematosus and rheumatoid arthritis, correlations with acute phase proteins.",
                "abstract": "We sought to investigate the influence of interleukin-10 (IL-10) and IL-6 on the acute phase proteins (APP) in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). IL-10, IL-6, Creactive protein (CRP), alpha-1-acid glycoprotein (AGP), and alpha1 antichymotrypsin (ACT) serum levels were determined in one hundred-eight patients (71 with SLE, 37 with RA). Quantification of the serum IL-10 level showed increased levels in SLE and RA patients as compared to healthy controls. Serum IL-6 level was found to be elevated in SLE and RA patients. A correlation between IL-10 and IL-6 serum level was found only in SLE. CRP and AGP serum levels were increased in RA as compared to controls, whereas in SLE only AGP was found elevated. A statistically significant correlation between IL-6 serum level and CRP, AGP and ACT was found only in RA. No correlation between IL-10 and serum level of CRP, AGP and ACT was established. Since IL-10 has a potent immunosuppressive activity, we expected it to be negatively correlated with APP levels. Surprisingly, IL-10 did not correlate with APP either in SLE or RA patients. However, the elevation of IL-10 serum levels in SLE and RA and the correlation between IL-10 and IL-6 in SLE may suggest that IL-10 may play a central role in inflammatory connective tissue diseases."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IL10)"
                }
            ],
            "evidence": "A correlation between IL-10 and IL-6 serum level was found only in SLE.\u00a0",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "We sought to investigate the influence of interleukin-10 (IL-10) and IL-6 on the acute phase proteins (APP) in systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA). IL-10, IL-6, Creactive protein (CRP), alpha-1-acid glycoprotein (AGP), and alpha1 antichymotrypsin (ACT) serum levels were determined in one hundred-eight patients (71 with SLE, 37 with RA). Quantification of the serum IL-10 level showed increased levels in SLE and RA patients as compared to healthy controls. Serum IL-6 level was found to be elevated in SLE and RA patients. A correlation between IL-10 and IL-6 serum level was found only in SLE. CRP and AGP serum levels were increased in RA as compared to controls, whereas in SLE only AGP was found elevated. A statistically significant correlation between IL-6 serum level and CRP, AGP and ACT was found only in RA. No correlation between IL-10 and serum level of CRP, AGP and ACT was established. Since IL-10 has a potent immunosuppressive activity, we expected it to be negatively correlated with APP levels. Surprisingly, IL-10 did not correlate with APP either in SLE or RA patients. However, the elevation of IL-10 serum levels in SLE and RA and the correlation between IL-10 and IL-6 in SLE may suggest that IL-10 may play a central role in inflammatory connective tissue diseases.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1eed2d6f-7987-4b19-9813-07d79801ec20",
        "_rev": "_WpvYGJ--_N",
        "nanopub": {
            "id": "1eed2d6f-7987-4b19-9813-07d79801ec20",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17884812",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT3)",
                    "relation": "increases",
                    "object": "p(HGNC:IL21)"
                }
            ],
            "evidence": "Additionally, IL-21 mRNA (Fig. 1C) and protein (D) were also undetectable in Stat3-deficient cells even though wild-type cells cultured under the same conditions produced comparatively high levels of this cytokine.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6adca5fe-1ab1-4aca-a0c6-1f486581bae6",
        "_rev": "_WpvYGJG-_T",
        "nanopub": {
            "id": "6adca5fe-1ab1-4aca-a0c6-1f486581bae6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.405",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "rSLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "17257812",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNFSF12)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "In a cross-sectional study of a large, multi-center cohort of systemic lupus erythematosus (SLE) patients, uTWEAK levels were higher in patients with active as compared to never or non-active nephritis (median (IQR): 16.3 (9.9-23.0) versus 5.5 (2.3-16.8) pg/mg creatinine, p=0.001), and levels of uTWEAK correlated with the renal SLE disease activity index (rSLEDAI) score (r=0.405, p<0.001).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ad134116-ab59-407d-98f3-09449afd27ce",
        "_rev": "_WpvYGJ--BS",
        "nanopub": {
            "id": "ad134116-ab59-407d-98f3-09449afd27ce",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "11581400",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"HIV Seropositivity\")",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IL7)"
                }
            ],
            "evidence": "The HIV-positive group had significantly (P < 0.001) higher levels of IL-7 than the healthy donor group ",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "73664949-0165-4e46-851f-46aa319e2311",
        "_rev": "_WpvYGJC-Br",
        "nanopub": {
            "id": "73664949-0165-4e46-851f-46aa319e2311",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"Human Umbilical Vein Endothelial Cells\"",
                    "label": "Human Umbilical Vein Endothelial Cells",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Herbst, U",
                    "Toborek, M",
                    "Kaiser, S",
                    "Mattson, M P",
                    "Hennig, B"
                ],
                "database": {
                    "id": "10497308",
                    "name": "PubMed"
                },
                "source_name": "Journal of cellular physiology",
                "title": "4-Hydroxynonenal induces dysfunction and apoptosis of cultured endothelial cells.",
                "abstract": "Lipolytic products of triglyceride-rich lipoproteins, i.e., free fatty acids, may cause activation and dysfunction of the vascular endothelium. Mechanisms of these effects may include lipid peroxidation. One of the major and biologically active products of peroxidation of n-6 fatty acids, such as linoleic acid or arachidonic acid, is the aldehyde 4-hydroxynonenal (HNE). To study the hypothesis that HNE may be a critical factor in endothelial cell dysfunction caused by free fatty acids, human umbilical endothelial cells (HUVEC) were treated with up to160 microM of linoleic or arachidonic acid. HNE formation was detected by immunocytochemistry in cells treated for 24 h with either fatty acid, but more markedly with arachidonic acid. To study the cellulareffects of HNE, HUVEC were treated with different concentrations of this aldehyde, and several markers of endothelial cell dysfunction were determined. Exposure to HNE for 6 and 9 h resulted in increased cellular oxidative stress. However, short time treatment with HNE did not cause activation of nuclear factor-kappaB (NF-kappaB). In addition, HUVEC exposure to HNE caused a dose-dependent decrease in production of both interleukin-8 (IL-8) and intercellular adhesion molecule-1 (ICAM-1). On the other hand, HNE exerted prominent cytotoxic effects in cultured HUVEC, manifested by morphological changes, diminished cellular viability, and impaired endothelial barrier function. Furthermore, HNE treatment induced apoptosis of HUVEC. These data provide evidence that HNE does not contribute to NF-kappaB-related mechanisms of the inflammatory response in HUVEC, but rather to endothelial dysfunction, cytotoxicity, and apoptotic cell death."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Arachidonic Acid\")",
                    "relation": "increases",
                    "object": "a(CHEBI:\"(2E,4R)-4-hydroxynon-2-enal\")"
                }
            ],
            "evidence": "To study the hypothesis that HNE may be a critical factor in endothelial cell dysfunction caused by free fatty acids, human umbilical endothelial cells (HUVEC) were treated with up to160 \u03bcM of linoleic or arachidonic acid. HNE formation was detected by immunocytochemistry in cells treated for 24 h with either fatty acid, but more markedly with arachidonic acid. \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f45c5386-2f2b-466f-bb83-77f57f93c76b",
        "_rev": "_WpvYGJG-Ax",
        "nanopub": {
            "id": "f45c5386-2f2b-466f-bb83-77f57f93c76b",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17884812",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT3)",
                    "relation": "increases",
                    "object": "r(HGNC:IL21)"
                }
            ],
            "evidence": "Additionally, IL-21 mRNA (Fig. 1C) and protein (D) were also undetectable in Stat3-deficient cells even though wild-type cells cultured under the same conditions produced comparatively high levels of this cytokine.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "98202ef6-040e-4e12-9fa7-86fad29191b4",
        "_rev": "_WpvYGJC--0",
        "nanopub": {
            "id": "98202ef6-040e-4e12-9fa7-86fad29191b4",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15100259",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "act(a(CL:\"regulatory T cell\"))",
                    "relation": "association",
                    "object": "sec(p(HGNC:IL10))"
                },
                {
                    "subject": "act(a(CL:\"regulatory T cell\"))\t",
                    "relation": "association",
                    "object": "p(HGNC:TGFB)"
                }
            ],
            "evidence": "The suppressive effects of Treg2 cells on the proliferative response of CD8+\u00a0cells to alloantigens are also cytokine dependent. The inhibition was reversed by neutralization of TGF-\u03b2 and IL-10.\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6e79035b-52de-48c9-8a31-4ef10e82ccc4",
        "_rev": "_WpvYGJC--w",
        "nanopub": {
            "id": "6e79035b-52de-48c9-8a31-4ef10e82ccc4",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "CL:\"pulmonary artery endothelial cell\"",
                    "label": "pulmonary artery endothelial cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Hart, C M",
                    "Karman, R J",
                    "Blackburn, T L",
                    "Gupta, M P",
                    "Garcia, J G",
                    "Mohler, E R"
                ],
                "database": {
                    "id": "9482161",
                    "name": "PubMed"
                },
                "source_name": "Prostaglandins, leukotrienes, and essential fatty acids",
                "title": "Role of 8-epi PGF2alpha, 8-isoprostane, in H2O2-induced derangements of pulmonary artery endothelial cell barrier function.",
                "abstract": "The non-enzymatic peroxidation product of arachidonic acid, 8-epi-PGF2alpha or 8-isoprostane (8-IP) was measured in H2O2-exposed cultured pulmonary artery endothelial cell (PAEC) monolayers using a commercially-available enzyme immunoassay kit. H2O2 (50 microM for 1-30 min) significantly increased 8-IP production in a time-dependent fashion. Treatment with higher H2O2 concentrations (100 or 250 microM) failed to further increase 8-IP generation. Determinations of thiobarbituric acid reactive substances (TBARS) and lipid hydroperoxides (LOOH) were not sufficiently sensitive to detect lipid peroxidation in PAEC exposed to 50 microM H2O2 for 15 min. 8-IP (100 pM-500 nM for 2 h) caused PAEC monolayer barrier dysfunction measured as the transmonolayer clearance of albumin without causing significant PAEC cytotoxicity (measured as intracellular lactate dehydrogenase release). This is the first report to provide evidence that 8-IP generated in H2O2-exposed PAEC contributes to oxidant-mediated alterations in monolayer barrier function at non-cytotoxic concentrations."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Hydrogen Peroxide\")",
                    "relation": "increases",
                    "object": "a(CHEBI:\"8-epi-prostaglandin F2alpha\")"
                }
            ],
            "evidence": "H2O2 (50 microM for 1-30 min) significantly increased 8-IP production in a time-dependent fashion.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "fd256f15-ae64-44e0-97b0-c964f6523f94",
        "_rev": "_WpvYGJ--_d",
        "nanopub": {
            "id": "fd256f15-ae64-44e0-97b0-c964f6523f94",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "7964469",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:\"regulatory T cell\")",
                    "relation": "decreases",
                    "object": "bp(GO:\"immunoglobulin production\")"
                }
            ],
            "evidence": "Whereas the addition of IL-2-activated NK cells did not have this effect, the combination of activated NK and CD8 \u00a7 cells markedly suppressed Ig production in eight separate experiments.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "aa2be82d-2db6-420f-9f91-fe9dc4928ee7",
        "_rev": "_WrNJiGK---",
        "nanopub": {
            "id": "aa2be82d-2db6-420f-9f91-fe9dc4928ee7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "40 SLE, 30 HCs",
                    "type": "cohort"
                },
                {
                    "id": "",
                    "label": "SELENA-SLEDAI",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "authors": [
                    "Henriques, Ana",
                    "Teixeira, Lu\u00eds",
                    "In\u00eas, Lu\u00eds",
                    "Carvalheiro, Tiago",
                    "Gon\u00e7alves, Ana",
                    "Martinho, Ant\u00f3nio",
                    "Pais, Maria Lu\u00edsa",
                    "da Silva, Jos\u00e9 Ant\u00f3nio Pereira",
                    "Paiva, Artur"
                ],
                "database": {
                    "id": "23377197",
                    "name": "PubMed"
                },
                "source_name": "Clinical rheumatology",
                "title": "NK cells dysfunction in systemic lupus erythematosus: relation to disease activity.",
                "abstract": "Through their cytotoxic capacities and cytokine production, natural killer (NK) cells modulate autoimmune diseases. However, their role in the pathogenesis of systemic lupus erythematosus (SLE) has not been extensively studied. The aim of this study was to analyse the immunophenotypic and functional characteristics of the two major NK cell subsets in SLE and relate them with disease activity. Peripheral blood samples from 44 patients with active (n\u2009=\u200918) and inactive SLE (n\u2009=\u200926) and 30 controls were analysed by flow cytometry to evaluate NK cell subsets, according to: the differential expression of CXCR3 and CD57; expression of granzyme B and perforin; and production of interferon gamma (IFN-\u03b3) and tumor necrosis alpha (TNF-\u03b1), after PMA/ionomycin activation. A clear decrease in absolute and relative numbers of circulating NK cells was found in SLE, particularly in active disease, while the proportions of the major NK cell subsets were unaffected. Active SLE was associated with a reduced CXCR3 expression on both NK cell subsets and a lower frequency of CD56(dim) NK cells expressing CXCR3. Furthermore, granzyme B expression was decreased in both SLE groups, but the percentage of NK cells expressing granzyme B and perforin was higher, particularly in active disease. We found a significant decrease in the percentage of CD56(bright) and CD56(dim) NK cells producing TNF-\u03b1 and of its expression on CD56(dim) NK cells in active disease, while IFN-\u03b3 expression on CD56(bright) NK cells was increased in both SLE groups. Our findings suggest that NK cell subsets exhibit unique phenotypic and functional changes that are particularly evident in active SLE, and they may have the potential to affect the disease outcome."
            },
            "assertions": [
                {
                    "subject": "a(CL:\"CD56-bright natural killer cell\")",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "A negative correlation was also observed between SLEDAI and (1) the proportion of TNF-\u03b1-producing CD56bright NK cells; (2) the proportion of CXCR3-expressing CD56dimNK cells; and (3) the expression of CXCR3 on both NK cell subsets (Fig. 2).",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Through their cytotoxic capacities and cytokine production, natural killer (NK) cells modulate autoimmune diseases. However, their role in the pathogenesis of systemic lupus erythematosus (SLE) has not been extensively studied. The aim of this study was to analyse the immunophenotypic and functional characteristics of the two major NK cell subsets in SLE and relate them with disease activity. Peripheral blood samples from 44 patients with active (n\u2009=\u200918) and inactive SLE (n\u2009=\u200926) and 30 controls were analysed by flow cytometry to evaluate NK cell subsets, according to: the differential expression of CXCR3 and CD57; expression of granzyme B and perforin; and production of interferon gamma (IFN-\u03b3) and tumor necrosis alpha (TNF-\u03b1), after PMA/ionomycin activation. A clear decrease in absolute and relative numbers of circulating NK cells was found in SLE, particularly in active disease, while the proportions of the major NK cell subsets were unaffected. Active SLE was associated with a reduced CXCR3 expression on both NK cell subsets and a lower frequency of CD56(dim) NK cells expressing CXCR3. Furthermore, granzyme B expression was decreased in both SLE groups, but the percentage of NK cells expressing granzyme B and perforin was higher, particularly in active disease. We found a significant decrease in the percentage of CD56(bright) and CD56(dim) NK cells producing TNF-\u03b1 and of its expression on CD56(dim) NK cells in active disease, while IFN-\u03b3 expression on CD56(bright) NK cells was increased in both SLE groups. Our findings suggest that NK cell subsets exhibit unique phenotypic and functional changes that are particularly evident in active SLE, and they may have the potential to affect the disease outcome.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.9020000",
                "gd:updateTS": "2018-04-17T13:29:16.158Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "88f36c27-ddaf-4507-92bc-6d708df4adb3",
        "_rev": "_WpvYGJ--B6",
        "nanopub": {
            "id": "88f36c27-ddaf-4507-92bc-6d708df4adb3",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"HeLa cell\"",
                    "label": "HeLa cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "11057907",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite(p(HGNC:UBC13), p(HGNC:UBE2V1 ))",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:IKBKA), pmod(Ph))"
                }
            ],
            "evidence": "n the presence of TRAF6, the recombinant Ubc13 and Uev1A activated IKK in a manner that correlated with the formation of the heterodimer (Figure 4A).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8e16f586-590b-42cf-ac1f-9de1ca932fa7",
        "_rev": "_WpvYGJ--A3",
        "nanopub": {
            "id": "8e16f586-590b-42cf-ac1f-9de1ca932fa7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "28713531",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fasting\")",
                    "relation": "increases",
                    "object": "p(HGNC:NGF)"
                }
            ],
            "evidence": "NGF levels in the second group showed a significant increase by 10% compared to the control group (P<0.05). In addition, the levels of NGF in the third group were significantly increased compared to the second group by 14.7% and control group by 23.2%\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "711584e6-990a-45e4-8ece-766ac18fbdd8",
        "_rev": "_WpvYGI6--_",
        "nanopub": {
            "id": "711584e6-990a-45e4-8ece-766ac18fbdd8",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"HBE135-E6E7 cell\"",
                    "label": "HBE135-E6E7 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "27723765",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:Act1)\t",
                    "relation": "increases",
                    "object": "r(HGNC:LCN2)"
                },
                {
                    "subject": "p(HGNC:Act1)\t",
                    "relation": "increases",
                    "object": "r(HGNC:IL19)"
                },
                {
                    "subject": "p(HGNC:Act1)",
                    "relation": "increases",
                    "object": "r(HGNC:CCL20)"
                }
            ],
            "evidence": "In addition to DEFB4, we found that a number of previously established IL-17A target genes were upregulated by Act1 expression, including: CCL20, IL-19, LCN2, S100A7, S100A9, S100A12 (Fig 3A).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a9a9a6a9-cb46-4ab1-952a-34f99b39677c",
        "_rev": "_WpvYGJ--_R",
        "nanopub": {
            "id": "a9a9a6a9-cb46-4ab1-952a-34f99b39677c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLAM-R",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "0.57",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL19)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e1f7155e-0ee3-4720-9ddf-7d2d68d85421",
        "_rev": "_WpvYGJC-_4",
        "nanopub": {
            "id": "e1f7155e-0ee3-4720-9ddf-7d2d68d85421",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "DAS20",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "0.021",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "44 Early RA, 78 Longstanding RA, 31 HC,\u00a0",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Ballara, S",
                    "Taylor, P C",
                    "Reusch, P",
                    "Marm\u00e9, D",
                    "Feldmann, M",
                    "Maini, R N",
                    "Paleolog, E M"
                ],
                "database": {
                    "id": "11592367",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritis.",
                "abstract": "To determine whether elevated levels of the angiogenic cytokine vascular endothelial growth factor (VEGF), detected on presentation to an early arthritis clinic, are associated with the development of chronic and erosive arthritis."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:VEGFA)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "Combination of the swollen joint counts, tender joint counts, and the ESR produced the DAS (20), and comparison of the DAS at first presentation with serum VEGF levels at the same time point in the patients with early RA showed a significant correlation (Pearson's r = 0.404, P = 0.021) (Figure 3b).\u00a0",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "fef877ab-010b-4108-aace-c34bd2b16906",
        "_rev": "_WpvYGJ--AZ",
        "nanopub": {
            "id": "fef877ab-010b-4108-aace-c34bd2b16906",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Chaleckis, Romanas",
                    "Murakami, Itsuo",
                    "Takada, Junko",
                    "Kondoh, Hiroshi",
                    "Yanagida, Mitsuhiro"
                ],
                "database": {
                    "id": "27036001",
                    "name": "PubMed"
                },
                "source_name": "Proceedings of the National Academy of Sciences of the United States of America",
                "title": "Individual variability in human blood metabolites identifies age-related differences.",
                "abstract": "Metabolites present in human blood document individual physiological states influenced by genetic, epigenetic, and lifestyle factors. Using high-resolution liquid chromatography-mass spectrometry (LC-MS), we performed nontargeted, quantitative metabolomics analysis in blood of 15 young (29 \u00b1 4 y of age) and 15 elderly (81 \u00b1 7 y of age) individuals. Coefficients of variation (CV = SD/mean) were obtained for 126 blood metabolites of all 30 donors. Fifty-five RBC-enriched metabolites, for which metabolomics studies have been scarce, are highlighted here. We found 14 blood compounds that show remarkable age-related increases or decreases; they include 1,5-anhydroglucitol, dimethyl-guanosine, acetyl-carnosine, carnosine, ophthalmic acid, UDP-acetyl-glucosamine,N-acetyl-arginine,N6-acetyl-lysine, pantothenate, citrulline, leucine, isoleucine, NAD(+), and NADP(+) Six of them are RBC-enriched, suggesting that RBC metabolomics is highly valuable for human aging research. Age differences are partly explained by a decrease in antioxidant production or increasing inefficiency of urea metabolism among the elderly. Pearson's coefficients demonstrated that some age-related compounds are correlated, suggesting that aging affects them concomitantly. Although our CV values are mostly consistent with those CVs previously published, we here report previously unidentified CVs of 51 blood compounds. Compounds having moderate to high CV values (0.4-2.5) are often modified. Compounds having low CV values, such as ATP and glutathione, may be related to various diseases because their concentrations are strictly controlled, and changes in them would compromise health. Thus, human blood is a rich source of information about individual metabolic differences.",
                "date_published": "2016-04-19"
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"D-glucose 6-phosphate\"",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:\"fructose 6-phosphate\")"
                }
            ],
            "evidence": "Second, potential correlations among RBC-enriched glucose-6-phosphate (G-6-P), fructose-6-phosphate (F-6-P), diphospho-glycerate (DG), and phosphoglycerate (PG) were examined (Fig. 2B). Very strong correlations were found between G-6-P and F-6-P, between DG and PG, between F-6-P and DG, and between G-6-P and DG. These RBC compounds are components of the glycolytic pathway.",
            "metadata": {
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d0032578-6ce1-4a29-8511-b75664506ad9",
        "_rev": "_WpvYGJG--h",
        "nanopub": {
            "id": "d0032578-6ce1-4a29-8511-b75664506ad9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Propidium Iodide Staining",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"B cell\"",
                    "label": "B cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12023955",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT6)",
                    "relation": "decreases",
                    "object": "bp(GO:\"apoptotic process\")"
                }
            ],
            "evidence": "In contrast to T cells, however, the addition of IL-4 to the Stat6-deficient B cell culture resulted in only a partial rescue from apoptosis (Fig.1\u00a0B).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7fe0444c-8f22-4262-8b27-291e184e7a8a",
        "_rev": "_WpvYGJG--q",
        "nanopub": {
            "id": "7fe0444c-8f22-4262-8b27-291e184e7a8a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"Pressure Ulcer\"",
                    "label": "Pressure Ulcer",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10582130",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Pressure Ulcer\")",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:Gly-Pro)"
                }
            ],
            "evidence": "The urine from patients with pressure sores contained significantly more gly-pro than the urine from the control.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "88dbc097-5d85-4431-b4c4-499dccc1c74d",
        "_rev": "_WpvYGI6--R",
        "nanopub": {
            "id": "88dbc097-5d85-4431-b4c4-499dccc1c74d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "AE7",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "16275766",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CKI)",
                    "relation": "increases",
                    "object": "p(HGNC:TBX21, pmod(Ph, S, 508))"
                }
            ],
            "evidence": "Although PKA-induced phosphorylation was not different among the WT, S508A, and S498A T-bet proteins, CKI-mediated phosphorylation of the S508A mutant, but not the S498A control mutant, was reduced dramatically compared with WT proteins (Fig. 2\u00a0C).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1c639e1e-8d2f-4f04-a5c8-08b2b0f8f2d0",
        "_rev": "_WpvYGJC--v",
        "nanopub": {
            "id": "1c639e1e-8d2f-4f04-a5c8-08b2b0f8f2d0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "p<0.003",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "12 VKH patients, 20 controlled",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "FCM",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"dendritic cell\"",
                    "label": "dendritic cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "23482469",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:berberine)",
                    "relation": "decreases",
                    "object": "surf(p(HGNC:CD86))"
                }
            ],
            "evidence": "BBR also suppressed the expression of costimulatory molecules in DCs, which is in agreement with earlier findings in animals, which showed that BBR was able to downregulate the expression of CD80 and CD86 in mouse DCs stimulated by LPS.\u00a0\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "14f90cda-cfd9-4f9a-83d0-3bd537ed63cb",
        "_rev": "_WpvYGJG-_v",
        "nanopub": {
            "id": "14f90cda-cfd9-4f9a-83d0-3bd537ed63cb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "22 pediatric SLE patients, 17 HC",
                    "type": "cohort"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Guo, Yanyan",
                    "Chai, Qinghe",
                    "Zhao, Yun",
                    "Li, Peng",
                    "Qiao, Jie",
                    "Huang, Jianping"
                ],
                "comments": "pediatric SLE",
                "database": {
                    "id": "26884963",
                    "name": "PubMed"
                },
                "source_name": "International journal of clinical and experimental medicine",
                "title": "Increased activation of toll-like receptors-7 and -8 of peripheral blood mononuclear cells and upregulated serum cytokines in patients with pediatric systemic lupus erythematosus.",
                "abstract": "Autoimmune disease systemic lupus erythematosus (SLE) is associated with increased expression of pro-inflammatory cytokines such as interferons (IFNs) and specific interleukins (ILs), which are induced by toll-like receptors (TLRs). The present study aimed to examine the serum levels of cytokines, the activation of TLR-7 and TLR-8 of peripheral blood mononuclear cells (PBMCs) from pediatric SLE patients, and to investigate the response of those PBMCs to viral RNA via the TLR-7 and TLR-8 signaling. Results demonstrated that pediatric SLE patients had increased serum concentrations of interleukin (IL)-1\u03b2, IL-6, IL-8, IL-10, and IFN-\u03b1, and promoted activation of TLR-7 and TLR-8, compared to control subjects. Moreover, the peripheral blood mononuclear cells (PBMCs) from pediatric SLE patients were more sensitive to the stimulation by the transfection with viral RNA from influenza virus, with a promoted activation of TLR-7 and TLR-8 signaling. In conclusion, pro-inflammatory cytokines, such as IL-1\u03b2, IL-6, IL-8, IL-10, and IFN-\u03b1 were promoted in pediatric SLE patients, with an increased activation of TLR-7 and TLR-8 to the stimuli, such as virus infection. It implies the TLR-7 and TLR-8 activation by virus infection might play an important role in the pathogenesis of pediatric SLE."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:TLR9)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "r(HGNC:TLR7)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Firstly, the percentage of PBMCs with the positivity of various type of TLR in each subject was counted. Table 2 indicated that there was no significant difference in the TLR-2- or TLR-4-positivity between pediatric SLE patients and normal subjects (P = 0.066 for TLR-2 or P = 0.066 for TLR-4), whereas there were significantly more TLR-7-, TLR-8- or TLR-9-positive PBMCs in the pediatric SLE patients than in normal subjects (P<0.0001 for TLR-7-positivity, P<0.001 for TLR-8-positivity or P<0.01 for TLR-9-positivity).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "72e3f200-3f17-4ec6-a6d3-cebbe4435b51",
        "_rev": "_WpvYGJC-_L",
        "nanopub": {
            "id": "72e3f200-3f17-4ec6-a6d3-cebbe4435b51",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL1RN)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "A significant pre-flare increase in IL-1\u03b2 and decrease in IL-1RA resulted in a 2.7-fold decrease in the IL-1RA:IL-1\u03b2 ratio compared to stable periods in the same patient (Figure 2G). \n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bfbf9316-07de-46cf-94d0-03e9e0e5a175",
        "_rev": "_WpvYGJG-A0",
        "nanopub": {
            "id": "bfbf9316-07de-46cf-94d0-03e9e0e5a175",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18469800",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite (p(HGNC:IL21), p(HGNC:TGFB))",
                    "relation": "increases",
                    "object": "r(HGNC:RORC2)"
                }
            ],
            "evidence": "The combination of TGF-\u03b2 and IL-21 induced high levels of\u00a0RORC2\u00a0(Fig. 2a), consistent with their ability to induce IL-17A secretion from naive human CD4+\u00a0T cells.\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e5410877-f12e-4dea-a10a-494e92cc0fb5",
        "_rev": "_WpvYGJ--Br",
        "nanopub": {
            "id": "e5410877-f12e-4dea-a10a-494e92cc0fb5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Gel Shift Assay",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "EFO:THP-1",
                    "label": "THP-1",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "9523025",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:tocopherol)",
                    "relation": "decreases",
                    "object": "tloc(complex(p(HGNC:NFKB1),p(HGNC:NFKB2)), fromloc(GOCC:\"cytoplasm\"), toloc(GOCC:\"nucleus\"))"
                }
            ],
            "evidence": "Treatment with TS decreased LPS-inducible activation of NF-\u03baB. Inhibition with 50 \u00b5M TS amounted to 43% (Fig. 3(B)). A\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6589db0a-76e9-4227-bb31-d631c274312f",
        "_rev": "_WpvYGJ--_5",
        "nanopub": {
            "id": "6589db0a-76e9-4227-bb31-d631c274312f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Frob\u00f8se, Helle",
                    "R\u00f8nn, Sif Groth",
                    "Heding, Peter E",
                    "Mendoza, Heidi",
                    "Cohen, Philip",
                    "Mandrup-Poulsen, Thomas",
                    "Billestrup, Nils"
                ],
                "comments": "NR2C2=TAK1",
                "database": {
                    "id": "16543409",
                    "name": "PubMed"
                },
                "source_name": "Molecular endocrinology (Baltimore, Md.)",
                "title": "Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex.",
                "abstract": "IL-1 plays a major role in inflammation and autoimmunity through activation of nuclear factor kappa B (NFkappaB) and MAPKs. Although a great deal is known about the mechanism of activation of NFkappaB and MAPKs by IL-1, much less is known about the down-regulation of this pathway. Suppressor of cytokine signaling (SOCS)-3 was shown to inhibit IL-1-induced transcription and activation of NFkappaB and the MAPKs JNK and p38, but the mechanism is unknown. We show here that SOCS-3 inhibits NFkappaB-dependent transcription induced by overexpression of the upstream IL-1 signaling molecules MyD88, IL-1R-activated kinase 1, TNF receptor-associated factor (TRAF)6, and TGFbeta-activated kinase (TAK)1, but not when the MAP3K MAPK/ERK kinase kinase-1 is used instead of TAK1, indicating that the target for SOCS-3 is the TRAF6/TAK1 signaling complex. By coimmunoprecipitation, it was shown that SOCS-3 inhibited the association between TRAF6 and TAK1 and that SOCS-3 coimmunoprecipitated with TAK1 and TRAF6. Furthermore, SOCS-3 inhibited the IL-1-induced catalytic activity of TAK1. Because ubiquitination of TRAF6 is required for activation of TAK1, we analyzed the role of SOCS-3 on TRAF6 ubiquitination and found that SOCS-3 inhibited ubiquitin modification of TRAF6. These results indicate that SOCS-3 inhibits IL-1 signal transduction by inhibiting ubiquitination of TRAF6, thus preventing association and activation of TAK1."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:SOCS3)",
                    "relation": "decreases",
                    "object": "p(HGNC:NR2C2, pmod(Ph))"
                }
            ],
            "evidence": "Similarly, we show that the adapter protein TAB2, which links TAK1 to TRAF6, is phosphorylated in response to IL-1, and find SOCS-3 to inhibit this phosphorylation, visualized by reversing the reduced electrophoretic mobility (Fig. 7B). We analyzed the electrophoretic mobility of TAB2 in cells stimulated with IL-1 and found that IL-1 induced a shift in mobility and that this shift was reduced in cells expressing SOCS-3 (Fig. 7B). Recombinant SOCS-3 did not directly affect the catalytic activity of purified TAK1/TAB1 (Fig. 7C), indicating that SOCS-3 inhibits pathways used in the activation of TAK1 rather than inhibiting the catalytic activity of TAK1 itself.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "IL-1 plays a major role in inflammation and autoimmunity through activation of nuclear factor kappa B (NFkappaB) and MAPKs. Although a great deal is known about the mechanism of activation of NFkappaB and MAPKs by IL-1, much less is known about the down-regulation of this pathway. Suppressor of cytokine signaling (SOCS)-3 was shown to inhibit IL-1-induced transcription and activation of NFkappaB and the MAPKs JNK and p38, but the mechanism is unknown. We show here that SOCS-3 inhibits NFkappaB-dependent transcription induced by overexpression of the upstream IL-1 signaling molecules MyD88, IL-1R-activated kinase 1, TNF receptor-associated factor (TRAF)6, and TGFbeta-activated kinase (TAK)1, but not when the MAP3K MAPK/ERK kinase kinase-1 is used instead of TAK1, indicating that the target for SOCS-3 is the TRAF6/TAK1 signaling complex. By coimmunoprecipitation, it was shown that SOCS-3 inhibited the association between TRAF6 and TAK1 and that SOCS-3 coimmunoprecipitated with TAK1 and TRAF6. Furthermore, SOCS-3 inhibited the IL-1-induced catalytic activity of TAK1. Because ubiquitination of TRAF6 is required for activation of TAK1, we analyzed the role of SOCS-3 on TRAF6 ubiquitination and found that SOCS-3 inhibited ubiquitin modification of TRAF6. These results indicate that SOCS-3 inhibits IL-1 signal transduction by inhibiting ubiquitination of TRAF6, thus preventing association and activation of TAK1.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "75a0eea5-3fcf-4e8e-8680-cb1d84a09411",
        "_rev": "_WpvYGJC-_z",
        "nanopub": {
            "id": "75a0eea5-3fcf-4e8e-8680-cb1d84a09411",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CD40LG)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "Compared to periods of stable disease, pre-flare periods were marked by increases in soluble TNF-\u03b1 and sFas (nonsignificant) and further increases in TNFRI, TNFRII, FasL, and CD40L (Figure 2E and Supplementary Table 4).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d0d07505-d8c2-4222-ae7e-16367e5931ff",
        "_rev": "_WpvYGI6--x",
        "nanopub": {
            "id": "d0d07505-d8c2-4222-ae7e-16367e5931ff",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "DAS28",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "44 RA patients, 16 HC age/sex matched",
                    "type": "cohort"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "authors": [
                    "Rioja, Inmaculada",
                    "Hughes, Fiona J",
                    "Sharp, Catriona H",
                    "Warnock, Linda C",
                    "Montgomery, Doug S",
                    "Akil, Mohammed",
                    "Wilson, Anthony G",
                    "Binks, Michael H",
                    "Dickson, Marion C"
                ],
                "database": {
                    "id": "18668547",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Potential novel biomarkers of disease activity in rheumatoid arthritis patients: CXCL13, CCL23, transforming growth factor alpha, tumor necrosis factor receptor superfamily member 9, and macrophage colony-stimulating factor.",
                "abstract": "To determine whether the plasma levels of a range of inflammatory proteins have utility as biomarkers of disease activity in rheumatoid arthritis (RA) patients."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CXCL13",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:OSM)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:CNTFR)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "a(CHEBI:Follistatin)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "a(CHEBI:Lymphotactin)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:TGFA)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:IL8)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:MMP8)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:MMP10)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "a(CHEBI:Endostatin)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:IL2)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:TNFRSF9)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:MIP3B)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:IL2RB)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:CXCL11)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:LTBR)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:FGF4)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:TNF)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:TNFRI)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:CD27)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "IL-6, CXCL13, CD27, TNFRI,TNF, fibroblast growth factor 4 (FGF-4), lymphotoxin receptor, interferon-inducible T cell  chemoattractant(I-TAC), and IL-2 receptor , that were statisticallysignificantly up-regulated in plasma from RA patients ascompared with those in healthy controls, showing foldchanges in protein expression of 1.5 and P values forthe FDR of 0.01 (Table 2), as well as a further 14markers with P values of 0.05. IL-6 (fold change 3.3; Pfor the FDR  0.0001), CXCL13/ B lymphocyte chemoattractant(fold change 1.7; P for the FDR  0.0004),and CD27 (fold change 1.7; P for the FDR  0.001),were the most differentially expressed markers in theRA patients as compared with the healthy controls(Figure 1).\n...\nFrom this analysis, 18 proteins were found to be statistically significantly up\u2010regulated in patients with active RA as compared with those in patients with quiescent RA (Table 2), showing fold changes in protein expression of \u22651.5 and P values for the FDR of \u22640.005. These included proteins previously shown to be elevated in RA patients, such as IL\u20106 (6, 23), oncostatin M (24), MMP\u201010 (11), IL\u20102 (25), MMP\u20108 (11), and TNFRSF9 (26, 27), as well as the less well\u2010validated markers, such as lymphotoxin \u03b2 receptor, CXCL13, the chemokines CCL23/myeloid progenitor inhibitory factor 1 (MPIF\u20101), CCL8/MCP\u20102, CXCL11/I\u2010TAC and lymphotactin, the growth factor\u2013related molecules and receptors transforming growth factor \u03b1 (TGF\u03b1), FGF\u20104, ciliary neurotrophic factor receptor \u03b1 (CNTFR\u03b1), and follistatin, and the cytokines macrophage colony\u2010stimulating factor (M\u2010CSF) and IL\u20109 (Table 2).\n\n\n",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "To determine whether the plasma levels of a range of inflammatory proteins have utility as biomarkers of disease activity in rheumatoid arthritis (RA) patients.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c12373de-a03f-46c1-b3a4-0216a61f37cd",
        "_rev": "_WpvYGJG-AC",
        "nanopub": {
            "id": "c12373de-a03f-46c1-b3a4-0216a61f37cd",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Microglia",
                    "label": "Microglia",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10116",
                    "label": "rat",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Przanowski, Piotr",
                    "Dabrowski, Michal",
                    "Ellert-Miklaszewska, Aleksandra",
                    "Kloss, Michal",
                    "Mieczkowski, Jakub",
                    "Kaza, Beata",
                    "Ronowicz, Anna",
                    "Hu, Feng",
                    "Piotrowski, Arkadiusz",
                    "Kettenmann, Helmut",
                    "Komorowski, Jan",
                    "Kaminska, Bozena"
                ],
                "database": {
                    "id": "24097101",
                    "name": "PubMed"
                },
                "source_name": "Journal of molecular medicine (Berlin, Germany)",
                "title": "The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia.",
                "abstract": "Most neurological diseases are associated with chronic inflammation initiated by the activation of microglia, which produce cytotoxic and inflammatory factors. Signal transducers and activators of transcription (STATs) are potent regulators of gene expression but contribution of particular STAT to inflammatory gene expression and STAT-dependent transcriptional networks underlying brain inflammation need to be identified. In the present study, we investigated the genomic distribution of Stat binding sites and the role of Stats in the gene expression in lipopolysaccharide (LPS)-activated primary microglial cultures. Integration of chromatin immunoprecipitation-promoter microarray data and transcriptome data revealed novel Stat-target genes including Jmjd3, Ccl5, Ezr, Ifih1, Irf7, Uba7, and Pim1. While knockdown of individual Stat had little effect on the expression of tested genes, knockdown of both Stat1 and Stat3 inhibited the expression of Jmjd3 and inflammatory genes. Transcriptional regulation of Jmjd3 by Stat1 and Stat3 is a novel mechanism crucial for launching inflammatory responses in microglia. The effects of Jmjd3 on inflammatory gene expression were independent of its H3K27me3 demethylase activity. Forced expression of constitutively activated Stat1 and Stat3 induced the expression of Jmjd3, inflammation-related genes, and the production of pro-inflammatory cytokines as potently as lipopolysacharide. Gene set enrichment and gene function analysis revealed categories linked to the inflammatory response in LPS and Stat1C + Stat3C groups. We defined upstream pathways that activate STATs in response to LPS and demonstrated contribution of Tlr4 and Il-6 and interferon-\u03b3 signaling. Our findings define novel direct transcriptional targets of Stat1 and Stat3 and highlight their contribution to inflammatory gene expression."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT3, pmod(Ph))\t",
                    "relation": "increases",
                    "object": "p(HGNC:IL10)"
                },
                {
                    "subject": "p(HGNC:STAT3, pmod(Ph))\t",
                    "relation": "increases",
                    "object": "p(HGNC:IFNG)"
                },
                {
                    "subject": "p(HGNC:STAT3, pmod(Ph))\t",
                    "relation": "increases",
                    "object": "p(HGNC:TNF)"
                },
                {
                    "subject": "p(HGNC:STAT3, pmod(Ph))",
                    "relation": "increases",
                    "object": "p(HGNC:CCL5)"
                }
            ],
            "evidence": "To determine whether forced expression of Stat1C and/or Stat3C alone or in combination with Jmjd3 can induce inflammatory activation of microglial cells, we measured the secretion of pro-inflammatory cytokines in conditioned media using a multiplexed cytokine ELISA (Luminex). Surprisingly, overexpression of Stat1C and Stat3C individually or a combination of either of the constitutive Stats with Jmjd3 increased the production of pro-inflammatory cytokines to levels similar to those observed following induction by LPS. The highest levels of Ccl5, IL-6, IFN-\u03b3, IL-1\u03b2, and TNF-\u03b1 were detected in the conditioned media of cells overexpressing Stat1C and Stat3C or a combination of either of these Stats with Jmjd3. For IL10 (detected at low levels in all samples), forced expression of constitutively active Stat1 and Stat3 resulted in a weak induction of cytokine production (Fig. 4c). ",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Most neurological diseases are associated with chronic inflammation initiated by the activation of microglia, which produce cytotoxic and inflammatory factors. Signal transducers and activators of transcription (STATs) are potent regulators of gene expression but contribution of particular STAT to inflammatory gene expression and STAT-dependent transcriptional networks underlying brain inflammation need to be identified. In the present study, we investigated the genomic distribution of Stat binding sites and the role of Stats in the gene expression in lipopolysaccharide (LPS)-activated primary microglial cultures. Integration of chromatin immunoprecipitation-promoter microarray data and transcriptome data revealed novel Stat-target genes including Jmjd3, Ccl5, Ezr, Ifih1, Irf7, Uba7, and Pim1. While knockdown of individual Stat had little effect on the expression of tested genes, knockdown of both Stat1 and Stat3 inhibited the expression of Jmjd3 and inflammatory genes. Transcriptional regulation of Jmjd3 by Stat1 and Stat3 is a novel mechanism crucial for launching inflammatory responses in microglia. The effects of Jmjd3 on inflammatory gene expression were independent of its H3K27me3 demethylase activity. Forced expression of constitutively activated Stat1 and Stat3 induced the expression of Jmjd3, inflammation-related genes, and the production of pro-inflammatory cytokines as potently as lipopolysacharide. Gene set enrichment and gene function analysis revealed categories linked to the inflammatory response in LPS and Stat1C + Stat3C groups. We defined upstream pathways that activate STATs in response to LPS and demonstrated contribution of Tlr4 and Il-6 and interferon-\u03b3 signaling. Our findings define novel direct transcriptional targets of Stat1 and Stat3 and highlight their contribution to inflammatory gene expression.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "48566d5c-7ca9-4c76-9fd6-acf137ea2b1f",
        "_rev": "_WpvYGJ--_F",
        "nanopub": {
            "id": "48566d5c-7ca9-4c76-9fd6-acf137ea2b1f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16622035",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:JAK2)",
                    "relation": "increases",
                    "object": "p(HGNC:STAT3, pmod(Ph))"
                }
            ],
            "evidence": "As shown in Fig. 7A, the phosphorylation of STAT3 was increased by IL-23, and this phosphorylation was clearly suppressed by pretreatment with AG490 (Jak2 inhibitor) or LY294002 (PI3K/Akt inhibitor) (Fig. 7A).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c93f3ccc-6dc1-49c3-81b7-170955809c8d",
        "_rev": "_WpvYGJ---x",
        "nanopub": {
            "id": "c93f3ccc-6dc1-49c3-81b7-170955809c8d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Erythrocytes",
                    "label": "Erythrocytes",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "7717994",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Hypochlorous Acid\")",
                    "relation": "increases",
                    "object": "a(MESH:\"Glutathione Disulfide\")"
                }
            ],
            "evidence": "Addition of low doses of HOCl to intact red blood cells resulted in loss of GSH (Figure 1).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9eb49111-9fd7-4c0b-90e5-3e62628a4403",
        "_rev": "_WpvYGJ--AD",
        "nanopub": {
            "id": "9eb49111-9fd7-4c0b-90e5-3e62628a4403",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17884812",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT3)",
                    "relation": "increases",
                    "object": "p(HGNC:IL17)"
                }
            ],
            "evidence": ". Indeed, Stat3-deficient T cells cultured under standard Th17 conditions failed to produce IL-17 mRNA or protein (see below).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "141f9fdc-ddc5-4ac8-b6ba-1565cf0b236c",
        "_rev": "_WpvYGJ--Be",
        "nanopub": {
            "id": "141f9fdc-ddc5-4ac8-b6ba-1565cf0b236c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "EFO:\"HUVEC cell line\"",
                    "label": "HUVEC cell line",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "authors": [
                    "Wen, Ya-Dan",
                    "Wang, Hong",
                    "Kho, Sok-Hong",
                    "Rinkiko, Suguro",
                    "Sheng, Xiong",
                    "Shen, Han-Ming",
                    "Zhu, Yi-Zhun"
                ],
                "database": {
                    "id": "23393548",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress.",
                "abstract": "Hydrogen sulfide (H\u2082S) has been shown to have cytoprotective effects in models of hypertension, ischemia/reperfusion and Alzheimer's disease. However, little is known about its effects or mechanisms of action in atherosclerosis. Therefore, in the current study we evaluated the pharmacological effects of H\u2082S on antioxidant defenses and mitochondria protection against hydrogen peroxide (H\u2082O\u2082) induced endothelial cells damage."
            },
            "assertions": [
                {
                    "subject": "a(PUBCHEM:malondialdehyde)",
                    "relation": "biomarkerFor",
                    "object": "bp(MESH:\"Oxidative Stress\")"
                }
            ],
            "evidence": "Treatment with H2O2 significantly increased cellular MDA levels indicating the elevation of oxidative stress (P<0.01, vs. control).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "p-value": "<0.01"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "eed26125-c3f7-45a1-b7ba-8c68cc6c0d33",
        "_rev": "_WpvYGJ--Cj",
        "nanopub": {
            "id": "eed26125-c3f7-45a1-b7ba-8c68cc6c0d33",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "A total of 1078\u00a0patients\u00a0were studied: 89.1% female, 71.5% white, mean age 33.6 (SD 12.6) years, and with median baseline SLEDAI-2K of 8",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "20516026",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:ALB)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "In\u00a0patients\u00a0with SLE, higher SLEDAI was associated with lower\u00a0serum\u00a0albumin\u00a0levels.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "30cb1f74-5724-46d0-9aef-c8b9adf154c3",
        "_rev": "_WpvYGJC-Bx",
        "nanopub": {
            "id": "30cb1f74-5724-46d0-9aef-c8b9adf154c3",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "",
                    "label": "NPSLE",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "518 SLE (southern Chinese cohort)",
                    "type": "Cohort"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "comments": "Object here is NPSLE",
                "database": {
                    "id": "11327248",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"lupus anticoagulant\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Univariate analysis revealed that NP-SLE was associated with a positive lupus anticoagulant (LAC) (p = 0.001), a strongly positive IgG anticardiolipin (aCL) (p = 0.01). leukopenia (p = 0.01), lymphopenia (p = 0.03), thrombocytopenia (p = 0.03), and pulmonary involvement (p = 0.03).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4d7b0969-5973-4274-844c-6e7c89b5ba1d",
        "_rev": "_WpvYGJC--e",
        "nanopub": {
            "id": "4d7b0969-5973-4274-844c-6e7c89b5ba1d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "authors": [
                    "Cho, Jung-Sun",
                    "Han, In-Hye",
                    "Lee, Hye Rim",
                    "Lee, Heung-Man"
                ],
                "database": {
                    "id": "25229003",
                    "name": "PubMed"
                },
                "source_name": "Allergy, asthma & immunology research",
                "title": "Prostaglandin E2 Induces IL-6 and IL-8 Production by the EP Receptors/Akt/NF-\u03baB Pathways in Nasal Polyp-Derived Fibroblasts.",
                "abstract": "Interleukin 6 (IL-6) and IL-8 participate in the pathogenesis of chronic rhinosinusitis with nasal polyps, and their levels are increased by prostaglandin E2 (PGE2) in different cell types. The purposes of this study were to determine whether PGE2 has any effect on the increase in the levels of IL-6 and IL-8 in nasal polyp-derived fibroblasts (NPDFs) and subsequently investigate the possible mechanism of this effect."
            },
            "assertions": [
                {
                    "subject": "p(RGD:Ptger2)",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "PGE2 significantly increased the mRNA and protein expression levels of IL-6 and IL-8 in NPDFs.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Interleukin 6 (IL-6) and IL-8 participate in the pathogenesis of chronic rhinosinusitis with nasal polyps, and their levels are increased by prostaglandin E2 (PGE2) in different cell types. The purposes of this study were to determine whether PGE2 has any effect on the increase in the levels of IL-6 and IL-8 in nasal polyp-derived fibroblasts (NPDFs) and subsequently investigate the possible mechanism of this effect.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "25d1e5c5-46d7-4c9b-986e-4a549fdeed29",
        "_rev": "_WpvYGJ---V",
        "nanopub": {
            "id": "25d1e5c5-46d7-4c9b-986e-4a549fdeed29",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=19",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Mandrekar, Pranoti",
                    "Catalano, Donna",
                    "White, Bernadette",
                    "Szabo, Gyongyi"
                ],
                "database": {
                    "id": "16433741",
                    "name": "PubMed"
                },
                "source_name": "Alcoholism, clinical and experimental research",
                "title": "Moderate alcohol intake in humans attenuates monocyte inflammatory responses: inhibition of nuclear regulatory factor kappa B and induction of interleukin 10.",
                "abstract": "In contrast to the deleterious effects of chronic excessive alcohol consumption on the liver and cardiovascular system, modest alcohol intake, such as 1 to 2 drinks per day, has benefits on cardiovascular mortality. Little is known about the length of time or the amounts of alcohol consumed that may cause alterations in inflammatory cells such as monocytes that are crucial to atherosclerotic vascular disease. Here, we determine in vivo effects of acute alcohol consumption on inflammatory cytokine production and nuclear regulatory factor kappaB (NF-kappaB) binding in human monocytes."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:ethanol)\t",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:TNF))"
                },
                {
                    "subject": "a(CHEBI:ethanol)\t",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IL10)"
                }
            ],
            "evidence": "Fig. 1. Moderate alcohol intake inhibits monocyte production of tumor necrosis factor a (TNF-a) and IL-1b and increases IL-10\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true,
                "gd:abstract": "In contrast to the deleterious effects of chronic excessive alcohol consumption on the liver and cardiovascular system, modest alcohol intake, such as 1 to 2 drinks per day, has benefits on cardiovascular mortality. Little is known about the length of time or the amounts of alcohol consumed that may cause alterations in inflammatory cells such as monocytes that are crucial to atherosclerotic vascular disease. Here, we determine in vivo effects of acute alcohol consumption on inflammatory cytokine production and nuclear regulatory factor kappaB (NF-kappaB) binding in human monocytes."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "56e41b46-11ba-4074-9b7b-49d1b749dc7f",
        "_rev": "_WpvYGJC-_m",
        "nanopub": {
            "id": "56e41b46-11ba-4074-9b7b-49d1b749dc7f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "8 young and 8 older healthy volunteers",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "22882710",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"Bifidobacterium longum\u00a0subsp.\u00a0infantis\u00a0CCUG 52486\")",
                    "relation": "decreases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "a(\"B. bifidum MF 20/5\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "a(\"B. longum SP 07/3\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "a(\"L. reuteri NCIMB 11951\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "a(\"L. plantarum NCIMB 8826\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "a(\"L. rhamnosus GG\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "a(\"L. casei Shirota\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "a(\"Bifidobacterium longum\u00a0subsp.\u00a0infantis\u00a0CCUG 52486\")",
                    "relation": "decreases",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "There was a significant effect of age on the production of IL-6 (P\u00a0< 0.05), IFN-\u03b3 (P\u00a0< 0.01) and RANTES (P\u00a0< 0.001), and of probiotics (P\u00a0< 0.001) on production of IL-1\u03b2, IFN-\u03b3, IL-6, IL-10, GM-CSF and RANTES (Figs\u00a05\u00a0and\u00a06)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ae020575-6b7d-491c-9a19-25ff90848ab1",
        "_rev": "_WpvYGI6--1",
        "nanopub": {
            "id": "ae020575-6b7d-491c-9a19-25ff90848ab1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Neutrophils",
                    "label": "Neutrophils",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9355763",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Hypochlorous Acid\")",
                    "relation": "increases",
                    "object": "a(MESH:\"Glutathione Disulfide\")"
                }
            ],
            "evidence": "As shown previously[13], the oxidation of pure GSH by HOCl gives two novel products as well as GSSG (Figure 4A).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a6447093-6664-4d1e-80b6-60589a5414fb",
        "_rev": "_WpvYGJC-__",
        "nanopub": {
            "id": "a6447093-6664-4d1e-80b6-60589a5414fb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Frob\u00f8se, Helle",
                    "R\u00f8nn, Sif Groth",
                    "Heding, Peter E",
                    "Mendoza, Heidi",
                    "Cohen, Philip",
                    "Mandrup-Poulsen, Thomas",
                    "Billestrup, Nils"
                ],
                "database": {
                    "id": "16543409",
                    "name": "PubMed"
                },
                "source_name": "Molecular endocrinology (Baltimore, Md.)",
                "title": "Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex.",
                "abstract": "IL-1 plays a major role in inflammation and autoimmunity through activation of nuclear factor kappa B (NFkappaB) and MAPKs. Although a great deal is known about the mechanism of activation of NFkappaB and MAPKs by IL-1, much less is known about the down-regulation of this pathway. Suppressor of cytokine signaling (SOCS)-3 was shown to inhibit IL-1-induced transcription and activation of NFkappaB and the MAPKs JNK and p38, but the mechanism is unknown. We show here that SOCS-3 inhibits NFkappaB-dependent transcription induced by overexpression of the upstream IL-1 signaling molecules MyD88, IL-1R-activated kinase 1, TNF receptor-associated factor (TRAF)6, and TGFbeta-activated kinase (TAK)1, but not when the MAP3K MAPK/ERK kinase kinase-1 is used instead of TAK1, indicating that the target for SOCS-3 is the TRAF6/TAK1 signaling complex. By coimmunoprecipitation, it was shown that SOCS-3 inhibited the association between TRAF6 and TAK1 and that SOCS-3 coimmunoprecipitated with TAK1 and TRAF6. Furthermore, SOCS-3 inhibited the IL-1-induced catalytic activity of TAK1. Because ubiquitination of TRAF6 is required for activation of TAK1, we analyzed the role of SOCS-3 on TRAF6 ubiquitination and found that SOCS-3 inhibited ubiquitin modification of TRAF6. These results indicate that SOCS-3 inhibits IL-1 signal transduction by inhibiting ubiquitination of TRAF6, thus preventing association and activation of TAK1."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:SOCS3)",
                    "relation": "decreases",
                    "object": "p(HGNC:TAB2, pmod(Ph))"
                }
            ],
            "evidence": "Similarly, we show that the adapter protein TAB2, which links TAK1 to TRAF6, is phosphorylated in response to IL-1, and find SOCS-3 to inhibit this phosphorylation, visualized by reversing the reduced electrophoretic mobility (Fig. 7B). We analyzed the electrophoretic mobility of TAB2 in cells stimulated with IL-1 and found that IL-1 induced a shift in mobility and that this shift was reduced in cells expressing SOCS-3 (Fig. 7B). Recombinant SOCS-3 did not directly affect the catalytic activity of purified TAK1/TAB1 (Fig. 7C), indicating that SOCS-3 inhibits pathways used in the activation of TAK1 rather than inhibiting the catalytic activity of TAK1 itself.",
            "metadata": {
                "gd:abstract": "IL-1 plays a major role in inflammation and autoimmunity through activation of nuclear factor kappa B (NFkappaB) and MAPKs. Although a great deal is known about the mechanism of activation of NFkappaB and MAPKs by IL-1, much less is known about the down-regulation of this pathway. Suppressor of cytokine signaling (SOCS)-3 was shown to inhibit IL-1-induced transcription and activation of NFkappaB and the MAPKs JNK and p38, but the mechanism is unknown. We show here that SOCS-3 inhibits NFkappaB-dependent transcription induced by overexpression of the upstream IL-1 signaling molecules MyD88, IL-1R-activated kinase 1, TNF receptor-associated factor (TRAF)6, and TGFbeta-activated kinase (TAK)1, but not when the MAP3K MAPK/ERK kinase kinase-1 is used instead of TAK1, indicating that the target for SOCS-3 is the TRAF6/TAK1 signaling complex. By coimmunoprecipitation, it was shown that SOCS-3 inhibited the association between TRAF6 and TAK1 and that SOCS-3 coimmunoprecipitated with TAK1 and TRAF6. Furthermore, SOCS-3 inhibited the IL-1-induced catalytic activity of TAK1. Because ubiquitination of TRAF6 is required for activation of TAK1, we analyzed the role of SOCS-3 on TRAF6 ubiquitination and found that SOCS-3 inhibited ubiquitin modification of TRAF6. These results indicate that SOCS-3 inhibits IL-1 signal transduction by inhibiting ubiquitination of TRAF6, thus preventing association and activation of TAK1.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f68a51d8-eb49-484d-a1ef-4e98e1c292f6",
        "_rev": "_WpvYGI6--0",
        "nanopub": {
            "id": "f68a51d8-eb49-484d-a1ef-4e98e1c292f6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Kiefer, Kerstin",
                    "Oropallo, Michael A",
                    "Cancro, Michael P",
                    "Marshak-Rothstein, Ann"
                ],
                "database": {
                    "id": "22430248",
                    "name": "PubMed"
                },
                "source_name": "Immunology and cell biology",
                "title": "Role of type I interferons in the activation of autoreactive B cells.",
                "abstract": "Type I interferons (IFNs) are a family of cytokines involved in the defense against viral infections that play a key role in the activation of both the innate and adaptive immune system. IFNs both directly and indirectly enhance the capacity of B lymphocytes to respond to viral challenge and produce cytotoxic and neutralizing antibodies. However, prolonged type I IFN exposure is not always beneficial to the host. If not regulated properly IFN can drive autoantibody production as well as other parameters of systemic autoimmune disease. Type I IFNs impact B-cell function through a variety of mechanisms, including effects on receptor engagement, Toll-like receptor expression, cell migration, antigen presentation, cytokine responsiveness, cytokine production, survival, differentiation and class-switch recombination. Type I IFNs are also cytotoxic for a variety of cell types and thereby contribute to the accumulation of cell debris that serves as a potential source for autoantigens. Type I IFN engagement of a variety of accessory cells further promotes B-cell survival and activation, as exemplified by the capacity of type I IFNs to increase the level of B-cell survival factors, such as B lymphocyte stimulator, produced by dendritic cells. Therefore, it is not surprising that the loss of expression of the type I IFN receptor can have dramatic effects on the production of autoantibodies and on the clinical features of systemic autoimmune diseases such as systemic lupus erythematosus."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNA1)",
                    "relation": "increases",
                    "object": "a(CL:\"B cell\")"
                }
            ],
            "evidence": "Soon after viral infection, the type I IFNs induce dendritic cell (DC) and macrophage maturation and activation,1 and then at later stages, promote T- and B-cell survival, activation and differentiation.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bca68c24-3a67-4f6c-9d03-2f8cdd7574b7",
        "_rev": "_WpvYGJG-_r",
        "nanopub": {
            "id": "bca68c24-3a67-4f6c-9d03-2f8cdd7574b7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "n=8",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Muscle, Skeletal\"",
                    "label": "Muscle, Skeletal",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "24476467",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Exercise\")",
                    "relation": "positiveCorrelation",
                    "object": "r(HGNC:IL1B)"
                }
            ],
            "evidence": "All modes upregulated IL-1 mRNA expression (Fig. 3E) at 1 h postexercise (RE = 2.0 \u00b1 0.4; AE = 3.1 \u00b1 0.6; CE = 2.9 \u00b1 0.8) (p < 0.05),\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ed02d86b-c46b-4016-846f-588b40d64051",
        "_rev": "_WpvYGJG-_D",
        "nanopub": {
            "id": "ed02d86b-c46b-4016-846f-588b40d64051",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Neutrophils",
                    "label": "Neutrophils",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9355763",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Hypochlorous Acid\")",
                    "relation": "decreases",
                    "object": "a(CHEBI:glutathione)"
                }
            ],
            "evidence": "\"The addition of HOCl to resting neutrophils caused\nconcentration-dependent losses of intracellular GSH and a\nproportionate number of protein thiols (Figure 1).\"\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b5807a7b-2c6b-4e69-94b5-e2c339b8ee9e",
        "_rev": "_WpvYGJG-AA",
        "nanopub": {
            "id": "b5807a7b-2c6b-4e69-94b5-e2c339b8ee9e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:\"left lung lobe\"",
                    "label": "left lung lobe",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "authors": [
                    "Mitanchez, Delphine",
                    "Chavatte-Palmer, Pascale"
                ],
                "database": {
                    "id": "29421859",
                    "name": "PubMed"
                },
                "source_name": "Acta paediatrica (Oslo, Norway : 1992)",
                "title": "Review shows that maternal obesity induces serious adverse neonatal effects and is associated with childhood obesity in their offspring."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:EGF)",
                    "relation": "increases",
                    "object": "p(HGNC:AKT1)"
                }
            ],
            "evidence": "",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0586c4a9-d346-421b-b29d-5216eb8f34c5",
        "_rev": "_WpvYGJ--BU",
        "nanopub": {
            "id": "0586c4a9-d346-421b-b29d-5216eb8f34c5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "MESH:\"Human Umbilical Vein Endothelial Cells\"",
                    "label": "Human Umbilical Vein Endothelial Cells",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Herbst, U",
                    "Toborek, M",
                    "Kaiser, S",
                    "Mattson, M P",
                    "Hennig, B"
                ],
                "database": {
                    "id": "10497308",
                    "name": "PubMed"
                },
                "source_name": "Journal of cellular physiology",
                "title": "4-Hydroxynonenal induces dysfunction and apoptosis of cultured endothelial cells.",
                "abstract": "Lipolytic products of triglyceride-rich lipoproteins, i.e., free fatty acids, may cause activation and dysfunction of the vascular endothelium. Mechanisms of these effects may include lipid peroxidation. One of the major and biologically active products of peroxidation of n-6 fatty acids, such as linoleic acid or arachidonic acid, is the aldehyde 4-hydroxynonenal (HNE). To study the hypothesis that HNE may be a critical factor in endothelial cell dysfunction caused by free fatty acids, human umbilical endothelial cells (HUVEC) were treated with up to160 microM of linoleic or arachidonic acid. HNE formation was detected by immunocytochemistry in cells treated for 24 h with either fatty acid, but more markedly with arachidonic acid. To study the cellulareffects of HNE, HUVEC were treated with different concentrations of this aldehyde, and several markers of endothelial cell dysfunction were determined. Exposure to HNE for 6 and 9 h resulted in increased cellular oxidative stress. However, short time treatment with HNE did not cause activation of nuclear factor-kappaB (NF-kappaB). In addition, HUVEC exposure to HNE caused a dose-dependent decrease in production of both interleukin-8 (IL-8) and intercellular adhesion molecule-1 (ICAM-1). On the other hand, HNE exerted prominent cytotoxic effects in cultured HUVEC, manifested by morphological changes, diminished cellular viability, and impaired endothelial barrier function. Furthermore, HNE treatment induced apoptosis of HUVEC. These data provide evidence that HNE does not contribute to NF-kappaB-related mechanisms of the inflammatory response in HUVEC, but rather to endothelial dysfunction, cytotoxicity, and apoptotic cell death."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:4-hydroxynon-2-enal)",
                    "relation": "increases",
                    "object": "a(bp(MESH:\"Oxidative Stress\"))"
                }
            ],
            "evidence": "Exposure to HNE for 6 and 9 h resulted in increased cellular oxidative stress.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8dcfe938-63e4-45f7-87f8-2efd6636c4e7",
        "_rev": "_WpvYGJC--J",
        "nanopub": {
            "id": "8dcfe938-63e4-45f7-87f8-2efd6636c4e7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.39",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CXCL2)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f270e635-b7c6-4451-8a88-a177fd21269c",
        "_rev": "_WpvYGJC-CN",
        "nanopub": {
            "id": "f270e635-b7c6-4451-8a88-a177fd21269c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                },
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "EMG",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "database": {
                    "id": "15001782",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL8)",
                    "relation": "increases",
                    "object": "a(\"Extracellular Traps\")"
                }
            ],
            "evidence": ", neutrophils stimulated with interleukin-8 (IL-8), phorbol myristate acetate (PMA), or lipopolysaccharide (LPS) became flat and formed membrane protrusions (Fig. 1B) as previously described (4).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "07672439-1512-4658-ba43-fd4447ae9894",
        "_rev": "_WpvYGJG-BP",
        "nanopub": {
            "id": "07672439-1512-4658-ba43-fd4447ae9894",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "70 RA patients, 30 SLE patients, 25 other autoimmune diseases, 20 osteoarthritis (OA), and 35 HC",
                    "type": "cohort"
                },
                {
                    "id": "",
                    "label": "C-Reactive Protein",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "authors": [
                    "Ni, Min",
                    "Wei, Wei",
                    "Wang, Yichao",
                    "Zhang, Na",
                    "Ding, Hongmei",
                    "Shen, Chen",
                    "Zheng, Fang"
                ],
                "database": {
                    "id": "23532497",
                    "name": "PubMed"
                },
                "source_name": "Journal of clinical immunology",
                "title": "Serum levels of calreticulin in correlation with disease activity in patients with rheumatoid arthritis.",
                "abstract": "The aim of our study was to investigate the contribution of serum calreticulin (CRT) in the assessment of disease activity in rheumatoid arthritis (RA).",
                "date_published": "2013-07-01"
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CRT)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "Significant positive correlation of CRT with DAS28, ESR and CRP was found in RA patients.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true,
                "gd:abstract": "The aim of our study was to investigate the contribution of serum calreticulin (CRT) in the assessment of disease activity in rheumatoid arthritis (RA)."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "fc766e6b-5607-42f2-989d-b938b7f7cf33",
        "_rev": "_WpvYGJ---d",
        "nanopub": {
            "id": "fc766e6b-5607-42f2-989d-b938b7f7cf33",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Synoviocytes",
                    "label": "Synoviocytes",
                    "type": "Cell"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "authors": [
                    "Hashizume, M",
                    "Hayakawa, N",
                    "Mihara, M"
                ],
                "comments": "HGNC:TNFSF11= RANKL",
                "database": {
                    "id": "18786965",
                    "name": "PubMed"
                },
                "source_name": "Rheumatology (Oxford, England)",
                "title": "IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.",
                "abstract": "We investigated the influence of cytokines on the expression of RANK ligand (RANKL) in fibroblast-like synoviocytes from RA patients (RA-FLS)."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "increases",
                    "object": "p(HGNC:TNFSF11)"
                },
                {
                    "subject": "p(HGNC:IL17A)\t",
                    "relation": "increases",
                    "object": "p(HGNC:TNFSF11)"
                },
                {
                    "subject": "p(HGNC:TNF)",
                    "relation": "increases",
                    "object": "p(HGNC:TNFSF11)"
                },
                {
                    "subject": "p(HGNC:IL1B)",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "p(HGNC:IL17A)",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "p(HGNC:TNF)",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "TNF-\u03b1 and IL-17 at a concentration of 10 ng/ml induced the proliferation of RA-FLS and the production of IL-6, demonstrating that RA-FLS used were responsive to TNF-\u03b1 and IL-17. Moreover, IL-6 + sIL-6R induced cell proliferation and IL-6 production. IL-1\u03b2 also induced IL-6 production. Since TNF-\u03b1 and IL-17 strongly induced IL-6 production, we hypothesized that TNF-\u03b1 and IL-17 would induce RANKL mRNA expression in the presence of sIL-6R. On investigation, we found this to be the case (Fig. 3).",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "We investigated the influence of cytokines on the expression of RANK ligand (RANKL) in fibroblast-like synoviocytes from RA patients (RA-FLS).",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f1f62f6b-8943-4add-bdc0-77560c4d035c",
        "_rev": "_WpvYGJG-AU",
        "nanopub": {
            "id": "f1f62f6b-8943-4add-bdc0-77560c4d035c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "16177117",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Zinc)",
                    "relation": "decreases",
                    "object": "p(HGNC:IL1B)"
                }
            ],
            "evidence": "TNF- and IL-1\u0001 were measured in supernatant and lysate of primary monocytes after treatment with LPS in the presence or the absence of zinc (Fig. 6C). Zinc abrogated the stimulatory effect of LPS in lysate and supernatant equally, with no zinc-induced accumulation of cytokines in the cellular fraction\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b1d883e8-da49-4e66-b518-00d002d21fef",
        "_rev": "_WpvYGJG-_Z",
        "nanopub": {
            "id": "b1d883e8-da49-4e66-b518-00d002d21fef",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "DAS28",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "0.001",
                    "type": "p-value"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "111 RA patients, 41 age/sex matched HC",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Liou, Lieh-bang",
                    "Tsai, Wen-pin",
                    "Chang, Chee J",
                    "Chao, Wan-ju",
                    "Chen, Meng-hsin"
                ],
                "database": {
                    "id": "23383162",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Blood monocyte chemotactic protein-1 (MCP-1) and adapted disease activity Score28-MCP-1: favorable indicators for rheumatoid arthritis activity.",
                "abstract": "We assessed blood pentraxin 3 (PTX3) and macrophage chemotactic factor-1 (MCP-1) levels as indicators of disease activity in rheumatoid arthritis (RA) patients, because data on disease activity score 28 (DAS28)-erythrocyte sedimentation rate (ESR) and DAS28-C-reactive protein (CRP) are still imperfect."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL2)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "Plasma MCP-1 level was modestly but significantly correlated (r <0.500) with DAS28 in the 111 RA patients",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "852cf6e7-3a9f-4edf-8405-942efe004531",
        "_rev": "_WpvYGJC-AY",
        "nanopub": {
            "id": "852cf6e7-3a9f-4edf-8405-942efe004531",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Northern Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9120387",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "increases",
                    "object": "r(HGNC:IL12RB2))"
                }
            ],
            "evidence": "T cells arising from stimulation in the presence of IL-4, anti\u2013IL-12 mAb and exogenous IFN-\u03b3 added during primary activation expressed high levels of the IL-12R \u03b22 mRNA (Fig.\u00a0\u200b(Fig.5,5, lane\u00a06)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6427f0bb-3ba7-4b61-b0a1-418b7f9be1bb",
        "_rev": "_WpvYGJC-AU",
        "nanopub": {
            "id": "6427f0bb-3ba7-4b61-b0a1-418b7f9be1bb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.02",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "n=19",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "16433741",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:ethanol)",
                    "relation": "decreases",
                    "object": "p(HGNC:TNF)"
                }
            ],
            "evidence": "We found that both TNF-a and IL-1b induction were significantly reduced in monocytes isolated 18 hours after alcohol intake compared with monocytes of the same individuals before alcohol consumption whether LPS (TNF-a 99% decrease; IL-1b 50% decrease) or SEB (TNF-a 61% decrease; IL-1b 56% decrease) were used as the ex vivo triggers of cytokine production\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a7afa382-ff70-4146-818f-f50b93e1dc08",
        "_rev": "_WpvYGJG-Au",
        "nanopub": {
            "id": "a7afa382-ff70-4146-818f-f50b93e1dc08",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "AUC=0.724",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p=0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "30 LN, 49 SLE without LN, 28 HC",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "19785730",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNFSF12)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                }
            ],
            "evidence": "A nonparametric ROC curve, constructed to quantify how well uTWEAK distinguishes between SLE patients with or without nephritis, has an AUC of 0.724 (P < 0.001; Figure \u200b2c).\u00a0\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b015b688-c873-41c8-80d2-34a5be7095c9",
        "_rev": "_WpvYGJ--_8",
        "nanopub": {
            "id": "b015b688-c873-41c8-80d2-34a5be7095c9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:monocyte",
                    "label": "monocyte",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "1940799",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL10)",
                    "relation": "decreases",
                    "object": "bp(GO:\"cytokine secretion\")"
                }
            ],
            "evidence": "IL-10 also inhibited cytokine production by monocytes activated by IFN-% or combinations of IFN-3, and LPS.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7cd13df5-f4a2-41f8-8719-465fdba395c5",
        "_rev": "_WpvYGJ--_n",
        "nanopub": {
            "id": "7cd13df5-f4a2-41f8-8719-465fdba395c5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "Fifty one SLE patients with active disease (lupus flare) were studied.\u00a0",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "27365721",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"anti-dsDNA\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Significant positive correlation was noticed between SLEDAI score and anti-dsDNA levels (0.01 level two-tailed prediction) and a significant negative correlation was observed with SLEDAI and C3, C4 levels (0.01 and 0.05 levels, two-tailed prediction) in our patients. On subgroup analysis it was noticed that this correlation is stronger for renal lupus. Negative correlation of SLEDAI and complement levels was not observed in non-renal flares.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c98698c0-2dfe-4e35-ab91-75dd5b8855c5",
        "_rev": "_WpvYGJC--X",
        "nanopub": {
            "id": "c98698c0-2dfe-4e35-ab91-75dd5b8855c5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:liver",
                    "label": "liver",
                    "type": "Anatomy"
                },
                {
                    "id": "MESH:\"Diabetes Mellitus, Experimental\"",
                    "label": "Diabetes Mellitus, Experimental",
                    "type": "Disease"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "24755741",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Diabetes Mellitus, Experimental\")",
                    "relation": "increases",
                    "object": "a(CHEBI:\"uric acid\")"
                }
            ],
            "evidence": "Consistent with this finding, intrahepatic uric acid levels, a downstream product of AMP metabolism through AMPD2 are significantly higher in diabetic mice compared to control animals (Fig. 1F).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "70f09b9b-cb5a-420d-9776-a60265723ee0",
        "_rev": "_WpvYGJC-CM",
        "nanopub": {
            "id": "70f09b9b-cb5a-420d-9776-a60265723ee0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "abstract": "Complement is an important component of the innate immune system that is crucial for defense from microbial infections and for clearance of immune complexes and injured cells. In normal conditions complement is tightly controlled by a number of fluid-phase and cell surface proteins to avoid injury to autologous tissues. When complement is hyperactivated, as occurs in autoimmune diseases or in subjects with dysfunctional regulatory proteins, it drives a severe inflammatory response in numerous organs. The kidney appears to be particularly vulnerable to complement-mediated inflammatory injury. Injury may derive from deposition of circulating active complement fragments in glomeruli, but complement locally produced and activated in the kidney also may have a role. Many kidney disorders have been linked to abnormal complement activation, including immune-complex-mediated glomerulonephritis and rare genetic kidney diseases, but also tubulointerstitial injury associated with progressive proteinuric diseases or ischemia-reperfusion.",
                "authors": [
                    "Noris, Marina",
                    "Remuzzi, Giuseppe"
                ],
                "database": {
                    "id": "24161035",
                    "name": "PubMed"
                },
                "source_name": "Seminars in nephrology",
                "title": "Overview of complement activation and regulation."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:C5B)",
                    "relation": "directlyIncreases",
                    "object": "complex(p(HGNC:C5B), p(HGNC:C9)"
                }
            ],
            "evidence": "The classical pathway (CP) uses C1 and is triggered by antigen\u2013antibody immune complexes. Inactive C1 circulates as a serum molecular complex comprising six C1q molecules and two molecules each of the serine proteases C1r and C1s. After binding to a cognate antigen, the fragment crystallizable (Fc) portion of an IgG or IgM antibody interacts with the collagen-like tail of C1q. This interaction leads to a conformational change resulting in the sequential activation of C1r and C1s. The activated C1s then cleaves C4 and C2 into small inactive fragments (C4a and C2b) and larger active fragments (C4b and C2a). C4b binds to the sugar moieties of cell surface glycoproteins and binds noncovalently to C2a, to generate the classic pathway C3 convertase C4bC2a (Fig. 1). C4bC2a is an enzymatic complex that cleaves C3, the central component of the complement cascade, into the anaphylatoxin C3a and C3b. In addition to activation by IgG and IgM immune complexes, C1q also may be activated by apoptotic and necrotic cells and by acute phase proteins such as C-reactive protein.6\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "095a2f84-929a-49aa-aa0e-6fb7f345dd1d",
        "_rev": "_WpvYGJG-BT",
        "nanopub": {
            "id": "095a2f84-929a-49aa-aa0e-6fb7f345dd1d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "32 healthy donors",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:monocyte",
                    "label": "monocyte",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9531313",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17)\t",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "p(HGNC:IL17)\t",
                    "relation": "increases",
                    "object": "a(CHEBI:\"prostaglandins E\")"
                },
                {
                    "subject": "p(HGNC:IL17)\t",
                    "relation": "increases",
                    "object": "p(HGNC:MMP3)"
                },
                {
                    "subject": "p(HGNC:IL17)\t",
                    "relation": "increases",
                    "object": "p(HGNC:IL10)"
                },
                {
                    "subject": "p(HGNC:IL17)\t",
                    "relation": "increases",
                    "object": "p(HGNC:IL12)"
                },
                {
                    "subject": "p(HGNC:IL17)\t",
                    "relation": "increases",
                    "object": "p(HGNC:TNF)"
                },
                {
                    "subject": "p(HGNC:IL17)",
                    "relation": "increases",
                    "object": "p(HGNC:IL1B)"
                }
            ],
            "evidence": "IL-17 (50 ng/ml) induced an up-regulation in the release of IL-1\u03b2 (0.62 \u00b1 0.02 ng/ml), TNF-\u03b1 (1.25 \u00b1 0.23 ng/ml), IL-12 (0.21 \u00b1 0.05 ng/ml), and IL-10 (0.21 \u00b1 0.01 ng/ml), and a 1.7 (NS)-, 3.3 (p\u00a0< 0.005)-, 39 (p\u00a0< 0.05)-, and 104 (p\u00a0< 0.007)-fold increase in IL-1Ra, stromelysin, PGE2, and IL-6 concentrations, respectively. IL-17 had no effect on nitrite (NO*) production (Table I\u21d1).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "679f5c46-8ffc-4dfa-8ce3-54669dd7a8d0",
        "_rev": "_WpvYGJG-_J",
        "nanopub": {
            "id": "679f5c46-8ffc-4dfa-8ce3-54669dd7a8d0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Assessment of footpad swelling",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "footpads",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "2530282",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "act(a(GO:\"T helper 1 cells\"))",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IFNG))"
                }
            ],
            "evidence": "When anti-IFN-y was injected simultaneously with the initiation of the response, it partially suppressed the DTH responses mediated by seven out of the nine Thl clones tested (Fig. 5).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5fd2e119-b4cd-423e-84b9-b942a5452492",
        "_rev": "_WpvYGJC-Az",
        "nanopub": {
            "id": "5fd2e119-b4cd-423e-84b9-b942a5452492",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Chondrocytes",
                    "label": "Chondrocytes",
                    "type": "Cell"
                },
                {
                    "id": "DO:osteoarthritis",
                    "label": "osteoarthritis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "14600251",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"(\u2212)-epigallocatechin 3-gallate\")\t",
                    "relation": "decreases",
                    "object": "act(p(MMP13))"
                },
                {
                    "subject": "a(CHEBI:\"(\u2212)-epigallocatechin 3-gallate\")",
                    "relation": "decreases",
                    "object": "act(p(HGNC:MMP1))"
                }
            ],
            "evidence": "Importantly, treatment of human chondrocytes with IL-1\u03b2 in the presence of different doses of EGCG (20, 50, or 100 \u03bcM) also inhibited the activities of MMP-1 and -13.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "af779464-7f95-4afc-b88e-77f15e4df423",
        "_rev": "_WpvYGJ--_7",
        "nanopub": {
            "id": "af779464-7f95-4afc-b88e-77f15e4df423",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "n=6",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "0.01",
                    "type": "p-value"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "10879444",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Exercise\")",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "IL-6 was signi\u00aecantly elevated (P \u0088 0.01) over baseline values at 12, 24, and 72 h after exercise, with values approaching signi\u00aecance at 48 h (Fig. 2).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "31f10814-5bc8-4bdc-ad6a-5262d0a54768",
        "_rev": "_WpvYGJ--Bc",
        "nanopub": {
            "id": "31f10814-5bc8-4bdc-ad6a-5262d0a54768",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Propidium Iodide Staining",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"B cell\"",
                    "label": "B cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12023955",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:BCL2L1)",
                    "relation": "decreases",
                    "object": "bp(GO:\"apoptotic process\")"
                }
            ],
            "evidence": "However, ectopic expression of Bcl-xL in either wild type or Stat6-deficient B cells led to a marked increase in the resistance of both wild type and Stat6-deificient cells to Fas-induced apoptosis, comparable with that observed for IL-4 and wild type B cells.\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e61d44e9-4dc7-49da-83f1-cafc661462cf",
        "_rev": "_WpvYGJG-As",
        "nanopub": {
            "id": "e61d44e9-4dc7-49da-83f1-cafc661462cf",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL2)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "In contrast, consistent with the results above, levels of several inflammatory mediators varied between pre-flare and non-flare periods (Figure 2 and Supplementary Table 4). Impending flares were associated with increased Th1, Th2, and Th17 (Figure 2A\u2013C) type cytokines, compared to both self non-flare and matched healthy control samples (Supplementary Figure 2A\u2013C).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5ceb1080-043d-48e0-bdbd-aeb90e80dd13",
        "_rev": "_WpvYGJC-Ad",
        "nanopub": {
            "id": "5ceb1080-043d-48e0-bdbd-aeb90e80dd13",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Immunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "EFO:HeLa",
                    "label": "HeLa",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "7628694",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IKBA, pmod(Ub))",
                    "relation": "increases",
                    "object": "bp(GO:\"positive regulation of proteasomal ubiquitin-dependent protein catabolic process\""
                }
            ],
            "evidence": "Quantitation of the data by Phosphorlmager analysis showed that ubiquitin-conjugated IKBa contained 67% of the total radioactivity, and the remaining 33% was unconjugated IKB~.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "08a8d4d9-ba72-4c8a-888c-3fdadc145bb2",
        "_rev": "_WpvYGJ---U",
        "nanopub": {
            "id": "08a8d4d9-ba72-4c8a-888c-3fdadc145bb2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "95 SLE patients, 40 non-SLE patients, and 34 healthy controls",
                    "type": "cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Chi, Shuhong",
                    "Yu, Yunxia",
                    "Shi, Juan",
                    "Zhang, Yurong",
                    "Yang, Jijuan",
                    "Yang, Lijuan",
                    "Liu, Xiaoming"
                ],
                "database": {
                    "id": "26549923",
                    "name": "PubMed"
                },
                "source_name": "Disease markers",
                "title": "Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis.",
                "abstract": "An early diagnosis of lupus nephritis (LN) has an important clinical implication in guiding treatments of systemic lupus erythematosus (SLE) in clinical settings. In this study, the diagnostic values of circulating autoantibodies to C1q alone or in combination with other markers for accessing active SLE and LN were evaluated."
            },
            "assertions": [
                {
                    "subject": "a(anti-C1q)\t",
                    "relation": "positiveCorrelation",
                    "object": "a(anti-dsDNA)"
                }
            ],
            "evidence": "the concentrations of antibodies to C1q and dsDNA correlated very well with each other.\u00a0",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "An early diagnosis of lupus nephritis (LN) has an important clinical implication in guiding treatments of systemic lupus erythematosus (SLE) in clinical settings. In this study, the diagnostic values of circulating autoantibodies to C1q alone or in combination with other markers for accessing active SLE and LN were evaluated.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "343ff0b8-1e2e-48e9-a7c5-9b826f33e1cc",
        "_rev": "_WpvYGJC-Ay",
        "nanopub": {
            "id": "343ff0b8-1e2e-48e9-a7c5-9b826f33e1cc",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Uterine Cervical Neoplasms\"",
                    "label": "Uterine Cervical Neoplasms",
                    "type": "Disease"
                },
                {
                    "id": "EFO:HeLa",
                    "label": "HeLa",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "16526022",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Curcumin)",
                    "relation": "decreases",
                    "object": "p(HGNC:NFKBIA, pmod(P, Ser, 32))"
                }
            ],
            "evidence": "Curcumin inhibited TNF-induced IkBa phosphorylation and degradation in these cells\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2ab50052-8dc1-4f02-a308-64c91bec7fbe",
        "_rev": "_WpvYGJC-_p",
        "nanopub": {
            "id": "2ab50052-8dc1-4f02-a308-64c91bec7fbe",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Chun, Hye-Young",
                    "Chung, Jae-Wook",
                    "Kim, Hyoun-Ah",
                    "Yun, Jeong-Moon",
                    "Jeon, Ja-Young",
                    "Ye, Young-Min",
                    "Kim, Seung-Hyun",
                    "Park, Hae-Sim",
                    "Suh, Chang-Hee"
                ],
                "database": {
                    "id": "17587156",
                    "name": "PubMed"
                },
                "source_name": "Journal of clinical immunology",
                "title": "Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus.",
                "abstract": "There is a great deal of interest in the identification of biomarkers that are closely associated with disease activity in systemic lupus erythematosus (SLE), but few biomarkers have been validated. Cytokines play an important role in the pathogenesis of SLE. Therefore, we evaluated the levels of cytokines and their possible association with disease activity. In the present study, we found that the SLE patients had higher IL-6, IL-10, IL-12, and IFN-gamma levels, but lower IL-2, than normal controls. Serum IL-6 level was significantly elevated in active SLE patients and correlated with the SLE activity index (SLEDAI), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). Serum IL-10 level was also significantly elevated in active SLE patients and revealed positive correlation with SLEDAI and anti-double-stranded DNA (dsDNA) titer and negative correlation with C3, C4, and lymphocyte counts. No significant differences in the levels of cytokines were observed between SLE patients with nephritis and those without nephritis. These data suggest that IL-6 and IL-10 may be a useful biomarker for disease activity in SLE."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL10)",
                    "relation": "positiveCorrelation",
                    "object": "path(DO:\"systemic lupus erythematosus\")"
                }
            ],
            "evidence": "In the present study, we found that the SLE patients had higher IL-6, IL-10, IL-12, and IFN-gamma levels, but lower IL-2, than normal controls.",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "There is a great deal of interest in the identification of biomarkers that are closely associated with disease activity in systemic lupus erythematosus (SLE), but few biomarkers have been validated. Cytokines play an important role in the pathogenesis of SLE. Therefore, we evaluated the levels of cytokines and their possible association with disease activity. In the present study, we found that the SLE patients had higher IL-6, IL-10, IL-12, and IFN-gamma levels, but lower IL-2, than normal controls. Serum IL-6 level was significantly elevated in active SLE patients and correlated with the SLE activity index (SLEDAI), erythrocyte sedimentation rate (ESR), and C-reactive protein (CRP). Serum IL-10 level was also significantly elevated in active SLE patients and revealed positive correlation with SLEDAI and anti-double-stranded DNA (dsDNA) titer and negative correlation with C3, C4, and lymphocyte counts. No significant differences in the levels of cytokines were observed between SLE patients with nephritis and those without nephritis. These data suggest that IL-6 and IL-10 may be a useful biomarker for disease activity in SLE.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "eaec5981-b0b4-4058-9ab3-f3e71572eaff",
        "_rev": "_WpvYGJC-CG",
        "nanopub": {
            "id": "eaec5981-b0b4-4058-9ab3-f3e71572eaff",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "n=21 cancer patients",
                    "type": "Cohort"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17277105",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL2)",
                    "relation": "increases",
                    "object": "bp(GO:\"regulatory T cell differentiation\")"
                }
            ],
            "evidence": "As illustrated in\u00a0Figure 3A, daily IL-2 treatment resulted in increased frequencies of CD4+CD25+\u00a0T cells within the total CD3+\u00a0population\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8ec3e84f-abcb-4256-bd33-5b4b64df8271",
        "_rev": "_WpvYGI6--7",
        "nanopub": {
            "id": "8ec3e84f-abcb-4256-bd33-5b4b64df8271",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Ray, A"
                ],
                "database": {
                    "id": "10975860",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology (Baltimore, Md. : 1950)",
                "title": "A SAF binding site in the promoter region of human gamma-fibrinogen gene functions as an IL-6 response element.",
                "abstract": "Expression of fibrinogen is highly induced during inflammation, and such abnormal expression of this protein is considered as a major cardiovascular risk factor. IL-6 is one of the main mediators of abnormal expression of fibrinogen leading to the pathogenic conditions. Transient transfection and EMSA were performed to investigate the molecular mechanism of IL-6-induced gamma-fibrinogen gene expression in hepatic cells. Using progressively deleted 5' fragments of the gamma-fibrinogen promoter coupled to chloramphenicol acetyltransferase gene, an IL-6 responsive element located between positions -273 and -259 was identified. Mutation of this element abrogates IL-6 responsiveness of the gamma-fibrinogen promoter. Interaction of this promoter with a zinc finger transcription factor, serum amyloid A activating factor (SAF)-1, was demonstrated by EMSA. Furthermore, overexpression of wild-type SAF-1 in transfected liver cells can increase transcription of the gamma-fibrinogen promoter. These data show that transcription factor SAF-1 is involved in the regulation of IL-6-mediated induction of the human gamma-fibrinogen gene in liver cells.",
                "date_published": "2000-09-15"
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "increases",
                    "object": "p(HGNC:FGG)"
                }
            ],
            "evidence": "To study the regulation of IL-6-stimulated transcription of the g-fibrinogen gene, it was necessary to determine the induction level of g-fibrinogen mRNA. Human liver-derived HepG2 cells were incubated in the absence or presence of 50 ng/ml IL-6 for 24 h, and the level of g-fibrinogen expression was monitored by RNA blotassay (Fig. 1). When treated with IL-6, HepG2 cells synthesized a much higher level of g-fibrinogen mRNA (Fig. 1A, lane 2) than the control untreated cells (Fig. 1A, lane 1). Although g-fibrinogen mRNA was constitutively synthesized by HepG2 cells, IL-6 caused marked induction of this level. These results established that the g-fibrinogen gene was indeed induced by IL-6 in the present culturing conditions in HepG2 liver cells.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Expression of fibrinogen is highly induced during inflammation, and such abnormal expression of this protein is considered as a major cardiovascular risk factor. IL-6 is one of the main mediators of abnormal expression of fibrinogen leading to the pathogenic conditions. Transient transfection and EMSA were performed to investigate the molecular mechanism of IL-6-induced gamma-fibrinogen gene expression in hepatic cells. Using progressively deleted 5' fragments of the gamma-fibrinogen promoter coupled to chloramphenicol acetyltransferase gene, an IL-6 responsive element located between positions -273 and -259 was identified. Mutation of this element abrogates IL-6 responsiveness of the gamma-fibrinogen promoter. Interaction of this promoter with a zinc finger transcription factor, serum amyloid A activating factor (SAF)-1, was demonstrated by EMSA. Furthermore, overexpression of wild-type SAF-1 in transfected liver cells can increase transcription of the gamma-fibrinogen promoter. These data show that transcription factor SAF-1 is involved in the regulation of IL-6-mediated induction of the human gamma-fibrinogen gene in liver cells.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "87a3a2fd-56f1-4157-a03d-c79fc99d3824",
        "_rev": "_WpvYGJ--AL",
        "nanopub": {
            "id": "87a3a2fd-56f1-4157-a03d-c79fc99d3824",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "DAS28",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "0.02",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "143 patients allocated to either placebo or pioglitazone treatment",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Marder, Wendy",
                    "Khalatbari, Shokoufeh",
                    "Myles, James D",
                    "Hench, Rita",
                    "Lustig, Susan",
                    "Yalavarthi, Srilakshmi",
                    "Parameswaran, Aishwarya",
                    "Brook, Robert D",
                    "Kaplan, Mariana J"
                ],
                "database": {
                    "id": "24252844",
                    "name": "PubMed"
                },
                "source_name": "Journal of the American Heart Association",
                "title": "The peroxisome proliferator activated receptor-\u03b3 pioglitazone improves vascular function and decreases disease activity in patients with rheumatoid arthritis.",
                "abstract": "Rheumatoid arthritis (RA) is associated with heightened mortality due to atherosclerotic cardiovascular disease (CVD). Inflammatory pathways in RA negatively affect vascular physiology and promote metabolic disturbances that contribute to CVD. We hypothesized that the peroxisome proliferator activated receptor-\u03b3 (PPAR-\u03b3) pioglitazone could promote potent vasculoprotective and anti-inflammatory effects in RA."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:pioglitazone)",
                    "relation": "decreases",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "When added to standard of care treatment of RA, disease activity measured by the DAS\u201028\u2010CRP28 significantly decreased from baseline measurements on the pioglitazone arm when compared to placebo arm (mean=0.31\u00b11.2 pioglitazone versus 0.15\u00b11.2, P=0.02) after 3 months of treatment.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0cb839a2-0ae4-4107-b1cc-d68bf1f90160",
        "_rev": "_WpvYGJG--Y",
        "nanopub": {
            "id": "0cb839a2-0ae4-4107-b1cc-d68bf1f90160",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "59 SLE patients (55 female/4 male)",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "27881058",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"IgG anticardiolipin\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "A positive correlation between IgG-aCL antibody titer and SLEDAI at first visit (P=0.049) was also seen.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "775968ff-2d71-4cb1-b4c7-362709ac9af3",
        "_rev": "_WpvYGJ--Bd",
        "nanopub": {
            "id": "775968ff-2d71-4cb1-b4c7-362709ac9af3",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.55",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "SLAM-R",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:ICAM3)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "85c4cc5f-1f90-4ffc-8eec-477f7fe4e417",
        "_rev": "_WpvYGJG--j",
        "nanopub": {
            "id": "85c4cc5f-1f90-4ffc-8eec-477f7fe4e417",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.03",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "Crossover study with 27 healthy subjects",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "19359242",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "r(complex(GO:\"interleukin-23 complex\"))"
                },
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "r(HGNC:IL1B)"
                }
            ],
            "evidence": "A significant decrease in expression was observed for IL-1\u00df, IL-10, and IL-23. Additionally, IL-5 and IL-17 showed strong trends toward decreased expression after supplementation.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "cd94c8f1-2a7d-4b83-9622-c41e7160093f",
        "_rev": "_WpvYGJ---u",
        "nanopub": {
            "id": "cd94c8f1-2a7d-4b83-9622-c41e7160093f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "21483218",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Occupational Stress\")",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:hydroxyproline)"
                }
            ],
            "evidence": "Urinary Hyp concentrations were related to stress (\u03b2 = 4.023, p = 0.02) with 0.051 of adjusted r2 .\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6603eb9a-4bc7-48cb-97dd-42e49c22f0a9",
        "_rev": "_WpvYGJC-_c",
        "nanopub": {
            "id": "6603eb9a-4bc7-48cb-97dd-42e49c22f0a9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "DO11.10 Cells",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "12006974",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT1)",
                    "relation": "increases",
                    "object": "r(HGNC:TBX21)"
                }
            ],
            "evidence": "Expression of the gene encoding T-bet after restimulation was Th1-specific and expressed in wild-type and STAT4-/- T cells, but were greatly reduced in STAT1-/- Th1 cells.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d3976d56-074e-4361-b516-32acc9d39b42",
        "_rev": "_WpvYGJ--_a",
        "nanopub": {
            "id": "d3976d56-074e-4361-b516-32acc9d39b42",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"Synovial Fluid\"",
                    "label": "Synovial Fluid",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "30 RA patients, 15 OA patients",
                    "type": "cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Hashimoto, Atsushi",
                    "Hayashi, Izumi",
                    "Murakami, Yousuke",
                    "Sato, Yoshinori",
                    "Kitasato, Hidero",
                    "Matsushita, Reiko",
                    "Iizuka, Nobuko",
                    "Urabe, Ken",
                    "Itoman, Moritoshi",
                    "Hirohata, Shunsei",
                    "Endo, Hirahito"
                ],
                "database": {
                    "id": "17918787",
                    "name": "PubMed"
                },
                "source_name": "The Journal of rheumatology",
                "title": "Antiinflammatory mediator lipoxin A4 and its receptor in synovitis of patients with rheumatoid arthritis.",
                "abstract": "To evaluate the role of an antiinflammatory lipid mediator, lipoxin A4 (LXA4), in inflammatory arthritis, we measured the level of LXA4 in synovial fluid and lipoxin A4 receptor (ALX) expression in synovial tissues obtained from patients with rheumatoid arthritis (RA) and osteoarthritis (OA)."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:LXA4)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "LXA4 and 15-epi-LXA4 showed significantly higher levels in RA synovial fluid (10.34 +/- 14.12 ng/ml for LXA4) than OA synovial fluid (0.66 +/- 0.77 ng/ml for LXA4).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0e518b41-6298-47a8-a2d8-7b8477e02312",
        "_rev": "_WpvYGJG-Bk",
        "nanopub": {
            "id": "0e518b41-6298-47a8-a2d8-7b8477e02312",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "McDonald, P P",
                    "Bald, A",
                    "Cassatella, M A"
                ],
                "comments": "NFKBIA=IkBa\np50=NFKB1\np65=RELA",
                "database": {
                    "id": "9129050",
                    "name": "PubMed"
                },
                "source_name": "Blood",
                "title": "Activation of the NF-kappaB pathway by inflammatory stimuli in human neutrophils.",
                "abstract": "Activated neutrophils have the ability to upregulate the expression of many genes, in particular those encoding cytokines and chemokines, and to subsequently release the corresponding proteins. Although little is known to date concerning the regulation of gene transcription in neutrophils, it is noteworthy that many of these genes depend on the activation of transcription factors, such as NF-kappaB, for inducible expression. We therefore investigated whether NF-kappaB/Rel proteins are expressed in human neutrophils, as well as their fate on cell activation. We now report that dimers consisting of p50 NFkappaB1, p65 RelA, and/or c-Rel are present in neutrophils and that the greater part of these protein complexes is physically associated with cytoplasmic IkappaB-alpha in resting cells. Following neutrophil stimulation with proinflammatory agonists (such as lipopolysaccharide [LPS], tumor necrosis factor-alpha [TNF-alpha], and fMet-Leu-Phe) that induce the production of cytokines and chemokines in these cells, NF-kappaB/Rel proteins translocated to nuclear fractions, resulting in a transient induction of NF-kappaB DNA binding activity, as determined in gel mobility shift assays. The onset of both processes was found to be closely paralleled by, and dependent on, IkappaB-alpha degradation. Proinflammatory neutrophil stimuli also promoted the accumulation of IkappaB-alpha mRNA transcripts, resulting in the reexpression of the IkappaB-alpha protein. To our knowledge, this constitutes the first indication that NF-kappaB activation may underlie the action of proinflammatory stimuli towards human neutrophil gene expression and, as such, adds a new facet to our understanding of neutrophil biology."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:NFKBIA)\t",
                    "relation": "increases",
                    "object": "p(HGNC:RELA)"
                },
                {
                    "subject": "p(HGNC:NFKBIA)",
                    "relation": "increases",
                    "object": "p(HGNC:NFKB1)"
                }
            ],
            "evidence": "keeping with the ability of IkB-a to directly interact with either p50, p65/RelA, or c-Rel and thereby keep them sequestered in the cytoplasm. Coimmunoprecipitation experiments not only confirmed that in neutrophils, IkB-a is physically associated with protein complexes containing p50, p65, or c-Rel, but also showed that some of these cytosolic complexes could be identified as p50/c-Rel, p50/p65, and p65/c-Rel heterodimers.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Activated neutrophils have the ability to upregulate the expression of many genes, in particular those encoding cytokines and chemokines, and to subsequently release the corresponding proteins. Although little is known to date concerning the regulation of gene transcription in neutrophils, it is noteworthy that many of these genes depend on the activation of transcription factors, such as NF-kappaB, for inducible expression. We therefore investigated whether NF-kappaB/Rel proteins are expressed in human neutrophils, as well as their fate on cell activation. We now report that dimers consisting of p50 NFkappaB1, p65 RelA, and/or c-Rel are present in neutrophils and that the greater part of these protein complexes is physically associated with cytoplasmic IkappaB-alpha in resting cells. Following neutrophil stimulation with proinflammatory agonists (such as lipopolysaccharide [LPS], tumor necrosis factor-alpha [TNF-alpha], and fMet-Leu-Phe) that induce the production of cytokines and chemokines in these cells, NF-kappaB/Rel proteins translocated to nuclear fractions, resulting in a transient induction of NF-kappaB DNA binding activity, as determined in gel mobility shift assays. The onset of both processes was found to be closely paralleled by, and dependent on, IkappaB-alpha degradation. Proinflammatory neutrophil stimuli also promoted the accumulation of IkappaB-alpha mRNA transcripts, resulting in the reexpression of the IkappaB-alpha protein. To our knowledge, this constitutes the first indication that NF-kappaB activation may underlie the action of proinflammatory stimuli towards human neutrophil gene expression and, as such, adds a new facet to our understanding of neutrophil biology.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6388d007-6714-4e3b-b59c-df3389e31ab6",
        "_rev": "_WpvYGJC-Aq",
        "nanopub": {
            "id": "6388d007-6714-4e3b-b59c-df3389e31ab6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "n=15",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10545482",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:ethanol)",
                    "relation": "decreases",
                    "object": "p(HGNC:IL1B)"
                }
            ],
            "evidence": "Figure 1\u00a0demonstrates that ethanol also down-regulates monocyte IL-1\u03b2 induction. Ethanol inhibited LPS-induced monocyte IL-1\u03b2 protein levels by 46 \u00b1 12% (n =\u00a015) with a concomitant decrease in the IL-1\u03b2 mRNA (76.3 \u00b1 8.2%;\u00a0n =\u00a03), suggesting that ethanol affects early signaling elements in IL-1\u03b2 regulation.\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1f3d573a-efe8-4ab6-8138-7b403ed5f27f",
        "_rev": "_WpvYGJG-_L",
        "nanopub": {
            "id": "1f3d573a-efe8-4ab6-8138-7b403ed5f27f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Complementation",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "U4A Cells",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "8232552",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "association",
                    "object": "p(HGNC:JAK1, pmod(Ph, Tyr))"
                },
                {
                    "subject": "p(HGNC:IFNB)",
                    "relation": "association",
                    "object": "p(HGNC:JAK1, pmod(Ph, Tyr))"
                },
                {
                    "subject": "p(HGNC:IFNA)",
                    "relation": "association",
                    "object": "p(HGNC:JAK1, pmod(Ph, Tyr))"
                }
            ],
            "evidence": "Transfection of U4A cells with JAK1 cdna EXPRESSION CONSTRUCTS RESULTED IN THE RESTORATION OF THE ifn-a/b and IFN-g response of all IFN-inducible genes tested\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "84e1614b-3970-439f-875a-287bcb9a8c29",
        "_rev": "_WpvYGJC-AG",
        "nanopub": {
            "id": "84e1614b-3970-439f-875a-287bcb9a8c29",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "418 SLE or APS patients",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "16960938",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"lupus anticoagulant\")",
                    "relation": "positiveCorrelation",
                    "object": "p(\"anti-IgG anti-beta2-GPI\")"
                }
            ],
            "evidence": "A positive association was found between the presence of the LAC by dilute RVVT and anti-beta2-GPI IgG (p < 0.0001), IgM (p < 0.0001), and IgA (p = 0.0002) antibodies.\n",
            "metadata": {
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "31775afb-afbe-4589-975e-a2b62783cc3a",
        "_rev": "_WpvYGJC-AD",
        "nanopub": {
            "id": "31775afb-afbe-4589-975e-a2b62783cc3a",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"CD4-positive helper T cell\"",
                    "label": "CD4-positive helper T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16698929",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:SOCS3)",
                    "relation": "regulates",
                    "object": "bp(GO:\"T-helper 17 cell differentiation\")"
                }
            ],
            "evidence": "Thus, Socs3 appears to be a critical regulator of Th17 generation regardless of whether IL-6, TGF-\u03b2, or IL-23 are used and evidently serves to attenuate Th17 generation even under Th1 conditions.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "31becf1f-c402-470c-845e-c600cb4852f7",
        "_rev": "_WpvYGJG-A3",
        "nanopub": {
            "id": "31becf1f-c402-470c-845e-c600cb4852f7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16648837",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite(p(HGNC:TGFB), complex(HGNC:\"Interleukin 23 complex\"))",
                    "relation": "increases",
                    "object": "bp(GO:\"T-helper 17 cell differentiation\")"
                }
            ],
            "evidence": "IL-23 alone is insufficient to promote robust TH17 development. Addition of TGF-b1 promoted a substantially increased fraction of IL-17\u00fe cells, which was only modestly augmented by co-addition of exogenous IL-23\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a290454e-124d-4b70-98a7-765ca2171d0c",
        "_rev": "_WpvYGJC-_s",
        "nanopub": {
            "id": "a290454e-124d-4b70-98a7-765ca2171d0c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"HT2 Clone A5E cell\"",
                    "label": "HT2 Clone A5E cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "2960769",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:\"T-helper 1 cell\")\t",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL3))"
                },
                {
                    "subject": "a(CL:\"T-helper 1 cell\")\t",
                    "relation": "increases",
                    "object": "sec(p(HGNC:TNF))"
                },
                {
                    "subject": "a(CL:\"T-helper 1 cell\")\t",
                    "relation": "increases",
                    "object": "sec(p(HGNC:GMCSF))"
                },
                {
                    "subject": "a(CL:\"T-helper 1 cell\")\t",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL2))"
                },
                {
                    "subject": "a(CL:\"T-helper 1 cell\")",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IFNG))"
                }
            ],
            "evidence": "Compared with the average expression levels of all T helper clones tested, Th 1 clones express high levels of IL-2, IFN-y, LT, GM-CSF, TNF, TY5, and IL-3 ; low levels of ppENK; and no IL-4, IL-5,\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0877f97e-d0ed-4f58-99a4-d2e8966688c7",
        "_rev": "_WpvYGJ--AY",
        "nanopub": {
            "id": "0877f97e-d0ed-4f58-99a4-d2e8966688c7",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17277312",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:STAT3))\t",
                    "relation": "decreases",
                    "object": "r(HGNC:TBET)"
                },
                {
                    "subject": "act(p(HGNC:STAT3))",
                    "relation": "decreases",
                    "object": "r(HGNC:GATA3)"
                },
                {
                    "subject": "act(p(HGNC:STAT3))\t",
                    "relation": "increases",
                    "object": "r(HGNC:RORGT)"
                }
            ],
            "evidence": "Moreover, STAT3 overactivation also reduced GATA3 and T-bet expression but increased the expression of ROR\u0001t, a transcription regulator of THi differentiation (20).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "fa692f62-69c3-49f2-9ffa-72b41463028f",
        "_rev": "_WpvYGJ--AQ",
        "nanopub": {
            "id": "fa692f62-69c3-49f2-9ffa-72b41463028f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Thymidine Incorporation",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"dendritic cell\"",
                    "label": "dendritic cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10898488",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:\"regulatory T cell\")",
                    "relation": "decreases",
                    "object": "bp(GO:\"positive regulation of T cell mediated immunity\")"
                }
            ],
            "evidence": "To study the role of the APC and co-stimulation for the function of CD4+ CD25+ T cells, we compared the ability of CD4+ CD25+ T cells to suppress the response of antiCD3-stimulated CD4+ CD25\u2013 T cells co-cultured with either B cells or DC. There was a significant difference in the potency of suppression depending on what kind of APC was used (Fig. 1 A).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "fde169d4-6f95-40c8-bbdc-d775f636aa9e",
        "_rev": "_WpvYGJC-A-",
        "nanopub": {
            "id": "fde169d4-6f95-40c8-bbdc-d775f636aa9e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Boulanger, Martin J",
                    "Chow, Dar-chone",
                    "Brevnova, Elena E",
                    "Garcia, K Christopher"
                ],
                "comments": "gp130=IL6ST",
                "database": {
                    "id": "12829785",
                    "name": "PubMed"
                },
                "source_name": "Science (New York, N.Y.)",
                "title": "Hexameric structure and assembly of the interleukin-6/IL-6 alpha-receptor/gp130 complex.",
                "abstract": "Interleukin-6 (IL-6) is an immunoregulatory cytokine that activates a cell-surface signaling assembly composed of IL-6, the IL-6 alpha-receptor (IL-6Ralpha), and the shared signaling receptor gp130. The 3.65 angstrom-resolution structure of the extracellular signaling complex reveals a hexameric, interlocking assembly mediated by a total of 10 symmetry-related, thermodynamically coupled interfaces. Assembly of the hexameric complex occurs sequentially: IL-6 is first engaged by IL-6Ralpha and then presented to gp130in the proper geometry to facilitate a cooperative transition into the high-affinity, signaling-competent hexamer. The quaternary structures of other IL-6/IL-12 family signaling complexes are likely constructed by means of a similar topological blueprint."
            },
            "assertions": [
                {
                    "subject": "p(SFAM:JAK family)",
                    "relation": "increases",
                    "object": "p(HGNC:STAT3)"
                },
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "increases",
                    "object": "p(SFAM:JAK family)"
                },
                {
                    "subject": "p(HGNC:SOCS3)",
                    "relation": "decreases",
                    "object": "p(HGNC:IL6ST)"
                },
                {
                    "subject": "p(HGNC:SOCS1)",
                    "relation": "decreases",
                    "object": "p(SFAM:JAK family)"
                },
                {
                    "subject": "p(HGNC:STAT3)\t",
                    "relation": "increases",
                    "object": "p(HGNC:SOCS3)"
                },
                {
                    "subject": "p(HGNC:STAT3)",
                    "relation": "increases",
                    "object": "p(HGNC:SOCS1)"
                },
                {
                    "subject": "p(HGNC:IL6ST)\t",
                    "relation": "increases",
                    "object": "p(HGNC:STAT3)"
                },
                {
                    "subject": "p(HGNC:IL6ST)",
                    "relation": "increases",
                    "object": "p(SFAM:JAK family)"
                }
            ],
            "evidence": "IL-6 receptor system and IL-6 blocker, a humanized anti-IL-6 receptor antibody tocilizumab. IL-6 binds to soluble and transmembrane IL-6R and the complex, then induces homodimerization of gp130, leading to activation of the signaling system. ...\nActivation of gp130 in turn triggers activation of downstream signaling molecules, that is, the Janus kinase (JAK)-STAT3 pathway and the JAK-SHP-2-mitogen-activated protein (MAP) kinase pathway. The regulation of various sets of IL-6 responsive genes, including acute phase proteins, is accounted for by the transcription factor STAT3, which also induces the suppressor of cytokine signaling 1 (SOCS1) and SOCS3, which share the SH2-domain. In this context, SOCS1 binds to tyrosine-phosphorylated JAK (Naka et al. 1997), whereas SOCS3 binds to tyrosine-phosphorylated gp130 (Schmitz et al. 2000) to stop IL-6 signaling by means of a negative feedback loop.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Interleukin-6 (IL-6) is an immunoregulatory cytokine that activates a cell-surface signaling assembly composed of IL-6, the IL-6 alpha-receptor (IL-6Ralpha), and the shared signaling receptor gp130. The 3.65 angstrom-resolution structure of the extracellular signaling complex reveals a hexameric, interlocking assembly mediated by a total of 10 symmetry-related, thermodynamically coupled interfaces. Assembly of the hexameric complex occurs sequentially: IL-6 is first engaged by IL-6Ralpha and then presented to gp130in the proper geometry to facilitate a cooperative transition into the high-affinity, signaling-competent hexamer. The quaternary structures of other IL-6/IL-12 family signaling complexes are likely constructed by means of a similar topological blueprint.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "62d242a4-05d1-42c3-acc4-fd4f89fc6e01",
        "_rev": "_WpvYGJG-Bu",
        "nanopub": {
            "id": "62d242a4-05d1-42c3-acc4-fd4f89fc6e01",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Hakkim, Abdul",
                    "F\u00fcrnrohr, Barbara G",
                    "Amann, Kerstin",
                    "Laube, Britta",
                    "Abed, Ulrike Abu",
                    "Brinkmann, Volker",
                    "Herrmann, Martin",
                    "Voll, Reinhard E",
                    "Zychlinsky, Arturo"
                ],
                "database": {
                    "id": "20439745",
                    "name": "PubMed"
                },
                "source_name": "Proceedings of the National Academy of Sciences of the United States of America",
                "title": "Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis.",
                "abstract": "Systemic lupus erythematosus (SLE) is an autoimmune disease in which patients develop autoantibodies to DNA, histones, and often to neutrophil proteins. These form immune complexes that are pathogenic and may cause lupus nephritis. In SLE patients, infections can initiate flares and are a major cause of mortality. Neutrophils respond to infections and release extracellular traps (NETs), which are antimicrobial and are made of DNA, histones, and neutrophil proteins. The timely removal of NETs may be crucial for tissue homeostasis to avoid presentation of self-antigens. We tested the hypothesis that SLE patients cannot clear NETs, contributing to the pathogenesis of lupus nephritis. Here we show that serum endonuclease DNase1 is essential for disassembly of NETs. Interestingly, a subset of SLE patients' sera degraded NETs poorly. Two mechanisms caused this impaired NET degradation: (i) the presence of DNase1 inhibitors or (ii) anti-NET antibodies prevented DNase1 access to NETs. Impairment of DNase1 function and failure to dismantle NETs correlated with kidney involvement. Hence, identification of SLE patients who cannot dismantle NETs might be a useful indicator of renal involvement. Moreover, NETs might represent a therapeutic target in SLE."
            },
            "assertions": [
                {
                    "subject": "a(DNAseI inhibitor)",
                    "relation": "decreases",
                    "object": "a(NETs)"
                }
            ],
            "evidence": "We used this property of G-actin and showed that it inhibited NET degradation in a dose-dependent manner (Fig. 1F), indicating that DNase1 degrades NETs. Anti-DNase1 Abs, but not an irrelevant Ab control, prevented serum-mediated NET degradation (Fig. 1H), confirming that DNase1 digests NETs. In addition, as controls, we showed that inhibitory concentrations of either G-actin (Fig. 1G) or anti-DNase1 Abs (Fig. 1I) block DNase1 but not MNase-mediated NET disintegration. These data indicate that serum DNase1 is essential for NET degradation.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2b53cf97-f012-44f2-878e-9958aa9e7a21",
        "_rev": "_WpvYGJG-Bl",
        "nanopub": {
            "id": "2b53cf97-f012-44f2-878e-9958aa9e7a21",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Not specified",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"B cell\"",
                    "label": "B cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "22503615",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17)",
                    "relation": "increases",
                    "object": "bp(GO:\"Immunoglobulin secretion\")"
                }
            ],
            "evidence": "Consistent with this, OVA-specific Ig production was impaired in IL-17/ mice (data not shown), as shown previously [7], when mice were immunized with OVA emulsified with alum.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e11ce8df-a671-41e6-a239-4692381265b5",
        "_rev": "_WpvYGJ--Ah",
        "nanopub": {
            "id": "e11ce8df-a671-41e6-a239-4692381265b5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"regulatory T cell\"",
                    "label": "regulatory T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "21474713",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "surf(p(HGNC:CTLA4))",
                    "relation": "increases",
                    "object": "tloc(p(HGNC:CD86), fromloc(GO:\"Cell surface\"), toloc(GO:\"Endosome\"))"
                }
            ],
            "evidence": "Using a flow cytometric assay, we observed substantial transfer of CD86 into CTLA-4+ cells (Fig. 1A and fig. S1).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "291ee47c-a105-41de-922d-b9aa95ae135c",
        "_rev": "_WpvYGJC--G",
        "nanopub": {
            "id": "291ee47c-a105-41de-922d-b9aa95ae135c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.17",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "0.004",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "1518 men and 1524 women",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Immunophlerometry",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "comments": "No \"high fish diet\" ontology; made do - Adrian",
                "database": {
                    "id": "15992645",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Seafood\")",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:CRP)"
                }
            ],
            "evidence": "All inflammatory markers showed an inverse dose-response relationship with fish consumption (Table 2).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "cfcd6fdc-ef6a-4995-99a3-0408f1f59ada",
        "_rev": "_WpvYGJG-A7",
        "nanopub": {
            "id": "cfcd6fdc-ef6a-4995-99a3-0408f1f59ada",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"epithelial cell of tracheobronchial tree\"",
                    "label": "epithelial cell of tracheobronchial tree",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "20008294",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"D3 vitamins\")",
                    "relation": "increases",
                    "object": "r(EG:4792)"
                }
            ],
            "evidence": "Treatment with vitamin D led to a statistically significant increase in I\u03baB\u03b1 mRNA (Fig. 1A).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "df807d31-086d-42d5-8024-e8c0dbebaf70",
        "_rev": "_WpvYGJC-_y",
        "nanopub": {
            "id": "df807d31-086d-42d5-8024-e8c0dbebaf70",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Northern Blot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8167346",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL10)",
                    "relation": "decreases",
                    "object": "r(EG:3576"
                }
            ],
            "evidence": "n both MNCs and PMNs, degradation of LPS-induced IL-8 mRNA was enhanced by IL-10.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e90a1837-1bdb-470f-bc5e-14b7cc92a73a",
        "_rev": "_WpvYGJ--_0",
        "nanopub": {
            "id": "e90a1837-1bdb-470f-bc5e-14b7cc92a73a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Garcia-Romo, Gina S",
                    "Caielli, Simone",
                    "Vega, Barbara",
                    "Connolly, John",
                    "Allantaz, Florence",
                    "Xu, Zhaohui",
                    "Punaro, Marilynn",
                    "Baisch, Jeanine",
                    "Guiducci, Cristiana",
                    "Coffman, Robert L",
                    "Barrat, Franck J",
                    "Banchereau, Jacques",
                    "Pascual, Virginia"
                ],
                "database": {
                    "id": "21389264",
                    "name": "PubMed"
                },
                "source_name": "Science translational medicine",
                "title": "Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus.",
                "abstract": "Systemic lupus erythematosus (SLE) is a systemic autoimmune disease characterized by a breakdown of tolerance to nuclear antigens and the development of immune complexes. Genomic approaches have shown that human SLE leukocytes homogeneously express type I interferon (IFN)-induced and neutrophil-related transcripts. Increased production and/or bioavailability of IFN-\u03b1 and associated alterations in dendritic cell (DC) homeostasis have been linked to lupus pathogenesis. Although neutrophils have long been shown to be associated with lupus, their potential role in disease pathogenesis remains elusive. Here, we show that mature SLE neutrophils are primed in vivo by type I IFN and die upon exposure to SLE-derived anti-ribonucleoprotein antibodies, releasing neutrophil extracellular traps (NETs). SLE NETs contain DNA as well as large amounts of LL37 and HMGB1, neutrophil proteins that facilitate the uptake and recognition of mammalian DNA by plasmacytoid DCs (pDCs). Indeed, SLE NETs activate pDCs to produce high levels of IFN-\u03b1 in a DNA- and TLR9 (Toll-like receptor 9)-dependent manner. Our results reveal an unsuspected role for neutrophils in SLE pathogenesis and identify a novel link between nucleic acid-recognizing antibodies and type I IFN production in this disease."
            },
            "assertions": [
                {
                    "subject": "a(NETs)",
                    "relation": "increases",
                    "object": "a(CL:plasmacytoid dendritic cell)"
                },
                {
                    "subject": "a(anti-RNP)",
                    "relation": "increases",
                    "object": "a(NETs)"
                }
            ],
            "evidence": "SLE NETs induced by anti-RNP antibodies are potent activators of pDCs",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "799619e4-392c-4eaf-b589-c34a308eeb15",
        "_rev": "_WpvYGJG--D",
        "nanopub": {
            "id": "799619e4-392c-4eaf-b589-c34a308eeb15",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "authors": [
                    "Vendelbo, Mikkel Holm",
                    "M\u00f8ller, Andreas Buch",
                    "Christensen, Britt",
                    "Nellemann, Birgitte",
                    "Clasen, Berthil Frederik Forrest",
                    "Nair, K Sreekumaran",
                    "J\u00f8rgensen, Jens Otto Lunde",
                    "Jessen, Niels",
                    "M\u00f8ller, Niels"
                ],
                "database": {
                    "id": "25020061",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Fasting increases human skeletal muscle net phenylalanine release and this is associated with decreased mTOR signaling.",
                "abstract": "Fasting is characterised by profound changes in energy metabolism including progressive loss of body proteins. The underlying mechanisms are however unknown and we therefore determined the effects of a 72-hour-fast on human skeletal muscle protein metabolism and activation of mammalian target of rapamycin (mTOR), a key regulator of cell growth.",
                "date_published": "2014-01-01"
            },
            "assertions": [
                {
                    "subject": "bp(MESH:Fasting)",
                    "relation": "increases",
                    "object": "bp(MESH:\"Regional Blood Flow\")"
                }
            ],
            "evidence": "Blood-flow was increased in the forearm after 72 hours of fasting (Table 1)\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true,
                "gd:abstract": "Fasting is characterised by profound changes in energy metabolism including progressive loss of body proteins. The underlying mechanisms are however unknown and we therefore determined the effects of a 72-hour-fast on human skeletal muscle protein metabolism and activation of mammalian target of rapamycin (mTOR), a key regulator of cell growth."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6d33449b-93dc-4b3d-8da8-390b9345109e",
        "_rev": "_WpvYGJ--_z",
        "nanopub": {
            "id": "6d33449b-93dc-4b3d-8da8-390b9345109e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16648838",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite(p(HGNC:IL6),p(HGNC:TGFB))",
                    "relation": "increases",
                    "object": "bp(GO:\"T-helper 17 cell differentiation\")"
                }
            ],
            "evidence": "We have shown that whereas IL-6 suppresses TGF-b-induced Foxp3 expression and Treg generation, the combination of IL-6 and TGF-b promotes the generation of TH17 cells\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "53706e24-f225-4cef-96aa-6fa176a3725a",
        "_rev": "_WpvYGJC-Bb",
        "nanopub": {
            "id": "53706e24-f225-4cef-96aa-6fa176a3725a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "DO:\"acute T cell leukemia\"",
                    "label": "acute T cell leukemia",
                    "type": "Disease"
                },
                {
                    "id": "CLO:\"JURKAT cell\"",
                    "label": "JURKAT cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "authors": [
                    "Liu, W",
                    "Kato, M",
                    "Akhand, A A",
                    "Hayakawa, A",
                    "Suzuki, H",
                    "Miyata, T",
                    "Kurokawa, K",
                    "Hotta, Y",
                    "Ishikawa, N",
                    "Nakashima, I"
                ],
                "database": {
                    "id": "10652256",
                    "name": "PubMed"
                },
                "source_name": "Journal of cell science",
                "title": "4-hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death.",
                "abstract": "4-Hydroxynonenal (HNE), a diffusible product of lipid peroxidation, has been suggested to be a key mediator of oxidative stress-induced cell death. In this study, we partially characterized the mechanism of HNE-mediated cytotoxicity. Incubation of human T lymphoma Jurkat cells with 20-50 microM HNE led to cell death accompanied by DNA fragmentation. Western blot analysis showed that HNE-treatment induced time- and dose-dependent activation of caspase-8, caspase-9 and caspase-3. HNE-induced caspase-3 processing was confirmed by a flow cytometric demonstration of increased catalytic activity on the substrate peptide. HNE treatment also led to remarkable cleavage of poly(ADP-ribose) polymerase (PARP), which was prevented by pretreatment of cells with DEVD-FMK as a caspase-3 inhibitor. The HNE-mediated activation of caspases, cleavage of PARP and DNA fragmentation were blocked by antioxidants cysteine, N-acety-L-cysteine and dithiothreitol, but not by two other HNE-reactive amino acids lysine and histidine, or by cystine, the oxidized form of cysteine. HNE rapidly decreased levels of intracellular reduced glutathione (GSH) and its oxidized form GSSG, and these were also attenuated by the reductants. Coincubation of Jurkat cells with a blocking anti-Fas antibody prevented Fas-induced but not HNE-induced activation of caspase-3. HNE also activated caspase-3 in K562 cells that do not express functional Fas. Our results thereby demonstrate that HNE triggers oxidative stress-linked apoptotic cell death through activation of the caspase cascade. The results also suggest a possible mechanism involving a direct scavenge of intracellular GSH by HNE."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:4-hydroxynon-2-enal)",
                    "relation": "decreases",
                    "object": "a(CHEBI:glutathione)"
                }
            ],
            "evidence": "\"As shown in Fig. 4A, intracellular GSH concentration in HNE-treated\ncells fell rapidly, and the peak of reduction was observed at 2 hours after incubation.\"\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "24cf4d33-ffd5-4aa4-903c-79e9fdf20fd0",
        "_rev": "_WpvYGJG-_h",
        "nanopub": {
            "id": "24cf4d33-ffd5-4aa4-903c-79e9fdf20fd0",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "EMSA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"embryonic fibroblast\"",
                    "label": "embryonic fibroblast",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10748240",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "complex(HGNC:\"NFKB complex\")",
                    "relation": "association",
                    "object": "p(HGNC:TRAF6)"
                }
            ],
            "evidence": "However, in TRAF6\u2212/\u2212cells, no NF-\u03baB activation was detected within the time frame examined. In agreement with a previous report, TRAF6\u2212/\u2212\u00a0cells also failed to respond to IL-1\u00a038.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "53930b34-b9fd-479a-a2fa-afb4a2406475",
        "_rev": "_WpvYGJC-Bc",
        "nanopub": {
            "id": "53930b34-b9fd-479a-a2fa-afb4a2406475",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001 (wrt controls)",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "20 CH patients, 15 cirrhosis patients, 10 hep C patients, 27 with CHE, 15 controls",
                    "type": "Cohort"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "RPC",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"hepatic encephalopathy\"",
                    "label": "hepatic encephalopathy",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10509899",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(DO:\"hepatic encephalopathy\")",
                    "relation": "increases",
                    "object": "a(CHEBI:\"L-pipecolic acid\")"
                },
                {
                    "subject": "path(DO:\"hepatic encephalopathy\")",
                    "relation": "increases",
                    "object": "a(CHEBI:\"D-pipecolic acid\")"
                }
            ],
            "evidence": "These levels in patients with both liver cirrhosis and CHE were significantly higher than those in normal subjects and chronic hepatitis ( p , 0.001 or p , 0.01)\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b9744f5d-c139-493d-8c6e-5934a128c09c",
        "_rev": "_WpvYGJC--8",
        "nanopub": {
            "id": "b9744f5d-c139-493d-8c6e-5934a128c09c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"umbilical artery endothelial cell\"",
                    "label": "umbilical artery endothelial cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Watkins, M T",
                    "Patton, G M",
                    "Soler, H M",
                    "Albadawi, H",
                    "Humphries, D E",
                    "Evans, J E",
                    "Kadowaki, H"
                ],
                "database": {
                    "id": "10585861",
                    "name": "PubMed"
                },
                "source_name": "The Biochemical journal",
                "title": "Synthesis of 8-epi-prostaglandin F2alpha by human endothelial cells: role of prostaglandin H2 synthase.",
                "abstract": "The experiments described in this paper were designed to determine the mechanism underlying the increase in 8-isoprostaglandin F(2alpha) (8-epi-PGF(2alpha)) production by cultured human endothelial cells during reoxygenation following hypoxia. Human umbilical artery endothelial cells were grown on microcarrier beads and exposed to sequential periods of normoxia, hypoxia, and reoxygenation. The amount of 8-epi-PGF(2alpha) in the medium was determined by ELISA. The production of 8-epi-PGF(2alpha) decreased by greater than 90% during hypoxia. Upon reoxygenation 8-epi-PGF(2alpha) production increased linearly for 90 min reaching nearly 3 times normoxic levels. When added to the medium during reoxygenation, neither superoxide dismutase nor Tiron, a cell-permeable superoxide scavenger, inhibited 8-epi-PGF(2alpha) production. However, 8-epi-PGF(2alpha) production was inhibited by catalase. The production of 8-epi-PGF(2alpha) was also inhibited by indomethacin and aspirin. Exogenous hydrogen peroxide stimulated 8-epi-PGF(2alpha) production by normoxic cells, and aspirin inhibited the hydrogen peroxide-mediated increase in 8-epi-PGF(2alpha) production. These results indicate that the reactive oxygen species responsible for 8-epi-PGF(2alpha) synthesis during reoxygenation is hydrogen peroxide and that in endothelial cells 8-epi-PGF(2alpha) synthesis is mediated by prostaglandin H(2) synthase (PGHS). To verify the role of PGHS in 8-epi-PGF(2alpha) synthesis, human PGHS-1 was expressed in COS-7 cells, a PGHS negative cell line that does not synthesize 8-epi-PGF(2alpha). In the presence of exogenous arachidonic acid the COS-7 cells expressing human PGHS-1 produced substantial amounts of PGE(2) and 8-epi-PGF(2alpha). These data indicate that human PGHS-1 can support the synthesis of 8-epi-PGF(2alpha) and that 8-epi-PGF(2alpha) synthesis by cultured human endothelial cells during reoxygenation is dependent on the activity of PGHS-1."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CAT)",
                    "relation": "increases",
                    "object": "a(CHEBI:\"8-epi-prostaglandin F2alpha\")"
                }
            ],
            "evidence": "In contrast, catalase(1200 units/ml) significantly inhibited 8-epi-PGF2alpha production during all reoxygenation intervals.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b01f0d22-670d-4c24-84cb-7f15b38e40de",
        "_rev": "_WpvYGJC-Am",
        "nanopub": {
            "id": "b01f0d22-670d-4c24-84cb-7f15b38e40de",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CLO:\"CT26.CL25 cell\"",
                    "label": "CT26.CL25 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "25909219",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fasting\")",
                    "relation": "increases",
                    "object": "bp(MESH:\"Oxidative Stress\")"
                }
            ],
            "evidence": "Indeed, STS and OXP markedly increased ROS generation in CT26 cells and STS+OXP further exacerbated ROS production (Figure\u00a0\u200b(Figure5A).5A).\u00a0\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "18d652cf-7c8e-4b2b-82df-e188b6d5ecf1",
        "_rev": "_WpvYGJG--W",
        "nanopub": {
            "id": "18d652cf-7c8e-4b2b-82df-e188b6d5ecf1",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "DLN cells",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "15657292",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "complex(GO\"Interleukin 23 complex\")",
                    "relation": "increases",
                    "object": "p(HGNC:TNF)"
                }
            ],
            "evidence": "TNF production was also markedly reduced in the IL-23p19\u2212/\u2212\u00a0cells, consistent with a previous paper suggesting that IL-23 is required for TNF production by CNS-infiltrating T cells (12).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8e88b707-9450-4aad-9dc5-93dffbe22657",
        "_rev": "_WpvYGJC-AE",
        "nanopub": {
            "id": "8e88b707-9450-4aad-9dc5-93dffbe22657",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Coimmunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"COS-1 cell\"",
                    "label": "COS-1 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "8700888",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:JAK1)",
                    "relation": "directlyIncreases",
                    "object": "complex(p(HGNC:JAK1), p(HGNC:IL2RB, pmod(Ph, Y, 338))"
                },
                {
                    "subject": "act(p(HGNC:IL2), ma(GO:\"Receptor Binding\"))",
                    "relation": "increases",
                    "object": "composite(p(HGNC:IL2RB), pmod(Ph, Y, 338), pmod(Ph, Y, 392), pmod(Ph, Y, 510))"
                }
            ],
            "evidence": "; in contrast, mutation of the other three tyrosines (Y338, Y392, and Y510) abolished IL-2 responsiveness (,BFYYYFF; Fig. 1B)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ec66a946-4159-4c23-b8d8-21e14fb26db0",
        "_rev": "_WpvYGJ--Bo",
        "nanopub": {
            "id": "ec66a946-4159-4c23-b8d8-21e14fb26db0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "132 Hispanic MS patients and 60 controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "FACS",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "comments": "p-value isn't specified",
                "database": {
                    "id": "19321461",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"D3 vitamins\")",
                    "relation": "increases",
                    "object": "bp(GO:\"regulatory T cell differentiation\")"
                }
            ],
            "evidence": "Culture of PBMC in the presence of 1,25 (OH)2\u00a0Vitamin D significantly increased the percentage of CD4+CD25+FoxP3+ regulatory T cells as measured by flow cytometry.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f8580224-fbad-4af3-b227-4e3e370761c8",
        "_rev": "_WpvYGJC-Av",
        "nanopub": {
            "id": "f8580224-fbad-4af3-b227-4e3e370761c8",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "EFO:HepG2",
                    "label": "HepG2",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "24755741",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:AMPD2)",
                    "relation": "increases",
                    "object": "bp(GO:gluconeogenesis)"
                }
            ],
            "evidence": "This treatment resulted in higher intracellular glucose levels in AMPD2-overexpressing cells compared to control HepG2 cells (Fig. 2E). The increase in intracellular glucose levels seems to be derived from increased glucose production rather than decreased utilization since removal of gluconeogenic substrate lactate and pyruvate resulted in no glucose accumulation under the same conditions (Fig. 2E).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b492e76a-812f-43fe-a48a-4f2a6d20daa1",
        "_rev": "_WpvYGJG-_s",
        "nanopub": {
            "id": "b492e76a-812f-43fe-a48a-4f2a6d20daa1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"regulatory T cell\"",
                    "label": "regulatory T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "21474713",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "surf(p(HGNC:CTLA4))",
                    "relation": "increases",
                    "object": "tloc(p(HGNC:CD80), fromloc(GO:\"Cell surface\"), toloc(GO:\"Endosome\"))"
                }
            ],
            "evidence": "See figure 2C\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "dfb71707-39dc-4e35-92df-57d05ffc2de8",
        "_rev": "_WpvYGJG-_1",
        "nanopub": {
            "id": "dfb71707-39dc-4e35-92df-57d05ffc2de8",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "2 hours",
                    "type": "Time"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "CLO:\"JURKAT cell\"",
                    "label": "JURKAT cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "abstract": "4-Hydroxynonenal (HNE), a diffusible product of lipid peroxidation, has been suggested to be a key mediator of oxidative stress-induced cell death. In this study, we partially characterized the mechanism of HNE-mediated cytotoxicity. Incubation of human T lymphoma Jurkat cells with 20-50 microM HNE led to cell death accompanied by DNA fragmentation. Western blot analysis showed that HNE-treatment induced time- and dose-dependent activation of caspase-8, caspase-9 and caspase-3. HNE-induced caspase-3 processing was confirmed by a flow cytometric demonstration of increased catalytic activity on the substrate peptide. HNE treatment also led to remarkable cleavage of poly(ADP-ribose) polymerase (PARP), which was prevented by pretreatment of cells with DEVD-FMK as a caspase-3 inhibitor. The HNE-mediated activation of caspases, cleavage of PARP and DNA fragmentation were blocked by antioxidants cysteine, N-acety-L-cysteine and dithiothreitol, but not by two other HNE-reactive amino acids lysine and histidine, or by cystine, the oxidized form of cysteine. HNE rapidly decreased levels of intracellular reduced glutathione (GSH) and its oxidized form GSSG, and these were also attenuated by the reductants. Coincubation of Jurkat cells with a blocking anti-Fas antibody prevented Fas-induced but not HNE-induced activation of caspase-3. HNE also activated caspase-3 in K562 cells that do not express functional Fas. Our results thereby demonstrate that HNE triggers oxidative stress-linked apoptotic cell death through activation of the caspase cascade. The results also suggest a possible mechanism involving a direct scavenge of intracellular GSH by HNE.",
                "authors": [
                    "Liu, W",
                    "Kato, M",
                    "Akhand, A A",
                    "Hayakawa, A",
                    "Suzuki, H",
                    "Miyata, T",
                    "Kurokawa, K",
                    "Hotta, Y",
                    "Ishikawa, N",
                    "Nakashima, I"
                ],
                "database": {
                    "id": "10652256",
                    "name": "PubMed"
                },
                "source_name": "Journal of cell science",
                "title": "4-hydroxynonenal induces a cellular redox status-related activation of the caspase cascade for apoptotic cell death."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:4-hydroxynon-2-enal)",
                    "relation": "decreases",
                    "object": "a(CHEBI:glutathione)"
                }
            ],
            "evidence": "As shown in Fig. 4A, intracellular GSH concentration in HNE-treated cells fell rapidly, and the peak of reduction was observed at 2 hours after incubation.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b4289f9e-83d0-401e-a493-313d59596c19",
        "_rev": "_WpvYGJ--Cl",
        "nanopub": {
            "id": "b4289f9e-83d0-401e-a493-313d59596c19",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:\"Alzheimer's disease\"",
                    "label": "Alzheimer's disease",
                    "type": "Disease"
                },
                {
                    "id": "",
                    "label": "54 patients with AD dementia, 75 patients with mild cognitive impairment (MCI), and 25 cognitively normal controls",
                    "type": "Cohort"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Zetterberg, Henrik",
                    "Wilson, David",
                    "Andreasson, Ulf",
                    "Minthon, Lennart",
                    "Blennow, Kaj",
                    "Randall, Jeffrey",
                    "Hansson, Oskar"
                ],
                "database": {
                    "id": "23551972",
                    "name": "PubMed"
                },
                "source_name": "Alzheimer's research & therapy",
                "title": "Plasma tau levels in Alzheimer's disease.",
                "abstract": "",
                "date_published": "2013-01-01"
            },
            "assertions": [
                {
                    "subject": "p(HGNC:MAPT)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Alzheimer Disease\")"
                }
            ],
            "evidence": "Tau levels in plasma were significantly higher in AD patients compared with both controls and MCI patients (Figure.1a). ",
            "metadata": {
                "gd:creator": "vhoang@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "33548ae7-b5b6-4299-8bcd-10e2dbaad4a6",
        "_rev": "_WpvYGJ--Ae",
        "nanopub": {
            "id": "33548ae7-b5b6-4299-8bcd-10e2dbaad4a6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Ahmadzadeh, Mojgan",
                    "Rosenberg, Steven A"
                ],
                "database": {
                    "id": "16304057",
                    "name": "PubMed"
                },
                "source_name": "Blood",
                "title": "IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients.",
                "abstract": "Interleukin-2 (IL-2) is historically known as a T-cell growth factor. Accumulating evidence from knockout mice suggests that IL-2 is crucial for the homeostasis and function of CD4+ CD25+ regulatory T cells in vivo. However, the impact of administered IL-2 in an immune intact host has not been studied in rodents or humans. Here, we studied the impact of IL-2 administration on the frequency and function of human CD4+ CD25(hi) T cells in immune intact patients with melanoma or renal cancer. We found that the frequency of CD4+ CD25(hi) T cells was significantly increased after IL-2 treatment, and these cells expressed phenotypic markers associated with regulatory T cells. In addition, both transcript and protein levels of Foxp3, a transcription factor exclusively expressed on regulatory T cells, were consistently increased in CD4 T cells following IL-2 treatment. Functional analysis of the increased number of CD4+ CD25(hi) T cells revealed that this population exhibited potent suppressive activity in vitro. Collectively, our results demonstrate that administration of high-dose IL-2 increased the frequency of circulating CD4+ CD25(hi) Foxp3+ regulatory T cells. Our findings suggest that selective inhibition of IL-2-mediated enhancement of regulatory T cells may improve the therapeutic effectiveness of IL-2 administration."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL2)",
                    "relation": "increases",
                    "object": "p(HGNC:FOXP3)"
                }
            ],
            "evidence": "Therefore, we used intracellular staining for Foxp3 protein to estimate the frequency of Foxp3-expressing CD4 T cells before and after IL-2 treatment. We found that IL-2 increased the frequency of CD4+CD25+\u00a0T cells expressing Foxp3 (Figure 4B, upper right quadrant, 6.3% in PRE, compared with 18.4% in REB).",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "Interleukin-2 (IL-2) is historically known as a T-cell growth factor. Accumulating evidence from knockout mice suggests that IL-2 is crucial for the homeostasis and function of CD4+ CD25+ regulatory T cells in vivo. However, the impact of administered IL-2 in an immune intact host has not been studied in rodents or humans. Here, we studied the impact of IL-2 administration on the frequency and function of human CD4+ CD25(hi) T cells in immune intact patients with melanoma or renal cancer. We found that the frequency of CD4+ CD25(hi) T cells was significantly increased after IL-2 treatment, and these cells expressed phenotypic markers associated with regulatory T cells. In addition, both transcript and protein levels of Foxp3, a transcription factor exclusively expressed on regulatory T cells, were consistently increased in CD4 T cells following IL-2 treatment. Functional analysis of the increased number of CD4+ CD25(hi) T cells revealed that this population exhibited potent suppressive activity in vitro. Collectively, our results demonstrate that administration of high-dose IL-2 increased the frequency of circulating CD4+ CD25(hi) Foxp3+ regulatory T cells. Our findings suggest that selective inhibition of IL-2-mediated enhancement of regulatory T cells may improve the therapeutic effectiveness of IL-2 administration.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "75291dfd-c244-4272-a70b-ca1ef46305d3",
        "_rev": "_WpvYGJC-_R",
        "nanopub": {
            "id": "75291dfd-c244-4272-a70b-ca1ef46305d3",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"Endothelial Cells\"",
                    "label": "Endothelial Cells",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Romano, M",
                    "Sironi, M",
                    "Toniatti, C",
                    "Polentarutti, N",
                    "Fruscella, P",
                    "Ghezzi, P",
                    "Faggioni, R",
                    "Luini, W",
                    "van Hinsbergh, V",
                    "Sozzani, S",
                    "Bussolino, F",
                    "Poli, V",
                    "Ciliberto, G",
                    "Mantovani, A"
                ],
                "comments": "MCP-1=CCL2",
                "database": {
                    "id": "9075932",
                    "name": "PubMed"
                },
                "source_name": "Immunity",
                "title": "Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment.",
                "abstract": "IL-6-/- mice showed impaired leukocyte accumulation in subcutaneous air pouches. Defective leukocyte accumulation was not due to a reduced migratory capacity of IL-6-/- leukocytes and was associated with a reduced in situ production of chemokines. These observations led to a reexamination of the interaction of IL-6 with endothelial cells (EC). EC express only the gp130 signal transducing chain and not the subunit-specific IL-6R and are therefore unresponsive to IL-6. However, EC are responsive to a combination of IL-6 and soluble IL-6R as measured by the activation of STAT3, chemokine expression, and augmentation of ICAM-1. Activation by IL-6-IL-6R complexes was inhibited by an IL-6 receptor antagonist and potentiated by a superagonist. Hence, in vivo and in vitro evidence supports the concept that the IL-6 system plays an unexpected positive role in local inflammatory reactions by amplifying leukocyte recruitment."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "increases",
                    "object": "p(HGNC:CCL2)"
                }
            ],
            "evidence": "combinations of IL-6 and sIL-6R induced substantial amounts of MCP-1, with 17.58 \u00b1 3.69 ng/ml in 24 hr (mean \u00b1 standard error of 11 experiments) compared with 2.16 \u00b1 0.38 ng/ml of medium control (p < 0.001) (Figure 4A).",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "IL-6-/- mice showed impaired leukocyte accumulation in subcutaneous air pouches. Defective leukocyte accumulation was not due to a reduced migratory capacity of IL-6-/- leukocytes and was associated with a reduced in situ production of chemokines. These observations led to a reexamination of the interaction of IL-6 with endothelial cells (EC). EC express only the gp130 signal transducing chain and not the subunit-specific IL-6R and are therefore unresponsive to IL-6. However, EC are responsive to a combination of IL-6 and soluble IL-6R as measured by the activation of STAT3, chemokine expression, and augmentation of ICAM-1. Activation by IL-6-IL-6R complexes was inhibited by an IL-6 receptor antagonist and potentiated by a superagonist. Hence, in vivo and in vitro evidence supports the concept that the IL-6 system plays an unexpected positive role in local inflammatory reactions by amplifying leukocyte recruitment.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ebefcf49-46fb-4361-918a-8cdda0a40468",
        "_rev": "_WpvYGJ---a",
        "nanopub": {
            "id": "ebefcf49-46fb-4361-918a-8cdda0a40468",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Enyedy, E J",
                    "Nambiar, M P",
                    "Liossis, S N",
                    "Dennis, G",
                    "Kammer, G M",
                    "Tsokos, G C"
                ],
                "database": {
                    "id": "11352243",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Fc epsilon receptor type I gamma chain replaces the deficient T cell receptor zeta chain in T cells of patients with systemic lupus erythematosus.",
                "abstract": "T cells from the majority of patients with systemic lupus erythematosus (SLE) express significantly lower levels of T cell receptor zeta chain, a critical signaling molecule. However, TCR/CD3 triggering of SLE T cells shows increased phosphorylation of downstream signaling intermediates and increased [Ca2+]i response, suggesting the presence of alternative signaling mechanisms. We investigated whether Fcepsilon receptor type I gamma chain (FcepsilonRIgamma) could substitute for TCR zeta chain and contribute to T cell signaling in SLE."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:FCER1G)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "These results demonstrate that the Fcepsilon RIgamma chain is expressed at high levels in a large proportion of SLE T cells",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "T cells from the majority of patients with systemic lupus erythematosus (SLE) express significantly lower levels of T cell receptor zeta chain, a critical signaling molecule. However, TCR/CD3 triggering of SLE T cells shows increased phosphorylation of downstream signaling intermediates and increased [Ca2+]i response, suggesting the presence of alternative signaling mechanisms. We investigated whether Fcepsilon receptor type I gamma chain (FcepsilonRIgamma) could substitute for TCR zeta chain and contribute to T cell signaling in SLE.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b2443070-abda-4159-a710-067fe69a700a",
        "_rev": "_WpvYGJC--n",
        "nanopub": {
            "id": "b2443070-abda-4159-a710-067fe69a700a",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "EMSA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"embryonic fibroblast\"",
                    "label": "embryonic fibroblast",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10748240",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17)\t",
                    "relation": "increases",
                    "object": "act(HGNC:IKBKB, ma(GO:\"Kinase activity\"))"
                },
                {
                    "subject": "p(HGNC:IL17)",
                    "relation": "increases",
                    "object": "p(HGNC:NFKBIA, pmod(Ph))"
                }
            ],
            "evidence": "Treatment of TRAF6+/\u2212\u00a0cells with TNF, IL-1, or IL-17 significantly enhanced the IKK activity, as evidenced by increased phosphorylation of I\u03baB-\u03b1, NEMO, and IKKs (Fig. 2\u00a0A).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bf9c6d62-d2ae-4e61-a352-b67ac3023e7a",
        "_rev": "_WpvYGJC-Bo",
        "nanopub": {
            "id": "bf9c6d62-d2ae-4e61-a352-b67ac3023e7a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.007",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=22 women",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "24673738",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Lactobacillus casei\")",
                    "relation": "decreases",
                    "object": "p(HGNC:IL10)"
                }
            ],
            "evidence": "e. At the end of the study period, ANCOVA test revealed a significant difference between the groups for IL-6, IL-12, TNF-a and IL-10\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f14de433-2d02-48f5-8c8f-8c1babaf0693",
        "_rev": "_WpvYGJ--Bh",
        "nanopub": {
            "id": "f14de433-2d02-48f5-8c8f-8c1babaf0693",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.002",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=48",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "MESH:\"Dermatitis, Atopic\"",
                    "label": "Dermatitis, Atopic",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "22955355",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Probiotic\")",
                    "relation": "increases",
                    "object": "bp(GO:\"regulatory T cell differentiation\")"
                }
            ],
            "evidence": "Unstimulated Tregs were significantly increased by probiotics; this effect persisted 2 months after treatment suspension (baseline vs. 2 mo after suspension: P = 0.002; 3 mo treatment vs. 2 mo after suspension: P= 0.034) (Figs. 3A, B). A similar trend was observed for LPS-stimulated Tregs\n",
            "metadata": {
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5d1d93c2-31c5-4123-b2ab-d98bd404110a",
        "_rev": "_WpvYGJ--Bj",
        "nanopub": {
            "id": "5d1d93c2-31c5-4123-b2ab-d98bd404110a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Furie, Richard",
                    "Khamashta, Munther",
                    "Merrill, Joan T",
                    "Werth, Victoria P",
                    "Kalunian, Kenneth",
                    "Brohawn, Philip",
                    "Illei, Gabor G",
                    "Drappa, Jorn",
                    "Wang, Liangwei",
                    "Yoo, Stephen",
                    ", "
                ],
                "database": {
                    "id": "28130918",
                    "name": "PubMed"
                },
                "source_name": "Arthritis & rheumatology (Hoboken, N.J.)",
                "title": "Anifrolumab, an Anti-Interferon-\u03b1 Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus.",
                "abstract": "To assess the efficacy and safety of anifrolumab, a type I interferon (IFN) receptor antagonist, in a phase IIb, randomized, double-blind, placebo-controlled study of adults with moderate-to-severe systemic lupus erythematosus (SLE)."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:anifrolumab)",
                    "relation": "decreases",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "The primary end point was met by more patients treated with anifrolumab (34.3% of 99 for 300 mg and 28.8% of 104 for 1,000 mg) than placebo (17.6% of 102) (P\u2009=\u20090.014 for 300 mg and P\u2009=\u20090.063 for 1,000 mg, versus placebo), with greater effect size in patients with a high IFN signature at baseline (13.2% in placebo\u2010treated patients versus 36.0% [P\u2009=\u20090.004] and 28.2% [P\u2009=\u20090.029]) in patients treated with anifrolumab 300 mg and 1,000 mg, respectively.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9763e8f2-6208-45a0-b560-6ece6d5d4afb",
        "_rev": "_WpvYGJ--C-",
        "nanopub": {
            "id": "9763e8f2-6208-45a0-b560-6ece6d5d4afb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"T-Lymphocyte Subsets\"",
                    "label": "T-Lymphocyte Subsets",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "28003811",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Potassium\")",
                    "relation": "increases",
                    "object": "surf(p(HGNC:FOXP3))"
                }
            ],
            "evidence": "As expected, potassium suppressed the T cells proliferation and induced Foxp3 expression (Figures\u00a01A,B).\u00a0\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Th17 Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e49e56c2-5f81-43fa-b14e-453c7d3640d1",
        "_rev": "_WpvYGJ--CW",
        "nanopub": {
            "id": "e49e56c2-5f81-43fa-b14e-453c7d3640d1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.6",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLAM-R",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL8)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c9c2e5e7-17dc-4291-b95c-6b1d20361dab",
        "_rev": "_WpvYGJ--BK",
        "nanopub": {
            "id": "c9c2e5e7-17dc-4291-b95c-6b1d20361dab",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.0124",
                    "type": "p-value"
                },
                {
                    "id": "CL:\"B cell\"",
                    "label": "B cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Thymidine Incorporation",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8602264",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT6)",
                    "relation": "increases",
                    "object": "bp(GO:\"B cell proliferation\")"
                },
                {
                    "subject": "p(HGNC:IL4)",
                    "relation": "increases",
                    "object": "p(HGNC:STAT6)"
                }
            ],
            "evidence": "IL-4 significantly stimulated proliferation of anti-IgM-treated splenic B cells from Stat6-/- mice, although at a level one-third that of wild-type mice (Fig. 2a, left; P=0.0124).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "cf964109-1596-4aba-b5c8-76883cc158ae",
        "_rev": "_WpvYGJC-_I",
        "nanopub": {
            "id": "cf964109-1596-4aba-b5c8-76883cc158ae",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "37 patients with pAPS, 11 SLE patients, and 21 age- and gender-matched HC",
                    "type": "cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Alvarez-Rodriguez, Lorena",
                    "Riancho-Zarrabeitia, Leyre",
                    "Calvo-Al\u00e9n, Jime",
                    "L\u00f3pez-Hoyos, Marcos",
                    "Mart\u00ednez-Taboada, Victor"
                ],
                "database": {
                    "id": "29462939",
                    "name": "PubMed"
                },
                "source_name": "International journal of molecular sciences",
                "title": "Peripheral B-Cell Subset Distribution in Primary Antiphospholipid Syndrome.",
                "abstract": "B-cell differentiation and B-cell tolerance checkpoints may be different in antiphospholipid syndrome (APS) from systemic lupus erythematosus (SLE) and can help to understand differences between them. Our aim was to define alterations of B-cell subsets in patients with primary APS (pAPS) and to compare them with SLE patients and healthy controls (HC)."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNFSF13B)",
                    "relation": "positiveCorrelation",
                    "object": "path(DO:\"systemic lupus erythematosus\")"
                }
            ],
            "evidence": "Serum BAFF levels were higher in SLE patients than in healthy controls and pAPS patients (p = 0.001 and p = 0.017, respectively).",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "B-cell differentiation and B-cell tolerance checkpoints may be different in antiphospholipid syndrome (APS) from systemic lupus erythematosus (SLE) and can help to understand differences between them. Our aim was to define alterations of B-cell subsets in patients with primary APS (pAPS) and to compare them with SLE patients and healthy controls (HC).",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "eda3b791-823b-452d-b16c-656acd9e385d",
        "_rev": "_WpvYGJ---X",
        "nanopub": {
            "id": "eda3b791-823b-452d-b16c-656acd9e385d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.0018",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "7,319 Chinese adults from the China Health and Nutrition Survey (CHNS).",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "linear mixed-effects model",
                    "type": "Methodology"
                },
                {
                    "id": "DO:obesity",
                    "label": "obesity",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "25618516",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(rs1458038)",
                    "relation": "positiveCorrelation",
                    "object": "bp(MESH:\"Blood Pressure\")"
                }
            ],
            "evidence": "The signal at rs1458038 exhibited a genotype-by-BMI interaction affecting blood pressure (P interaction = 0.0018 for SBP; P interaction = 0.049 for DBP), with the strongest variant effects in those with the highest BMI.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "82c84288-bc6f-40d3-a6a6-d5240bef93ec",
        "_rev": "_WpvYGJ---m",
        "nanopub": {
            "id": "82c84288-bc6f-40d3-a6a6-d5240bef93ec",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.627",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "32 renal failure patients, 15 healthy controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Column Chromatography",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"kidney failure\"",
                    "label": "kidney failure",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "1126056",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:urea)",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:\"N-amidinoaspartic acid\")"
                }
            ],
            "evidence": "In patients with renal failure there was a marked increase in plasma GSA concentration which was closely correlated with increase in the plasma urea concentration (Fig. 4).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "716b48e1-209f-4313-956a-9fb3ea1a8e61",
        "_rev": "_WpvYGJG--b",
        "nanopub": {
            "id": "716b48e1-209f-4313-956a-9fb3ea1a8e61",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.59",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL2)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f203cb49-51e7-4afd-80ca-b186d08827b1",
        "_rev": "_WpvYGJG-Ay",
        "nanopub": {
            "id": "f203cb49-51e7-4afd-80ca-b186d08827b1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "EMSA, Flow Cytometry, ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"embryonic fibroblast\"",
                    "label": "embryonic fibroblast",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10748240",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:IL17), ma(GO:\"Receptor binding\"))",
                    "relation": "increases",
                    "object": "p(HGNC:TRAF6)"
                }
            ],
            "evidence": "Together, these results indicate that TRAF6, but not TRAF2, is a crucial component in the IL-17 signaling pathway leading to proinflammatory responses.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c29f2fed-b700-419d-8ae7-5949385eaa78",
        "_rev": "_WpvYGJG-_S",
        "nanopub": {
            "id": "c29f2fed-b700-419d-8ae7-5949385eaa78",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Kaul, Arvind",
                    "Gordon, Caroline",
                    "Crow, Mary K",
                    "Touma, Zahi",
                    "Urowitz, Murray B",
                    "van Vollenhoven, Ronald",
                    "Ruiz-Irastorza, Guillermo",
                    "Hughes, Graham"
                ],
                "database": {
                    "id": "27306639",
                    "name": "PubMed"
                },
                "source_name": "Nature reviews. Disease primers",
                "title": "Systemic lupus erythematosus.",
                "abstract": "Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect many organs, including the skin, joints, the central nervous system and the kidneys. Women of childbearing age and certain racial groups are typically predisposed to developing the condition. Rare, inherited, single-gene complement deficiencies are strongly associated with SLE, but the disease is inherited in a polygenic manner in most patients. Genetic interactions with environmental factors, particularly UV light exposure, Epstein-Barr virus infection and hormonal factors, might initiate the disease, resulting in immune dysregulation at the level of cytokines, T cells, B cells and macrophages. Diagnosis is primarily clinical and remains challenging because of the heterogeneity of SLE. Classification criteria have aided clinical trials, but, despite this, only one drug (that is, belimumab) has been approved for use in SLE in the past 60 years. The 10-year mortality has improved and toxic adverse effects of older medications such as cyclophosphamide and glucocorticoids have been partially offset by newer drugs such as mycophenolate mofetil and glucocorticoid-sparing regimes. However, further improvements have been hampered by the adverse effects of renal and neuropsychiatric involvement and late diagnosis. Adding to this burden is the increased risk of premature cardiovascular disease in SLE together with the risk of infection made worse by immunosuppressive therapy. Challenges remain with treatment-resistant disease and symptoms such as fatigue. Newer therapies may bring hope of better outcomes, and the refinement to stem cell and genetic techniques might offer a cure in the future."
            },
            "assertions": [
                {
                    "subject": "a(GO:\"T cell activation\")",
                    "relation": "increases",
                    "object": "p(HGNC:CD40LG)"
                }
            ],
            "evidence": "T\u00a0cells derived from patients with\nSLE readily express CD40 ligand (CD40L) after activation\nand maintain the expression of this important costimulatory\nmolecule longer than T\u00a0cells derived from\nhealthy controls65, leading to augmented help for the\nactivation and differentiation of B\u00a0cells.",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect many organs, including the skin, joints, the central nervous system and the kidneys. Women of childbearing age and certain racial groups are typically predisposed to developing the condition. Rare, inherited, single-gene complement deficiencies are strongly associated with SLE, but the disease is inherited in a polygenic manner in most patients. Genetic interactions with environmental factors, particularly UV light exposure, Epstein-Barr virus infection and hormonal factors, might initiate the disease, resulting in immune dysregulation at the level of cytokines, T cells, B cells and macrophages. Diagnosis is primarily clinical and remains challenging because of the heterogeneity of SLE. Classification criteria have aided clinical trials, but, despite this, only one drug (that is, belimumab) has been approved for use in SLE in the past 60 years. The 10-year mortality has improved and toxic adverse effects of older medications such as cyclophosphamide and glucocorticoids have been partially offset by newer drugs such as mycophenolate mofetil and glucocorticoid-sparing regimes. However, further improvements have been hampered by the adverse effects of renal and neuropsychiatric involvement and late diagnosis. Adding to this burden is the increased risk of premature cardiovascular disease in SLE together with the risk of infection made worse by immunosuppressive therapy. Challenges remain with treatment-resistant disease and symptoms such as fatigue. Newer therapies may bring hope of better outcomes, and the refinement to stem cell and genetic techniques might offer a cure in the future.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ee2bcf16-e8c5-49a7-a901-a72060fe64a2",
        "_rev": "_WpvYGJC-A7",
        "nanopub": {
            "id": "ee2bcf16-e8c5-49a7-a901-a72060fe64a2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Rate of Superoxide Formation",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "3032939",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"1,2-dihexadecadienoyl-sn-glycerol\")",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:superoxide)"
                }
            ],
            "evidence": "In the presence of cytochalasin B, the EDb0 for 0; generation was 82.5 f 4 nM (n = 4) ionomycin, while the EDSo for DG accumulation was 270 f 31 nM (n = 4). In the absence of cytochalasin B, 195 f 26 nM (n = 4) ionomycin produced a half-maximal 0; response, but 555 f 66 nM (n = 4) was required for half-maximal accumulation of DG.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "fc1694c1-0bcb-410e-80c1-73dba52d71f0",
        "_rev": "_WpvYGJC--y",
        "nanopub": {
            "id": "fc1694c1-0bcb-410e-80c1-73dba52d71f0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "43 RA patients, 14 age/sex matched HC",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Pandya, Jayesh M",
                    "Lundell, Anna-Carin",
                    "Andersson, Kerstin",
                    "Nordstr\u00f6m, Inger",
                    "Theander, Elke",
                    "Rudin, Anna"
                ],
                "database": {
                    "id": "28148302",
                    "name": "PubMed"
                },
                "source_name": "Arthritis research & therapy",
                "title": "Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker.",
                "abstract": "We have recently analyzed the profile of T-cell subtypes based on chemokine receptor expression in blood from untreated early rheumatoid arthritis (ueRA) patients compared to healthy controls (HC). Here, we compared the levels of the respective chemokines in blood plasma of ueRA patients with those of HC. We also studied the association of chemokine levels with the proportions of circulating T-cell subsets and the clinical disease activity."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL22)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:CCL4)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:CXCL13)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:CXCL9)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:CXCL10)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "CXCL9, CXCL10, CXCL13, CCL4, and CCL22, which were significantly higher in ueRA compared to HC in univariate analyses.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "77feafc3-f702-4225-b750-fa8fb09c7c12",
        "_rev": "_WpvYGI6--c",
        "nanopub": {
            "id": "77feafc3-f702-4225-b750-fa8fb09c7c12",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=35",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Crohn Disease\"",
                    "label": "Crohn Disease",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:\"colonic mucosa\"",
                    "label": "colonic mucosa",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "16225487",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:butyrate)\t",
                    "relation": "decreases",
                    "object": "complex(p(HGNC:NFKB1),p(HGNC:NFKB2))"
                },
                {
                    "subject": "a(CHEBI:butyrate)",
                    "relation": "decreases",
                    "object": "p(HGNC:IL1B)"
                }
            ],
            "evidence": "Our\u00a0in vivo\u00a0study showed a significant reduction of NF-\u03baB and IL-1\u03b2\u00a0after butyrate administration in Crohn's disease patients, thus confirming the anti-inflammatory effects of butyrate reported\u00a0in vitro\u00a0on Crohn's disease lamina propria mononuclear cells by Segain\u00a0et al.15\n\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "86b95cf2-0211-4cd3-a7b7-b1ffdd0414c1",
        "_rev": "_WpvYGJG--N",
        "nanopub": {
            "id": "86b95cf2-0211-4cd3-a7b7-b1ffdd0414c1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "n=21 cancer patients",
                    "type": "Cohort"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17277105",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL2)",
                    "relation": "increases",
                    "object": "r(HGNC:FOXP3)"
                }
            ],
            "evidence": "As illustrated in\u00a0Figure 3A, daily IL-2 treatment resulted in increased frequencies of CD4+CD25+\u00a0T cells within the total CD3+\u00a0population\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c2c567ee-9b32-4a57-848c-09f509deb203",
        "_rev": "_WpvYGJ---I",
        "nanopub": {
            "id": "c2c567ee-9b32-4a57-848c-09f509deb203",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": ">0.80",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "discovery (14 active/inactive LN, 8 HC) and validation (28 active/inactive LN, 9 HC)",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "27211902",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:AXL)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                }
            ],
            "evidence": "Most importantly, four serum proteins (AXL, Ferritin, Angiostatin, and sTNFRII) had the capacity to distinguish active LN from inactive disease with ROC AUC exceeding 80%, all with p < 0.01 significance (Table 3).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e5908eec-29f3-4e81-b64c-b82c21a3ba20",
        "_rev": "_WpvYGJ--AJ",
        "nanopub": {
            "id": "e5908eec-29f3-4e81-b64c-b82c21a3ba20",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:\"human immunodeficiency virus infectious disease\"",
                    "label": "human immunodeficiency virus infectious disease",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16425129",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL7)",
                    "relation": "negativeCorrelation",
                    "object": "a(GO:CD8 positive T lymphocytes)"
                },
                {
                    "subject": "p(HGNC:IL7)",
                    "relation": "negativeCorrelation",
                    "object": "a(GO:CD4 positive T lymphocytes)"
                },
                {
                    "subject": "p(HGNC:IL7)",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:\"Lymphocytes\")"
                }
            ],
            "evidence": "Across the patient cohort, pretherapy plasma IL-7 level was significantly inversely correlated to total lymphocyte count, CD4+\u00a0T cell count, and CD8+\u00a0T cell count but not to viral load or age.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "fec690cc-460f-4fdc-bd7f-b4a741898dc8",
        "_rev": "_WpvYGJ--By",
        "nanopub": {
            "id": "fec690cc-460f-4fdc-bd7f-b4a741898dc8",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "",
                    "label": "94 SLE, 26 HC",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Hervier, Baptiste",
                    "Beziat, Vivien",
                    "Haroche, Julien",
                    "Mathian, Alexis",
                    "Lebon, Pierre",
                    "Ghillani-Dalbin, Pascale",
                    "Musset, Lucile",
                    "Debr\u00e9, Patrice",
                    "Amoura, Zahir",
                    "Vieillard, Vincent"
                ],
                "comments": "in patients with SLE. excess IFNalpha may cause over production of IFNgamma in NK cells even though the number of NK cells is reduced in SLE patients. This causes reduction in cytotoxicity",
                "database": {
                    "id": "21370226",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-\u03b3 production in patients with active disease.",
                "abstract": "To determine the phenotype and the functionality of natural killer (NK) cells in patients with systemic lupus erythematosus (SLE)."
            },
            "assertions": [
                {
                    "subject": "\tp(HGNC:IFNG)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "p(HGNC:IFNA1)",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IFNG)"
                }
            ],
            "evidence": "There was a significant positive correlation between the increased level of IFN\u03b1 in the serum and the enhanced frequency of IFN\u03b3+ cells in patients with active SLE (r = 0.370, P = 0.04).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "439180ad-f52d-4cd8-9998-6b00334f76a0",
        "_rev": "_WpvYGJ--Cm",
        "nanopub": {
            "id": "439180ad-f52d-4cd8-9998-6b00334f76a0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "Chemiluminescent Assay",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:chondrocyte",
                    "label": "chondrocyte",
                    "type": "Cell"
                },
                {
                    "id": "MESH:Osteoarthritis",
                    "label": "Osteoarthritis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "14600251",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"(\u2212)-epigallocatechin 3-gallate\")",
                    "relation": "decreases",
                    "object": "act(complex(p(HGNC:NFKB1),p(HGNC:NFKB2)), ma(GO:\"DNA binding\")))"
                }
            ],
            "evidence": "Treatment with EGCG inhibited the activity of NF-\u03baB by 56 to 94% in a dose-dependent manner (Fig. 7A).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0dbf828f-654c-433a-b39b-c5962607a70a",
        "_rev": "_WpvYGI6--y",
        "nanopub": {
            "id": "0dbf828f-654c-433a-b39b-c5962607a70a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"regulatory T cell\"",
                    "label": "regulatory T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "20624644",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "surf(p(HGNC:ICOS))",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IFNG)"
                }
            ],
            "evidence": "Indeed, CD4+CD25-ICOS+FoxP3+\u00a0cells inhibited IFN-\u03b3 secretion but not proliferation of hapten-specific CD8+\u00a0T cells, whereas neither was suppressed by CD4+CD25-ICOS+FoxP3-\u00a0cells (Fig 3,\u00a0B).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9cb6ee8e-da3d-4864-b785-290a993f5b2a",
        "_rev": "_WpvYGJ---w",
        "nanopub": {
            "id": "9cb6ee8e-da3d-4864-b785-290a993f5b2a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Krishnan, Sandeep",
                    "Juang, Yuang-Taung",
                    "Chowdhury, Bhabadeb",
                    "Magilavy, Abigail",
                    "Fisher, Carolyn U",
                    "Nguyen, Hang",
                    "Nambiar, Madhusoodana P",
                    "Kyttaris, Vasileios",
                    "Weinstein, Arthur",
                    "Bahjat, Rena",
                    "Pine, Polly",
                    "Rus, Violeta",
                    "Tsokos, George C"
                ],
                "database": {
                    "id": "19018007",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology (Baltimore, Md. : 1950)",
                "title": "Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells.",
                "abstract": "Diminished expression of TCR zeta and reciprocal up-regulation and association of FcRgamma with the TCR/CD3 complex is a hallmark of systemic lupus erythematosus (SLE) T cells. In this study we explored whether differential molecular associations of the spleen tyrosine kinase Syk that preferentially binds to FcRgamma contribute to pathological amplification of signals downstream of this \"rewired TCR\" in SLE. We detected higher amounts of Syk expression and activity in SLE compared with normal T cells. Selective inhibition of the activity of Syk reduced the strength of TCR-induced calcium responses and slowed the rapid kinetics of actin polymerization exclusively in SLE T cells. Syk and ZAP-70 also associated differently with key molecules involved in cytoskeletal and calcium signaling in SLE T cells. Thus, while Vav-1 and LAT preferentially bound to Syk, phospholipase C-gamma1 bound to both Syk and ZAP-70. Our results show that differential associations of Syk family kinases contribute to the enhanced TCR-induced signaling responses in SLE T cells. Thus, we propose molecular targeting of Syk as a measure to control abnormal T cell responses in SLE."
            },
            "assertions": [
                {
                    "subject": "complex(p(HGNC:SYK), p(HGNC:LAT))",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "complex(p(HGNC:LAT), p(HGNC:ZAP70))",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Compared with normal T cells, SLE T cells demonstrate decreased association between ZAP-70 and LAT, whereas Syk associates with LAT in high amounts (Fig. 5\u21d1B), suggesting that Syk is the predominant kinase that regulates signaling events involving LAT such as calcium responses in SLE T cells.",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "Diminished expression of TCR zeta and reciprocal up-regulation and association of FcRgamma with the TCR/CD3 complex is a hallmark of systemic lupus erythematosus (SLE) T cells. In this study we explored whether differential molecular associations of the spleen tyrosine kinase Syk that preferentially binds to FcRgamma contribute to pathological amplification of signals downstream of this \"rewired TCR\" in SLE. We detected higher amounts of Syk expression and activity in SLE compared with normal T cells. Selective inhibition of the activity of Syk reduced the strength of TCR-induced calcium responses and slowed the rapid kinetics of actin polymerization exclusively in SLE T cells. Syk and ZAP-70 also associated differently with key molecules involved in cytoskeletal and calcium signaling in SLE T cells. Thus, while Vav-1 and LAT preferentially bound to Syk, phospholipase C-gamma1 bound to both Syk and ZAP-70. Our results show that differential associations of Syk family kinases contribute to the enhanced TCR-induced signaling responses in SLE T cells. Thus, we propose molecular targeting of Syk as a measure to control abnormal T cell responses in SLE.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e136fdc0-ef10-426f-81ba-73fd01ed1d77",
        "_rev": "_WpvYGJC-Be",
        "nanopub": {
            "id": "e136fdc0-ef10-426f-81ba-73fd01ed1d77",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "132 Hispanic MS patients and 60 controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "19321461",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"D3 vitamins\")",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL10))"
                }
            ],
            "evidence": "1,25 (OH)2\u00a0Vitamin D increases the development of IL-10 secreting cells and down-regulates the number of IL-6 and L-17 secreting cells.\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "46dc7317-055a-4a94-a713-a8fd23dd6563",
        "_rev": "_WpvYGJG--g",
        "nanopub": {
            "id": "46dc7317-055a-4a94-a713-a8fd23dd6563",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16648838",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite(p(HGNC:IL6),p(HGNC:TGFB))",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL17))"
                }
            ],
            "evidence": "Although neither TGF-b nor IL-6 alone induced the generation of IL-17-producing T cells from naive 2D2 TCR transgenic T cells, a combination of the two cytokines (IL-6 plus TGF-b), consistent with a recently published report16, induced most naive T cells (80.9%) to produce IL-17 (Fig. 2c).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1426a3bd-f9cb-4330-ad2a-1c7604d67559",
        "_rev": "_WpvYGJG--v",
        "nanopub": {
            "id": "1426a3bd-f9cb-4330-ad2a-1c7604d67559",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"epithelial cell of tracheobronchial tree\"",
                    "label": "epithelial cell of tracheobronchial tree",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "20008294",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"D3 vitamins\")",
                    "relation": "decreases",
                    "object": "p(HGNC:CXCL10)"
                }
            ],
            "evidence": "\u00a0Vitamin D decreased RSV induction of the chemokine CXCL10\u00a0\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c2d69ade-aa22-4bc7-904d-3e7abf4494df",
        "_rev": "_WpvYGJG-Al",
        "nanopub": {
            "id": "c2d69ade-aa22-4bc7-904d-3e7abf4494df",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=14 RA patients",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Lansbury articular index",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "2837251",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Fasting\")",
                    "relation": "decreases",
                    "object": "path(DO:\"Rheumatoid arthiritis\")"
                }
            ],
            "evidence": "During fasting, the duration of morning stiffness, articular index, and ESR decreased in all 14 patients studied (Figure I).\n",
            "metadata": {
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f0c30e21-db76-48ce-a870-e650338b728c",
        "_rev": "_WpvYGJC-_d",
        "nanopub": {
            "id": "f0c30e21-db76-48ce-a870-e650338b728c",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17277312",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:STAT3))\t",
                    "relation": "increases",
                    "object": "r(HGNC:IL22)"
                }
            ],
            "evidence": "Remarkably, IL-22, a cytokine expressed in THi cells that may synergize with IL-17 in inflammation (8, 9), was highly up-regulated in STAT3C-transduced TH cells\n",
            "metadata": {
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ff6e0602-26b3-419d-85ac-9de726e2a6c8",
        "_rev": "_WpvYGJ--BF",
        "nanopub": {
            "id": "ff6e0602-26b3-419d-85ac-9de726e2a6c8",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "8 young and 8 older healthy volunteers",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "22882710",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"B. bifidum MF 20/5\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL10)"
                },
                {
                    "subject": "a(\"L. plantarum NCIMB 8826\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL10)"
                },
                {
                    "subject": "a(\"L. rhamnosus GG\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL10)"
                },
                {
                    "subject": "a(\"L. casei Shirota\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL10)"
                },
                {
                    "subject": "a(\"Bifidobacterium longum\u00a0subsp.\u00a0infantis\u00a0CCUG 52486\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL10)"
                }
            ],
            "evidence": "There was a significant effect of age on the production of IL-6 (P\u00a0< 0.05), IFN-\u03b3 (P\u00a0< 0.01) and RANTES (P\u00a0< 0.001), and of probiotics (P\u00a0< 0.001) on production of IL-1\u03b2, IFN-\u03b3, IL-6, IL-10, GM-CSF and RANTES (Figs\u00a05\u00a0and\u00a06)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2eb1334a-9bef-4769-8b26-d08ce47a1ff1",
        "_rev": "_WpvYGJ--AB",
        "nanopub": {
            "id": "2eb1334a-9bef-4769-8b26-d08ce47a1ff1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16645171",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL2)",
                    "relation": "increases",
                    "object": "p(HGNC:FOXP3)"
                }
            ],
            "evidence": "Incubation with IL-2 for 6 hours substantially increased the level of expression of\u00a0FOXP3\u00a0in CD4+CD25+\u00a0T cells but not in CD4+CD25-\u00a0cells.\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ba7fcf57-08ad-4ba8-8256-5d540c6cc420",
        "_rev": "_WpvYGJ--AX",
        "nanopub": {
            "id": "ba7fcf57-08ad-4ba8-8256-5d540c6cc420",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "10545482",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:ethanol)",
                    "relation": "decreases",
                    "object": "tloc(p(HGNC:NFKB1), fromloc(GOCC:\"\"cytoplasm\"\"), toloc(GOCC:\"\"nucleus\"\"))"
                }
            ],
            "evidence": "However, when LPS stimulation was combined with 25 mM ethanol for 60 min, there was a decrease in the nuclear p50 level compared to the LPS-stimulated cells, indicating that ethanol may interfere with the LPS-induced nuclear translocation of the p50 subunit of NF\u03baB.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "feec5032-8794-4409-84ae-0a83c32047d7",
        "_rev": "_WpvYGJG--M",
        "nanopub": {
            "id": "feec5032-8794-4409-84ae-0a83c32047d7",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "32 healthy donors",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Radioimmunoassay",
                    "type": "Methodology"
                },
                {
                    "id": "CL:monocyte",
                    "label": "monocyte",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9531313",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17)\t",
                    "relation": "decreases",
                    "object": "a(CHEBI:3',5'-cyclic AMP)"
                }
            ],
            "evidence": "Incubation of adherent human monocytes with IL-17 (50 ng/ml) resulted in time-dependent decrease in the levels of [cAMP]i\u00a0(Fig. 3\u21d3A).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7478f7f2-dd27-4676-a318-b4db6cc19225",
        "_rev": "_WpvYGJG--U",
        "nanopub": {
            "id": "7478f7f2-dd27-4676-a318-b4db6cc19225",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "FACS",
                    "type": "Methodology"
                },
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "3926894",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNG)\t",
                    "relation": "increases",
                    "object": "bp(GO:\"antibody-dependent cellular cytotoxicity\")"
                },
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "increases",
                    "object": "bp(GO:phagocytosis)"
                }
            ],
            "evidence": "The treatment with nHuTNF-p or rHuIFN-y resulted in a significant increase in PMN phagocytic ability and PMN-mediated antibody dependent cellular cytotoxicity (ADCC) against chicken red blood cells (CRBC\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "27507e4d-23b1-41ff-b816-27ec06916004",
        "_rev": "_WpvYGJ--BM",
        "nanopub": {
            "id": "27507e4d-23b1-41ff-b816-27ec06916004",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Frob\u00f8se, Helle",
                    "R\u00f8nn, Sif Groth",
                    "Heding, Peter E",
                    "Mendoza, Heidi",
                    "Cohen, Philip",
                    "Mandrup-Poulsen, Thomas",
                    "Billestrup, Nils"
                ],
                "database": {
                    "id": "16543409",
                    "name": "PubMed"
                },
                "source_name": "Molecular endocrinology (Baltimore, Md.)",
                "title": "Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex.",
                "abstract": "IL-1 plays a major role in inflammation and autoimmunity through activation of nuclear factor kappa B (NFkappaB) and MAPKs. Although a great deal is known about the mechanism of activation of NFkappaB and MAPKs by IL-1, much less is known about the down-regulation of this pathway. Suppressor of cytokine signaling (SOCS)-3 was shown to inhibit IL-1-induced transcription and activation of NFkappaB and the MAPKs JNK and p38, but the mechanism is unknown. We show here that SOCS-3 inhibits NFkappaB-dependent transcription induced by overexpression of the upstream IL-1 signaling molecules MyD88, IL-1R-activated kinase 1, TNF receptor-associated factor (TRAF)6, and TGFbeta-activated kinase (TAK)1, but not when the MAP3K MAPK/ERK kinase kinase-1 is used instead of TAK1, indicating that the target for SOCS-3 is the TRAF6/TAK1 signaling complex. By coimmunoprecipitation, it was shown that SOCS-3 inhibited the association between TRAF6 and TAK1 and that SOCS-3 coimmunoprecipitated with TAK1 and TRAF6. Furthermore, SOCS-3 inhibited the IL-1-induced catalytic activity of TAK1. Because ubiquitination of TRAF6 is required for activation of TAK1, we analyzed the role of SOCS-3 on TRAF6 ubiquitination and found that SOCS-3 inhibited ubiquitin modification of TRAF6. These results indicate that SOCS-3 inhibits IL-1 signal transduction by inhibiting ubiquitination of TRAF6, thus preventing association and activation of TAK1.",
                "date_published": "2006-07-01"
            },
            "assertions": [
                {
                    "subject": "p(HGNC:SOCS3)",
                    "relation": "decreases",
                    "object": "p(HGNC:TRAF6, pmod(Ub))"
                }
            ],
            "evidence": "Having found that SOCS-3 reduces the association between TRAF6 and TAK1 and inhibits IL-1-induced TAK1 activity, we hypothesized that SOCS-3 inhibits steps in the physiological activation of TAK1 by TRAF6. Because ubiquitination of TRAF6 (by lysine-63 ligation) is known to be required for the activation of TAK1 and because SOCS-3 is able to bind Elongin B and C, which are components of cullin-RING E3 ubiquitin ligases, we investigated whether SOCS-3 had an effect on TRAF6 ubiquitination. As shown in Fig. 8, ubiquitination of TRAF6 was found in cells overexpressing hemagluttinin (HA)-tagged ubiquitin and TRAF6 at different concentrations. When SOCS-3 was cotransfected with TRAF6, the ubiquitination of TRAF6 was reduced, indicating that SOCS-3 inhibits E3 ubiquitin ligase activity. SOCS-3 reduced the TRAF6 ubiquitination by 36% in the presence of 0.4 \u03bcg TRAF6, P < 0.05 and by 18% when using 0.2 \u03bcg TRAF6 expressing plasmid (P < 0.05). As can be seen in the lower panel, the total amount of TRAF6 in the immunoprecipitates was not affected by the presence of SOCS-3.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "IL-1 plays a major role in inflammation and autoimmunity through activation of nuclear factor kappa B (NFkappaB) and MAPKs. Although a great deal is known about the mechanism of activation of NFkappaB and MAPKs by IL-1, much less is known about the down-regulation of this pathway. Suppressor of cytokine signaling (SOCS)-3 was shown to inhibit IL-1-induced transcription and activation of NFkappaB and the MAPKs JNK and p38, but the mechanism is unknown. We show here that SOCS-3 inhibits NFkappaB-dependent transcription induced by overexpression of the upstream IL-1 signaling molecules MyD88, IL-1R-activated kinase 1, TNF receptor-associated factor (TRAF)6, and TGFbeta-activated kinase (TAK)1, but not when the MAP3K MAPK/ERK kinase kinase-1 is used instead of TAK1, indicating that the target for SOCS-3 is the TRAF6/TAK1 signaling complex. By coimmunoprecipitation, it was shown that SOCS-3 inhibited the association between TRAF6 and TAK1 and that SOCS-3 coimmunoprecipitated with TAK1 and TRAF6. Furthermore, SOCS-3 inhibited the IL-1-induced catalytic activity of TAK1. Because ubiquitination of TRAF6 is required for activation of TAK1, we analyzed the role of SOCS-3 on TRAF6 ubiquitination and found that SOCS-3 inhibited ubiquitin modification of TRAF6. These results indicate that SOCS-3 inhibits IL-1 signal transduction by inhibiting ubiquitination of TRAF6, thus preventing association and activation of TAK1.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d4d53f2c-0293-4012-a5b5-dac209cf894a",
        "_rev": "_WrNfuly---",
        "nanopub": {
            "id": "d4d53f2c-0293-4012-a5b5-dac209cf894a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Noris, Marina",
                    "Remuzzi, Giuseppe"
                ],
                "database": {
                    "id": "24161035",
                    "name": "PubMed"
                },
                "source_name": "Seminars in nephrology",
                "title": "Overview of complement activation and regulation.",
                "abstract": "Complement is an important component of the innate immune system that is crucial for defense from microbial infections and for clearance of immune complexes and injured cells. In normal conditions complement is tightly controlled by a number of fluid-phase and cell surface proteins to avoid injury to autologous tissues. When complement is hyperactivated, as occurs in autoimmune diseases or in subjects with dysfunctional regulatory proteins, it drives a severe inflammatory response in numerous organs. The kidney appears to be particularly vulnerable to complement-mediated inflammatory injury. Injury may derive from deposition of circulating active complement fragments in glomeruli, but complement locally produced and activated in the kidney also may have a role. Many kidney disorders have been linked to abnormal complement activation, including immune-complex-mediated glomerulonephritis and rare genetic kidney diseases, but also tubulointerstitial injury associated with progressive proteinuric diseases or ischemia-reperfusion."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:C1Q)\t",
                    "relation": "increases",
                    "object": "p(HGNC:C3A)"
                },
                {
                    "subject": "p(HGNC:C1Q)\t",
                    "relation": "increases",
                    "object": "p(HGNC:C3B)"
                },
                {
                    "subject": "complex(p(HGNC:C4B),p(HGNC:C2A))\t",
                    "relation": "increases",
                    "object": "p(HGNC:C3A)"
                },
                {
                    "subject": "complex(p(HGNC:C4B),p(HGNC:C2A))\t",
                    "relation": "increases",
                    "object": "p(HGNC:C3B)"
                },
                {
                    "subject": "complex(p(HGNC:C4B),p(HGNC:C2A))\t",
                    "relation": "decreases",
                    "object": "p(HGNC:C3)"
                },
                {
                    "subject": "p(HGNC:C1S)\t",
                    "relation": "increases",
                    "object": "p(HGNC:C4B)"
                },
                {
                    "subject": "p(HGNC:C1S)\t",
                    "relation": "increases",
                    "object": "p(HGNC:C2A)"
                },
                {
                    "subject": "p(HGNC:C4B)\t",
                    "relation": "directlyIncreases",
                    "object": "complex(p(HGNC:C4B),p(HGNC:C2A))"
                },
                {
                    "subject": "p(HGNC:C1S)\t",
                    "relation": "increases",
                    "object": "p(HGNC:C2B)"
                },
                {
                    "subject": "p(HGNC:C1S)\t",
                    "relation": "increases",
                    "object": "p(HGNC:C4A)"
                },
                {
                    "subject": "p(HGNC:C1S)\t",
                    "relation": "decreases",
                    "object": "p(HGNC:C2)"
                },
                {
                    "subject": "p(HGNC:C1S)\t",
                    "relation": "decreases",
                    "object": "p(HGNC:C4)"
                },
                {
                    "subject": "p(EG:8857)\t",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:C1Q)"
                },
                {
                    "subject": "p(HGNC:FCMR)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:C1Q)"
                },
                {
                    "subject": "p(HGNC:C1Q)\t",
                    "relation": "directlyIncreases",
                    "object": "complex(p(HGNC:C1r), p(HGNC:C1s), p(HGNC:C1Q))"
                },
                {
                    "subject": "p(HGNC:C1Q)\t",
                    "relation": "increases",
                    "object": "p(HGNC:C1R)"
                },
                {
                    "subject": "p(HGNC:C1Q)\t",
                    "relation": "increases",
                    "object": "p(HGNC:C1S)"
                },
                {
                    "subject": "p(HGNC:C3B)\t",
                    "relation": "decreases",
                    "object": "p(HGNC:C5)"
                },
                {
                    "subject": "p(HGNC:C1Q)\t",
                    "relation": "decreases",
                    "object": "p(HGNC:C3)"
                }
            ],
            "evidence": "The classical pathway (CP) uses C1 and is triggered by antigen\u2013antibody immune complexes. Inactive C1 circulates as a serum molecular complex comprising six C1q molecules and two molecules each of the serine proteases C1r and C1s. After binding to a cognate antigen, the fragment crystallizable (Fc) portion of an IgG or IgM antibody interacts with the collagen-like tail of C1q. This interaction leads to a conformational change resulting in the sequential activation of C1r and C1s. The activated C1s then cleaves C4 and C2 into small inactive fragments (C4a and C2b) and larger active fragments (C4b and C2a). C4b binds to the sugar moieties of cell surface glycoproteins and binds noncovalently to C2a, to generate the classic pathway C3 convertase C4bC2a (Fig. 1). C4bC2a is an enzymatic complex that cleaves C3, the central component of the complement cascade, into the anaphylatoxin C3a and C3b.",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Complement is an important component of the innate immune system that is crucial for defense from microbial infections and for clearance of immune complexes and injured cells. In normal conditions complement is tightly controlled by a number of fluid-phase and cell surface proteins to avoid injury to autologous tissues. When complement is hyperactivated, as occurs in autoimmune diseases or in subjects with dysfunctional regulatory proteins, it drives a severe inflammatory response in numerous organs. The kidney appears to be particularly vulnerable to complement-mediated inflammatory injury. Injury may derive from deposition of circulating active complement fragments in glomeruli, but complement locally produced and activated in the kidney also may have a role. Many kidney disorders have been linked to abnormal complement activation, including immune-complex-mediated glomerulonephritis and rare genetic kidney diseases, but also tubulointerstitial injury associated with progressive proteinuric diseases or ischemia-reperfusion.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.9010000",
                "gd:updateTS": "2018-04-17T13:53:30.745Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9208db26-b64a-4369-a3c2-850cd8aa8d9f",
        "_rev": "_WpvYGJ--Aa",
        "nanopub": {
            "id": "9208db26-b64a-4369-a3c2-850cd8aa8d9f",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"3F6 cell\"",
                    "label": "3F6 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "7722452",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL12)\t",
                    "relation": "increases",
                    "object": "complex(p(HGNC:STAT3), p(HGNC:STAT4))"
                },
                {
                    "subject": "p(HGNC:IL12)",
                    "relation": "increases",
                    "object": "act(p(HGNC:STAT4), ma(GO:\"protein homodimerization activity\")"
                }
            ],
            "evidence": "These results indicate that IL-12-induced phosphorylation of Star3 and Stat4 generates a heterodimer of Stat3 and Star4 and a probable homodimer of Stat4.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "954856fd-ab42-47b5-92b3-23e2e931d126",
        "_rev": "_WpvYGJ--_f",
        "nanopub": {
            "id": "954856fd-ab42-47b5-92b3-23e2e931d126",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.034",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "73 patients with\u00a0diffuse proliferative glomerulonephritis (51 without renal flare, 22 with renal flare)",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "17659436",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CSF1)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "The patients experiencing renal flare showed higher urinary RANTES, MCP-1 and M-CSF. However, independent predictors of renal flares were increased urinary RANTES and M-CSF.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6f847db8-e294-45b9-b806-57aca318eaad",
        "_rev": "_WpvYGI6--S",
        "nanopub": {
            "id": "6f847db8-e294-45b9-b806-57aca318eaad",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16990136",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite(p(HGNC:IL6),p(HGNC:TGFB))\t",
                    "relation": "increases",
                    "object": "r(HGNC:RORGT)"
                },
                {
                    "subject": "composite(p(HGNC:IL6),p(HGNC:TGFB))",
                    "relation": "increases",
                    "object": "r(HGNC:IL17)"
                }
            ],
            "evidence": "Consistent with this observation, incubation of anti-CD3/CD28-stimulated T cells with IL-6 plus TGF-\u03b2 resulted in induction of ROR\u03b3t mRNA, as well as transcripts for IL-17 and IL-17F (Figure\u00a03B).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ef3013c2-9c11-4294-8d11-3085d1ca39f4",
        "_rev": "_WpvYGJ--CL",
        "nanopub": {
            "id": "ef3013c2-9c11-4294-8d11-3085d1ca39f4",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Lai Kwan Lam, Queenie",
                    "King Hung Ko, Otis",
                    "Zheng, Bo-Jian",
                    "Lu, Liwei"
                ],
                "database": {
                    "id": "18820032",
                    "name": "PubMed"
                },
                "source_name": "Proceedings of the National Academy of Sciences of the United States of America",
                "title": "Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis.",
                "abstract": "Rheumatoid arthritis (RA) is a chronic disease characterized by synovial inflammation and joint damage. Although both T cells and B cells mediate the disease pathogenesis, proinflammatory cytokines are critically involved. The TNF superfamily member B cell-activating factor (BAFF) plays an important role in humoral immunity and in autoimmune diseases, including RA. Here, we show that intra-articular injection of lentivirus expressing shRNA for BAFF gene silencing provides long-term suppression of arthritic development in a collagen-induced arthritis model. Local BAFF gene targeting inhibited proinflammatory cytokine expression, suppressed generation of plasma cells and Th17 cells, and markedly ameliorated joint pathology. Lentivirus targets dendritic cells in the joint tissue and BAFF gene silencing inhibits dendritic cell maturation and their function in driving Th17-cell differentiation in vitro. Moreover, we revealed a previously unrecognized role for BAFF in promoting the expansion of Th17 cells and demonstrated IL-17 as a crucial effector cytokine for BAFF-mediated proinflammatory effects during collagen-induced arthritis development. Taken together, these findings identify BAFF as a valuable gene-silencing target potentially for the effective treatment of RA."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNFSF13B)",
                    "relation": "increases",
                    "object": "r(HGNC:CCL19)"
                }
            ],
            "evidence": "Analysis of LV-shBAFF\u2013treated joint tissue revealed significantlydown-regulated mRNA levels of IL-17A and IL-17F. IL-6 andIL-23 were also markedly reduced in their expression (Fig. S4Aonline). Moreover, chemokine levels of CXCL12, CXCL13, andCCL19 were significantly down-regulated. As expected, the contraryresults were observed in the LV-BAFF\u2013treated group (Fig. 2G\u2013J; Fig. S4B online).",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Rheumatoid arthritis (RA) is a chronic disease characterized by synovial inflammation and joint damage. Although both T cells and B cells mediate the disease pathogenesis, proinflammatory cytokines are critically involved. The TNF superfamily member B cell-activating factor (BAFF) plays an important role in humoral immunity and in autoimmune diseases, including RA. Here, we show that intra-articular injection of lentivirus expressing shRNA for BAFF gene silencing provides long-term suppression of arthritic development in a collagen-induced arthritis model. Local BAFF gene targeting inhibited proinflammatory cytokine expression, suppressed generation of plasma cells and Th17 cells, and markedly ameliorated joint pathology. Lentivirus targets dendritic cells in the joint tissue and BAFF gene silencing inhibits dendritic cell maturation and their function in driving Th17-cell differentiation in vitro. Moreover, we revealed a previously unrecognized role for BAFF in promoting the expansion of Th17 cells and demonstrated IL-17 as a crucial effector cytokine for BAFF-mediated proinflammatory effects during collagen-induced arthritis development. Taken together, these findings identify BAFF as a valuable gene-silencing target potentially for the effective treatment of RA.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "03166835-f139-4143-8364-117215204381",
        "_rev": "_WpvYGJ--CO",
        "nanopub": {
            "id": "03166835-f139-4143-8364-117215204381",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "van der Lans, Anouk A J J",
                    "Boon, Mari\u00ebtte R",
                    "Haks, Mari\u00eblle C",
                    "Quinten, Edwin",
                    "Schaart, Gert",
                    "Ottenhoff, Tom H",
                    "van Marken Lichtenbelt, Wouter D"
                ],
                "database": {
                    "id": "26149277",
                    "name": "PubMed"
                },
                "source_name": "Physiological reports",
                "title": "Cold acclimation affects immune composition in skeletal muscle of healthy lean subjects.",
                "abstract": "Low environmental temperatures have a profound effect on biological processes in the body, including the immune system. Cold exposure coincides with hormonal changes, which may directly or indirectly alter the immune system, even in the skeletal muscle. The aim of the present study was to investigate the effect of cold acclimation on immune composition in skeletal muscle. Skeletal muscle biopsies were obtained from 17 healthy lean subjects before and after 10\u00a0days of mild cold exposure (15 \u00b0: C, 6\u00a0h/day). Nonshivering thermogenesis was calculated by indirect calorimetry. We found that cold acclimation increased nonshivering thermogenesis from 10.8\u00a0\u00b1\u00a07.5 before to 17.8\u00a0\u00b1\u00a011.1% after cold acclimation (P\u00a0<\u00a00.01), but did not affect plasma catecholamine nor cytokine levels. In contrast, cold acclimation affected mRNA expression of several immune cell markers in skeletal muscle. It downregulated expression of the Th17 markers RORC (-28%, P\u00a0<\u00a00.01) and NEDD4L (-15%, P\u00a0<\u00a00.05), as well as the regulatory T-cell marker FOXP3 (-13%, P\u00a0<\u00a00.05). Furthermore, cold acclimation downregulated expression of the M2 macrophage markers CCL22 (-50%, P\u00a0<\u00a00.05), CXCL13 (-17%, P\u00a0<\u00a00.05) and CD209 (-15%, P\u00a0<\u00a00.05), while the M1 macrophage marker IL12B was upregulated (+141%, P\u00a0<\u00a00.05). Cold acclimation also enhanced several markers related to interferon (IFN) signaling, including TAP1 (+12%, P\u00a0<\u00a00.01), IFITM1/3 (+11%, P\u00a0<\u00a00.05), CD274 (+36%, P\u00a0<\u00a00.05) and STAT 2 (+10%, P\u00a0<\u00a00.05). In conclusion, 10\u00a0days of intermittent cold exposure induces marked changes in the expression of immune cell markers in skeletal muscle of healthy lean subjects. The physiological consequences and therapeutic relevance of these changes remain to be determined.",
                "date_published": "2015-07-01"
            },
            "assertions": [
                {
                    "subject": "bp(GO:\"cold acclimation\")",
                    "relation": "increases",
                    "object": "bp(GO:\"adaptive thermogenesis\")"
                }
            ],
            "evidence": "We found that cold acclimation increased nonshivering thermogenesis from 10.8 \u00b1 7.5 before to 17.8 \u00b1 11.1% after cold acclimation (P < 0.01), but did not affect plasma catecholamine nor cytokine levels. ",
            "metadata": {
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "08873071-b6a4-420a-a94b-3b3096695209",
        "_rev": "_WpvYGJG-_K",
        "nanopub": {
            "id": "08873071-b6a4-420a-a94b-3b3096695209",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=9",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Radioimmunoassay",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "2783477",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "p(HGNC:TNF)"
                },
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "p(HGNC:IL1B)"
                }
            ],
            "evidence": "Endotoxin-induced concentrations of IL-1alpha and TNF decreased in a similar pattern (Fig. 2a)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "802bb18f-8c4e-4b2b-aa5a-3a8c6f78aee0",
        "_rev": "_WpvYGJC-A_",
        "nanopub": {
            "id": "802bb18f-8c4e-4b2b-aa5a-3a8c6f78aee0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "One hundred and eighty subjects were successfully recruited, of whom 107 had multiple study visits.",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "20144927",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:LCN2)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "We found that uNGAL was a significant predictor for the following visit\u2019s renal SLEDAI score (P < 0.0001), whereas it was not a significant predictor for the non-renal SLEDAI (P = 0.860). Results were similar in multivariate models that adjusted for age, sex and race (Table 4).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e652d734-8699-4294-b087-5af465ac20c3",
        "_rev": "_WpvYGJG-By",
        "nanopub": {
            "id": "e652d734-8699-4294-b087-5af465ac20c3",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16622035",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:JAK2)",
                    "relation": "increases",
                    "object": "p(HGNC:IKBA, pmod(Ph))"
                }
            ],
            "evidence": "Furthermore, we confirmed that AG490 suppresses the IL-23-stimulated phosphorylation of IB-\u0005 (Fig. 7F), which is consistent with previous reports that Jak2 leads to the phosphorylation of the inhibitor of NF-B (IB-\u0005) in neurons (34, 35).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "769a83bd-f5d8-4171-b54d-b9ab0b63e0e8",
        "_rev": "_WpvYGJC-Bt",
        "nanopub": {
            "id": "769a83bd-f5d8-4171-b54d-b9ab0b63e0e8",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "EFO:HepG2",
                    "label": "HepG2",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "24755741",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:AMPD2)",
                    "relation": "increases",
                    "object": "p(EG:2538)"
                },
                {
                    "subject": "p(HGNC:AMPD2)",
                    "relation": "increases",
                    "object": "p(EG:5105)"
                }
            ],
            "evidence": "Interestingly and as shown in\u00a0Fig. 2C,\u00a0D, overexpression of AMPD2 resulted in a significant up-regulation of PEPCK and G6Pc.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1f6d0bfe-1c10-46d9-8836-f9b55927dbca",
        "_rev": "_WpvYGJ--_b",
        "nanopub": {
            "id": "1f6d0bfe-1c10-46d9-8836-f9b55927dbca",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "28713531",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fasting\")",
                    "relation": "increases",
                    "object": "a(CHEBI:serotonin)"
                }
            ],
            "evidence": "Plasma serotonin levels in the second group significantly increased by 33.4% when compared to the control group (P<0.05). In addition, the levels of serotonin in the third group were significantly increased compared to the second group by 14.7% and control group by 43.1%.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "84dca404-72b0-4de6-8746-484d9885c3c2",
        "_rev": "_WpvYGJ---e",
        "nanopub": {
            "id": "84dca404-72b0-4de6-8746-484d9885c3c2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "27822475",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"antirheumatic drug\")\t",
                    "relation": "negativeCorrelation",
                    "object": "surf(p(HGNC:TNFRSF11A))"
                },
                {
                    "subject": "a(CHEBI:\"antirheumatic drug\")",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:RF)"
                }
            ],
            "evidence": "Both RF and CD14+RANKhigh\u00a0on monocytes decreased in parallel with the disease activity of RA in these patients treated with disease modifying antirheumatic drugs (DMARDs).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "28b56a9f-dcf8-4e3c-830d-3c809140207b",
        "_rev": "_WpvYGJC-_E",
        "nanopub": {
            "id": "28b56a9f-dcf8-4e3c-830d-3c809140207b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.03",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "In vitro assay",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:\"Hair Follicle\"",
                    "label": "Hair Follicle",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "24989505",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:FGF5)",
                    "relation": "negativeCorrelation",
                    "object": "bp(GO:\"positive regulation of hair cycle\")"
                }
            ],
            "evidence": "Strikingly, the human follicles entered catagen prematurely after 2\u20134 d in the presence of recombinant FGF5, whereas untreated hairs entered catagen after 5\u20137 d (Fig. 4D). Their growth was significantly (P\u00a0= 0.03) reduced after incubation with recombinant FGF5 protein, allowing us to conclude that, whereas a lack of FGF5 results in increased hair length as seen in our patients, overexposure to FGF5 inhibits hair growth in an organ culture model by initiating catagen.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "81d7ddff-fe19-4f54-af0e-5c5ef03b4134",
        "_rev": "_WpvYGJC--O",
        "nanopub": {
            "id": "81d7ddff-fe19-4f54-af0e-5c5ef03b4134",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "co-immunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Yang, Mingjin",
                    "Wang, Chen",
                    "Zhu, Xuhui",
                    "Tang, Songqing",
                    "Shi, Liyun",
                    "Cao, Xuetao",
                    "Chen, Taoyong"
                ],
                "database": {
                    "id": "21911421",
                    "name": "PubMed"
                },
                "source_name": "The Journal of experimental medicine",
                "title": "E3 ubiquitin ligase CHIP facilitates Toll-like receptor signaling by recruiting and polyubiquitinating Src and atypical PKC{zeta}.",
                "abstract": "The carboxyl terminus of constitutive heat shock cognate 70 (HSC70)-interacting protein (CHIP, also known as Stub1) is a U box-containing E3 ubiquitin ligase that is important for protein quality control. The role of CHIP in innate immunity is not known. Here, we report that CHIP knockdown inhibits Toll-like receptor (TLR) 4- and TLR9-driven signaling, but not TLR3-driven signaling; proinflammatory cytokine and type 1 interferon (IFN) production; and maturation of antigen-presenting cells, including macrophages and dendritic cells. We demonstrate that CHIP can recruit the tyrosine kinase Src and atypical protein kinase C \u03b6 (PKC\u03b6) to the TLR complex, thereby leading to activation of IL-1 receptor-associated kinase 1, TANK-binding kinase 1, and IFN regulatory factors 3 and 7. CHIP acts as an E3 ligase for Src and PKC\u03b6 during TLR signaling. CHIP-mediated enhancement of TLR signaling is inhibited by IFNAR deficiency or expression of ubiquitination resistant mutant forms of Src or PKC\u03b6. These findings suggest that CHIP facilitates the formation of a TLR signaling complex by recruiting, ubiquitinating, and activating Src and PKC\u03b6."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TLR9)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:MYD88)"
                }
            ],
            "evidence": "In LPS/CpG-treated RAW264.7 cells, we found that CHIP, together with MyD88, TRIF, IRAK1, TBK1, TRAF6, HSC70, Src, or PKC\u03b6, could be coimmunoprecipitated with TLR4 and TLR9 (but not TLR3; Fig. 4 A), indicating that CHIP may be a component of a TLR4/9 complex that initiates signaling.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4adef723-795a-473a-9a52-7d8183a9dfd2",
        "_rev": "_WpvYGJG-BS",
        "nanopub": {
            "id": "4adef723-795a-473a-9a52-7d8183a9dfd2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "13 donors with atopic dermatitis",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8096238",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL12)",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IFNG))"
                }
            ],
            "evidence": "The ability of PPD-specific T cell lines to produce IFN-7 was not influenced by culturing the cells in presence of anti-I1:12 mAb, but their ability to produce IL-4 was significantly enhanced.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c0e6ef01-ebfc-44a8-9091-6ce095de8c6b",
        "_rev": "_WpvYGJG-B2",
        "nanopub": {
            "id": "c0e6ef01-ebfc-44a8-9091-6ce095de8c6b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.04",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=16 intervention and n=12 controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"ulcerative colitis\"",
                    "label": "ulcerative colitis",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"gastrointestinal tract (lamina propria) macrophage\"",
                    "label": "gastrointestinal tract (lamina propria) macrophage",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18240282",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"VSL#3\")",
                    "relation": "increases",
                    "object": "bp(GO:\"regulatory T cell differentiation\")"
                }
            ],
            "evidence": "A significant increase in the percentage of CD4+CD24high LPMCs was seen during follow-up in patients treated with VSL#3\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "46f1d7c6-013a-4ca6-ac18-469c972dc011",
        "_rev": "_WpvYGJ--_C",
        "nanopub": {
            "id": "46f1d7c6-013a-4ca6-ac18-469c972dc011",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CLO:\"Hep 3B cell\"",
                    "label": "Hep 3B cell",
                    "type": "CellLine"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Ganter, U",
                    "Arcone, R",
                    "Toniatti, C",
                    "Morrone, G",
                    "Ciliberto, G"
                ],
                "database": {
                    "id": "2555173",
                    "name": "PubMed"
                },
                "source_name": "The EMBO journal",
                "title": "Dual control of C-reactive protein gene expression by interleukin-1 and interleukin-6.",
                "abstract": "Human C-reactive protein (CRP) is the major acute phase reactant during acute inflammation. The human CRP promoter is expressed in an inducible and cell-specific manner when linked to the bacterial CAT gene and transfected into human hepatoma cell cultures. In this paper we analyze the effect of several recombinant cytokines or CRP promoter inducibility in human Hep3B cells. When cytokines are tested singly the major inducer of CRP-CAT fusions is interleukin-6 (IL-6). Maximal CAT gene expression, however, is only achieved when both interleukin-1 beta (IL-1 beta) and IL-6 are present. The response to the two cytokines is cooperative. Cooperativity is maintained when the CRP promoter is linked to a different coding region, that of the bacterial neomycin phosphotransferase II gene. With a series of 5' and 3' deletions we show the existence of two distinct and independent regions responsive to IL-6 and located upstream to the TATA box. The IL-1 effect is exerted at the level of downstream sequences that are probably important for optimal mRNA translatability or nuclear-cytoplasmic transport. Inducibility is not influenced by the activation of protein kinases C or A and does not require new protein synthesis."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "increases",
                    "object": "p(HGNC:CRP)"
                }
            ],
            "evidence": "In this paper we analyze the effect of several recombinant cytokines or CRP promoter inducibility in human Hep3B cells. When cytokines are tested singly the major inducer of CRP-CAT fusions is interleukin-6 (IL-6).",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Human C-reactive protein (CRP) is the major acute phase reactant during acute inflammation. The human CRP promoter is expressed in an inducible and cell-specific manner when linked to the bacterial CAT gene and transfected into human hepatoma cell cultures. In this paper we analyze the effect of several recombinant cytokines or CRP promoter inducibility in human Hep3B cells. When cytokines are tested singly the major inducer of CRP-CAT fusions is interleukin-6 (IL-6). Maximal CAT gene expression, however, is only achieved when both interleukin-1 beta (IL-1 beta) and IL-6 are present. The response to the two cytokines is cooperative. Cooperativity is maintained when the CRP promoter is linked to a different coding region, that of the bacterial neomycin phosphotransferase II gene. With a series of 5' and 3' deletions we show the existence of two distinct and independent regions responsive to IL-6 and located upstream to the TATA box. The IL-1 effect is exerted at the level of downstream sequences that are probably important for optimal mRNA translatability or nuclear-cytoplasmic transport. Inducibility is not influenced by the activation of protein kinases C or A and does not require new protein synthesis.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c4206fc5-8525-45e2-9cc4-1bbe71f32532",
        "_rev": "_WpvYGI6--N",
        "nanopub": {
            "id": "c4206fc5-8525-45e2-9cc4-1bbe71f32532",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Prostatic Neoplasms\"",
                    "label": "Prostatic Neoplasms",
                    "type": "Disease"
                },
                {
                    "id": "EFO:\"DU 145\"",
                    "label": "DU 145",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "12429649",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Zinc)",
                    "relation": "increases",
                    "object": "p(HGNC:NFKBIA)"
                }
            ],
            "evidence": "\u00a0In prostate cancer cells pretreated with zinc, the lack of nuclear accumulation of RelA corresponded with failure to degrade I\u03baB\u03b1 (Fig. 1B)\u21d3\u00a0\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "238bb561-7216-49e4-b44b-4cf7da5dbe02",
        "_rev": "_WpvYGJC-CC",
        "nanopub": {
            "id": "238bb561-7216-49e4-b44b-4cf7da5dbe02",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.67",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLAM-R",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CXCL11)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5c573d45-c6af-45e7-b95c-8151d304749f",
        "_rev": "_WpvYGJG-Bh",
        "nanopub": {
            "id": "5c573d45-c6af-45e7-b95c-8151d304749f",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Lai Kwan Lam, Queenie",
                    "King Hung Ko, Otis",
                    "Zheng, Bo-Jian",
                    "Lu, Liwei"
                ],
                "database": {
                    "id": "18820032",
                    "name": "PubMed"
                },
                "source_name": "Proceedings of the National Academy of Sciences of the United States of America",
                "title": "Local BAFF gene silencing suppresses Th17-cell generation and ameliorates autoimmune arthritis.",
                "abstract": "Rheumatoid arthritis (RA) is a chronic disease characterized by synovial inflammation and joint damage. Although both T cells and B cells mediate the disease pathogenesis, proinflammatory cytokines are critically involved. The TNF superfamily member B cell-activating factor (BAFF) plays an important role in humoral immunity and in autoimmune diseases, including RA. Here, we show that intra-articular injection of lentivirus expressing shRNA for BAFF gene silencing provides long-term suppression of arthritic development in a collagen-induced arthritis model. Local BAFF gene targeting inhibited proinflammatory cytokine expression, suppressed generation of plasma cells and Th17 cells, and markedly ameliorated joint pathology. Lentivirus targets dendritic cells in the joint tissue and BAFF gene silencing inhibits dendritic cell maturation and their function in driving Th17-cell differentiation in vitro. Moreover, we revealed a previously unrecognized role for BAFF in promoting the expansion of Th17 cells and demonstrated IL-17 as a crucial effector cytokine for BAFF-mediated proinflammatory effects during collagen-induced arthritis development. Taken together, these findings identify BAFF as a valuable gene-silencing target potentially for the effective treatment of RA."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNFSF13B)",
                    "relation": "increases",
                    "object": "r(HGNC:IL6)"
                }
            ],
            "evidence": "We furthermore found that BAFF overexpression with LV-BAFF treatment substantially increased numbers of IL-6\u2013expressing cells in joint tissue by immunohistochemical studies (Fig. S4C online).",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Rheumatoid arthritis (RA) is a chronic disease characterized by synovial inflammation and joint damage. Although both T cells and B cells mediate the disease pathogenesis, proinflammatory cytokines are critically involved. The TNF superfamily member B cell-activating factor (BAFF) plays an important role in humoral immunity and in autoimmune diseases, including RA. Here, we show that intra-articular injection of lentivirus expressing shRNA for BAFF gene silencing provides long-term suppression of arthritic development in a collagen-induced arthritis model. Local BAFF gene targeting inhibited proinflammatory cytokine expression, suppressed generation of plasma cells and Th17 cells, and markedly ameliorated joint pathology. Lentivirus targets dendritic cells in the joint tissue and BAFF gene silencing inhibits dendritic cell maturation and their function in driving Th17-cell differentiation in vitro. Moreover, we revealed a previously unrecognized role for BAFF in promoting the expansion of Th17 cells and demonstrated IL-17 as a crucial effector cytokine for BAFF-mediated proinflammatory effects during collagen-induced arthritis development. Taken together, these findings identify BAFF as a valuable gene-silencing target potentially for the effective treatment of RA.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "91a4f7cd-ac64-4744-a1ba-0e5e17c364c9",
        "_rev": "_WpvYGJ--BC",
        "nanopub": {
            "id": "91a4f7cd-ac64-4744-a1ba-0e5e17c364c9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.4",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLAM-R",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL5)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "p(HGNC:IL18)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1c8ecc1f-b6c7-4daf-9686-a41eb5a757a6",
        "_rev": "_WpvYGJG--X",
        "nanopub": {
            "id": "1c8ecc1f-b6c7-4daf-9686-a41eb5a757a6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Ghosh, Chandra C",
                    "Ramaswami, Sitharam",
                    "Juvekar, Ashish",
                    "Vu, Hai-Yen",
                    "Galdieri, Luciano",
                    "Davidson, Dennis",
                    "Vancurova, Ivana"
                ],
                "database": {
                    "id": "20696864",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology (Baltimore, Md. : 1950)",
                "title": "Gene-specific repression of proinflammatory cytokines in stimulated human macrophages by nuclear I\u03baB\u03b1.",
                "abstract": "We have previously shown that increased nuclear accumulation of IkappaBalpha inhibits NF-kappaB activity and induces apoptosis in human leukocytes. In this study, we wanted to explore the possibility that the nucleocytoplasmic distribution of IkappaBalpha can be used as a therapeutic target for the regulation of NF-kappaB-dependent cytokine synthesis. Treatment of LPS-stimulated human U937 macrophages with an inhibitor of chromosome region maintenance 1-dependent nuclear export, leptomycin B, resulted in the increased nuclear accumulation of IkappaBalpha and inhibition of NF-kappaB DNA binding activity, caused by the nuclear IkappaBalpha-p65 NF-kappaB interaction. Surprisingly, however, whereas mRNA expression and cellular release of TNF-alpha, the beta form of pro-IL-1 (IL-1beta), and IL-6 were inhibited by the leptomycin B-induced nuclear IkappaBalpha, IL-8 mRNA expression and cellular release were not significantly affected. Analysis of in vivo recruitment of p65 NF-kappaB to NF-kappaB-regulated promoters by chromatin immunoprecipitation in U937 cells and human PBMCs indicated that although the p65 recruitment to TNF-alpha, IL-1beta, and IL-6 promoters was inhibited by the nuclear IkappaBalpha, p65 recruitment to IL-8 promoter was not repressed. Chromatin immunoprecipitation analyses using IkappaBalpha and S536 phosphospecific p65 NF-kappaB Abs demonstrated that although the newly synthesized IkappaBalpha induced by postinduction repression is recruited to TNF-alpha, IL-1beta, and IL-6 promoters but not to the IL-8 promoter, S536-phosphorylated p65 is recruited to IL-8 promoter, but not to TNF-alpha, IL-1beta, or IL-6 promoters. Together, these data indicate that the inhibition of NF-kappaB-dependent transcription by nuclear IkappaBalpha in LPS-stimulated macrophages is gene specific and depends on the S536 phosphorylation status of the recruited p65 NF-kappaB."
            },
            "assertions": [
                {
                    "subject": "complex(p(HGNC:RELA),p(HGNC:NFKB1))\t",
                    "relation": "increases",
                    "object": "p(HGNC:TNF, loc(MESH:\"Cell Nucleus\"))"
                },
                {
                    "subject": "complex(p(HGNC:RELA),p(HGNC:NFKB1))\t",
                    "relation": "increases",
                    "object": "p(HGNC:IL1B, loc(MESH:\"Cell Nucleus\"))"
                },
                {
                    "subject": "complex(p(HGNC:RELA),p(HGNC:NFKB1))",
                    "relation": "increases",
                    "object": "p(HGNC:IL6, loc(MESH:\"Cell Nucleus\"))"
                }
            ],
            "evidence": "the unphosphorylated p65 is recruited topromoters of TNF-a, IL-1b, and IL-6 genes.\u00a0",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "We have previously shown that increased nuclear accumulation of IkappaBalpha inhibits NF-kappaB activity and induces apoptosis in human leukocytes. In this study, we wanted to explore the possibility that the nucleocytoplasmic distribution of IkappaBalpha can be used as a therapeutic target for the regulation of NF-kappaB-dependent cytokine synthesis. Treatment of LPS-stimulated human U937 macrophages with an inhibitor of chromosome region maintenance 1-dependent nuclear export, leptomycin B, resulted in the increased nuclear accumulation of IkappaBalpha and inhibition of NF-kappaB DNA binding activity, caused by the nuclear IkappaBalpha-p65 NF-kappaB interaction. Surprisingly, however, whereas mRNA expression and cellular release of TNF-alpha, the beta form of pro-IL-1 (IL-1beta), and IL-6 were inhibited by the leptomycin B-induced nuclear IkappaBalpha, IL-8 mRNA expression and cellular release were not significantly affected. Analysis of in vivo recruitment of p65 NF-kappaB to NF-kappaB-regulated promoters by chromatin immunoprecipitation in U937 cells and human PBMCs indicated that although the p65 recruitment to TNF-alpha, IL-1beta, and IL-6 promoters was inhibited by the nuclear IkappaBalpha, p65 recruitment to IL-8 promoter was not repressed. Chromatin immunoprecipitation analyses using IkappaBalpha and S536 phosphospecific p65 NF-kappaB Abs demonstrated that although the newly synthesized IkappaBalpha induced by postinduction repression is recruited to TNF-alpha, IL-1beta, and IL-6 promoters but not to the IL-8 promoter, S536-phosphorylated p65 is recruited to IL-8 promoter, but not to TNF-alpha, IL-1beta, or IL-6 promoters. Together, these data indicate that the inhibition of NF-kappaB-dependent transcription by nuclear IkappaBalpha in LPS-stimulated macrophages is gene specific and depends on the S536 phosphorylation status of the recruited p65 NF-kappaB.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d89ff05b-6ecb-4c68-9545-ceee2658aa8a",
        "_rev": "_WpvYGJC-CO",
        "nanopub": {
            "id": "d89ff05b-6ecb-4c68-9545-ceee2658aa8a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "13 LN (OSS cohort)",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Lupus Nephritis\"",
                    "label": "Lupus Nephritis",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "19785730",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNFSF12)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "As shown in Figure3, uTWEAK levels peaked during the flare, gradually increasing before and decreasing after the flare. Statistically significant differences were found between uTWEAK levels at flare as compared with 4 and 6 months before and after the flare timepoint (\u00b1 4 months, P = 0.035 and P = 0.025, respectively; \u00b1 6 months, P = 0.017 for both timepoints)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "35753a54-70b8-4ce1-84ea-7f5b26789c1c",
        "_rev": "_WpvYGJG-_C",
        "nanopub": {
            "id": "35753a54-70b8-4ce1-84ea-7f5b26789c1c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL7)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": " In addition, levels of plasma IP-10, MCP-1 and MCP-3 (Figure 2D), along with IL-8 and ICAM-1 (Supplementary Figure 2H), were significantly elevated in pre-flare periods compared to periods of stable disease.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2efe26a1-36a9-471b-ac8d-f52816000830",
        "_rev": "_WpvYGJ--CJ",
        "nanopub": {
            "id": "2efe26a1-36a9-471b-ac8d-f52816000830",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"3F6 cell\"",
                    "label": "3F6 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "7722452",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL12)\t",
                    "relation": "increases",
                    "object": "p(HGNC:STAT4, pmod(Ph))"
                },
                {
                    "subject": "p(HGNC:IL12)",
                    "relation": "increases",
                    "object": "p(HGNC:STAT3, pmod(Ph))"
                }
            ],
            "evidence": "IL-12 induced tyrosine phosphorylation of both Stat3 and Star4, whereas IFN-t~ caused tyrosine phosphorylation of neither.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "22c2b8a2-ec0a-488e-9a14-a9a9f3062b54",
        "_rev": "_WpvYGI6--V",
        "nanopub": {
            "id": "22c2b8a2-ec0a-488e-9a14-a9a9f3062b54",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "immunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Li, Shitao",
                    "Wang, Lingyan",
                    "Berman, Michael",
                    "Kong, Young-Yun",
                    "Dorf, Martin E"
                ],
                "database": {
                    "id": "21903422",
                    "name": "PubMed"
                },
                "source_name": "Immunity",
                "title": "Mapping a dynamic innate immunity protein interaction network regulating type I interferon production.",
                "abstract": "To systematically investigate innate immune signaling networks regulating production of type I interferon, we analyzed protein complexes formed after microbial recognition. Fifty-eight baits were associated with 260 interacting proteins forming a human innate immunity interactome for type I interferon (HI5) of 401 unique interactions; 21% of interactions were modulated by RNA, DNA, or LPS. Overexpression and depletion analyses identified 22 unique genes that regulated NF-\u03baB and ISRE reporter activity, viral replication, or virus-induced interferon production. Detailed mechanistic analysis defined a role for mind bomb (MIB) E3 ligases in K63-linked ubiquitination of TBK1, a kinase that phosphorylates IRF transcription factors controlling interferon production. Mib genes selectively controlled responses to cytosolic RNA. MIB deficiency reduced antiviral activity, establishing the role of MIB proteins as positive regulators of antiviral responses. The HI5 provides a dynamic physical and regulatory network that serves as a resource for mechanistic analysis of innate immune signaling."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IRAK4)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:IRF7)"
                }
            ],
            "evidence": "Other nodes of high interconnectivity include the IRAK complex, which is wired to the UNC93B1-STING module, and PKR, which is linked with LPG2 or OAS3 (Figure 1). Again >90% of the interactions were confirmed by coimmunoprecipitation (Figures S3J\u2013S3M and Table S3). In the HI5, 19 baits were connected to >3 unique HCIP, establishing distinct subnetworks. We validated 10 subnetworks in vitro including MAL, IRAK2, IRF3, IRF4, IRF7, and DAI (Figures S3N\u2013S3S and Table S3).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3d787b4a-edf1-4d55-b44d-751f440c5dfe",
        "_rev": "_WpvYGJ--Ap",
        "nanopub": {
            "id": "3d787b4a-edf1-4d55-b44d-751f440c5dfe",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:10090",
                    "label": "mouse"
                }
            ],
            "citation": {
                "authors": [
                    "Korn, Thomas",
                    "Mitsdoerffer, Meike",
                    "Croxford, Andrew L",
                    "Awasthi, Amit",
                    "Dardalhon, Val\u00e9rie A",
                    "Galileos, George",
                    "Vollmar, Patrick",
                    "Stritesky, Gretta L",
                    "Kaplan, Mark H",
                    "Waisman, Ari",
                    "Kuchroo, Vijay K",
                    "Oukka, Mohamed"
                ],
                "database": {
                    "id": "19015529",
                    "name": "PubMed"
                },
                "source_name": "Proceedings of the National Academy of Sciences of the United States of America",
                "title": "IL-6 controls Th17 immunity in vivo by inhibiting the conversion of conventional T cells into Foxp3+ regulatory T cells.",
                "abstract": "The conditions leading to the induction of adaptive Foxp3(+) regulatory T cells (T-regs) from peripheral T cells in vivo are incompletely understood. Here, we show that unresponsiveness of T cells to IL-6 by T cell-selective deletion of gp130 or immunization of wild-type mice with antigen in incomplete Freund's adjuvant (IFA), which fails to induce IL-6, promotes the conversion of peripheral CD4(+) T cells into adaptive Foxp3(+) T-regs. Thus, both T cell-conditional gp130 knockout (KO) mice immunized with MOG35-55 in complete Freund's adjuvant (CFA) and wild-type mice immunized with MOG35-55 in IFA develop overwhelming antigen-specific T-reg responses and are protected from experimental autoimmune encephalomyelitis (EAE). Depletion of T-regs restores T helper (Th)17 responses and clinical EAE in MOG/CFA-immunized T cell-conditional gp130 KO mice, but not in MOG/IFA-immunized wild-type mice. We conclude that in the absence of T-regs, IL-6 signaling is dispensable for the induction of Th17 cells, and alternative pathways exist to induce Th17 cells and EAE in the absence of IL-6 signaling. However, IL-6 signaling is dominant in inhibiting the conversion of conventional T cells into Foxp3(+) T-regs in vivo, and in the absence of IL-6 signaling, no other cytokine can substitute in inhibiting T-reg conversion. These data identify IL-6 as an important target to modulate autoimmune responses and chronic inflammation."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "decreases",
                    "object": "a(CL:\"regulatory T cell\")"
                }
            ],
            "evidence": "IL-6 inhibits the conversion of conventional Foxp3\u2212 T cells into Foxp3+ T-regs and blocks the generation of antigen-specific T-regs in vivo",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "The conditions leading to the induction of adaptive Foxp3(+) regulatory T cells (T-regs) from peripheral T cells in vivo are incompletely understood. Here, we show that unresponsiveness of T cells to IL-6 by T cell-selective deletion of gp130 or immunization of wild-type mice with antigen in incomplete Freund's adjuvant (IFA), which fails to induce IL-6, promotes the conversion of peripheral CD4(+) T cells into adaptive Foxp3(+) T-regs. Thus, both T cell-conditional gp130 knockout (KO) mice immunized with MOG35-55 in complete Freund's adjuvant (CFA) and wild-type mice immunized with MOG35-55 in IFA develop overwhelming antigen-specific T-reg responses and are protected from experimental autoimmune encephalomyelitis (EAE). Depletion of T-regs restores T helper (Th)17 responses and clinical EAE in MOG/CFA-immunized T cell-conditional gp130 KO mice, but not in MOG/IFA-immunized wild-type mice. We conclude that in the absence of T-regs, IL-6 signaling is dispensable for the induction of Th17 cells, and alternative pathways exist to induce Th17 cells and EAE in the absence of IL-6 signaling. However, IL-6 signaling is dominant in inhibiting the conversion of conventional T cells into Foxp3(+) T-regs in vivo, and in the absence of IL-6 signaling, no other cytokine can substitute in inhibiting T-reg conversion. These data identify IL-6 as an important target to modulate autoimmune responses and chronic inflammation.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2d9993cc-17f0-421a-8121-3e4a5ede9c76",
        "_rev": "_WpvYGJC-Ah",
        "nanopub": {
            "id": "2d9993cc-17f0-421a-8121-3e4a5ede9c76",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "2D-Gel electrophoresis",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"YT cell\"",
                    "label": "YT cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "2787319",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:IL2), ma(GO:\"Receptor Binding\"))",
                    "relation": "increases",
                    "object": "bp(GO:\"Peptidyl-tyrosine phosphorylation\")"
                }
            ],
            "evidence": "Although there was some increase in the basal phosphorylation of a number of a-pTyr antibody-purified proteins, including those found in the 66- 75-kDa range, IL 2 clearly stimulated increased phosphorylation of substrates also observed in normal lymphocytes.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0cc2c858-250e-485a-857d-70cf42cb9f46",
        "_rev": "_WpvYGJC-CK",
        "nanopub": {
            "id": "0cc2c858-250e-485a-857d-70cf42cb9f46",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Uterine Cervical Neoplasms\"",
                    "label": "Uterine Cervical Neoplasms",
                    "type": "Disease"
                },
                {
                    "id": "EFO:HeLa",
                    "label": "HeLa",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "16526022",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:curcumin)",
                    "relation": "decreases",
                    "object": "act(complex(p(HGNC:NFKB1),p(HGNC:NFKB2)), ma(tscript)))"
                }
            ],
            "evidence": "As shown in Figure 7A, TNF-a-induced activation of NFkB (lane 4) which was suppressed by curcumin in a time dependentmanner (lanes 2, 3, and 5). At 1 h, complete inhibition was observed\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "88e9c786-af05-4aa3-a4f5-7942301b1540",
        "_rev": "_WpvYGJC--T",
        "nanopub": {
            "id": "88e9c786-af05-4aa3-a4f5-7942301b1540",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ChIP",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18549798",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:Jak3)",
                    "relation": "association",
                    "object": "act(p(HGNC:TBX21), ma(tscript))"
                }
            ],
            "evidence": "Following Th1 differentiation, T-bet bound to the\u00a0Ifng\u00a0promoter was easily detectable in Jak3+/\u2212\u00a0T cells, but substantially diminished in Jak3\u2212/\u2212\u00a0T cells (lane 9 and lane 12).\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e2ecfe89-823f-43a5-9860-4d95c2080152",
        "_rev": "_WpvYGJC-_X",
        "nanopub": {
            "id": "e2ecfe89-823f-43a5-9860-4d95c2080152",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16200070",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL4)",
                    "relation": "decreases",
                    "object": "bp(GO:\"T-helper 17 cell differentiation\")"
                },
                {
                    "subject": "p(HGNC:IFN-G)",
                    "relation": "decreases",
                    "object": "bp(GO:\"T-helper 17 cell differentiation\")"
                }
            ],
            "evidence": "The development of TH-17 cells from naive precursor cells was potently inhibited by interferon-\u03b3 (IFN-\u03b3) and IL-4,\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "72aa118a-64ec-4015-b467-14356c3e30c8",
        "_rev": "_WpvYGJ---g",
        "nanopub": {
            "id": "72aa118a-64ec-4015-b467-14356c3e30c8",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "65 healthy donors and 103 SLE patients",
                    "type": "cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Dominguez-Gutierrez, Paul R",
                    "Ceribelli, Angela",
                    "Satoh, Minoru",
                    "Sobel, Eric S",
                    "Reeves, Westley H",
                    "Chan, Edward K L"
                ],
                "database": {
                    "id": "24460726",
                    "name": "PubMed"
                },
                "source_name": "Arthritis research & therapy",
                "title": "Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset.",
                "abstract": "Our recent data showed that signal transducers and activators of transcription 1 (STAT1), adenosine deaminase acting on RNA (ADAR), C-C motif chemokine ligand 2 (CCL2), and C-X-C motif chemokine 10 (CXCL10) were significantly elevated in a systemic lupus erythematosus (SLE) cohort compared to healthy donors. High and low STAT1 subsets were identified in SLE patient visits. The present study analyzed the correlation of common treatments used in SLE with the levels of these biomarkers."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CXCL10)",
                    "relation": "positiveCorrelation",
                    "object": "path(DO:\"systemic lupus erythematosus\")"
                },
                {
                    "subject": "p(HGNC:CCL2)",
                    "relation": "positiveCorrelation",
                    "object": "path(DO:\"systemic lupus erythematosus\")"
                }
            ],
            "evidence": "CCL2 and CXCL10 were significantly higher in untreated patients compared to treated patients",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Our recent data showed that signal transducers and activators of transcription 1 (STAT1), adenosine deaminase acting on RNA (ADAR), C-C motif chemokine ligand 2 (CCL2), and C-X-C motif chemokine 10 (CXCL10) were significantly elevated in a systemic lupus erythematosus (SLE) cohort compared to healthy donors. High and low STAT1 subsets were identified in SLE patient visits. The present study analyzed the correlation of common treatments used in SLE with the levels of these biomarkers.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "fa51cdbf-602c-4c50-9232-e6b40ae6ebbb",
        "_rev": "_WpvYGI6--Q",
        "nanopub": {
            "id": "fa51cdbf-602c-4c50-9232-e6b40ae6ebbb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Diehl, Sean A",
                    "Schmidlin, Heike",
                    "Nagasawa, Maho",
                    "Blom, Bianca",
                    "Spits, Hergen"
                ],
                "database": {
                    "id": "22491065",
                    "name": "PubMed"
                },
                "source_name": "Immunology and cell biology",
                "title": "IL-6 triggers IL-21 production by human CD4+ T cells to drive STAT3-dependent plasma cell differentiation in B cells.",
                "abstract": "Interleukin (IL)-21-producing CD4(+)T cells are central to humoral immunity. Deciphering the signals that induce IL-21 production in CD4(+) T cells and those triggered by IL-21 in B cells are, therefore, of importance for understanding the generation of antibody (Ab) responses. Here, we show that IL-6 increased IL-21 production by human CD4(+) T cells, particularly in those that express the transcriptional regulator B cell lymphoma (BCL)6, which is required in mice for the development of C-X-C chemokine receptor type 5 (CXCR5(+)) IL-21-producing T follicular helper (T(FH)) cells. However, retroviral overexpression of BCL6 in total human CD4(+) T cells only transiently increased CXCR5, the canonical T(FH)-defining surface marker. We show here that IL-21 was required for the induction of Ab production by IL-6. In IL-21-treated B cells, signal transducer and activator of transcription (STAT)3 was required for optimal immunoglobulin production and upregulation of PR domain containing 1 (PRDM1(+)), the master plasma cell factor. These results, therefore, demonstrate the critical importance of STAT3 activation in B cells during IL-21-driven humoral immunity and suggest that BCL6 expression, although not sufficient, may serve as a platform for the acquisition of a T(FH)-like phenotype by human CD4(+) T cells."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "increases",
                    "object": "p(HGNC:IL21)"
                }
            ],
            "evidence": "we show that IL-6 increased IL-21 production by human CD4+ T cells, particularly in those that express the transcriptional regulator B cell lymphoma (BCL)6, which is required in mice for the development of CXCR5+ IL-21-producing T follicular helper (TFH) cells.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6060dd04-59a2-4d04-bf46-d5b721ca79c9",
        "_rev": "_WpvYGJC--z",
        "nanopub": {
            "id": "6060dd04-59a2-4d04-bf46-d5b721ca79c9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "n=679",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "OR",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "12922955",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Cigarette Smoking\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthiritis, Rheumatoid\")"
                }
            ],
            "evidence": "According to the results in this study, cigarette smokers of both sexes have an increased risk of developing RF+ RA, but not RF\u2212 RA, compared with never-smokers. The increased risk of developing RA occurred after a long duration but merely a moderate intensity of smoking, and remained for several years after smoking cessation\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "56ee71d3-e7b7-4700-9678-4f79cd87b02a",
        "_rev": "_WpvYGJG-Aw",
        "nanopub": {
            "id": "56ee71d3-e7b7-4700-9678-4f79cd87b02a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "5 men and 5 women with UC balanced with 6 controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"ulcerative colitis\"",
                    "label": "ulcerative colitis",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Colon",
                    "label": "Colon",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "19477911",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"vitamin A\")",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:TNF))"
                }
            ],
            "evidence": "The concentration of TNF\u2010\u03b1 in the supernatants was determined by ELISA.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d6731404-4de7-43ec-97c3-6f6cc1d3d592",
        "_rev": "_WpvYGJ--Ak",
        "nanopub": {
            "id": "d6731404-4de7-43ec-97c3-6f6cc1d3d592",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "2419430",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(GO:\"T helper 1 cells\")",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IFNG))"
                }
            ],
            "evidence": "A group of bands in the 17.000 to 18,000 dalton region was characteristic of TH1 clones. Immunoprecipitation with an antiserum specific for interferon-y demonstrated that these bands were due to interferon, and that these components were absent in TH2 samples (Fig. 8)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "86da5b04-ac38-41af-8f08-0aa97edc8502",
        "_rev": "_WpvYGJC-B_",
        "nanopub": {
            "id": "86da5b04-ac38-41af-8f08-0aa97edc8502",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Immunofluorometry",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "10940278",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:butyrate)",
                    "relation": "decreases",
                    "object": "ma(tloc(p(HGNC:RELA)), fromloc(GOCC:\"cytoplasm\"), toloc(GOCC:\"nucleus\"))"
                }
            ],
            "evidence": "Stimulation of PBMC with LPS induced translocation of NF\u00eaB p65 from the cytoplasm to the nucleus (fig 3B), which was inhibited by butyrate (fig 3C).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a95c6b9f-b25e-482d-9df2-55590c18f94c",
        "_rev": "_WpvYGJC-_w",
        "nanopub": {
            "id": "a95c6b9f-b25e-482d-9df2-55590c18f94c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"mature neutrophil\"",
                    "label": "mature neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Martinelli, Sibylla",
                    "Urosevic, Mirjana",
                    "Daryadel, Arezoo",
                    "Oberholzer, Patrick Antony",
                    "Baumann, Christa",
                    "Fey, Martin F",
                    "Dummer, Reinhard",
                    "Simon, Hans-Uwe",
                    "Yousefi, Shida"
                ],
                "database": {
                    "id": "15302890",
                    "name": "PubMed"
                },
                "source_name": "The Journal of biological chemistry",
                "title": "Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation.",
                "abstract": "Interferons (IFNs) are cytokines that possess potent anti-viral and immunoregulatory activities. In contrast, their potential role(s) in anti-bacterial defense and neutrophil activation mechanisms is less well explored. By comparing gene expression patterns between immature and mature human neutrophils, we obtained evidence that intracellular proteases and other anti-bacterial proteins are produced at earlier stages of maturation, whereas the genes for receptors and signaling molecules required for the release of these effector molecules are preferentially induced during terminal differentiation. For instance, mature neutrophils strongly expressed genes that increase their responses to type I and type II IFNs. Interestingly, granulocyte/macrophage colony-stimulating factor was identified as a repressor of IFN signaling components and consequently of IFN-responsive genes. Both IFN-alpha and IFN-gamma induced strong tyrosine phosphorylation of STAT1 in mature but not in immature neutrophils. Functional in vitro studies suggested that IFNs act as priming factors on mature neutrophils, allowing the formation of extracellular traps upon subsequent stimulation with complement factor 5a (C5a). In contrast, both IFN-alpha and IFN-gamma had only little capacity to prime immature cells in this system. Moreover, both IFNs did not have significant anti-proliferative effects on immature neutrophils. These data contribute to our understanding regarding changes of gene expression during neutrophil differentiation and IFN-mediated anti-bacterial defense mechanisms."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "increases",
                    "object": "a(NETs)"
                },
                {
                    "subject": "p(HGNC:IFNA1)",
                    "relation": "increases",
                    "object": "a(NETs)"
                }
            ],
            "evidence": "Because IFN-\u03b3 has been shown to enhance anti-fungal activities of neutrophils (30-32), we asked whether IFN-\u03b1 or IFN-\u03b3 might be able to help in the formation of neutrophil extracellular traps. Indeed, using two different techniques we demonstrated that IFN priming and subsequent C5a stimulation resulted in DNA release in mature but not in immature neutrophils.\n...\nIFN-\u03b1 and IFN-\u03b3 amplified both C5a-induced DNA (Fig. 7A) and MPO (Fig. 7B) release from mature neutrophils.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b8dfc354-3937-45a0-badf-9309116045e0",
        "_rev": "_WpvYGJ--_Q",
        "nanopub": {
            "id": "b8dfc354-3937-45a0-badf-9309116045e0",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "authors": [
                    "Viedt, Christiane",
                    "Dechend, Ralph",
                    "Fei, Jianwei",
                    "H\u00e4nsch, Gertrud M",
                    "Kreuzer, J\u00f6rg",
                    "Orth, Stephan R"
                ],
                "database": {
                    "id": "12039983",
                    "name": "PubMed"
                },
                "source_name": "Journal of the American Society of Nephrology : JASN",
                "title": "MCP-1 induces inflammatory activation of human tubular epithelial cells: involvement of the transcription factors, nuclear factor-kappaB and activating protein-1.",
                "abstract": "Monocyte chemoattractant protein-1 (MCP-1) is a potent chemokine synthesized by several cell types, e.g., inflammatory cells, such as monocytes, and resident renal cells, such as human tubular epithelial cells (TECs). Besides induction of monocyte recruitment, MCP-1 has been suggested to induce non-leukocytes to produce cytokines and adhesion molecules. Inflammation of the tubulointerstitium is a hallmark of many renal diseases and contributes to progression of renal failure; the purpose therefore of this study was to investigate the influence of MCP-1 on markers of inflammatory activation in human TECs. MCP-1 stimulated interleukin-6 (IL-6) secretion and intercellular adhesion molecule-1 (ICAM-1) synthesis in a time- and dose-dependent manner. In parallel, MCP-1 increased IL-6 and ICAM-1 mRNA expression in human TECs. Pretreatment with pertussis toxin, GF109203X, BAPTA-AM, and pyrrolidine dithiocarbamate inhibited MCP-1-dependent IL-6 and ICAM-1 synthesis, suggesting the involvement of Gi-proteins, protein kinase C, intracellular Ca(2+), and nuclear factor-kappaB (NF-kappaB) in MCP-1 signaling. Using electrophoretic gel mobility shift assay, we observed that MCP-1 stimulated binding activity of NF-kappaB. Binding activity of the activator protein-1 (AP-1), which has been implicated to regulate induction of the IL-6 gene together with NF-kappaB, was also stimulated by MCP-1. In the present experiments, NF-kappaB and AP-1 were involved in the MCP-1-mediated induction of IL-6, as demonstrated by cis element double-stranded (decoy) oligonucleotides (ODN). In contrast to IL-6 release, MCP-1-induced ICAM-1 expression was predominantly dependent on NF-kappaB activation. These results document for the first time that MCP-1 induces an inflammatory response in human TECs. This may be an important new mechanism in the pathogenesis of tubulointerstitial inflammation."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL2)",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "The present data demonstrate that MCP-1 induces an inflammatory response in human TECs via activation of the transcription factors, NF-\u03baB and AP-1, by inducing expression of the proinflammatory cytokine, IL-6, and the adhesion molecule, ICAM-1.",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Monocyte chemoattractant protein-1 (MCP-1) is a potent chemokine synthesized by several cell types, e.g., inflammatory cells, such as monocytes, and resident renal cells, such as human tubular epithelial cells (TECs). Besides induction of monocyte recruitment, MCP-1 has been suggested to induce non-leukocytes to produce cytokines and adhesion molecules. Inflammation of the tubulointerstitium is a hallmark of many renal diseases and contributes to progression of renal failure; the purpose therefore of this study was to investigate the influence of MCP-1 on markers of inflammatory activation in human TECs. MCP-1 stimulated interleukin-6 (IL-6) secretion and intercellular adhesion molecule-1 (ICAM-1) synthesis in a time- and dose-dependent manner. In parallel, MCP-1 increased IL-6 and ICAM-1 mRNA expression in human TECs. Pretreatment with pertussis toxin, GF109203X, BAPTA-AM, and pyrrolidine dithiocarbamate inhibited MCP-1-dependent IL-6 and ICAM-1 synthesis, suggesting the involvement of Gi-proteins, protein kinase C, intracellular Ca(2+), and nuclear factor-kappaB (NF-kappaB) in MCP-1 signaling. Using electrophoretic gel mobility shift assay, we observed that MCP-1 stimulated binding activity of NF-kappaB. Binding activity of the activator protein-1 (AP-1), which has been implicated to regulate induction of the IL-6 gene together with NF-kappaB, was also stimulated by MCP-1. In the present experiments, NF-kappaB and AP-1 were involved in the MCP-1-mediated induction of IL-6, as demonstrated by cis element double-stranded (decoy) oligonucleotides (ODN). In contrast to IL-6 release, MCP-1-induced ICAM-1 expression was predominantly dependent on NF-kappaB activation. These results document for the first time that MCP-1 induces an inflammatory response in human TECs. This may be an important new mechanism in the pathogenesis of tubulointerstitial inflammation.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b4bc0608-c376-4043-899a-b5c2274eb1aa",
        "_rev": "_WpvYGJ--Ad",
        "nanopub": {
            "id": "b4bc0608-c376-4043-899a-b5c2274eb1aa",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Schmiel, Shirdi E",
                    "Yang, Jessica A",
                    "Jenkins, Marc K",
                    "Mueller, Daniel L"
                ],
                "database": {
                    "id": "27986907",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology (Baltimore, Md. : 1950)",
                "title": "Cutting Edge: Adenosine A2a Receptor Signals Inhibit Germinal Center T Follicular Helper Cell Differentiation during the Primary Response to Vaccination.",
                "abstract": "Adenosine A2a receptor (A2aR) signaling acts as a barrier to autoimmunity by promoting anergy, inducing regulatory T cells, and inhibiting effector T cells. However, in vivo effects of A2aR signaling on polyclonal CD4 T cells during a primary response to foreign Ag has yet to be determined. To address this problem, we immunized mice with peptide Ag 2W1S coupled to PE in CFA and treated with the selective A2aR agonist CGS-21680 (CGS). 2W1S:I-A",
                "date_published": "2017-01-15"
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:ADAR))",
                    "relation": "decreases",
                    "object": "a(CL:\"effector T cell\")"
                }
            ],
            "evidence": "Adenosine A2a receptor (A2aR) signaling acts as a barrier to autoimmunity by promoting anergy, inducing regulatory T cells (Tregs), and inhibiting effector T cells.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a27aaa45-fb42-4826-842c-dadbb3191977",
        "_rev": "_WpvYGJ--CT",
        "nanopub": {
            "id": "a27aaa45-fb42-4826-842c-dadbb3191977",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Bortoluzzi, Alessandra",
                    "Vincenzi, Fabrizio",
                    "Govoni, Marcello",
                    "Padovan, Melissa",
                    "Ravani, Annalisa",
                    "Borea, Pier Andrea",
                    "Varani, Katia"
                ],
                "database": {
                    "id": "27566294",
                    "name": "PubMed"
                },
                "source_name": "Arthritis research & therapy",
                "title": "A2A adenosine receptor upregulation correlates with disease activity in patients with systemic lupus erythematosus.",
                "abstract": "Adenosine is a purine nucleoside implicated in the regulation of the innate and adaptive immune systems, acting through its interaction with four cell surface receptors: A1, A2A, A2B, and A3. There is intense interest in understanding how adenosine functions in health and during disease, but surprisingly little is known about the actual role of adenosine-mediated mechanisms in systemic lupus erythematosus (SLE). With this background, the aim of the present study was to test the hypothesis that dysregulation of A1, A2A, A2B, and A3 adenosine receptors (ARs) in lymphocytes of patients with SLE may be involved in the pathogenesis of the disease and to examine the correlations between the status of the ARs and the clinical parameters of SLE."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:ADAR)\t",
                    "relation": "decreases",
                    "object": "p(HGNC:TNF)"
                }
            ],
            "evidence": "Similar results were obtained when we evaluated the capability of CGS-21680 to inhibit the release of TNF-\u03b1 induced by LPS (Fig. 3b). Again, the inhibitory effect of the A2AAR agonist was more evident in lymphocytes of patients with SLE than in those of healthy subjects (p\u2009<\u20090.0001) (see Table 3).\u00a0",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Adenosine is a purine nucleoside implicated in the regulation of the innate and adaptive immune systems, acting through its interaction with four cell surface receptors: A1, A2A, A2B, and A3. There is intense interest in understanding how adenosine functions in health and during disease, but surprisingly little is known about the actual role of adenosine-mediated mechanisms in systemic lupus erythematosus (SLE). With this background, the aim of the present study was to test the hypothesis that dysregulation of A1, A2A, A2B, and A3 adenosine receptors (ARs) in lymphocytes of patients with SLE may be involved in the pathogenesis of the disease and to examine the correlations between the status of the ARs and the clinical parameters of SLE.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "79af356b-41e4-400a-a837-1f49ba2914a9",
        "_rev": "_WpvYGI6--P",
        "nanopub": {
            "id": "79af356b-41e4-400a-a837-1f49ba2914a9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "10 old and 10 young males",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "qPCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9469419",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(GO:aging)",
                    "relation": "decreases",
                    "object": "r(HGNC:BCL2)"
                }
            ],
            "evidence": "As seen in Figure 5\u21d3A, a significantly (p\u00a0< 0.001) lower cpm ratio for\u00a0bcl-2:\u03b2-actin\u00a0was observed in aging (1 and 2 \u03bcl cDNA for\u00a0bcl-2, and 1 \u03bcl for\u00a0\u03b2-actin: mean \u00b1 SD cpm, 0.14 \u00b1 0.01 and 0.3 \u00b1 0.03) as compared with young controls (1 and 2 \u03bcl cDNA for\u00a0bcl-2, and 1 \u03bcl for\u00a0\u03b2-actin: mean \u00b1 SD cpm, 0.29 \u00b1 0.02 and 0.56 \u00b1 0.02), demonstrating a lowered\u00a0bcl-2\u00a0expression in aging.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a270c0ed-9a22-4237-ad42-4d7cc92bbaa5",
        "_rev": "_WpvYGJC-_f",
        "nanopub": {
            "id": "a270c0ed-9a22-4237-ad42-4d7cc92bbaa5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r^2=0.92",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "21602271",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "m(HGNC:MIR21)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "miR-21 was upregulated and strongly correlated with SLE disease activity (r(2)=0.92). Compared with controls, CD4 T lymphocytes from patients with SLE had higher basal and activation-induced miR-21 expression. Silencing of miR-21 reversed the activated phenotype of T cells from patients with SLE--namely, enhanced proliferation, interleukin 10 production, CD40L expression and their capacity to drive B cell maturation into Ig-secreting CD19+CD38(hi)IgD-(plasma cells. Overexpression of mMiR-21 in normal T cells led to acquisition of an activated phenotype.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f4c0d81c-801d-4b93-b80e-198bd67b43dd",
        "_rev": "_WpvYGI6--L",
        "nanopub": {
            "id": "f4c0d81c-801d-4b93-b80e-198bd67b43dd",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Immunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"CTLL-2 cell\"",
                    "label": "CTLL-2 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "1996324",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:IL2), ma(GO:\"Receptor Binding\"))",
                    "relation": "increases",
                    "object": "p(HGNC:RAF1, pmod(Ph))"
                }
            ],
            "evidence": "As shown in Fig. 1, stimulation of CTLL-2 cells for 15 min with IL-2 induced increased phosphorylation and retarded mobility of the Raf-1 protein.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "cee2685e-048f-44a2-8a9a-75ee94e2744c",
        "_rev": "_WpvYGJ--Bs",
        "nanopub": {
            "id": "cee2685e-048f-44a2-8a9a-75ee94e2744c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9200453",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL2)\t",
                    "relation": "increases",
                    "object": "p(HGNC:JAK3, pmod(Ph))"
                },
                {
                    "subject": "p(HGNC:IL2)",
                    "relation": "increases",
                    "object": "p(HGNC:JAK1, pmod(Ph))"
                }
            ],
            "evidence": "Western blot analysis of immunoprecipitates from Con A-activated T cells following stimulation with 100 U/mI of IL-2 for 10 min showed an increase in the tyrosine phosphorylation of Jak-1 (Fig. 3A) and Jak-3 kinases (Fig. 3B)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e51d089e-8c3c-4f17-bbaa-449b147159ee",
        "_rev": "_WpvYGJC-BW",
        "nanopub": {
            "id": "e51d089e-8c3c-4f17-bbaa-449b147159ee",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "EFO:Caco-2",
                    "label": "Caco-2",
                    "type": "CellLine"
                },
                {
                    "id": "EFO:HeLa",
                    "label": "HeLa",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "19056931",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Beta-Cryptoxanthin",
                    "relation": "decreases",
                    "object": "a(bp(MESH:\"DNA Damage\"))"
                }
            ],
            "evidence": "Incubation of H(2)O(2)-treated cells with beta-cryptoxanthin led to a doubling of the rate of rejoining of strand breaks and had a similar effect on the rate of removal of oxidized purines by base excision repair.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "75fd970c-ba10-40da-850e-5f8c6c78912a",
        "_rev": "_WpvYGJC-Aw",
        "nanopub": {
            "id": "75fd970c-ba10-40da-850e-5f8c6c78912a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "DO:\"human immunodeficiency virus infectious disease\"",
                    "label": "human immunodeficiency virus infectious disease",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16425129",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL7)",
                    "relation": "decreases",
                    "object": "surf(p(HGNC:IL7R))"
                }
            ],
            "evidence": "Culturing of PBMCs with IL-7 (10ng/mL) resulted in the down-regulation of CD127, but not CD132, within 4\u20135 h.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "60fa2542-fe5f-4720-a950-99f2d0e01eea",
        "_rev": "_WpvYGJC-AA",
        "nanopub": {
            "id": "60fa2542-fe5f-4720-a950-99f2d0e01eea",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.005",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"B cell\"",
                    "label": "B cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8118869",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "decreases",
                    "object": "sec(p(\"IgM\"))"
                }
            ],
            "evidence": "The results presented in Fig. 1 (one of five similar experiments) reveal that IFN-G significantly inhibited LPS-induced IgM secretion even when added as late as 48 hr after culture initiation.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4a3628ba-ec6d-40ee-90a9-c8f656d8ddbf",
        "_rev": "_WpvYGJG-Aq",
        "nanopub": {
            "id": "4a3628ba-ec6d-40ee-90a9-c8f656d8ddbf",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CLO:\"THP-1 cell\"",
                    "label": "THP-1 cell",
                    "type": "CellLine"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Stachowska, Ewa",
                    "Ba\u015bkiewicz-Masiuk, Magdalena",
                    "Dziedziejko, Violetta",
                    "Gutowska, Izabela",
                    "Baranowska-Bosiacka, Irena",
                    "Marchlewicz, Mariola",
                    "Do\u0142egowska, Barbara",
                    "Wiszniewska, Barbara",
                    "Machali\u0144ski, Bogus\u0142aw",
                    "Chlubek, Dariusz"
                ],
                "database": {
                    "id": "18165130",
                    "name": "PubMed"
                },
                "source_name": "Nutrition (Burbank, Los Angeles County, Calif.)",
                "title": "Conjugated linoleic acid increases intracellular ROS synthesis and oxygenation of arachidonic acid in macrophages.",
                "abstract": "Conjugated linoleic acids (CLAs) have potential antiatherosclerotic properties: they may inhibit atherosclerotic processes by reducing the intensity of inflammatory processes. However, in vivo studies have shown that the application of trans-10, cis-12 CLA in obese men increased their oxidative stress. The objective of this study was to determine whether CLA can lead to an increase in oxidative stress and to isoprostane synthesis in macrophages."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"linoleic acid\")",
                    "relation": "increases",
                    "object": "a(MESH:\"Reactive Oxygen Species\")"
                }
            ],
            "evidence": "In cells cultured with CLAs intercellular ROS synthesis increased.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "fd69b667-5632-46f1-9564-a4f7b4c69d89",
        "_rev": "_WpvYGJC-CS",
        "nanopub": {
            "id": "fd69b667-5632-46f1-9564-a4f7b4c69d89",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "Thymidine Incorporation",
                    "type": "Methodology"
                },
                {
                    "id": "EFO:MGC-803",
                    "label": "MGC-803",
                    "type": "CellLine"
                },
                {
                    "id": "CLO:\"U373 MG cell\"",
                    "label": "U373 MG cell",
                    "type": "CellLine"
                },
                {
                    "id": "CLO:\"T98G cell\"",
                    "label": "T98G cell",
                    "type": "CellLine"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18362893",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:FGF5)",
                    "relation": "increases",
                    "object": "path(\"Tumor Proliferation\")"
                }
            ],
            "evidence": ". rFGF5 significantly stimulated GBM cell proliferation in all three cell lines with different potency (Figure 2a).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "aa497812-16f3-43d0-84f7-f18308e30b47",
        "_rev": "_WpvYGJ--Au",
        "nanopub": {
            "id": "aa497812-16f3-43d0-84f7-f18308e30b47",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "DAS28",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "64 RA patients, 25 OA patients",
                    "type": "cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "authors": [
                    "Nielen, Markus M J",
                    "van Schaardenburg, Dirkjan",
                    "Reesink, Henk W",
                    "Twisk, Jos W R",
                    "van de Stadt, Rob J",
                    "van der Horst-Bruinsma, Irene E",
                    "de Gast, Truus",
                    "Habibuw, Moud R",
                    "Vandenbroucke, Jan P",
                    "Dijkmans, Ben A C"
                ],
                "database": {
                    "id": "15334453",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Increased levels of C-reactive protein in serum from blood donors before the onset of rheumatoid arthritis.",
                "abstract": "We previously reported that approximately half of the patients with rheumatoid arthritis (RA) have specific serologic abnormalities (elevated serum concentrations of IgM rheumatoid factor and/or anti-cyclic citrullinated peptide antibodies) starting several years before the onset of symptoms. In this study, the presence of serologic signs of inflammation in patients with preclinical RA was investigated with serial measurements of C-reactive protein (CRP)."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CRP)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:TNF)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:IL12A)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:IL15)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:IL18)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "Significantly higher S and SF levels of all four cytokines and serum CRP values were found in RA patients with high disease activity (DAS 28>5.1) compared to those with mild (DAS 28>3.2) and low disease activity (DAS 28>2.6) (p<0.01). Serum and SF concentrations of all four cytokines positively correlated with DAS 28 index values, i.e., disease activity.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c3f41e8d-59b7-4e88-8088-482c15c52a75",
        "_rev": "_WpvYGJ--B-",
        "nanopub": {
            "id": "c3f41e8d-59b7-4e88-8088-482c15c52a75",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "authors": [
                    "Chaleckis, Romanas",
                    "Murakami, Itsuo",
                    "Takada, Junko",
                    "Kondoh, Hiroshi",
                    "Yanagida, Mitsuhiro"
                ],
                "database": {
                    "id": "27036001",
                    "name": "PubMed"
                },
                "source_name": "Proceedings of the National Academy of Sciences of the United States of America",
                "title": "Individual variability in human blood metabolites identifies age-related differences.",
                "abstract": "Metabolites present in human blood document individual physiological states influenced by genetic, epigenetic, and lifestyle factors. Using high-resolution liquid chromatography-mass spectrometry (LC-MS), we performed nontargeted, quantitative metabolomics analysis in blood of 15 young (29 \u00b1 4 y of age) and 15 elderly (81 \u00b1 7 y of age) individuals. Coefficients of variation (CV = SD/mean) were obtained for 126 blood metabolites of all 30 donors. Fifty-five RBC-enriched metabolites, for which metabolomics studies have been scarce, are highlighted here. We found 14 blood compounds that show remarkable age-related increases or decreases; they include 1,5-anhydroglucitol, dimethyl-guanosine, acetyl-carnosine, carnosine, ophthalmic acid, UDP-acetyl-glucosamine,N-acetyl-arginine,N6-acetyl-lysine, pantothenate, citrulline, leucine, isoleucine, NAD(+), and NADP(+) Six of them are RBC-enriched, suggesting that RBC metabolomics is highly valuable for human aging research. Age differences are partly explained by a decrease in antioxidant production or increasing inefficiency of urea metabolism among the elderly. Pearson's coefficients demonstrated that some age-related compounds are correlated, suggesting that aging affects them concomitantly. Although our CV values are mostly consistent with those CVs previously published, we here report previously unidentified CVs of 51 blood compounds. Compounds having moderate to high CV values (0.4-2.5) are often modified. Compounds having low CV values, such as ATP and glutathione, may be related to various diseases because their concentrations are strictly controlled, and changes in them would compromise health. Thus, human blood is a rich source of information about individual metabolic differences."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:ergothioneine)",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:S-methyl-L-ergothioneine)"
                },
                {
                    "subject": "a(PUBCHEM:\"Nalpha,Nalpha,Nalpha-Trimethyl-L-histidine\")",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:S-methyl-L-ergothioneine)"
                },
                {
                    "subject": "a(PUBCHEM:\"Nalpha,Nalpha,Nalpha-Trimethyl-L-histidine\")",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:ergothioneine)"
                }
            ],
            "evidence": "We first examined whether correlations exist between trimethyl-histidine, ergothioneine, and S-methyl-ergothioneine because they are structurally related and the former two compounds are linked in a biochemical pathway. Abundance of these compounds was very strongly, positively correlated (r2 = 0.81\u223c0.92) (Fig. 2A).",
            "metadata": {
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e88dbaf3-477d-4134-b6c2-cdcac8922ac9",
        "_rev": "_WpvYGJG-_M",
        "nanopub": {
            "id": "e88dbaf3-477d-4134-b6c2-cdcac8922ac9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:FASLG)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "Compared to periods of stable disease, pre-flare periods were marked by increases in soluble TNF-\u03b1 and sFas (nonsignificant) and further increases in TNFRI, TNFRII, FasL, and CD40L (Figure 2E and Supplementary Table 4).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "eabeab0b-bd51-453d-b51e-9ee8678524e1",
        "_rev": "_WpvYGJC--7",
        "nanopub": {
            "id": "eabeab0b-bd51-453d-b51e-9ee8678524e1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "27413244",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Squalene)",
                    "relation": "decreases",
                    "object": "r(HGNC:MMP1)"
                }
            ],
            "evidence": "As shown in Fig. 6A, the incubation with 50 \u0006M of squalene for 18 h caused a significant down-regulation of MMP-1 and MMP-9 gene expression in LPStreated human monocytes\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1c3a73ba-29ca-45b9-b496-0d8ea001eb72",
        "_rev": "_WpvYGI6--3",
        "nanopub": {
            "id": "1c3a73ba-29ca-45b9-b496-0d8ea001eb72",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.0008",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=76",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Immunophlerometry",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "12818406",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "p(HGNC:CRP)"
                }
            ],
            "evidence": "CRP, SAA and IL-6 levels showed a statistically significant reduction after administration of ALA (Table 3).\u00a0\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "54f06fb5-d94b-4296-bb6e-23f223bad902",
        "_rev": "_WpvYGJ--_o",
        "nanopub": {
            "id": "54f06fb5-d94b-4296-bb6e-23f223bad902",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"Leukemia\"",
                    "label": "myeloid leukemia",
                    "type": "Disease"
                },
                {
                    "id": "CLO:\"Raji cell\"",
                    "label": "Raji cell",
                    "type": "CellLine"
                },
                {
                    "id": "CLO:\"JURKAT cell\"",
                    "label": "JURKAT cell",
                    "type": "CellLine"
                },
                {
                    "id": "CLO:\"HL-60 cell\"",
                    "label": "HL-60 cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "authors": [
                    "Pomp\u00e9ia, C",
                    "Cury-Boaventura, M F",
                    "Curi, R"
                ],
                "database": {
                    "id": "14576910",
                    "name": "PubMed"
                },
                "source_name": "Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas",
                "title": "Arachidonic acid triggers an oxidative burst in leukocytes.",
                "abstract": "The change in cellular reducing potential, most likely reflecting an oxidative burst, was investigated in arachidonic acid- (AA) stimulated leukocytes. The cells studied included the human leukemia cell lines HL-60 (undifferentiated and differentiated into macrophage-like and polymorphonuclear-like cells), Jurkat and Raji, and thymocytes and macrophages from rat primary cultures. The oxidative burst was assessed by nitroblue tetrazolium reduction. AA increased the oxidative burst until an optimum AA concentration was reached and the burst decreased thereafter. In the leukemia cell lines, optimum concentration ranged from 200 to 400 microM (up to 16-fold), whereas in rat cells it varied from 10 to 20 microM. Initial rates of superoxide generation were high, decreasing steadily and ceasing about 2 h post-treatment. The continuous presence of AA was not needed to stimulate superoxide generation. It seems that the NADPH oxidase system participates in AA-stimulated superoxide production in these cells since the oxidative burst was stimulated by NADPH and inhibited by N-ethylmaleimide, diphenyleneiodonium and superoxide dismutase. Some of the effects of AA on the oxidative burst may be due to its detergent action. There apparently was no contribution of other superoxide-generating systems such as xanthine-xanthine oxidase, cytochromes p-450 and mitochondrial electron transport chain, as assessed by the use of inhibitors. Eicosanoids and nitric oxide also do not seem to interfere with the AA-stimulated oxidative burst since there was no systematic effect of cyclooxygenase, lipoxygenase or nitric oxide synthase inhibitors, but lipid peroxides may play a role, as indicated by the inhibition of nitroblue tetrazolium reduction promoted by tocopherol."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"arachidonic acid\")",
                    "relation": "increases",
                    "object": "a(CHEBI:superoxide)"
                }
            ],
            "evidence": "AA increased NBT reduction in the leukemia cell lines and in normal rat thymocytes (Figure 1). This effect was more pronounced on HL-60 cells, both undifferentiated and differentiated into PMN-like cells (maximum increases around 16-fold). The human leukemia cell lines, Raji and Jurkat, and normal rat thymocytes showed a less pronounced response (a 2-4-fold increase).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "80b92ddd-66c0-4fe4-b67e-44483f116c64",
        "_rev": "_WpvYGJC-Bw",
        "nanopub": {
            "id": "80b92ddd-66c0-4fe4-b67e-44483f116c64",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Krishnan, Sandeep",
                    "Juang, Yuang-Taung",
                    "Chowdhury, Bhabadeb",
                    "Magilavy, Abigail",
                    "Fisher, Carolyn U",
                    "Nguyen, Hang",
                    "Nambiar, Madhusoodana P",
                    "Kyttaris, Vasileios",
                    "Weinstein, Arthur",
                    "Bahjat, Rena",
                    "Pine, Polly",
                    "Rus, Violeta",
                    "Tsokos, George C"
                ],
                "database": {
                    "id": "19018007",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology (Baltimore, Md. : 1950)",
                "title": "Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells.",
                "abstract": "Diminished expression of TCR zeta and reciprocal up-regulation and association of FcRgamma with the TCR/CD3 complex is a hallmark of systemic lupus erythematosus (SLE) T cells. In this study we explored whether differential molecular associations of the spleen tyrosine kinase Syk that preferentially binds to FcRgamma contribute to pathological amplification of signals downstream of this \"rewired TCR\" in SLE. We detected higher amounts of Syk expression and activity in SLE compared with normal T cells. Selective inhibition of the activity of Syk reduced the strength of TCR-induced calcium responses and slowed the rapid kinetics of actin polymerization exclusively in SLE T cells. Syk and ZAP-70 also associated differently with key molecules involved in cytoskeletal and calcium signaling in SLE T cells. Thus, while Vav-1 and LAT preferentially bound to Syk, phospholipase C-gamma1 bound to both Syk and ZAP-70. Our results show that differential associations of Syk family kinases contribute to the enhanced TCR-induced signaling responses in SLE T cells. Thus, we propose molecular targeting of Syk as a measure to control abnormal T cell responses in SLE."
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:SYK))",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "We detected higher amounts of Syk expression and activity in SLE compared with normal T cells.",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "Diminished expression of TCR zeta and reciprocal up-regulation and association of FcRgamma with the TCR/CD3 complex is a hallmark of systemic lupus erythematosus (SLE) T cells. In this study we explored whether differential molecular associations of the spleen tyrosine kinase Syk that preferentially binds to FcRgamma contribute to pathological amplification of signals downstream of this \"rewired TCR\" in SLE. We detected higher amounts of Syk expression and activity in SLE compared with normal T cells. Selective inhibition of the activity of Syk reduced the strength of TCR-induced calcium responses and slowed the rapid kinetics of actin polymerization exclusively in SLE T cells. Syk and ZAP-70 also associated differently with key molecules involved in cytoskeletal and calcium signaling in SLE T cells. Thus, while Vav-1 and LAT preferentially bound to Syk, phospholipase C-gamma1 bound to both Syk and ZAP-70. Our results show that differential associations of Syk family kinases contribute to the enhanced TCR-induced signaling responses in SLE T cells. Thus, we propose molecular targeting of Syk as a measure to control abnormal T cell responses in SLE.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "70692153-461a-4971-ab5d-f40557f6c513",
        "_rev": "_WpvYGJG--4",
        "nanopub": {
            "id": "70692153-461a-4971-ab5d-f40557f6c513",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.046",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "87 SLE (41 with history of thrombosis)",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12559629",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"IgG anticardiolipin\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:Thrombocytopenia)"
                }
            ],
            "evidence": "Thrombosis was significantly associated with IgG-aPA (p = 0.044), IgG-aPI (p = 0.038), IgG-aPS (p = 0.026), IgG-abeta(2)-GPI, IgM-aPA (p = 0.044), IgM-aPI (p = 0.024), and IgM-aPS (p = 0.01), irrespective of antibody titer, whereas IgG-aCL were associated with thrombosis and thrombocytopenia when taken at medium-high titer (p = 0.009 and p = 0.046, respectively).\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "89f43c83-e3ed-440f-b3b3-45ccc699afe6",
        "_rev": "_WpvYGJ--CD",
        "nanopub": {
            "id": "89f43c83-e3ed-440f-b3b3-45ccc699afe6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "190 SLE, 110 HC",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Denny, Michael F",
                    "Yalavarthi, Srilakshmi",
                    "Zhao, Wenpu",
                    "Thacker, Seth G",
                    "Anderson, Marc",
                    "Sandy, Ashley R",
                    "McCune, W Joseph",
                    "Kaplan, Mariana J"
                ],
                "database": {
                    "id": "20164424",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology (Baltimore, Md. : 1950)",
                "title": "A distinct subset of proinflammatory neutrophils isolated from patients with systemic lupus erythematosus induces vascular damage and synthesizes type I IFNs.",
                "abstract": "Neutrophil-specific genes are abundant in PBMC microarrays from lupus patients because of the presence of low-density granulocytes (LDGs) in mononuclear cell fractions. The functionality and pathogenicity of these LDGs have not been characterized. We developed a technique to purify LDGs from lupus PBMCs and assessed their phenotype, function, and potential role in disease pathogenesis. LDGs, their autologous lupus neutrophils, and healthy control neutrophils were compared with regard to their microbicidal and phagocytic capacities, generation of reactive oxygen species, activation status, inflammatory cytokine profile, and type I IFN expression and signatures. The capacity of LDGs to kill endothelial cells and their antiangiogenic potential were also assessed. LDGs display an activated phenotype, secrete increased levels of type I IFNs, TNF-alpha, and IFN-gamma, but show impaired phagocytic potential. LDGs induce significant endothelial cell cytotoxicity and synthesize sufficient levels of type I IFNs to disrupt the capacity of endothelial progenitor cells to differentiate into mature endothelial cells. LDG depletion restores the functional capacity of endothelial progenitor cells. We conclude that lupus LDGs are proinflammatory and display pathogenic features, including the capacity to synthesize type I IFNs. They may play an important dual role in premature cardiovascular disease development in systemic lupus erythematosus by simultaneously mediating enhanced vascular damage and inhibiting vascular repair."
            },
            "assertions": [
                {
                    "subject": "a(LDGs)\t",
                    "relation": "increases",
                    "object": "p(HGNC:IFNG)"
                },
                {
                    "subject": "a(LDGs)\t",
                    "relation": "increases",
                    "object": "p(HGNC:TNF)"
                }
            ],
            "evidence": "Upon stimulation with PMA, LDGs secreted significantly increased levels of TNF-\u03b1 when compared to healthy control or autologous lupus neutrophils, and of IFN-\u03b3 when compared to control neutrophils (Figure 4D).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7d1d0fb3-04a0-448d-9646-a29cbb0065de",
        "_rev": "_WpvYGJG-BX",
        "nanopub": {
            "id": "7d1d0fb3-04a0-448d-9646-a29cbb0065de",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "95 SLE,\u00a024 HC",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "microarray and QRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "comments": "Multiple analyses were performed to select the 21-gene panel whose genes are inducible by IFN treatment, overexpressed in SLE patients and neutralized by anti-IFNa\u00a0mAb (see Figure 7).\n",
                "database": {
                    "id": "20948567",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(EG:26010)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:PLSCR1)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:RTP4)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:OAS2)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:IFIT3)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:EPSTI1)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:LAMP3)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:MX1)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:HERC5)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:OAS3)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:IFIT1)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:ISG15)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:SIGLEC1)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:OAS1)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:LY6E)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:USP18)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:IFI44L)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:IFI44)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:RSAD2)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:IFI6)"
                },
                {
                    "subject": "p(MESH:\"Interferon Type 1\")",
                    "relation": "increases",
                    "object": "r(HGNC:IFI27)"
                }
            ],
            "evidence": "77 transcripts were common to this list of 161 transcripts (identified in the neutralization experiments) and the previously determined list of 110 transcripts (identified to be overexpressed in WB of 41 SLE patients). These transcripts are both IFN-\u03b1/\u03b2-inducible and can be neutralized by an anti-IFN-\u03b1 mAb. Each of the 77 transcripts was ranked by the average fold-change magnitude across all SLE patients and the percentage of patients displaying a change \u22652 folds. The 21 most prevalently overexpressed IFN-\u03b1/\u03b2-inducible genes (that represent unique genes using the NetAffx annotation file for the Affymetrix U133v2.0 plus array; ESTs were excluded) from this ranking were selected as candidate PD markers for anti-IFN-\u03b1 therapy in SLE.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "project": "Lupus Interferon Signatures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a3ca982a-d523-4252-bae4-2a76f2e86c4a",
        "_rev": "_WpvYGJ--BI",
        "nanopub": {
            "id": "a3ca982a-d523-4252-bae4-2a76f2e86c4a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "22 pediatric SLE patients, 17 HC",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Guo, Yanyan",
                    "Chai, Qinghe",
                    "Zhao, Yun",
                    "Li, Peng",
                    "Qiao, Jie",
                    "Huang, Jianping"
                ],
                "comments": "pediatric SLE",
                "database": {
                    "id": "26884963",
                    "name": "PubMed"
                },
                "source_name": "International journal of clinical and experimental medicine",
                "title": "Increased activation of toll-like receptors-7 and -8 of peripheral blood mononuclear cells and upregulated serum cytokines in patients with pediatric systemic lupus erythematosus.",
                "abstract": "Autoimmune disease systemic lupus erythematosus (SLE) is associated with increased expression of pro-inflammatory cytokines such as interferons (IFNs) and specific interleukins (ILs), which are induced by toll-like receptors (TLRs). The present study aimed to examine the serum levels of cytokines, the activation of TLR-7 and TLR-8 of peripheral blood mononuclear cells (PBMCs) from pediatric SLE patients, and to investigate the response of those PBMCs to viral RNA via the TLR-7 and TLR-8 signaling. Results demonstrated that pediatric SLE patients had increased serum concentrations of interleukin (IL)-1\u03b2, IL-6, IL-8, IL-10, and IFN-\u03b1, and promoted activation of TLR-7 and TLR-8, compared to control subjects. Moreover, the peripheral blood mononuclear cells (PBMCs) from pediatric SLE patients were more sensitive to the stimulation by the transfection with viral RNA from influenza virus, with a promoted activation of TLR-7 and TLR-8 signaling. In conclusion, pro-inflammatory cytokines, such as IL-1\u03b2, IL-6, IL-8, IL-10, and IFN-\u03b1 were promoted in pediatric SLE patients, with an increased activation of TLR-7 and TLR-8 to the stimuli, such as virus infection. It implies the TLR-7 and TLR-8 activation by virus infection might play an important role in the pathogenesis of pediatric SLE."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL8)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Systemic lupus erythematosus\")"
                },
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Systemic lupus erythematosus\")"
                },
                {
                    "subject": "p(HGNC:IL1B)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Systemic lupus erythematosus\")"
                },
                {
                    "subject": "p(HGNC:IFNA1)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Systemic lupus erythematosus\")"
                }
            ],
            "evidence": "the serum level of IL-1\u03b2 was 1.599 \u00b1 0.1957 ng/mL in pediatric SLE patients, significantly higher than 1.110 \u00b1 0.07064 ng/mL (P<0.05) in normal subjects. And the serum levels of IL-6, IFN-\u03b1 and IL-8 were also significantly higher in pediatric SLE patients, than in normal subjects (4.272 \u00b1 0.4222 ng/mL vs 2.848 \u00b1 0.2344 ng/mL for IL-6 with a p value of 0.0099, 3.597 \u00b1 0.3220 ng/mL vs 1.917 \u00b1 0.1908 ng/mL for IFN-\u03b1, with a p value of 0.0002, and 14.55 \u00b1 1.873 vs 3.944 \u00b1 0.3602 for IL-8, with a p value of less than 0.0001).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "80c892cc-4ed8-4ede-b493-df7861ba5bdb",
        "_rev": "_WpvYGJC-Bz",
        "nanopub": {
            "id": "80c892cc-4ed8-4ede-b493-df7861ba5bdb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16220542",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Arthritis, Rheumatoid\")\t",
                    "relation": "positiveCorrelation",
                    "object": "surf(p(HGNC:RANKL))"
                },
                {
                    "subject": "path(MESH:\"Arthritis, Rheumatoid\")",
                    "relation": "positiveCorrelation",
                    "object": "sec(p(HGNC:IFNG)"
                }
            ],
            "evidence": "the ratio of CD4+ T cells expressing both IFN-c and RANKL was significantly higher in patients with RA than those with OA (28.4 9.3% vs. 21.1 7.6%, p=0.0064) (Fig. 5B).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e29c88f6-104c-4665-a07b-87566d031a0a",
        "_rev": "_WpvYGJC-_1",
        "nanopub": {
            "id": "e29c88f6-104c-4665-a07b-87566d031a0a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "36 SLE patients and 42 healthy controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "p=0.009",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "BILAG",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "22549432",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:N-acetyl-L-cysteine)",
                    "relation": "decreases",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Considered together, 2.4 gm and 4.8 gm NAC reduced the SLEDAI score after 1 month (P = 0.0007), 2 months (P = 0.0009), 3 months (P = 0.0030), and 4 months (P = 0.0046); the BILAG score after 1 month (P = 0.029) and 3 months (P = 0.009); and the FAS score after 2 months (P = 0.0006) and 3 months (P = 0.005).\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c849d368-ce28-4103-a5d2-5c2315de74aa",
        "_rev": "_WpvYGJ--_W",
        "nanopub": {
            "id": "c849d368-ce28-4103-a5d2-5c2315de74aa",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SELENA-SLEDAI Flare Score",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "0.02",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "48 SLE, 48 matched HC, 22 rheumatic disease controls",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "16947629",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:ISG15)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "r(HGNC:MX1)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "r(HGNC:OASL)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "r(HGNC:OAS1)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "r(HGNC:LY6E)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "\"When disease activity was defined as stable, mild/moderate flare, or severe flare according to the\nSELENA-SLEDAI flare system (34), we found that patients with severe flares had higher IFN scores than did patients with mild/moderate flares (P  0.02) or those without flare (P  0.02) (Figure 2C). \"\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c365c95f-2593-4151-b60c-0fdbdf66cb69",
        "_rev": "_WpvYGJC--o",
        "nanopub": {
            "id": "c365c95f-2593-4151-b60c-0fdbdf66cb69",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "R\u00f6nnblom, Lars",
                    "Elkon, Keith B"
                ],
                "database": {
                    "id": "20440285",
                    "name": "PubMed"
                },
                "source_name": "Nature reviews. Rheumatology",
                "title": "Cytokines as therapeutic targets in SLE.",
                "abstract": "Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease involving most immune cells. Studies in both experimental animal models of lupus and patients with SLE have revealed a number of cytokine pathways that are important in the disease process. Among these are B-cell activating factor, which promotes B-cell survival and autoantibody production, interferon-alpha, which acts as an immune adjuvant, and tumor necrosis factor, which contributes to organ inflammation. This knowledge, in combination with the successful use of anti-TNF treatment in rheumatoid arthritis, has spurred the development of several biologic agents targeting different cytokines or their receptors in SLE. Consequently, many trials of anticytokine therapies for SLE are underway. Although most of these trials are small or in early phases, the results of some large studies have also been reported. In this Review, we discuss the rationale for anticytokine therapies in SLE and review agents currently in use, and those being developed and tested experimentally. We present the results from published trials and discuss the tentative conclusions that can be drawn regarding the efficacy of the new agents. Finally, we provide suggestions for the future of treatment for SLE, including new therapeutic strategies.",
                "date_published": "2010-06-01"
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNFSF13B)",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "Figure 1 of paper",
            "metadata": {
                "": "SLE model innate immunity",
                "gd:abstract": "Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease involving most immune cells. Studies in both experimental animal models of lupus and patients with SLE have revealed a number of cytokine pathways that are important in the disease process. Among these are B-cell activating factor, which promotes B-cell survival and autoantibody production, interferon-alpha, which acts as an immune adjuvant, and tumor necrosis factor, which contributes to organ inflammation. This knowledge, in combination with the successful use of anti-TNF treatment in rheumatoid arthritis, has spurred the development of several biologic agents targeting different cytokines or their receptors in SLE. Consequently, many trials of anticytokine therapies for SLE are underway. Although most of these trials are small or in early phases, the results of some large studies have also been reported. In this Review, we discuss the rationale for anticytokine therapies in SLE and review agents currently in use, and those being developed and tested experimentally. We present the results from published trials and discuss the tentative conclusions that can be drawn regarding the efficacy of the new agents. Finally, we provide suggestions for the future of treatment for SLE, including new therapeutic strategies.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "23b05eb9-fcc3-4adc-ba5d-c8083fb23395",
        "_rev": "_WpvYGJ---0",
        "nanopub": {
            "id": "23b05eb9-fcc3-4adc-ba5d-c8083fb23395",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "23997720",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Betaine)",
                    "relation": "decreases",
                    "object": "a(CHEBI:L-homocysteine)"
                }
            ],
            "evidence": "Betaine's effect on plasma homocysteine illustrates that all 5 trials presented with an intervention-related trend toward a reduction in homocysteine, with 4 of the 5 showing statistically significant reductions (P\u00a0< .05) in plasma homocysteine when compared with the control group (Fig\u00a02).\u00a0\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c1675f94-3ed1-4963-8032-93c46bd820f9",
        "_rev": "_WpvYGJG-_j",
        "nanopub": {
            "id": "c1675f94-3ed1-4963-8032-93c46bd820f9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "SELENA-SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "48 SLE, 48 matched HC, 22 rheumatic disease controls",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "16947629",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:LY6E)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "LY6E expression, the highest among the 5 tested genes correlating with IFN scores (r =0.91), also showed an association with SLEDAI scores (P =0.001) and physician\u2019s global assessment scores (P  0.005) (Figures 2D and E).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e88718ea-013d-41f6-a69f-fa4ab796f40f",
        "_rev": "_WpvYGJC-Ac",
        "nanopub": {
            "id": "e88718ea-013d-41f6-a69f-fa4ab796f40f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "n=17",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "Bioplex Suspension Array",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Hypertriglyceridemia",
                    "label": "Hypertriglyceridemia",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "19158225",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fish Oils\")\t",
                    "relation": "decreases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "p(HGNC:CSF2)"
                }
            ],
            "evidence": "DHA supplementation for 91 d decreased the concentrations of GM-CSF and IL-6 by \u223c20% and tended to decrease that of G-CSF (P\u00a0= 0.18); concentrations of these markers did not change in the placebo group (Fig. 2).\u00a0\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6e0b3f97-7b1f-4471-9ccd-0f89337695b4",
        "_rev": "_WpvYGJ---S",
        "nanopub": {
            "id": "6e0b3f97-7b1f-4471-9ccd-0f89337695b4",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.044",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "87 SLE (41 with history of thrombosis)",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "12559629",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"IgG antiphosphatidic acid\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Thrombosis\")"
                }
            ],
            "evidence": "Thrombosis was significantly associated with IgG-aPA (p = 0.044), IgG-aPI (p = 0.038), IgG-aPS (p = 0.026), IgG-abeta(2)-GPI, IgM-aPA (p = 0.044), IgM-aPI (p = 0.024), and IgM-aPS (p = 0.01), irrespective of antibody titer, whereas IgG-aCL were associated with thrombosis and thrombocytopenia when taken at medium-high titer (p = 0.009 and p = 0.046, respectively).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b6e5436c-1213-4182-a530-844b95cbb782",
        "_rev": "_WpvYGJG--3",
        "nanopub": {
            "id": "b6e5436c-1213-4182-a530-844b95cbb782",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Moore, K P",
                    "Darley-Usmar, V",
                    "Morrow, J",
                    "Roberts, L J"
                ],
                "database": {
                    "id": "7614720",
                    "name": "PubMed"
                },
                "source_name": "Circulation research",
                "title": "Formation of F2-isoprostanes during oxidation of human low-density lipoprotein and plasma by peroxynitrite.",
                "abstract": "F2-Isoprostanes are novel bioactive prostaglandin F2-like compounds produced by nonenzymatic free radical-catalyzed peroxidation of arachidonic acid. F2-Isoprostanes are initially formed in situ on phospholipids and subsequently released. Quantification of the F2-isoprostanes has been found to represent a valuable and reliable marker of lipid peroxidation. Oxidative modification of low-density lipoprotein (LDL) is a key process for the recognition of LDL by the scavenger receptors on macrophages. The oxidative mechanism responsible for the modification of LDL in vivo remains unclear, but an attractive candidate is the powerful oxidant peroxynitrite, which can be formed by reaction of nitric oxide and superoxide in the vessel wall. To further explore the potential role of peroxynitrite in the oxidative modification of plasma lipids, we investigated whether incubation of LDL and plasma with peroxynitrite or SIN-1, which decomposes to form nitric oxide and superoxide, catalyzes the formation of F2-isoprostanes. Incubation of LDL with peroxynitrite (0.125 to 1 mmol/L) or SIN-1 (0.5 and 1 mmol/L) induced a concentration-dependent increase in the formation of F2-isoprostanes, reaching a maximum of 5.5 +/- 2.05-fold (SEM) and 18.2 +/- 4.0-fold above control values, respectively. The increase of F2-isoprostanes induced by SIN-1 was essentially completely inhibited by superoxide dismutase. Incubation of plasma with peroxynitrite or SIN-1 yielded similar results. These results indicate that peroxynitrite can induce the formation of F2-isoprostanes in lipoproteins. Since F2-isoprostanes can exert potent biological activity such as vasoconstriction, they may contribute to the vascular pathobiology associated with atherosclerosis."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:SOD1)",
                    "relation": "decreases",
                    "object": "a(MESH:F2-Isoprostanes)"
                }
            ],
            "evidence": "The formation of F2-isoprostanes by SIN-1 was inhibited by coincubation with SOD (100 U/mL).\n",
            "metadata": {
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "653cbb32-be25-4af2-b70d-7af947a364e2",
        "_rev": "_WpvYGJG--F",
        "nanopub": {
            "id": "653cbb32-be25-4af2-b70d-7af947a364e2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=8",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Muscle, Skeletal\"",
                    "label": "Muscle, Skeletal",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "24476467",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Exercise\")",
                    "relation": "positiveCorrelation",
                    "object": "r(SP:P19438)"
                }
            ],
            "evidence": "TNF-R1 mRNA expression (Fig. 3C) increased at 1 h postexercise after AE (1.7 \u00b1 0.1; p < 0.05 vs. CE) and RE (1.5 \u00b1 0.2) (p < 0.05), though not after CE (p > 0.05). T\n",
            "metadata": {
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1715ea07-fc68-443d-b49f-9e9e9f8e38ef",
        "_rev": "_WpvYGJC-AB",
        "nanopub": {
            "id": "1715ea07-fc68-443d-b49f-9e9e9f8e38ef",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Immunoblot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12594853",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TYK2, pmod(Ph))",
                    "relation": "increases",
                    "object": "p(HGNC:STAT3, pmod(Ph))"
                },
                {
                    "subject": "p(HGNC:TYK2, pmod(Ph))",
                    "relation": "increases",
                    "object": "p(HGNC:STAT4, pmod(Ph))"
                }
            ],
            "evidence": "A1 but not B42 inhibited STAT4/STAT3 phosphorylation and IFN- +production following IL-12 stimulation.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b9562c02-3645-4394-9eb7-fda86e201dae",
        "_rev": "_WpvYGJC-As",
        "nanopub": {
            "id": "b9562c02-3645-4394-9eb7-fda86e201dae",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:\"type 2 diabetes mellitus\"",
                    "label": "type 2 diabetes mellitus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17151862",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "\tp(HGNC:BDNF)",
                    "relation": "association",
                    "object": "path(MESH:\"Glucose Intolerance\")"
                },
                {
                    "subject": "p(HGNC:BDNF)",
                    "relation": "association",
                    "object": "path(DO:obesity)"
                }
            ],
            "evidence": "A significant effect of glycaemia group (p\u2009<\u20090.0001) and of obesity (p\u2009=\u20090.02) on plasma BDNF concentrations was observed\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9974d867-4d32-4e3e-8d87-48f51c55e841",
        "_rev": "_WpvYGJG--L",
        "nanopub": {
            "id": "9974d867-4d32-4e3e-8d87-48f51c55e841",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:obesity",
                    "label": "obesity",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8574277",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"procollagen Type III-N-terminal peptide\")",
                    "relation": "positiveCorrelation",
                    "object": "bp(MESH:\"Weight Loss\")"
                },
                {
                    "subject": "a(MESH:\"Fasting\")",
                    "relation": "decreases",
                    "object": "a(MESH:\"procollagen Type III-N-terminal peptide\")"
                }
            ],
            "evidence": "",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a4208d23-ca20-4de5-b52c-2541a23c6b42",
        "_rev": "_WpvYGJC-CL",
        "nanopub": {
            "id": "a4208d23-ca20-4de5-b52c-2541a23c6b42",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"embryonic fibroblast\"",
                    "label": "embryonic fibroblast",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10748240",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TRAF6)",
                    "relation": "increases",
                    "object": "tloc(complex(HGNC:\"NFKB Complex\"), fromloc(GOCC:\"Cytoplasm\"), toloc(GOCC:\"Nucleus\"))"
                },
                {
                    "subject": "p(HGNC:TRAF6)",
                    "relation": "association",
                    "object": "act(p(HGNC:IL17), ma(GO:\"Receptor Signalling\"))"
                }
            ],
            "evidence": "In wild-type cells, NF-\u03baB activation was detected 10 min after IL-17 treatment, followed by a continued increase up to 40 min (Fig. 1\u00a0A). Similar results were obtained with heterozygous EF cells (TRAF6+/\u2212; data not shown). However, in TRAF6\u2212/\u2212cells, no NF-\u03baB activation was detected within the time frame examined.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a0a638f5-c5e0-4aa5-842e-541ee1fb03b2",
        "_rev": "_WpvYGI6--E",
        "nanopub": {
            "id": "a0a638f5-c5e0-4aa5-842e-541ee1fb03b2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "MESH:Hypertriglyceridemia",
                    "label": "Hypertriglyceridemia",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "19158225",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "DHA supplementation for 91 d decreased the concentrations of GM-CSF and IL-6 by \u223c20% and tended to decrease that of G-CSF (P\u00a0= 0.18); concentrations of these markers did not change in the placebo group (Fig. 2).\u00a0\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e15308a2-2fd0-43c0-9581-fbb43e75219d",
        "_rev": "_WpvYGJ--__",
        "nanopub": {
            "id": "e15308a2-2fd0-43c0-9581-fbb43e75219d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Hashizume, M",
                    "Hayakawa, N",
                    "Mihara, M"
                ],
                "comments": "HGNC:TNFSF11= RANKL",
                "database": {
                    "id": "18786965",
                    "name": "PubMed"
                },
                "source_name": "Rheumatology (Oxford, England)",
                "title": "IL-6 trans-signalling directly induces RANKL on fibroblast-like synovial cells and is involved in RANKL induction by TNF-alpha and IL-17.",
                "abstract": "We investigated the influence of cytokines on the expression of RANK ligand (RANKL) in fibroblast-like synoviocytes from RA patients (RA-FLS)."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT3)",
                    "relation": "increases",
                    "object": "p(HGNC:TNFSF11)"
                },
                {
                    "subject": "p(HGNC:IL17A)",
                    "relation": "increases",
                    "object": "p(HGNC:TNFSF11)"
                },
                {
                    "subject": "p(HGNC:TNF)",
                    "relation": "increases",
                    "object": "p(HGNC:TNFSF11)"
                }
            ],
            "evidence": "Janus kinase/STAT pathway is involved in RANKL expressionStimulation with IL-6/sIL-6R-induced STAT3 and ERK1/2 phosphorylation, and induction of these phosphorylations was completely inhibited by PAR and PD, respectively (Fig. 6A). The inhibition of STAT3 and ERK1/2 phosphorylation was not due to decreased expression of STAT and ERK, however, because PAR and PD did not cause a decrease in STAT or ERK protein content (data not shown). IL-6/sIL-6R complex-induced RANKL expression was completely inhibited by PAR, but was not affected by PD (Fig. 6B).",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "We investigated the influence of cytokines on the expression of RANK ligand (RANKL) in fibroblast-like synoviocytes from RA patients (RA-FLS).",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1c163236-803f-48c1-be13-89fbf3d66668",
        "_rev": "_WpvYGJC-Au",
        "nanopub": {
            "id": "1c163236-803f-48c1-be13-89fbf3d66668",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "12 VKH patients, 20 controlled",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "FCM",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"dendritic cell\"",
                    "label": "dendritic cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "23482469",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:berberine)",
                    "relation": "decreases",
                    "object": "surf(p(HGNC:CD40))"
                }
            ],
            "evidence": "BBR also suppressed the expression of costimulatory molecules in DCs, which is in agreement with earlier findings in animals, which showed that BBR was able to downregulate the expression of CD80 and CD86 in mouse DCs stimulated by LPS.\u00a0\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "841444a2-5120-4d9f-8f0d-3a9eff0601cf",
        "_rev": "_WpvYGJ--Ce",
        "nanopub": {
            "id": "841444a2-5120-4d9f-8f0d-3a9eff0601cf",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "VAS-Fatigue",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "GC-MS",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "p=0.008",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "Seventy-one SLE patients with low disease activity (mean SLEDAI\u2009=\u20091.62 standard error (SE) 0.37, range 0-8) were compared to 51 controls",
                    "type": "Cohort"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "22508802",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:F2-Isoprostanes)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Fatigue\")"
                }
            ],
            "evidence": "F(2)-isoprostane was higher in SLE patients with fatigue compared to not-fatigued SLE subjects (p\u2009=\u2009.0076) who were otherwise similar in ethnicity, disease activity and cardiovascular risk factors. Plasma F(2)-isoprostane was strongly correlated with FSS and Profile of Somatic Fatigue (Prof-S) (p\u2009<\u2009.0001), VAS fatigue (p\u2009=\u2009.005), CES-D (p\u2009=\u2009.008) and with BMI (p\u2009=\u2009.0001.) In a multivariate model, F(2)-isoprostane was a significant predictor of FSS after adjustment for age, BMI, pain and depression (p\u2009=\u2009.0002).\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ce898c0f-ee21-43e1-8379-c39c738c552c",
        "_rev": "_WpvYGJG--R",
        "nanopub": {
            "id": "ce898c0f-ee21-43e1-8379-c39c738c552c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "BILAG",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "70 SLE patients and 20 healthy controls",
                    "type": "Cohort"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "28502135",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNFSF10)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Estimated serum sTRAIL, TNF-\u03b1 and IL-6 levels showed positive significant correlation with calculated BILAG activity score, while estimated serum IL-10 levels showed negative significant correlation with activity score.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8809c90d-4818-4b34-9656-17639b6284b6",
        "_rev": "_WpvYGJG-Ak",
        "nanopub": {
            "id": "8809c90d-4818-4b34-9656-17639b6284b6",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "32 healthy donors",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:monocyte",
                    "label": "monocyte",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9531313",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:IL17), ma (GO:\"Receptor binding\")",
                    "relation": "association",
                    "object": "p(HGNC:PKA)"
                }
            ],
            "evidence": "The cAMP protein kinase (PKA) inhibitor KT-5720 (2 \u03bcM) suppressed the stimulatory effects of IL-17 in terms of TNF-\u03b1 release by 96.5% (p\u00a0< 0.003,\u00a0n\u00a0= 4)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bebf4171-a29c-43da-a02c-6b64da2675dc",
        "_rev": "_WpvYGJC--g",
        "nanopub": {
            "id": "bebf4171-a29c-43da-a02c-6b64da2675dc",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": ">0.80",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "discovery (14 active/inactive LN, 8 HC) and validation (28 active/inactive LN, 9 HC)",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "27211902",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Angiostatins)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                }
            ],
            "evidence": "Most importantly, four serum proteins (AXL, Ferritin, Angiostatin, and sTNFRII) had the capacity to distinguish active LN from inactive disease with ROC AUC exceeding 80%, all with p < 0.01 significance (Table 3).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "35ac3ced-9312-4824-8f43-fb60c4965038",
        "_rev": "_WpvYGJ--_Z",
        "nanopub": {
            "id": "35ac3ced-9312-4824-8f43-fb60c4965038",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "14 women",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Commercial Kit",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "8530611",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Fasting\")",
                    "relation": "decreases",
                    "object": "bp(GO:\"bone formation\")"
                }
            ],
            "evidence": "Serum OC and PICP, markers of bone formation, decreased significantly after 4 days of fasting in both treatment groups\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "99a97db4-0ca1-4c90-85d3-04a4a119f458",
        "_rev": "_WpvYGJC-B3",
        "nanopub": {
            "id": "99a97db4-0ca1-4c90-85d3-04a4a119f458",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "OR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "n=144 patients",
                    "type": "Cohort"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "authors": [
                    "Zautra, Alex J",
                    "Davis, Mary C",
                    "Reich, John W",
                    "Nicassario, Perry",
                    "Tennen, Howard",
                    "Finan, Patrick",
                    "Kratz, Anna",
                    "Parrish, Brendt",
                    "Irwin, Michael R"
                ],
                "database": {
                    "id": "18540734",
                    "name": "PubMed"
                },
                "source_name": "Journal of consulting and clinical psychology",
                "title": "Comparison of cognitive behavioral and mindfulness meditation interventions on adaptation to rheumatoid arthritis for patients with and without history of recurrent depression.",
                "abstract": "This research examined whether cognitive behavioral therapy and mindfulness interventions that target responses to chronic stress, pain, and depression reduce pain and improve the quality of everyday life for adults with rheumatoid arthritis (RA). The 144 RA participants were clustered into groups of 6-10 participants and randomly assigned to 1 of 3 treatments: cognitive behavioral therapy for pain (P); mindfulness meditation and emotion regulation therapy (M); or education-only group (E), which served as an attention placebo control. The authors took a multimethod approach, employing daily diaries and laboratory assessment of pain and mitogen-stimulated levels of interleukin-6 (IL-6), a proinflammatory cytokine. Participants receiving P showed the greatest Pre to Post improvement in self-reported pain control and reductions in the IL-6; both P and M groups showed more improvement in coping efficacy than did the E group. The relative value of the treatments varied as a function of depression history. RA patients with recurrent depression benefited most from M across several measures, including negative and positive affect and physicians' ratings of joint tenderness, indicating that the emotion regulation aspects of that treatment were most beneficial to those with chronic depressive features."
            },
            "assertions": [
                {
                    "subject": "a(\"Mindfulness Meditation\")",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Arthiritis, Rheumatoid\")"
                }
            ],
            "evidence": "An analysis of physicians\u2019 ratings of tenderness revealed a time effect, F(1, 605) \u0001 26.72, p \u0005 .001, with lower tenderness ratings from Pre to Post across the board, and significant Group \u0004 Time, F(2, 605) \u0001 16.93, p \u0005 .05\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true,
                "gd:abstract": "This research examined whether cognitive behavioral therapy and mindfulness interventions that target responses to chronic stress, pain, and depression reduce pain and improve the quality of everyday life for adults with rheumatoid arthritis (RA). The 144 RA participants were clustered into groups of 6-10 participants and randomly assigned to 1 of 3 treatments: cognitive behavioral therapy for pain (P); mindfulness meditation and emotion regulation therapy (M); or education-only group (E), which served as an attention placebo control. The authors took a multimethod approach, employing daily diaries and laboratory assessment of pain and mitogen-stimulated levels of interleukin-6 (IL-6), a proinflammatory cytokine. Participants receiving P showed the greatest Pre to Post improvement in self-reported pain control and reductions in the IL-6; both P and M groups showed more improvement in coping efficacy than did the E group. The relative value of the treatments varied as a function of depression history. RA patients with recurrent depression benefited most from M across several measures, including negative and positive affect and physicians' ratings of joint tenderness, indicating that the emotion regulation aspects of that treatment were most beneficial to those with chronic depressive features."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "db2a618f-d436-4034-b35c-933a518c31a4",
        "_rev": "_WpvYGJ--BP",
        "nanopub": {
            "id": "db2a618f-d436-4034-b35c-933a518c31a4",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"Human Umbilical Vein Endothelial Cells\"",
                    "label": "Human Umbilical Vein Endothelial Cells",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Wen, Ya-Dan",
                    "Wang, Hong",
                    "Kho, Sok-Hong",
                    "Rinkiko, Suguro",
                    "Sheng, Xiong",
                    "Shen, Han-Ming",
                    "Zhu, Yi-Zhun"
                ],
                "database": {
                    "id": "23393548",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress.",
                "abstract": "Hydrogen sulfide (H\u2082S) has been shown to have cytoprotective effects in models of hypertension, ischemia/reperfusion and Alzheimer's disease. However, little is known about its effects or mechanisms of action in atherosclerosis. Therefore, in the current study we evaluated the pharmacological effects of H\u2082S on antioxidant defenses and mitochondria protection against hydrogen peroxide (H\u2082O\u2082) induced endothelial cells damage."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Hydrogen Peroxide\")",
                    "relation": "increases",
                    "object": "a(MESH:\"Reactive Oxygen Species\")"
                }
            ],
            "evidence": "Administration of H2O2 induced an increase in the fluorescence intensity of H2DCFDA, as compared to the control group (P<0.05). Pre-incubation with NaHS inhibited the levels of ROS induced by H2O2 (P<0.05).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "35b28d0f-32ef-427a-920e-b09ca8bd1124",
        "_rev": "_WpvYGI6--b",
        "nanopub": {
            "id": "35b28d0f-32ef-427a-920e-b09ca8bd1124",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17884812",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT3)",
                    "relation": "increases",
                    "object": "r(HGNC:IL17)"
                }
            ],
            "evidence": ". Indeed, Stat3-deficient T cells cultured under standard Th17 conditions failed to produce IL-17 mRNA or protein (see below).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "61e5766c-0022-4513-99f2-b7bfa75e7bf0",
        "_rev": "_WpvYGJ---A",
        "nanopub": {
            "id": "61e5766c-0022-4513-99f2-b7bfa75e7bf0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "43 RA patients, 14 age/sex matched HC",
                    "type": "cohort"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "erythrocyte sedimentation rate",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Pandya, Jayesh M",
                    "Lundell, Anna-Carin",
                    "Andersson, Kerstin",
                    "Nordstr\u00f6m, Inger",
                    "Theander, Elke",
                    "Rudin, Anna"
                ],
                "database": {
                    "id": "28148302",
                    "name": "PubMed"
                },
                "source_name": "Arthritis research & therapy",
                "title": "Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker.",
                "abstract": "We have recently analyzed the profile of T-cell subtypes based on chemokine receptor expression in blood from untreated early rheumatoid arthritis (ueRA) patients compared to healthy controls (HC). Here, we compared the levels of the respective chemokines in blood plasma of ueRA patients with those of HC. We also studied the association of chemokine levels with the proportions of circulating T-cell subsets and the clinical disease activity."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CXCL10)\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "CXCL10 correlated with multiple disease activity measures, including DAS28-CRP, DAS28-ESR, CDAI, SJC in 66 joints, CRP, and ESR.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "We have recently analyzed the profile of T-cell subtypes based on chemokine receptor expression in blood from untreated early rheumatoid arthritis (ueRA) patients compared to healthy controls (HC). Here, we compared the levels of the respective chemokines in blood plasma of ueRA patients with those of HC. We also studied the association of chemokine levels with the proportions of circulating T-cell subsets and the clinical disease activity.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9526cd15-7e24-416e-8e70-e80355474bac",
        "_rev": "_WpvYGJG-_H",
        "nanopub": {
            "id": "9526cd15-7e24-416e-8e70-e80355474bac",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "MESH:D009504",
                    "label": "Neutrophils",
                    "type": "Anatomy;Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Carr, A C",
                    "Winterbourn, C C"
                ],
                "database": {
                    "id": "9355763",
                    "name": "PubMed"
                },
                "source_name": "The Biochemical journal",
                "title": "Oxidation of neutrophil glutathione and protein thiols by myeloperoxidase-derived hypochlorous acid.",
                "abstract": "Neutrophils, when stimulated, generate reactive oxygen species including myeloperoxidase-derived HOCl. There is an associated decrease in reduced glutathione (GSH) concentration. We have shown that neutrophil GSH levels decrease on exposure to reagent HOCl, whereas the equivalent concentration of H2O2 had no effect. GSH loss occurred without cell lysis, was not reversible, and was accompanied by the loss of an equivalent proportion of the total protein thiols. No glutathione disulphide was formed. Studies with 35S-labelled cells indicated that much of the GSH lost was accounted for by mixed disulphides with protein and a product that co-migrated on HPLC with a novel compound formed in the reaction of HOCl and pure GSH. The properties of this compound are consistent with an intramolecular sulphonamide. Neutrophils stimulated with PMA lost 30-40% of their GSH and a similar proportion of protein thiols. Little glutathione disulphide was formed and the products were the same as seen with HOCl-treated cells. From the results and studies with inhibitors and scavengers, we conclude that HOCl was responsible for the GSH loss. Propargylglycine and buthionine sulphoximine, inhibitors of glutathione synthesis, enhanced GSH loss, but their effects were due to the production of long-lived chloramines that oxidized GSH with greater efficiency than HOCl, rather than to the inhibition of GSH synthesis. The lack of thiol selectivity by HOCl and irreversibility of oxidation means that GSH will provide limited antioxidant protection for thiol enzymes in stimulated neutrophils."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"hypochlorous acid\")",
                    "relation": "increases",
                    "object": "a(CHEBI:\"glutathione disulfide\")"
                }
            ],
            "evidence": "As shown previously[13], the oxidation of pure GSH by HOCl gives two novel products as well as GSSG (Figure 4A).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d5b5b304-54ab-413e-9c03-626e05f29afa",
        "_rev": "_WpvYGJG-A-",
        "nanopub": {
            "id": "d5b5b304-54ab-413e-9c03-626e05f29afa",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "418 SLE or APS patients",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "authors": [
                    "Danowski, Adriana",
                    "Kickler, Thomas S",
                    "Petri, Michelle"
                ],
                "comments": "no full text",
                "database": {
                    "id": "16960938",
                    "name": "PubMed"
                },
                "source_name": "The Journal of rheumatology",
                "title": "Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.",
                "abstract": "Antibodies to beta2-glycoprotein I (anti-beta2-GPI) are found in a large percentage of patients with primary or secondary antiphospholipid syndrome (APS). Our aim was to identify the prevalence and clinical correlation of these antibodies in patients with APS and systemic lupus erythematosus (SLE), in comparison to anticardiolipin (aCL) and the lupus anticoagulant (LAC). We investigated whether serial samples improve clinical utility."
            },
            "assertions": [
                {
                    "subject": "p(\"IgM anti-beta2-GPI\")\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Venous Thrombosis\")"
                },
                {
                    "subject": "p(\"IgM anti-beta2-GPI\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arterial Thrombosis\")"
                },
                {
                    "subject": "p(\"IgG anti-beta2-GPI\")\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arterial Thrombosis\")"
                },
                {
                    "subject": "p(\"IgG anti-beta2-GPI\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Venous Thrombosis\")"
                }
            ],
            "evidence": "Persistent positivity increased the association of venous and arterial thrombosis with anti-beta2-GPI (IgG and IgM isotypes).\n",
            "metadata": {
                "gd:abstract": "Antibodies to beta2-glycoprotein I (anti-beta2-GPI) are found in a large percentage of patients with primary or secondary antiphospholipid syndrome (APS). Our aim was to identify the prevalence and clinical correlation of these antibodies in patients with APS and systemic lupus erythematosus (SLE), in comparison to anticardiolipin (aCL) and the lupus anticoagulant (LAC). We investigated whether serial samples improve clinical utility.",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1eebd35a-062d-4a92-a427-a10ebd35f1c1",
        "_rev": "_WpvYGJG-AP",
        "nanopub": {
            "id": "1eebd35a-062d-4a92-a427-a10ebd35f1c1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.0002",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "267 SLE patients followed longitudinally for one year",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "19790071",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL2)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                },
                {
                    "subject": "p(HGNC:CCL19)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                },
                {
                    "subject": "p(HGNC:CXCL10)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "Chemokine-high patients were at significantly increased risk for renal flares as compared to both chemokine-low (p=2\u00d710\u22123) and chemokine-intermediate patients (p=9\u00d710\u22124) (Figure 5B).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "af1d07ad-a99c-4ba5-a275-76849bc485a6",
        "_rev": "_WpvYGJ--BW",
        "nanopub": {
            "id": "af1d07ad-a99c-4ba5-a275-76849bc485a6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "authors": [
                    "Vendelbo, Mikkel Holm",
                    "M\u00f8ller, Andreas Buch",
                    "Christensen, Britt",
                    "Nellemann, Birgitte",
                    "Clasen, Berthil Frederik Forrest",
                    "Nair, K Sreekumaran",
                    "J\u00f8rgensen, Jens Otto Lunde",
                    "Jessen, Niels",
                    "M\u00f8ller, Niels"
                ],
                "database": {
                    "id": "25020061",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Fasting increases human skeletal muscle net phenylalanine release and this is associated with decreased mTOR signaling.",
                "abstract": "Fasting is characterised by profound changes in energy metabolism including progressive loss of body proteins. The underlying mechanisms are however unknown and we therefore determined the effects of a 72-hour-fast on human skeletal muscle protein metabolism and activation of mammalian target of rapamycin (mTOR), a key regulator of cell growth."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:Fasting)",
                    "relation": "decreases",
                    "object": "a(CHEBI:\"3,3',5-triiodo-L-thyronine\")"
                },
                {
                    "subject": "bp(MESH:Fasting)",
                    "relation": "increases",
                    "object": "p(HGNC:GCG)"
                },
                {
                    "subject": "bp(MESH:Fasting)",
                    "relation": "decreases",
                    "object": "a(MESH:C-Peptide)"
                },
                {
                    "subject": "bp(MESH:Fasting)",
                    "relation": "decreases",
                    "object": "a(MESH:Insulin)"
                }
            ],
            "evidence": "These changes in metabolic substrates were accompanied with a significant decrease in the circulating levels of insulin, c-peptide and triiodothyronine, and increased glucagon levels.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true,
                "gd:abstract": "Fasting is characterised by profound changes in energy metabolism including progressive loss of body proteins. The underlying mechanisms are however unknown and we therefore determined the effects of a 72-hour-fast on human skeletal muscle protein metabolism and activation of mammalian target of rapamycin (mTOR), a key regulator of cell growth."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9180a928-6c71-4e04-bdb0-d504b6cc6ee8",
        "_rev": "_WpvYGJ--CU",
        "nanopub": {
            "id": "9180a928-6c71-4e04-bdb0-d504b6cc6ee8",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "132 Hispanic MS patients and 60 controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "FACS",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "comments": "I do not like this citation. It doesn't seem specific enough. - Adrian",
                "database": {
                    "id": "19321461",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"D3 vitamins\")",
                    "relation": "decreases",
                    "object": "bp(GO:\"CD4-positive, alpha-beta T cell differentiation\")"
                }
            ],
            "evidence": "Vitamin D inhibits the proliferation of human CD4+ T cells and MBP peptide-specific T-cell lines.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "aca8c7a3-274a-4aa5-bc2d-ca49280083b9",
        "_rev": "_WpvYGJ--BJ",
        "nanopub": {
            "id": "aca8c7a3-274a-4aa5-bc2d-ca49280083b9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CXCL10)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": " In addition, levels of plasma IP-10, MCP-1 and MCP-3 (Figure 2D), along with IL-8 and ICAM-1 (Supplementary Figure 2H), were significantly elevated in pre-flare periods compared to periods of stable disease.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1f02cf3f-226e-4bbd-b2b6-2dabb3df058f",
        "_rev": "_WpvYGI6--k",
        "nanopub": {
            "id": "1f02cf3f-226e-4bbd-b2b6-2dabb3df058f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "CL:\"aortic endothelial cell\"",
                    "label": "aortic endothelial cell",
                    "type": "Cell"
                },
                {
                    "id": "MESH:D005786",
                    "label": "Gene Expression Regulation",
                    "type": ""
                },
                {
                    "id": "MESH:D012216",
                    "label": "Rheumatic Diseases",
                    "type": "Disease"
                },
                {
                    "id": "MESH:D008180",
                    "label": "Lupus Erythematosus, Systemic",
                    "type": "Disease"
                },
                {
                    "id": "MESH:D012313",
                    "label": "RNA",
                    "type": ""
                },
                {
                    "id": "MESH:D008181",
                    "label": "Lupus Nephritis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "abstract": "No Abstract Loaded.",
                "authors": [
                    "Feng, Xuebing",
                    "Wu, Hui",
                    "Grossman, Jennifer M",
                    "Hanvivadhanakul, Punchong",
                    "FitzGerald, John D",
                    "Park, Grace S",
                    "Dong, Xin",
                    "Chen, Weiling",
                    "Kim, Michelle H",
                    "Weng, Haoling H",
                    "Furst, Daniel E",
                    "Gorn, Alan",
                    "McMahon, Maureen",
                    "Taylor, Mihaela",
                    "Brahn, Ernest",
                    "Hahn, Bevra H",
                    "Tsao, Betty P"
                ],
                "database": {
                    "id": "16947629",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus."
            },
            "assertions": [
                {
                    "subject": "a",
                    "relation": "",
                    "object": "b"
                }
            ],
            "evidence": "",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f28b96b8-0845-4cf9-8ea5-fccfdf33c8f7",
        "_rev": "_WpvYGJC--h",
        "nanopub": {
            "id": "f28b96b8-0845-4cf9-8ea5-fccfdf33c8f7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=48",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "SCORAD",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Dermatitis, Atopic\"",
                    "label": "Dermatitis, Atopic",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "22955355",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Probiotic\")",
                    "relation": "decreases",
                    "object": "path(MESH:\"Dermatitis, Atopic\")"
                }
            ],
            "evidence": "Patients receiving probiotics showed a significant reduction of SCORAD at the end of treatment\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ac4f3f48-0798-499c-a19d-c1e488011c94",
        "_rev": "_WpvYGJC-_T",
        "nanopub": {
            "id": "ac4f3f48-0798-499c-a19d-c1e488011c94",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Fluorimetric Assay",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "\u00a02832315",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "increases",
                    "object": "a(CHEBI:Hydrogen peroxide)"
                }
            ],
            "evidence": "Also, the basal unstimulated production of H202 was enhanced by rIFN-y treatment,\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b507024c-a838-4bda-a4bf-b8a32c0200e9",
        "_rev": "_WpvYGJG--1",
        "nanopub": {
            "id": "b507024c-a838-4bda-a4bf-b8a32c0200e9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Muzio, M",
                    "Ni, J",
                    "Feng, P",
                    "Dixit, V M"
                ],
                "database": {
                    "id": "9374458",
                    "name": "PubMed"
                },
                "source_name": "Science (New York, N.Y.)",
                "title": "IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling.",
                "abstract": "The interleukin-1 receptor (IL-1R) signaling pathway leads to nuclear factor kappa B (NF-kappaB) activation in mammals and is similar to the Toll pathway in Drosophila: the IL-1R-associated kinase (IRAK) is homologous to Pelle. Two additional proximal mediators were identified that are required for IL-1R-induced NF-kappaB activation: IRAK-2, a Pelle family member, and MyD88, a death domain-containing adapter molecule. Both associate with the IL-1R signaling complex. Dominant negative forms of either attenuate IL-1R-mediated NF-kappaB activation. Therefore, IRAK-2 and MyD88 may provide additional therapeutic targets for inhibiting IL-1-induced inflammation.",
                "date_published": "1997-11-28"
            },
            "assertions": [
                {
                    "subject": "p(HGNC:MYD88)",
                    "relation": "increases",
                    "object": "p(HGNC:IRAK2)"
                }
            ],
            "evidence": "To molecularly order the proximalcomponents of the IL-1R signaling complexidentified herein, we tested whether adominant negative version of MyD88 orIRAK-2 could inhibit the active form ofthe other (Fig. 4C). Dominant negativeMyD88 did not inhibit IRAK-2\u2013inducedNF-kB activation, but dominant negativeIRAK-2 significantly inhibited MyD88-induced NF-kB activity. These results areconsistent with MyD88 acting upstream ofIRAK-2 in the IL-1R signaling pathway.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "The interleukin-1 receptor (IL-1R) signaling pathway leads to nuclear factor kappa B (NF-kappaB) activation in mammals and is similar to the Toll pathway in Drosophila: the IL-1R-associated kinase (IRAK) is homologous to Pelle. Two additional proximal mediators were identified that are required for IL-1R-induced NF-kappaB activation: IRAK-2, a Pelle family member, and MyD88, a death domain-containing adapter molecule. Both associate with the IL-1R signaling complex. Dominant negative forms of either attenuate IL-1R-mediated NF-kappaB activation. Therefore, IRAK-2 and MyD88 may provide additional therapeutic targets for inhibiting IL-1-induced inflammation.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0aa333e4-bb90-43ee-8153-86bf7a9ed681",
        "_rev": "_WpvYGI6--J",
        "nanopub": {
            "id": "0aa333e4-bb90-43ee-8153-86bf7a9ed681",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17277312",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT3)",
                    "relation": "biomarkerFor",
                    "object": "bp(GO:\"T-helper 17 cell differentiation\")"
                },
                {
                    "subject": "act(p(HGNC:STAT3))\t",
                    "relation": "decreases",
                    "object": "r(HGNC:TBET)"
                }
            ],
            "evidence": "). Consistently in both systems, expression of IL-17 by Stat3-deficient T cells was greatly impaired, and expression of IFN-\u0001 was moderately increased (Fig. 3A), indicating an essential role of STAT3 in THi differentiation in vitro.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "343d6aeb-65c1-440a-bc7b-d3743bf3217f",
        "_rev": "_WpvYGJ---t",
        "nanopub": {
            "id": "343d6aeb-65c1-440a-bc7b-d3743bf3217f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:\"lymph node\"",
                    "label": "lymph node",
                    "type": "Anatomy"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Northern Blot",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12594853",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:JAK2, pmod(Ph))",
                    "relation": "increases",
                    "object": "r(HGNC:CMYC)"
                }
            ],
            "evidence": "The c-myc gene was activated and peaked 3 h after IL-12 stimulation (Fig. 2B), and cMyc protein was detected (Fig. 2C)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "490898fe-5920-437f-93f9-c71c1f7409ad",
        "_rev": "_WpvYGJC-_M",
        "nanopub": {
            "id": "490898fe-5920-437f-93f9-c71c1f7409ad",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "EFO:HeLa",
                    "label": "HeLa",
                    "type": "CellLine"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Huang, Ying",
                    "Li, Wenge",
                    "Kong, Ah-Ng Tony"
                ],
                "database": {
                    "id": "23190551",
                    "name": "PubMed"
                },
                "source_name": "Cell & bioscience",
                "title": "Anti-oxidative stress regulator NF-E2-related factor 2 mediates the adaptive induction of antioxidant and detoxifying enzymes by lipid peroxidation metabolite 4-hydroxynonenal.",
                "abstract": "NF-E2-related factor 2 (NRF2) regulates a battery of antioxidative and phase II drug metabolizing/detoxifying genes through binding to the antioxidant response elements (ARE). NRF2-ARE signaling plays a central role in protecting cells from a wide spectrum of reactive toxic species including reactive oxygen/nitrogen species (RONS). 4-hydroxylnonenal (4-HNE) is a major end product from lipid peroxidation of omega-6 polyunsaturated fatty acids (PUFA) induced by oxidative stress, and it is highly reactive to nucleophilic sites in DNA and proteins, causing cytotoxicity and genotoxicity. In this study, we examined the role of NRF2 in regulating the 4-HNE induced gene expression of antioxidant and detoxifying enzymes."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:4-hydroxynon-2-enal)",
                    "relation": "increases",
                    "object": "r(HGNC:GSTA4)"
                },
                {
                    "subject": "a(CHEBI:4-hydroxynon-2-enal)",
                    "relation": "increases",
                    "object": "r(HGNC:AKR1C1)"
                },
                {
                    "subject": "a(CHEBI:4-hydroxynon-2-enal)",
                    "relation": "increases",
                    "object": "r(HGNC:HMOX1)"
                }
            ],
            "evidence": "When HeLa cells were treated with 4-HNE, in agreement with the enhanced ARE-luciferase activity, RT-PCR results showed that 4-HNE induced the transcription of AKR1C1, GSTA4 and HO-1 in a dose-dependent manner (Figure \u200b(Figure3A).3A). ",
            "metadata": {
                "Methodology": "RT-PCR",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1a38e93c-032f-480e-894e-5dcbe74e444b",
        "_rev": "_WpvYGJG-AY",
        "nanopub": {
            "id": "1a38e93c-032f-480e-894e-5dcbe74e444b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "250 pairs of liver tumor and adjacent non-tumorous liver tissues (ANLTs)",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "miRNA Array",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"liver carcinoma\"",
                    "label": "liver carcinoma",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:liver",
                    "label": "liver",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "25998163",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Carcinoma, Hepatocellular\")",
                    "relation": "negativeCorrelation",
                    "object": "m(\"miR-188-5p\")"
                }
            ],
            "evidence": "We found that miR-188-5p was one of miRNAs decreased in HCC more than three folds compared to ANLTs (Fig. 1A).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9bda4b66-a63f-4870-82b5-86ab77691272",
        "_rev": "_WpvYGJC-BI",
        "nanopub": {
            "id": "9bda4b66-a63f-4870-82b5-86ab77691272",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "AE7",
                    "type": "CellLine"
                },
                {
                    "id": "",
                    "label": "OF6",
                    "type": "CellLine"
                },
                {
                    "id": "",
                    "label": "PL17",
                    "type": "CellLine"
                },
                {
                    "id": "",
                    "label": "Northern Blot",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "database": {
                    "id": "10761931",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TBX21)",
                    "relation": "increases",
                    "object": "bp(GO:\"T-helper 1 cell differentiation\")"
                }
            ],
            "evidence": "\u00a0Northern blot analysis of RNA isolated from Th1 cell clones (PL17, OF6, and AE7) or Th2 clones (CDC35 and D10) revealed T-bet transcripts only in the Th1 clones (Figure 2A).\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e062e813-8fdb-4405-b78f-aba4cabd44ad",
        "_rev": "_WpvYGJG--P",
        "nanopub": {
            "id": "e062e813-8fdb-4405-b78f-aba4cabd44ad",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=6",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "10879444",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Exercise\")",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IL10)"
                }
            ],
            "evidence": "IL-10 was signi\u00aecantly elevated (P \u0088 0.009) over baseline values at 48, 72, 96, 120, 144 h after exercise (Fig. 3)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b87fc7d7-4f5b-4da1-be0f-fb27fef4c8fd",
        "_rev": "_WpvYGJC--9",
        "nanopub": {
            "id": "b87fc7d7-4f5b-4da1-be0f-fb27fef4c8fd",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "r(HGNC:RORGT)",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite(p(HGNC:IL6), p(HGNC:TGFB), p(HGNC:TNFA), p(HGNC:IL1B))",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL17))"
                }
            ],
            "evidence": "In a DC free culture system with anti-CD3- and anti-CD28-coated beads, addition of IL-6 together with TGF\u03b21 to naive CD4 T cells stimulated by antibody-coated beads induced a dose-dependent increase in IL-17 differentiation (Figure 4E, panels). The differentiation of IL-17-producing T cells was further augmented by the presence of two additional DC-derived proinflammatory cytokines, TNF\u03b1 and IL-1\u03b2 (Figure 4F).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f43f6da4-2904-4b53-acfe-821eedf61a95",
        "_rev": "_WpvYGJ--CI",
        "nanopub": {
            "id": "f43f6da4-2904-4b53-acfe-821eedf61a95",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "EFO:D10.G4.1",
                    "label": "D10.G4.1",
                    "type": "CellLine"
                },
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "database": {
                    "id": "10761931",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TBX21)",
                    "relation": "decreases",
                    "object": "p(HGNC:IL5)"
                },
                {
                    "subject": "p(HGNC:TBX21)",
                    "relation": "decreases",
                    "object": "p(HGNC:IL4)"
                }
            ],
            "evidence": "In D10 cells, T-bet inhibited the Th2 genetic program as evidenced by the reduced number of T-bet/GFP-transduced cells producing IL-4 (54% to 12%) and IL-5 (70% to 14%)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3b3fbfc5-6be9-4d7b-85cd-0e525fe4547e",
        "_rev": "_WpvYGJ--_h",
        "nanopub": {
            "id": "3b3fbfc5-6be9-4d7b-85cd-0e525fe4547e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "32 renal failure patients, 15 HC",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Column Chromatography",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"kidney failure\"",
                    "label": "kidney failure",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "1126056",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Renal Insufficiency\")\t",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:\"N-amidinoaspartic acid\")"
                },
                {
                    "subject": "path(MESH:\"Renal Insufficiency\")\t",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:creatinine)"
                },
                {
                    "subject": "path(MESH:\"Renal Insufficiency\")",
                    "relation": "positiveCorrelation",
                    "object": "a(CHEBI:urea)"
                }
            ],
            "evidence": "See Table 3.",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "15c4825f-2440-434f-bab6-bd2dfbc895ff",
        "_rev": "_WpvYGJ--B0",
        "nanopub": {
            "id": "15c4825f-2440-434f-bab6-bd2dfbc895ff",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12417590",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "complex(GO\"Interleukin 23 complex\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL17)"
                }
            ],
            "evidence": "Murine spleen cell cultures, in the presence of IL-23, resulted in high levels of IL-17 production in a dose-dependent manner (Fig.2\u00a0A).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ab4025d3-79c9-4ec3-939e-bceea25b4f77",
        "_rev": "_WpvYGJG-AG",
        "nanopub": {
            "id": "ab4025d3-79c9-4ec3-939e-bceea25b4f77",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CLO:\"HCT-15 cell\"",
                    "label": "HCT-15 cell",
                    "type": "CellLine"
                },
                {
                    "id": "EFO:HT-29",
                    "label": "HT-29",
                    "type": "CellLine"
                },
                {
                    "id": "CLO:\"SW480 cell\"",
                    "label": "SW480 cell",
                    "type": "CellLine"
                },
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"LOVO cell\"",
                    "label": "LOVO cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "17785825",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:JAK3)",
                    "relation": "increases",
                    "object": "p(HGNC:STAT6, pmod(Ph))"
                }
            ],
            "evidence": "When activation was analyzed, we found that IL-4 could induce STAT6 phosphorylation in all cell lines regardless of JAK3 expression (Fig. 6B)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "85da836d-946d-4762-843f-24f12edbbe6e",
        "_rev": "_WpvYGJ--Bg",
        "nanopub": {
            "id": "85da836d-946d-4762-843f-24f12edbbe6e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=17",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Chemiluminescence Assay",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Hypertriglyceridemia",
                    "label": "Hypertriglyceridemia",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Blood",
                    "label": "Blood",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "19158225",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "p(HGNC:CRP)"
                }
            ],
            "evidence": "there was a significant 15% reduction in the concentration of serum CRP and a significant 7% increase in the concentration of plasma MMP-2 when compared with their concentrations at baseline (Fig. 1).\u00a0\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2d1d6b93-866c-4d0a-ad6b-ddd2fa1ab16d",
        "_rev": "_WpvYGJC--L",
        "nanopub": {
            "id": "2d1d6b93-866c-4d0a-ad6b-ddd2fa1ab16d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "20 individuals with GAD (8 male, 12 female) and 20 controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "0.028",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "20865305",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"Substance P\")",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL17A))"
                },
                {
                    "subject": "a(CHEBI:\"Substance P\")",
                    "relation": "increases",
                    "object": "sec(p(HGNC:TNF))"
                }
            ],
            "evidence": "With regard of SP, this neuropeptide significantly up-regulated the production of TNF-\u03b1 and IL17 from both control and GAD groups (Fig. 3).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "da231c26-39af-4643-9961-685d1d3fcea6",
        "_rev": "_WpvYGI6--U",
        "nanopub": {
            "id": "da231c26-39af-4643-9961-685d1d3fcea6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "15 young and 15 old males",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "qPCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "9469419",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(GO:\"Aging\")",
                    "relation": "increases",
                    "object": "r(HGNC:FAS)"
                }
            ],
            "evidence": "\u00a0As seen in Figure 2\u21d3A, there was a significant increase (p\u00a0< 0.001) in cpm ratio for\u00a0fas/\u03b2-actin\u00a0in lymphocytes from aging (mean \u00b1 SD cpm for 1 and 2 \u03bcl\u00a0fas\u00a0and 1 \u03bcl\u00a0\u03b2-actin: 1.06 \u00b1 0.03 and 2.4 \u00b1 0.05) as compared with young (mean \u00b1 SD cpm for 1 and 2 \u03bcl\u00a0fas\u00a0and 1 \u03bcl\u00a0\u03b2-actin: 0.45 \u00b1 0.03 and 1.05 \u00b1 0.04), demonstrating an increase of\u00a0fas\u00a0expression at mRNA level in aging.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e9e55aec-8ecd-4f93-9bea-0f5f381211e2",
        "_rev": "_WpvYGJ--Bu",
        "nanopub": {
            "id": "e9e55aec-8ecd-4f93-9bea-0f5f381211e2",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "13 donors with atopic dermatitis",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8096238",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL12)",
                    "relation": "increases",
                    "object": "bp(GO:\"T-helper 1 cell differentiation\")"
                }
            ],
            "evidence": "The results of the present study indicate that 11112 promotes the in vitro differentiation of Th lymphocytes into cells showing a Thl-like profile of cytokine production.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a3ef0a4e-af57-40b7-a84c-e73dd1b3bfb2",
        "_rev": "_WpvYGI6--f",
        "nanopub": {
            "id": "a3ef0a4e-af57-40b7-a84c-e73dd1b3bfb2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Nine obese subjects were studied during 13 periods of starvation at the Clinical Center of the Peter Bent Brigham Hospital (Table I).",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Ion Exchange Chromatography",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:obesity",
                    "label": "obesity",
                    "type": "Disease"
                }
            ],
            "citation": {
                "comments": "p-values not stated.",
                "database": {
                    "id": "5773094",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Fasting\")\t",
                    "relation": "decreases",
                    "object": "a(CHEBI:methionine)"
                },
                {
                    "subject": "bp(MESH:\"Fasting\")\t",
                    "relation": "decreases",
                    "object": "a(CHEBI:isoleucine)"
                },
                {
                    "subject": "bp(MESH:\"Fasting\")\t",
                    "relation": "decreases",
                    "object": "a(CHEBI:leucine)"
                },
                {
                    "subject": "bp(MESH:\"Fasting\")\t",
                    "relation": "decreases",
                    "object": "a(CHEBI:valine)"
                },
                {
                    "subject": "bp(MESH:\"Fasting\")\t",
                    "relation": "decreases",
                    "object": "a(CHEBI:tryptophan)"
                },
                {
                    "subject": "bp(MESH:\"Fasting\")\t",
                    "relation": "decreases",
                    "object": "a(CHEBI:ornithine)"
                },
                {
                    "subject": "bp(MESH:\"Fasting\")\t",
                    "relation": "decreases",
                    "object": "a(CHEBI:cysteine)"
                },
                {
                    "subject": "bp(MESH:\"Fasting\")\t",
                    "relation": "decreases",
                    "object": "a(CHEBI:alanine)"
                },
                {
                    "subject": "bp(MESH:\"Fasting\")\t",
                    "relation": "decreases",
                    "object": "a(CHEBI:proline)"
                },
                {
                    "subject": "bp(MESH:\"Fasting\")",
                    "relation": "decreases",
                    "object": "a(CHEBI:citrulline)"
                },
                {
                    "subject": "bp(MESH:\"Fasting\")",
                    "relation": "decreases",
                    "object": "a(CHEBI:arginine)"
                }
            ],
            "evidence": "The most common pattern was either a progressive or delayed decrease in plasma amino acid levels so that after 5-6 wk of fasting, 13 of the 20 amino acids measured were significantly lower than at the time starvation was initiated\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "02e67982-ac01-496e-8c15-e38661bffda9",
        "_rev": "_WpvYGJ--CP",
        "nanopub": {
            "id": "02e67982-ac01-496e-8c15-e38661bffda9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18549798",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:Jak3)",
                    "relation": "association",
                    "object": "p(HGNC:IFNG)"
                }
            ],
            "evidence": "\u00a0As shown in\u00a0Figure 1a, in the absence of Jak3, the percentage of IFN-\u03b3-producing cells was reduced from an average of 12.5\u00b12.7% to 0.5\u00b10.4% (P < 0.001) and 27.1\u00b14.1% to 7.0\u00b16.8% (P < 0.01)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b1b8ed46-4828-4035-935f-6c7f87b8cddc",
        "_rev": "_WpvYGJ--AA",
        "nanopub": {
            "id": "b1b8ed46-4828-4035-935f-6c7f87b8cddc",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"B cell\"",
                    "label": "B cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18523280",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TGFB)",
                    "relation": "increases",
                    "object": "BP(GO:\"Isotype switching\")"
                }
            ],
            "evidence": "As shown in Fig. 1\u21d3A, the mean serum IgG1 concentration is 0.003 mg/ml in TGF wild-type (WT)/CD3 KO compared with 0.56 mg/ml in the presence of T cells (Fig. 1\u21d3C). Upon introduction of the TGF-\u03b21 deficiency on the CD3\u03b5-null background, we noted a marked decrease in serum IgA (0.006 mg/ml in TGF KO vs 0.016 mg/ml in TGF WT) and a parallel increase in serum IgG1 (0.01 mg/ml TGF KO vs 0.003 mg/ml in TGF WT).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "674b745f-9f4b-4841-8813-1256563908db",
        "_rev": "_WpvYGJ--Cb",
        "nanopub": {
            "id": "674b745f-9f4b-4841-8813-1256563908db",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Psoriasis",
                    "label": "Psoriasis",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "23365685",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Phototherapy\")",
                    "relation": "increases",
                    "object": "a(bp(GO:\"regulatory T cell differentiation\"))"
                },
                {
                    "subject": "a(MESH:\"Phototherapy\")",
                    "relation": "decreases",
                    "object": "a(bp(GO:\"T-helper 17 cell differentiation\"))"
                }
            ],
            "evidence": "Photo(chemo)therapy significantly reduced Th17 levels from 5.66\u00b13.15% to 2.96\u00b12.89% in patients with increased Th17 (Th17/CD4>3.01% [mean+SD of controls]). In contrast, photo(chemo)therapy significantly increased Treg levels from 2.77\u00b10.75 to 3.40\u00b11.88% in patients with less than 4.07% Treg level, defined as the mean of controls. \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Th17 Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f0e3792d-c57a-419c-8d2c-18f8b2f4e2ec",
        "_rev": "_WpvYGJG-AD",
        "nanopub": {
            "id": "f0e3792d-c57a-419c-8d2c-18f8b2f4e2ec",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "95 SLE patients, 40 non-SLE patients, and 34 healthy controls",
                    "type": "cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Chi, Shuhong",
                    "Yu, Yunxia",
                    "Shi, Juan",
                    "Zhang, Yurong",
                    "Yang, Jijuan",
                    "Yang, Lijuan",
                    "Liu, Xiaoming"
                ],
                "database": {
                    "id": "26549923",
                    "name": "PubMed"
                },
                "source_name": "Disease markers",
                "title": "Antibodies against C1q Are a Valuable Serological Marker for Identification of Systemic Lupus Erythematosus Patients with Active Lupus Nephritis.",
                "abstract": "An early diagnosis of lupus nephritis (LN) has an important clinical implication in guiding treatments of systemic lupus erythematosus (SLE) in clinical settings. In this study, the diagnostic values of circulating autoantibodies to C1q alone or in combination with other markers for accessing active SLE and LN were evaluated."
            },
            "assertions": [
                {
                    "subject": "a(anti-C1q)",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:C4)"
                },
                {
                    "subject": "a(anti-C1q)\t",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:C3)"
                }
            ],
            "evidence": "The titer of serum anti-C1q antibodies was positively correlated to anti-dsDNA antibodies () and SLEDAI () but inversely correlated to serum levels of complements C3 () and C4 () (Table 5).",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "An early diagnosis of lupus nephritis (LN) has an important clinical implication in guiding treatments of systemic lupus erythematosus (SLE) in clinical settings. In this study, the diagnostic values of circulating autoantibodies to C1q alone or in combination with other markers for accessing active SLE and LN were evaluated.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c2849fef-5459-424c-9e31-9ec83fa11796",
        "_rev": "_WpvYGJ--AP",
        "nanopub": {
            "id": "c2849fef-5459-424c-9e31-9ec83fa11796",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Affimetrix Gene Chip Analysis",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16990136",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:RORGT)",
                    "relation": "positiveCorrelation",
                    "object": "bp(GO:\"T-helper 17 cell differentiation\")"
                }
            ],
            "evidence": "\u00a0In Th17 culture conditions, ROR\u03b3t mRNA levels were found to be elevated (B.S.M. and D.J.C., unpublished data).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f6b4d8ef-b47f-4111-8340-e9f74a7c1479",
        "_rev": "_WpvYGJC-BX",
        "nanopub": {
            "id": "f6b4d8ef-b47f-4111-8340-e9f74a7c1479",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=35",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "CDAI",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:\"Crohn Disease\"",
                    "label": "Crohn Disease",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "16225487",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:butyrate)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Crohn disease\")"
                }
            ],
            "evidence": "\u00a0The median pre-treatment CDAI (252, range 223\u2013306) decreased significantly (P\u00a0<\u00a00.0001) to 162 (range 76\u2013247) after 4\u00a0weeks and to 140 (93\u2013263) after 8\u00a0weeks.\u00a0\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "761e1368-ad7f-4086-a2d0-a8b58f2ac383",
        "_rev": "_WpvYGJC-A6",
        "nanopub": {
            "id": "761e1368-ad7f-4086-a2d0-a8b58f2ac383",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "1.88\u00d710\u22129",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "DAS28",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "authors": [
                    "Chamberlain, Nathan D",
                    "Vila, Olga M",
                    "Volin, Michael V",
                    "Volkov, Suncica",
                    "Pope, Richard M",
                    "Swedler, William",
                    "Mandelin, Arthur M",
                    "Shahrara, Shiva"
                ],
                "database": {
                    "id": "22661088",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology (Baltimore, Md. : 1950)",
                "title": "TLR5, a novel and unidentified inflammatory mediator in rheumatoid arthritis that correlates with disease activity score and joint TNF-\u03b1 levels.",
                "abstract": "The innate immune system plays an important role in rheumatoid arthritis (RA) pathogenesis. Previous studies support the role of TLR2 and 4 in RA and experimental arthritis models; however, the regulation and pathogenic effect of TLR5 is undefined in RA. In this study, we show that TLR5 is elevated in RA and osteoarthritis ST lining and sublining macrophages and endothelial cells compared with normal individuals. Furthermore, expression of TLR5 is elevated in RA synovial fluid macrophages and RA peripheral blood monocytes compared with RA and normal peripheral blood in vitro-differentiated macrophages. We also found that TLR5 on RA monocytes is an important modulator of TNF-\u03b1 in RA synovial fluid and that TLR5 expression on these cells strongly correlates with RA disease activity and TNF-\u03b1 levels. Interestingly, TNF-\u03b1 has a feedback regulation with TLR5 expression in RA monocytes, whereas expression of this receptor is regulated by IL-17 and IL-8 in RA macrophages and fibroblasts. We show that RA monocytes and macrophages are more responsive to TLR5 ligation compared with fibroblasts despite the proinflammatory response being mediated through the same signaling pathways in macrophages and fibroblasts. In conclusion, we document the potential role of TLR5 ligation in modulating transcription of TNF-\u03b1 from RA synovial fluid and the strong correlation of TLR5 and TNF-\u03b1 with each other and with disease activity score in RA monocytes. Our results suggest that expression of TLR5 may be a predictor for RA disease progression and that targeting TLR5 may suppress RA."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TLR5)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "data analyzed by regression analysis demonstrated that patients with greater levels of DAS28 had increased expression of TLR5 (R2=0.57, p=1.88\u00d710\u22129) (Fig. 3D)",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f1a73c80-ac86-4b16-a9b6-a82becc3121f",
        "_rev": "_WpvYGJ---y",
        "nanopub": {
            "id": "f1a73c80-ac86-4b16-a9b6-a82becc3121f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.005",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=6",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "10879444",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Exercise\")",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:CSF1)"
                }
            ],
            "evidence": "M-CSF (P \u0088 0.005) was signi\u00aecantly elevated over baseline values at 12 h, and then from 48 to 144 h after exercise (Fig. 4)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4a8665bb-8ba0-4c50-8dee-8c8cc6731cfd",
        "_rev": "_WpvYGJC-AN",
        "nanopub": {
            "id": "4a8665bb-8ba0-4c50-8dee-8c8cc6731cfd",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Ohta, Akio",
                    "Kini, Radhika",
                    "Ohta, Akiko",
                    "Subramanian, Meenakshi",
                    "Madasu, Manasa",
                    "Sitkovsky, Michail"
                ],
                "database": {
                    "id": "22783261",
                    "name": "PubMed"
                },
                "source_name": "Frontiers in immunology",
                "title": "The development and immunosuppressive functions of CD4(+) CD25(+) FoxP3(+) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway.",
                "abstract": "The A2A adenosine receptor (A2AR)-mediated immunosuppression is firmly implicated in the life-saving down-regulation of collateral tissue damage during the anti-pathogen immune response and in highly undesirable protection of cancerous tissues during anti-tumor immune response. Therefore, depending on specific clinical situation there is a need to either weaken or strengthen the intensity of A2AR signal. While the A2AR-mediated immunosuppression was shown to be T cell autonomous in studies of effector T cells, it was not clear how A2AR stimulation affects regulatory T cells (Treg). Here we show in parallel assays that while A2AR stimulation on T cells directly inhibits their activation, there is also indirect and longer-lasting T cell inhibitory effect through modulation of Treg. A2AR stimulation expanded CD4(+) CD25(hi) FoxP3(+) cells, which also express CD39, CD73, and CTLA-4. Treg cultured with A2AR agonist showed increased expression of CTLA-4 and stronger immunosuppressive activity. There was a significant increase of Treg cell number after A2AR stimulation. The CD4(+) FoxP3(+) population contained those induced from CD4(+) CD25(-) cells, but CD4(+) FoxP3(+) cells predominantly derived from CD4(+) CD25(+) natural Treg. Thus, A2AR stimulation numerically and functionally enhanced Treg-mediated immunosuppressive mechanism. These data suggest that the A2AR-mediated stimulation of lymphocytes using A2AR agonists should be considered in protocols for ex vivo expansion of Treg before the transfer to patients in different medical applications."
            },
            "assertions": [
                {
                    "subject": "act(p(HGNC:ADAR))",
                    "relation": "increases",
                    "object": "a(CL:\"T-regulatory cell\")"
                }
            ],
            "evidence": "There was a significant increase of Treg cell number after A2AR stimulation.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "803753b8-3e3b-406c-afad-01183c480964",
        "_rev": "_WpvYGJG--z",
        "nanopub": {
            "id": "803753b8-3e3b-406c-afad-01183c480964",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=-0.576",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "Fifty one SLE patients with active disease (lupus flare) were studied.\u00a0",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "27365721",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:C3)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Significant positive correlation was noticed between SLEDAI score and anti-dsDNA levels (0.01 level two-tailed prediction) and a significant negative correlation was observed with SLEDAI and C3, C4 levels (0.01 and 0.05 levels, two-tailed prediction) in our patients. On subgroup analysis it was noticed that this correlation is stronger for renal lupus. Negative correlation of SLEDAI and complement levels was not observed in non-renal flares.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3c36bcc8-10fc-4f09-b3ac-fb2c8f91f7dc",
        "_rev": "_WpvYGI6--h",
        "nanopub": {
            "id": "3c36bcc8-10fc-4f09-b3ac-fb2c8f91f7dc",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "",
                    "label": "30 RA patients, with random assignement to treatment with placebo, anti-TNFalpha, or anti-INFgamma",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Sigidin, Y A",
                    "Loukina, G V",
                    "Skurkovich, B",
                    "Skurkovich, S"
                ],
                "database": {
                    "id": "11578014",
                    "name": "PubMed"
                },
                "source_name": "Scandinavian journal of rheumatology",
                "title": "Randomized, double-blind trial of anti-interferon-gamma antibodies in rheumatoid arthritis.",
                "abstract": "An increasing body of evidence indicates that interferon (IFN )-gamma is an immunoregulator and may play a key role in the pathogenesis of autoimmune diseases, including rheumatoid arthritis (RA)."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:anti-IFNG)",
                    "relation": "decreases",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "a(CHEBI:anti-TNFA)",
                    "relation": "decreases",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": " According to the physician's assessment, improvement was achieved by the 7th day in 9 patients receiving anti-TNF-alpha, 7 receiving anti-IFN-gamma, and 2 receiving placebo. By day 28 the corresponding figures were 8, 8, and 0, respectively.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7cec3382-8a08-47c4-858a-be4c08470d36",
        "_rev": "_WpvYGJC-BL",
        "nanopub": {
            "id": "7cec3382-8a08-47c4-858a-be4c08470d36",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "MESH:\"Lupus Nephritis\"",
                    "label": "Lupus Nephritis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "authors": [
                    "Nishitani, Y",
                    "Kubo, A",
                    "Iwano, M",
                    "Minamino, N",
                    "Hamano, K",
                    "Fujimoto, T",
                    "Nishino, T",
                    "Shiiki, H",
                    "Yonemasu, K",
                    "Dohi, K"
                ],
                "database": {
                    "id": "11422212",
                    "name": "PubMed"
                },
                "source_name": "Clinical and experimental immunology",
                "title": "Imbalance between interleukin-6 and adrenomedullin mRNA levels in peripheral blood mononuclear cells of patients with lupus nephritis.",
                "abstract": "In this study, we measured the mRNA levels of adrenomedullin (AM), C-type natriuretic peptide, vascular endothelial growth factor, interleukin-1beta (IL-1beta) and interleukin-6 (IL-6) in peripheral blood mononuclear cells (PBMC) of 34 patients with lupus nephritis (LN) (15 active and 19 inactive) and 30 healthy volunteers. mRNA levels were measured using a real-time quantitative PCR METHOD: Compared with healthy volunteers, IL-6 mRNA levels were elevated in LN patients (P < 0.005), while AM mRNA levels were decreased (P < 0.05). Also, IL-6 mRNA levels were higher and AM mRNA levels lower in active LN patients compared with inactive LN patients. In addition, IL-6 mRNA levels positively correlated and AM mRNA levels negatively correlated with SLE disease activity index and laboratory findings, such as blood urea nitrogen, serum creatinine, 50% haemolytic unit of complement and urinary excretion of protein over 24 h. Furthermore, IL-6 mRNA levels were negatively correlated with AM mRNA levels within the same LN patients. With regard to pathological findings, our results showed that IL-6 mRNA levels were higher, and AM mRNA levels significantly lower in patients with a high activity index compared to those with a low activity index. Following treatment with prednisolone, IL-6 mRNA levels in active LN patients decreased and AM mRNA levels increased to levels comparable to those in inactive LN and healthy volunteers. In vitro studies further demonstrated that elevated IL-6 mRNA levels in active LN patient PBMC were suppressed by the addition of adrenomedullin. Our results suggest that an imbalance between IL-6 and AM levels may play an important role in the progression of SLE, and that the mRNA levels of these genes in PBMC may be used as a disease activity index for SLE."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:IL6)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Furthermore, IL-6 mRNA levels correlated positively, and AM mRNA levels correlated negatively, with SLEDAI (Fig. 2).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:abstract": "In this study, we measured the mRNA levels of adrenomedullin (AM), C-type natriuretic peptide, vascular endothelial growth factor, interleukin-1beta (IL-1beta) and interleukin-6 (IL-6) in peripheral blood mononuclear cells (PBMC) of 34 patients with lupus nephritis (LN) (15 active and 19 inactive) and 30 healthy volunteers. mRNA levels were measured using a real-time quantitative PCR METHOD: Compared with healthy volunteers, IL-6 mRNA levels were elevated in LN patients (P < 0.005), while AM mRNA levels were decreased (P < 0.05). Also, IL-6 mRNA levels were higher and AM mRNA levels lower in active LN patients compared with inactive LN patients. In addition, IL-6 mRNA levels positively correlated and AM mRNA levels negatively correlated with SLE disease activity index and laboratory findings, such as blood urea nitrogen, serum creatinine, 50% haemolytic unit of complement and urinary excretion of protein over 24 h. Furthermore, IL-6 mRNA levels were negatively correlated with AM mRNA levels within the same LN patients. With regard to pathological findings, our results showed that IL-6 mRNA levels were higher, and AM mRNA levels significantly lower in patients with a high activity index compared to those with a low activity index. Following treatment with prednisolone, IL-6 mRNA levels in active LN patients decreased and AM mRNA levels increased to levels comparable to those in inactive LN and healthy volunteers. In vitro studies further demonstrated that elevated IL-6 mRNA levels in active LN patient PBMC were suppressed by the addition of adrenomedullin. Our results suggest that an imbalance between IL-6 and AM levels may play an important role in the progression of SLE, and that the mRNA levels of these genes in PBMC may be used as a disease activity index for SLE.",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8eecb1c5-2a41-483f-8c05-b790dae438a2",
        "_rev": "_WpvYGJC-Bg",
        "nanopub": {
            "id": "8eecb1c5-2a41-483f-8c05-b790dae438a2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:\"cerebrospinal fluid\"",
                    "label": "cerebrospinal fluid",
                    "type": "Anatomy"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "MESH:\"Amyotrophic Lateral Sclerosis\"",
                    "label": "Amyotrophic Lateral Sclerosis",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "26332465",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Amyotrophic Lateral Sclerosis\")",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IFNG)"
                }
            ],
            "evidence": "Compared to the non-ALS patients, the ALS patients displayed significantly increased levels of IFN-\u03b3 in both CSF and serum, and these values consistently correlated with disease progression.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "77ae90af-6334-4291-a008-e196026e6e5c",
        "_rev": "_WpvYGJG-_2",
        "nanopub": {
            "id": "77ae90af-6334-4291-a008-e196026e6e5c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:obesity",
                    "label": "obesity",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "5773094",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fasting\")\t",
                    "relation": "decreases",
                    "object": "a(CHEBI:isoleucine)"
                },
                {
                    "subject": "a(MESH:\"Fasting\")\t",
                    "relation": "decreases",
                    "object": "a(CHEBI:leucine)"
                },
                {
                    "subject": "a(MESH:\"Fasting\")",
                    "relation": "decreases",
                    "object": "a(CHEBI:valine)"
                }
            ],
            "evidence": "The secondary decline extended to levels significantly below baseline (day 0) in the case of valine, leucine, and isoleucine.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c0d02dbe-2e26-47e3-ab57-915fefa2bc2a",
        "_rev": "_WpvYGJG-BQ",
        "nanopub": {
            "id": "c0d02dbe-2e26-47e3-ab57-915fefa2bc2a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "n=7",
                    "type": "Cohort"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "22054064",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"B. bifidum MF 20/5\")",
                    "relation": "increases",
                    "object": "p(HGNC:TNF)"
                },
                {
                    "subject": "a(\"B. longum SP 07/3\")",
                    "relation": "increases",
                    "object": "p(HGNC:TNF)"
                },
                {
                    "subject": "a(\"L. reuteri NCIMB 11951\")",
                    "relation": "increases",
                    "object": "p(HGNC:TNF)"
                },
                {
                    "subject": "a(\"L. plantarum NCIMB 8826\")",
                    "relation": "increases",
                    "object": "p(HGNC:TNF)"
                },
                {
                    "subject": "a(\"L. rhamnosus GG\")",
                    "relation": "increases",
                    "object": "p(HGNC:TNF)"
                },
                {
                    "subject": "a(\"L. casei Shirota\")",
                    "relation": "increases",
                    "object": "p(HGNC:TNF)"
                }
            ],
            "evidence": "\u00a0The production of four of the cytokines selected (IL-2, IL-4, IL-5 and TNF-\u03b2) was undetectable in both unstimulated and stimulated culture super()tants, whereas IL-8 and RANTES production was detected at much higher levels even in unstimulated cultures (3166\u00b73 and 55\u00b78\u00a0pg/ml, respectively). All strains increased the production of IL-1\u03b2, IL-6, IL-10, TNF-\u03b1, GM-CSF and MIP-1\u03b1 to different extents (Fig. 4). IFN-\u03b3 production was stimulated by all strains except for\u00a0L. rhamnosus\u00a0GG. IL-12 production was only significantly increased by\u00a0L. casei\u00a0Shirota and\u00a0L. plantarum\u00a0NCIMB 8826 (Fig. 4).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d3ad604c-3e5c-4289-9b51-8d021e3c4ecb",
        "_rev": "_WpvYGJ--_M",
        "nanopub": {
            "id": "d3ad604c-3e5c-4289-9b51-8d021e3c4ecb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Northern Blot",
                    "type": "Methodology"
                },
                {
                    "id": "mouse",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "1997655",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:neutrophil)",
                    "relation": "increases",
                    "object": "r(HGNC:IL8)"
                }
            ],
            "evidence": "1 . Phagocytosis of YIgG induced a significant, timedependent increase in the level ofthe specific mRNA, which was already evident 1 h after addition of the particles\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "af796496-f148-4ed5-b2d4-f6518aecd1dd",
        "_rev": "_WpvYGJC--2",
        "nanopub": {
            "id": "af796496-f148-4ed5-b2d4-f6518aecd1dd",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "DAS28",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "43 RA patients, 14 age/sex matched HC",
                    "type": "cohort"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Pandya, Jayesh M",
                    "Lundell, Anna-Carin",
                    "Andersson, Kerstin",
                    "Nordstr\u00f6m, Inger",
                    "Theander, Elke",
                    "Rudin, Anna"
                ],
                "database": {
                    "id": "28148302",
                    "name": "PubMed"
                },
                "source_name": "Arthritis research & therapy",
                "title": "Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker.",
                "abstract": "We have recently analyzed the profile of T-cell subtypes based on chemokine receptor expression in blood from untreated early rheumatoid arthritis (ueRA) patients compared to healthy controls (HC). Here, we compared the levels of the respective chemokines in blood plasma of ueRA patients with those of HC. We also studied the association of chemokine levels with the proportions of circulating T-cell subsets and the clinical disease activity."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CXCL10)\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "CXCL10 correlated with multiple disease activity measures, including DAS28-CRP, DAS28-ESR, CDAI, SJC in 66 joints, CRP, and ESR.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "We have recently analyzed the profile of T-cell subtypes based on chemokine receptor expression in blood from untreated early rheumatoid arthritis (ueRA) patients compared to healthy controls (HC). Here, we compared the levels of the respective chemokines in blood plasma of ueRA patients with those of HC. We also studied the association of chemokine levels with the proportions of circulating T-cell subsets and the clinical disease activity.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "50ebf49f-2e92-4af6-9976-a0da9b37b83f",
        "_rev": "_WpvYGJG--y",
        "nanopub": {
            "id": "50ebf49f-2e92-4af6-9976-a0da9b37b83f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Cell",
                    "id": "MESH:D061307",
                    "label": "Human Umbilical Vein Endothelial Cells"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Wen, Ya-Dan",
                    "Wang, Hong",
                    "Kho, Sok-Hong",
                    "Rinkiko, Suguro",
                    "Sheng, Xiong",
                    "Shen, Han-Ming",
                    "Zhu, Yi-Zhun"
                ],
                "database": {
                    "id": "23393548",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress.",
                "abstract": "Hydrogen sulfide (H\u2082S) has been shown to have cytoprotective effects in models of hypertension, ischemia/reperfusion and Alzheimer's disease. However, little is known about its effects or mechanisms of action in atherosclerosis. Therefore, in the current study we evaluated the pharmacological effects of H\u2082S on antioxidant defenses and mitochondria protection against hydrogen peroxide (H\u2082O\u2082) induced endothelial cells damage.",
                "date_published": "2013-01-01"
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"hydrogen peroxide\")",
                    "relation": "decreases",
                    "object": "p(HGNC:SOD1)"
                }
            ],
            "evidence": "When cells were stimulated with H2O2 a significant decreases in the activities of superoxide dismutase (SOD), catalase, glutathione Peroxidase (GPx) and glutathione S-transferase (GST) were observed (P<0.05, vs. control, n\u200a=\u200a6).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "71ba4de1-8b94-42d7-80e2-57290e88bb14",
        "_rev": "_WpvYGJ--CM",
        "nanopub": {
            "id": "71ba4de1-8b94-42d7-80e2-57290e88bb14",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16648838",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17)",
                    "relation": "biomarkerFor",
                    "object": "bp(GO:\"T-helper 17 cell differentiation\")"
                }
            ],
            "evidence": "Although neither TGF-b nor IL-6 alone induced the generation of IL-17-producing T cells from naive 2D2 TCR transgenic T cells, a combination of the two cytokines (IL-6 plus TGF-b), consistent with a recently published report16, induced most naive T cells (80.9%) to produce IL-17 (Fig. 2c).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d8a3ab17-7a99-4bfa-8c2d-0dedb03ec767",
        "_rev": "_WpvYGJG-BI",
        "nanopub": {
            "id": "d8a3ab17-7a99-4bfa-8c2d-0dedb03ec767",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                },
                {
                    "id": "MESH:\"Synovial Fluid\"",
                    "label": "Synovial Fluid",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "40 RA patients, 36 age/sex matched HC",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Zheng, Yingxia",
                    "Sun, Lei",
                    "Jiang, Ting",
                    "Zhang, Dongqing",
                    "He, Dongyi",
                    "Nie, Hong"
                ],
                "database": {
                    "id": "25436214",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology research",
                "title": "TNF\u03b1 promotes Th17 cell differentiation through IL-6 and IL-1\u03b2 produced by monocytes in rheumatoid arthritis.",
                "abstract": "TNF\u03b1 plays an important role in autoimmune pathogenesis and is the main therapeutic target of rheumatoid arthritis. However, its underlying mechanism is not completely understood. In this study, we described that Th17 cells were accumulated in synovial fluid, which was attributable to TNF\u03b1 aberrantly produced in rheumatoid synovium. Interestingly, TNF\u03b1 cannot induce IL-17 production of CD4(+) T cells directly, but through the monocytes high levels of IL-1\u03b2 and IL-6 in a TNFRI and TNFRII dependent manner from the active RA patients are produced. TNF\u03b1 was shown to enhance the phosphorylation level of STAT3 and the expression level of transcription factor RORC of CD4(+) T cells when cultured with CD14(+) monocytes. Treatment with an approved TNF\u03b1 blocking antibody showed marked reduction in the levels of IL-6, IL-1\u03b2, and IL-17 and the expression level of STAT3 phosphorylation in relation to Th17 cell differentiation in patients with rheumatoid arthritis. The study provides new evidence supporting the critical role of TNF\u03b1 in the pathogenic Th17 cell differentiation in rheumatoid arthritis."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:anti-TNF)\t",
                    "relation": "decreases",
                    "object": "p(HGNC:IL17)"
                },
                {
                    "subject": "a(CHEBI:anti-TNF)",
                    "relation": "decreases",
                    "object": "p(HGNC:IL1B)"
                },
                {
                    "subject": "a(CHEBI:anti-TNF)",
                    "relation": "decreases",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "Treatment with an approved TNF\u03b1 blocking antibody showed marked reduction in the levels of IL-6, IL-1\u03b2, and IL-17 and the expression level of STAT3 phosphorylation in relation to Th17 cell differentiation in patients with rheumatoid arthritis.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "TNF\u03b1 plays an important role in autoimmune pathogenesis and is the main therapeutic target of rheumatoid arthritis. However, its underlying mechanism is not completely understood. In this study, we described that Th17 cells were accumulated in synovial fluid, which was attributable to TNF\u03b1 aberrantly produced in rheumatoid synovium. Interestingly, TNF\u03b1 cannot induce IL-17 production of CD4(+) T cells directly, but through the monocytes high levels of IL-1\u03b2 and IL-6 in a TNFRI and TNFRII dependent manner from the active RA patients are produced. TNF\u03b1 was shown to enhance the phosphorylation level of STAT3 and the expression level of transcription factor RORC of CD4(+) T cells when cultured with CD14(+) monocytes. Treatment with an approved TNF\u03b1 blocking antibody showed marked reduction in the levels of IL-6, IL-1\u03b2, and IL-17 and the expression level of STAT3 phosphorylation in relation to Th17 cell differentiation in patients with rheumatoid arthritis. The study provides new evidence supporting the critical role of TNF\u03b1 in the pathogenic Th17 cell differentiation in rheumatoid arthritis.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9facfbf9-a92f-4747-adee-c9e3918c84c8",
        "_rev": "_WpvYGJG--G",
        "nanopub": {
            "id": "9facfbf9-a92f-4747-adee-c9e3918c84c8",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL1B)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "A significant pre-flare increase in IL-1\u03b2 and decrease in IL-1RA resulted in a 2.7-fold decrease in the IL-1RA:IL-1\u03b2 ratio compared to stable periods in the same patient (Figure 2G). \n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2af12a37-a2c0-4fe1-9147-1d9368343769",
        "_rev": "_WpvYGI6--d",
        "nanopub": {
            "id": "2af12a37-a2c0-4fe1-9147-1d9368343769",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "r=0.37",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CXCL10)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "117171a4-f54a-4c7e-a24c-c97763bbd0c0",
        "_rev": "_WpvYGJC-Af",
        "nanopub": {
            "id": "117171a4-f54a-4c7e-a24c-c97763bbd0c0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Frob\u00f8se, Helle",
                    "R\u00f8nn, Sif Groth",
                    "Heding, Peter E",
                    "Mendoza, Heidi",
                    "Cohen, Philip",
                    "Mandrup-Poulsen, Thomas",
                    "Billestrup, Nils"
                ],
                "database": {
                    "id": "16543409",
                    "name": "PubMed"
                },
                "source_name": "Molecular endocrinology (Baltimore, Md.)",
                "title": "Suppressor of cytokine Signaling-3 inhibits interleukin-1 signaling by targeting the TRAF-6/TAK1 complex.",
                "abstract": "IL-1 plays a major role in inflammation and autoimmunity through activation of nuclear factor kappa B (NFkappaB) and MAPKs. Although a great deal is known about the mechanism of activation of NFkappaB and MAPKs by IL-1, much less is known about the down-regulation of this pathway. Suppressor of cytokine signaling (SOCS)-3 was shown to inhibit IL-1-induced transcription and activation of NFkappaB and the MAPKs JNK and p38, but the mechanism is unknown. We show here that SOCS-3 inhibits NFkappaB-dependent transcription induced by overexpression of the upstream IL-1 signaling molecules MyD88, IL-1R-activated kinase 1, TNF receptor-associated factor (TRAF)6, and TGFbeta-activated kinase (TAK)1, but not when the MAP3K MAPK/ERK kinase kinase-1 is used instead of TAK1, indicating that the target for SOCS-3 is the TRAF6/TAK1 signaling complex. By coimmunoprecipitation, it was shown that SOCS-3 inhibited the association between TRAF6 and TAK1 and that SOCS-3 coimmunoprecipitated with TAK1 and TRAF6. Furthermore, SOCS-3 inhibited the IL-1-induced catalytic activity of TAK1. Because ubiquitination of TRAF6 is required for activation of TAK1, we analyzed the role of SOCS-3 on TRAF6 ubiquitination and found that SOCS-3 inhibited ubiquitin modification of TRAF6. These results indicate that SOCS-3 inhibits IL-1 signal transduction by inhibiting ubiquitination of TRAF6, thus preventing association and activation of TAK1."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:SOCS3)",
                    "relation": "decreases",
                    "object": "complex(p(HGNC:NR2C2), p(HGNC:TRAF6))"
                },
                {
                    "subject": "p(HGNC:TRAF6)",
                    "relation": "increases",
                    "object": "complex(p(HGNC:TRAF6), p(HGNC:NR2C2), p(HGNC:TAB2))"
                }
            ],
            "evidence": "Having identified the level of inhibition likely to be at the level of the TAK1/TAB1 complex, we next analyzed whether SOCS-3 was able to inhibit the formation of the active TRAF6/TAK1/TAB complex. Because binding of TAK1 to TRAF6 is a crucial step in the activation of TAK1 catalytic activity, we analyzed the binding of TAK1 to TRAF6 by coimmunoprecipitation. We found that transfection of human embryonic kidney (HEK) 293 cells with TRAF6, TAK1, and TAB1 resulted in TRAF6 and TAK1 interaction revealed by specific coimmunoprecipitation of TRAF6 and TAK1 (Fig. 5, middle panel, lane 7). When cotransfected with SOCS-3, the amount of TAK1 coimmunoprecipitated with TRAF-6 was reduced (Fig. 5, middle panel, compare lanes 7 and 8).",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "IL-1 plays a major role in inflammation and autoimmunity through activation of nuclear factor kappa B (NFkappaB) and MAPKs. Although a great deal is known about the mechanism of activation of NFkappaB and MAPKs by IL-1, much less is known about the down-regulation of this pathway. Suppressor of cytokine signaling (SOCS)-3 was shown to inhibit IL-1-induced transcription and activation of NFkappaB and the MAPKs JNK and p38, but the mechanism is unknown. We show here that SOCS-3 inhibits NFkappaB-dependent transcription induced by overexpression of the upstream IL-1 signaling molecules MyD88, IL-1R-activated kinase 1, TNF receptor-associated factor (TRAF)6, and TGFbeta-activated kinase (TAK)1, but not when the MAP3K MAPK/ERK kinase kinase-1 is used instead of TAK1, indicating that the target for SOCS-3 is the TRAF6/TAK1 signaling complex. By coimmunoprecipitation, it was shown that SOCS-3 inhibited the association between TRAF6 and TAK1 and that SOCS-3 coimmunoprecipitated with TAK1 and TRAF6. Furthermore, SOCS-3 inhibited the IL-1-induced catalytic activity of TAK1. Because ubiquitination of TRAF6 is required for activation of TAK1, we analyzed the role of SOCS-3 on TRAF6 ubiquitination and found that SOCS-3 inhibited ubiquitin modification of TRAF6. These results indicate that SOCS-3 inhibits IL-1 signal transduction by inhibiting ubiquitination of TRAF6, thus preventing association and activation of TAK1.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3a67c48d-42cb-48e3-9f50-089527fcd082",
        "_rev": "_WpvYGJG--2",
        "nanopub": {
            "id": "3a67c48d-42cb-48e3-9f50-089527fcd082",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"umbilical artery endothelial cell\"",
                    "label": "umbilical artery endothelial cell",
                    "type": "Cell"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Watkins, M T",
                    "Patton, G M",
                    "Soler, H M",
                    "Albadawi, H",
                    "Humphries, D E",
                    "Evans, J E",
                    "Kadowaki, H"
                ],
                "database": {
                    "id": "10585861",
                    "name": "PubMed"
                },
                "source_name": "The Biochemical journal",
                "title": "Synthesis of 8-epi-prostaglandin F2alpha by human endothelial cells: role of prostaglandin H2 synthase.",
                "abstract": "The experiments described in this paper were designed to determine the mechanism underlying the increase in 8-isoprostaglandin F(2alpha) (8-epi-PGF(2alpha)) production by cultured human endothelial cells during reoxygenation following hypoxia. Human umbilical artery endothelial cells were grown on microcarrier beads and exposed to sequential periods of normoxia, hypoxia, and reoxygenation. The amount of 8-epi-PGF(2alpha) in the medium was determined by ELISA. The production of 8-epi-PGF(2alpha) decreased by greater than 90% during hypoxia. Upon reoxygenation 8-epi-PGF(2alpha) production increased linearly for 90 min reaching nearly 3 times normoxic levels. When added to the medium during reoxygenation, neither superoxide dismutase nor Tiron, a cell-permeable superoxide scavenger, inhibited 8-epi-PGF(2alpha) production. However, 8-epi-PGF(2alpha) production was inhibited by catalase. The production of 8-epi-PGF(2alpha) was also inhibited by indomethacin and aspirin. Exogenous hydrogen peroxide stimulated 8-epi-PGF(2alpha) production by normoxic cells, and aspirin inhibited the hydrogen peroxide-mediated increase in 8-epi-PGF(2alpha) production. These results indicate that the reactive oxygen species responsible for 8-epi-PGF(2alpha) synthesis during reoxygenation is hydrogen peroxide and that in endothelial cells 8-epi-PGF(2alpha) synthesis is mediated by prostaglandin H(2) synthase (PGHS). To verify the role of PGHS in 8-epi-PGF(2alpha) synthesis, human PGHS-1 was expressed in COS-7 cells, a PGHS negative cell line that does not synthesize 8-epi-PGF(2alpha). In the presence of exogenous arachidonic acid the COS-7 cells expressing human PGHS-1 produced substantial amounts of PGE(2) and 8-epi-PGF(2alpha). These data indicate that human PGHS-1 can support the synthesis of 8-epi-PGF(2alpha) and that 8-epi-PGF(2alpha) synthesis by cultured human endothelial cells during reoxygenation is dependent on the activity of PGHS-1."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"hydrogen peroxide\")",
                    "relation": "increases",
                    "object": "a(CHEBI:\"8-epi-prostaglandin F2alpha\")"
                }
            ],
            "evidence": "Hydrogen peroxide (50 uM) progressivelyincreased 8-epi-PGF2alpha production (Figure 4, solidbars).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2a5b38d7-0007-414a-94d2-bb8dbb476ca3",
        "_rev": "_WpvYGJG-_b",
        "nanopub": {
            "id": "2a5b38d7-0007-414a-94d2-bb8dbb476ca3",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8602264",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT6)",
                    "relation": "regulates",
                    "object": "bp(GO:\"T helper 2 cell differentiation\")"
                }
            ],
            "evidence": "Although naive lymphoid cell development was normal, Stat6 -/- mice were deficient in IL-4-mediated functions including Th2 helper T-cell differentiation, expression of cell surface markers, and immunoglobulin class switching to IgE.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "816aa829-8f08-4f87-9987-d96ce156e4c7",
        "_rev": "_WpvYGJC-AR",
        "nanopub": {
            "id": "816aa829-8f08-4f87-9987-d96ce156e4c7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "MESH:D008180",
                    "label": "Lupus Erythematosus, Systemic",
                    "type": "Disease"
                }
            ],
            "citation": {
                "authors": [
                    "Munroe, Melissa E",
                    "Vista, Evan S",
                    "Guthridge, Joel M",
                    "Thompson, Linda F",
                    "Merrill, Joan T",
                    "James, Judith A"
                ],
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "source_name": "Arthritis & rheumatology (Hoboken, N.J.)",
                "title": "Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare.",
                "abstract": "Systemic lupus erythematosus (SLE) is a multifaceted disease characterized by immune dysregulation and unpredictable disease activity. This study sought to evaluate the changes in plasma concentrations of soluble mediators that precede clinically defined disease flares."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CXCL10)",
                    "relation": "positiveCorrelation",
                    "object": "path(flare)"
                }
            ],
            "evidence": "In addition, levels of plasma IP-10, MCP-1 and MCP-3 (Figure 2D), along with IL-8 and ICAM-1 (Supplementary Figure 2H), were significantly elevated in pre-flare periods compared to periods of stable disease.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:abstract": "Systemic lupus erythematosus (SLE) is a multifaceted disease characterized by immune dysregulation and unpredictable disease activity. This study sought to evaluate the changes in plasma concentrations of soluble mediators that precede clinically defined disease flares.",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bd1a786b-b972-4cdc-892d-06e0d3f1a9b0",
        "_rev": "_WpvYGJC--U",
        "nanopub": {
            "id": "bd1a786b-b972-4cdc-892d-06e0d3f1a9b0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "authors": [
                    "Vendelbo, Mikkel Holm",
                    "M\u00f8ller, Andreas Buch",
                    "Christensen, Britt",
                    "Nellemann, Birgitte",
                    "Clasen, Berthil Frederik Forrest",
                    "Nair, K Sreekumaran",
                    "J\u00f8rgensen, Jens Otto Lunde",
                    "Jessen, Niels",
                    "M\u00f8ller, Niels"
                ],
                "database": {
                    "id": "25020061",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Fasting increases human skeletal muscle net phenylalanine release and this is associated with decreased mTOR signaling.",
                "abstract": "Fasting is characterised by profound changes in energy metabolism including progressive loss of body proteins. The underlying mechanisms are however unknown and we therefore determined the effects of a 72-hour-fast on human skeletal muscle protein metabolism and activation of mammalian target of rapamycin (mTOR), a key regulator of cell growth.",
                "date_published": "2014-01-01"
            },
            "assertions": [
                {
                    "subject": "bp(MESH:Fasting)",
                    "relation": "increases",
                    "object": "a(MESH:\"Fatty Acids\")"
                }
            ],
            "evidence": "During fasting FFA concentration was increased by \u223c100%\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true,
                "gd:abstract": "Fasting is characterised by profound changes in energy metabolism including progressive loss of body proteins. The underlying mechanisms are however unknown and we therefore determined the effects of a 72-hour-fast on human skeletal muscle protein metabolism and activation of mammalian target of rapamycin (mTOR), a key regulator of cell growth."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4bf0ff78-4a1b-46bf-b514-5ea2d2d5a4d9",
        "_rev": "_WpvYGJG-_o",
        "nanopub": {
            "id": "4bf0ff78-4a1b-46bf-b514-5ea2d2d5a4d9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SELENA-SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "Two hundred forty-five SLE patients were evaluated prospectively over a 2-year period; Ninety-two percent of the patients were female. Sixty-seven percent were white, 31% African American, and 2% Asian (all of these groups may include Hispanic).",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "18668552",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNFSF13B)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Univariate analysis showed that plasma BLyS levels were associated with anti-dsDNA titers (P = 0.0465) and SELENA-SLEDAI scores (P = 0.0002). In multivariate analyses, a greater increase in the SELENA-SLEDAI score from the previous visit was associated with higher BLyS levels at the previous visit (P = 0.0042) and with a greater increase in the BLyS level from the previous visit (P = 0.0007).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9bb3be1c-05be-4d1a-9d39-9d2d302fdeae",
        "_rev": "_WpvYGJ--AW",
        "nanopub": {
            "id": "9bb3be1c-05be-4d1a-9d39-9d2d302fdeae",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "authors": [
                    "Vendelbo, Mikkel Holm",
                    "M\u00f8ller, Andreas Buch",
                    "Christensen, Britt",
                    "Nellemann, Birgitte",
                    "Clasen, Berthil Frederik Forrest",
                    "Nair, K Sreekumaran",
                    "J\u00f8rgensen, Jens Otto Lunde",
                    "Jessen, Niels",
                    "M\u00f8ller, Niels"
                ],
                "database": {
                    "id": "25020061",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Fasting increases human skeletal muscle net phenylalanine release and this is associated with decreased mTOR signaling.",
                "abstract": "Fasting is characterised by profound changes in energy metabolism including progressive loss of body proteins. The underlying mechanisms are however unknown and we therefore determined the effects of a 72-hour-fast on human skeletal muscle protein metabolism and activation of mammalian target of rapamycin (mTOR), a key regulator of cell growth."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:Fasting)",
                    "relation": "increases",
                    "object": "bp(\"Muscle Breakdown\")"
                },
                {
                    "subject": "bp(MESH:Fasting)",
                    "relation": "increases",
                    "object": "a(CHEBI:phenylalanine)"
                }
            ],
            "evidence": "phenylalanine kinetics across the forearm revealed a significant increase in net skeletal muscle breakdown as noted by an \u223c100% increase in net phenylalanine release.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true,
                "gd:abstract": "Fasting is characterised by profound changes in energy metabolism including progressive loss of body proteins. The underlying mechanisms are however unknown and we therefore determined the effects of a 72-hour-fast on human skeletal muscle protein metabolism and activation of mammalian target of rapamycin (mTOR), a key regulator of cell growth."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0bc6dafd-3a7c-4641-9206-9ac329bd185a",
        "_rev": "_WpvYGJG--5",
        "nanopub": {
            "id": "0bc6dafd-3a7c-4641-9206-9ac329bd185a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "250 pairs of liver tumor and adjacent non-tumorous liver tissues (ANLTs)",
                    "type": "Cohort"
                },
                {
                    "id": "DO:\"hepatocellular carcinoma\"",
                    "label": "hepatocellular carcinoma",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:liver",
                    "label": "liver",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "Colony Formation Assay",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "25998163",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "m(\"miR-188-5p\")",
                    "relation": "decreases",
                    "object": "path(MESH:\"Carcinoma, Hepatocellular\")"
                }
            ],
            "evidence": "The result showed that compared with the control group, HCCLM3miR-188-5p cells had more than 60% decrease in colony numbers (197 \u00b1 42 vs. 76 \u00b1 25, p\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7cad07d4-bd49-4f7b-845c-a18ccb5c39c6",
        "_rev": "_WpvYGJC-CD",
        "nanopub": {
            "id": "7cad07d4-bd49-4f7b-845c-a18ccb5c39c6",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "10358188",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:neutrophil)\t",
                    "relation": "increases",
                    "object": "r(HGNC:MIP1B)"
                },
                {
                    "subject": "a(CL:neutrophil)",
                    "relation": "increases",
                    "object": "r(HGNC:MIP1A)"
                }
            ],
            "evidence": "As shown in Fig. 3, RT-PCR analysis demonstrates rapid up-regulation of transcripts for both MIP-1a and MIP-1b, and up-regulation of these transcripts was sustained for at least 12 h following culture initiation\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "dd59df01-dfab-483b-a35d-2173c4deb7fc",
        "_rev": "_WpvYGJG--7",
        "nanopub": {
            "id": "dd59df01-dfab-483b-a35d-2173c4deb7fc",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "authors": [
                    "van der Lans, Anouk A J J",
                    "Boon, Mari\u00ebtte R",
                    "Haks, Mari\u00eblle C",
                    "Quinten, Edwin",
                    "Schaart, Gert",
                    "Ottenhoff, Tom H",
                    "van Marken Lichtenbelt, Wouter D"
                ],
                "database": {
                    "id": "26149277",
                    "name": "PubMed"
                },
                "source_name": "Physiological reports",
                "title": "Cold acclimation affects immune composition in skeletal muscle of healthy lean subjects.",
                "abstract": "Low environmental temperatures have a profound effect on biological processes in the body, including the immune system. Cold exposure coincides with hormonal changes, which may directly or indirectly alter the immune system, even in the skeletal muscle. The aim of the present study was to investigate the effect of cold acclimation on immune composition in skeletal muscle. Skeletal muscle biopsies were obtained from 17 healthy lean subjects before and after 10\u00a0days of mild cold exposure (15 \u00b0: C, 6\u00a0h/day). Nonshivering thermogenesis was calculated by indirect calorimetry. We found that cold acclimation increased nonshivering thermogenesis from 10.8\u00a0\u00b1\u00a07.5 before to 17.8\u00a0\u00b1\u00a011.1% after cold acclimation (P\u00a0<\u00a00.01), but did not affect plasma catecholamine nor cytokine levels. In contrast, cold acclimation affected mRNA expression of several immune cell markers in skeletal muscle. It downregulated expression of the Th17 markers RORC (-28%, P\u00a0<\u00a00.01) and NEDD4L (-15%, P\u00a0<\u00a00.05), as well as the regulatory T-cell marker FOXP3 (-13%, P\u00a0<\u00a00.05). Furthermore, cold acclimation downregulated expression of the M2 macrophage markers CCL22 (-50%, P\u00a0<\u00a00.05), CXCL13 (-17%, P\u00a0<\u00a00.05) and CD209 (-15%, P\u00a0<\u00a00.05), while the M1 macrophage marker IL12B was upregulated (+141%, P\u00a0<\u00a00.05). Cold acclimation also enhanced several markers related to interferon (IFN) signaling, including TAP1 (+12%, P\u00a0<\u00a00.01), IFITM1/3 (+11%, P\u00a0<\u00a00.05), CD274 (+36%, P\u00a0<\u00a00.05) and STAT 2 (+10%, P\u00a0<\u00a00.05). In conclusion, 10\u00a0days of intermittent cold exposure induces marked changes in the expression of immune cell markers in skeletal muscle of healthy lean subjects. The physiological consequences and therapeutic relevance of these changes remain to be determined."
            },
            "assertions": [
                {
                    "subject": "bp(GO:\"cold acclimation\")",
                    "relation": "causesNoChange",
                    "object": "a(CHEBI:catecholamine)"
                }
            ],
            "evidence": "We found that cold acclimation increased nonshivering thermogenesis from 10.8 \u00b1 7.5 before to 17.8 \u00b1 11.1% after cold acclimation (P < 0.01), but did not affect plasma catecholamine nor cytokine levels. ",
            "metadata": {
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "65eaf716-3703-42de-aed8-cb01fc5b5238",
        "_rev": "_WpvYGJC--r",
        "nanopub": {
            "id": "65eaf716-3703-42de-aed8-cb01fc5b5238",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.038",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "87 SLE (41 with history of thrombosis)",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12559629",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"IgG antiphosphatidylinositol\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:Thrombosis)"
                }
            ],
            "evidence": "Thrombosis was significantly associated with IgG-aPA (p = 0.044), IgG-aPI (p = 0.038), IgG-aPS (p = 0.026), IgG-abeta(2)-GPI, IgM-aPA (p = 0.044), IgM-aPI (p = 0.024), and IgM-aPS (p = 0.01), irrespective of antibody titer, whereas IgG-aCL were associated with thrombosis and thrombocytopenia when taken at medium-high titer (p = 0.009 and p = 0.046, respectively).\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "07a3cb19-646a-4a7b-b7d0-87257252b758",
        "_rev": "_WpvYGJC-CI",
        "nanopub": {
            "id": "07a3cb19-646a-4a7b-b7d0-87257252b758",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "MESH:D061307",
                    "label": "Human Umbilical Vein Endothelial Cells",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Wen, Ya-Dan",
                    "Wang, Hong",
                    "Kho, Sok-Hong",
                    "Rinkiko, Suguro",
                    "Sheng, Xiong",
                    "Shen, Han-Ming",
                    "Zhu, Yi-Zhun"
                ],
                "comments": "SOD1 and SOD2 were separately measured in this experiment.",
                "database": {
                    "id": "23393548",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress.",
                "abstract": "Hydrogen sulfide (H\u2082S) has been shown to have cytoprotective effects in models of hypertension, ischemia/reperfusion and Alzheimer's disease. However, little is known about its effects or mechanisms of action in atherosclerosis. Therefore, in the current study we evaluated the pharmacological effects of H\u2082S on antioxidant defenses and mitochondria protection against hydrogen peroxide (H\u2082O\u2082) induced endothelial cells damage."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"hydrogen peroxide\")",
                    "relation": "decreases",
                    "object": "p(HGNC:SOD2)"
                }
            ],
            "evidence": "When cells were stimulated with H2O2 a significant decreases in the activities of superoxide dismutase (SOD), catalase, glutathione Peroxidase (GPx) and glutathione S-transferase (GST) were observed (P<0.05, vs. control, n\u200a=\u200a6).",
            "metadata": {
                "Methodology": "western blot",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "038833e0-4004-46c5-8436-cff3469d2e1b",
        "_rev": "_WpvYGJ---z",
        "nanopub": {
            "id": "038833e0-4004-46c5-8436-cff3469d2e1b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNFRSF1B)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Symptom Flare Up\")"
                },
                {
                    "subject": "p(HGNC:TNFRSF1A)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Symptom Flare Up\")"
                },
                {
                    "subject": "p(HGNC:TNF)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "Compared to periods of stable disease, pre-flare periods were marked by increases in soluble TNF-\u03b1 and sFas (nonsignificant) and further increases in TNFRI, TNFRII, FasL, and CD40L (Figure 2E and Supplementary Table 4).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b0bcfe85-8a33-4b65-a003-f9e7528e1280",
        "_rev": "_WpvYGJG-BE",
        "nanopub": {
            "id": "b0bcfe85-8a33-4b65-a003-f9e7528e1280",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "61 SLE,\u00a030 RA,\u00a054 HC",
                    "type": "cohort"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Hakkim, Abdul",
                    "F\u00fcrnrohr, Barbara G",
                    "Amann, Kerstin",
                    "Laube, Britta",
                    "Abed, Ulrike Abu",
                    "Brinkmann, Volker",
                    "Herrmann, Martin",
                    "Voll, Reinhard E",
                    "Zychlinsky, Arturo"
                ],
                "database": {
                    "id": "20439745",
                    "name": "PubMed"
                },
                "source_name": "Proceedings of the National Academy of Sciences of the United States of America",
                "title": "Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis.",
                "abstract": "Systemic lupus erythematosus (SLE) is an autoimmune disease in which patients develop autoantibodies to DNA, histones, and often to neutrophil proteins. These form immune complexes that are pathogenic and may cause lupus nephritis. In SLE patients, infections can initiate flares and are a major cause of mortality. Neutrophils respond to infections and release extracellular traps (NETs), which are antimicrobial and are made of DNA, histones, and neutrophil proteins. The timely removal of NETs may be crucial for tissue homeostasis to avoid presentation of self-antigens. We tested the hypothesis that SLE patients cannot clear NETs, contributing to the pathogenesis of lupus nephritis. Here we show that serum endonuclease DNase1 is essential for disassembly of NETs. Interestingly, a subset of SLE patients' sera degraded NETs poorly. Two mechanisms caused this impaired NET degradation: (i) the presence of DNase1 inhibitors or (ii) anti-NET antibodies prevented DNase1 access to NETs. Impairment of DNase1 function and failure to dismantle NETs correlated with kidney involvement. Hence, identification of SLE patients who cannot dismantle NETs might be a useful indicator of renal involvement. Moreover, NETs might represent a therapeutic target in SLE.",
                "date_published": "2010-05-25"
            },
            "assertions": [
                {
                    "subject": "a(NETs)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\" )"
                }
            ],
            "evidence": "In the NET degradation assay, sera from healthy donors dismantled NETs efficiently, with a mean percentage degradation of 98.1% and an SD of \u00b18.2% (Fig. 2A). All but one of the sera from control RA patients degraded NETs normally (mean 91.3% \u00b1 16.7%). Interestingly, we identified two populations in the SLE sera; 63.9% were \u201cdegraders\u201d and 36.1% were \u201cnondegraders\u201d. These results were confirmed by microscopy; accordingly, we observed that NETs were degraded by sera from healthy donors (Fig. 2B) and a subgroup of SLE patients (Fig. 2C).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "174e9f72-35de-42a2-8702-2ac6d3f07156",
        "_rev": "_WpvYGJ---3",
        "nanopub": {
            "id": "174e9f72-35de-42a2-8702-2ac6d3f07156",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Pickering, M C",
                    "Walport, M J"
                ],
                "database": {
                    "id": "10725062",
                    "name": "PubMed"
                },
                "source_name": "Rheumatology (Oxford, England)",
                "title": "Links between complement abnormalities and systemic lupus erythematosus.",
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(anti-C1q)\t",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:C1Q)"
                },
                {
                    "subject": "a(anti-C1q)\t",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:C3)"
                },
                {
                    "subject": "a(anti-C1q)",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:C4)"
                }
            ],
            "evidence": "Anti\u2010C1q antibodies are IgG autoantibodies that are directed against neo\u2010epitopes on the collagen\u2010like region of the C1q molecule [69]. These antibodies, found in 34\u201359% of lupus patients [75], show a significant inverse correlation with levels of C1q, C3 and C4 [73, 76].",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7362936b-8c0a-434a-92eb-33c2a8e5d184",
        "_rev": "_WpvYGJC-AJ",
        "nanopub": {
            "id": "7362936b-8c0a-434a-92eb-33c2a8e5d184",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"C-Reactive Protein\"",
                    "label": "C-Reactive Protein",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "43 RA patients, 14 age/sex matched HC",
                    "type": "cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Pandya, Jayesh M",
                    "Lundell, Anna-Carin",
                    "Andersson, Kerstin",
                    "Nordstr\u00f6m, Inger",
                    "Theander, Elke",
                    "Rudin, Anna"
                ],
                "database": {
                    "id": "28148302",
                    "name": "PubMed"
                },
                "source_name": "Arthritis research & therapy",
                "title": "Blood chemokine profile in untreated early rheumatoid arthritis: CXCL10 as a disease activity marker.",
                "abstract": "We have recently analyzed the profile of T-cell subtypes based on chemokine receptor expression in blood from untreated early rheumatoid arthritis (ueRA) patients compared to healthy controls (HC). Here, we compared the levels of the respective chemokines in blood plasma of ueRA patients with those of HC. We also studied the association of chemokine levels with the proportions of circulating T-cell subsets and the clinical disease activity."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CXCL10)\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "CXCL10 correlated with multiple disease activity measures, including DAS28-CRP, DAS28-ESR, CDAI, SJC in 66 joints, CRP, and ESR.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true,
                "gd:abstract": "We have recently analyzed the profile of T-cell subtypes based on chemokine receptor expression in blood from untreated early rheumatoid arthritis (ueRA) patients compared to healthy controls (HC). Here, we compared the levels of the respective chemokines in blood plasma of ueRA patients with those of HC. We also studied the association of chemokine levels with the proportions of circulating T-cell subsets and the clinical disease activity."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "51f9449f-bd2f-459a-8bb8-e8fc8b870d06",
        "_rev": "_WpvYGJC-Bm",
        "nanopub": {
            "id": "51f9449f-bd2f-459a-8bb8-e8fc8b870d06",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "90 SLE with no manifestations of APS",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "9918247",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"anticardiolipin\")\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "p(\"anticardiolipin\")",
                    "relation": "positiveCorrelation",
                    "object": "p(\"anti-dsDNA\")"
                }
            ],
            "evidence": "Presence of aCL also correlated with hemoglobin level, anti-DNA antibody, leukocyte count, and the SLE Disease Activity Index (SLEDAI).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d4e9345c-d68a-466c-a4c6-ba14243c4036",
        "_rev": "_WpvYGJ---b",
        "nanopub": {
            "id": "d4e9345c-d68a-466c-a4c6-ba14243c4036",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Leffler, Jonatan",
                    "Bengtsson, Anders A",
                    "Blom, Anna M"
                ],
                "database": {
                    "id": "24845390",
                    "name": "PubMed"
                },
                "source_name": "Annals of the rheumatic diseases",
                "title": "The complement system in systemic lupus erythematosus: an update.",
                "abstract": "The complement system plays a major role in the autoimmune disease, systemic lupus erythematosus (SLE). However, the role of complement in SLE is complex since it may both prevent and exacerbate the disease. In this review, we explore the latest findings in complement-focused research in SLE. C1q deficiency is the strongest genetic risk factor for SLE, although such deficiency is very rare. Various recently discovered genetic associations include mutations in the complement receptors 2 and 3 as well as complement inhibitors, the latter related to earlier onset of nephritis. Further, autoantibodies are a distinct feature of SLE that are produced as the result of an adaptive immune response and how complement can affect that response is also being reviewed. SLE generates numerous disease manifestations involving contributions from complement such as glomerulonephritis and the increased risk of thrombosis. Furthermore, since most of the complement system is present in plasma, complement is very accessible and may be suitable as biomarker for diagnosis or monitoring of disease activity. This review highlights the many roles of complement for SLE pathogenesis and how research has progressed during recent years."
            },
            "assertions": [
                {
                    "subject": "a(anti-C1Q)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                }
            ],
            "evidence": "The level of C1q antibodies is a good predicative marker for LN,47 48 since the antibodies amplify the effect of C1q-containing ICs in the kidneys.",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "The complement system plays a major role in the autoimmune disease, systemic lupus erythematosus (SLE). However, the role of complement in SLE is complex since it may both prevent and exacerbate the disease. In this review, we explore the latest findings in complement-focused research in SLE. C1q deficiency is the strongest genetic risk factor for SLE, although such deficiency is very rare. Various recently discovered genetic associations include mutations in the complement receptors 2 and 3 as well as complement inhibitors, the latter related to earlier onset of nephritis. Further, autoantibodies are a distinct feature of SLE that are produced as the result of an adaptive immune response and how complement can affect that response is also being reviewed. SLE generates numerous disease manifestations involving contributions from complement such as glomerulonephritis and the increased risk of thrombosis. Furthermore, since most of the complement system is present in plasma, complement is very accessible and may be suitable as biomarker for diagnosis or monitoring of disease activity. This review highlights the many roles of complement for SLE pathogenesis and how research has progressed during recent years.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "00850c18-f4c6-446b-b4b5-1c6b6e169352",
        "_rev": "_WpvYGJ--CV",
        "nanopub": {
            "id": "00850c18-f4c6-446b-b4b5-1c6b6e169352",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"Hep G2 cell\"",
                    "label": "Hep G2 cell",
                    "type": "CellLine"
                },
                {
                    "id": "MESH:\"Epithelial Cells\"",
                    "label": "Epithelial Cells",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Brighenti, E",
                    "Calabrese, C",
                    "Liguori, G",
                    "Giannone, F A",
                    "Trer\u00e8, D",
                    "Montanaro, L",
                    "Derenzini, M"
                ],
                "database": {
                    "id": "24531714",
                    "name": "PubMed"
                },
                "source_name": "Oncogene",
                "title": "Interleukin 6 downregulates p53 expression and activity by stimulating ribosome biogenesis: a new pathway connecting inflammation to cancer.",
                "abstract": "Chronic inflammation is an established risk factor for the onset of cancer, and the inflammatory cytokine IL-6 has a role in tumorigenesis by enhancing proliferation and hindering apoptosis. As factors stimulating proliferation also downregulate p53 expression by enhancing ribosome biogenesis, we hypothesized that IL-6 may cause similar changes in inflamed tissues, thus activating a mechanism that favors neoplastic transformation. Here, we showed that IL-6 downregulated the expression and activity of p53 in transformed and untransformed human cell lines. This was the consequence of IL-6-dependent stimulation of c-MYC mRNA translation, which was responsible for the upregulation of rRNA transcription. The enhanced rRNA transcription stimulated the MDM2-mediated proteasomal degradation of p53, by reducing the availability of ribosome proteins for MDM2 binding. The p53 downregulation induced the acquisition of cellular phenotypic changes characteristic of epithelial-mesenchymal transition, such as a reduced level of E-cadherin expression, increased cell invasiveness and a decreased response to cytotoxic stresses. We found that these changes also occurred in colon epithelial cells of patients with ulcerative colitis, a very representative example of chronic inflammation at high risk for tumor development. Histochemical and immunohistochemical analysis of colon biopsy samples showed an upregulation of ribosome biogenesis, a reduced expression of p53, together with a focal reduction or absence of E-cadherin expression in chronic colitis in comparison with normal mucosa samples. These changes disappeared after treatment with anti-inflammatory drugs. Taken together, the present results highlight a new mechanism that may link chronic inflammation to cancer, based on p53 downregulation, which is activated by the enhancement of rRNA transcription upon IL-6 exposure."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "increases",
                    "object": "p(HGNC:MYC)"
                }
            ],
            "evidence": "in order to study the mechanism involved in the IL-6 stimulation of rRNA transcription, we investigated whether IL-6 enhanced the expression of c-myc protein also in the human epithelial cells used in the present study. For this reason we exposed both the NCM460 and the HepG2 cell lines to IL-6. We found that IL-6 significantly increased c-myc protein expression as early as 1\u2009h after IL-6 stimulation in both cell lines, as evaluated by western blot analysis (Figure 1c). ",
            "metadata": {
                "project": "Inflammation Index",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true,
                "gd:abstract": "Chronic inflammation is an established risk factor for the onset of cancer, and the inflammatory cytokine IL-6 has a role in tumorigenesis by enhancing proliferation and hindering apoptosis. As factors stimulating proliferation also downregulate p53 expression by enhancing ribosome biogenesis, we hypothesized that IL-6 may cause similar changes in inflamed tissues, thus activating a mechanism that favors neoplastic transformation. Here, we showed that IL-6 downregulated the expression and activity of p53 in transformed and untransformed human cell lines. This was the consequence of IL-6-dependent stimulation of c-MYC mRNA translation, which was responsible for the upregulation of rRNA transcription. The enhanced rRNA transcription stimulated the MDM2-mediated proteasomal degradation of p53, by reducing the availability of ribosome proteins for MDM2 binding. The p53 downregulation induced the acquisition of cellular phenotypic changes characteristic of epithelial-mesenchymal transition, such as a reduced level of E-cadherin expression, increased cell invasiveness and a decreased response to cytotoxic stresses. We found that these changes also occurred in colon epithelial cells of patients with ulcerative colitis, a very representative example of chronic inflammation at high risk for tumor development. Histochemical and immunohistochemical analysis of colon biopsy samples showed an upregulation of ribosome biogenesis, a reduced expression of p53, together with a focal reduction or absence of E-cadherin expression in chronic colitis in comparison with normal mucosa samples. These changes disappeared after treatment with anti-inflammatory drugs. Taken together, the present results highlight a new mechanism that may link chronic inflammation to cancer, based on p53 downregulation, which is activated by the enhancement of rRNA transcription upon IL-6 exposure."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4bd1b8d8-e6ec-4b06-8b9d-b6d67c8ff2df",
        "_rev": "_WpvYGJG-BG",
        "nanopub": {
            "id": "4bd1b8d8-e6ec-4b06-8b9d-b6d67c8ff2df",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.0003",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "77 SLE, 22 disease controls, 28 HC",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "15880830",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:IFI44)",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:C3)"
                },
                {
                    "subject": "r(HGNC:IFIT1)",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:C3)"
                },
                {
                    "subject": "r(EG:5610)",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:C3)"
                }
            ],
            "evidence": "Moreover, in the total patient group, the C3 level was significantly negatively correlated with the IFN\u03b1 score (Figure 3C).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "50ee2a54-63d2-43ff-a246-ccf0b8aba17a",
        "_rev": "_WpvYGJG-Ad",
        "nanopub": {
            "id": "50ee2a54-63d2-43ff-a246-ccf0b8aba17a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "8 young and 8 older healthy volunteers",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "FACS",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "22882710",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"Lactobacillus casei\u00a0Shirota\")",
                    "relation": "increases",
                    "object": "bp(GO:\"natural killer cell mediated cytotoxicity\")"
                },
                {
                    "subject": "a(\"Bifidobacterium longum\u00a0SP 07/3\")",
                    "relation": "increases",
                    "object": "bp(GO:\"natural killer cell mediated cytotoxicity\")"
                },
                {
                    "subject": "a(\"B.\u00a0infantis\u00a0CCUG 52486\")",
                    "relation": "increases",
                    "object": "bp(GO:\"natural killer cell mediated cytotoxicity\")"
                }
            ],
            "evidence": "Ex vivo\u00a0exposure to\u00a0B.\u00a0infantis\u00a052486,\u00a0B.\u00a0longum\u00a0SP 07/3 and LcS for 24\u00a0h significantly increased NK activity relative to control in both young and older subjects (Fig.\u00a01).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3de60af6-5696-4144-834b-fbc6e28d25bf",
        "_rev": "_WpvYGJC--C",
        "nanopub": {
            "id": "3de60af6-5696-4144-834b-fbc6e28d25bf",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Yan, H",
                    "Krishnan, K",
                    "Greenlund, A C",
                    "Gupta, S",
                    "Lim, J T",
                    "Schreiber, R D",
                    "Schindler, C W",
                    "Krolewski, J J"
                ],
                "comments": "simplified statement for the following event:\nOnce STAT is docked at the IFNAR, it becomes phosphorylated by JAK, leading to STAT dimerization and subsequent transfer to the nucleus",
                "database": {
                    "id": "8605876",
                    "name": "PubMed"
                },
                "source_name": "The EMBO journal",
                "title": "Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein.",
                "abstract": "Interferon-alpha (IFN alpha) induces rapid tyrosine phosphorylation of its receptors, two JAK kinases and three STAT transcription factors. One kinase, p135tyk2, is complexed with the IFNaR1 receptor, and may catalyze some of these phosphorylation events. We demonstrate that, in vitro, p135tyk2 phosphorylates two tyrosines on IFNaR1. A phosphopeptide corresponding to the major phosphorylation site (Tyr466) binds STAT2, but not STAT1, in an SH-2-dependent manner. Furthermore, only latent, non-phosphorylated STAT2 interacts with this phosphopeptide. When this phosphopeptide is introduced into permeabilized cells, the IFN alpha-dependent tyrosine phosphorylation of both STATs is blocked. Finally, mutant versions of IFNaR1, in which Tyr466 is changed to phenylalanine, can act in a dominant negative manner to inhibit phosphorylation of STAT2. These observations are consistent with a model in which IFNaR1 mediates the interaction between JAK kinases and the STAT transcription factors."
            },
            "assertions": [
                {
                    "subject": "p(SFAM:JAK family)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:STAT2, pmod(Ph))"
                }
            ],
            "evidence": "Figure 1 (top panels) shows that all three wildtype JAK kinases (JAK-1, JAK-2 and tyk2; lanes labeled J 1, J2 and WT, respectively) were able to phosphorylate both STAT proteins, while the kinase-deficient form of tyk2 (Colamonici et al., 1994b) (lanes labeled K) was not. Portions of the same lysate were immunoprecipitated with anti-JAK antibodies, and then immunoblotted with an anti-phosphotyrosine antibody, indicating that the extent of STAT phosphorylation was generally proportional to the degree of autophosphorylation for a particular kinase (Figure 1, bottom panels), and suggesting a correlation with kinase activity.\u00a0",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6cf01289-4cf7-40fc-9847-37ff5da9ebc1",
        "_rev": "_WpvYGJC-Bi",
        "nanopub": {
            "id": "6cf01289-4cf7-40fc-9847-37ff5da9ebc1",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Coimmunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"embryonic fibroblast\"",
                    "label": "embryonic fibroblast",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10748240",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17RA)",
                    "relation": "association",
                    "object": "p(HGNC:TRAF6)"
                }
            ],
            "evidence": "\u00a0In contrast, TRAF6 coimmunoprecipitated with IL-17R or CD40 (Fig. 5).\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5c1a45f7-54cf-4d16-859d-bc0a31e559a0",
        "_rev": "_WpvYGJC--I",
        "nanopub": {
            "id": "5c1a45f7-54cf-4d16-859d-bc0a31e559a0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10358188",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:neutrophil)",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL12))"
                }
            ],
            "evidence": "As shown in Fig. 1, parasite Ag induced IL-12 (p70) release from each of the donors\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "15ca2910-7b80-4e6d-8b51-8c6d2582a0b2",
        "_rev": "_WpvYGI6--H",
        "nanopub": {
            "id": "15ca2910-7b80-4e6d-8b51-8c6d2582a0b2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "19 SLE patients",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "17080911",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNFSF13B)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "In SLE, BAFF levels correlated with SLEDAI scores but not with anti-dsDNA Ab levels. SLE patients with increased BAFF levels had higher SLEDAI and CRP levels.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "401cd3f6-c129-42bf-8d24-7537b27aa1de",
        "_rev": "_WpvYGJ--_K",
        "nanopub": {
            "id": "401cd3f6-c129-42bf-8d24-7537b27aa1de",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "16177117",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Zinc)",
                    "relation": "decreases",
                    "object": "p(HGNC:TNF)"
                }
            ],
            "evidence": "Although 1 M zinc in the presence of pyrithione increased TNF- production significantly, 25 M suppressed the secretion of this cytokine.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "dfb95a76-cb0b-4c41-86f3-070071a71a9c",
        "_rev": "_WpvYGJG-_c",
        "nanopub": {
            "id": "dfb95a76-cb0b-4c41-86f3-070071a71a9c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"epithelial cell of tracheobronchial tree\"",
                    "label": "epithelial cell of tracheobronchial tree",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "20008294",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"D3 vitamins\")",
                    "relation": "decreases",
                    "object": "r(HGNC:CXCL10)"
                }
            ],
            "evidence": "The suppression in transcription was more pronounced for CXCL10 (ISRE and NF-\u03baB sites) with 86% reduction in CXCL10 mRNA,\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "25479990-ae10-4052-8a05-73d1a1388082",
        "_rev": "_WpvYGJG-AB",
        "nanopub": {
            "id": "25479990-ae10-4052-8a05-73d1a1388082",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Thirty-seven healthy male volunteers aged between 19 and 29 years (mean age 21.65 years) and weighing between 66 and 105 kg (mean weight 80.78 kg) took part in the study; 19 had elevated TSB concentrations (above 25 gmol F-l) on at least three occasions and 18 had normal TSB concentrations (below 25 ,umol 1-1).",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "TSB concentrations were assayed by the method of Van den Bergh & Muller [6] which entails the measurement of azobilirubin after reaction with diazotized sulphanilic acid.",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "7742155",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Fasting\")",
                    "relation": "increases",
                    "object": "a(CHEBI:bilirubin)"
                }
            ],
            "evidence": "\"For both groups, a slight increase in TSB concentrations was recorded when the fasting and non-fasting states were compared after 10 h. A clinically relevant rise in TSB concentration took place after 12 h, and TSB concentrations at 24 h were about 2.5 times higher after a fast compared with the nonfasting\ntreatment (Figure 1, Table 1).\"\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b2d85e48-4671-4888-891d-8a1f3a75d7db",
        "_rev": "_WpvYGJG-A8",
        "nanopub": {
            "id": "b2d85e48-4671-4888-891d-8a1f3a75d7db",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.03",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=16 intervention and n=12 controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:\"colonic mucosa\"",
                    "label": "colonic mucosa",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"ulcerative colitis\"",
                    "label": "ulcerative colitis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "18240282",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"VSL#3\")",
                    "relation": "decreases",
                    "object": "r(HGNC:IL1B)"
                }
            ],
            "evidence": "as shown in figure 2, the reduction in PDAI score was associated with a significant reduction in expression of mRNA for the inflammatory cytokine IL-1B.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ea934001-95a5-4d47-9b70-64145498a1db",
        "_rev": "_WpvYGJG-_O",
        "nanopub": {
            "id": "ea934001-95a5-4d47-9b70-64145498a1db",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Takatsu, K"
                ],
                "database": {
                    "id": "9160040",
                    "name": "PubMed"
                },
                "source_name": "Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)",
                "title": "Cytokines involved in B-cell differentiation and their sites of action.",
                "abstract": "B cells originate from pluripotent hematopoietic stem cells and differentiate in the bone marrow into mature B cells. The differentiation of a stem cell into a mature B cell can be subdivided into five steps: early pro-B cells, late pro-B cell stage, pre-B cell stage, immature B cells, and mature B cells. Each differentiation step appears to be regulated by co-receptor and cytokines. The earliest B-cell progenitors are bound to the stromal cell surface by adhesive interactions through cell surface molecules to promote the binding of c-kit to stem cell factor (SCF). At the late pro-B cell stage, interleukin-7 (IL-7) induces proliferation and differentiation of pro-B cells to pre-B cells. Surface Ig-expressing mature B cells leave bone marrow and circulate into peripheral lymphoid organs in which they can be activated to proliferate and to differentiate into antibody-secreting cells by encountering antigens and \"helper\" T (TH) cells. TH cells activate B cells by their products, cytokines such as IL-4, IL-5, and IL-6, and membrane-bound stimulatory molecules including CD40 ligand. Each cytokine has pleiotropic activity on B cells and other cell types, and acts through a specific receptor. Abnormal expression of a cytokine receptor and aberrant signal transduction causes functional abnormality of B cells."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "increases",
                    "object": "a(CL:\"B cell\")"
                }
            ],
            "evidence": "TH cells activate B cells by their products, cytokines such as IL-4, IL-5, and IL-6, and membrane-bound stimulatory molecules including CD40 ligand. Each cytokine has pleiotropic activity on B cells and other cell types, and acts through a specific receptor. Abnormal expression of a cytokine receptor and aberrant signal transduction causes functional abnormality of B cells.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "18d975c4-d720-4a1e-97b0-279d1231d50b",
        "_rev": "_WpvYGJ--Bx",
        "nanopub": {
            "id": "18d975c4-d720-4a1e-97b0-279d1231d50b",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15976028",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(MGI:Il6)",
                    "relation": "increases",
                    "object": "p(MGI:Cxcl10)"
                }
            ],
            "evidence": "These analyses showed that IL-6 deficiency is associated with defective expression of CCL4, CCL5, CCL17, and CXCL10, whereas a marginal difference was observed for CCL11 (Fig. 3A).",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "Monocyte chemoattractant protein-1 (MCP-1) is a potent chemokine synthesized by several cell types, e.g., inflammatory cells, such as monocytes, and resident renal cells, such as human tubular epithelial cells (TECs). Besides induction of monocyte recruitment, MCP-1 has been suggested to induce non-leukocytes to produce cytokines and adhesion molecules. Inflammation of the tubulointerstitium is a hallmark of many renal diseases and contributes to progression of renal failure; the purpose therefore of this study was to investigate the influence of MCP-1 on markers of inflammatory activation in human TECs. MCP-1 stimulated interleukin-6 (IL-6) secretion and intercellular adhesion molecule-1 (ICAM-1) synthesis in a time- and dose-dependent manner. In parallel, MCP-1 increased IL-6 and ICAM-1 mRNA expression in human TECs. Pretreatment with pertussis toxin, GF109203X, BAPTA-AM, and pyrrolidine dithiocarbamate inhibited MCP-1-dependent IL-6 and ICAM-1 synthesis, suggesting the involvement of Gi-proteins, protein kinase C, intracellular Ca(2+), and nuclear factor-kappaB (NF-kappaB) in MCP-1 signaling. Using electrophoretic gel mobility shift assay, we observed that MCP-1 stimulated binding activity of NF-kappaB. Binding activity of the activator protein-1 (AP-1), which has been implicated to regulate induction of the IL-6 gene together with NF-kappaB, was also stimulated by MCP-1. In the present experiments, NF-kappaB and AP-1 were involved in the MCP-1-mediated induction of IL-6, as demonstrated by cis element double-stranded (decoy) oligonucleotides (ODN). In contrast to IL-6 release, MCP-1-induced ICAM-1 expression was predominantly dependent on NF-kappaB activation. These results document for the first time that MCP-1 induces an inflammatory response in human TECs. This may be an important new mechanism in the pathogenesis of tubulointerstitial inflammation.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9000fb8d-e729-447b-b24c-b4696395fd32",
        "_rev": "_WpvYGJC-_q",
        "nanopub": {
            "id": "9000fb8d-e729-447b-b24c-b4696395fd32",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "n=9",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "High voltage electrophoresis",
                    "type": "Methodology"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15944906",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:pipecolic acid)",
                    "relation": "biomarkerFor",
                    "object": "path(\"Pyridoxine-dependent Epilepsy\")"
                }
            ],
            "evidence": "Pipecolic acid in plasma was 4.3- to 15.3fold elevated compared to the upper normal range before pyridoxine and remained in the mildly elevated range hwile on pyridoxine.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "37287ece-aeee-495d-8d8c-fb4a78b653e2",
        "_rev": "_WpvYGJG--O",
        "nanopub": {
            "id": "37287ece-aeee-495d-8d8c-fb4a78b653e2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "MESH:Obesity",
                    "label": "Obesity",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "28484491",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:valine)\t",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Body Mass Index\")"
                },
                {
                    "subject": "a(CHEBI:valine)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Waist Circumference\")"
                },
                {
                    "subject": "a(CHEBI:tyrosine)\t",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Body Mass Index\")"
                },
                {
                    "subject": "a(CHEBI:tyrosine)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Waist Circumference\")"
                },
                {
                    "subject": "a(CHEBI:threonine)\t",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:\"Body Mass Index\")"
                },
                {
                    "subject": "a(CHEBI:threonine)",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:\"Waist Circumference\")"
                },
                {
                    "subject": "a(CHEBI:serine)\t",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:\"Body Mass Index\")"
                },
                {
                    "subject": "a(CHEBI:serine)",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:\"Waist Circumference\")"
                },
                {
                    "subject": "a(CHEBI:proline)\t",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Body Mass Index\")"
                },
                {
                    "subject": "a(CHEBI:proline)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Waist Circumference\")"
                },
                {
                    "subject": "a(CHEBI:phenylalanine)\t",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Body Mass Index\")"
                },
                {
                    "subject": "a(CHEBI:phenylalanine)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Waist Circumference\")"
                },
                {
                    "subject": "a(CHEBI:ornithine)\t",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:\"Body Mass Index\")"
                },
                {
                    "subject": "a(CHEBI:ornithine)",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:\"Waist Circumference\")"
                },
                {
                    "subject": "a(CHEBI:leucine)\t",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Body Mass Index\")"
                },
                {
                    "subject": "a(CHEBI:leucine)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Waist Circumference\")"
                },
                {
                    "subject": "a(CHEBI:isoleucine)\t",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Body Mass Index\")"
                },
                {
                    "subject": "a(CHEBI:isoleucine)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Waist Circumference\")"
                },
                {
                    "subject": "a(CHEBI:glycine)\t",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:\"Body Mass Index\")"
                },
                {
                    "subject": "a(CHEBI:glycine)",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:\"Waist Circumference\")"
                },
                {
                    "subject": "a(CHEBI:glutamine)\t",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:\"Body Mass Index\")"
                },
                {
                    "subject": "a(CHEBI:glutamine)",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:\"Waist Circumference\")"
                },
                {
                    "subject": "a(CHEBI:glutamate)\t",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Body Mass Index\")"
                },
                {
                    "subject": "a(CHEBI:glutamate)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Waist Circumference\")"
                },
                {
                    "subject": "\ta(CHEBI:asparagine)",
                    "relation": "negativeCorrelation",
                    "object": "\ta(MESH:\"Body Mass Index\")"
                },
                {
                    "subject": "a(CHEBI:asparagine)",
                    "relation": "negativeCorrelation",
                    "object": "a(MESH:\"Waist Circumference\")"
                },
                {
                    "subject": "a(CHEBI:alanine)\t",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Body Mass Index\")"
                },
                {
                    "subject": "a(CHEBI:alanine)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Waist Circumference\")"
                }
            ],
            "evidence": "Univariate linear regression analysis of data from the MDC-CC showed that the plasma levels of 12 out of 18 identified AAs were associated with WC after adjusting for sex and age (Table 2). Adjustment for T2D and CVD risk factors (SBP and AHT) reduced the number of associated AAs to ten, six showing a positive and four showing a negative correlation. With the exception of leucine, which showed no correlation to BMI in the fully adjusted model, the same AAs were associated with BMI as with WC (Table 2).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a29f3bf3-147c-44f5-b719-31b099c6ccbd",
        "_rev": "_WpvYGJC-CB",
        "nanopub": {
            "id": "a29f3bf3-147c-44f5-b719-31b099c6ccbd",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "172 RA patients, 147 HC",
                    "type": "cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "authors": [
                    "Ben-Hadj-Mohamed, Manel",
                    "Khelil, Souhir",
                    "Ben Dbibis, Mokhles",
                    "Khlifi, Latifa",
                    "Chahed, Hend",
                    "Ferchichi, Salima",
                    "Bouajina, Elyes",
                    "Miled, Abdelh\u00e9di"
                ],
                "comments": "AAG=alpha - 1 acid glycoprotein=ORM1\nHP=Heparin\n",
                "database": {
                    "id": "28894708",
                    "name": "PubMed"
                },
                "source_name": "Iranian journal of public health",
                "title": "Hepatic Proteins and Inflammatory Markers in Rheumatoid Arthritis Patients.",
                "abstract": "Rheumatoid arthritis is an autoimmune inflammatory rheumatic disease that causes chronic synovial inflammation eventually leading to joint destruction and disability. The aim of this study was to determine the variations of hepatic proteins, myeloperoxidase, and iron in rheumatoid arthritis Tunisian patients and their implications in inflammation and in iron metabolism."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Iron)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "a(MESH:\"Serum Albumin\")",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "a(CHEBI:heparin)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:MPO)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:ORM1)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                },
                {
                    "subject": "p(HGNC:CRP)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "Hepatic protein variations were shown in Table 2. The RA patients presented significantly higher levels of CRPhs, AAG, MPO, and Hp than the healthy group. The levels of albumin and iron in serum of patients were significantly decreased compared to the placebo group.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c828ed5e-9ec0-4a9c-ba82-46ae58983259",
        "_rev": "_WpvYGJ--_c",
        "nanopub": {
            "id": "c828ed5e-9ec0-4a9c-ba82-46ae58983259",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "6 men and 4 women",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "p<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "Serum concentrations of triacylglycerol and cholesterol were measured by a Hitachi 717 Analyzer (BMC/Roche, Indianapolis, IN) using reagents from Boehringer Mannheim Diagnostics (Treyburn, NC). HDL cholesterol was determined by a Fara/Cobas Analyzer (BMC/Roche) using the Dextran Sulfate (MW 50,000) method (Weisweiler et al. 1979). LDL cholesterol was calculated from serum concentrations of triacylglycerol, cholesterol and HDL cholesterol using the Friedewald formula. The serum concentration of apolipoprotein B (apo B) was determined by immunoprecipitation using a specific antibody (Smith Kline Beecham Laboratories, Atlanta, GA) (Kottke et al. 1986). The rate of increase in the intensity of light scattered by the antigen-antibody complex was measured by a nephelometer (Array 360 System, Beckman/Coulter, Brea, CA). The apo B concentration was compared with a pooled reference serum in which the concentration of apo B is known. Immunoreactive IGF-I was measured by a highly specific nonequilibrium RIA (Copeland et al. 1980) after removal of IGF-binding proteins by C18\u00a0cartridge chromatography (Sep-Pak, Waters Associates, Milford, MA) (Davenport et al. 1990). The intra-assay CV were 1.9% for cholesterol, 2.0% for triacylglycerol, 3.1% for HDL, 6.0% for apo B and 6.8% for IGF-I.",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "10539776",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Fasting\")\t",
                    "relation": "increases",
                    "object": "p(HGNC:IGF1)"
                },
                {
                    "subject": "bp(MESH:\"Fasting\")\t",
                    "relation": "increases",
                    "object": "p(HGNC:APOB)"
                },
                {
                    "subject": "bp(MESH:\"Fasting\")",
                    "relation": "increases",
                    "object": "a(CHEBI:cholesterol)"
                }
            ],
            "evidence": "One week of fasting increased serum concentrations of total cholesterol by 1.83 \u00b1 0.26 mmol/L (37.3 \u00b1 5.0%,\u00a0P\u00a0< 0.0001, one-way ANOVA), LDL cholesterol by 1.95 \u00b1 0.22 mmol/L (66.1 \u00b1 6.6%,\u00a0P\u00a0< 0.0001) and apo B by 0.54 \u00b1 0.08 g/L (65.0 \u00b1 9.2%,\u00a0P\u00a0< 0.0001)\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bc39443b-9877-445e-8179-d9ec70da6dc2",
        "_rev": "_WpvYGJ--Ar",
        "nanopub": {
            "id": "bc39443b-9877-445e-8179-d9ec70da6dc2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"HT2 Clone A5E cell\"",
                    "label": "HT2 Clone A5E cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "2960769",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Th2 Cells)\t",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL3))"
                },
                {
                    "subject": "a(MESH:Th2 Cells)\t",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL5))"
                },
                {
                    "subject": "a(MESH:Th2 Cells)",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL4))"
                }
            ],
            "evidence": "In contrast, Th2 clones express high levels of IL-4, IL-5, P600, ppENK, and IL-3 ; low levels of GM-CSF and TNF; and no detectable IL-2, IFN-y, or LT.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "92899bf7-9ec8-427d-be88-ec20686d449e",
        "_rev": "_WpvYGJG-Ar",
        "nanopub": {
            "id": "92899bf7-9ec8-427d-be88-ec20686d449e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "abstract": "Complement is an important component of the innate immune system that is crucial for defense from microbial infections and for clearance of immune complexes and injured cells. In normal conditions complement is tightly controlled by a number of fluid-phase and cell surface proteins to avoid injury to autologous tissues. When complement is hyperactivated, as occurs in autoimmune diseases or in subjects with dysfunctional regulatory proteins, it drives a severe inflammatory response in numerous organs. The kidney appears to be particularly vulnerable to complement-mediated inflammatory injury. Injury may derive from deposition of circulating active complement fragments in glomeruli, but complement locally produced and activated in the kidney also may have a role. Many kidney disorders have been linked to abnormal complement activation, including immune-complex-mediated glomerulonephritis and rare genetic kidney diseases, but also tubulointerstitial injury associated with progressive proteinuric diseases or ischemia-reperfusion.",
                "authors": [
                    "Noris, Marina",
                    "Remuzzi, Giuseppe"
                ],
                "database": {
                    "id": "24161035",
                    "name": "PubMed"
                },
                "source_name": "Seminars in nephrology",
                "title": "Overview of complement activation and regulation."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:C5B)\t",
                    "relation": "directlyIncreases",
                    "object": "complex(p(HGNC:C5B), p(HGNC:C9)"
                },
                {
                    "subject": "p(HGNC:C3B)\t",
                    "relation": "increases",
                    "object": "p(HGNC:C5B)"
                },
                {
                    "subject": "p(HGNC:C3B)\t",
                    "relation": "increases",
                    "object": "p(HGNC:C5A)"
                }
            ],
            "evidence": "The incorporation of C3b in the C3 convertases results in the formation of the C5 convertases: C3bBbC3b for the AP and C4bC2aC3b for the CP and LP (Fig. 1). These C5 convertases cleave C5 into C5a and C5b, ultimately resulting in the formation of the multimeric MAC (C5b-9) (Fig. 1).",
            "metadata": {
                "gd:abstract": "Complement is an important component of the innate immune system that is crucial for defense from microbial infections and for clearance of immune complexes and injured cells. In normal conditions complement is tightly controlled by a number of fluid-phase and cell surface proteins to avoid injury to autologous tissues. When complement is hyperactivated, as occurs in autoimmune diseases or in subjects with dysfunctional regulatory proteins, it drives a severe inflammatory response in numerous organs. The kidney appears to be particularly vulnerable to complement-mediated inflammatory injury. Injury may derive from deposition of circulating active complement fragments in glomeruli, but complement locally produced and activated in the kidney also may have a role. Many kidney disorders have been linked to abnormal complement activation, including immune-complex-mediated glomerulonephritis and rare genetic kidney diseases, but also tubulointerstitial injury associated with progressive proteinuric diseases or ischemia-reperfusion.",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f89890ef-179c-4989-aa53-23acc69cd806",
        "_rev": "_WpvYGJG-BJ",
        "nanopub": {
            "id": "f89890ef-179c-4989-aa53-23acc69cd806",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Absorption Measurements",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "1692808",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CSF)",
                    "relation": "increases",
                    "object": "a(CHEBI:superoxide)"
                }
            ],
            "evidence": "Cells cultured with rG-CSF showed greater response to all stimuli than cells cultured with medium alone or medium plus LPS. When compared with the amount of 02 generation by neutrophils before culture, cells in medium with rG-CSF and LPS maintained their abilities to generate 02 well and moderately, respectively.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5b52e95d-9efc-47ab-9b1d-d3253b87c764",
        "_rev": "_WpvYGJC--f",
        "nanopub": {
            "id": "5b52e95d-9efc-47ab-9b1d-d3253b87c764",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "47 RA patients, 42 OA patients, 41 HC",
                    "type": "cohort"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "HAQ",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "0.032",
                    "type": "p-value\t"
                }
            ],
            "citation": {
                "authors": [
                    "Cerezo, Lucie Andr\u00e9s",
                    "Kuklov\u00e1, Mark\u00e9ta",
                    "Hulejov\u00e1, Hana",
                    "Vernerov\u00e1, Zde\u0148ka",
                    "Kasp\u0159\u00edkov\u00e1, Nikola",
                    "Veigl, David",
                    "Pavelka, Karel",
                    "Vencovsk\u00fd, Ji\u0159\u00ed",
                    "\u0160enolt, Ladislav"
                ],
                "database": {
                    "id": "26339140",
                    "name": "PubMed"
                },
                "source_name": "Mediators of inflammation",
                "title": "Progranulin Is Associated with Disease Activity in Patients with Rheumatoid Arthritis.",
                "abstract": "Progranulin (PGRN) is implicated in the pathogenesis of rheumatoid arthritis (RA). The aim of this study was to assess the relationship between PGRN and disease activity in RA."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:PGRN)\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "Serum PGRN levels correlated with DAS28 (r = 0.327, P = 0.049) and HAQ score (r = 0.323, P = 0.032",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Progranulin (PGRN) is implicated in the pathogenesis of rheumatoid arthritis (RA). The aim of this study was to assess the relationship between PGRN and disease activity in RA.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c5061848-8aea-42de-b898-2e1e389a1709",
        "_rev": "_WpvYGJG-AM",
        "nanopub": {
            "id": "c5061848-8aea-42de-b898-2e1e389a1709",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:\"Human Umbilical Vein Endothelial Cells\"",
                    "label": "Human Umbilical Vein Endothelial Cells",
                    "type": "Cell"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Herbst, U",
                    "Toborek, M",
                    "Kaiser, S",
                    "Mattson, M P",
                    "Hennig, B"
                ],
                "database": {
                    "id": "10497308",
                    "name": "PubMed"
                },
                "source_name": "Journal of cellular physiology",
                "title": "4-Hydroxynonenal induces dysfunction and apoptosis of cultured endothelial cells."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"arachidonic acid\")",
                    "relation": "increases",
                    "object": "a(CHEBI:4-hydroxynon-2-enal)"
                }
            ],
            "evidence": "To study the hypothesis that HNE may be a critical factor in endothelial cell dysfunction caused by free fatty acids, human umbilical endothelial cells (HUVEC) were treated with up to160 \u03bcM of linoleic or arachidonic acid. HNE formation was detected by immunocytochemistry in cells treated for 24 h with either fatty acid, but more markedly with arachidonic acid.\u00a0",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ec4b6aac-02a0-4cf9-8a05-633fe314ae87",
        "_rev": "_WpvYGJG--B",
        "nanopub": {
            "id": "ec4b6aac-02a0-4cf9-8a05-633fe314ae87",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:monocyte",
                    "label": "monocyte",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "1940799",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL10)\t",
                    "relation": "decreases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "p(HGNC:IL10)\t",
                    "relation": "decreases",
                    "object": "p(HGNC:IL1B)"
                },
                {
                    "subject": "p(HGNC:IL10)\t",
                    "relation": "decreases",
                    "object": "p(HGNC:GCSF)"
                },
                {
                    "subject": "p(HGNC:IL10)\t",
                    "relation": "decreases",
                    "object": "p(HGNC:GMCSF)"
                },
                {
                    "subject": "p(HGNC:IL10)",
                    "relation": "decreases",
                    "object": "p(HGNC:TNF)"
                },
                {
                    "subject": "p(HGNC:IL10)",
                    "relation": "decreases",
                    "object": "p(HGNC:IL1A)"
                }
            ],
            "evidence": "). The strongest inhibitory effects of I1.-10 were observed on the production of I1:1c~, TNFol, GM-CSF, and G-CSF, which were blocked by 80-100%. The inhibition of I1:1/3 and I1:6 production was less pronounced,\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "192a6382-5009-4900-a4df-fbe318ce9c76",
        "_rev": "_WpvYGJ---M",
        "nanopub": {
            "id": "192a6382-5009-4900-a4df-fbe318ce9c76",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.038",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=43",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "CAI",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"ulcerative colitis\"",
                    "label": "ulcerative colitis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "17101300",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:curcumin)",
                    "relation": "decreases",
                    "object": "path(MESH:\"Ulcerative colitis\")"
                }
            ],
            "evidence": "Furthermore, curcumin improved both CAI (P\u00a0= .038) and EI (P\u00a0= .0001), thus suppressing the morbidity associated with UC.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9e351919-a7ca-49b5-a4e2-77d261f968b5",
        "_rev": "_WpvYGJ---D",
        "nanopub": {
            "id": "9e351919-a7ca-49b5-a4e2-77d261f968b5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "M12",
                    "label": "",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "17785825",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL4)",
                    "relation": "increases",
                    "object": "p(HGNC:STAT6, pmod(Ph))"
                }
            ],
            "evidence": "See fig. 2B\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6898f89b-dfd7-4915-85ad-c3be052f4c78",
        "_rev": "_WpvYGJG--n",
        "nanopub": {
            "id": "6898f89b-dfd7-4915-85ad-c3be052f4c78",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.002",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=22 women",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "24673738",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Lactobacillus casei\")",
                    "relation": "decreases",
                    "object": "p(HGNC:TNF)"
                }
            ],
            "evidence": "e. At the end of the study period, ANCOVA test revealed a significant difference between the groups for IL-6, IL-12, TNF-a and IL-10\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "57bdb216-436b-4f95-9b6b-83e1d085a201",
        "_rev": "_WpvYGJC--W",
        "nanopub": {
            "id": "57bdb216-436b-4f95-9b6b-83e1d085a201",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "800 SLE Patients",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "r=0.39",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "SLAM-R",
                    "type": "Methodology"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:serum",
                    "label": "serum",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17177599",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL2)",
                    "relation": "positiveCorrelation",
                    "object": "path(SDIS:\"Systemic Lupus Erythematosus\")"
                }
            ],
            "evidence": "Twenty analytes showed one or more significant correlations with clinical measures of disease activity (Figure 4). Many of the IFN-regulated analytes showed strong positive correlations with the SLEDAI [13] and the SLAM-R [14], two validated measures of global disease activity, as well as with the ESR and titers of anti-dsDNA antibodies.\n",
            "metadata": {
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a638e270-fe27-40e2-a838-3f20b0208a27",
        "_rev": "_WpvYGJC-BV",
        "nanopub": {
            "id": "a638e270-fe27-40e2-a838-3f20b0208a27",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "DAS28",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "20 RA patients",
                    "type": "cohort"
                },
                {
                    "id": "",
                    "label": "p<0.0001",
                    "type": "p-value"
                }
            ],
            "citation": {
                "authors": [
                    "Jois, R N",
                    "Masding, A",
                    "Somerville, M",
                    "Gaffney, K",
                    "Scott, D G I"
                ],
                "comments": "rituximab (CD40 inhibitor)",
                "database": {
                    "id": "17384180",
                    "name": "PubMed"
                },
                "source_name": "Rheumatology (Oxford, England)",
                "title": "Rituximab therapy in patients with resistant rheumatoid arthritis: real-life experience.",
                "abstract": "Rituximab has recently been shown to be effective in suppressing disease activity in patients with rheumatoid arthritis (RA) who fail anti-TNF therapy. We present our experience of treating patients with long-standing, multi-DMARD and anti-TNF resistant RA with rituximab in 'real-life' setting."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:rituximab)",
                    "relation": "decreases",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "Rituximab treatment led to a significant reduction in DAS28 score(P < 0.0001) at 3 months and various other disease parameters. The benefit was sustained at 6 months.",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "35d5262d-8c57-4c1f-9bea-b37971c9a385",
        "_rev": "_WpvYGJC--4",
        "nanopub": {
            "id": "35d5262d-8c57-4c1f-9bea-b37971c9a385",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Yan, H",
                    "Krishnan, K",
                    "Greenlund, A C",
                    "Gupta, S",
                    "Lim, J T",
                    "Schreiber, R D",
                    "Schindler, C W",
                    "Krolewski, J J"
                ],
                "database": {
                    "id": "8605876",
                    "name": "PubMed"
                },
                "source_name": "The EMBO journal",
                "title": "Phosphorylated interferon-alpha receptor 1 subunit (IFNaR1) acts as a docking site for the latent form of the 113 kDa STAT2 protein.",
                "abstract": "Interferon-alpha (IFN alpha) induces rapid tyrosine phosphorylation of its receptors, two JAK kinases and three STAT transcription factors. One kinase, p135tyk2, is complexed with the IFNaR1 receptor, and may catalyze some of these phosphorylation events. We demonstrate that, in vitro, p135tyk2 phosphorylates two tyrosines on IFNaR1. A phosphopeptide corresponding to the major phosphorylation site (Tyr466) binds STAT2, but not STAT1, in an SH-2-dependent manner. Furthermore, only latent, non-phosphorylated STAT2 interacts with this phosphopeptide. When this phosphopeptide is introduced into permeabilized cells, the IFN alpha-dependent tyrosine phosphorylation of both STATs is blocked. Finally, mutant versions of IFNaR1, in which Tyr466 is changed to phenylalanine, can act in a dominant negative manner to inhibit phosphorylation of STAT2. These observations are consistent with a model in which IFNaR1 mediates the interaction between JAK kinases and the STAT transcription factors."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNAR1, pmod(Ph, TYR, 466))",
                    "relation": "directlyIncreases",
                    "object": "complex(p(HGNC:IFNAR1), p(HGNC:STAT2))"
                }
            ],
            "evidence": "To determine if the phosphorylated version of either Y466or Y481 can act as a docking site for a STAT protein, we synthesized biotinylated phosphopeptides corresponding to the sequences surrounding these two sites. These peptides, along with a set of control phosphopeptides, were bound to strepavidin beads and then incubated withinsect cell lysates containing either STATI or STAT2protein. The washed complexes were immunoblotted with the appropriate anti-STAT antibodies. Figure 3A demonstrates that STAT2 binds strongly and specifically to the phosphopeptide corresponding to the region surroundingY466. STAT1 does not bind to this peptide, but does bind to a phosphopeptide corresponding to the Y440 of theIFNy receptor ax-subunit, as shown previously (Greenlundet al., 1994).We observed weak binding of p 131TAT2 to the phosphopeptide corresponding to the region surrounding Y481, as evidenced by the faint band in Figure 3A. This binding has been observed frequently in repeat experiments (data not shown), suggesting that it represents bone fide binding and not simply an artifact. In addition to the controls shown, phosphopeptides corresponding to the two tyrosines in the IFNaRl subunit (positions 527 and 538) which were not phosphorylated in vitro (Colamonici et al.,",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f3062be6-3b74-4344-9eb8-3c51d7e721f0",
        "_rev": "_WpvYGJ--CE",
        "nanopub": {
            "id": "f3062be6-3b74-4344-9eb8-3c51d7e721f0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8530611",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fasting\")",
                    "relation": "decreases",
                    "object": "p(HGNC:IGF1)"
                }
            ],
            "evidence": "Serum IGF-1 levels decreased significantly  in the control and bicarbonate treatment groups.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f37f0103-ff8b-47bf-8614-b9cf5c771dae",
        "_rev": "_WpvYGJ--Cg",
        "nanopub": {
            "id": "f37f0103-ff8b-47bf-8614-b9cf5c771dae",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16990136",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:RORGT)",
                    "relation": "positiveCorrelation",
                    "object": "bp(GO:\"T-helper 17 cell differentiation\")"
                }
            ],
            "evidence": "in ROR\u03b3t null (Ror\u03b3tgfp/gfp) mice, IL-17+\u00a0cells in the lamina propria were reduced by at least 10-fold to less than 1% of the CD4+\u00a0T cells, suggesting that ROR\u03b3t may be necessary for the generation of Th17 cells in vivo (Figure\u00a02B).\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f4445d2b-8edc-4a45-a3bd-abd9aaa2a77e",
        "_rev": "_WpvYGJC-C-",
        "nanopub": {
            "id": "f4445d2b-8edc-4a45-a3bd-abd9aaa2a77e",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Histology",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:\"small intestine Peyer's patch\"",
                    "label": "small intestine Peyer's patch",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10510089",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:\"regulatory T cell\")",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IL10))"
                }
            ],
            "evidence": "These data indicate that production of IL-10 by CD45RBlow\u00a0CD4+\u00a0cells is essential for cells within this population to mediate their immune-suppressive function.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "9298b1ee-4ea7-446f-9718-7dbf6d9421cf",
        "_rev": "_WpvYGJC-BM",
        "nanopub": {
            "id": "9298b1ee-4ea7-446f-9718-7dbf6d9421cf",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"naive B cell\"",
                    "label": "naive B cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "2934482",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNG)\t",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IGG1))"
                },
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "decreases",
                    "object": "sec(p(HGNC:IGE))"
                }
            ],
            "evidence": "Titration of recombinant mouse IFN--( into T-depleted spleen cultures Stimulated with LPS plus D9-SUP revealed that very small amounts of IFN--( can totally eliminate the stimulation of IgE and IgGl production mediated by D9-SUP (Fig. 4a)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "658b45c3-839a-461f-a4f8-15aa614608a2",
        "_rev": "_WpvYGJ---_",
        "nanopub": {
            "id": "658b45c3-839a-461f-a4f8-15aa614608a2",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T-helper 1 cell\"",
                    "label": "T-helper 1 cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18549798",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL12)",
                    "relation": "increases",
                    "object": "p(HGNC:STAT4, pmod(Ph))"
                }
            ],
            "evidence": "further, differentiated Jak3+/\u2212\u00a0and Jak3\u2212/\u2212Th1 cells were assessed for STAT4 phosphorylation in response to IL-12 stimulation (Fig. 2b). As shown, both of these responses are intact in the absence of Jak3.\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "69aadc6f-078e-46d6-8ead-15797a4d7ca9",
        "_rev": "_WpvYGJ--BR",
        "nanopub": {
            "id": "69aadc6f-078e-46d6-8ead-15797a4d7ca9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:\"small intestine Peyer's patch\"",
                    "label": "small intestine Peyer's patch",
                    "type": "Anatomy"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "3498768",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL4)",
                    "relation": "increases",
                    "object": "sec(p(\"IgA\"))"
                }
            ],
            "evidence": "Furthermore, addition of IL-5 in combination with IL-4 increased the level of IgA secretion two- to threefold to a magnitude similar to that observed with PT-1 Sn\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "deac8053-a9c2-4e49-bf28-10dfcf3256cb",
        "_rev": "_WpvYGJ--B1",
        "nanopub": {
            "id": "deac8053-a9c2-4e49-bf28-10dfcf3256cb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "EFO:\"HUVEC cell line\"",
                    "label": "HUVEC cell line",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "authors": [
                    "Wen, Ya-Dan",
                    "Wang, Hong",
                    "Kho, Sok-Hong",
                    "Rinkiko, Suguro",
                    "Sheng, Xiong",
                    "Shen, Han-Ming",
                    "Zhu, Yi-Zhun"
                ],
                "database": {
                    "id": "23393548",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress.",
                "abstract": "Hydrogen sulfide (H\u2082S) has been shown to have cytoprotective effects in models of hypertension, ischemia/reperfusion and Alzheimer's disease. However, little is known about its effects or mechanisms of action in atherosclerosis. Therefore, in the current study we evaluated the pharmacological effects of H\u2082S on antioxidant defenses and mitochondria protection against hydrogen peroxide (H\u2082O\u2082) induced endothelial cells damage."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"hydrogen peroxide\")",
                    "relation": "increases",
                    "object": "a(CHEBI:malonaldehyde)"
                }
            ],
            "evidence": "Treatment with H2O2 significantly increased cellular MDA levels indicating the elevation of oxidative stress (P<0.01, vs. control).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "2156cecf-3f37-478d-919c-07ea339c79f3",
        "_rev": "_WpvYGJC-BG",
        "nanopub": {
            "id": "2156cecf-3f37-478d-919c-07ea339c79f3",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "EMSA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8690900",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL10)",
                    "relation": "decreases",
                    "object": "complex(GO:\"NfkB complex\")"
                }
            ],
            "evidence": "In the extracts of PBMC stimulated via CD3 in the presence of IL-IO (lune e), the NF-KB/Rel nuclear activity decreased\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d224fb62-186f-4793-b925-a66e42057b19",
        "_rev": "_WpvYGJ--AR",
        "nanopub": {
            "id": "d224fb62-186f-4793-b925-a66e42057b19",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "not stated",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18469800",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL21)",
                    "relation": "decreases",
                    "object": "p(HGNC:FOXP3)"
                },
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "decreases",
                    "object": "p(HGNC:FOXP3)"
                }
            ],
            "evidence": "Induction of\u00a0FOXP3\u00a0was inhibited by IL-6 and to a greater extent by IL-21\u2014transcription factors that induce RORC2.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "12efda5d-f577-4aef-8936-a1c8bebb90e5",
        "_rev": "_WpvYGJC-CR",
        "nanopub": {
            "id": "12efda5d-f577-4aef-8936-a1c8bebb90e5",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "8 young and 8 older healthy volunteers",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "22882710",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(\"B. bifidum MF 20/5\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL1B)"
                },
                {
                    "subject": "a(\"B. longum SP 07/3\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL1B)"
                },
                {
                    "subject": "a(\"L. reuteri NCIMB 11951\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL1B)"
                },
                {
                    "subject": "a(\"L. plantarum NCIMB 8826\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL1B)"
                },
                {
                    "subject": "a(\"L. rhamnosus GG\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL1B)"
                },
                {
                    "subject": "a(\"L. casei Shirota\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL1B)"
                },
                {
                    "subject": "a(\"Bifidobacterium longum\u00a0subsp.\u00a0infantis\u00a0CCUG 52486\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL1B)"
                }
            ],
            "evidence": "There was a significant effect of age on the production of IL-6 (P\u00a0< 0.05), IFN-\u03b3 (P\u00a0< 0.01) and RANTES (P\u00a0< 0.001), and of probiotics (P\u00a0< 0.001) on production of IL-1\u03b2, IFN-\u03b3, IL-6, IL-10, GM-CSF and RANTES (Figs\u00a05\u00a0and\u00a06)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e808a825-b1bd-4a7e-acaf-693cec5a09af",
        "_rev": "_WpvYGJG--0",
        "nanopub": {
            "id": "e808a825-b1bd-4a7e-acaf-693cec5a09af",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:obesity",
                    "label": "obesity",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8574277",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"procollagen Type III-N-terminal peptide\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Waist Circumference\")"
                }
            ],
            "evidence": "Changes in S-PIIINP correlated with weight loss, with changes in waist circumference and changes in WHR\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "87399433-6cf7-42ca-8199-754c5c2479c9",
        "_rev": "_WpvYGJG-Bj",
        "nanopub": {
            "id": "87399433-6cf7-42ca-8199-754c5c2479c9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "authors": [
                    "Przanowski, Piotr",
                    "Dabrowski, Michal",
                    "Ellert-Miklaszewska, Aleksandra",
                    "Kloss, Michal",
                    "Mieczkowski, Jakub",
                    "Kaza, Beata",
                    "Ronowicz, Anna",
                    "Hu, Feng",
                    "Piotrowski, Arkadiusz",
                    "Kettenmann, Helmut",
                    "Komorowski, Jan",
                    "Kaminska, Bozena"
                ],
                "database": {
                    "id": "24097101",
                    "name": "PubMed"
                },
                "source_name": "Journal of molecular medicine (Berlin, Germany)",
                "title": "The signal transducers Stat1 and Stat3 and their novel target Jmjd3 drive the expression of inflammatory genes in microglia.",
                "abstract": "Most neurological diseases are associated with chronic inflammation initiated by the activation of microglia, which produce cytotoxic and inflammatory factors. Signal transducers and activators of transcription (STATs) are potent regulators of gene expression but contribution of particular STAT to inflammatory gene expression and STAT-dependent transcriptional networks underlying brain inflammation need to be identified. In the present study, we investigated the genomic distribution of Stat binding sites and the role of Stats in the gene expression in lipopolysaccharide (LPS)-activated primary microglial cultures. Integration of chromatin immunoprecipitation-promoter microarray data and transcriptome data revealed novel Stat-target genes including Jmjd3, Ccl5, Ezr, Ifih1, Irf7, Uba7, and Pim1. While knockdown of individual Stat had little effect on the expression of tested genes, knockdown of both Stat1 and Stat3 inhibited the expression of Jmjd3 and inflammatory genes. Transcriptional regulation of Jmjd3 by Stat1 and Stat3 is a novel mechanism crucial for launching inflammatory responses in microglia. The effects of Jmjd3 on inflammatory gene expression were independent of its H3K27me3 demethylase activity. Forced expression of constitutively activated Stat1 and Stat3 induced the expression of Jmjd3, inflammation-related genes, and the production of pro-inflammatory cytokines as potently as lipopolysacharide. Gene set enrichment and gene function analysis revealed categories linked to the inflammatory response in LPS and Stat1C + Stat3C groups. We defined upstream pathways that activate STATs in response to LPS and demonstrated contribution of Tlr4 and Il-6 and interferon-\u03b3 signaling. Our findings define novel direct transcriptional targets of Stat1 and Stat3 and highlight their contribution to inflammatory gene expression."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:STAT3)",
                    "relation": "increases",
                    "object": "r(HGNC:IL6)"
                }
            ],
            "evidence": "Nine representative candidate genes, based on their known functions in inflammation, were selected for validation by PCR with independent biological samples. This group included Jmjd3 (two independent binding sites), Ccl5, Ezr, Ifih1, Irf7, Uba7, Il-6, and Pim1. The ChIP-PCR confirmed the specific binding of Stat1 and/or Stat3 for eight of the nine promoters analyzed (Fig. 2b); the exception was Tlr7.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Most neurological diseases are associated with chronic inflammation initiated by the activation of microglia, which produce cytotoxic and inflammatory factors. Signal transducers and activators of transcription (STATs) are potent regulators of gene expression but contribution of particular STAT to inflammatory gene expression and STAT-dependent transcriptional networks underlying brain inflammation need to be identified. In the present study, we investigated the genomic distribution of Stat binding sites and the role of Stats in the gene expression in lipopolysaccharide (LPS)-activated primary microglial cultures. Integration of chromatin immunoprecipitation-promoter microarray data and transcriptome data revealed novel Stat-target genes including Jmjd3, Ccl5, Ezr, Ifih1, Irf7, Uba7, and Pim1. While knockdown of individual Stat had little effect on the expression of tested genes, knockdown of both Stat1 and Stat3 inhibited the expression of Jmjd3 and inflammatory genes. Transcriptional regulation of Jmjd3 by Stat1 and Stat3 is a novel mechanism crucial for launching inflammatory responses in microglia. The effects of Jmjd3 on inflammatory gene expression were independent of its H3K27me3 demethylase activity. Forced expression of constitutively activated Stat1 and Stat3 induced the expression of Jmjd3, inflammation-related genes, and the production of pro-inflammatory cytokines as potently as lipopolysacharide. Gene set enrichment and gene function analysis revealed categories linked to the inflammatory response in LPS and Stat1C + Stat3C groups. We defined upstream pathways that activate STATs in response to LPS and demonstrated contribution of Tlr4 and Il-6 and interferon-\u03b3 signaling. Our findings define novel direct transcriptional targets of Stat1 and Stat3 and highlight their contribution to inflammatory gene expression.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5528526d-b6c8-45a3-8eb1-48dddb91cbfc",
        "_rev": "_WpvYGJ--B7",
        "nanopub": {
            "id": "5528526d-b6c8-45a3-8eb1-48dddb91cbfc",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "not stated",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18469800",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite (p(HGNC:IL21), p(HGNC:TGFB))\t",
                    "relation": "increases",
                    "object": "r(MGI:Rorc)"
                },
                {
                    "subject": "composite (p(HGNC:IL21), p(HGNC:TGFB))",
                    "relation": "increases",
                    "object": "r(HGNC:IL17A)"
                }
            ],
            "evidence": "TGF-\u03b2 and IL-21 induced the upregulation of\u00a0IL17Aand\u00a0RORC2\u00a0mRNA (Fig. 2c).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a5e8e0b7-c533-4326-bcaa-370200e961ea",
        "_rev": "_WpvYGI6--j",
        "nanopub": {
            "id": "a5e8e0b7-c533-4326-bcaa-370200e961ea",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Crossover study with 15 healthy subjects",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "21385360",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Fasting\")",
                    "relation": "decreases",
                    "object": "r(HGNC:TNF)"
                }
            ],
            "evidence": "\u00a0LPS-induced TNF-\u03b1 release at 1 month time point was significantly lower in OMD fed subjects compared to the TMD group.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3fa8937c-6180-4c20-8a4b-aab21ec7db39",
        "_rev": "_WpvYGJ---1",
        "nanopub": {
            "id": "3fa8937c-6180-4c20-8a4b-aab21ec7db39",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "21 children",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Radioimmuno assay",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:hypoglycemia",
                    "label": "hypoglycemia",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "9851789",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "bp(MESH:\"Fasting\")",
                    "relation": "increases",
                    "object": "p(HGNC:IGFBP1)"
                }
            ],
            "evidence": "IGFBP-1 levels rose during fasting, from mean (\u00b1SE) baseline levels of 28 \u00b1 5 ng/mL to a mean level \u00b1\u00a0SEM\u00a0of 336 \u00b1 59 ng/mL at the time of hypoglycemia, which occurred after 13\u201332 h in all of the children studied.\u00a0\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "48c247b7-bd0d-4815-aa94-f6eb2f784cc7",
        "_rev": "_WpvYGJG--T",
        "nanopub": {
            "id": "48c247b7-bd0d-4815-aa94-f6eb2f784cc7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"epithelial cell of tracheobronchial tree\"",
                    "label": "epithelial cell of tracheobronchial tree",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Hansdottir, Sif",
                    "Monick, Martha M",
                    "Lovan, Nina",
                    "Powers, Linda",
                    "Gerke, Alicia",
                    "Hunninghake, Gary W"
                ],
                "database": {
                    "id": "20008294",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology (Baltimore, Md. : 1950)",
                "title": "Vitamin D decreases respiratory syncytial virus induction of NF-kappaB-linked chemokines and cytokines in airway epithelium while maintaining the antiviral state.",
                "abstract": "Epidemiological studies suggest that low vitamin D levels may increase the risk or severity of respiratory viral infections. In this study, we examined the effect of vitamin D on respiratory syncytial virus (RSV)-infected human airway epithelial cells. Airway epithelium converts 25-hydroxyvitamin D3 (storage form) to 1,25-dihydroxyvitamin D3 (active form). Active vitamin D, generated locally in tissues, is important for the nonskeletal actions of vitamin D, including its effects on immune responses. We found that vitamin D induces IkappaBalpha, an NF-kappaB inhibitor, in airway epithelium and decreases RSV induction of NF-kappaB-driven genes such as IFN-beta and CXCL10. We also found that exposing airway epithelial cells to vitamin D reduced induction of IFN-stimulated proteins with important antiviral activity (e.g., myxovirus resistance A and IFN-stimulated protein of 15 kDa). In contrast to RSV-induced gene expression, vitamin D had no effect on IFN signaling, and isolated IFN induced gene expression. Inhibiting NF-kappaB with an adenovirus vector that expressed a nondegradable form of IkappaBalpha mimicked the effects of vitamin D. When the vitamin D receptor was silenced with small interfering RNA, the vitamin D effects were abolished. Most importantly we found that, despite inducing IkappaBalpha and dampening chemokines and IFN-beta, there was no increase in viral mRNA or protein or in viral replication. We conclude that vitamin D decreases the inflammatory response to viral infections in airway epithelium without jeopardizing viral clearance. This suggests that adequate vitamin D levels would contribute to reduced inflammation and less severe disease in RSV-infected individuals."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"D3 vitamins\")\t",
                    "relation": "decreases",
                    "object": "p(HGNC:STAT1, pmod(P, Ser, 727))"
                },
                {
                    "subject": "a(CHEBI:\"D3 vitamins\")\t",
                    "relation": "decreases",
                    "object": "p(HGNC:STAT1, pmod(P, Tyr, 701))"
                },
                {
                    "subject": "a(CHEBI:\"D3 vitamins\")",
                    "relation": "decreases",
                    "object": "p(HGNC:STAT1)"
                },
                {
                    "subject": "a(CHEBI:\"D3 vitamins\")",
                    "relation": "decreases",
                    "object": "r(HGNC:IFNB1)"
                }
            ],
            "evidence": "Treatment with 1,25D resulted in significant reduction of IFN\u03b2 mRNA and of IFN\u03b2 induced STAT1 protein and STAT1 translocation to the nucleus (Fig. 2B).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation",
                "gd:abstract": "Epidemiological studies suggest that low vitamin D levels may increase the risk or severity of respiratory viral infections. In this study, we examined the effect of vitamin D on respiratory syncytial virus (RSV)-infected human airway epithelial cells. Airway epithelium converts 25-hydroxyvitamin D3 (storage form) to 1,25-dihydroxyvitamin D3 (active form). Active vitamin D, generated locally in tissues, is important for the nonskeletal actions of vitamin D, including its effects on immune responses. We found that vitamin D induces IkappaBalpha, an NF-kappaB inhibitor, in airway epithelium and decreases RSV induction of NF-kappaB-driven genes such as IFN-beta and CXCL10. We also found that exposing airway epithelial cells to vitamin D reduced induction of IFN-stimulated proteins with important antiviral activity (e.g., myxovirus resistance A and IFN-stimulated protein of 15 kDa). In contrast to RSV-induced gene expression, vitamin D had no effect on IFN signaling, and isolated IFN induced gene expression. Inhibiting NF-kappaB with an adenovirus vector that expressed a nondegradable form of IkappaBalpha mimicked the effects of vitamin D. When the vitamin D receptor was silenced with small interfering RNA, the vitamin D effects were abolished. Most importantly we found that, despite inducing IkappaBalpha and dampening chemokines and IFN-beta, there was no increase in viral mRNA or protein or in viral replication. We conclude that vitamin D decreases the inflammatory response to viral infections in airway epithelium without jeopardizing viral clearance. This suggests that adequate vitamin D levels would contribute to reduced inflammation and less severe disease in RSV-infected individuals."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3be23615-57f7-4510-a557-9c944bf11e2f",
        "_rev": "_WpvYGJ--_P",
        "nanopub": {
            "id": "3be23615-57f7-4510-a557-9c944bf11e2f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "10761931",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TBX21)",
                    "relation": "increases",
                    "object": "p(HGNC:IFNG)"
                }
            ],
            "evidence": "Transduction of primary CD4+\u00a0T cells with T-bet resulted both in a dramatic increase in the number of cells producing IFN\u03b3 (74% versus 4%) and in the amount of IFN\u03b3 produced per cell as compared to cells transduced with GFP alone (Figure 5B).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ba2f4870-307f-465d-99a6-cda8f3dd1f51",
        "_rev": "_WpvYGI6--C",
        "nanopub": {
            "id": "ba2f4870-307f-465d-99a6-cda8f3dd1f51",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "p=0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=76",
                    "type": "Cohort"
                },
                {
                    "id": "DO:\"lipid metabolism disorder\"",
                    "label": "lipid metabolism disorder",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "12818406",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"linoleic acid\")",
                    "relation": "decreases",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "CRP, SAA and IL-6 levels showed a statistically significant reduction after administration of ALA (Table 3).\u00a0\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "167a8de4-46b5-4593-8128-e73639a62cad",
        "_rev": "_WpvYGJ--CF",
        "nanopub": {
            "id": "167a8de4-46b5-4593-8128-e73639a62cad",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15987711",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(MESH:\"Lupus Erythematosus, Systemic\")",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:ICOS)"
                }
            ],
            "evidence": "The proportions of PB CD4 and CD8 T cells expressing ICOS were significantly increased in all groups of SLE patients, compared with those in patients with RA and healthy subjects\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1245e0f6-ca10-41ed-8fec-3f16f909bd99",
        "_rev": "_WpvYGJ--CZ",
        "nanopub": {
            "id": "1245e0f6-ca10-41ed-8fec-3f16f909bd99",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18993086",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "composite(p(HGNC:TBX21), p(HGNC:STAT4))",
                    "relation": "increases",
                    "object": "r(HGNC:IL18R1)"
                },
                {
                    "subject": "composite(p(HGNC:TBX21), p(HGNC:STAT4))",
                    "relation": "increases",
                    "object": "r(HGNC:IFNG)"
                }
            ],
            "evidence": "We found that the expression of\u00a0Ifng,\u00a0Ccr5,\u00a0Il18r1,\u00a0Hlx1\u00a0and\u00a0Etv5\u00a0were largely dependent upon the presence of both Stat4 and T-bet (Fig. 1A).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b9019303-8207-4621-aa1d-0c9508fb3c28",
        "_rev": "_WpvYGJ--Av",
        "nanopub": {
            "id": "b9019303-8207-4621-aa1d-0c9508fb3c28",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CLO:\"JURKAT cell\"",
                    "label": "JURKAT cell",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "7628694",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IKBA, pmod(Ph))",
                    "relation": "increases",
                    "object": "p(HGNC:IKBA, pmod(Ub))"
                }
            ],
            "evidence": "As shown in Figure 1B, a ladder of high molecular mass proteins accumulated following stimulation with calyculin A/MG132 (lanes 4--9). The molecular mass increments of these ladders were -8.5 kD, which is the size of ubiquitin. Ubiquitination of IKBcx peaked at 5-15 min following stimulation (lanes 4-6)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "818cc519-847f-4321-8b8f-0ee64feec652",
        "_rev": "_WpvYGJG-Bt",
        "nanopub": {
            "id": "818cc519-847f-4321-8b8f-0ee64feec652",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "BILAG",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "70 SLE patients and 20 healthy controls",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "28502135",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL10)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Estimated serum sTRAIL, TNF-\u03b1 and IL-6 levels showed positive significant correlation with calculated BILAG activity score, while estimated serum IL-10 levels showed negative significant correlation with activity score.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "b8434115-e4d5-4427-be01-63892bff7738",
        "_rev": "_WpvYGJ--_l",
        "nanopub": {
            "id": "b8434115-e4d5-4427-be01-63892bff7738",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "TEM",
                    "type": "Methodology"
                },
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "15001782",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:neutrophil)",
                    "relation": "increases",
                    "object": "a(\"Extracellular Traps\")"
                }
            ],
            "evidence": "Surprisingly, we found that activated neutrophils but not na\u0131\u00a8ve cells made prominent extracellular structures (arrows, Fig. 1, B and D).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "665cb2ff-9246-4869-a4e6-c1abd4f9d37f",
        "_rev": "_WpvYGI6--9",
        "nanopub": {
            "id": "665cb2ff-9246-4869-a4e6-c1abd4f9d37f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CLO:\"CTLL cell\"",
                    "label": "CTLL cell",
                    "type": "CellLine"
                },
                {
                    "id": "",
                    "label": "Immunoprecipitation/SDS-PAGE",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8022485",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL4)",
                    "relation": "increases",
                    "object": "p(HGNC:JAK3, pmod(Ph, Tyr))"
                }
            ],
            "evidence": "To assess Jak-3 in signalling, cytokine-induced tyrosine phosphorylation was examined. Phosphorylation was not seen with erythropoietin, IL-3, granulocyte macrophage colony-stimulating factor (GM-CSF), G-CSF, interferon-alpha (IFN-a), IFN-gamma or IL-6 (data not shown), but was seen in IL-2 or IL-4-stimulated cells.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "6bcb1cd4-b63b-4ecb-b759-32ff95bd02aa",
        "_rev": "_WpvYGJC-A2",
        "nanopub": {
            "id": "6bcb1cd4-b63b-4ecb-b759-32ff95bd02aa",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "database": {
                    "id": "23751346",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Particulate Matter\")",
                    "relation": "increases",
                    "object": "a(MESH:\"Glutathione Disulfide\")"
                }
            ],
            "evidence": "In HAEC exposed to UFP, GSH levels were decreased (control=17.1\u00b11.8 \u03bcM, UFP=12.0 \u00b12.4 \u03bcM, n=4, p < 0.05), whereas GSSG levels were increased (control=0.62\u00b10.26 \u03bcM, UFP=1.60 \u00b10.20 \u03bcM, n=4, p < 0.05) (Fig. 2A). \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "a3707995-2d4b-4ddf-aa45-18af46d65be7",
        "_rev": "_WpvYGJ---H",
        "nanopub": {
            "id": "a3707995-2d4b-4ddf-aa45-18af46d65be7",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17277105",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL2)",
                    "relation": "association",
                    "object": "bp(GO:\"regulatory T cell differentiation\")"
                }
            ],
            "evidence": "In the presence of a dose of anti-IL-2 Abs that did not inhibit TGF-\u03b2 enhancement of CD25 expression, we observed that this partial neutralization of IL-2 almost completely abolished the ability of TGF-\u03b2 to induce Foxp3.\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0cb7e118-4a7a-4b8e-9d33-501bf56e446f",
        "_rev": "_WpvYGJG-Bi",
        "nanopub": {
            "id": "0cb7e118-4a7a-4b8e-9d33-501bf56e446f",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "p<0.02",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "n=84",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "18540734",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Psychotherapy\")",
                    "relation": "negativeCorrelation",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "The findings indicated that IL-6 production decreased from Pre (M \u0001 8.94, SE \u0001 0.23) to Post (M \u0001 8.51, SE \u0001 0.18) only for the P group: Group \u0004 Time interaction, F(2, 420) \u0001 4.27, p \u0005 .02.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "ec3ca3d9-6d3d-473f-8dda-3b4de065cf0a",
        "_rev": "_WpvYGJ--_e",
        "nanopub": {
            "id": "ec3ca3d9-6d3d-473f-8dda-3b4de065cf0a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "EFO:Caco-2",
                    "label": "Caco-2",
                    "type": "CellLine"
                },
                {
                    "id": "EFO:HeLa",
                    "label": "HeLa",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "19056931",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Beta-Cryptoxanthin)",
                    "relation": "decreases",
                    "object": "a(bp(MESH:\"Oxidative Stress\"))"
                }
            ],
            "evidence": "At low concentrations, close to those found in plasma, beta-cryptoxanthin does not itself cause damage, but protects transformed human cells (HeLa and Caco-2) from damage induced by H(2)O(2) or by visible light in the presence of a photosensitizer.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1f25f9a3-fa26-4c95-890c-e57efbf9f887",
        "_rev": "_WpvYGJG-Bv",
        "nanopub": {
            "id": "1f25f9a3-fa26-4c95-890c-e57efbf9f887",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "",
                    "label": "22 pediatric SLE patients, 17 HC",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "systemic lupus erythematosus pediatric",
                    "type": "Disease"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Guo, Yanyan",
                    "Chai, Qinghe",
                    "Zhao, Yun",
                    "Li, Peng",
                    "Qiao, Jie",
                    "Huang, Jianping"
                ],
                "comments": "pediatric lupus  ",
                "database": {
                    "id": "26884963",
                    "name": "PubMed"
                },
                "source_name": "International journal of clinical and experimental medicine",
                "title": "Increased activation of toll-like receptors-7 and -8 of peripheral blood mononuclear cells and upregulated serum cytokines in patients with pediatric systemic lupus erythematosus.",
                "abstract": "Autoimmune disease systemic lupus erythematosus (SLE) is associated with increased expression of pro-inflammatory cytokines such as interferons (IFNs) and specific interleukins (ILs), which are induced by toll-like receptors (TLRs). The present study aimed to examine the serum levels of cytokines, the activation of TLR-7 and TLR-8 of peripheral blood mononuclear cells (PBMCs) from pediatric SLE patients, and to investigate the response of those PBMCs to viral RNA via the TLR-7 and TLR-8 signaling. Results demonstrated that pediatric SLE patients had increased serum concentrations of interleukin (IL)-1\u03b2, IL-6, IL-8, IL-10, and IFN-\u03b1, and promoted activation of TLR-7 and TLR-8, compared to control subjects. Moreover, the peripheral blood mononuclear cells (PBMCs) from pediatric SLE patients were more sensitive to the stimulation by the transfection with viral RNA from influenza virus, with a promoted activation of TLR-7 and TLR-8 signaling. In conclusion, pro-inflammatory cytokines, such as IL-1\u03b2, IL-6, IL-8, IL-10, and IFN-\u03b1 were promoted in pediatric SLE patients, with an increased activation of TLR-7 and TLR-8 to the stimuli, such as virus infection. It implies the TLR-7 and TLR-8 activation by virus infection might play an important role in the pathogenesis of pediatric SLE."
            },
            "assertions": [
                {
                    "subject": "a(ssRNA)",
                    "relation": "increases",
                    "object": "p(HGNC:IL6)"
                },
                {
                    "subject": "a(ssRNA)",
                    "relation": "increases",
                    "object": "p(HGNC:IL1B)"
                },
                {
                    "subject": "a(ssRNA)",
                    "relation": "increases",
                    "object": "p(HGNC:IFNA1)"
                }
            ],
            "evidence": "To associate the high production of serum cytokines in pediatric SLE patients with the activation of TLRs in PBMCs, we then inoculated PBMCs from pediatric SLE patients or from normal subjects. Figure 3 demonstrated that the single-stranded RNA (ssRNA) sensitized the lupus PBMCs more significantly than the normal PBMCs, the transfection with 100, 200 or 500 nM ssRNA promoted higher levels of IL-1\u03b2 (P<0.05 for 100 or 500 nM, P<0.01 for 200 nM; Figure 3A), IL-6 (P<0.05 for 100 nM or P<0.01 for 200 nM; Figure 3B), or IFN-\u03b1 (P<0.05 for 100 or 200 nM; Figure 3C).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "edb786fc-e6c1-487a-8c49-f3e3c64edb35",
        "_rev": "_WpvYGJ--_L",
        "nanopub": {
            "id": "edb786fc-e6c1-487a-8c49-f3e3c64edb35",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Mak, Anselm",
                    "Kow, Nien Yee"
                ],
                "comments": "EG:919= CD3zeta",
                "database": {
                    "id": "24864268",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology research",
                "title": "The pathology of T cells in systemic lupus erythematosus.",
                "abstract": "Systemic lupus erythematosus (SLE) is characterized by the production of a wide array of autoantibodies. Thus, the condition was traditionally classified as a \"B-cell disease\". Compelling evidence has however shown that without the assistance of the helper T lymphocytes, it is indeed difficult for the \"helpless\" B cells to become functional enough to trigger SLE-related inflammation. T cells have been recognized to be crucial in the pathogenicity of SLE through their capabilities to communicate with and offer enormous help to B cells for driving autoantibody production. Recently, a number of phenotypic and functional alterations which increase the propensity to trigger lupus-related inflammation have been identified in lupus T cells. Here, potential mechanisms involving alterations in T-cell receptor expressions, postreceptor downstream signalling, epigenetics, and oxidative stress which favour activation of lupus T cells will be discussed. Additionally, how regulatory CD4+, CD8+, and \u03b3\u03b4 T cells tune down lupus-related inflammation will be highlighted. Lastly, while currently available outcomes of clinical trials evaluating therapeutic agents which manipulate the T cells such as calcineurin inhibitors indicate that they are at least as efficacious and safe as conventional immunosuppressants in treating lupus glomerulonephritis, larger clinical trials are undoubtedly required to validate these as-yet favourable findings."
            },
            "assertions": [
                {
                    "subject": "p(EG:919)",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "CD3\u03b6 subunits are suboptimally synthetized in T cells from patients with SLE [18]. Moreover, reduction of stability and increase in degradation of CD3\u03b6 in lupus T cells are evident",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "Systemic lupus erythematosus (SLE) is characterized by the production of a wide array of autoantibodies. Thus, the condition was traditionally classified as a \"B-cell disease\". Compelling evidence has however shown that without the assistance of the helper T lymphocytes, it is indeed difficult for the \"helpless\" B cells to become functional enough to trigger SLE-related inflammation. T cells have been recognized to be crucial in the pathogenicity of SLE through their capabilities to communicate with and offer enormous help to B cells for driving autoantibody production. Recently, a number of phenotypic and functional alterations which increase the propensity to trigger lupus-related inflammation have been identified in lupus T cells. Here, potential mechanisms involving alterations in T-cell receptor expressions, postreceptor downstream signalling, epigenetics, and oxidative stress which favour activation of lupus T cells will be discussed. Additionally, how regulatory CD4+, CD8+, and \u03b3\u03b4 T cells tune down lupus-related inflammation will be highlighted. Lastly, while currently available outcomes of clinical trials evaluating therapeutic agents which manipulate the T cells such as calcineurin inhibitors indicate that they are at least as efficacious and safe as conventional immunosuppressants in treating lupus glomerulonephritis, larger clinical trials are undoubtedly required to validate these as-yet favourable findings.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "bd787a36-0ae8-4d3f-97f0-1c3df1f036f5",
        "_rev": "_WpvYGJC--P",
        "nanopub": {
            "id": "bd787a36-0ae8-4d3f-97f0-1c3df1f036f5",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"embryonic fibroblast\"",
                    "label": "embryonic fibroblast",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Coimmunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "17035243",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:Act1)",
                    "relation": "decreases",
                    "object": "p(HGNC:IL6)"
                }
            ],
            "evidence": "Upon treatments with IL-17 in the presence or absence of TNF-\u03b1, IL-6 production was reduced by about 50% in Act1-shRNA MEF (Fig. 3B).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "291484b6-456d-4c80-8f14-f84a6428b134",
        "_rev": "_WpvYGJ--_t",
        "nanopub": {
            "id": "291484b6-456d-4c80-8f14-f84a6428b134",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL6)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                },
                {
                    "subject": "p(HGNC:IL23A)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                },
                {
                    "subject": "p(HGNC:IL21)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": "In contrast, consistent with the results above, levels of several inflammatory mediators varied between pre-flare and non-flare periods (Figure 2 and Supplementary Table 4). Impending flares were associated with increased Th1, Th2, and Th17 (Figure 2A\u2013C) type cytokines, compared to both self non-flare and matched healthy control samples (Supplementary Figure 2A\u2013C).\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "df6d6838-e5d1-4676-8342-b28683d851b2",
        "_rev": "_WpvYGI6---",
        "nanopub": {
            "id": "df6d6838-e5d1-4676-8342-b28683d851b2",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "472 patients, 4 treatment groups (121 of which are placebo)",
                    "type": "cohort"
                },
                {
                    "id": "",
                    "label": "HAQ",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Bresnihan, B",
                    "Alvaro-Gracia, J M",
                    "Cobby, M",
                    "Doherty, M",
                    "Domljan, Z",
                    "Emery, P",
                    "Nuki, G",
                    "Pavelka, K",
                    "Rau, R",
                    "Rozman, B",
                    "Watt, I",
                    "Williams, B",
                    "Aitchison, R",
                    "McCabe, D",
                    "Musikic, P"
                ],
                "database": {
                    "id": "9870876",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.",
                "abstract": "To evaluate the efficacy and safety of interleukin-1 receptor antagonist (IL-1Ra) in patients with rheumatoid arthritis (RA).",
                "date_published": "1998-12-01"
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:IL1R treatment)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "Moreover, statistically significant improvements in the HAQ scores compared with placebo were observed in all 3 treatment groups at 24 weeks (150 mg.day P=0.0007, 75 mg/day P=0.048, and 30 mg/day P=0.011).",
            "metadata": {
                "project": "Inflammation Index",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true,
                "gd:abstract": "To evaluate the efficacy and safety of interleukin-1 receptor antagonist (IL-1Ra) in patients with rheumatoid arthritis (RA)."
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "fb7c35cc-d40d-457d-a947-af0390f06d11",
        "_rev": "_WpvYGJ--A2",
        "nanopub": {
            "id": "fb7c35cc-d40d-457d-a947-af0390f06d11",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Olmos, Gabriel",
                    "Llad\u00f3, Jer\u00f2nia"
                ],
                "database": {
                    "id": "24966471",
                    "name": "PubMed"
                },
                "source_name": "Mediators of inflammation",
                "title": "Tumor necrosis factor alpha: a link between neuroinflammation and excitotoxicity.",
                "abstract": "Tumor necrosis factor alpha (TNF- \u03b1) is a proinflammatory cytokine that exerts both homeostatic and pathophysiological roles in the central nervous system. In pathological conditions, microglia release large amounts of TNF-\u03b1; this de novo production of TNF-\u03b1 is an important component of the so-called neuroinflammatory response that is associated with several neurological disorders. In addition, TNF-\u03b1 can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca(+2) permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons. Thus, the net effect of TNF-\u03b1 is to alter the balance of excitation and inhibition resulting in a higher synaptic excitatory/inhibitory ratio. This review summarizes the current knowledge of the cellular and molecular mechanisms by which TNF-\u03b1 links the neuroinflammatory and excitotoxic processes that occur in several neurodegenerative diseases, but with a special emphasis on amyotrophic lateral sclerosis (ALS). As microglial activation and upregulation of TNF-\u03b1 expression is a common feature of several CNS diseases, as well as chronic opioid exposure and neuropathic pain, modulating TNF-\u03b1 signaling may represent a valuable target for intervention.",
                "date_published": "2014-01-01"
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TNF)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:TNFRSF1A)"
                }
            ],
            "evidence": "TNF-\u03b1, through TNFR1 signaling, promotes further microglial TNF-\u03b1 release and also induces glutamate release from hemichannels of gap junctions. In astrocytes, TNF-\u03b1 stimulates TNFR1 to induce glutamate exocytosis and also inhibits glutamate uptake, thus increasing extracellular glutamate levels. In neurons TNF-\u03b1, via TNFR1, rapidly increases the excitatory synaptic strength by inducing increased Ca2+ permeable-AMPA receptors and/or NMDA receptors and also decreases the surface expression of inhibitory GABAA receptors.",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Tumor necrosis factor alpha (TNF- \u03b1) is a proinflammatory cytokine that exerts both homeostatic and pathophysiological roles in the central nervous system. In pathological conditions, microglia release large amounts of TNF-\u03b1; this de novo production of TNF-\u03b1 is an important component of the so-called neuroinflammatory response that is associated with several neurological disorders. In addition, TNF-\u03b1 can potentiate glutamate-mediated cytotoxicity by two complementary mechanisms: indirectly, by inhibiting glutamate transport on astrocytes, and directly, by rapidly triggering the surface expression of Ca(+2) permeable-AMPA receptors and NMDA receptors, while decreasing inhibitory GABAA receptors on neurons. Thus, the net effect of TNF-\u03b1 is to alter the balance of excitation and inhibition resulting in a higher synaptic excitatory/inhibitory ratio. This review summarizes the current knowledge of the cellular and molecular mechanisms by which TNF-\u03b1 links the neuroinflammatory and excitotoxic processes that occur in several neurodegenerative diseases, but with a special emphasis on amyotrophic lateral sclerosis (ALS). As microglial activation and upregulation of TNF-\u03b1 expression is a common feature of several CNS diseases, as well as chronic opioid exposure and neuropathic pain, modulating TNF-\u03b1 signaling may represent a valuable target for intervention.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c6c9d8e4-beeb-40b8-8209-84439b851960",
        "_rev": "_WpvYGJ--A5",
        "nanopub": {
            "id": "c6c9d8e4-beeb-40b8-8209-84439b851960",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:Erythrocytes",
                    "label": "Erythrocytes",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "5389100",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "catof(p(HGNC:SOD1))",
                    "relation": "directlyIncreases",
                    "object": "rxn(reactants(a(CHEBI:superoxide), a(CHEBI:hydrogen)),products(a(CHEBI:\"hydrogen peroxide\"), a(CHEBI:oxygen)))"
                }
            ],
            "evidence": "An enzyme which catalyzes the dismutation of superoxideradicals (O2.- + 02.- + 2H+ -> \u00a0O2 + H2O2) has been purified by a simple procedure from bovine erythrocptes. This enzyme, called superoxide dismutase, contains 2 eq of copper per mole of enzyme. The copper may be reversibly removed, and it is required for activity. Superoxide dismutase has been shown to be identical with the previously described copper-containing erythrocuprein (human) andhemocuprein (bovine).\u00a0\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Oxidative Stress Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "148d4930-3a75-42c7-bfb9-0a93577985ae",
        "_rev": "_WpvYGJ--AN",
        "nanopub": {
            "id": "148d4930-3a75-42c7-bfb9-0a93577985ae",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "28  female European American SLE (pre-flare, developed flare 6-8wk later), 28 matched SLE without flare (for at least 12 wk), 28 matched HC",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "24578190",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CCL2)",
                    "relation": "positiveCorrelation",
                    "object": "a(MESH:\"Symptom Flare Up\")"
                }
            ],
            "evidence": " In addition, levels of plasma IP-10, MCP-1 and MCP-3 (Figure 2D), along with IL-8 and ICAM-1 (Supplementary Figure 2H), were significantly elevated in pre-flare periods compared to periods of stable disease.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c42e0911-94c4-4b9e-a1b8-b606687b1815",
        "_rev": "_WpvYGJG-_p",
        "nanopub": {
            "id": "c42e0911-94c4-4b9e-a1b8-b606687b1815",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "UBERON:blood",
                    "label": "blood",
                    "type": "Anatomy"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "19463807",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IGFBP1)",
                    "relation": "negativeCorrelation",
                    "object": "a(CHEBI:\"insulin (human)\")"
                }
            ],
            "evidence": "In the subjects overall over both visits, IGFBP-1 was negatively correlated with FPI (r=\u22120.24, pb0.05).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "1b9a8afc-8a66-4da9-98f0-aef2e125197d",
        "_rev": "_WpvYGJG-_t",
        "nanopub": {
            "id": "1b9a8afc-8a66-4da9-98f0-aef2e125197d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "MESH:D005786",
                    "label": "Gene Expression Regulation",
                    "type": ""
                },
                {
                    "id": "MESH:D012216",
                    "label": "Rheumatic Diseases",
                    "type": "Disease"
                },
                {
                    "id": "MESH:D008180",
                    "label": "Lupus Erythematosus, Systemic",
                    "type": "Disease"
                },
                {
                    "id": "MESH:D012313",
                    "label": "RNA",
                    "type": ""
                },
                {
                    "id": "MESH:D008181",
                    "label": "Lupus Nephritis",
                    "type": "Disease"
                },
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "Feng, Xuebing",
                    "Wu, Hui",
                    "Grossman, Jennifer M",
                    "Hanvivadhanakul, Punchong",
                    "FitzGerald, John D",
                    "Park, Grace S",
                    "Dong, Xin",
                    "Chen, Weiling",
                    "Kim, Michelle H",
                    "Weng, Haoling H",
                    "Furst, Daniel E",
                    "Gorn, Alan",
                    "McMahon, Maureen",
                    "Taylor, Mihaela",
                    "Brahn, Ernest",
                    "Hahn, Bevra H",
                    "Tsao, Betty P"
                ],
                "database": {
                    "id": "16947629",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus."
            },
            "assertions": [
                {
                    "subject": "",
                    "relation": "",
                    "object": ""
                }
            ],
            "evidence": "",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7f6a98ec-0f07-48df-b7dc-7b1a6ecda732",
        "_rev": "_WpvYGI6--F",
        "nanopub": {
            "id": "7f6a98ec-0f07-48df-b7dc-7b1a6ecda732",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "88 SLE, 26 HC",
                    "type": "cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Lin, Syh-Jae",
                    "Kuo, Ming-Ling",
                    "Hsiao, Hsiu-Shan",
                    "Lee, Pei-Tzu",
                    "Chen, Ji-Yih",
                    "Huang, Jing-Long"
                ],
                "database": {
                    "id": "29023581",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Activating and inhibitory receptors on natural killer cells in patients with systemic lupus erythematosis-regulation with interleukin-15.",
                "abstract": "Natural killer (NK) cells may play an important role in the pathogenesis of SLE. Interleukin(IL)-15, an NK-enhancing cytokine, is over-expressed in SLE patients. In the present study, we examined the effect of IL-15 on NK cytotoxicity of SLE patients, and the expression of various activating and inhibitory NK receptors on NK cells from SLE patients in relation to disease activity. We also sought to determine how IL-15 would affect the NK receptor expression on NK cells from SLE patients. PBMCs were collected from 88 SLE patients with inactive disease activity (SLEDAI score<6) and active disease activity (SLEDAI score\u22656), 26 age-matched healthy adults were used as controls. PBMC were incubated in the presence or absence of IL-15 (10ng/ml) for eighteen hours. CD3-CD56+ lymphoctes were gated using flow cytometry and further divided into CD56dim and CD56bright subsets according to the MFI of CD56. We observed that 1. Serum IL-15 was elevated in SLE patients, and higher in active disease than in inactive disease; 2. NK cytotoxicity of SLE patients was deficient compared to controls and showed an impaired response to IL-15 compared to controls; 3.CD69, CD94, NKG2A, NKp30, and CD158b on NK cells from SLE patients were higher than controls, and could be further enhanced by IL-15; 4. NKp46 expression from SLE patients was higher than controls, but down-regulated by IL-15; 5.Deficient NKG2D and NKAT-2 expression were found on NK cells from SLE patients, which were enhanced by IL-15; 6. A unique NKp46- subset and CD158b+ subsets were observed in NK cells from SLE patients but not controls. 7. Unlike controls, CD158k on NK cells from SLE patients failed to respond to IL-15. Taken together, we demonstrated the aberrant NCR and iNKR expression on NK cells and their distinct response to IL-15 in SLE patients. As IL-15 predominantly aggravates the aberrant NKR expression found in SLE, IL-15 antagonist may have therapeutic benefits in SLE patients."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL15)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "An increased level of IL-15 was detected in sera from active and inactive patients compared with healthy controls (Fig 1). Although no significant correlation was found between disease activity and IL-15 serum levels (r = 0.004, P = 0.649). SLE patients with active disease show higher IL-15 serum levels compared to inactive patients (19.4\u00b14.1 pg/ml vs. 8.6\u00b11.0 pg/ml, p = 0.019)",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8dc2cec0-08c4-464a-955b-b541805f1e77",
        "_rev": "_WpvYGJC-_b",
        "nanopub": {
            "id": "8dc2cec0-08c4-464a-955b-b541805f1e77",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "80 SLE with (40) and without (40) renal disease, 40 HC (Chinese cohort)",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "0.333",
                    "type": "Coefficient"
                },
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "SLEDAI",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "15975968",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:CXCL8)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Upon subgroup analysis, IP10, RANTES, MIG, MCP\u20101, IL8, and IL18 correlated significantly with SLEDAI score of the SLE group, while IP10, IL8, IL10, and IL18 concentrations correlated significantly with SLEDAI of RSLE patients (all p<0.05). \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4932cc28-2a0f-4844-8b18-7b83a8071b6a",
        "_rev": "_WpvYGJG-Ae",
        "nanopub": {
            "id": "4932cc28-2a0f-4844-8b18-7b83a8071b6a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "89 Finnish patients with familial and 203 with sporadic SLE",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "comments": "no full text",
                "database": {
                    "id": "15370721",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"anti-thrombin\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arterial Thrombosis\")"
                },
                {
                    "subject": "p(\"anti-beta2-GPI\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arterial Thrombosis\")"
                },
                {
                    "subject": "p(\"IgG anticardiolipin\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arterial Thrombosis\")"
                }
            ],
            "evidence": " A high risk of arterial thrombosis (TIA or stroke) was associated with positivity of IgG-aCL, anti beta 2-GPI, and anti-prothrombin. \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "f55555d1-7f1f-4fc3-a263-94cd138202fb",
        "_rev": "_WpvYGJG-BA",
        "nanopub": {
            "id": "f55555d1-7f1f-4fc3-a263-94cd138202fb",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "52 samples from 26 LN patients, 10 samples from healthy females",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "UBERON:urine",
                    "label": "urine",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "16518330",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:TGFB1)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                }
            ],
            "evidence": "Urinary interferon-producing protein 10 and its CXC chemokine receptor (CXCR)3, transforming growth factor-\u03b2 (TGF-\u03b2), and vascular endothelial growth factor (VEGF) mRNA levels were analyzed by quantitative real-time polymerase chain reactions. Levels of chemokine or growth factor mRNAs in urine could distinguish class IV LN from others, with a sensitivity of 85% and a specificity of 94%. \n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "182b63fa-65f5-4fbb-9061-11c92cbb9619",
        "_rev": "_WpvYGJC-B0",
        "nanopub": {
            "id": "182b63fa-65f5-4fbb-9061-11c92cbb9619",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                }
            ],
            "citation": {
                "database": {
                    "id": "16177117",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:Zinc)",
                    "relation": "decreases",
                    "object": "r(HGNC:TNF)"
                }
            ],
            "evidence": "LPS-induced TNF- and IL-1\u0001 mRNA expressions were blocked by addition of zinc (25 M) plus pyrithione (50 M)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "627f5092-2a52-4adf-a204-ea0cb5727a00",
        "_rev": "_WpvYGJG-AV",
        "nanopub": {
            "id": "627f5092-2a52-4adf-a204-ea0cb5727a00",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                }
            ],
            "citation": {
                "authors": [
                    "McDonald, P P",
                    "Bald, A",
                    "Cassatella, M A"
                ],
                "database": {
                    "id": "9129050",
                    "name": "PubMed"
                },
                "source_name": "Blood",
                "title": "Activation of the NF-kappaB pathway by inflammatory stimuli in human neutrophils.",
                "abstract": "Activated neutrophils have the ability to upregulate the expression of many genes, in particular those encoding cytokines and chemokines, and to subsequently release the corresponding proteins. Although little is known to date concerning the regulation of gene transcription in neutrophils, it is noteworthy that many of these genes depend on the activation of transcription factors, such as NF-kappaB, for inducible expression. We therefore investigated whether NF-kappaB/Rel proteins are expressed in human neutrophils, as well as their fate on cell activation. We now report that dimers consisting of p50 NFkappaB1, p65 RelA, and/or c-Rel are present in neutrophils and that the greater part of these protein complexes is physically associated with cytoplasmic IkappaB-alpha in resting cells. Following neutrophil stimulation with proinflammatory agonists (such as lipopolysaccharide [LPS], tumor necrosis factor-alpha [TNF-alpha], and fMet-Leu-Phe) that induce the production of cytokines and chemokines in these cells, NF-kappaB/Rel proteins translocated to nuclear fractions, resulting in a transient induction of NF-kappaB DNA binding activity, as determined in gel mobility shift assays. The onset of both processes was found to be closely paralleled by, and dependent on, IkappaB-alpha degradation. Proinflammatory neutrophil stimuli also promoted the accumulation of IkappaB-alpha mRNA transcripts, resulting in the reexpression of the IkappaB-alpha protein. To our knowledge, this constitutes the first indication that NF-kappaB activation may underlie the action of proinflammatory stimuli towards human neutrophil gene expression and, as such, adds a new facet to our understanding of neutrophil biology.",
                "date_published": "1997-05-01"
            },
            "assertions": [
                {
                    "subject": "p(HGNC:NFKB1)",
                    "relation": "directlyIncreases",
                    "object": "complex(p(HGNC:NFKB1), p(HGNC:RELA))"
                }
            ],
            "evidence": "\"Thus, it appears that the inducible NF-kB complex primarily consists of p50/p65 heterodimers but that it may also contain minor amounts of c-Rel-containing complexes.\"",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "Activated neutrophils have the ability to upregulate the expression of many genes, in particular those encoding cytokines and chemokines, and to subsequently release the corresponding proteins. Although little is known to date concerning the regulation of gene transcription in neutrophils, it is noteworthy that many of these genes depend on the activation of transcription factors, such as NF-kappaB, for inducible expression. We therefore investigated whether NF-kappaB/Rel proteins are expressed in human neutrophils, as well as their fate on cell activation. We now report that dimers consisting of p50 NFkappaB1, p65 RelA, and/or c-Rel are present in neutrophils and that the greater part of these protein complexes is physically associated with cytoplasmic IkappaB-alpha in resting cells. Following neutrophil stimulation with proinflammatory agonists (such as lipopolysaccharide [LPS], tumor necrosis factor-alpha [TNF-alpha], and fMet-Leu-Phe) that induce the production of cytokines and chemokines in these cells, NF-kappaB/Rel proteins translocated to nuclear fractions, resulting in a transient induction of NF-kappaB DNA binding activity, as determined in gel mobility shift assays. The onset of both processes was found to be closely paralleled by, and dependent on, IkappaB-alpha degradation. Proinflammatory neutrophil stimuli also promoted the accumulation of IkappaB-alpha mRNA transcripts, resulting in the reexpression of the IkappaB-alpha protein. To our knowledge, this constitutes the first indication that NF-kappaB activation may underlie the action of proinflammatory stimuli towards human neutrophil gene expression and, as such, adds a new facet to our understanding of neutrophil biology.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5e6c7a79-8083-420d-8e1f-1108ce6dd72d",
        "_rev": "_WpvYGJ---6",
        "nanopub": {
            "id": "5e6c7a79-8083-420d-8e1f-1108ce6dd72d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Immunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "7528775",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "increases",
                    "object": "p(HGNC:JAK2, pmod(Ph))"
                }
            ],
            "evidence": "IFN-3, similarly induced tyrosine phosphorylation of JAK2 (lane 3).\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e24acb12-4ac9-42f3-9b73-ff16f9a175de",
        "_rev": "_WpvYGJG-_d",
        "nanopub": {
            "id": "e24acb12-4ac9-42f3-9b73-ff16f9a175de",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "DO:\"human immunodeficiency virus infectious disease\"",
                    "label": "human immunodeficiency virus infectious disease",
                    "type": "Disease"
                },
                {
                    "id": "MESH:\"CD4-Positive T-Lymphocytes\"",
                    "label": "CD4-Positive T-Lymphocytes",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16425129",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "path(DO:\"human immunodeficiency virus infectious disease\")",
                    "relation": "positiveCorrelation",
                    "object": "p(HGNC:IL2RG)"
                },
                {
                    "subject": "path(DO:\"human immunodeficiency virus infectious disease\")",
                    "relation": "negativeCorrelation",
                    "object": "surf(p(HGNC:IL7R))"
                }
            ],
            "evidence": "PHI was associated with a significant decrease in the percentage of CD4+127+132\u2212\u00a0T cells and an increase in the percentage of CD4+127\u2212132+\u00a0T cells. These changes were even more pronounced in patients with CHI (figure 3A)\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c708e01c-3c02-4601-98a1-26c536ff126d",
        "_rev": "_WpvYGJC-Ax",
        "nanopub": {
            "id": "c708e01c-3c02-4601-98a1-26c536ff126d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "<0.001",
                    "type": "p-value"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "240 RA patients, 240 controls",
                    "type": "cohort"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                }
            ],
            "citation": {
                "authors": [
                    "Hern\u00e1ndez-Bello, J",
                    "Oreg\u00f3n-Romero, E",
                    "V\u00e1zquez-Villamar, M",
                    "Garc\u00eda-Arellano, S",
                    "Valle, Y",
                    "Padilla-Guti\u00e9rrez, J R",
                    "Rom\u00e1n-Fern\u00e1ndez, I V",
                    "Palafox-S\u00e1nchez, C A",
                    "Mart\u00ednez-Bonilla, G E",
                    "Mu\u00f1oz-Valle, J F"
                ],
                "database": {
                    "id": "28254559",
                    "name": "PubMed"
                },
                "source_name": "Cytokine",
                "title": "Aberrant expression of interleukin-10 in rheumatoid arthritis: Relationship with IL10 haplotypes and autoantibodies.",
                "abstract": "Interleukin 10 (IL-10) is an immunomodulatory cytokinethat plays a central rolein the pathogenesis of autoimmune diseases. Different studies consistently show increased IL-10 serum levels in rheumatoid arthritis (RA) and it appears to be caused by genetic variants. Three polymorphisms situated at positions -1082, -819 and -592 of IL10 gene and its major haplotypes have been associated with regulating IL10 promoter activity. In this study, we evaluated whether IL10 haplotypes are associated with mRNA expression and IL-10 serum levels as well as susceptibility to RA in a Western Mexican population. A total of 240 RA patients and 240 control subjects (CS) were included. Genotyping of IL10 polymorphisms was performed by PCR and PCR-RFLP, respectively. IL10 mRNA expression was determined by real-time PCR and IL-10 serum levels were measured using an ELISA kit. IL10 mRNA expression was 50-fold higher in RA patients than CS (p<0.001), while IL-10 serum levels did not show differences between groups. However, high IL-10 serum levels were positively related to a higherseropositivityfor rheumatoid factor (FR) and anti-CCP antibodies (p<0.05). No significant differences between the distribution of haplotype frequencies were observed between both study groups, but GCC haplotype was associated with higher IL-10 serum levels compared with the ACC and ATA haplotypes in RA patients (p<0.05). In addition, patients carrying ATA and GCC haplotypes showed higher mRNA expression than ACC (5.4-fold and 8.8-fold, respectively) and surprisingly, this trend was reversed in the controls, although it was not significant. In conclusion, our findings suggest that IL10 (GCC, ACC, and ATA) haplotypes may not be a susceptibility marker for RA in a population from Western Mexico. Nevertheless, independently of the presence of these variants, there is an aberrant overexpression of IL10 gene in RA, and it may play an important role in the pathogenesis of RA."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:IL10)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arthritis, Rheumatoid\")"
                }
            ],
            "evidence": "IL10 mRNA expression was 50-fold higher in RA patients than CS (p < 0.001), while IL-10 serum levels did not show differences between groups.\u00a0",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Inflammation Index"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "12a751c3-e5d2-4977-84fb-e10d5d2cf89d",
        "_rev": "_WpvYGJG-BW",
        "nanopub": {
            "id": "12a751c3-e5d2-4977-84fb-e10d5d2cf89d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Western Blot",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "7544001",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL2)",
                    "relation": "increases",
                    "object": "p(HGNC:STAT1B, pmod(Ph, Tyr, 701))"
                }
            ],
            "evidence": "Given this finding and the fact that the anti-phospho-Statl antibodies recognized a protein of identical mobility from IL-2-treated NKL cells by Western blotting (Fig. 2A), we conclude that Statl is phosphorylated on tyrosine in response to IL-2\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c609e939-af08-4fca-9f36-ac742553c7cc",
        "_rev": "_WpvYGI6--A",
        "nanopub": {
            "id": "c609e939-af08-4fca-9f36-ac742553c7cc",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.006",
                    "type": "p-value"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Ahmadzadeh, Mojgan",
                    "Rosenberg, Steven A"
                ],
                "database": {
                    "id": "16304057",
                    "name": "PubMed"
                },
                "source_name": "Blood",
                "title": "IL-2 administration increases CD4+ CD25(hi) Foxp3+ regulatory T cells in cancer patients.",
                "abstract": "Interleukin-2 (IL-2) is historically known as a T-cell growth factor. Accumulating evidence from knockout mice suggests that IL-2 is crucial for the homeostasis and function of CD4+ CD25+ regulatory T cells in vivo. However, the impact of administered IL-2 in an immune intact host has not been studied in rodents or humans. Here, we studied the impact of IL-2 administration on the frequency and function of human CD4+ CD25(hi) T cells in immune intact patients with melanoma or renal cancer. We found that the frequency of CD4+ CD25(hi) T cells was significantly increased after IL-2 treatment, and these cells expressed phenotypic markers associated with regulatory T cells. In addition, both transcript and protein levels of Foxp3, a transcription factor exclusively expressed on regulatory T cells, were consistently increased in CD4 T cells following IL-2 treatment. Functional analysis of the increased number of CD4+ CD25(hi) T cells revealed that this population exhibited potent suppressive activity in vitro. Collectively, our results demonstrate that administration of high-dose IL-2 increased the frequency of circulating CD4+ CD25(hi) Foxp3+ regulatory T cells. Our findings suggest that selective inhibition of IL-2-mediated enhancement of regulatory T cells may improve the therapeutic effectiveness of IL-2 administration."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL2)",
                    "relation": "increases",
                    "object": "r(HGNC:FOXP3)"
                }
            ],
            "evidence": "We thus examined mRNA levels of\u00a0Foxp3\u00a0in highly purified CD4 T cells before and after IL-2 treatment. We found that the mRNA levels of\u00a0Foxp3\u00a0in CD4 T cells were consistently increased in the rebound phase compared with pretreatment levels (P\u00a0= .006, paired\u00a0ttest) in all 8 patients (Figure 4A, REB vs PRE).",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "Interleukin-2 (IL-2) is historically known as a T-cell growth factor. Accumulating evidence from knockout mice suggests that IL-2 is crucial for the homeostasis and function of CD4+ CD25+ regulatory T cells in vivo. However, the impact of administered IL-2 in an immune intact host has not been studied in rodents or humans. Here, we studied the impact of IL-2 administration on the frequency and function of human CD4+ CD25(hi) T cells in immune intact patients with melanoma or renal cancer. We found that the frequency of CD4+ CD25(hi) T cells was significantly increased after IL-2 treatment, and these cells expressed phenotypic markers associated with regulatory T cells. In addition, both transcript and protein levels of Foxp3, a transcription factor exclusively expressed on regulatory T cells, were consistently increased in CD4 T cells following IL-2 treatment. Functional analysis of the increased number of CD4+ CD25(hi) T cells revealed that this population exhibited potent suppressive activity in vitro. Collectively, our results demonstrate that administration of high-dose IL-2 increased the frequency of circulating CD4+ CD25(hi) Foxp3+ regulatory T cells. Our findings suggest that selective inhibition of IL-2-mediated enhancement of regulatory T cells may improve the therapeutic effectiveness of IL-2 administration.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "26135e92-681f-4e01-b078-56fe1a301210",
        "_rev": "_WpvYGJC-Ag",
        "nanopub": {
            "id": "26135e92-681f-4e01-b078-56fe1a301210",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Thymidine Incorporation",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "8624821",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL4)",
                    "relation": "regulates",
                    "object": "bp(GO:\"T helper 2 cell differentiation\")"
                }
            ],
            "evidence": "\u00a0As shown in\u00a0Figure 3A, the proliferative response of lymphocytes from\u00a0Stat6\u2212/\u2212\u00a0mice is almost completely abrogated. In contrast with lymphocytes from control mice, which show a 40-fold increase in proliferation in response to 1,000 U/ml IL-4, the proliferative response of lymphocytes from\u00a0Stat6\u2212/\u2212\u00a0mice is only 4- to 5-fold over background at this concentration of IL-4 and undetectable at 100 U/ml IL-4.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0f061b1a-51f2-4b89-a54a-32f0a7060113",
        "_rev": "_WpvYGI6--r",
        "nanopub": {
            "id": "0f061b1a-51f2-4b89-a54a-32f0a7060113",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15153495",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL12)",
                    "relation": "increases",
                    "object": "r(HGNC:IFNG)"
                }
            ],
            "evidence": "The strongest induction by IL-12 was seen in the up-regulation of\u00a0Ifn\u03b3.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "c3d95985-63cd-4cdc-8c06-3d137845de3b",
        "_rev": "_WpvYGJC-BN",
        "nanopub": {
            "id": "c3d95985-63cd-4cdc-8c06-3d137845de3b",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "",
                    "label": "0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "118",
                    "type": "N"
                }
            ],
            "citation": {
                "database": {
                    "id": "16947629",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "r(HGNC:LY6E)",
                    "relation": "positiveCorrelation",
                    "object": "path(\"SELENA-SLEDAI\")"
                }
            ],
            "evidence": "LY6E expression, the highest among the 5 tested genes correlating with IFN scores (r =0.91), also showed an association with SLEDAI scores (P =0.001) and physician\u2019s global assessment scores (P  0.005) (Figures 2D and E).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "29f259a0-2b78-428f-81bb-ccab196d5955",
        "_rev": "_WpvYGJG--l",
        "nanopub": {
            "id": "29f259a0-2b78-428f-81bb-ccab196d5955",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"naive T cell\"",
                    "label": "naive T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "18469800",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL17)",
                    "relation": "biomarkerFor",
                    "object": "bp(GO:\"T-helper 17 cell differentiation\")"
                }
            ],
            "evidence": "we always observed induction of IL-17A after differentiation in the presence of TGF-\u03b2 with IL-21.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "8195660c-0fb4-4117-aff3-e8b7ca670b6d",
        "_rev": "_WpvYGJC-Bq",
        "nanopub": {
            "id": "8195660c-0fb4-4117-aff3-e8b7ca670b6d",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "0.09",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "qRT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "Crossover study with 27 healthy subjects",
                    "type": "Cohort"
                },
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "19359242",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Fish Oils\")\t",
                    "relation": "decreases",
                    "object": "r(HGNC:IL17A)"
                },
                {
                    "subject": "a(MESH:\"Fish Oils\")",
                    "relation": "decreases",
                    "object": "r(HGNC:IL10)"
                }
            ],
            "evidence": "A significant decrease in expression was observed for IL-1\u00df, IL-10, and IL-23. Additionally, IL-5 and IL-17 showed strong trends toward decreased expression after supplementation.\n",
            "metadata": {
                "project": "RA Biomarker Interventions Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "e3fe3f44-bd19-438d-bd1e-bb1b707bcd50",
        "_rev": "_WpvYGJG-_i",
        "nanopub": {
            "id": "e3fe3f44-bd19-438d-bd1e-bb1b707bcd50",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Coimmunoprecipitation",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "AE7",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "16275766",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TBX21, pmod(Ph, S, 508))",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:RELA)"
                }
            ],
            "evidence": "Coimmunoprecipitation assays of overexpressed T-bet and RelA proteins revealed that T-bet interacted physically with RelA. Notably, this interaction required T-betS508\u00a0as revealed by the failure of the S508A mutant T-bet to coimmunoprecipitate RelA (Fig. 5, A and B) .\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "5b6cb70b-3dde-4f22-ba6f-545ea2eb94b0",
        "_rev": "_WpvYGJC--F",
        "nanopub": {
            "id": "5b6cb70b-3dde-4f22-ba6f-545ea2eb94b0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "authors": [
                    "Krishnan, Sandeep",
                    "Juang, Yuang-Taung",
                    "Chowdhury, Bhabadeb",
                    "Magilavy, Abigail",
                    "Fisher, Carolyn U",
                    "Nguyen, Hang",
                    "Nambiar, Madhusoodana P",
                    "Kyttaris, Vasileios",
                    "Weinstein, Arthur",
                    "Bahjat, Rena",
                    "Pine, Polly",
                    "Rus, Violeta",
                    "Tsokos, George C"
                ],
                "database": {
                    "id": "19018007",
                    "name": "PubMed"
                },
                "source_name": "Journal of immunology (Baltimore, Md. : 1950)",
                "title": "Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells.",
                "abstract": "Diminished expression of TCR zeta and reciprocal up-regulation and association of FcRgamma with the TCR/CD3 complex is a hallmark of systemic lupus erythematosus (SLE) T cells. In this study we explored whether differential molecular associations of the spleen tyrosine kinase Syk that preferentially binds to FcRgamma contribute to pathological amplification of signals downstream of this \"rewired TCR\" in SLE. We detected higher amounts of Syk expression and activity in SLE compared with normal T cells. Selective inhibition of the activity of Syk reduced the strength of TCR-induced calcium responses and slowed the rapid kinetics of actin polymerization exclusively in SLE T cells. Syk and ZAP-70 also associated differently with key molecules involved in cytoskeletal and calcium signaling in SLE T cells. Thus, while Vav-1 and LAT preferentially bound to Syk, phospholipase C-gamma1 bound to both Syk and ZAP-70. Our results show that differential associations of Syk family kinases contribute to the enhanced TCR-induced signaling responses in SLE T cells. Thus, we propose molecular targeting of Syk as a measure to control abnormal T cell responses in SLE."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"calcium(2+)\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                },
                {
                    "subject": "act(complex(GO:\"T cell receptor complex\"))",
                    "relation": "increases",
                    "object": "a(CHEBI:\"calcium(2+)\")"
                }
            ],
            "evidence": "TCR-induced calcium signaling is another intracytoplasmic event that is augmented in SLE. Our observation that suppression of Syk resulted in significant reduction in the calcium response suggests a critical role of Syk in the pathological augmentation of TCR-induced calcium flux in SLE (Fig. 4\u21d1).",
            "metadata": {
                "project": "SLE model adaptive immunity",
                "gd:abstract": "Diminished expression of TCR zeta and reciprocal up-regulation and association of FcRgamma with the TCR/CD3 complex is a hallmark of systemic lupus erythematosus (SLE) T cells. In this study we explored whether differential molecular associations of the spleen tyrosine kinase Syk that preferentially binds to FcRgamma contribute to pathological amplification of signals downstream of this \"rewired TCR\" in SLE. We detected higher amounts of Syk expression and activity in SLE compared with normal T cells. Selective inhibition of the activity of Syk reduced the strength of TCR-induced calcium responses and slowed the rapid kinetics of actin polymerization exclusively in SLE T cells. Syk and ZAP-70 also associated differently with key molecules involved in cytoskeletal and calcium signaling in SLE T cells. Thus, while Vav-1 and LAT preferentially bound to Syk, phospholipase C-gamma1 bound to both Syk and ZAP-70. Our results show that differential associations of Syk family kinases contribute to the enhanced TCR-induced signaling responses in SLE T cells. Thus, we propose molecular targeting of Syk as a measure to control abnormal T cell responses in SLE.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "607ff445-1362-4d40-88e8-9ffccc7e2d16",
        "_rev": "_WpvYGJG-BV",
        "nanopub": {
            "id": "607ff445-1362-4d40-88e8-9ffccc7e2d16",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "16220542",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "increases",
                    "object": "bp(GO:\"osteoclast development\")"
                }
            ],
            "evidence": ". However, the number of osteoclasts formed by IFN-c+ T cells was smaller than that in the presence of sRANKL (100 ng/ mL) (Fig. 2A, B).\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "347b38c1-ddd7-4e9a-a239-c36963f517ca",
        "_rev": "_WpvYGJ---B",
        "nanopub": {
            "id": "347b38c1-ddd7-4e9a-a239-c36963f517ca",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15790681",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:FOXP3)\t",
                    "relation": "decreases",
                    "object": "r(HGNC:IL4)"
                },
                {
                    "subject": "p(HGNC:FOXP3)\t",
                    "relation": "decreases",
                    "object": "r(HGNC:IFNG)"
                },
                {
                    "subject": "p(HGNC:FOXP3)",
                    "relation": "decreases",
                    "object": "r(HGNC:IL2)"
                }
            ],
            "evidence": "Interestingly only Foxp3, but not Foxp1 or Foxp2, expression in T cells suppressed the production of IL-2, IL-4, and IFN- (Fig. 1 A\u2013C)\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "153a87ca-b0f1-4d98-906a-4cb9c2f98847",
        "_rev": "_WpvYGJC-A4",
        "nanopub": {
            "id": "153a87ca-b0f1-4d98-906a-4cb9c2f98847",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"peripheral blood mononuclear cell\"",
                    "label": "peripheral blood mononuclear cell",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "Radioimmunoassay",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "1672545",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL12)",
                    "relation": "increases",
                    "object": "sec(p(HGNC:IFNG))"
                }
            ],
            "evidence": "NKSF, in a dose-dependent manner, synergized with PHA (Fig. 1 A), the phorbol diesters TPA (Fig. 1 B) and PDBu (not shown), and anti-CD3 antibodies (Fig. 1 C) at all concentrations tested, to induce IFN-y secretion .\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "80e7cd24-e6cc-49c3-88e8-3f5e7a193004",
        "_rev": "_WpvYGJC-AI",
        "nanopub": {
            "id": "80e7cd24-e6cc-49c3-88e8-3f5e7a193004",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "31 LN,\u00a021 Active Lupus no LN, 30 Inactive Lupus, 11 HC. Almost all patients on prednisone; other drugs allowed as well. Brazilian cohort; sex not reported",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "25799079",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"uric acid\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                },
                {
                    "subject": "a(CHEBI:urea)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Lupus Nephritis\")"
                }
            ],
            "evidence": "Also, urea (p<0.001) and uric acid (p<0.001) levels were significantly elevated in LN patients compared to other study groups.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0db4374a-27cc-4d10-af05-805d456856a1",
        "_rev": "_WpvYGJG--x",
        "nanopub": {
            "id": "0db4374a-27cc-4d10-af05-805d456856a1",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "CL:neutrophil",
                    "label": "neutrophil",
                    "type": "Cell"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "2212667",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CL:neutrophil)",
                    "relation": "increases",
                    "object": "r(HGNC:IL1B)"
                }
            ],
            "evidence": "As can be seen in Figure 2, IL-lp increases steady state mRNA levels of IL-I@ in a dose-dependent fashion.\n",
            "metadata": {
                "project": "Canonical Immune Cell Type",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "be673114-97ab-44fd-8144-754fd2e1186d",
        "_rev": "_WpvYGJG-Ba",
        "nanopub": {
            "id": "be673114-97ab-44fd-8144-754fd2e1186d",
            "type": {
                "name": "BEL",
                "version": "1.0.0"
            },
            "annotations": [
                {
                    "id": "CL:\"T cell\"",
                    "label": "T cell",
                    "type": "Cell"
                },
                {
                    "id": "UBERON:spleen",
                    "label": "spleen",
                    "type": "Anatomy"
                },
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:10090",
                    "label": "mouse",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "15153495",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IFNG)",
                    "relation": "increases",
                    "object": "r(HGNC:IFNG)"
                }
            ],
            "evidence": "\u00a0Importantly, addition of exogenous IFN-\u03b3 to the cells cultured in Th1 conditions (anti-CD3 + anti-CD28 + IL-12 + IFN-\u03b3 + anti-IL-4) was able to restore the defect in induction of IFN-\u03b3 production in STAT4-knockout cells, whereas in wild-type cells addition of IFN-\u03b3 had no effect (Fig. 3\u21d3c).\u00a0\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "7fdbd60f-f607-4b06-947f-65c67192faec",
        "_rev": "_WpvYGJ--Ax",
        "nanopub": {
            "id": "7fdbd60f-f607-4b06-947f-65c67192faec",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "type": "Species",
                    "id": "TAX:9606",
                    "label": "human"
                },
                {
                    "id": "MESH:D061307",
                    "label": "Human Umbilical Vein Endothelial Cells",
                    "type": "Cell"
                }
            ],
            "citation": {
                "authors": [
                    "Wen, Ya-Dan",
                    "Wang, Hong",
                    "Kho, Sok-Hong",
                    "Rinkiko, Suguro",
                    "Sheng, Xiong",
                    "Shen, Han-Ming",
                    "Zhu, Yi-Zhun"
                ],
                "database": {
                    "id": "23393548",
                    "name": "PubMed"
                },
                "source_name": "PloS one",
                "title": "Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress.",
                "abstract": "Hydrogen sulfide (H\u2082S) has been shown to have cytoprotective effects in models of hypertension, ischemia/reperfusion and Alzheimer's disease. However, little is known about its effects or mechanisms of action in atherosclerosis. Therefore, in the current study we evaluated the pharmacological effects of H\u2082S on antioxidant defenses and mitochondria protection against hydrogen peroxide (H\u2082O\u2082) induced endothelial cells damage."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"hydrogen peroxide\")",
                    "relation": "decreases",
                    "object": "a(MESH:\"Glutathione Peroxidase\")"
                }
            ],
            "evidence": "When cells were stimulated with H2O2 a significant decreases in the activities of superoxide dismutase (SOD), catalase, glutathione Peroxidase (GPx) and glutathione S-transferase (GST) were observed (P<0.05, vs. control, n\u200a=\u200a6).",
            "metadata": {
                "Methodology": "western blot",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "ncatlett@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "80feb1f1-f937-402e-9430-8b365f9765ac",
        "_rev": "_WrNI8xe---",
        "nanopub": {
            "id": "80feb1f1-f937-402e-9430-8b365f9765ac",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "",
                    "label": "36 SLE, 18 HC",
                    "type": "cohort"
                }
            ],
            "citation": {
                "authors": [
                    "Ren, Yi",
                    "Tang, Jinling",
                    "Mok, M Y",
                    "Chan, Albert W K",
                    "Wu, Adrian",
                    "Lau, C S"
                ],
                "database": {
                    "id": "14558095",
                    "name": "PubMed"
                },
                "source_name": "Arthritis and rheumatism",
                "title": "Increased apoptotic neutrophils and macrophages and impaired macrophage phagocytic clearance of apoptotic neutrophils in systemic lupus erythematosus.",
                "abstract": "To evaluate whether patients with systemic lupus erythematosus (SLE) have a higher rate of apoptosis in and secondary necrosis of polymorphonuclear neutrophils (PMNs) and macrophages compared with controls; to compare the rate of macrophage phagocytic clearance of apoptotic PMNs in patients with SLE and healthy controls; to evaluate whether in vitro PMN and macrophage apoptosis and secondary necrosis, and the ability of macrophages to phagocytose apoptotic bodies, are correlated with lupus disease activity; and to determine whether macrophage clearance of apoptotic bodies in patients with SLE and normal controls is related to certain serum factors."
            },
            "assertions": [
                {
                    "subject": "bp(GO:phagocytosis, CL:macrophage)\t",
                    "relation": "negativeCorrelation",
                    "object": "path(MESH:\"Lupus Erythematosus, Systemic\")"
                }
            ],
            "evidence": "Macrophages from SLE patients were less capable of phagocytosing apoptotic PMNs compared with macrophages obtained from controls.\n",
            "metadata": {
                "project": "SLE model innate immunity",
                "gd:abstract": "To evaluate whether patients with systemic lupus erythematosus (SLE) have a higher rate of apoptosis in and secondary necrosis of polymorphonuclear neutrophils (PMNs) and macrophages compared with controls; to compare the rate of macrophage phagocytic clearance of apoptotic PMNs in patients with SLE and healthy controls; to evaluate whether in vitro PMN and macrophage apoptosis and secondary necrosis, and the ability of macrophages to phagocytose apoptotic bodies, are correlated with lupus disease activity; and to determine whether macrophage clearance of apoptotic bodies in patients with SLE and normal controls is related to certain serum factors.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.9020000",
                "gd:updateTS": "2018-04-17T13:28:37.939Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "843c5b37-dea1-47f3-b39b-c735b2d49a8c",
        "_rev": "_WpvYGI6--l",
        "nanopub": {
            "id": "843c5b37-dea1-47f3-b39b-c735b2d49a8c",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "RT-PCR",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "n=34 (17 healthy test subjects, 17 controls)",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Serum",
                    "label": "Serum",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "18580406",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Exercise\")",
                    "relation": "positiveCorrelation",
                    "object": "r(HGNC:PPARG)"
                }
            ],
            "evidence": "As can be seen in\u00a0Figure 2A, exercise significantly increased PPAR\u03b3 (4 wk, 1.82 \u00b1 0.89-fold; 8 wk, 4.27 \u00b1 1.89-fold) gene expression.\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.901Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.901Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "33cc253f-9d0c-4bf8-ab8e-bd1173420955",
        "_rev": "_WpvYGJG-_f",
        "nanopub": {
            "id": "33cc253f-9d0c-4bf8-ab8e-bd1173420955",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Yeast two hybrid",
                    "type": "Methodology"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "authors": [
                    "Brown, Victoria",
                    "Brown, Rachel A",
                    "Ozinsky, Adrian",
                    "Hesselberth, Jay R",
                    "Fields, Stanley"
                ],
                "database": {
                    "id": "16482509",
                    "name": "PubMed"
                },
                "source_name": "European journal of immunology",
                "title": "Binding specificity of Toll-like receptor cytoplasmic domains.",
                "abstract": "MyD88 participates in signal transduction by binding to the cytoplasmic Toll/IL-1 receptor (TIR) domains of activated Toll-like receptors (TLR). Yeast two-hybrid experiments reveal that the TIR domains of human TLR differ in their ability to associate with MyD88: The TIR of TLR2 binds to MyD88 but the TIR of the closely related TLR1, 6, or 10 do not. Using chimeric TIR domains, we define the critical region responsible for differential MyD88 binding, and use a computational analysis of the critical region to reveal the amino acids that differ between MyD88 binders and non-binders. Remarkably, a single missense mutation created in TLR1 (N672D) confers on it the ability to bind MyD88, without affecting its association with other proteins. Mutations identified as critical for MyD88 binding also affect signaling of TLR pairs in mammalian cells. To investigate the difference between MyD88 binders and non-binders, we identify novel interacting proteins for each cytoplasmic domain of TLR1, 2, 6, and 10. For example, heat shock protein (HSP)60 binds to TLR1 but not to TLR2, and HSP60 and MyD88 appear to bind the same region of the TIR domain. In summary, interactions between the TLR, MyD88, and novel associated proteins have been characterized."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:TLR7)",
                    "relation": "directlyIncreases",
                    "object": "p(HGNC:MYD88)"
                }
            ],
            "evidence": "The BD-TLR homodimers differentially associated with MyD88; TLR2, 5, 7, and 8 bound, but TLR1, 6, and 10 did not (TLR3 does not signal through MyD88, and its cytoplasmic domain did not bind MyD88 in the two-hybrid assay).",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "SLE model innate immunity"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0edecf5a-6c20-46f1-8feb-ce705d0c52fc",
        "_rev": "_WpvYGJG-_9",
        "nanopub": {
            "id": "0edecf5a-6c20-46f1-8feb-ce705d0c52fc",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Seventy-one SLE patients with low disease activity (mean SLEDAI\u2009=\u20091.62 standard error (SE) 0.37, range 0-8) were compared to 51 controls",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "p<0.0001",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "GC-MS",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "Prof-S",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:\"blood plasma\"",
                    "label": "blood plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "22508802",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(MESH:F2-Isoprostanes)",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:Fatigue)"
                }
            ],
            "evidence": "F(2)-isoprostane was higher in SLE patients with fatigue compared to not-fatigued SLE subjects (p\u2009=\u2009.0076) who were otherwise similar in ethnicity, disease activity and cardiovascular risk factors. Plasma F(2)-isoprostane was strongly correlated with FSS and Profile of Somatic Fatigue (Prof-S) (p\u2009<\u2009.0001), VAS fatigue (p\u2009=\u2009.005), CES-D (p\u2009=\u2009.008) and with BMI (p\u2009=\u2009.0001.) In a multivariate model, F(2)-isoprostane was a significant predictor of FSS after adjustment for age, BMI, pain and depression (p\u2009=\u2009.0002).\n",
            "metadata": {
                "project": "Lupus Biomeasures Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "d650e2b2-f0e7-4cb3-878a-ca5b5e34d1a9",
        "_rev": "_WpvYGJG-Bn",
        "nanopub": {
            "id": "d650e2b2-f0e7-4cb3-878a-ca5b5e34d1a9",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.01",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "250 pairs of liver tumor and adjacent non-tumorous liver tissues (ANLTs)",
                    "type": "Cohort"
                },
                {
                    "id": "",
                    "label": "Reporter assay",
                    "type": "Methodology"
                },
                {
                    "id": "UBERON:liver",
                    "label": "liver",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"hepatocellular carcinoma\"",
                    "label": "hepatocellular carcinoma",
                    "type": "Disease"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                }
            ],
            "citation": {
                "database": {
                    "id": "25998163",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "m(\"miR-188-5p\")",
                    "relation": "decreases",
                    "object": "g(HGNC:FGF5)"
                }
            ],
            "evidence": "Measurement of luciferase activity revealed that miR-188-5p expression was associated with marked reduction of the activity of FGF5 UTR.\n",
            "metadata": {
                "project": "Fasting Presentation Curation",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.903Z",
                "gd:updateTS": "2018-04-13T00:14:05.903Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3d06e712-4cdc-4b49-bd35-786aec747d7a",
        "_rev": "_WpvYGJG-AN",
        "nanopub": {
            "id": "3d06e712-4cdc-4b49-bd35-786aec747d7a",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "Flow Cytometry",
                    "type": "Methodology"
                },
                {
                    "id": "EFO:\"MEL cell line\"",
                    "label": "MEL cell line",
                    "type": "CellLine"
                }
            ],
            "citation": {
                "database": {
                    "id": "12006974",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(HGNC:IL12)",
                    "relation": "increases",
                    "object": "surf(p(HGNC:IL12RB2))"
                }
            ],
            "evidence": "We found that IL-12-treated wild-type T cells induced IL-12RB2 expression on day 2 and maintained expression on day 7, with or without neutralization of IL-4.\n",
            "metadata": {
                "project": "Canonical Immune Cell Types",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "4f875a70-17d1-4f94-b867-b0fe4c05c5b0",
        "_rev": "_WpvYGJ--Ao",
        "nanopub": {
            "id": "4f875a70-17d1-4f94-b867-b0fe4c05c5b0",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p<0.05",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "ELISA",
                    "type": "Methodology"
                },
                {
                    "id": "",
                    "label": "n=20",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                }
            ],
            "citation": {
                "database": {
                    "id": "10692003",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "a(CHEBI:\"vitamin A\")",
                    "relation": "decreases",
                    "object": "p(HGNC:TNF)"
                },
                {
                    "subject": "a(CHEBI:\"vitamin A\")",
                    "relation": "increases",
                    "object": "p(HGNC:IL10)"
                }
            ],
            "evidence": "After initiating vitamin A substitution there was a marked increase in plasma vitamin A levels (Fig. 4). Concomitantly, there was a marked rise in plasma levels of IL-10 and a signi\u00aecant decrease in TNFa and neopterin (Fig. 4).\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "RA Biomarker Interventions Curation"
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "0cb89643-a4e5-4473-9c57-e46b1786d861",
        "_rev": "_WpvYGJ--Bp",
        "nanopub": {
            "id": "0cb89643-a4e5-4473-9c57-e46b1786d861",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "DO:\"rheumatoid arthritis\"",
                    "label": "rheumatoid arthritis",
                    "type": "Disease"
                }
            ],
            "citation": {
                "authors": [
                    "Kim, W",
                    "Min, S",
                    "Cho, M",
                    "Youn, J",
                    "Min, J",
                    "Lee, S",
                    "Park, S",
                    "Cho, C",
                    "Kim, H",
                    "Kim, W U",
                    "Min, S Y",
                    "Cho, M L",
                    "Min, D J",
                    "Lee, S H",
                    "Park, S H",
                    "Cho, C S",
                    "Kim, H Y"
                ],
                "database": {
                    "id": "10606980",
                    "name": "PubMed"
                },
                "source_name": "Clinical and experimental immunology",
                "title": "The role of IL-12 in inflammatory activity of patients with rheumatoid arthritis (RA).",
                "abstract": "The aim of this study was to investigate the role of IL-12 in patients with RA. IL-12 (p70) and its associated cytokines were measured in sera and synovial fluid (SF) using an enzyme-linked immunosorbent method. Seven American College of Rheumatology (ACR) core set measures as well as IL-12 levels were sequentially monitored at the commencement and 4 months after treatment with a low-dose steroid and disease-modifying anti-rheumatic drugs (DMARDs). In sera, 64 (42.2%) of 152 RA patients had detectable concentrations of IL-12 (p70), whereas one (1.4%) of 69 osteoarthritis (OA) patients and five (10%) of 50 healthy controls had detectable IL-12 (P < 0.001). The median level of circulating IL-12 was also higher in RA patients (P < 0.001). In SF, the number of patients with detectable IL-12 and the median IL-12 levels were significantly higher in RA patients (n = 53) than in OA patients (n = 22). In paired samples (n = 53) of sera and SF from RA patients, IL-12 levels were higher in the SF than in sera (P < 0.001). Patients with detectable IL-12 (n = 51) in sera had higher tender joint scores (P = 0.003), swollen joint scores (P < 0.001) and C-reactive protein (CRP; P = 0.036), than those without (n = 55). Four months after treatment with DMARDs, the improved group showed a larger IL-12 decrease than the non-improved group (P = 0.017). The levels of IL-12 correlated positively with those of IL-2, interferon-gamma, IL-6, and tumour necrosis factor-alpha, but were correlated inversely with those of IL-10. Our results demonstrate that IL-12 levels reflect RA disease activity and that IL-12 is involved in the production of proinflammatory cytokines. An IL-12 blockade could be useful for the treatment of RA."
            },
            "assertions": [
                {
                    "subject": "a(MESH:\"Th2 Cells\")\t",
                    "relation": "increases",
                    "object": "p(HGNC:IL10)"
                },
                {
                    "subject": "a(MESH:\"Th2 Cells\")\t",
                    "relation": "increases",
                    "object": "p(HGNC:IL5)"
                },
                {
                    "subject": "a(MESH:\"Th2 Cells\")\t",
                    "relation": "increases",
                    "object": "p(HGNC:IL4)"
                },
                {
                    "subject": "a(MESH:\"Th1 Cells\")\t",
                    "relation": "increases",
                    "object": "p(HGNC:IFNG)"
                },
                {
                    "subject": "a(MESH:\"Th1 Cells\")",
                    "relation": "increases",
                    "object": "IL-2"
                }
            ],
            "evidence": "CD4 T lymphocytes could be functionally classified into T helper 1 (Th1), which secrete IL-2 and interferon-gamma (IFN-\u03b3), and T helper 2 (Th2), which secrete IL-4, IL-5 and IL-10 [6,7]. In experimental animal models of arthritis it is known that Th1 lymphocytes induce a pathogenic response, whereas Th2 lymphocytes induce a protective response",
            "metadata": {
                "project": "Inflammation Index",
                "gd:abstract": "The aim of this study was to investigate the role of IL-12 in patients with RA. IL-12 (p70) and its associated cytokines were measured in sera and synovial fluid (SF) using an enzyme-linked immunosorbent method. Seven American College of Rheumatology (ACR) core set measures as well as IL-12 levels were sequentially monitored at the commencement and 4 months after treatment with a low-dose steroid and disease-modifying anti-rheumatic drugs (DMARDs). In sera, 64 (42.2%) of 152 RA patients had detectable concentrations of IL-12 (p70), whereas one (1.4%) of 69 osteoarthritis (OA) patients and five (10%) of 50 healthy controls had detectable IL-12 (P < 0.001). The median level of circulating IL-12 was also higher in RA patients (P < 0.001). In SF, the number of patients with detectable IL-12 and the median IL-12 levels were significantly higher in RA patients (n = 53) than in OA patients (n = 22). In paired samples (n = 53) of sera and SF from RA patients, IL-12 levels were higher in the SF than in sera (P < 0.001). Patients with detectable IL-12 (n = 51) in sera had higher tender joint scores (P = 0.003), swollen joint scores (P < 0.001) and C-reactive protein (CRP; P = 0.036), than those without (n = 55). Four months after treatment with DMARDs, the improved group showed a larger IL-12 decrease than the non-improved group (P = 0.017). The levels of IL-12 correlated positively with those of IL-2, interferon-gamma, IL-6, and tumour necrosis factor-alpha, but were correlated inversely with those of IL-10. Our results demonstrate that IL-12 levels reflect RA disease activity and that IL-12 is involved in the production of proinflammatory cytokines. An IL-12 blockade could be useful for the treatment of RA.",
                "gd:creator": "mfriedrichsen@patientslikeme.com",
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "gd:published": true
            }
        }
    },
    {
        "isDeleted": false,
        "isPublished": true,
        "_key": "3fa0d2ab-0598-4b97-a479-ecdea9a62428",
        "_rev": "_WpvYGJG-_6",
        "nanopub": {
            "id": "3fa0d2ab-0598-4b97-a479-ecdea9a62428",
            "type": {
                "name": "BEL",
                "version": "2.0.0"
            },
            "annotations": [
                {
                    "id": "",
                    "label": "p=0.002",
                    "type": "p-value"
                },
                {
                    "id": "",
                    "label": "88 Korean SLE (82 w/o APS)",
                    "type": "Cohort"
                },
                {
                    "id": "TAX:9606",
                    "label": "human",
                    "type": "Species"
                },
                {
                    "id": "MESH:Plasma",
                    "label": "Plasma",
                    "type": "Anatomy"
                },
                {
                    "id": "DO:\"systemic lupus erythematosus\"",
                    "label": "systemic lupus erythematosus",
                    "type": "Disease"
                }
            ],
            "citation": {
                "database": {
                    "id": "20197721",
                    "name": "PubMed"
                },
                "abstract": "No Abstract Loaded."
            },
            "assertions": [
                {
                    "subject": "p(\"lupus anticoagulant\")\t",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Venous Thrombosis\")"
                },
                {
                    "subject": "p(\"lupus anticoagulant\")",
                    "relation": "positiveCorrelation",
                    "object": "path(MESH:\"Arterial Thrombosis\")"
                }
            ],
            "evidence": "Positivity for LAC was strongly associated with venous/arterial thrombosis (P=0.002)\n",
            "metadata": {
                "gd:createTS": "2018-04-13T00:14:05.902Z",
                "gd:creator": "amontagut@patientslikeme.com",
                "gd:published": true,
                "gd:updateTS": "2018-04-13T00:14:05.902Z",
                "project": "Lupus Biomeasures Curation"
            }
        }
    }
]
